data_2ka9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.84 144.15 21.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -179.39 159.01 0.89 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.845 0.355 . . . . 0.0 111.445 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -101.01 156.41 17.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.656 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -158.46 155.19 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -110.22 121.7 45.9 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.854 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 8.3 tp -116.16 93.3 4.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.429 0.633 . . . . 0.0 110.337 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.28 135.34 42.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.224 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.423 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 2.3 mtp180 -56.29 103.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.691 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.13 -28.81 13.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.469 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.07 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.45 . . . . 0.0 109.929 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -109.15 30.67 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.683 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.423 ' CA ' ' HG2' ' A' ' 10' ' ' ARG . . . 147.03 171.26 16.06 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -84.04 -49.36 8.99 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.905 0.384 . . . . 0.0 110.991 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.22 80.18 1.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.577 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.9 p90 -164.43 149.91 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.713 0.292 . . . . 0.0 110.483 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 36' ' ' ILE . 18.1 p -105.85 127.01 52.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 111.55 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 pt -119.51 166.0 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.857 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.78 153.6 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.71 -120.45 2.67 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.27 141.02 8.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.172 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 69' ' ' THR . 2.2 t -56.91 -18.81 14.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 12.4 t0 -91.57 -52.51 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -119.5 79.56 21.52 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.26 138.31 23.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 0.0 112.414 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -69.28 -18.63 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.48 -36.98 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 110.985 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.37 24.79 6.05 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.01 40.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -162.15 98.82 1.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 17.7 Cg_endo -57.62 -27.0 75.23 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.09 . . . . 0.0 112.194 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -74.04 141.2 45.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.03 152.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.1 p90 -142.26 166.48 24.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.617 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 53.1 mt -92.19 153.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.474 ' N ' HG21 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -106.15 -39.77 5.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.628 0.251 . . . . 0.0 111.664 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.28 156.42 14.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.107 0.479 . . . . 0.0 111.644 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.413 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -118.42 141.33 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.5 mt -88.14 126.78 59.7 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 16.9 Cg_exo -66.76 63.13 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.141 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.5 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.84 -177.82 0.93 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.466 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.82 -18.72 60.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.04 -57.38 13.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.13 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.14 69.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.32 -41.56 66.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -76.02 -32.23 59.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.7 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.64 44.61 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 113.901 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HD3' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -93.1 21.71 5.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.695 0.247 . . . . 0.0 111.581 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -176.36 170.11 2.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.999 0.428 . . . . 0.0 111.325 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.61 163.44 12.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.499 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.617 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -71.06 -46.54 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 112.04 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -69.53 11.41 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -76.92 176.92 8.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -127.87 102.66 6.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 2.4 pt -57.43 94.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 111.157 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.48 -28.54 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.501 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -163.25 150.57 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 131.68 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 45.3 38.82 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.192 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 61.6 33.92 18.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 141.68 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.173 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.93 100.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 37.9 t -133.1 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.106 0.479 . . . . 0.0 110.911 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -105.06 -14.51 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.93 47.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.813 0.339 . . . . 0.0 111.131 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.62 149.64 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.21 0.528 . . . . 0.0 111.102 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.2 OUTLIER -49.74 154.77 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.937 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -51.81 -48.36 63.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.258 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.63 -36.41 24.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.03 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.56 63.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -40.7 68.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.696 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.42 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -65.7 -35.54 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.633 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 3.1 mt-10 -69.59 -32.48 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.875 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.31 76.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.447 0.641 . . . . 0.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.84 -26.5 57.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.47 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -68.82 -35.89 77.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.218 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.64 28.87 8.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.79 -29.25 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.355 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.49 -101.08 2.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.607 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 69.1 m -152.65 -52.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.798 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -98.33 84.93 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.63 113.73 23.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.676 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -92.78 78.83 4.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.075 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -99.08 154.03 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.402 -178.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 1.9 t80 -109.51 115.0 29.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.151 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 31.6 m -108.46 168.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 112.397 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.25 109.42 7.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.634 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.754 0.312 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.22 115.71 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.269 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.45 166.6 12.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.605 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.96 106.58 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.882 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.19 155.36 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.475 ' CG ' ' CD2' ' A' ' 180' ' ' TYR . 2.7 mtmp? -108.02 123.92 49.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.428 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.449 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 2.5 tt -129.91 118.62 21.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.4 pt -93.96 144.61 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -70.64 152.79 43.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.095 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.62 160.72 23.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.756 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.97 -37.5 86.07 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.094 1.863 . . . . 0.0 112.033 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 20.96 9.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.048 0.451 . . . . 0.0 110.053 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.47 -155.46 17.92 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.283 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.48 -13.36 46.3 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.075 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.66 63.11 2.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.862 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' CD2' HG23 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.84 150.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.355 . . . . 0.0 110.999 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.72 116.88 32.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 HG23 ' CD2' ' A' ' 112' ' ' PHE . 8.9 pt -136.52 153.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.55 125.0 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.581 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.84 -175.13 25.58 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.205 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.9 178.36 51.07 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.442 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.08 150.27 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.819 0.342 . . . . 0.0 111.039 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.37 -29.46 6.12 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.858 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.71 69.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.48 -4.63 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.688 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.546 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 62.6 t60 72.48 -58.1 0.6 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.547 0.689 . . . . 0.0 110.578 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.472 HD11 ' CG ' ' A' ' 130' ' ' TYR . 2.0 mt -88.46 137.56 30.55 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.428 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 123' ' ' ILE . 49.6 Cg_endo -68.71 62.21 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.236 1.957 . . . . 0.0 112.339 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.1 57.29 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.723 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.44 99.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.873 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -60.44 -19.72 57.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.324 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -57.31 151.3 16.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.581 HG12 ' HA3' ' A' ' 116' ' ' GLY . 2.8 mt -91.03 115.35 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.472 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.2 m-85 -109.33 153.9 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.62 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.72 155.72 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.03 -27.62 1.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 147.96 27.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.982 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 146' ' ' LEU . 42.0 mt -137.21 141.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.51 173.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -93.55 133.15 37.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.82 26.47 73.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.35 176.77 54.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.63 -53.81 16.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -70.25 -34.63 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -51.91 -58.65 5.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.465 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -72.94 -48.69 34.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.467 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.59 -59.6 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -59.68 -44.28 97.04 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.413 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 63.23 17.8 10.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.602 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 150' ' ' ASP . 0.1 OUTLIER -81.52 83.66 6.94 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -65.55 152.58 43.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.656 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 148' ' ' ILE . 34.4 mt -46.57 106.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.438 0.637 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 146.41 -14.29 1.62 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.544 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 p-10 -80.45 162.29 24.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.875 0.369 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -142.59 128.31 19.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.549 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 183' ' ' VAL . 0.3 OUTLIER -102.19 133.12 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.114 0.483 . . . . 0.0 110.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.2 pp -100.68 -4.13 28.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 170.35 141.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.468 ' HB ' HG21 ' A' ' 158' ' ' VAL . 76.6 t -96.74 99.79 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.798 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 69.27 -58.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.084 0.468 . . . . 0.0 109.846 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.1 25.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.799 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.468 HG21 ' HB ' ' A' ' 155' ' ' VAL . 24.3 t -92.3 155.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 121.351 0.596 . . . . 0.0 111.367 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -101.93 73.25 0.34 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.759 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 129' ' ' ILE . 22.1 mt -69.95 20.47 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -163.56 56.49 0.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.268 0.556 . . . . 0.0 110.812 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.58 28.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.555 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.9 OUTLIER -151.86 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.9 mtp 173.78 164.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.426 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.41 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 19.7 p-80 -53.77 -30.02 42.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.492 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.73 50.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.305 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.443 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.36 -35.51 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 0.0 110.743 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.39 73.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.942 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 11.9 t -70.23 -43.5 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.15 -30.35 66.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.9 -25.55 53.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.18 -39.91 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.202 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -75.52 -26.55 58.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.02 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.04 -10.54 59.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 81.6 p -54.1 -175.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.831 0.348 . . . . 0.0 111.479 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -102.36 168.97 8.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.379 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 t0 -52.03 -23.05 4.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.586 ' CG1' ' O ' ' A' ' 178' ' ' VAL . 4.0 p -145.18 92.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.383 0.611 . . . . 0.0 110.389 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.51 148.43 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.23 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.475 ' CD2' ' CG ' ' A' ' 102' ' ' LYS . 5.6 m-85 -97.9 120.51 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.752 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -98.08 144.11 27.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.24 109.31 21.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.47 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 20.8 t -101.39 161.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.423 ' CB ' ' HD2' ' A' ' 151' ' ' LYS . . . -141.89 142.74 33.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.802 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.631 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.62 82.41 4.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.142 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -116.5 153.2 32.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 151.22 23.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -142.74 108.91 5.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.853 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.68 -168.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 111.652 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 135.95 26.99 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.466 HD22 ' HD3' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -113.02 88.84 2.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.475 0.655 . . . . 0.0 110.892 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.4 tt0 -84.73 123.88 30.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.199 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -38.94 96.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.39 -24.04 28.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.576 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -176.47 -84.76 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 p -109.28 30.75 6.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.8 179.99 23.32 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.815 -1.184 . . . . 0.0 112.819 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.34 -50.32 7.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.39 -0.405 . . . . 0.0 111.415 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.8 64.25 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.924 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 9.2 p90 -164.94 169.03 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.72 130.04 44.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.357 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -120.21 162.4 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.94 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.294 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.49 -121.61 2.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.27 136.95 5.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' CG2' ' A' ' 69' ' ' THR . 1.2 t -55.77 -19.65 12.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 2.6 m-20 -93.2 -52.15 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.188 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -117.86 78.37 12.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.29 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.25 142.62 5.92 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.725 2.283 . . . . 0.0 112.623 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -74.34 -18.34 60.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.76 -29.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.63 28.16 8.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.526 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.84 37.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -167.46 95.34 0.65 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.76 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 10.6 Cg_endo -53.98 -28.63 50.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -65.06 169.86 4.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.432 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.93 151.99 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.366 . . . . 0.0 111.123 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.504 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 5.5 p90 -142.56 144.29 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.462 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 69.0 mt -70.94 151.78 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 36' ' ' ILE . 28.3 p -99.85 -43.86 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 149.14 6.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.47 . . . . 0.0 111.798 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.448 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -106.19 141.61 21.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.032 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 40' ' ' ILE . 2.5 mt -84.49 119.94 73.62 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.06 84.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.359 2.039 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.04 -39.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.62 175.95 2.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.36 57.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -51.02 -57.69 7.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.955 0.407 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.35 69.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -72.09 -34.64 68.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.791 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -89.57 -21.31 22.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.423 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 79.36 0.72 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.276 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.42 32.0 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 0.0 110.095 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 2.1 pp 38.48 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.185 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.4 141.43 51.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.035 0.445 . . . . 0.0 111.366 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -69.57 -40.78 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.154 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -52.73 -16.84 1.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.78 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 20.4 p-10 -59.18 171.69 0.7 Allowed 'General case' 0 C--O 1.23 0.032 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 t -130.17 122.57 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 57' ' ' ILE . 15.2 pt -63.16 94.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.544 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.37 -24.31 67.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 1.3 t80 -164.19 140.35 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.894 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.495 ' O ' ' C ' ' A' ' 61' ' ' ASN . 1.4 p -101.97 -176.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.495 ' C ' ' O ' ' A' ' 60' ' ' VAL . 18.1 m-20 -22.38 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.539 0.524 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -162.79 25.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' HG11 ' A' ' 60' ' ' VAL . 2.6 t -121.71 142.12 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.626 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 7.5 t0 -80.36 84.19 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.114 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.83 30.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptt85 -89.42 7.63 34.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 179.25 49.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.048 0.451 . . . . 0.0 109.959 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.73 139.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.257 0.551 . . . . 0.0 112.39 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.449 ' CG2' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -50.06 166.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.547 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.3 t-160 -57.06 -48.71 77.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.037 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -41.91 70.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.04 74.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.456 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.76 68.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.413 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 53.1 t -64.52 -36.13 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.576 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.56 -33.11 72.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.694 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -42.91 74.43 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.37 0.605 . . . . 0.0 110.404 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.99 -26.88 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.31 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -44.2 62.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.005 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.13 28.43 5.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.281 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.87 -27.7 36.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.6 -123.04 6.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.371 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 83' ' ' ILE . 13.4 m -135.21 8.15 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -156.93 94.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.96 119.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.21 102.32 14.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.469 ' HG ' HG21 ' A' ' 60' ' ' VAL . 4.9 mp -103.75 139.78 38.52 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 5' ' ' GLU . 3.7 m-85 -107.8 114.74 28.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -115.92 168.45 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.308 0.575 . . . . 0.0 112.496 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 mtp -143.29 109.04 5.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.241 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.808 0.337 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.94 112.86 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -87.8 166.43 14.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.355 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.81 106.4 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.0 mm -116.46 155.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -106.23 123.62 48.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.299 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 2.2 tt -122.85 118.53 28.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.571 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -100.06 144.71 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.029 0.443 . . . . 0.0 111.233 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -72.01 162.55 29.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -139.22 161.89 26.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.74 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.49 -39.32 91.69 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 122.062 1.841 . . . . 0.0 111.94 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -95.4 21.93 7.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.052 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 105.84 -155.44 16.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.466 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.24 -13.38 46.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.868 0.334 . . . . 0.0 111.227 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.26 51.83 7.19 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.56 154.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -116.08 119.25 35.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.375 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.488 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 15.5 pt -125.26 156.38 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 122' ' ' HIS . . . -154.91 125.42 6.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.95 165.9 31.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.685 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.06 -131.73 14.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.199 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.46 154.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.05 -37.85 3.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.403 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 163.8 82.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 111.43 23.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.161 0.505 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.464 ' CE1' ' CB ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -57.31 -16.56 8.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.206 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.3 OUTLIER -87.94 104.78 7.4 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.457 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 123' ' ' ILE . 13.6 Cg_endo -57.08 94.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.534 2.156 . . . . 0.0 112.571 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.68 44.5 8.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.886 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -142.21 85.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.022 0.439 . . . . 0.0 110.85 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -47.82 -26.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -55.89 162.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.4 mt -96.24 125.31 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.151 0.501 . . . . 0.0 111.387 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.524 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.1 m-85 -116.21 161.33 19.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.229 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.96 144.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 1.5 t -115.04 -49.21 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.99 144.17 30.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.877 0.37 . . . . 0.0 111.634 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 31.4 mt -136.89 139.85 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 135' ' ' ILE . 1.2 mt -82.99 173.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -91.88 147.31 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.21 27.69 57.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.503 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.01 53.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.31 -59.86 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 111.405 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.439 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -69.96 -33.33 71.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.45 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -57.54 -60.2 4.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 0.0 110.24 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -41.7 64.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -80.6 -59.46 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -70.31 -30.81 69.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.215 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.73 21.0 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.726 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.406 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -93.37 82.33 4.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.71 172.99 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.8 mt -47.54 122.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.305 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.7 -22.6 6.11 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.365 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -64.47 134.55 54.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.333 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -119.42 124.72 47.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -104.25 129.45 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 110.717 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 -0.28 43.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.161 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . -179.57 169.14 1.39 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.408 ' CG1' ' ND2' ' A' ' 156' ' ' ASN . 57.8 t -126.76 100.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.465 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.502 HD22 ' HB ' ' A' ' 179' ' ' VAL . 25.5 m-80 69.97 -57.7 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.195 0.522 . . . . 0.0 109.977 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.16 27.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.613 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 2.0 t -116.6 154.26 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-O 120.986 0.422 . . . . 0.0 111.332 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -113.0 77.86 0.24 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -78.21 24.76 0.24 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 159' ' ' GLY . 2.3 pt-20 -127.68 41.35 3.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.382 0.611 . . . . 0.0 110.963 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.19 28.0 0.35 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.039 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -134.75 -78.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.2 mtm 173.57 166.87 0.17 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -53.88 -29.78 43.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.963 0.411 . . . . 0.0 110.602 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.42 -48.18 35.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -68.49 -37.85 80.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 160' ' ' LEU . . . -70.27 -38.66 75.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.4 ' O ' ' HG3' ' A' ' 173' ' ' LYS . 4.5 t -67.25 -46.02 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.369 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.62 67.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.532 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.57 50.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 175' ' ' THR . 0.5 OUTLIER -79.46 -39.97 30.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.177 0.513 . . . . 0.0 109.828 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 169' ' ' VAL . 4.3 mtmt -75.88 -26.58 57.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.07 -33.64 74.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.047 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -52.72 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.398 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -95.27 169.23 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.488 . . . . 0.0 111.341 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -56.78 -16.75 7.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.615 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.96 90.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.585 0.231 . . . . 0.0 110.934 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.502 ' HB ' HD22 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -124.63 148.28 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.129 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 1.4 p90 -95.02 130.42 41.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.627 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -108.18 155.91 19.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.751 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 114.8 26.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.26 161.65 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -119.74 135.78 54.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 0.0 111.349 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -85.76 85.78 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.097 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.945 0.402 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD2' ' CG ' ' A' ' 89' ' ' MET . 1.0 OUTLIER -129.43 171.87 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.587 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -167.5 136.82 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.6 109.33 10.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.378 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -127.7 -170.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.129 0.49 . . . . 0.0 111.98 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 128.14 49.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.416 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 10.1 tp -125.32 91.71 3.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.629 0.728 . . . . 0.0 110.087 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 mt-10 -70.1 165.41 22.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.949 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -83.21 99.18 9.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.98 -26.55 8.77 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.562 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -168.87 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.176 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 t -109.18 30.64 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.65 177.03 20.06 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.358 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -84.54 -43.17 14.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.758 0.313 . . . . 0.0 111.069 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.84 76.61 1.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.784 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.7 p90 -164.72 148.46 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.041 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -95.97 126.99 41.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.41 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 36.0 pt -115.41 154.73 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.129 0.49 . . . . 0.0 112.019 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 27' ' ' HIS . . . -173.12 118.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . 152.65 29.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.061 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.41 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -58.22 167.13 6.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.41 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 1.2 t -73.03 -31.45 64.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 8.3 t70 -83.84 -51.57 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 111.595 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -119.76 78.4 22.51 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.501 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.87 156.34 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.515 2.143 . . . . 0.0 112.203 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 15.6 t60 -100.81 -19.45 15.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.6 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -108.48 -26.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.666 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.25 32.18 8.5 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.147 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 177.7 39.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -166.56 107.87 0.68 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.897 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 14.2 Cg_exo -69.04 -24.74 32.65 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.684 2.256 . . . . 0.0 112.098 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -74.57 126.29 30.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HA ' ' C ' ' A' ' 21' ' ' GLY . 0.7 OUTLIER -70.25 148.24 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.201 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -139.83 171.41 14.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.388 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 41.3 mt -99.42 150.57 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.446 ' N ' HG21 ' A' ' 36' ' ' ILE . 22.4 m -108.5 -30.32 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -175.6 148.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 111.455 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.401 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -108.81 141.22 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.983 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 pt -89.69 146.58 35.83 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 58.45 6.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.6 2.2 . . . . 0.0 112.404 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.61 -57.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.02 176.61 1.8 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.54 -24.81 59.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.631 0.253 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.43 10.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.916 0.389 . . . . 0.0 111.292 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.988 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.91 -39.33 69.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 0.0 109.505 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 2.5 m-20 -80.19 -28.39 38.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.31 49.42 0.05 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.278 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -103.56 21.71 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.584 0.23 . . . . 0.0 111.491 -179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.39 163.19 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 158.32 15.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.245 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.701 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 34.2 m -71.16 -44.13 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -58.74 1.25 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' VAL . 55.1 p30 -89.87 163.43 15.01 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.088 -0.383 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -119.26 123.87 45.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.328 . . . . 0.0 111.075 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 pt -61.88 94.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' H ' ' HA ' ' A' ' 88' ' ' VAL . 3.6 pp -76.01 -20.57 57.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -158.0 119.58 3.59 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.077 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 HG23 ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -118.33 119.51 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 84' ' ' VAL . 50.7 m-20 52.22 42.5 30.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.185 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.66 30.89 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.09 141.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.31 113.92 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' A' ' 60' ' ' VAL . 14.6 p -146.59 26.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -87.45 6.51 33.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 177.67 50.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.937 0.398 . . . . 0.0 110.088 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.04 144.61 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.623 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.433 ' N ' ' CG2' ' A' ' 23' ' ' THR . 3.9 m -49.93 162.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.766 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.4 t-160 -55.66 -48.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.457 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -50.01 -40.77 45.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.247 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.08 76.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.79 -41.3 68.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.459 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 46.3 t -64.82 -36.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.628 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 6.2 mt-10 -69.3 -30.82 68.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.737 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -36.95 74.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.451 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 pp -82.18 -26.19 33.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -75.99 -32.66 59.56 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.865 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 29.78 7.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.56 -20.53 18.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.19 -131.25 10.28 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.616 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -124.84 16.61 8.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 111.321 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -153.63 94.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG11 ' ND2' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -102.14 136.56 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.08 90.28 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.9 mt -85.12 114.97 22.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.536 0.684 . . . . 0.0 112.764 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -110.02 114.29 27.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 58' ' ' LEU . 34.9 m -123.04 168.37 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -123.26 109.01 13.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.278 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.28 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.34 120.25 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.82 166.13 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -129.94 106.36 8.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.438 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.29 155.61 20.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.468 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -115.1 137.07 52.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.539 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.428 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 3.1 tt -135.28 118.44 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.2 pt -100.72 144.66 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.011 0.434 . . . . 0.0 111.219 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -76.7 158.47 30.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.52 -164.88 10.06 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.994 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.76 -33.06 4.12 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.258 1.972 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 19.3 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.037 0.446 . . . . 0.0 110.53 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.64 -144.38 15.8 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 112' ' ' PHE . 2.9 mp -86.43 -21.44 27.09 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.108 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.73 46.08 5.83 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.974 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.54 157.64 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 0.0 110.748 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 133' ' ' LYS . 43.9 t -125.15 116.76 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.724 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 8.1 pt -123.05 151.59 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.425 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . . . -149.87 125.52 10.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.099 0.476 . . . . 0.0 111.696 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.79 -175.29 24.92 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.043 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.22 -144.33 34.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.871 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.67 154.62 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.854 0.359 . . . . 0.0 111.696 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.11 -32.24 7.41 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.236 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 176.54 79.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 0.0 110.163 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -111.07 112.44 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.269 -179.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -57.21 -20.14 25.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.222 0.534 . . . . 0.0 110.892 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.468 HD12 ' CZ ' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -103.09 145.46 30.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.735 -178.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 5.6 Cg_exo -77.52 37.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.998 2.465 . . . . 0.0 112.689 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -122.65 -27.88 1.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.153 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.447 ' CB ' ' HG2' ' A' ' 121' ' ' GLN . 3.2 p30 46.79 28.43 0.82 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.907 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -135.58 -48.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.213 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.4 m -88.66 126.85 35.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.445 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.428 HG13 ' CB ' ' A' ' 161' ' ' GLU . 18.6 mt -83.22 128.75 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.263 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.468 ' CZ ' HD12 ' A' ' 123' ' ' ILE . 17.5 m-85 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.712 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.13 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.05 -45.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -149.43 128.64 12.83 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.916 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.9 mt -120.09 141.7 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mm -77.18 174.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.624 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -92.19 133.86 35.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.96 25.22 45.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.497 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.84 -171.07 18.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.04 -53.65 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.428 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -69.99 -31.91 69.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -56.84 -60.92 2.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.211 0.529 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -42.42 63.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.117 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -80.85 -59.47 2.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 112.043 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -65.2 -42.13 96.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.053 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.49 21.22 11.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.96 85.03 3.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 169.07 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.598 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.6 mt -47.2 120.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.303 0.573 . . . . 0.0 111.429 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.46 -22.56 5.25 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.335 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -64.06 125.31 24.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.677 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.46 ' HB3' ' CE2' ' A' ' 130' ' ' TYR . 4.1 pttt -109.86 122.53 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.424 ' CD1' ' HB ' ' A' ' 129' ' ' ILE . 0.3 OUTLIER -103.9 130.0 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.57 -0.53 34.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.461 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . -179.9 164.85 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.347 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 57.4 t -115.97 101.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 63.6 m-80 70.56 -58.89 0.54 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 109.778 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.55 21.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -115.33 144.43 22.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.962 0.411 . . . . 0.0 110.983 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.97 71.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.97 30.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 0.0 111.746 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.428 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.85 67.31 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 0.0 110.777 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -176.98 29.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.234 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 2.4 t -123.8 -75.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 7.1 mtm -172.13 -171.38 0.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.921 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.432 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 11.0 p80 -73.23 -30.31 63.39 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.078 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 165' ' ' HIS . 16.4 mt-10 -73.74 -46.94 42.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -66.07 -42.55 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.25 73.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 16.9 t -74.02 -40.34 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.53 69.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.84 -29.95 58.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.316 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 3.6 pp -82.09 -37.33 26.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.407 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -75.03 -26.5 59.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.903 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.04 -11.5 60.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.35 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 38.2 p -58.61 -167.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 111.364 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -112.8 172.15 7.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 1.1 m-20 -56.42 -15.13 3.64 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.0 t -147.7 92.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.31 148.19 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.973 0.416 . . . . 0.0 111.962 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 5.5 m-85 -97.24 136.01 38.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.671 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 148.73 36.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 0.0 110.258 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 152' ' ' ILE . 13.8 mttp -96.84 114.55 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -102.03 160.16 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.47 145.88 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.378 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' SER . . . . . 0.42 ' HB3' HD22 ' A' ' 172' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.798 0.332 . . . . 0.0 111.103 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.68 87.67 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.678 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.309 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.862 0.363 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 161.52 41.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.727 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -179.33 150.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.233 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 7.1 tt0 -109.2 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.512 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.25 -174.1 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.082 0.467 . . . . 0.0 111.645 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 126.0 45.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.458 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.524 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 14.0 tp -123.62 94.49 4.26 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.703 0.764 . . . . 0.0 110.216 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.3 mp0 -68.59 161.85 27.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.687 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 12' ' ' ASN . 15.8 mtt180 -80.63 108.05 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.48 68.4 0.16 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.165 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER 78.81 -78.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.436 0.294 . . . . 0.0 110.549 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -109.53 30.71 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.79 178.01 15.31 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.552 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.524 ' CD2' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.41 -48.57 9.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.846 0.355 . . . . 0.0 110.979 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 76.54 1.3 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.602 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.6 p90 -160.68 152.14 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.558 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.443 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 25.4 m -95.21 126.45 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.4 pt -132.74 160.89 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.33 173.74 4.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.61 -128.11 9.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.453 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.83 150.16 10.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.4 t -55.77 -22.41 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.292 . . . . 0.0 111.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.61 -44.57 8.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.946 0.403 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -123.89 77.61 57.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.16 128.31 22.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.587 2.192 . . . . 0.0 112.427 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -66.7 -20.17 65.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.21 -28.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.233 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.82 27.68 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.43 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -170.6 112.85 0.44 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.42 -27.42 47.09 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.721 2.281 . . . . 0.0 112.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.7 t -67.56 141.75 56.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.8 151.47 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.793 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -142.61 160.94 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 110.983 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 34.6 mt -92.6 147.88 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.2 p -98.81 -41.83 7.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.63 0.253 . . . . 0.0 111.471 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -167.8 152.54 6.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.367 . . . . 0.0 111.262 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -104.35 141.01 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.033 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.11 120.99 72.85 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.199 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 83.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.113 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.02 -54.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.0 170.47 4.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.546 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.93 -17.76 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.621 0.248 . . . . 0.0 111.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.13 -57.44 11.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.762 0.315 . . . . 0.0 111.154 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.95 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -72.35 -38.1 68.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.512 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 5.0 m-20 -79.18 -30.54 43.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.741 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.62 48.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.524 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.512 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 18.89 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.019 0.409 . . . . 0.0 111.296 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 2.1 pt? -176.11 167.51 2.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.96 0.41 . . . . 0.0 111.679 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 153.57 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.064 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.626 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 27.6 m -70.99 -46.49 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -72.8 15.52 0.19 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -80.56 -167.65 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 104.78 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.9 pt -59.56 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.063 0.459 . . . . 0.0 111.201 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -61.74 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.174 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 64' ' ' ASP . 69.6 m-85 -160.97 160.82 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.54 134.06 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.691 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.6 36.27 5.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.52 29.27 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.9 t -120.76 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 12.8 p-10 -73.74 91.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 60' ' ' VAL . 17.4 t -114.4 34.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -99.75 11.33 39.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.34 40.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.39 148.61 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.163 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.4 m -49.91 156.86 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.336 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.464 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.7 t-160 -54.6 -48.61 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.603 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -57.61 -34.39 69.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.161 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.49 82.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.01 -42.53 66.3 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.289 0.566 . . . . 0.0 109.81 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.464 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 68.3 t -65.32 -36.1 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.781 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 2.9 mt-10 -69.33 -32.33 71.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.766 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.76 74.78 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.45 0.643 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.04 -27.01 48.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.59 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 1.7 tttt -72.94 -37.76 67.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.312 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -103.24 26.39 8.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.634 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.66 -13.47 16.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.514 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -157.13 23.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.592 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.534 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -100.18 21.05 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 111.297 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mt -155.28 95.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.78 140.16 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 112.367 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.8 mtm180 -96.9 95.32 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.759 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mp -93.78 123.84 37.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -104.0 114.46 28.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.01 168.58 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -142.39 108.97 5.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.464 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.687 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttt . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 153.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.51 166.59 23.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 111.322 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.67 106.28 6.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 mm -113.17 155.26 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -122.91 124.81 44.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.42 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.7 tt -126.38 118.91 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -95.4 144.72 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -62.28 160.81 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -141.11 -159.23 7.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.886 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.35 -41.32 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.235 1.957 . . . . 0.0 112.649 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -91.73 21.73 4.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.23 -133.36 11.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.61 -27.09 24.08 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.825 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.92 45.01 4.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.793 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.59 146.6 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -106.68 117.03 32.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.495 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 12.9 pt -129.54 164.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -162.29 124.93 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 111.812 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -154.65 173.42 33.08 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.106 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.81 170.67 13.38 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.473 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.06 154.84 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.26 79.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.03 78.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.043 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -93.4 123.07 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.993 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -48.11 -29.1 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.589 0.709 . . . . 0.0 110.694 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -97.28 146.51 31.47 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.699 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.93 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.564 2.176 . . . . 0.0 112.805 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.84 61.32 1.0 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.353 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.2 m-20 -172.67 90.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 110.825 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.404 ' N ' ' HG2' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -55.82 -22.82 26.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.376 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HA ' ' CG ' ' A' ' 161' ' ' GLU . 38.9 m -47.47 123.12 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.549 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 35.9 mt -59.58 123.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.253 0.549 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.488 ' CE1' ' CB ' ' A' ' 151' ' ' LYS . 3.2 m-85 -121.23 173.53 7.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.784 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -111.16 141.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.166 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.409 HG21 ' CE1' ' A' ' 122' ' ' HIS . 3.3 p -102.74 -60.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 146.89 26.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.513 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.418 HG22 ' CD2' ' A' ' 141' ' ' HIS . 2.6 mt -117.14 141.64 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.429 ' O ' ' CE1' ' A' ' 141' ' ' HIS . 2.4 mm -82.8 173.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.546 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -112.58 36.25 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.99 -29.13 52.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.542 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.89 51.88 0.59 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.59 -84.51 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.17 -31.79 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.233 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.7 m170 -53.47 -56.98 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -50.27 25.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.343 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.33 -59.3 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 0.0 111.696 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -55.37 -56.27 24.28 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.02 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.88 21.78 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -103.77 83.03 2.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.909 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -59.97 166.55 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.587 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 148' ' ' ILE . 31.1 mt -47.86 121.24 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.283 0.563 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 123.02 -19.4 7.79 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.495 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -64.49 126.16 26.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.515 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.488 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.17 124.02 49.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.091 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 182' ' ' LYS . 1.6 mt -98.26 132.51 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.676 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -91.05 -2.04 57.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 153' ' ' LEU . . . 154.58 153.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.217 0.323 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.52 99.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.412 ' OD1' ' CZ ' ' A' ' 180' ' ' TYR . 23.0 m-80 68.32 -59.46 0.44 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.4 p -171.47 31.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.292 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.406 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.6 t -134.87 148.18 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.351 0.595 . . . . 0.0 112.205 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 161' ' ' GLU . . . 91.97 -76.58 1.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 32.12 34.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.258 -0.971 . . . . 0.0 112.284 178.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 159' ' ' GLY . 2.2 pm0 34.37 36.88 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.011 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -116.14 36.24 4.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -149.71 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.943 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.01 166.41 0.93 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 1.9 p80 -53.98 -37.22 63.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.938 0.399 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.07 -40.42 62.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.469 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -76.02 -37.49 58.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.861 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.71 -34.99 72.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.023 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 25.4 t -74.21 -43.1 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.81 69.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.145 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.406 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.11 -26.69 56.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.436 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 3.9 pp -81.41 -36.62 29.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.423 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 11.8 tttp -72.23 -26.9 62.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.306 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -70.5 -9.46 56.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.463 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 16.9 p -49.2 -178.58 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.053 0.454 . . . . 0.0 112.051 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -107.56 171.4 7.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.295 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 6.4 m-20 -53.41 -18.23 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.546 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.1 t -147.38 91.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.494 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.75 147.54 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.026 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 15.7 p90 -111.46 125.99 54.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.224 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.2 158.47 19.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 111.307 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.406 ' O ' HG21 ' A' ' 152' ' ' ILE . 2.0 mptt -100.85 119.76 39.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.353 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 20.8 t -101.74 160.87 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.997 0.427 . . . . 0.0 111.419 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.91 133.21 50.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.56 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -80.61 94.31 6.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.013 -179.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.833 0.349 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.23 153.27 35.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.537 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -170.81 159.46 6.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -110.26 137.34 48.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.632 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 7' ' ' THR . 25.3 mt -149.12 164.15 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.127 0.489 . . . . 0.0 111.418 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -123.11 136.73 54.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.074 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 1.5 tp -127.19 89.19 2.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.628 0.728 . . . . 0.0 110.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 tt0 -74.72 134.79 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.244 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -57.5 104.61 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.2 -27.52 5.45 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.636 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -174.8 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -109.29 30.54 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.856 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.22 178.1 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.485 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.27 -50.68 7.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.35 70.4 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.639 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.8 p90 -164.68 157.71 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.56 129.38 56.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.13 160.81 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.353 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.54 12.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.05 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.01 -128.68 9.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.12 147.76 10.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.592 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.4 t -52.2 -25.15 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.685 0.279 . . . . 0.0 111.468 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.77 -45.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.531 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -123.87 78.31 57.55 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.573 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.84 134.5 28.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.547 2.164 . . . . 0.0 112.277 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 38.6 t60 -71.32 -25.71 62.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.193 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.99 -28.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 26.78 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.531 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.7 31.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 110.802 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 5.0 t0 -165.4 95.84 0.84 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 11.4 Cg_endo -54.85 -22.9 31.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.414 2.076 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.72 164.62 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -106.88 146.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.43 150.13 40.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.456 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 65.6 mt -72.64 151.89 7.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.495 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.456 ' N ' HG21 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -103.23 -35.45 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -169.59 152.24 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.423 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.7 mt -118.23 141.27 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.14 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 pt -85.84 141.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.062 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.27 74.13 3.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.458 2.105 . . . . 0.0 112.391 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.04 -40.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.11 176.29 1.96 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.615 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.36 57.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.557 0.217 . . . . 0.0 111.434 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -47.69 -57.37 5.6 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.43 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.44 69.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.02 -37.08 69.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.312 0.577 . . . . 0.0 109.644 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.45 -25.7 33.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.023 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 80.67 51.54 4.81 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.307 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NE ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.84 44.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER 33.77 -153.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 150.1 46.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.058 0.456 . . . . 0.0 111.37 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.456 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 33.4 m -71.04 -39.67 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.492 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -51.69 -14.97 0.39 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.369 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HB3' HD13 ' A' ' 51' ' ' LEU . 32.9 p-10 -61.85 156.73 19.95 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.8 m -122.68 124.36 43.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.32 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 3.7 pt -62.92 94.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -23.42 65.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -158.79 127.09 5.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -123.72 133.12 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.372 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 45.78 33.52 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 13.8 tt0 67.56 32.46 5.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 18.1 t -120.92 141.78 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.19 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 98.94 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.793 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.24 38.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -103.48 12.55 35.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.58 38.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -115.86 145.83 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.334 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.457 ' N ' ' CG2' ' A' ' 23' ' ' THR . 2.5 m -49.94 161.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.757 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 t-160 -55.03 -48.53 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -49.79 -42.34 46.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.862 0.363 . . . . 0.0 111.391 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.18 75.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.031 0.443 . . . . 0.0 110.742 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.53 69.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.614 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.453 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 41.1 t -64.48 -35.34 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.736 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.44 -34.16 74.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.43 -43.42 73.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.328 0.585 . . . . 0.0 110.482 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.25 -26.69 56.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.454 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -70.98 -42.86 69.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.231 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.26 31.4 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.11 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.05 -27.0 26.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.555 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.68 -121.46 6.38 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.579 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 83' ' ' ILE . 88.7 p -137.97 9.8 2.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 82' ' ' SER . 1.6 mt -152.09 94.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -94.84 117.27 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -102.75 91.07 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 pp -121.64 154.04 37.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 m-85 -105.04 119.37 38.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.267 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 26.8 m -104.11 167.81 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.249 0.547 . . . . 0.0 112.298 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.88 109.59 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HB3' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.85 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.805 0.336 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.2 t -132.17 113.12 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 183' ' ' VAL . 2.0 ttm -86.89 166.28 15.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.38 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -133.99 106.75 7.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.149 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.412 ' O ' ' CD1' ' A' ' 180' ' ' TYR . 2.8 mm -114.02 155.53 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -134.86 122.86 22.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.75 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.25 118.35 27.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.579 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -93.75 144.5 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.547 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 177' ' ' ASP . 2.0 tptm -57.71 141.77 47.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.49 -164.4 11.92 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.949 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -43.43 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.122 1.881 . . . . 0.0 112.228 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -92.52 20.46 6.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.071 0.462 . . . . 0.0 110.115 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.29 -142.37 15.48 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.7 -21.7 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.961 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.5 47.72 6.25 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.41 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.34 152.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.2 m -116.31 124.83 51.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 112' ' ' PHE . 20.0 pt -141.63 157.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.726 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.82 125.5 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.581 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.26 -175.08 25.06 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.436 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.02 -179.38 45.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.298 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.04 150.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.742 0.306 . . . . 0.0 111.208 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.74 -19.16 42.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.338 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 10.7 t-20 -179.53 70.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.034 0.445 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.3 mt-30 -71.55 -7.49 47.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.481 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.544 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 61.4 t60 71.82 -57.09 0.62 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.521 0.676 . . . . 0.0 110.975 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -86.56 134.62 37.49 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.7 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.68 77.18 2.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.448 2.098 . . . . 0.0 112.606 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.01 46.55 0.55 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.92 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -172.95 96.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.26 -21.4 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 p -55.26 129.73 39.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.322 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.581 HG12 ' HA3' ' A' ' 116' ' ' GLY . 39.2 mt -66.19 130.84 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 111.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.504 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 2.4 m-85 -123.86 166.73 15.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.334 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 68.8 t -101.9 155.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.377 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.5 p -115.19 -58.99 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.578 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.18 148.7 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.14 141.68 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 mm -79.75 174.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.62 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.91 151.01 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.916 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.53 25.15 54.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -77.06 -169.14 30.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.93 -62.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.381 . . . . 0.0 111.306 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.15 -31.78 69.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.324 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -58.75 -48.69 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -72.58 -49.41 32.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.883 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.23 -59.39 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.853 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -62.96 -33.71 87.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.963 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.84 14.65 9.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.37 144.57 46.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.072 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 25.8 mt -49.28 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.802 0.811 . . . . 0.0 110.562 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 141.83 -17.9 2.58 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.431 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 120.21 13.3 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.43 119.77 39.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.946 0.403 . . . . 0.0 111.475 -178.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 182' ' ' LYS . 1.8 mt -92.77 129.75 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.363 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.513 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 1.5 pp -87.08 -0.59 56.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 153' ' ' LEU . . . 166.0 153.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.059 0.224 . . . . 0.0 110.66 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 25.3 t -108.5 99.61 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 72.3 m-80 73.24 -59.84 0.55 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.8 t -169.96 23.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.377 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 160' ' ' LEU . 2.3 t -135.91 155.24 35.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.714 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . 89.06 -6.9 83.26 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.828 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.505 ' HG ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -68.61 23.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.626 0.77 . . . . 0.0 111.445 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 159' ' ' GLY . 24.0 mt-10 71.31 54.0 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.28 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.873 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -157.18 -83.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.052 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.9 mtm 166.92 162.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.423 ' CG ' ' HB3' ' A' ' 120' ' ' ASN . 11.1 t-160 -53.77 -30.22 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.022 0.439 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -41.16 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.068 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -76.22 -33.88 59.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.18 75.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.566 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 39.5 t -74.23 -41.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.484 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.15 62.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.334 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.425 ' CB ' ' CB ' ' A' ' 158' ' ' VAL . . . -72.12 -43.44 64.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.3 pp -67.86 -36.56 80.51 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.429 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 9.2 ttpp -75.3 -26.09 58.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.469 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -48.6 76.52 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.4 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.63 -52.45 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.118 0.485 . . . . 0.0 110.663 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 2.3 t80 66.7 107.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.888 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t0 82.38 -23.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.895 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.15 93.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.623 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.06 148.43 11.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.107 0.479 . . . . 0.0 111.008 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -124.0 135.83 53.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.975 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.77 136.67 46.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.965 0.412 . . . . 0.0 111.338 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.18 113.83 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 9.2 t -101.79 162.88 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.513 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.53 134.68 34.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.711 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.71 103.18 14.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 112' ' ' PHE . 15.3 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.16 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.838 0.351 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -104.59 178.12 4.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -170.72 155.5 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.014 0.435 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -151.72 100.97 2.73 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -125.87 -171.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 112.133 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.48 125.17 28.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.4 tp -116.68 94.76 4.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 111.048 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -69.53 141.2 53.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.511 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 101.03 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.969 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.63 8.63 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.446 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.89 -84.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -109.14 30.54 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.819 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.84 -179.76 20.98 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.314 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.45 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.36 -50.52 7.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.603 0.24 . . . . 0.0 111.397 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.41 30.29 3.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.147 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 3.5 p90 -123.03 147.96 46.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.368 0.584 . . . . 0.0 110.646 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.6 m -108.03 126.79 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.339 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.97 171.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.865 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.74 139.89 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.39 -121.99 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.62 140.0 7.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.326 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.6 t -54.35 -21.6 9.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.256 . . . . 0.0 111.534 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.09 -56.94 3.63 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -123.74 86.55 53.0 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.394 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.0 129.93 19.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.78 2.32 . . . . 0.0 112.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -61.66 -20.43 63.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.585 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -105.63 -41.86 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.01 0.433 . . . . 0.0 110.843 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.39 24.99 5.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.542 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.49 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 14.3 t70 -158.26 98.34 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.776 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 13.7 Cg_endo -56.52 -29.94 80.48 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.413 2.076 . . . . 0.0 112.001 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -71.06 164.64 25.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.699 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.17 155.81 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.34 166.7 23.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 42.6 mt -96.07 154.71 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 36' ' ' ILE . 19.0 p -108.7 -42.46 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.47 150.8 9.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.96 141.52 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 HD11 HG23 ' A' ' 40' ' ' ILE . 2.4 mt -84.2 127.81 64.96 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.087 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.1 Cg_exo -65.18 66.9 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.525 2.15 . . . . 0.0 112.254 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.31 -52.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.436 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.68 -178.31 2.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.423 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.86 -20.77 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -60.31 -57.31 13.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -28.04 69.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.05 -43.44 64.92 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.572 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 4.8 t0 -74.39 -31.27 62.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.874 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.83 48.54 0.02 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.425 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.83 18.63 12.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.435 ' CD2' ' NH1' ' A' ' 50' ' ' ARG . 1.7 pt? -175.06 179.81 1.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.995 0.426 . . . . 0.0 111.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 152.71 22.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.341 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 28.0 m -70.95 -38.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.031 0.443 . . . . 0.0 112.17 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.66 15.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -80.11 -158.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 100.61 3.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.758 0.314 . . . . 0.0 110.991 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 3.0 tp -61.97 95.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 110.717 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.1 -22.63 63.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.85 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -160.06 130.77 5.64 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.457 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -113.31 117.68 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.167 178.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 46.57 37.82 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 69.44 30.92 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.87 125.86 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -45.85 125.71 6.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.358 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' CG1' HG23 ' A' ' 60' ' ' VAL . 14.2 p -153.12 23.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -94.91 11.76 30.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.354 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 174.82 46.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.981 0.42 . . . . 0.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.12 138.07 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.302 0.573 . . . . 0.0 111.983 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.42 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.1 OUTLIER -50.74 166.23 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.607 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.429 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -56.14 -48.55 76.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.062 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -56.2 -42.51 77.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.1 -33.87 75.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.534 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.51 68.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 109.521 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.42 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 50.5 t -64.75 -35.83 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.572 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 -33.34 72.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.832 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 -43.74 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.315 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.71 -26.77 57.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.459 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -71.89 -43.23 65.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.179 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -105.62 31.21 5.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.164 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -28.65 38.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.526 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.95 -103.7 3.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.6 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 74.6 m -151.75 -52.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 18.2 mt -100.82 85.1 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.26 116.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.901 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -75.28 84.56 2.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.4 mt -85.13 139.45 31.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.519 0.676 . . . . 0.0 112.459 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 2.3 m-85 -124.01 114.51 19.84 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 12.9 m -125.53 168.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.4 mtm -127.87 108.99 11.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.244 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.282 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.857 0.36 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.9 154.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.6 tpt -134.55 164.31 27.77 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.699 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.02 106.63 12.62 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' CG2' ' A' ' 183' ' ' VAL . 2.0 mm -120.5 155.66 23.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 180' ' ' TYR . 2.4 mtmp? -115.38 123.26 48.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.358 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 tt -123.0 118.57 28.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -95.64 144.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.24 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 153.14 26.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.955 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 -177.88 15.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.842 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.48 -31.64 21.38 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.063 1.842 . . . . 0.0 112.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -96.79 19.78 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.042 0.449 . . . . 0.0 110.422 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.58 -153.06 17.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.488 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.46 -14.99 41.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.73 50.66 4.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.901 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.474 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.7 155.02 0.79 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.5 m -113.97 116.97 30.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.563 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 7.0 pt -132.79 155.1 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.4 125.04 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.061 0.457 . . . . 0.0 111.99 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.612 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.66 -175.13 25.44 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.273 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 -168.91 40.52 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.126 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 39.4 t -84.51 145.04 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.53 -25.28 16.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.1 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.61 70.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 0.0 109.738 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -72.55 -5.98 40.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.633 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.543 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 59.1 t60 72.04 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.607 0.718 . . . . 0.0 110.561 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 3.4 mt -84.04 144.21 44.05 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.91 63.32 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.548 2.166 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.08 62.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.36 96.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.988 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -23.72 19.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.18 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 t -55.49 143.79 28.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.03 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.612 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.3 mt -84.33 119.46 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.354 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.464 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 4.5 m-85 -114.93 155.08 27.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.175 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -85.99 155.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.7 p -116.03 -57.3 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -152.65 150.04 29.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.258 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 146' ' ' LEU . 8.0 mt -130.27 141.63 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.054 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 mt -75.98 173.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.98 138.09 35.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.67 27.2 73.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.548 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.06 -173.35 47.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.8 -58.18 3.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 111.168 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -63.93 -31.79 73.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -57.3 -62.18 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -72.94 -38.67 66.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.999 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.43 -59.37 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 112.029 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -72.24 -43.49 46.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.077 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.68 18.64 11.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.309 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -85.96 79.59 9.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -60.47 171.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.5 mt -48.14 127.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 118.43 -25.63 8.08 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.346 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -58.52 151.07 21.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.748 0.309 . . . . 0.0 110.713 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -138.1 124.45 20.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.147 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.2 130.25 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.627 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.08 -0.98 37.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 171.22 155.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.875 0.369 . . . . 0.0 111.334 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 21.5 t -111.07 99.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.023 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 67.3 m-80 69.24 -59.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.267 0.556 . . . . 0.0 109.694 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.4 t -164.07 27.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.229 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 11.7 t -101.05 155.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.391 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.38 77.13 0.27 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.417 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.99 24.8 0.49 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -137.14 31.17 2.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.164 0.507 . . . . 0.0 110.763 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.67 27.71 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.059 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -137.61 -76.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.375 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 2.7 mtm 172.56 165.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.461 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.403 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 51.6 p-80 -53.95 -29.67 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.897 0.38 . . . . 0.0 110.467 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.42 -46.16 50.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.382 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.69 -37.36 73.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.608 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.38 -38.72 74.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.837 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 9.9 t -70.36 -41.57 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.382 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.431 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.75 -31.31 66.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.077 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.05 -27.23 57.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.657 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.0 pp -81.74 -37.33 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.851 0.358 . . . . 0.0 110.317 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -75.37 -26.54 58.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.714 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.09 -9.79 59.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 78.2 p -52.04 -178.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.947 0.403 . . . . 0.0 111.596 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.1 t80 -100.97 167.1 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.327 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.487 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.4 t70 -50.66 -24.85 3.63 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.214 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.0 t -147.75 92.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 148.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.26 125.97 38.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.787 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.99 145.09 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 111.332 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -96.38 112.29 24.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.085 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.413 ' CG2' HG13 ' A' ' 101' ' ' ILE . 21.8 t -102.64 162.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.321 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 97' ' ' LYS . . . -121.0 133.15 55.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.122 0.487 . . . . 0.0 110.918 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.343 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 96.5 p -97.83 84.33 3.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.099 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -109.71 128.88 55.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.393 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -177.73 172.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 111.618 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 1.5 pm0 -90.08 150.48 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.412 ' CD1' ' HG3' ' A' ' 50' ' ' ARG . 8.1 mt -144.18 153.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.281 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -116.91 125.67 51.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.005 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.449 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 8.5 tp -127.05 91.43 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.556 0.693 . . . . 0.0 110.361 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 11.2 mt-10 -77.27 163.16 26.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.786 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -69.56 97.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.592 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -175.28 -85.35 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -109.11 30.53 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.808 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.06 177.73 15.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.358 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.38 -44.83 13.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.804 0.335 . . . . 0.0 111.195 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 90.39 77.15 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.783 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -163.33 155.55 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.788 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.1 t -111.97 126.85 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -120.54 163.93 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.883 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.35 156.94 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.28 -126.07 5.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.537 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.45 132.53 5.18 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.448 ' N ' ' HA ' ' A' ' 69' ' ' THR . 1.6 t -48.46 -26.97 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.317 . . . . 0.0 111.345 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.46 -44.31 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -123.77 78.75 56.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.82 134.13 40.85 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.665 2.244 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 27.8 t60 -69.32 -22.93 63.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.18 -30.73 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 27.81 10.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.661 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -172.67 33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.78 111.04 0.47 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.26 -30.14 37.85 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.716 2.277 . . . . 0.0 112.034 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.56 129.27 39.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 152.3 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.3 165.13 28.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.702 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 43.1 mt -94.2 153.79 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.464 ' N ' HG21 ' A' ' 36' ' ' ILE . 15.9 p -106.93 -44.53 4.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.726 0.298 . . . . 0.0 111.494 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -156.59 152.5 27.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 111.39 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -111.01 141.27 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.822 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 40' ' ' ILE . 2.5 mt -86.26 135.83 36.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.82 57.25 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.261 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.09 -53.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.69 -174.83 0.85 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.465 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.64 58.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.47 -51.04 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.324 . . . . 0.0 111.49 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.2 67.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -72.2 -38.97 68.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.749 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -81.56 -31.11 32.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.729 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.56 47.19 0.01 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.503 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -99.15 22.64 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.997 0.399 . . . . 0.0 110.98 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -168.84 -178.14 3.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.49 171.5 8.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.652 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 33.7 m -71.44 -46.67 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -69.39 11.52 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -67.86 -179.74 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -135.75 100.35 4.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.709 0.29 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.1 pt -61.25 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.414 0.626 . . . . 0.0 110.994 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.85 -24.77 66.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.596 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -160.75 155.53 23.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.642 ' O ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -129.66 -176.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.209 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -41.64 78.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.927 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.6 tt0 63.76 21.71 12.78 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.208 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 2.2 t -121.44 141.99 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 0.0 111.678 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.37 82.29 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.321 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -94.72 31.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.583 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.85 -4.39 59.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.345 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 176.64 56.66 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.033 0.444 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.69 142.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.748 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.448 ' HA ' ' N ' ' A' ' 23' ' ' THR . 1.2 m -50.2 161.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.631 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.4 t-160 -53.76 -48.59 69.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.554 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -49.92 -43.72 49.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.06 73.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.61 69.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.604 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 40.0 t -64.4 -35.87 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.644 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.49 -33.74 73.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.12 73.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.396 0.617 . . . . 0.0 110.555 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -76.28 -26.74 56.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.486 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.16 -42.53 68.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.196 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -104.16 29.77 5.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.379 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.33 -25.78 26.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.435 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.64 -137.36 20.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.488 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 83' ' ' ILE . 35.8 m -121.91 16.43 10.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.572 0.225 . . . . 0.0 111.346 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.17 92.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.2 t -87.22 149.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 111.921 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -137.98 84.86 2.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.723 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -116.67 154.21 30.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.2 t80 -105.66 114.93 29.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.686 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.8 m -121.37 167.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.408 ' HG3' ' HB3' ' A' ' 3' ' ' TYR . 1.1 ttp -121.08 109.61 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.959 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.927 0.394 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.19 154.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.0 mmm -128.86 166.68 18.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.236 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -127.86 106.45 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG13 ' CG2' ' A' ' 183' ' ' VAL . 1.8 mm -118.07 155.31 20.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.619 . . . . 0.0 112.606 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -111.93 126.91 55.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.062 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tt -129.91 118.72 22.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.6 pt -95.97 144.74 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -80.0 156.93 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.998 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 -174.01 13.46 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.86 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.74 -39.72 6.2 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.035 1.823 . . . . 0.0 112.063 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -95.21 22.75 6.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.66 -165.61 12.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.63 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.4 mp -80.85 -13.49 58.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.175 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.17 51.84 3.43 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.829 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.94 149.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.665 0.269 . . . . 0.0 110.75 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.413 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 17.0 m -115.31 116.92 29.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.798 0.332 . . . . 0.0 110.674 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 5.5 pt -127.47 152.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -143.49 125.02 14.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.785 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.65 -175.06 25.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.915 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.62 134.71 8.54 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -59.24 153.13 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.58 -32.13 6.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 178.48 76.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 171.61 7.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.103 0.477 . . . . 0.0 110.924 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.53 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 66.9 t60 -49.8 -50.54 44.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.071 0.938 . . . . 0.0 110.516 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -96.58 129.63 32.61 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.836 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.14 78.47 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.307 2.005 . . . . 0.0 112.593 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.47 37.57 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.938 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.33 95.16 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.956 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -52.13 -25.18 8.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.2 m -54.45 115.9 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.785 HG12 ' HA3' ' A' ' 116' ' ' GLY . 11.7 mt -61.8 120.53 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.475 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.2 m-85 -111.98 156.97 21.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.317 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -87.95 153.32 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.823 0.344 . . . . 0.0 110.683 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 113' ' ' SER . 11.6 p -115.54 -58.04 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 147.69 23.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.016 0.436 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mt -125.32 141.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -74.18 173.44 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -90.35 147.24 23.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.82 55.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.44 174.33 53.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.17 50.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.422 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.369 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -54.87 -54.82 37.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -72.87 -51.96 16.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.053 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.56 -59.36 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 111.85 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.6 -52.1 35.12 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.133 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 60.88 19.81 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.401 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -98.57 78.48 2.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.01 174.26 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.703 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.441 HD11 HG23 ' A' ' 148' ' ' ILE . 30.0 mt -48.06 132.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.172 0.51 . . . . 0.0 111.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 112.66 -28.36 9.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.251 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -61.16 145.3 51.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.672 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -132.65 136.85 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.419 ' CD1' ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -105.66 132.4 52.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.713 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -1.65 32.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 173.97 162.98 0.18 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.967 0.413 . . . . 0.0 111.283 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 25.6 t -117.67 99.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.143 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 65.4 m-80 69.2 -59.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.309 0.576 . . . . 0.0 109.817 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.45 26.77 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.353 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 6.3 t -109.23 154.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.26 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.37 76.88 0.26 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.412 ' HB3' ' CB ' ' A' ' 171' ' ' ALA . 0.3 OUTLIER -80.26 24.01 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.72 58.01 1.56 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.1 29.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 2.4 t -136.61 -74.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.3 mtm -174.45 -170.3 0.5 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.453 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -70.86 -32.87 70.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.943 0.401 . . . . 0.0 110.589 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.79 -46.7 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.77 -35.14 69.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 129' ' ' ILE . . . -70.28 -39.01 75.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.315 0.579 . . . . 0.0 109.463 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 t -73.65 -39.95 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.48 71.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.03 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 160' ' ' LEU . . . -78.17 -25.68 47.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.929 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 173' ' ' LYS . 0.4 OUTLIER -81.05 -40.71 23.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.427 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.51 59.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.19 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -12.33 32.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.416 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.53 147.52 0.84 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 111.587 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.2 t80 -86.13 169.54 13.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.419 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 3.2 t70 -46.77 -30.81 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.079 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.91 91.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.649 0.261 . . . . 0.0 110.539 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.83 148.4 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.433 . . . . 0.0 111.734 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.3 m-85 -98.34 128.32 44.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.421 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.54 152.67 28.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -96.56 118.7 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.408 ' CG2' HG13 ' A' ' 101' ' ' ILE . 20.8 t -102.35 161.26 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.352 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.26 52.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.739 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -90.96 100.26 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.102 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.821 0.344 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.92 163.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.567 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -174.86 162.17 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.376 . . . . 0.0 111.259 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 6.0 pt-20 -95.97 147.47 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 7' ' ' THR . 27.0 mt -146.78 165.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -129.74 147.17 51.49 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.198 0.523 . . . . 0.0 111.835 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.533 HD22 ' HD3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -135.51 87.33 2.31 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.412 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -79.81 118.85 21.97 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.251 179.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -41.78 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.65 8.05 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.591 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.28 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.31 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -109.23 30.69 6.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.24 177.98 24.72 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.716 -1.23 . . . . 0.0 112.809 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -84.26 -47.33 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.499 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.09 62.14 1.02 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.827 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.6 p90 -165.13 169.19 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 111.351 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.56 126.76 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.535 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.0 pt -116.45 157.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.241 0.544 . . . . 0.0 111.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.71 148.09 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.502 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.7 16.9 2.41 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.585 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.06 173.46 0.02 OUTLIER Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.488 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.8 t -77.56 -35.7 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 5.3 t0 -86.38 -42.44 13.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.334 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -123.86 77.25 57.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.429 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.49 171.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.619 2.213 . . . . 0.0 112.275 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 20.7 t60 -111.57 -21.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.339 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.539 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.94 -25.82 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 29.52 7.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.381 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.62 40.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 108.48 2.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.837 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 16.8 Cg_exo -67.43 -22.32 45.53 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -82.92 136.81 34.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.68 145.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.219 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.539 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.7 p90 -142.17 142.95 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.568 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 33.9 mt -69.75 146.87 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.418 ' N ' HG23 ' A' ' 36' ' ' ILE . 3.0 m -101.26 -33.87 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.24 143.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.291 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -107.24 141.45 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.137 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.47 135.13 41.41 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 63.72 4.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.48 -43.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.06 178.5 1.87 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.18 -19.76 58.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . . . -52.92 -57.55 9.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.934 0.397 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.5 69.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.903 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -72.02 -35.02 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.575 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.43 -20.19 25.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.454 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 80.26 1.0 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HD3' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -88.3 22.02 2.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 90' ' ' ARG . 3.2 pp 36.7 -154.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.11 128.72 38.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 111.158 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . 26.4 m -57.77 -41.61 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.229 0.538 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -50.45 -17.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.944 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -57.67 150.43 19.5 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -121.7 129.8 53.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.82 94.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.47 -26.89 63.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -162.93 145.45 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.563 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 61' ' ' ASN . 1.0 OUTLIER -108.3 -176.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.376 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 60' ' ' VAL . 7.4 m120 -21.78 -52.35 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.943 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.63 25.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HB ' HG11 ' A' ' 60' ' ' VAL . 2.7 t -121.58 142.06 39.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.529 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 8.0 p-10 -79.61 87.13 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 m -94.09 30.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.75 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -82.66 2.03 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.862 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.98 58.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.61 142.8 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.715 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 23' ' ' THR . 5.4 m -49.81 161.94 0.21 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.126 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.1 t-160 -60.34 -48.61 81.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.301 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -37.99 81.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.48 76.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.05 -43.13 65.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.968 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 53.6 t -64.63 -35.71 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.912 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.53 -33.35 72.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.863 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.03 74.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.525 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -77.11 -26.76 53.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.538 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -72.51 -41.1 66.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.399 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 28.45 6.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.878 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.63 -19.13 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.512 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.94 -159.29 16.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.862 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -99.75 10.09 41.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.619 0.247 . . . . 0.0 111.464 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -152.93 94.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 8' ' ' LEU . 26.9 m -90.64 134.89 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -116.7 102.11 9.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -128.82 154.25 46.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.404 0.621 . . . . 0.0 112.546 -178.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -103.77 115.27 30.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.677 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 34.4 m -104.22 167.94 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 112.388 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.4 ttp -126.0 109.62 12.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.844 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HB3' HD11 ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.134 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.833 0.349 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.0 p -84.66 114.48 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.53 166.69 11.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 111.861 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -135.49 106.5 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.4 mm -114.14 155.27 15.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 3.7 mttp -114.2 120.93 42.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.364 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.9 tt -119.52 118.75 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.369 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -95.14 144.68 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.967 0.413 . . . . 0.0 111.226 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -58.79 151.65 20.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.135 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.93 160.16 23.21 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.646 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -40.54 80.51 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 C-N-CA 122.119 1.879 . . . . 0.0 112.129 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.71 19.69 9.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.05 0.452 . . . . 0.0 110.101 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.4 -144.57 16.0 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 mp -86.56 -20.06 28.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.084 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.33 61.51 3.89 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.92 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 145.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.8 t -109.98 117.4 33.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.412 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 6.3 pt -130.87 154.66 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.65 125.0 10.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 111.755 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.535 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.54 -175.01 25.2 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.516 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.4 -164.17 54.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.195 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.46 150.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 111.149 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.21 -30.51 7.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.973 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -164.66 69.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.053 0.454 . . . . 0.0 109.897 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.9 mt-30 -67.1 -11.24 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.655 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 60.8 t60 72.43 -54.68 0.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.65 0.738 . . . . 0.0 110.944 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -92.38 138.14 24.28 Favored Pre-proline 0 C--N 1.31 -1.117 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.741 -179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.54 60.94 4.3 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.356 2.037 . . . . 0.0 112.563 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 130.74 55.87 0.09 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -175.55 96.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -57.85 -22.13 46.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -58.33 141.92 49.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.535 HG12 ' HA3' ' A' ' 116' ' ' GLY . 14.9 mt -74.65 127.66 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 111.249 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.493 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 5.9 m-85 -122.4 146.52 47.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.93 155.59 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 p -119.62 -59.18 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.07 146.69 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.924 0.393 . . . . 0.0 111.157 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 146' ' ' LEU . 17.1 mt -134.4 141.49 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.74 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.672 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.0 153.17 18.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 52.59 31.2 36.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.738 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.36 -167.97 39.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.697 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.02 -60.92 2.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -68.3 -31.94 71.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.273 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.07 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.212 0.529 . . . . 0.0 110.009 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -72.82 -52.99 12.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.772 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.6 -59.24 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.794 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -52.63 -53.34 33.04 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.068 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 64.98 16.46 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.019 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -94.05 78.46 4.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.518 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -61.14 175.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.3 mt -47.94 129.9 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 115.48 -27.04 8.67 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.297 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.0 OUTLIER -64.09 138.33 58.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 110.546 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -126.83 131.31 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.037 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -102.51 134.56 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.884 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.82 -1.92 33.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.923 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 176.15 163.71 0.38 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.46 99.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.224 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.434 ' OD1' ' CG ' ' A' ' 180' ' ' TYR . 66.9 m-80 69.82 -59.91 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.395 0.617 . . . . 0.0 109.762 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.75 27.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.17 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 4.1 t -108.47 154.55 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.295 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.45 77.1 0.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.415 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.93 24.44 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -132.09 30.97 4.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.173 0.511 . . . . 0.0 110.905 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -141.98 28.44 1.73 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.272 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.5 t -139.93 -78.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.383 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtp -179.14 -169.74 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -70.43 -31.59 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.494 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -47.57 39.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -69.96 -37.12 75.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.84 0.352 . . . . 0.0 110.642 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.8 75.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.237 0.542 . . . . 0.0 109.634 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 13.1 t -72.28 -39.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.411 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.74 -29.73 64.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.016 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.54 55.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.1 pp -81.7 -37.87 26.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.469 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -74.96 -26.44 59.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -15.24 53.29 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.409 ' HB ' ' CG2' ' A' ' 179' ' ' VAL . 25.3 p -50.11 -178.74 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.735 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.486 ' CD1' HG12 ' A' ' 179' ' ' VAL . 9.0 p90 -132.46 -160.41 1.05 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.733 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.519 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 6.3 t0 -53.37 -34.79 59.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.427 ' O ' ' CZ ' ' A' ' 176' ' ' TYR . 35.2 t -147.86 92.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 0.0 111.596 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.486 HG12 ' CD1' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -111.01 131.38 62.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.054 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 10.2 p90 -94.05 124.47 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -109.58 153.87 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 111.374 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -96.93 110.91 23.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.21 159.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.306 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -140.74 145.24 36.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.54 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 mttt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.63 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.821 0.343 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -86.49 116.4 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.117 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.794 0.331 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.27 178.7 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HB2' ' NH2' ' A' ' 90' ' ' ARG . 5.7 tt0 -174.04 142.81 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 8.6 pt-20 -108.86 111.47 23.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.744 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -120.29 -169.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.168 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.82 133.36 28.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -113.29 88.93 2.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 111.067 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -82.54 116.79 22.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.377 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -40.63 95.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.406 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.15 -26.87 6.68 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.828 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -169.65 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -109.17 30.66 6.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.82 177.41 23.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.984 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' CD2' ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.28 -45.77 12.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.251 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.54 64.27 1.27 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.682 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 10.1 p90 -164.9 146.38 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.0 110.784 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -96.01 165.3 12.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.0 pt -152.96 159.63 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.82 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.22 154.95 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.225 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.49 -127.45 6.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.9 144.31 8.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.458 HG23 ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -57.91 -20.01 33.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.349 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' HG22 ' A' ' 69' ' ' THR . 19.3 t70 -94.34 -42.1 9.08 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.696 0.284 . . . . 0.0 111.085 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -123.76 77.59 56.82 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -47.46 129.4 16.42 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.715 2.276 . . . . 0.0 112.477 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.406 ' HB3' ' HE1' ' A' ' 35' ' ' PHE . 78.6 t60 -57.22 -72.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.078 0.466 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.407 HD11 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -55.9 -42.0 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.551 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.36 23.63 5.07 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.444 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.28 29.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 2.4 m-20 -160.43 103.44 1.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.813 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.8 Cg_endo -55.89 -26.08 56.11 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.465 2.11 . . . . 0.0 111.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -66.71 147.94 52.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.28 151.74 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 111.288 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -142.39 158.07 44.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.717 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 65.4 mt -77.03 148.65 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.31 -30.05 10.38 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.514 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 146.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.45 141.11 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 pt -89.65 139.45 27.96 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.17 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.93 64.25 7.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.564 2.176 . . . . 0.0 112.414 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.14 -41.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.14 177.35 15.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 -20.94 57.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.404 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.96 -57.28 10.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.944 0.402 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.76 -28.32 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.87 -40.28 69.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.23 0.538 . . . . 0.0 109.605 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.55 -20.22 43.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.333 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.54 83.85 0.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.443 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -89.37 13.8 12.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.72 0.295 . . . . 0.0 111.16 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.42 -163.68 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.392 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.86 146.85 20.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 111.281 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 6.6 m -63.18 -42.55 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.576 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 35' ' ' PHE . 19.9 m-80 -52.36 -11.81 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.44 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -63.55 152.56 38.32 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 p -119.04 120.22 36.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.009 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.6 pt -60.83 94.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.575 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.409 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -60.7 -26.28 67.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.907 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.417 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.6 m-85 -164.87 140.1 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.381 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -125.13 118.87 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.44 -76.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.9 tt0 -160.44 30.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 17.7 t -120.82 140.73 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.27 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 5.3 p-10 -79.71 107.97 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.1 t -125.57 39.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -95.51 -2.07 49.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -175.77 49.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.172 0.51 . . . . 0.0 109.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.96 142.35 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.638 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.458 ' CG2' HG23 ' A' ' 23' ' ' THR . 66.7 p -49.65 161.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.839 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.446 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.4 t-160 -59.01 -48.71 80.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -58.78 -40.8 85.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.37 68.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.46 69.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.59 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 39.8 t -64.92 -35.3 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.469 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -69.47 -33.51 73.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.57 73.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -74.77 -26.41 59.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.387 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -41.41 83.37 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.157 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.55 28.24 7.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.688 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.37 -24.74 23.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.36 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.57 -160.49 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.909 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 68.3 m -97.34 -36.54 10.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 mt -112.87 85.1 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 8' ' ' LEU . 17.7 m -90.61 115.15 29.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.091 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.28 101.25 13.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -117.28 154.28 31.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.51 114.99 28.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.328 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.3 m -104.38 159.91 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.195 0.522 . . . . 0.0 112.229 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 109.66 15.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.658 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' NH2' ' HB2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HB3' ' HG3' ' A' ' 185' ' ' LYS . 16.9 tttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.4 t -123.61 136.33 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.54 166.64 15.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 111.431 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.97 106.41 6.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mm -114.53 155.21 15.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -108.89 123.73 49.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.226 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.436 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 3.1 tt -126.14 118.57 25.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.755 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -95.46 144.65 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.66 155.77 25.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.66 178.11 18.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.892 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.93 -31.25 38.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.103 1.869 . . . . 0.0 112.006 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -96.89 19.68 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.76 -156.36 16.55 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.539 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.5 -13.27 46.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.12 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.24 49.45 5.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.978 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.2 154.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.808 0.337 . . . . 0.0 111.079 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.2 t -116.84 116.64 27.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 14.3 pt -129.52 157.25 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.44 125.75 7.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.674 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.47 -175.24 25.42 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.19 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.67 -165.76 48.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.182 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.3 t -87.95 148.25 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.172 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.61 -10.97 60.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.516 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.97 65.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.537 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -76.21 -0.61 22.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.908 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 82.4 t60 72.69 -60.99 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.702 0.763 . . . . 0.0 110.568 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.504 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.8 OUTLIER -94.6 107.03 27.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.668 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.49 89.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.394 2.062 . . . . 0.0 112.512 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 108.46 34.4 2.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.402 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -155.47 90.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.977 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -53.9 -23.26 12.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.348 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 m -56.67 137.48 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.674 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.7 mt -78.86 116.22 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.392 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.504 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.9 m-85 -113.06 150.08 32.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 155.72 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -128.52 -45.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.34 146.27 32.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.731 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.0 mt -136.81 141.43 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 mt -71.89 173.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 137.28 32.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.844 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.42 27.19 40.03 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.627 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.59 178.43 50.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.14 -54.72 25.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -70.11 -32.75 70.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -60.0 -55.36 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.239 0.542 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -46.56 52.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.867 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -80.73 -59.47 2.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.032 0.444 . . . . 0.0 112.053 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -60.95 -46.34 94.77 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.247 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.54 17.25 10.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.74 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -91.39 79.2 5.62 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -60.0 170.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.0 mt -47.6 126.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.281 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.99 -23.87 9.12 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.514 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -65.12 129.12 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.827 0.346 . . . . 0.0 110.517 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -115.62 131.45 56.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.244 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.417 ' CD1' ' CG2' ' A' ' 129' ' ' ILE . 0.3 OUTLIER -104.9 134.61 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.715 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.9 -2.07 26.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 176.61 159.9 0.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.896 0.379 . . . . 0.0 111.457 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 11.7 t -115.52 100.19 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 180' ' ' TYR . 20.2 m-80 69.28 -59.5 0.48 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.367 0.604 . . . . 0.0 109.635 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.49 28.96 0.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.989 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 9.9 t -106.46 154.81 7.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -114.36 76.45 0.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.431 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -78.15 24.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 159' ' ' GLY . 4.2 pt-20 -136.91 35.23 2.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.234 0.54 . . . . 0.0 110.742 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.02 28.59 1.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.4 t -142.04 -77.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.083 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.6 mtm -179.4 -171.59 0.2 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -71.84 -32.67 67.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.301 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.72 -42.4 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.461 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.11 -37.81 66.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.569 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 129' ' ' ILE . . . -70.48 -38.71 74.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 23.8 t -72.69 -43.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.481 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 174' ' ' ASN . . . -71.86 -30.18 65.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.044 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.51 -29.14 56.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.472 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.2 pp -81.66 -37.58 27.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.55 59.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.937 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -69.99 -13.67 62.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.439 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.7 p -56.84 -168.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 64.0 t80 -106.18 172.46 6.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.428 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 2.2 m-20 -58.28 -15.97 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.202 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.52 92.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.262 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.86 147.91 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.282 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.424 ' CE1' ' HA ' ' A' ' 156' ' ' ASN . 18.4 p90 -100.93 129.71 46.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -108.99 154.37 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 116.93 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.786 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.6 t -101.89 162.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.83 117.23 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 0.0 111.936 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 97' ' ' LYS . 4.4 ptpt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.599 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.922 0.392 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.82 73.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.091 -179.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.26 141.1 27.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.584 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 5.7 pt-20 -175.01 165.92 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 111.417 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -109.37 123.47 49.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.771 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -123.62 -172.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.316 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -140.44 127.95 21.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.259 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 5.8 tp -119.05 91.42 3.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.638 0.732 . . . . 0.0 110.561 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -73.79 138.84 44.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.601 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 82' ' ' SER . 2.5 ptm180 -57.85 103.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.35 -26.91 7.3 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.547 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -168.15 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -109.15 30.71 6.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.725 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.94 174.68 19.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.441 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.33 -50.49 7.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.942 0.401 . . . . 0.0 111.304 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.23 74.64 1.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.69 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.9 p90 -164.65 156.46 15.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.029 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 p -105.93 126.81 52.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 2.4 pp -120.43 154.49 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 0.0 111.945 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.97 147.49 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.754 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.41 19.62 1.34 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.993 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.11 162.92 0.08 OUTLIER Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.542 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.3 t -66.68 -38.73 87.39 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.431 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 12.5 t0 -83.77 -49.17 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 111.631 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.69 76.89 10.77 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.582 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.69 172.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.646 2.23 . . . . 0.0 112.274 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 17.5 t60 -108.8 -21.45 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.212 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.74 -25.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.86 7.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.703 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.89 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.13 101.49 2.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.017 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.15 61.83 2.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.903 2.402 . . . . 0.0 111.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 m -176.86 134.61 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.741 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 145.1 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.52 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.6 p90 -142.24 163.64 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.453 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.615 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 49.2 mt -93.97 148.67 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 110.84 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.479 ' N ' HG23 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -106.67 -31.77 8.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.344 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -172.55 148.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -106.95 141.62 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.78 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.05 128.05 64.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.965 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.2 62.14 2.6 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 -43.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.62 -177.26 22.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.94 -21.27 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.631 0.253 . . . . 0.0 111.532 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.0 -57.62 12.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.313 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.13 -28.25 67.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.75 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.21 -36.21 69.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.652 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' GLY . 34.0 m-20 -87.21 -25.98 23.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.327 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 28.47 54.7 0.13 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.148 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' NH1' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -84.16 4.84 28.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -177.76 -177.9 0.68 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.106 0.479 . . . . 0.0 111.547 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 165.19 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.396 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 34.5 m -71.13 -45.51 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 17.6 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' VAL . 7.5 p-10 -75.34 -166.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.33 100.05 3.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.84 95.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.465 0.65 . . . . 0.0 111.058 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -70.94 -25.68 62.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -154.55 129.84 9.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 2.5 t -137.13 145.87 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.927 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.5 m120 42.24 32.43 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.471 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 65.66 32.7 8.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' VAL . 21.8 t -121.07 141.88 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.46 78.13 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.78 33.26 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.427 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -84.24 3.56 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.05 47.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.039 0.447 . . . . 0.0 109.837 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.71 140.99 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.176 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.434 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.6 OUTLIER -49.67 164.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.905 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.3 t-160 -57.39 -48.49 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.372 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -41.4 63.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.151 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.58 76.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.94 -40.75 68.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.55 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 49.7 t -64.23 -35.83 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.658 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -34.07 73.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.815 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -42.92 74.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 110.477 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.8 pp -76.8 -26.74 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.385 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -45.09 59.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.382 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -103.18 28.82 5.99 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.415 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 77' ' ' LEU . . . -81.56 -27.83 34.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.508 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.09 -124.58 8.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.635 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 83' ' ' ILE . 69.6 p -130.83 4.62 4.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.84 96.73 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 26.6 m -87.41 114.37 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -100.9 110.38 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.47 154.1 51.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.474 ' CE1' ' N ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -107.83 114.68 28.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.219 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -118.97 168.1 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.113 0.482 . . . . 0.0 112.151 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ptm -124.33 109.53 13.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.155 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.75 -179.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.73 152.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.906 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttt -135.31 166.3 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 mm -114.96 155.6 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.603 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' HD2' ' CZ ' ' A' ' 180' ' ' TYR . 1.6 ttpt -113.7 124.53 52.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 tt -125.79 118.4 25.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.87 144.68 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.195 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -65.75 155.24 36.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -134.82 -169.64 11.98 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.68 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.12 -40.13 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.022 1.815 . . . . 0.0 112.322 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 20.2 8.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 110.277 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 106.81 -133.93 11.9 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -86.71 -27.03 23.94 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.935 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.1 40.75 4.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.669 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.526 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.12 154.59 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 111.08 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.5 t -102.23 123.15 45.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.489 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.526 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 16.4 pt -130.1 155.26 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 122' ' ' HIS . . . -162.41 125.47 2.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.051 0.453 . . . . 0.0 111.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.93 -175.48 25.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.622 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.25 34.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.962 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -104.26 154.7 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.853 0.358 . . . . 0.0 111.377 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 -35.83 4.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 175.05 78.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 115.11 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.425 ' CE1' ' HB1' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -58.98 -17.58 26.15 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.537 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 1.1 mt -83.55 122.62 76.88 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.742 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.39 96.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.47 2.114 . . . . 0.0 112.165 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.85 58.31 14.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.93 87.01 1.95 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.571 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -43.53 -28.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t -53.57 168.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.619 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.53 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt -105.86 127.27 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.935 0.398 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.3 m-30 -117.27 154.67 30.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.502 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.07 152.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 5.9 t -123.62 -50.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.424 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -134.22 142.42 47.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 30.7 mt -136.99 138.46 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.16 172.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -91.37 134.52 34.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.922 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.36 26.29 56.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.88 -138.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.4 -72.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 111.19 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -61.47 -31.79 71.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.7 t-160 -56.41 -62.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 110.993 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -72.63 -34.3 67.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.985 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -59.36 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -88.13 -29.23 20.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.844 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 141' ' ' HIS . 1.3 ttm180 67.75 27.8 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.01 0.405 . . . . 0.0 110.527 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -88.64 82.71 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -68.38 176.35 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.87 121.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.299 0.571 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.4 -23.36 5.15 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.059 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 t0 -57.94 139.51 54.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.773 0.321 . . . . 0.0 110.524 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -130.98 119.51 22.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.146 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.99 131.98 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.092 0.472 . . . . 0.0 110.79 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 pp -104.3 -1.36 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.201 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 179.83 168.68 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 58.6 t -117.88 100.44 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.635 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 66.4 m-80 70.42 -57.45 0.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.072 0.463 . . . . 0.0 110.081 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 m -165.31 21.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.325 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -116.32 132.61 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.165 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.0 68.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.26 28.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.848 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.412 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -122.29 37.17 4.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.168 0.508 . . . . 0.0 110.939 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -142.42 29.05 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.8 t -116.08 -76.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.2 mtm -176.45 -170.2 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.744 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -69.99 -34.17 72.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.663 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.7 -45.41 52.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.91 -37.46 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.806 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.93 73.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.061 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 11.4 t -73.95 -39.97 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.2 -33.6 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.96 -27.04 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -76.18 -36.73 58.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -26.87 60.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.44 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -9.95 55.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.519 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 p -47.73 149.53 1.24 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 0.0 111.442 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -87.58 169.78 11.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t0 -45.12 -35.3 3.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.044 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.8 t -147.85 91.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.95 148.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.661 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.415 ' CZ ' ' HD2' ' A' ' 102' ' ' LYS . 13.2 m-85 -96.42 127.05 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.602 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 mt -104.94 150.71 24.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.954 0.407 . . . . 0.0 110.597 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 152' ' ' ILE . 5.9 tttm -96.8 114.27 25.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.8 t -101.68 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 111.288 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -123.1 141.15 52.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.671 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.866 0.365 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -80.9 95.82 6.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.108 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.9 151.52 20.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -177.07 158.5 1.54 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 111.311 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -113.81 114.71 26.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.727 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -119.27 -176.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 120.979 0.418 . . . . 0.0 111.429 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.13 125.16 38.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.724 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 13.9 tp -124.19 92.73 3.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.683 0.754 . . . . 0.0 109.97 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.16 161.69 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.22 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 15.0 ptm180 -73.14 98.51 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.876 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.87 -26.57 8.48 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.526 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -168.45 -87.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.143 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -109.18 30.73 6.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 177.4 18.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.019 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.496 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.48 -37.08 21.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.187 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 72.47 1.29 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.967 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -156.49 157.11 34.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 178.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -104.5 126.89 52.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.467 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 35.5 pt -105.4 163.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 0.0 111.74 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . . . -162.36 144.38 10.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.42 -144.75 18.21 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.708 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.09 142.83 5.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.366 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.3 t -48.6 -27.63 2.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.58 -45.21 16.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.975 0.417 . . . . 0.0 110.735 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -123.92 84.73 54.44 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -41.99 144.19 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.868 2.379 . . . . 0.0 112.618 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.503 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 72.1 t60 -75.98 -49.61 17.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.637 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.73 -29.26 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.29 23.23 6.13 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.0 30.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -164.06 111.08 0.92 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.639 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.28 -23.68 75.47 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.732 2.288 . . . . 0.0 112.122 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -57.94 175.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mp -104.01 160.81 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 27' ' ' HIS . 3.5 m-85 -132.21 166.28 22.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.189 0.519 . . . . 0.0 111.419 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 11.2 mt -116.71 151.54 18.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.42 ' N ' HG22 ' A' ' 36' ' ' ILE . 32.2 p -109.99 -44.31 3.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.8 158.38 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.196 0.522 . . . . 0.0 112.09 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.08 141.11 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 mt -87.32 129.08 52.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.167 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.0 Cg_exo -65.34 64.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.15 -43.45 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.271 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.56 160.21 52.85 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.319 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.86 -28.79 52.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -58.89 -55.38 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.66 -27.26 68.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -71.71 -42.47 67.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.667 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 3.2 m-20 -77.11 -36.22 55.7 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.394 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 27.3 44.01 0.03 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.391 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -76.1 -37.65 57.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -120.33 179.78 4.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 150.91 21.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.769 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -71.25 -35.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.403 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -70.21 14.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 53' ' ' VAL . 32.1 p-10 -83.38 -162.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.84 100.82 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -55.26 96.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 111.191 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 5.1 mt -68.17 -33.85 75.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.892 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 58' ' ' LEU . 69.1 m-85 -157.08 167.7 29.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.295 0.569 . . . . 0.0 111.955 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -147.15 -177.95 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.013 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.32 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 111.592 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 50.32 31.02 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.069 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.94 128.85 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.385 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -95.81 80.26 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -97.17 32.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.43 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -75.88 -5.3 45.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.266 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.62 46.8 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.936 0.398 . . . . 0.0 110.174 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.3 m -117.28 140.4 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.082 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.0 OUTLIER -50.61 166.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.501 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.428 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.3 t-160 -59.73 -48.64 80.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.434 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.56 69.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.53 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.7 -35.23 67.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.014 0.435 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -42.56 65.13 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -64.51 -36.37 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.976 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.4 mt-10 -69.36 -33.68 73.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.65 -41.41 75.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.426 0.632 . . . . 0.0 110.53 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -79.52 -26.9 41.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.457 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -71.49 -36.62 71.19 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.225 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.06 22.91 9.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.811 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.91 16.48 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.192 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.29 103.89 0.88 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 166.45 -70.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.409 . . . . 0.0 110.602 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -152.44 93.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.859 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 m -93.6 113.71 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -79.3 80.39 5.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.58 132.25 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -109.88 114.54 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.84 168.36 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 0.0 112.234 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 ttt -141.63 109.26 5.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.457 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.688 0.28 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.92 147.0 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtm -134.73 166.12 23.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.212 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.04 106.21 6.7 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mm -113.86 155.57 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.425 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -121.57 125.96 47.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.254 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.84 118.78 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.033 0.444 . . . . 0.0 110.733 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.8 pt -93.83 144.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.944 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -69.93 155.49 40.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -135.84 -160.62 8.94 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.58 -42.02 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.184 1.923 . . . . 0.0 112.484 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -92.07 21.37 5.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.025 0.441 . . . . 0.0 110.427 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 107.44 -141.57 15.66 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 HD22 ' CE1' ' A' ' 112' ' ' PHE . 5.1 mp -86.44 -23.0 26.2 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.901 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.95 47.06 4.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.842 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -175.87 153.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 m -111.23 129.9 55.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.463 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 13.5 pt -142.54 156.6 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.9 125.27 5.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.618 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.44 -175.08 25.21 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.104 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.91 -174.08 51.06 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.073 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.35 145.35 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.754 0.312 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.07 -27.19 9.43 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.201 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.82 68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 109.755 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.537 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -73.4 -4.57 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 62.1 t60 72.02 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.51 0.671 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 130' ' ' TYR . 2.0 mt -88.74 145.56 35.24 Favored Pre-proline 0 C--N 1.313 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.511 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 16.8 Cg_exo -67.26 62.33 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.509 2.14 . . . . 0.0 112.14 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 118.43 60.37 0.28 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.33 94.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.824 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.15 -23.32 20.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 m -60.01 147.71 38.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.618 HG12 ' HA3' ' A' ' 116' ' ' GLY . 1.1 mt -87.57 110.53 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.487 ' CG ' HD11 ' A' ' 123' ' ' ILE . 6.6 m-85 -104.93 150.6 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.2 147.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.7 p -103.06 -56.61 2.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.308 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 147.1 22.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.427 HG23 ' CD2' ' A' ' 141' ' ' HIS . 2.9 mt -114.77 141.58 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.08 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.738 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.74 30.48 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.82 -28.91 66.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.325 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.22 21.33 8.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.79 -82.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.427 ' CD2' HG23 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -52.79 -56.3 16.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 0.0 110.535 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.79 -50.39 24.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.264 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.19 -59.42 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.978 0.418 . . . . 0.0 111.888 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -56.07 -57.56 18.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 60.02 26.41 15.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.41 86.43 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -58.91 165.84 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.673 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.3 mt -48.19 115.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 111.288 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.64 -18.19 5.18 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.0 122.24 17.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.878 0.37 . . . . 0.0 110.858 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -110.75 128.63 55.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 131.73 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.94 -2.91 46.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.086 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 167.38 146.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.86 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 158' ' ' VAL . 95.0 t -101.88 99.66 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.12 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 69.34 -59.66 0.48 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.48 26.14 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.329 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 15.0 t -98.07 155.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.255 0.55 . . . . 0.0 111.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -115.26 77.76 0.27 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.619 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.73 25.69 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.614 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.6 OUTLIER -152.85 53.69 0.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.336 0.589 . . . . 0.0 110.777 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.86 28.24 0.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.6 t -150.64 -74.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtm 175.17 169.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.711 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.411 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 14.5 p-80 -54.96 -29.87 57.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.942 0.401 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -73.41 -48.39 34.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.178 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.62 -36.58 73.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.904 0.383 . . . . 0.0 110.583 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.27 73.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.058 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 5.5 t -72.07 -42.55 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.17 -30.81 66.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.627 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.95 49.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.248 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.32 -39.85 24.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.11 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -26.51 58.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.5 -9.89 55.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.405 ' HB ' ' CG2' ' A' ' 179' ' ' VAL . 7.7 p -50.96 -178.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 111.8 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -103.02 169.46 8.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t70 -52.16 -21.32 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.535 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.58 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.714 0.292 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.24 148.3 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.116 0.484 . . . . 0.0 112.3 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -102.53 124.18 47.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.798 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -104.68 146.22 29.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 0.0 111.334 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.46 115.76 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.8 t -101.83 160.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.145 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.42 ' CB ' ' HD2' ' A' ' 151' ' ' LYS . . . -139.57 132.72 29.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.252 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.907 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.778 0.323 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -98.63 105.44 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.041 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.889 0.376 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -121.64 154.76 36.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 23.8 mm-40 -145.82 118.25 8.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.561 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -125.1 95.76 4.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.443 HG13 ' CB ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -126.79 -169.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 111.922 -178.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.69 135.03 54.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.637 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 3.9 tp -128.2 91.35 3.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.785 0.802 . . . . 0.0 110.022 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -72.69 160.64 31.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.12 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -70.5 95.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.11 -25.92 11.44 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.478 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -172.45 -86.85 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -109.35 30.74 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -179.77 21.86 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.419 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 1.2 mp -84.43 -48.74 9.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.805 0.336 . . . . 0.0 111.515 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 76.29 1.31 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.742 -0.742 . . . . 0.0 114.1 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.5 p90 -164.66 148.68 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.689 0.28 . . . . 0.0 110.756 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -100.73 126.86 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 111.392 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.9 pt -125.06 164.31 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.07 154.78 7.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.46 -113.54 2.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.281 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.12 22.15 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.544 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.459 ' CG2' ' N ' ' A' ' 69' ' ' THR . 2.8 t -58.21 -18.44 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.9 m-20 -93.44 -49.71 5.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -121.96 79.35 41.82 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.438 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.95 136.9 22.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.606 2.204 . . . . 0.0 112.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -70.38 -21.8 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.108 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.507 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.61 -29.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.935 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.52 29.55 9.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.17 35.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.9 95.97 1.0 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.46 -23.24 30.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.126 . . . . 0.0 112.005 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -76.18 142.53 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.1 mt -93.18 154.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 111.182 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.507 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.9 p90 -142.39 167.82 21.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.299 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 40.5 mt -98.09 152.44 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.47 ' N ' HG22 ' A' ' 36' ' ' ILE . 1.9 p -108.62 -36.34 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.673 0.273 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.81 154.52 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.969 0.414 . . . . 0.0 111.291 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.2 141.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.999 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.8 mt -85.44 123.61 72.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.6 Cg_exo -66.06 64.02 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.68 -52.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.34 166.8 8.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.362 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.05 66.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -61.88 -57.37 12.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.167 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.14 -28.1 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.534 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -38.44 69.28 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.999 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 40.7 m-20 -87.56 -25.27 23.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 33.58 70.58 0.13 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.593 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -109.46 -14.06 14.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.541 0.21 . . . . 0.0 111.371 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.63 168.87 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.71 165.12 11.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.121 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.744 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 33.9 m -71.54 -47.77 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -62.24 4.63 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -86.99 170.57 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.298 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 m -120.37 116.15 24.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.579 0.228 . . . . 0.0 110.648 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.47 94.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.226 0.536 . . . . 0.0 111.19 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 mt -70.07 -28.81 65.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.18 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 143.11 17.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.601 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -152.22 131.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.587 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 52.09 40.47 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.0 26.96 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.81 131.47 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.067 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.3 100.93 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 68' ' ' VAL . 25.0 t -112.71 41.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.012 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.95 9.7 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.655 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -177.76 37.59 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.417 ' CG2' HG11 ' A' ' 65' ' ' VAL . 14.9 m -118.96 150.57 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.447 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.9 OUTLIER -49.56 156.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.705 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.473 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.8 t-160 -58.23 -48.56 80.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.554 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -59.45 -34.79 72.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.366 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.98 -37.45 78.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.36 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.37 65.26 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 109.693 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.473 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 78.9 t -64.2 -35.05 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.684 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.3 tt0 -69.19 -33.99 74.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.96 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.466 0.651 . . . . 0.0 110.466 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.92 -27.05 39.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.368 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -70.87 -35.56 72.41 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.141 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 21.64 10.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.655 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.87 16.27 5.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.048 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.52 95.83 0.11 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.781 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.513 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.1 m 169.59 -66.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.79 94.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.249 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.31 140.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -86.87 95.02 9.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 57' ' ' ILE . 2.2 tm? -84.81 115.53 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 0.0 112.067 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CD1' ' CG ' ' A' ' 5' ' ' GLU . 1.3 t80 -121.75 114.44 21.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.3 168.06 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.46 109.08 15.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.631 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.819 -179.36 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.975 0.417 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.1 135.14 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.7 166.73 11.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -135.14 106.41 6.75 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mm -114.15 155.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -113.04 123.28 49.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.257 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 2.0 tt -124.8 118.6 26.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.587 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -97.04 144.68 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.115 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -75.17 155.93 36.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.2 -177.85 15.19 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.905 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 -33.43 16.23 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.064 1.843 . . . . 0.0 112.093 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.53 18.22 13.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 0.0 110.416 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' HA3' ' OXT' ' C' ' 9' ' ' VAL . . . 106.4 -148.1 16.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.457 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.57 -18.84 30.47 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.213 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.64 49.95 6.32 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.083 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.76 151.99 0.75 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 110.718 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.2 m -113.48 116.88 30.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -128.78 155.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.607 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -155.33 125.14 6.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 111.886 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.83 -175.1 25.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.449 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.16 -174.13 21.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.596 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 155.02 4.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 111.4 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.77 20.23 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.28 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -173.9 74.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 130.76 38.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.006 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.462 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 16.1 t60 -43.28 -34.69 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.049 0.928 . . . . 0.0 110.64 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.446 HD13 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.27 138.3 19.85 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.901 -178.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.21 2.78 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.361 2.041 . . . . 0.0 112.719 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.72 48.76 0.08 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.26 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.42 96.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -58.14 -22.43 51.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 136.87 40.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.575 HG12 ' HA3' ' A' ' 116' ' ' GLY . 4.8 mt -73.85 120.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.999 0.428 . . . . 0.0 111.229 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 151' ' ' LYS . 5.4 m-85 -116.28 147.57 41.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.396 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.96 139.51 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.5 p -97.49 -58.9 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.627 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.15 150.86 27.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 111.468 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.87 141.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 mt -74.36 173.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.608 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -87.06 146.29 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.976 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.28 26.1 55.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.1 164.27 45.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.32 66.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 111.201 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.12 -32.01 69.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -56.27 -54.63 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.202 0.525 . . . . 0.0 110.377 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -72.83 -50.75 22.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.092 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.56 -59.58 2.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 111.886 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -55.6 -50.05 62.33 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.169 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.98 19.52 10.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.757 0.313 . . . . 0.0 110.653 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -94.16 79.86 4.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 175.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.4 mt -49.75 129.53 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.159 0.504 . . . . 0.0 111.295 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.5 -24.35 11.35 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.571 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -60.74 129.33 40.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.753 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.9 pttp -117.47 125.28 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.999 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -100.46 132.26 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.116 0.484 . . . . 0.0 110.756 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 -1.28 39.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.158 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 171.35 158.86 0.09 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.831 0.348 . . . . 0.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 20.6 t -116.44 100.07 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.195 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 180' ' ' TYR . 14.2 m-80 68.84 -59.3 0.47 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.225 0.536 . . . . 0.0 109.814 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 97.4 p -163.4 26.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.385 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 5.6 t -102.47 155.02 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-O 121.07 0.462 . . . . 0.0 111.314 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -118.09 79.05 0.3 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.6 mt -77.61 24.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.92 0.391 . . . . 0.0 112.048 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 159' ' ' GLY . 3.3 mt-10 -139.83 38.68 1.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.099 0.476 . . . . 0.0 110.736 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.77 28.62 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.311 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -145.83 -75.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.388 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 172.84 166.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 169' ' ' VAL . 50.9 t-80 -53.99 -29.92 45.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.79 0.328 . . . . 0.0 110.649 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.31 -46.45 49.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.42 -36.89 68.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.97 72.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.443 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.495 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.0 t -72.08 -40.28 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.83 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.92 -36.33 69.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.35 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.42 -26.88 58.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 4.1 pp -82.07 -36.88 27.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.829 0.347 . . . . 0.0 110.377 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 1.0 OUTLIER -75.07 -26.4 59.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.54 -9.59 54.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.188 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.426 ' HB ' HG23 ' A' ' 179' ' ' VAL . 1.2 p -42.34 166.91 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.059 0.457 . . . . 0.0 112.2 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 75.0 t80 -96.95 167.26 11.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -47.83 -29.2 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.315 -179.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.9 91.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 110.7 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.68 148.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.686 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 156' ' ' ASN . 27.6 p90 -103.51 125.23 49.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.179 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -106.75 155.9 19.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.829 -178.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 113.45 24.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.55 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.1 t -102.2 164.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.897 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.05 42.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.64 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.812 -179.754 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.809 0.338 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 125.16 28.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . 0.401 ' OXT' ' HA3' ' A' ' 109' ' ' GLY . 11.6 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.095 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.748 0.309 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.1 m-85 -135.68 170.65 15.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -178.29 125.79 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.415 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -110.22 106.55 16.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.347 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -122.35 -167.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.008 0.432 . . . . 0.0 111.639 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 135.94 44.65 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -120.32 88.97 3.04 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.6 0.714 . . . . 0.0 110.986 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.21 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.886 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASN . 8.5 mtt180 -44.43 105.04 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.82 0.343 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.91 66.11 0.33 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.48 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ARG . 11.2 m-80 77.03 -73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.632 0.253 . . . . 0.0 110.891 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -109.29 30.41 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.67 -176.92 18.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.948 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.27 -51.32 7.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.278 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 97.5 69.12 0.97 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.94 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 5.5 p90 -164.93 155.82 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 m -117.53 138.19 52.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.08 166.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.05 160.7 33.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.51 -132.48 10.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.09 146.95 7.82 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.504 HG22 ' CG2' ' A' ' 69' ' ' THR . 1.3 t -61.76 -16.3 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HB3' HG21 ' A' ' 69' ' ' THR . 30.2 p-10 -102.04 -39.29 7.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.704 0.288 . . . . 0.0 110.92 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.38 76.57 53.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.634 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' CG ' ' HA ' ' A' ' 30' ' ' ASP . 99.8 Cg_exo -43.72 155.55 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.944 2.43 . . . . 0.0 112.344 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 6.0 t60 -122.7 -11.95 8.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.691 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.582 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.16 -58.08 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' ASP . . . -173.74 33.93 0.11 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.088 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' HA ' ' CG ' ' A' ' 26' ' ' PRO . 1.1 t0 81.51 53.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.835 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -118.92 114.8 35.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.695 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 32.3 Cg_exo -59.18 82.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.78 2.32 . . . . 0.0 112.165 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.75 143.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.29 148.27 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -142.61 145.28 33.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.365 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 53' ' ' VAL . 70.9 mt -72.94 144.9 12.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 36' ' ' ILE . 21.8 p -95.49 -43.25 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.655 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 158.46 27.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.202 0.525 . . . . 0.0 111.743 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.437 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -116.92 141.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.85 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.92 133.9 45.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.35 77.82 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.56 2.173 . . . . 0.0 112.189 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.57 -31.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.328 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -61.12 168.95 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.543 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.92 -21.16 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.87 -57.58 11.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.42 69.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -72.05 -37.51 69.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.665 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.74 -20.25 36.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.375 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.05 72.43 1.25 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.985 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.544 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.51 35.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 37.57 -156.91 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.056 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' N ' HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.08 138.09 58.29 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.015 0.436 . . . . 0.0 111.223 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.437 ' CG1' HG13 ' A' ' 39' ' ' ILE . 31.6 m -65.24 -37.85 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.342 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -53.19 -15.27 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.23 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -59.05 170.64 0.83 Allowed 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -123.27 114.11 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 57' ' ' ILE . 14.3 pt -58.6 94.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.03 -29.0 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.878 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.03 125.55 4.59 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' A' ' 86' ' ' LEU . 4.9 m -114.33 118.59 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.648 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER 53.87 41.99 31.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.002 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 66.91 29.56 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.02 136.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -82.5 111.05 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.55 25.6 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -79.65 5.11 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.21 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -163.96 41.32 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.023 0.44 . . . . 0.0 109.908 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.55 143.24 30.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 112.529 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 23' ' ' THR . 21.5 p -49.52 171.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.131 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.441 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.1 t-160 -70.16 -48.66 56.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.861 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -44.14 74.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.81 73.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.55 68.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.392 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 53.9 t -64.96 -36.83 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.64 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.41 -30.64 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.575 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.7 74.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.299 0.571 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -82.13 -25.84 34.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.85 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.35 -32.87 58.88 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.104 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.56 29.87 7.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.41 -24.24 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.64 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.06 -135.33 12.07 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.775 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.9 m -131.24 11.46 4.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 111.566 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 82' ' ' SER . 1.7 mt -151.56 92.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 8' ' ' LEU . 3.5 m -104.26 115.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.71 91.92 7.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HG ' ' CG1' ' A' ' 60' ' ' VAL . 1.7 mp -93.16 144.51 25.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 17.7 t80 -122.81 114.38 20.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.97 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.25 168.48 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 0.0 112.289 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.9 ttt -138.15 109.05 6.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.491 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 90' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.836 0.35 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.94 133.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.7 mmt -112.27 166.48 11.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.54 106.41 7.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.406 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HG13 ' CG2' ' A' ' 183' ' ' VAL . 3.1 mm -114.95 155.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.515 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 4.8 mptt -113.1 126.97 56.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 tt -130.6 118.84 21.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -92.7 144.79 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -69.01 164.42 22.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.159 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.88 -162.52 9.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.786 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.42 -35.28 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.166 1.911 . . . . 0.0 112.554 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 20.54 7.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.957 0.408 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.87 -127.85 9.22 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 1.2 mp -86.77 -30.88 21.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.65 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.69 38.1 3.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.875 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -177.93 160.15 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 111.305 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -110.51 117.06 32.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 45.5 pt -113.43 173.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 111.488 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.419 ' O ' HG21 ' A' ' 129' ' ' ILE . . . -99.07 -176.0 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.368 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.429 ' HA3' ' CD2' ' A' ' 165' ' ' HIS . . . -145.72 143.61 11.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.47 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.22 -66.33 2.43 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.061 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.82 153.29 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.62 -9.78 61.26 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.038 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 168.39 81.17 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.845 0.355 . . . . 0.0 110.122 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 4.1 mt-30 -64.54 -15.1 60.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.331 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.546 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.1 t60 71.82 -54.99 0.67 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.6 0.714 . . . . 0.0 110.612 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 3.9 mt -92.02 143.37 27.56 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.659 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.37 77.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.366 2.044 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 87.77 65.14 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 94.0 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -55.13 -23.46 21.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 p -57.92 120.2 8.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 160' ' ' LEU . 21.9 mt -70.56 122.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.456 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.6 m-85 -111.84 151.01 29.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.962 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -86.31 121.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.304 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 p -79.28 -59.06 2.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.649 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -151.12 152.75 33.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 141' ' ' HIS . 2.5 mt -118.19 141.38 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.844 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.454 ' O ' ' CE1' ' A' ' 141' ' ' HIS . 1.5 mt -75.31 172.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -103.7 30.45 5.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.822 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.04 -28.61 58.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.65 10.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.672 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.01 -82.35 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.937 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.06 -31.71 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.3 m170 -52.15 -62.2 1.79 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -42.14 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.577 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.21 -59.36 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -70.84 -41.16 63.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.198 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.37 22.34 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 0.0 110.536 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -95.71 85.45 4.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.92 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.45 166.67 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.523 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.1 mt -47.44 116.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.262 0.553 . . . . 0.0 111.38 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.89 -14.42 6.33 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.666 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.418 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -73.92 120.06 18.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.787 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.45 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -99.96 122.8 43.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.671 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -101.33 118.54 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.211 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.58 -0.64 47.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.744 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 175.18 159.25 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.513 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 45.6 t -121.73 98.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.276 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' HB ' ' A' ' 179' ' ' VAL . 31.8 m-80 69.27 -57.19 0.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 m -147.01 -20.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -76.16 140.72 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.408 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.73 12.68 33.77 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.897 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 152' ' ' ILE . 24.7 mt 38.96 33.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.229 0.538 . . . . 0.0 111.985 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.52 68.48 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -162.92 26.49 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -161.9 -82.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.674 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.65 170.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.049 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.429 ' CD2' ' HA3' ' A' ' 116' ' ' GLY . 0.2 OUTLIER -54.03 -30.6 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -47.92 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.995 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.37 -32.37 62.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.816 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.7 t -70.03 -40.5 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.559 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.08 -30.43 66.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.672 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.98 -25.83 48.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -40.69 23.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -26.63 58.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.068 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -21.4 65.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 47.7 p -54.73 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -100.88 171.33 7.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -58.48 -14.51 8.04 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.429 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.4 t -147.55 90.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 0.0 110.288 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.421 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -120.15 148.49 23.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.729 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -100.03 127.62 46.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.23 153.96 22.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.981 0.419 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -96.59 119.04 34.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.398 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 39.2 t -101.82 164.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.91 140.74 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.691 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.436 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' SER . . . . . 0.424 ' OG ' ' CD2' ' A' ' 165' ' ' HIS . 21.8 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.862 0.363 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 35.9 t -83.63 109.57 17.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.952 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.907 0.384 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -151.46 145.85 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.577 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -176.82 156.27 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.402 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -86.5 167.74 14.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.454 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -164.94 165.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.944 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.48 126.34 24.08 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.992 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 1.6 tp -122.01 88.58 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.457 0.646 . . . . 0.0 111.367 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pm0 -73.66 152.35 40.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -67.32 93.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.717 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.07 -25.46 10.38 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.638 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.62 -91.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -109.1 30.8 6.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.14 -178.98 25.37 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.135 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.34 -47.59 10.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.816 0.341 . . . . 0.0 111.293 -179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.36 74.18 1.25 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.084 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -164.85 169.34 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.312 . . . . 0.0 110.922 178.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.27 130.8 53.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.459 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.54 164.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 164.1 9.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.84 -119.22 4.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.99 145.06 14.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.427 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.508 HG21 ' HA ' ' A' ' 68' ' ' VAL . 1.3 t -53.9 -24.75 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.73 -55.99 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -120.25 83.06 31.67 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.49 132.01 29.0 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.437 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 25.8 t60 -68.05 -21.38 65.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.508 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.72 -28.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.118 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 29.65 12.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.37 33.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -173.03 111.05 0.34 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.92 -27.91 50.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.126 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.79 128.02 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.19 150.34 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.48 151.09 41.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 77.2 mt -77.13 146.17 9.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.257 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.424 ' N ' HG22 ' A' ' 36' ' ' ILE . 66.0 m -99.77 -35.98 9.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.541 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.03 158.29 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.513 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mt -115.94 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.0 mt -85.76 123.71 71.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -66.18 63.52 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.23 -54.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.485 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.21 -175.77 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 -27.53 57.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 111.369 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -57.56 -29.19 64.22 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.063 0.459 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.86 -27.45 49.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.46 -43.5 66.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.018 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -31.65 15.95 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.17 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 84.48 -27.56 4.64 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER 45.21 30.37 0.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.865 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp 65.17 -173.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 131.1 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.763 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 34.4 m -53.5 -37.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.731 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -62.15 -3.93 1.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.354 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -58.34 175.3 0.24 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 110.671 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.9 t -130.24 102.78 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.02 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 3.2 mt -59.84 -35.39 74.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 1.5 m-85 -158.57 123.57 4.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.409 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -114.16 119.85 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 53.8 37.52 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.67 30.34 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.88 133.74 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' CZ ' ' A' ' 59' ' ' PHE . 1.4 m-20 -72.79 77.64 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 60' ' ' VAL . 21.1 t -107.65 35.11 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.055 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -101.08 1.04 38.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.083 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -156.1 33.74 0.34 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.758 0.314 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 ' HA ' HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -124.0 158.28 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 23' ' ' THR . 7.3 m -50.07 163.08 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.056 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 t-160 -61.34 -48.56 80.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.834 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 t -52.73 -35.87 56.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.07 77.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.964 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.62 67.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.221 0.534 . . . . 0.0 109.652 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 42.0 t -64.4 -36.01 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.4 -33.39 72.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.815 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.76 75.71 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.435 0.636 . . . . 0.0 110.476 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.69 -26.92 40.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.552 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.63 -37.85 67.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.955 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.34 25.79 7.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.401 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.95 -23.67 23.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.18 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.27 -152.3 22.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 83' ' ' ILE . 3.9 m -101.51 11.74 38.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.497 0.189 . . . . 0.0 111.338 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -151.53 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.5 t -90.59 149.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 102.29 4.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.976 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.9 154.01 50.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE1' ' N ' ' A' ' 4' ' ' GLU . 1.3 t80 -105.68 114.8 29.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.614 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.45 168.03 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.324 0.583 . . . . 0.0 112.414 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.25 109.66 7.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.134 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.064 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 121.024 0.44 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.26 144.49 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.268 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.0 166.41 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.424 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -133.19 106.6 7.68 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mm -115.57 155.92 16.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.742 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.95 126.07 54.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.104 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 6.4 tt -126.38 118.54 25.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.4 pt -96.84 144.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.034 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.45 158.44 36.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -136.02 -175.11 13.65 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.869 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.51 -40.75 9.85 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.269 1.98 . . . . 0.0 112.31 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -91.99 19.97 6.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.488 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.02 -141.27 15.22 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 6.6 mp -86.53 -22.35 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.926 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.43 58.39 3.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.887 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.96 155.43 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.7 t -116.38 116.9 28.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 10.3 pt -134.16 154.82 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.091 0.472 . . . . 0.0 112.048 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.573 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.94 -174.99 25.51 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.494 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.63 -176.54 52.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.536 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.0 t -81.45 154.8 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.931 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.06 6.1 81.96 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.19 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -168.69 52.97 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.394 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -33.35 -43.47 0.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 47.6 t60 73.28 -45.53 0.62 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.027 0.918 . . . . 0.0 108.891 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 121' ' ' GLN . 0.6 OUTLIER -122.65 130.85 24.48 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.161 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.24 89.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.445 2.097 . . . . 0.0 112.919 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.95 44.93 4.97 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.217 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -150.71 78.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.195 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -53.92 -22.97 11.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.218 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -55.31 145.49 21.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.573 HG12 ' HA3' ' A' ' 116' ' ' GLY . 8.2 mt -80.03 117.43 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.534 ' CD2' HD13 ' A' ' 123' ' ' ILE . 4.1 m-85 -114.92 156.25 25.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.521 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.52 155.63 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.212 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.17 -32.51 1.8 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -160.66 145.63 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.842 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.413 HG22 ' CD2' ' A' ' 141' ' ' HIS . 5.1 mt -131.64 141.8 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.74 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -73.54 175.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -99.47 139.71 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.48 29.18 60.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.583 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.91 -132.45 1.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.578 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.38 -61.29 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.934 0.397 . . . . 0.0 111.184 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -67.15 -31.4 71.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.413 ' CD2' HG22 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -51.81 -60.39 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -46.12 54.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.305 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.48 -59.5 2.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -62.31 -44.93 96.97 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.262 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 145' ' ' ARG . 0.7 OUTLIER 61.26 20.34 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -91.75 82.79 5.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.709 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 169.84 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.751 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.91 121.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.276 0.56 . . . . 0.0 111.235 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.5 -22.5 6.19 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.376 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -68.85 124.97 25.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -112.73 128.96 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.71 130.72 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.072 0.463 . . . . 0.0 110.538 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.4 pp -98.42 -1.16 42.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.294 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 172.19 152.6 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.719 0.295 . . . . 0.0 111.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 40.2 t -107.4 99.7 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 68.9 m-80 69.18 -59.44 0.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.319 0.58 . . . . 0.0 109.739 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.02 27.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.172 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.478 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 11.5 t -100.6 155.22 4.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.277 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.0 77.4 0.28 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.11 24.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.94 0.4 . . . . 0.0 111.928 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -139.73 32.7 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 110.652 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.79 28.05 1.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -143.29 -77.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 174.74 165.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.605 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.41 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 2.9 p-80 -53.9 -30.7 47.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -45.2 54.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.279 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.66 -37.08 68.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.107 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 13.4 t -73.81 -42.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.43 -33.01 69.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.78 -27.71 50.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.465 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -36.72 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -26.85 60.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.519 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.1 -9.89 59.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.293 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 69.9 p -52.59 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.926 0.393 . . . . 0.0 111.515 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -103.61 169.8 8.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t70 -54.31 -18.85 4.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.4 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.58 92.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.94 148.19 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 112.006 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -95.65 127.16 41.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 179.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.87 144.32 33.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 0.0 110.869 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 112.45 24.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.153 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.91 161.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.09 28.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 97.6 p -91.23 119.33 31.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.327 -0.845 . . . . 0.0 111.195 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.27 162.69 26.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.7 161.49 2.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.639 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 165.33 14.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.568 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.455 HG22 ' NH2' ' A' ' 50' ' ' ARG . 2.0 tt -164.45 166.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 111.809 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -133.82 138.96 45.97 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.677 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.515 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -135.73 86.73 2.26 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.596 0.712 . . . . 0.0 110.99 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -76.63 155.23 33.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.248 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -66.3 86.7 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.85 -26.03 10.41 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.781 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.25 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 m -109.12 30.81 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.0 -179.09 27.05 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -84.33 -42.74 15.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.822 0.344 . . . . 0.0 111.407 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.01 64.81 1.34 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 114.042 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 6.0 p90 -161.78 139.57 8.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 110.594 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.9 m -91.76 130.98 37.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.689 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.56 163.59 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.634 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 164.0 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.371 . . . . 0.0 111.378 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.79 -113.84 2.38 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.534 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.96 141.45 9.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.293 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -56.2 -21.26 22.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.609 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 38.0 t0 -93.53 -43.92 8.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -123.83 78.48 57.27 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.207 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.3 142.15 9.35 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.708 2.272 . . . . 0.0 112.633 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -74.97 -19.41 60.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.495 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.87 -27.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.274 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.09 28.89 9.45 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -171.14 32.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.6 111.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.6 -29.03 52.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.707 2.271 . . . . 0.0 112.009 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -62.26 169.59 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.59 149.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.981 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.495 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 10.3 p90 -142.84 144.71 32.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.578 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 57.9 mt -72.69 146.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.119 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.413 ' N ' HG23 ' A' ' 36' ' ' ILE . 16.6 m -101.19 -33.17 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.598 0.237 . . . . 0.0 111.508 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.94 152.67 5.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.447 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -116.36 141.25 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -92.74 141.49 24.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.78 61.58 6.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.513 2.142 . . . . 0.0 112.392 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.23 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.462 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.99 175.64 23.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.709 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.11 -15.33 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -55.81 -57.46 11.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.95 0.405 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -28.55 69.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.933 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -71.92 -35.72 69.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -84.88 -25.37 28.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.009 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 82.37 56.07 2.91 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.392 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 42.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.2 pp 33.34 -153.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -63.81 144.29 57.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.791 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.469 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 35.2 m -70.61 -37.62 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.515 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -54.86 -13.95 1.26 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -57.45 163.1 2.5 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.6 p -122.16 110.48 15.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.707 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.9 pt -58.99 94.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 5.8 mt -65.14 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.037 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.403 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 9.3 m-85 -146.18 168.6 20.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.105 0.479 . . . . 0.0 111.83 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -147.18 -177.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.547 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -53.96 82.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 110.675 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER 65.5 26.74 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 2.5 t -121.24 141.86 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 111.368 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.49 76.36 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.777 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 m -99.48 31.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.356 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -12.88 59.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -173.37 56.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.117 0.484 . . . . 0.0 109.706 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 19.1 m -117.31 140.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.5 m -50.25 169.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.201 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 1.8 t-160 -51.08 -48.75 61.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -51.63 -47.9 63.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.862 0.363 . . . . 0.0 111.536 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -60.24 -32.46 71.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.86 64.46 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.616 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 43.0 t -65.1 -35.22 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.739 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.32 -32.17 71.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.822 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.13 73.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.4 0.619 . . . . 0.0 110.385 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.559 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.08 -39.51 68.93 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.383 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.26 29.06 7.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.628 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.49 34.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.304 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.53 -132.43 11.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.499 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 83' ' ' ILE . 5.4 m -125.97 5.72 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.501 0.191 . . . . 0.0 111.397 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -151.06 91.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' THR . 1.7 t -93.75 148.56 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.035 0.445 . . . . 0.0 111.897 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 108.28 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -130.3 153.8 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 112.629 -178.056 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.32 115.11 29.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.298 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 27.1 m -104.24 168.07 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.442 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -127.08 109.51 11.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.954 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.731 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.795 0.331 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.96 116.65 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.472 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 tpt -101.31 166.04 10.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.485 0.659 . . . . 0.0 111.942 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -137.32 106.59 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.56 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.459 HG23 ' HA3' ' A' ' 144' ' ' GLY . 3.7 mm -113.22 155.13 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 180' ' ' TYR . 5.5 tttt -120.89 119.11 31.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.966 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tt -120.67 118.7 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.48 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -95.13 144.75 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.597 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -55.69 143.63 29.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.975 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -175.46 14.09 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.814 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.59 -38.9 3.98 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 121.978 1.785 . . . . 0.0 112.1 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 18.32 11.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.479 . . . . 0.0 110.302 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.64 11.12 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.08 -27.31 23.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.886 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.7 47.24 4.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.93 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.07 149.23 0.55 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.922 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -109.2 124.31 50.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -135.76 155.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -152.39 125.15 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.429 . . . . 0.0 111.868 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.69 -174.99 25.31 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.195 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.11 -179.5 46.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.196 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.4 ' HB ' ' HG2' ' A' ' 164' ' ' MET . 39.5 t -78.99 145.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.758 0.313 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.9 -32.12 5.81 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.624 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 2.7 t-20 -157.11 66.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.67 -4.18 22.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.96 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.2 t60 72.28 -57.71 0.61 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.449 0.642 . . . . 0.0 110.478 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 130' ' ' TYR . 1.3 mt -91.67 128.43 46.35 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.442 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.57 74.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.421 2.08 . . . . 0.0 112.423 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 117.93 47.74 0.43 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.84 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.98 93.75 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.839 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -56.86 -22.08 34.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.308 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -56.02 151.13 12.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.575 HG12 ' HA3' ' A' ' 116' ' ' GLY . 6.4 mt -89.02 119.44 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.335 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.484 ' CD1' HD12 ' A' ' 123' ' ' ILE . 5.2 m-85 -115.77 155.09 28.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.29 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.33 155.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.739 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.4 p -117.62 -57.89 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.486 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 146.28 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.66 141.38 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.883 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -79.29 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.05 143.38 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.05 22.88 65.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.56 -173.82 23.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.37 -69.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -63.28 -31.63 72.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 23.4 t-160 -53.38 -62.1 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.993 0.425 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -38.2 67.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.178 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.33 -59.29 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 145' ' ' ARG . . . -80.81 -18.87 69.16 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.006 -0.616 . . . . 0.0 114.024 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER 50.95 26.99 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.15 0.475 . . . . 0.0 110.791 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.4 81.25 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.59 175.14 3.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.536 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.0 mt -46.85 126.5 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.25 0.548 . . . . 0.0 111.293 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 120.12 -23.21 8.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.514 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.84 159.23 20.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.678 0.275 . . . . 0.0 110.456 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -145.82 138.8 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.004 0.431 . . . . 0.0 111.388 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -105.3 132.22 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.491 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.62 -1.87 37.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.292 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 169.71 154.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.204 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 35.4 t -108.61 99.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.875 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 68.6 m-80 69.53 -59.51 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.404 0.621 . . . . 0.0 109.578 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.9 p -164.33 28.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.028 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 10.5 t -102.33 155.09 5.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.489 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.85 76.74 0.25 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.304 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -81.09 25.76 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.46 56.2 1.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.333 0.587 . . . . 0.0 110.796 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -165.29 29.37 0.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.352 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.2 t -141.59 -76.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.553 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.4 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 176.62 167.76 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.605 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 120' ' ' ASN . 10.8 t-80 -54.46 -30.11 51.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.69 -49.16 27.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.049 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.66 -33.12 68.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.033 0.444 . . . . 0.0 110.225 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.23 -41.17 73.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.487 0.66 . . . . 0.0 109.484 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.9 t -69.03 -43.99 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.153 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -32.44 71.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.222 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.42 48.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.983 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -38.47 26.93 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -75.19 -26.66 59.19 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.924 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.53 -9.91 52.25 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.399 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 p -42.85 147.21 0.32 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -90.34 170.47 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -44.93 -32.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.9 t -148.22 91.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.389 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.22 148.32 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 0.0 111.925 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 102' ' ' LYS . 7.8 m-85 -101.71 133.35 46.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.771 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -118.98 149.62 41.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.941 0.401 . . . . 0.0 111.092 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -96.52 112.02 23.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.78 159.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.328 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.27 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.829 0.347 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 98.7 p -86.28 110.77 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.038 179.858 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.876 0.369 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.49 164.04 35.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -179.79 152.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.454 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -84.11 148.66 26.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 6' ' ' ILE . 19.3 mt -148.44 152.84 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.239 0.542 . . . . 0.0 111.834 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -116.21 130.28 56.72 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.9 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 3.7 tp -134.98 91.5 2.76 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.608 0.718 . . . . 0.0 110.451 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 mt-10 -69.6 168.86 13.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.721 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 2.6 mtt180 -72.63 104.26 3.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -69.69 65.74 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.108 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 75.83 -76.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.261 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -109.31 30.53 6.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.4 -177.95 17.2 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -84.5 -52.28 6.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.28 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 78.14 1.4 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.845 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.74 155.76 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.74 0.305 . . . . 0.0 110.732 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 m -109.29 126.84 53.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.7 pt -120.73 164.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.755 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.75 157.84 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 0.0 111.305 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.93 -118.11 3.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.265 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 144.46 11.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.9 t -57.37 -19.27 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.555 0.217 . . . . 0.0 111.483 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 3.7 m-20 -88.78 -54.7 4.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.868 0.366 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -120.33 81.83 30.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.9 138.04 21.42 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.643 2.229 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 18.5 t60 -70.02 -19.55 63.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.552 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.29 -30.43 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.49 28.79 8.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.496 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.91 33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.07 112.66 1.04 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 23.7 Cg_exo -64.29 -29.32 63.72 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.739 2.293 . . . . 0.0 112.135 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 176.29 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.789 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 152.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 2.2 p90 -139.79 168.56 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 46.6 mt -95.45 153.44 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.501 ' N ' HG23 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.68 -31.33 7.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 9.7 tmtt? -171.32 150.21 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 0.0 111.594 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.407 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -110.58 141.34 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.846 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.9 mt -85.81 123.5 72.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 20.2 Cg_exo -65.59 64.79 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.558 2.172 . . . . 0.0 112.218 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.17 -51.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.508 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.39 174.08 5.12 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.438 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -59.23 -34.6 72.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 0.0 111.369 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.24 63.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.623 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -71.9 -39.16 69.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.682 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 49' ' ' GLY . 1.2 m-20 -85.96 -28.17 24.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 19.38 59.27 0.01 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.941 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -111.61 -15.35 13.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -118.36 167.72 11.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.061 0.458 . . . . 0.0 111.281 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -107.75 159.05 16.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.049 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.4 m -70.88 -48.25 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 112.023 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.22 1.37 0.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -84.52 160.91 20.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.21 113.22 18.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 110.735 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.539 ' O ' HG13 ' A' ' 57' ' ' ILE . 16.6 pt -56.27 95.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -21.79 66.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.757 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 2.5 t80 -155.78 145.35 21.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -129.56 117.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.722 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 56.77 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 60' ' ' VAL . 29.1 mt-10 -150.76 30.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 21.4 t -120.86 141.69 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 4.8 m-20 -77.39 90.58 3.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' CG1' HG22 ' A' ' 60' ' ' VAL . 15.0 p -103.2 33.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.423 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 6.04 38.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 173.87 53.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 0.0 110.011 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.64 141.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.004 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.0 OUTLIER -49.95 157.85 0.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.466 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -51.58 -48.57 63.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.508 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -55.8 -42.69 76.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.37 69.13 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.547 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 47.5 t -64.6 -35.55 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.649 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -33.71 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.839 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.46 73.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.393 0.616 . . . . 0.0 110.491 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.57 -26.76 55.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.42 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -69.95 -38.56 76.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.067 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.27 27.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.442 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.23 -25.15 25.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.329 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.7 -152.91 30.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.656 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.489 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -101.82 11.09 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.641 0.258 . . . . 0.0 111.438 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -150.64 92.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.8 t -85.23 148.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.401 0.62 . . . . 0.0 111.869 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -138.16 84.13 2.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.562 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 1.7 pp -115.6 154.02 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.397 0.618 . . . . 0.0 112.569 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CE1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -104.84 114.84 29.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.608 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 33.0 m -105.83 167.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.121 0.486 . . . . 0.0 112.193 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.4 ttp -131.62 109.44 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.312 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 179.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.742 0.306 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.94 125.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.84 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.3 mtm -102.18 164.14 11.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.337 0.589 . . . . 0.0 112.08 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -127.98 106.8 9.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.492 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.2 mm -115.86 155.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 180' ' ' TYR . 9.9 tttp -117.15 118.65 32.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.376 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 7.9 tt -115.69 118.71 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.137 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.5 pt -98.42 144.69 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -74.64 161.18 29.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.965 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.08 -168.66 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.849 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.09 -40.02 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.076 1.851 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -93.75 20.58 7.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.81 -142.83 15.56 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.404 HD22 ' CE1' ' A' ' 112' ' ' PHE . 10.2 mp -86.65 -21.31 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.869 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.84 50.77 8.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.52 148.01 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 111.029 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.3 t -107.01 116.9 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 48.2 pt -115.38 173.6 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' CB ' ' CB ' ' A' ' 122' ' ' HIS . . . -99.13 -176.53 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.82 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.445 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -143.15 149.14 21.08 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.103 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.47 -94.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.072 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.411 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 34.3 t -87.38 148.63 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.28 -21.19 41.73 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.388 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.93 69.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.259 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -59.83 -19.85 53.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.274 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 49.6 t60 72.51 -52.62 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 110.817 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 3.2 mt -93.3 141.09 23.53 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.839 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.7 83.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.4 2.067 . . . . 0.0 112.233 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 80.01 62.13 2.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.797 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -159.91 93.22 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -55.98 -22.34 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.269 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -54.67 122.88 11.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 110.778 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 160' ' ' LEU . 17.1 mt -72.19 117.8 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.085 0.469 . . . . 0.0 111.744 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.485 ' CD1' ' CB ' ' A' ' 151' ' ' LYS . 3.8 m-85 -111.95 153.9 26.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.05 134.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.25 -45.35 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -122.09 132.59 54.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 111.745 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -137.36 128.63 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.943 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -74.74 173.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.35 15.19 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.616 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.85 -157.41 3.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.583 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.54 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.17 -31.81 69.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.379 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -55.3 -58.06 9.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.196 0.522 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.8 -47.5 45.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.041 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.69 -59.42 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.24 -35.87 91.55 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.19 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 61.1 20.13 10.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.875 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.72 81.28 3.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.798 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.68 176.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.508 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.9 mt -47.82 129.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.214 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 116.28 -24.92 9.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.532 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -63.99 133.44 53.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.349 . . . . 0.0 110.749 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -122.9 130.1 52.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.53 137.03 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.849 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 2.6 pp -98.91 -2.71 36.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.762 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 165.4 147.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.124 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 181' ' ' LEU . 47.5 t -101.36 99.69 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 69.44 -58.73 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 109.666 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.3 p -163.1 25.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.728 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 23.9 t -91.59 156.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-O 121.364 0.602 . . . . 0.0 111.524 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -99.29 74.05 0.51 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.749 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.57 ' O ' HG13 ' A' ' 129' ' ' ILE . 37.7 mt -70.61 24.1 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.717 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.551 ' H ' ' C ' ' A' ' 159' ' ' GLY . 8.3 pt-20 -176.26 56.63 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.3 0.572 . . . . 0.0 110.924 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -161.48 27.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.573 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.451 ' O ' ' HG3' ' A' ' 164' ' ' MET . 0.4 OUTLIER -153.23 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.146 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.5 mtp 173.06 164.48 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.482 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.405 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 2.6 p-80 -53.83 -29.86 42.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.939 0.399 . . . . 0.0 110.446 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.57 -45.41 53.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.151 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.22 -35.66 66.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.968 0.413 . . . . 0.0 110.604 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.71 73.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.776 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 14.0 t -74.01 -39.94 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.493 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.82 68.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.671 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.36 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -80.79 -36.79 31.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -26.88 60.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.493 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.26 -12.8 60.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.207 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 70.9 p -55.66 -172.59 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 111.341 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -107.68 170.22 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -55.47 -16.96 4.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.347 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.88 92.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.92 148.41 20.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.071 0.463 . . . . 0.0 111.987 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -94.81 131.19 40.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.28 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -118.36 146.99 43.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 108.11 20.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.6 t -102.71 157.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.062 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.83 44.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.7 p -94.22 116.38 28.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.123 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.47 25.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 179.28 156.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.54 158.45 35.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.313 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.428 HG23 ' HG3' ' A' ' 50' ' ' ARG . 3.5 mt -152.78 142.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.294 0.568 . . . . 0.0 111.942 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -122.22 119.38 31.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.965 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 3.1 tp -125.31 93.96 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.637 0.732 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -79.08 165.32 23.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.911 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.9 93.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.67 -25.89 9.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.595 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -173.53 -85.6 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 30.6 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.622 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 177.02 18.59 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.213 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.22 -43.45 14.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 -179.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 92.95 71.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.713 . . . . 0.0 114.078 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.77 155.27 14.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.794 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -112.97 126.96 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.446 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.49 164.07 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.26 142.31 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 136.76 -126.89 3.89 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.71 128.47 4.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 69' ' ' THR . 2.2 t -49.58 -25.78 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -91.75 -40.92 10.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.038 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.82 77.24 57.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.67 134.89 34.22 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.644 2.23 . . . . 0.0 112.413 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 28.0 t60 -68.51 -21.41 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.61 -31.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.12 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.02 28.34 8.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.597 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -176.69 36.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 4.7 t0 -162.38 95.67 1.2 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.3 Cg_endo -55.68 -23.71 42.15 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.458 2.106 . . . . 0.0 112.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 159.27 32.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.01 150.77 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.4 p90 -142.53 144.96 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 64.8 mt -74.43 147.25 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' N ' HG21 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -96.59 -46.52 6.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.62 -179.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.44 158.29 39.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.093 0.473 . . . . 0.0 111.671 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -111.09 141.23 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.7 mt -84.5 118.16 70.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.22 76.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.42 2.08 . . . . 0.0 112.099 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . 174.22 -45.62 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.422 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.62 -178.47 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 -28.41 57.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.588 0.232 . . . . 0.0 111.396 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -55.74 -43.6 76.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.959 0.409 . . . . 0.0 110.749 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.09 65.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.866 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -71.57 -40.89 69.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.695 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -25.01 25.45 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.273 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.87 -39.24 2.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.597 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 35.23 37.05 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.348 0.594 . . . . 0.0 111.095 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 40.99 -162.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.401 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.32 146.88 54.35 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.243 0.544 . . . . 0.0 111.8 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.443 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . 19.6 m -71.0 -36.0 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.329 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -54.36 -15.12 1.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.103 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -57.17 178.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.477 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 t -136.97 110.45 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.543 ' O ' HG13 ' A' ' 57' ' ' ILE . 14.2 pt -58.96 95.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -21.98 66.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.542 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -157.18 148.36 21.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -142.69 125.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 45.85 47.94 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 64.69 26.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 16.8 t -120.79 141.76 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.016 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.63 127.47 35.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 34.3 m -143.71 32.52 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.076 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -76.29 2.38 13.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.555 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -173.28 46.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.108 0.48 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 35.6 m -110.6 141.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.754 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.437 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.0 OUTLIER -50.23 160.89 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.706 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.437 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -50.97 -48.58 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.404 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.61 -40.86 63.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.933 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.84 75.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.373 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.17 69.14 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.429 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 47.9 t -64.64 -36.06 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.54 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 7.8 mt-10 -69.54 -33.12 72.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.787 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.34 -42.81 74.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.424 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.84 -26.84 54.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.352 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.65 -44.53 61.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.098 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.27 29.19 5.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.04 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.87 58.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.444 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.51 32.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.474 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.48 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -108.76 5.51 24.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.1 mt -155.85 93.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' THR . 30.2 m -95.13 111.46 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 68.64 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . 4.4 pp -89.21 153.97 20.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.636 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.45 120.13 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.476 178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.6 m -117.67 167.87 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 112.458 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.1 ptm -147.89 109.21 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.845 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 26.1 ttp180 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 111.167 0.062 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.31 151.25 4.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 111.833 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.92 166.85 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.858 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -122.46 106.82 11.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.403 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 1.6 mm -119.25 155.55 21.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.519 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 5.1 tttt -111.74 127.16 55.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.687 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.43 118.56 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.2 pt -100.73 144.72 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -65.44 152.77 43.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.798 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -132.37 157.71 22.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.829 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.52 -33.72 69.22 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.046 1.831 . . . . 0.0 112.16 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.05 18.38 13.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.25 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.33 -148.28 16.73 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.56 -17.99 32.63 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.166 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.01 51.95 9.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.081 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.33 145.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.654 0.264 . . . . 0.0 110.695 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.2 t -110.95 116.75 31.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.737 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.47 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 7.3 pt -126.99 153.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -149.06 125.02 10.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.0 111.789 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.76 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.71 -175.09 25.44 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.199 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 121' ' ' GLN . . . 111.75 -178.43 19.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.352 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.49 144.4 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.709 0.29 . . . . 0.0 111.349 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.04 -21.17 46.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.541 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 173.0 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.501 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 117' ' ' GLY . 9.7 pm0 -103.4 -179.66 4.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.086 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 68.0 t60 -57.95 -50.24 74.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.042 0.925 . . . . 0.0 110.662 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.49 ' CD1' ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -102.61 102.86 28.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.033 -178.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.42 92.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.371 2.047 . . . . 0.0 112.237 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.99 20.87 3.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.935 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -155.64 91.3 1.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -49.99 -25.86 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 p -54.01 116.32 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.76 HG12 ' HA3' ' A' ' 116' ' ' GLY . 5.6 mt -61.61 121.08 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.49 ' CG ' ' CD1' ' A' ' 123' ' ' ILE . 3.2 m-85 -114.34 156.75 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.13 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.1 155.5 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.691 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.5 p -119.87 -57.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -148.87 148.28 29.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.72 139.04 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.56 173.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -90.86 149.52 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.0 25.33 45.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.4 54.13 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.511 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.36 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.03 -32.02 69.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -59.24 -45.74 90.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 110.145 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -72.71 -57.07 4.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.572 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.32 -59.24 2.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.03 -49.16 43.83 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.889 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 63.13 18.11 10.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.597 0.237 . . . . 0.0 111.039 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.416 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -93.85 78.26 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.73 177.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.1 mt -47.2 134.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.084 0.468 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.44 13.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.539 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.2 m-20 -63.37 140.58 58.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.337 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -125.31 131.74 53.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.054 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.1 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 pp -96.6 -1.55 46.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.353 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 174.49 158.74 0.17 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 111.223 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.414 ' CG1' ' ND2' ' A' ' 156' ' ' ASN . 22.7 t -118.65 100.07 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.488 HD22 ' HB ' ' A' ' 179' ' ' VAL . 13.0 m-80 70.41 -59.36 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 109.665 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 p -165.57 28.33 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.123 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 4.2 t -103.11 154.81 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.367 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -116.85 78.6 0.29 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.557 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.52 23.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER -140.85 40.3 1.83 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.095 0.474 . . . . 0.0 110.803 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.35 28.38 0.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.459 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.1 t -148.75 -76.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 174.98 169.69 0.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.666 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -55.86 -29.94 60.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.79 38.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.332 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.446 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.78 -36.93 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 110.571 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.71 73.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.489 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.3 t -71.5 -39.94 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.93 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.03 -25.98 56.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.304 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -80.32 -36.83 33.72 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -73.0 -26.87 61.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.385 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.82 -9.88 58.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.315 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.8 p -45.56 159.59 0.06 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.633 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -92.6 168.94 10.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.197 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.23 -34.18 6.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.396 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.3 t -148.1 90.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 0.0 110.757 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.488 ' HB ' HD22 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -123.49 148.58 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 111.504 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 36.6 p90 -92.27 132.27 36.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.01 153.86 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.432 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -96.68 114.38 26.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.787 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.02 163.91 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -145.56 149.86 35.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.396 0.617 . . . . 0.0 112.161 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.005 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 36.8 m -85.71 118.64 25.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.362 -0.828 . . . . 0.0 111.086 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.934 0.397 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.07 128.2 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -178.03 174.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.414 . . . . 0.0 111.641 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -93.55 149.67 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.632 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.3 mt -148.05 150.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 111.561 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.9 OUTLIER -115.27 119.87 37.78 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.665 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 10.9 tp -121.91 93.62 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.45 0.643 . . . . 0.0 110.097 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -75.27 151.4 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.001 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -72.02 103.87 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.9 -26.89 6.09 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.774 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -169.47 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 p -109.28 30.73 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.39 173.73 17.89 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.519 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.4 -50.02 8.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.753 0.311 . . . . 0.0 111.138 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.93 79.15 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.674 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.503 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -164.7 159.2 18.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.607 178.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HG21 ' A' ' 36' ' ' ILE . 30.8 t -112.74 126.85 55.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.7 pt -118.21 171.71 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.62 149.02 2.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.44 -120.66 4.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.196 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.23 145.68 13.86 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.686 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.489 ' N ' ' HA ' ' A' ' 69' ' ' THR . 1.2 t -50.67 -24.94 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.682 0.277 . . . . 0.0 111.472 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 19.2 t0 -86.68 -48.2 8.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.213 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.89 80.36 56.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 126.64 19.12 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.596 2.197 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 35' ' ' PHE . 17.0 t60 -67.3 -19.42 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.487 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.87 -26.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.14 34.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -168.32 111.56 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.83 -28.73 59.01 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.151 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -72.88 144.21 47.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.0 mt -93.55 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.39 153.5 43.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.544 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 59.9 mt -84.8 150.74 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.473 ' N ' HG22 ' A' ' 36' ' ' ILE . 61.2 p -100.02 -46.61 5.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.871 0.367 . . . . 0.0 111.037 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.07 155.92 31.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.344 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.427 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mt -113.87 141.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.927 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 40' ' ' ILE . 3.8 mt -84.25 134.43 43.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.55 60.38 5.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.094 . . . . 0.0 112.301 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.7 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.65 168.81 26.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.58 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -25.86 67.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 111.506 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.4 -57.54 12.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.2 -28.27 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.956 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -72.1 -41.95 66.68 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -72.61 -33.27 66.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.414 178.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 29.31 39.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.838 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.8 ptm180 -98.69 28.45 4.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -176.43 164.89 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.002 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.89 164.09 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.656 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -70.93 -47.27 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.015 0.436 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -58.87 -4.85 0.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -62.31 175.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.312 -0.242 . . . . 0.0 110.552 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 p -141.52 106.03 4.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.134 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -54.55 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.429 0.633 . . . . 0.0 111.159 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.32 -25.66 63.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.118 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.5 t80 -163.87 144.03 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.711 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 61' ' ' ASN . 1.1 p -103.92 -176.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.012 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 60' ' ' VAL . 7.7 m120 -21.59 -51.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.601 0.563 . . . . 0.0 111.857 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 tt0 -163.72 27.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.702 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.463 ' HB ' HG11 ' A' ' 60' ' ' VAL . 2.8 t -121.59 142.0 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.693 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 23.5 p30 -79.63 84.34 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.058 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.04 26.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.02 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -95.91 9.26 41.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.286 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -166.14 37.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.256 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.68 141.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.9 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' N ' ' A' ' 23' ' ' THR . 3.8 m -50.34 166.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.5 t-160 -59.09 -48.71 80.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.2 m -60.73 -36.86 79.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.33 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.976 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.08 -42.32 66.33 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.65 -35.96 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.806 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.49 -33.2 72.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.798 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.53 -42.4 74.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 110.416 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.18 -26.85 47.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.439 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -71.71 -40.03 69.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.072 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.07 26.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.525 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.08 -19.49 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.342 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.37 -120.03 6.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.637 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -137.17 18.13 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.548 0.213 . . . . 0.0 111.244 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.76 94.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 7' ' ' THR . 34.8 m -90.39 112.75 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -101.2 80.9 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 1.7 pp -109.79 153.08 24.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.258 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 4.7 t80 -102.04 114.66 28.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.847 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.05 167.98 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.209 0.528 . . . . 0.0 112.172 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 mtp -127.87 109.52 11.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.817 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 120.87 0.367 . . . . 0.0 111.14 -179.308 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.832 0.349 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.85 142.59 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.71 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.42 17.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.112 0.482 . . . . 0.0 111.366 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.84 106.21 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.422 HG13 ' CG2' ' A' ' 183' ' ' VAL . 3.2 mm -116.84 155.34 18.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.648 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 17.7 pttm -114.15 126.57 55.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.359 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 3.9 tt -127.58 118.64 24.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -95.97 144.69 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -72.82 156.28 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.975 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.55 -168.79 12.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.821 -0.705 . . . . 0.0 111.826 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.25 -39.55 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.107 1.871 . . . . 0.0 112.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 19.6 8.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.049 0.452 . . . . 0.0 110.334 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.92 -143.21 15.78 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.275 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.72 -21.5 26.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.184 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.23 4.38 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.701 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.14 148.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -108.6 116.96 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.475 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 27.4 pt -121.79 162.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.636 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 129' ' ' ILE . . . -122.96 127.62 49.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.82 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -80.63 156.8 39.18 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.715 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . -49.58 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.7 t -54.38 134.37 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.822 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.6 -26.14 19.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.92 83.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.549 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -67.44 2.7 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.954 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.627 ' CD2' HG12 ' A' ' 123' ' ' ILE . 79.9 t60 79.63 -60.54 0.33 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.799 0.809 . . . . 0.0 110.497 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.627 HG12 ' CD2' ' A' ' 122' ' ' HIS . 1.5 mm -118.06 101.25 51.77 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.514 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.42 94.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.478 2.119 . . . . 0.0 112.092 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.95 -15.61 1.54 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.774 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.4 84.57 2.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.903 0.382 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -41.65 -28.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -51.8 152.69 2.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.546 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.82 HG12 ' HA2' ' A' ' 116' ' ' GLY . 51.1 mt -75.44 124.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.977 0.418 . . . . 0.0 111.285 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 151' ' ' LYS . 4.9 m-85 -114.71 132.26 56.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.68 155.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.345 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.3 p -118.61 -57.71 2.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.396 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 143.64 25.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.246 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mt -129.96 141.63 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.801 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.39 173.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.12 149.1 21.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.99 29.29 51.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.67 -167.55 43.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.54 -55.08 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.13 -31.88 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.267 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.04 -55.67 31.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 0.0 110.316 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -72.8 -48.56 37.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.56 -59.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.891 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -58.5 -49.74 73.81 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.077 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 18.23 11.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.645 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.416 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.17 81.01 3.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.715 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.41 171.2 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.678 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.1 mt -46.67 127.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.316 0.579 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.09 -24.81 9.15 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.339 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.2 m-20 -67.95 131.59 45.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -116.87 134.11 55.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.118 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -105.39 131.94 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.71 -4.1 41.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.231 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 169.19 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.435 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 181' ' ' LEU . 38.4 t -103.92 99.7 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.759 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 69.28 -59.41 0.48 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.338 0.59 . . . . 0.0 109.592 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 m -165.02 29.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.941 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 10.0 t -104.26 155.08 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.564 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -110.91 74.57 0.21 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.645 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.05 25.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.984 0.421 . . . . 0.0 111.586 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -155.79 27.87 0.38 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.53 27.74 2.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.4 t -144.99 -72.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.643 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 174.78 162.58 0.22 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.241 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.409 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -53.54 -30.09 40.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.271 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -45.17 53.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -73.1 -35.37 66.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.918 0.39 . . . . 0.0 110.637 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.92 72.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.167 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 10.5 t -71.93 -44.09 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.99 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.128 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.73 -27.7 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.75 -39.44 24.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.005 0.431 . . . . 0.0 110.192 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -26.69 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.055 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -10.0 59.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.198 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 63.8 p -58.91 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.794 0.331 . . . . 0.0 111.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -102.19 169.95 8.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.26 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.7 -17.41 5.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.361 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.41 91.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.9 148.14 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.733 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.9 m-85 -101.71 125.9 48.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.423 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -111.83 152.72 27.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 120.37 36.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.884 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.422 ' CG2' HG13 ' A' ' 101' ' ' ILE . 18.1 t -102.21 160.67 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.87 133.89 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.793 0.33 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -117.12 118.01 31.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.34 -0.838 . . . . 0.0 111.111 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 90' ' ' ARG . 8.5 tp10 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.869 0.366 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.426 ' CD2' HD23 ' A' ' 58' ' ' LEU . 4.0 m-85 -110.82 161.39 15.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -176.69 141.34 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.889 0.375 . . . . 0.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 16.3 pt-20 -110.35 154.62 23.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.451 HG23 ' CD ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -166.11 159.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 111.972 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -107.17 123.44 48.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.364 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.405 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 2.5 tp -116.1 93.52 4.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.598 0.713 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 11.2 mt-10 -66.66 143.1 57.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.798 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.68 101.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.485 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.22 -27.4 5.39 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.725 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.6 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -109.28 30.63 6.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.883 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.04 -179.65 20.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.008 -1.091 . . . . 0.0 112.248 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -84.47 -63.19 1.38 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.649 0.262 . . . . 0.0 111.309 -179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.79 62.66 0.39 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.599 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 7.9 p90 -149.5 138.9 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.543 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 5.9 m -79.48 126.69 31.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 pt -131.23 155.11 41.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.31 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 152.7 2.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.74 -122.82 2.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.36 128.82 4.46 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.404 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.526 HG23 ' CG2' ' A' ' 69' ' ' THR . 1.9 t -51.84 -27.23 11.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.87 -42.01 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.79 77.45 57.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.26 146.21 13.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.718 2.279 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t60 -77.57 -19.38 55.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.15 -32.74 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 111.007 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.95 26.04 6.53 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.539 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.49 38.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.37 96.64 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.04 -22.68 48.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.485 2.124 . . . . 0.0 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.86 158.66 33.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.74 149.27 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.53 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 7.1 p90 -142.73 163.5 32.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.898 0.38 . . . . 0.0 111.042 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 45.7 mt -94.82 148.49 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.501 ' N ' HG23 ' A' ' 36' ' ' ILE . 1.1 p -104.4 -33.99 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.627 0.251 . . . . 0.0 111.401 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.34 150.93 4.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.38 . . . . 0.0 111.348 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.45 141.07 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.997 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 pt -89.63 136.03 30.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.115 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.67 58.2 6.7 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.53 2.153 . . . . 0.0 112.387 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.0 -61.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.618 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.56 -173.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.628 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.04 -26.45 62.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.576 0.227 . . . . 0.0 111.522 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.1 -57.4 11.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.85 67.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.109 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -71.87 -45.68 60.5 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -68.39 -35.49 77.76 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.252 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.07 48.4 0.01 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.203 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.451 ' CD ' HG23 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.96 20.62 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.732 0.266 . . . . 0.0 111.291 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -158.23 162.96 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.334 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.18 158.25 15.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.396 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.616 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.2 m -71.2 -46.14 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.83 3.96 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -76.17 174.15 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.9 t -129.8 102.86 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 110.961 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.454 ' HA ' ' CG1' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -55.65 95.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.734 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -73.3 -22.65 60.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.1 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -153.46 155.22 35.88 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.965 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -152.52 130.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.447 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.58 35.07 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.228 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.13 30.96 2.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 t -120.92 141.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -73.34 116.02 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 60' ' ' VAL . 33.4 t -143.98 40.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -100.3 9.24 43.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.153 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 178.5 44.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.928 0.394 . . . . 0.0 110.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.6 m -109.63 147.26 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.562 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.526 ' CG2' HG23 ' A' ' 23' ' ' THR . 65.0 p -49.32 170.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.845 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.419 ' CD2' HG22 ' A' ' 74' ' ' VAL . 2.2 t-160 -63.67 -49.02 74.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.323 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -36.34 83.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -35.53 72.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.23 64.74 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 109.804 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 70' ' ' HIS . 58.4 t -63.99 -36.57 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -32.81 71.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.74 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -43.37 73.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 110.636 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.78 -26.77 54.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.461 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -40.64 72.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.134 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 8.8 tt0 -101.24 27.32 6.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.317 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.77 -23.06 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.423 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.93 -161.81 24.82 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.785 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 9.7 t -86.23 -51.29 6.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 17.0 mt -99.25 84.69 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 13.9 m -85.24 116.26 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.677 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 80.5 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -84.89 135.41 34.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.24 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -116.72 114.49 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.391 178.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 57' ' ' ILE . 6.1 m -124.89 168.41 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.093 0.473 . . . . 0.0 111.998 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 109.06 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.802 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.675 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 111.7 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 0.0 110.755 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 mmm -93.61 166.66 12.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.398 0.618 . . . . 0.0 111.798 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -136.34 106.54 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.443 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 2.7 mm -112.7 155.16 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -110.82 126.13 54.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.304 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 6.7 tt -127.16 118.56 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.6 pt -96.44 144.64 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.43 157.47 30.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.19 -169.38 12.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.921 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.69 -30.78 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.145 1.896 . . . . 0.0 112.283 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.52 18.38 12.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.061 0.458 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.2 -146.34 16.06 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.46 -20.36 28.24 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.908 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.74 46.13 7.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.346 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.58 154.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.687 0.244 . . . . 0.0 110.98 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.31 126.33 51.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.455 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 9.0 pt -134.97 153.18 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.633 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.55 124.91 9.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.854 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.67 -175.11 25.43 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.065 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.38 -169.25 54.8 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.422 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.64 154.56 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.337 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.45 -25.59 17.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.03 77.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.1 pt20 -72.91 6.83 2.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.384 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 71.2 t60 72.72 -59.17 0.57 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.53 0.681 . . . . 0.0 111.331 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.51 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.4 OUTLIER -87.7 111.58 43.03 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.895 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 79.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.475 2.117 . . . . 0.0 112.243 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 121.68 40.24 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.523 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -175.52 96.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.79 0.328 . . . . 0.0 110.74 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.55 -23.36 50.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 58.3 m -47.44 128.34 12.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.522 HG12 ' HA3' ' A' ' 116' ' ' GLY . 37.7 mt -65.9 123.96 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.934 0.397 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.51 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.0 m-85 -122.89 156.91 33.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.499 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.32 151.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 122' ' ' HIS . 11.3 p -111.44 -58.46 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.496 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 147.91 28.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 147' ' ' GLN . 6.5 mt -128.37 141.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.06 175.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.623 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.93 133.67 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.857 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.5 25.19 33.87 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.85 -160.72 1.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.513 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.57 -59.72 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.0 111.277 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.13 -31.97 69.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.582 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -53.88 -54.34 40.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.19 0.519 . . . . 0.0 110.392 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -72.9 -53.15 12.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.043 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.74 -59.29 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.153 0.502 . . . . 0.0 111.943 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -49.02 -46.94 32.9 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.453 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 65.76 16.99 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.617 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -106.87 83.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.483 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.96 175.81 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.3 mt -47.46 122.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.354 0.597 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.06 -21.73 6.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.311 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 8.5 p-10 -64.2 131.99 49.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.882 0.372 . . . . 0.0 110.409 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.497 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -108.24 125.05 51.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.61 133.92 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.046 0.451 . . . . 0.0 110.647 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -93.98 -4.03 50.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 173.52 156.65 0.12 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.936 0.398 . . . . 0.0 110.857 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.92 100.07 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.55 ' ND2' ' HB ' ' A' ' 179' ' ' VAL . 2.1 m-80 56.82 32.21 20.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p 82.92 25.83 0.13 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.856 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.21 146.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-O 121.426 0.631 . . . . 0.0 112.659 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' N ' HD12 ' A' ' 160' ' ' LEU . . . 96.29 -73.54 0.8 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.584 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.425 ' HG ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER 35.83 33.5 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.821 -0.689 . . . . 0.0 111.955 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 128' ' ' SER . 0.9 OUTLIER 35.82 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.926 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -114.43 36.95 3.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -151.17 -71.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.344 0.592 . . . . 0.0 110.607 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.1 mtm 175.42 160.45 0.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 74.7 t60 -53.68 -31.43 47.71 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.175 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.92 -41.03 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.456 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.58 -38.43 62.65 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.683 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.6 -38.96 74.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.648 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 29.3 t -72.99 -46.93 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.092 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.38 69.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.36 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.42 -33.99 58.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.373 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -81.34 -36.85 29.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.945 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -72.94 -26.83 61.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.482 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.29 -10.04 59.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.264 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.9 p -60.44 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 111.486 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -114.28 173.12 6.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -13.08 3.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.6 t -147.34 91.11 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.55 ' HB ' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -128.93 148.61 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.995 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 39.3 p90 -107.61 135.29 49.31 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-O 121.052 0.453 . . . . 0.0 111.99 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.06 159.3 17.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.677 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -100.28 117.35 34.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.8 t -101.9 159.67 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.3 141.04 52.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 52.9 p -92.63 118.78 31.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.245 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -134.04 166.05 23.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -176.63 159.06 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 13.6 pt-20 -96.05 154.76 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 86' ' ' LEU . 19.2 tt -153.37 164.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.568 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -123.27 122.82 39.32 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.704 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HB2' ' NE ' ' A' ' 50' ' ' ARG . 1.2 tp -125.8 93.04 3.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.752 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -73.65 166.08 23.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.591 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -80.97 95.37 6.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.63 8.03 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.598 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -168.98 -89.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.069 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -109.22 30.85 6.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.51 177.07 24.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.395 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -84.43 -48.66 9.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.766 0.317 . . . . 0.0 111.5 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.24 65.53 0.67 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.77 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.4 p90 -164.69 162.9 21.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.298 . . . . 0.0 110.689 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.75 133.79 54.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.531 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 pt -120.43 171.28 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.8 152.34 3.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.345 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 119.08 -115.25 3.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.49 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 146.23 15.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.257 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 68' ' ' VAL . 1.3 t -54.05 -23.87 15.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.615 0.245 . . . . 0.0 111.475 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.83 0.347 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.06 77.55 41.63 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 129.14 21.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.401 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.8 t60 -66.57 -20.67 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.32 -27.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.309 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.31 26.51 18.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.628 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -168.69 33.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.29 100.85 0.7 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.754 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.68 -26.85 67.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.401 2.068 . . . . 0.0 112.142 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -66.95 177.94 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.614 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -125.88 153.43 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.0 p90 -142.49 148.89 38.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 73.2 mt -75.15 150.45 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.409 ' N ' HG21 ' A' ' 36' ' ' ILE . 2.5 p -102.88 -40.51 6.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.601 0.239 . . . . 0.0 111.621 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -165.77 146.26 6.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.0 111.437 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -103.52 141.33 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.108 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mm -85.28 136.28 38.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.29 58.79 5.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.212 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.58 -54.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.03 -175.38 0.2 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.86 -31.4 59.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.666 0.269 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 49' ' ' GLY . . . -55.72 -26.25 44.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.542 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.49 48.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.574 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.35 -43.75 66.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.954 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.74 -29.02 15.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 89.15 -33.69 4.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.63 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.506 ' NE ' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER 48.32 25.17 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' CD2' ' HG3' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 66.86 -167.58 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.959 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 153.05 25.08 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.097 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.52 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 28.5 m -71.16 -36.72 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -52.06 -16.14 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 37.0 p-10 -59.03 156.31 12.01 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 35.6 m -121.55 126.28 48.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 ' HA ' ' CG1' ' A' ' 88' ' ' VAL . 9.4 pt -65.63 94.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.276 0.56 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -76.77 -28.2 55.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.482 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 116.15 5.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.69 125.55 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 55.02 36.87 27.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.13 27.49 17.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.25 141.69 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.34 72.04 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 20.2 t -98.04 34.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -9.63 27.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.51 43.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.76 0.314 . . . . 0.0 111.615 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -123.94 155.57 30.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.232 0.539 . . . . 0.0 111.038 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.461 ' N ' ' CG2' ' A' ' 23' ' ' THR . 21.2 m -49.99 161.8 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.901 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 t-160 -58.98 -48.49 81.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.531 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -52.09 -37.53 54.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.401 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.37 80.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.59 66.47 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.264 0.554 . . . . 0.0 109.578 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 55.0 t -64.81 -35.29 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.682 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 47.4 tt0 -69.65 -32.33 70.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.938 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.36 -41.54 76.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.378 0.609 . . . . 0.0 110.361 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.7 pp -76.31 -26.22 55.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 4.1 tttt -72.39 -35.21 68.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -113.35 28.76 8.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.203 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 77' ' ' LEU . . . -92.42 -21.44 20.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.63 -137.51 13.39 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' HG12 ' A' ' 83' ' ' ILE . 8.6 t -121.17 17.49 11.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.675 0.274 . . . . 0.0 111.414 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -154.07 95.84 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -102.01 143.38 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.215 0.531 . . . . 0.0 112.429 -178.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 15.9 tpp85 -100.35 93.4 5.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.782 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -88.4 115.36 25.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.347 0.594 . . . . 0.0 112.555 -177.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.5 114.06 27.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 57' ' ' ILE . 4.5 m -132.21 168.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.3 ttp -107.91 109.23 20.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.492 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HG3' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.463 . . . . 0.0 111.551 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.844 0.354 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.78 148.13 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.422 ' HB2' ' HB ' ' A' ' 183' ' ' VAL . 13.9 mtp -124.21 166.73 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 0.0 111.208 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.3 7.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.053 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mm -113.62 155.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.418 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.99 128.43 56.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.989 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 6.1 tt -130.39 118.32 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.071 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.73 144.53 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.987 0.422 . . . . 0.0 111.059 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -66.93 149.11 51.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.979 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.08 -174.6 13.65 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.006 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.44 -36.8 14.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.317 2.011 . . . . 0.0 112.317 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -93.84 19.46 8.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.938 0.399 . . . . 0.0 110.498 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.73 -140.97 15.12 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.41 HD21 ' CE1' ' A' ' 112' ' ' PHE . 7.4 mp -86.64 -22.39 26.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.01 46.9 5.2 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.013 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 146.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.611 0.243 . . . . 0.0 110.861 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 m -108.67 116.85 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.46 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 8.5 pt -129.15 152.9 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.561 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -151.82 125.84 9.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 112.063 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.64 -175.26 25.57 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.882 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.91 176.49 14.49 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.732 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.66 153.65 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.854 0.359 . . . . 0.0 111.357 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.16 -5.89 65.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.72 79.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.87 142.49 27.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.447 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.52 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 8.3 t60 -45.08 -37.85 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.803 0.811 . . . . 0.0 110.517 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 130' ' ' TYR . 1.5 mt -100.43 143.14 25.97 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.583 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.7 83.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.615 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.13 53.49 2.81 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.102 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -154.7 87.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 111.149 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -52.85 -24.4 8.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.9 m -52.12 125.55 16.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.61 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.3 mt -73.69 113.4 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.833 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.455 ' CD1' HD12 ' A' ' 123' ' ' ILE . 4.1 m-85 -106.96 172.83 6.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.722 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.44 148.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.813 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 -29.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 137.65 31.34 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.835 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 43.9 mt -137.12 138.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.67 173.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.25 140.94 29.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.876 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.02 26.23 55.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.33 -175.07 9.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.08 -66.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.01 -37.34 75.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.429 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -51.96 -45.85 64.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.038 0.446 . . . . 0.0 110.67 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -57.3 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.038 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.56 -59.59 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.64 -33.6 85.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.176 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 59.94 20.96 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 1.2 pp -83.79 83.79 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.62 170.92 6.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.63 120.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.277 0.56 . . . . 0.0 111.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.28 -19.7 5.97 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -66.29 118.39 9.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.735 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -99.28 123.85 43.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.985 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.473 ' HB ' ' CD1' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -99.86 121.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 110.067 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -0.44 56.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.72 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 172.97 159.98 0.12 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.562 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.452 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 36.9 t -117.52 98.85 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 180' ' ' TYR . 7.1 m-80 68.32 -57.72 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.394 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 p -146.01 -18.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -78.02 129.14 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.42 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 154' ' ' ALA . . . -66.68 7.75 1.38 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.547 ' HB3' HG13 ' A' ' 129' ' ' ILE . 20.3 mt 42.71 29.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.469 0.634 . . . . 0.0 112.044 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -178.14 75.36 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -157.68 26.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.8 t -157.0 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.923 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 178.63 -172.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.45 -37.42 82.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.027 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.469 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.3 -35.55 61.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.854 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.24 76.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.44 -41.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.355 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.28 -29.27 64.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.727 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.94 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.28 -39.45 25.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.109 0.481 . . . . 0.0 109.929 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -75.18 -26.78 59.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.102 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -20.75 23.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.42 ' HB ' ' CG2' ' A' ' 179' ' ' VAL . 76.6 p -54.52 -172.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 178' ' ' VAL . 8.8 p90 -125.03 -162.24 1.08 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.7 m-20 -59.7 -21.6 60.84 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 38.2 t -147.66 91.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 118.728 0.694 . . . . 0.0 111.511 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.92 148.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.919 0.39 . . . . 0.0 111.887 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.438 ' CE2' ' OD1' ' A' ' 156' ' ' ASN . 21.8 p90 -105.23 126.18 51.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.328 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.75 149.05 27.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -96.39 119.16 34.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 11.8 t -101.89 161.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.78 144.76 47.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.64 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t -83.47 111.31 18.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.164 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB3' ' CE2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.808 0.337 . . . . 0.0 111.199 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -98.3 156.42 16.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 1' ' ' MET . 0.1 OUTLIER -154.84 144.15 21.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -179.39 159.01 0.89 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.845 0.355 . . . . 0.0 111.445 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -101.01 156.41 17.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.656 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -158.46 155.19 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -110.22 121.7 45.9 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.854 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 8.3 tp -116.16 93.3 4.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.429 0.633 . . . . 0.0 110.337 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.28 135.34 42.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.224 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.423 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 2.3 mtp180 -56.29 103.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.691 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.13 -28.81 13.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.469 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.07 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.45 . . . . 0.0 109.929 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -109.15 30.67 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.683 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' CA ' ' HG2' ' A' ' 10' ' ' ARG . . . 147.03 171.26 16.06 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -84.04 -49.36 8.99 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.905 0.384 . . . . 0.0 110.991 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.22 80.18 1.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.577 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.9 p90 -164.43 149.91 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.713 0.292 . . . . 0.0 110.483 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 36' ' ' ILE . 18.1 p -105.85 127.01 52.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 111.55 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.4 pt -119.51 166.0 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.857 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.78 153.6 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.71 -120.45 2.67 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.27 141.02 8.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.172 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 69' ' ' THR . 2.2 t -56.91 -18.81 14.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 12.4 t0 -91.57 -52.51 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -119.5 79.56 21.52 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.26 138.31 23.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 0.0 112.414 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -69.28 -18.63 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.48 -36.98 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 110.985 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.37 24.79 6.05 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.01 40.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -162.15 98.82 1.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 17.7 Cg_endo -57.62 -27.0 75.23 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.09 . . . . 0.0 112.194 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -74.04 141.2 45.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.03 152.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.1 p90 -142.26 166.48 24.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.617 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 53.1 mt -92.19 153.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.474 ' N ' HG21 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -106.15 -39.77 5.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.628 0.251 . . . . 0.0 111.664 -179.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.28 156.42 14.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.107 0.479 . . . . 0.0 111.644 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.413 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -118.42 141.33 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.5 mt -88.14 126.78 59.7 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 16.9 Cg_exo -66.76 63.13 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.141 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.5 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.84 -177.82 0.93 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.466 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.82 -18.72 60.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.04 -57.38 13.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.13 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.14 69.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.32 -41.56 66.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -76.02 -32.23 59.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.7 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.64 44.61 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 113.901 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HD3' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -93.1 21.71 5.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.695 0.247 . . . . 0.0 111.581 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -176.36 170.11 2.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.999 0.428 . . . . 0.0 111.325 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.61 163.44 12.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.499 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.617 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -71.06 -46.54 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 112.04 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -69.53 11.41 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -76.92 176.92 8.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -127.87 102.66 6.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 2.4 pt -57.43 94.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 111.157 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.48 -28.54 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.501 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -163.25 150.57 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 131.68 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 45.3 38.82 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.192 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 61.6 33.92 18.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 141.68 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.173 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.93 100.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 37.9 t -133.1 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.106 0.479 . . . . 0.0 110.911 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -105.06 -14.51 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.93 47.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.813 0.339 . . . . 0.0 111.131 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.62 149.64 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.21 0.528 . . . . 0.0 111.102 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.48 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.2 OUTLIER -49.74 154.77 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.937 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -51.81 -48.36 63.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.258 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.63 -36.41 24.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.03 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.56 63.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -40.7 68.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.696 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.42 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -65.7 -35.54 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.633 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 3.1 mt-10 -69.59 -32.48 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.875 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.31 76.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.447 0.641 . . . . 0.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.84 -26.5 57.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.47 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -68.82 -35.89 77.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.218 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.64 28.87 8.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.79 -29.25 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.355 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.49 -101.08 2.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.607 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 69.1 m -152.65 -52.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.798 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -98.33 84.93 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.7 m -84.63 113.73 23.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.676 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -92.78 78.83 4.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.075 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -99.08 154.03 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.402 -178.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 1.9 t80 -109.51 115.0 29.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.151 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 31.6 m -108.46 168.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 112.397 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.25 109.42 7.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.634 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -113.23 112.75 24.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.93 144.4 56.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.125 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -55.67 164.29 1.65 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.039 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.13 149.13 91.01 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.487 2.124 . . . . 0.0 112.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 188' ' ' ASN . 16.5 Cg_exo -67.35 -161.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.529 2.153 . . . . 0.0 112.228 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -158.7 28.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.452 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 187' ' ' SER . 41.1 tt0 -86.15 111.88 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 142.19 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.22 115.71 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.269 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.45 166.6 12.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.605 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.96 106.58 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.882 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.19 155.36 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' CG ' ' CD2' ' A' ' 180' ' ' TYR . 2.7 mtmp? -108.02 123.92 49.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.428 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.449 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 2.5 tt -129.91 118.62 21.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.4 pt -93.96 144.61 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -70.64 152.79 43.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.095 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.62 160.72 23.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.756 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.97 -37.5 86.07 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.094 1.863 . . . . 0.0 112.033 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 20.96 9.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.048 0.451 . . . . 0.0 110.053 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.47 -155.46 17.92 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.283 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.48 -13.36 46.3 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.075 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.66 63.11 2.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.862 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' CD2' HG23 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.84 150.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.355 . . . . 0.0 110.999 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.72 116.88 32.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 HG23 ' CD2' ' A' ' 112' ' ' PHE . 8.9 pt -136.52 153.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.55 125.0 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.581 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.84 -175.13 25.58 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.205 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.9 178.36 51.07 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.442 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.08 150.27 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.819 0.342 . . . . 0.0 111.039 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.37 -29.46 6.12 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.858 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.71 69.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.48 -4.63 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.688 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.546 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 62.6 t60 72.48 -58.1 0.6 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.547 0.689 . . . . 0.0 110.578 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.472 HD11 ' CG ' ' A' ' 130' ' ' TYR . 2.0 mt -88.46 137.56 30.55 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.428 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 123' ' ' ILE . 49.6 Cg_endo -68.71 62.21 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.236 1.957 . . . . 0.0 112.339 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.1 57.29 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.723 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.44 99.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.873 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -60.44 -19.72 57.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.324 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -57.31 151.3 16.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.581 HG12 ' HA3' ' A' ' 116' ' ' GLY . 2.8 mt -91.03 115.35 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.472 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.2 m-85 -109.33 153.9 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.62 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 75.7 t -90.72 155.72 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.03 -27.62 1.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 147.96 27.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.982 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 146' ' ' LEU . 42.0 mt -137.21 141.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.51 173.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.604 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -93.55 133.15 37.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.82 26.47 73.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.35 176.77 54.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.63 -53.81 16.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 111.288 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -70.25 -34.63 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -51.91 -58.65 5.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.465 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -72.94 -48.69 34.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.467 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.59 -59.6 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -59.68 -44.28 97.04 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.413 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 63.23 17.8 10.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.602 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 150' ' ' ASP . 0.1 OUTLIER -81.52 83.66 6.94 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -65.55 152.58 43.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.656 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.405 HG22 HD12 ' A' ' 148' ' ' ILE . 34.4 mt -46.57 106.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.438 0.637 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 146.41 -14.29 1.62 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.544 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 p-10 -80.45 162.29 24.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.875 0.369 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -142.59 128.31 19.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.549 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 183' ' ' VAL . 0.3 OUTLIER -102.19 133.12 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.114 0.483 . . . . 0.0 110.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.2 pp -100.68 -4.13 28.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 170.35 141.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.468 ' HB ' HG21 ' A' ' 158' ' ' VAL . 76.6 t -96.74 99.79 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.798 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 69.27 -58.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.084 0.468 . . . . 0.0 109.846 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.1 25.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.799 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.468 HG21 ' HB ' ' A' ' 155' ' ' VAL . 24.3 t -92.3 155.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 121.351 0.596 . . . . 0.0 111.367 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -101.93 73.25 0.34 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.759 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 129' ' ' ILE . 22.1 mt -69.95 20.47 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -163.56 56.49 0.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.268 0.556 . . . . 0.0 110.812 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.58 28.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.555 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.9 OUTLIER -151.86 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.9 mtp 173.78 164.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.426 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.41 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 19.7 p-80 -53.77 -30.02 42.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.492 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.73 50.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.305 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.443 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.36 -35.51 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 0.0 110.743 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.17 -35.39 73.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.942 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 11.9 t -70.23 -43.5 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.15 -30.35 66.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.9 -25.55 53.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.18 -39.91 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.202 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -75.52 -26.55 58.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.02 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.04 -10.54 59.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 81.6 p -54.1 -175.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.831 0.348 . . . . 0.0 111.479 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -102.36 168.97 8.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.379 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 t0 -52.03 -23.05 4.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.586 ' CG1' ' O ' ' A' ' 178' ' ' VAL . 4.0 p -145.18 92.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.383 0.611 . . . . 0.0 110.389 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.51 148.43 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.23 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.475 ' CD2' ' CG ' ' A' ' 102' ' ' LYS . 5.6 m-85 -97.9 120.51 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.752 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -98.08 144.11 27.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.24 109.31 21.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.47 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 20.8 t -101.39 161.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.423 ' CB ' ' HD2' ' A' ' 151' ' ' LYS . . . -141.89 142.74 33.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.802 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 146.25 36.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.631 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.3 107.96 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.576 2.184 . . . . 0.0 112.293 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 96' ' ' GLU . 5.1 m -53.03 154.12 3.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 12.3 m-20 49.94 30.48 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.085 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -131.15 -51.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.08 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.466 ' HB ' ' HD3' ' B' ' 4' ' ' PRO . 44.3 t -95.19 -47.6 0.26 Allowed Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 89.6 Cg_endo -84.09 136.64 6.97 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.328 2.019 . . . . 0.0 112.56 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.41 176.19 5.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.1 p -63.32 158.16 21.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.7 t -108.33 107.26 17.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.61 90.18 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.185 -179.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.791 0.329 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -115.97 97.34 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.636 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 14.1 p -84.08 -28.11 0.41 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' C' ' 3' ' ' VAL . 95.8 Cg_endo -81.69 -9.22 12.25 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.945 1.763 . . . . 0.0 112.834 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.31 -38.5 9.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.883 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.5 136.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -81.6 84.52 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.62 82.41 4.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.142 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.796 0.332 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.8 147.4 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -116.5 153.2 32.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 151.22 23.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -142.74 108.91 5.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.853 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.68 -168.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 111.652 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 135.95 26.99 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.466 HD22 ' HD3' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -113.02 88.84 2.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.475 0.655 . . . . 0.0 110.892 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.4 tt0 -84.73 123.88 30.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.199 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -38.94 96.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -54.39 -24.04 28.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.576 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -176.47 -84.76 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 p -109.28 30.75 6.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.8 179.99 23.32 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.815 -1.184 . . . . 0.0 112.819 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.34 -50.32 7.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.39 -0.405 . . . . 0.0 111.415 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.8 64.25 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.924 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 9.2 p90 -164.94 169.03 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.72 130.04 44.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.357 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.0 pt -120.21 162.4 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.725 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.94 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.294 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.49 -121.61 2.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.27 136.95 5.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.449 HG22 ' CG2' ' A' ' 69' ' ' THR . 1.2 t -55.77 -19.65 12.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 2.6 m-20 -93.2 -52.15 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.188 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -117.86 78.37 12.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.29 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.25 142.62 5.92 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.725 2.283 . . . . 0.0 112.623 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -74.34 -18.34 60.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.76 -29.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.63 28.16 8.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.526 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.84 37.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -167.46 95.34 0.65 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.76 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 10.6 Cg_endo -53.98 -28.63 50.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -65.06 169.86 4.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.432 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.93 151.99 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.366 . . . . 0.0 111.123 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.504 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 5.5 p90 -142.56 144.29 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.462 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 69.0 mt -70.94 151.78 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 36' ' ' ILE . 28.3 p -99.85 -43.86 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 149.14 6.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.47 . . . . 0.0 111.798 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.448 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -106.19 141.61 21.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.032 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 40' ' ' ILE . 2.5 mt -84.49 119.94 73.62 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.06 84.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.359 2.039 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.04 -39.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.62 175.95 2.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.06 -20.36 57.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -51.02 -57.69 7.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.955 0.407 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.35 69.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -72.09 -34.64 68.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.791 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -89.57 -21.31 22.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.423 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 79.36 0.72 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.276 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.42 32.0 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 0.0 110.095 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 2.1 pp 38.48 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.185 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.4 141.43 51.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.035 0.445 . . . . 0.0 111.366 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -69.57 -40.78 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.154 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -52.73 -16.84 1.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.78 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 20.4 p-10 -59.18 171.69 0.7 Allowed 'General case' 0 C--O 1.23 0.032 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 t -130.17 122.57 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 57' ' ' ILE . 15.2 pt -63.16 94.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.544 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.37 -24.31 67.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CD2' ' HA ' ' A' ' 64' ' ' ASP . 1.3 t80 -164.19 140.35 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.894 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 ' O ' ' C ' ' A' ' 61' ' ' ASN . 1.4 p -101.97 -176.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.495 ' C ' ' O ' ' A' ' 60' ' ' VAL . 18.1 m-20 -22.38 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.539 0.524 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -162.79 25.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' HB ' HG11 ' A' ' 60' ' ' VAL . 2.6 t -121.71 142.12 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.626 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 7.5 t0 -80.36 84.19 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.114 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.83 30.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptt85 -89.42 7.63 34.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 179.25 49.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.048 0.451 . . . . 0.0 109.959 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.73 139.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.257 0.551 . . . . 0.0 112.39 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.449 ' CG2' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -50.06 166.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.547 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.3 t-160 -57.06 -48.71 77.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.037 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -41.91 70.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.04 74.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.456 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.76 68.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.413 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 53.1 t -64.52 -36.13 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.576 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -69.56 -33.11 72.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.694 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -42.91 74.43 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.37 0.605 . . . . 0.0 110.404 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.99 -26.88 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.31 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 -44.2 62.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.005 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.13 28.43 5.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.281 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.87 -27.7 36.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.6 -123.04 6.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.371 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 83' ' ' ILE . 13.4 m -135.21 8.15 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -156.93 94.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.96 119.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.21 102.32 14.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.469 ' HG ' HG21 ' A' ' 60' ' ' VAL . 4.9 mp -103.75 139.78 38.52 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 5' ' ' GLU . 3.7 m-85 -107.8 114.74 28.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.1 m -115.92 168.45 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.308 0.575 . . . . 0.0 112.496 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 mtp -143.29 109.04 5.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -107.61 139.24 42.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 141.59 39.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.953 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.501 ' C ' ' HD3' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -98.93 -53.52 0.19 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.474 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 92' ' ' LYS . 52.6 Cg_endo -103.21 60.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.406 2.737 . . . . 0.0 113.939 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.501 ' HD3' ' C ' ' A' ' 92' ' ' LYS . 94.3 Cg_endo -80.84 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.168 1.912 . . . . 0.0 111.977 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 77.91 43.31 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.457 . . . . 0.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 187' ' ' SER . 7.2 mt-10 73.36 134.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -124.74 135.16 52.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.999 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.94 112.86 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -87.8 166.43 14.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.355 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.81 106.4 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.0 mm -116.46 155.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -106.23 123.62 48.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.299 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 2.2 tt -122.85 118.53 28.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.571 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -100.06 144.71 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.029 0.443 . . . . 0.0 111.233 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -72.01 162.55 29.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -139.22 161.89 26.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.74 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.49 -39.32 91.69 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 122.062 1.841 . . . . 0.0 111.94 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -95.4 21.93 7.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.052 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 105.84 -155.44 16.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.466 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.24 -13.38 46.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.868 0.334 . . . . 0.0 111.227 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.26 51.83 7.19 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.56 154.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -116.08 119.25 35.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.375 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.488 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 15.5 pt -125.26 156.38 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.464 ' CB ' ' CE1' ' A' ' 122' ' ' HIS . . . -154.91 125.42 6.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.95 165.9 31.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.685 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.06 -131.73 14.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.199 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.46 154.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 114.05 -37.85 3.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.403 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.447 ' ND2' ' CG ' ' C' ' 5' ' ' PHE . 2.1 m-80 163.8 82.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 110.276 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 111.43 23.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.161 0.505 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.464 ' CE1' ' CB ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -57.31 -16.56 8.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.206 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.524 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.3 OUTLIER -87.94 104.78 7.4 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.457 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 123' ' ' ILE . 13.6 Cg_endo -57.08 94.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.534 2.156 . . . . 0.0 112.571 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.68 44.5 8.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.886 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -142.21 85.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.022 0.439 . . . . 0.0 110.85 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -47.82 -26.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -55.89 162.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.4 mt -96.24 125.31 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.151 0.501 . . . . 0.0 111.387 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.524 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.1 m-85 -116.21 161.33 19.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.229 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.96 144.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 1.5 t -115.04 -49.21 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.99 144.17 30.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.877 0.37 . . . . 0.0 111.634 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 31.4 mt -136.89 139.85 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 135' ' ' ILE . 1.2 mt -82.99 173.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -91.88 147.31 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.21 27.69 57.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.503 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.01 53.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.31 -59.86 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 111.405 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.439 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -69.96 -33.33 71.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.45 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -57.54 -60.2 4.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 0.0 110.24 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -41.7 64.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -80.6 -59.46 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -70.31 -30.81 69.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.215 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.73 21.0 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.726 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.406 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.5 OUTLIER -93.37 82.33 4.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.71 172.99 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.8 mt -47.54 122.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.305 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.7 -22.6 6.11 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.365 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -64.47 134.55 54.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.333 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -119.42 124.72 47.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -104.25 129.45 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 110.717 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.55 -0.28 43.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.161 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . -179.57 169.14 1.39 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.408 ' CG1' ' ND2' ' A' ' 156' ' ' ASN . 57.8 t -126.76 100.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.465 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.502 HD22 ' HB ' ' A' ' 179' ' ' VAL . 25.5 m-80 69.97 -57.7 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.195 0.522 . . . . 0.0 109.977 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.16 27.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.613 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 2.0 t -116.6 154.26 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-O 120.986 0.422 . . . . 0.0 111.332 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -113.0 77.86 0.24 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -78.21 24.76 0.24 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 159' ' ' GLY . 2.3 pt-20 -127.68 41.35 3.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.382 0.611 . . . . 0.0 110.963 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.19 28.0 0.35 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.039 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -134.75 -78.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.2 mtm 173.57 166.87 0.17 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -53.88 -29.78 43.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.963 0.411 . . . . 0.0 110.602 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.42 -48.18 35.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -68.49 -37.85 80.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 160' ' ' LEU . . . -70.27 -38.66 75.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.4 ' O ' ' HG3' ' A' ' 173' ' ' LYS . 4.5 t -67.25 -46.02 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.369 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.62 67.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.532 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.48 -25.57 50.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 175' ' ' THR . 0.5 OUTLIER -79.46 -39.97 30.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.177 0.513 . . . . 0.0 109.828 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 169' ' ' VAL . 4.3 mtmt -75.88 -26.58 57.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.07 -33.64 74.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.047 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -52.72 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.398 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -95.27 169.23 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.488 . . . . 0.0 111.341 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -56.78 -16.75 7.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.615 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.96 90.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.585 0.231 . . . . 0.0 110.934 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.502 ' HB ' HD22 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -124.63 148.28 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.129 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 1.4 p90 -95.02 130.42 41.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.627 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -108.18 155.91 19.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.751 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 114.8 26.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.26 161.65 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -119.74 135.78 54.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 0.0 111.349 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 2.1 mtpt -88.4 138.39 30.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 29.9 Cg_exo -61.48 78.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.562 2.175 . . . . 0.0 112.613 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 189' ' ' ALA . 3.1 m 55.1 -145.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.12 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -65.61 68.2 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.119 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.209 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.885 0.374 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' CE2' ' B' ' 5' ' ' PHE . 14.7 p -129.51 33.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.035 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.448 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 1.8 t -87.93 -49.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 6.5 Cg_exo -73.77 -54.32 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.762 2.308 . . . . 0.0 112.203 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' B' ' 2' ' ' VAL . 0.1 OUTLIER 61.39 21.08 11.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.05 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m -165.57 113.13 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.5 143.52 53.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 90.6 p -149.51 112.89 4.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.164 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' C' ' 2' ' ' VAL . 1.9 mp0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.665 0.269 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' C' ' 1' ' ' GLN . 8.8 p 51.38 161.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.891 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.15 153.7 34.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.306 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.58 173.29 10.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . 0.447 ' CG ' ' ND2' ' A' ' 120' ' ' ASN . 1.7 m-85 -101.57 109.92 21.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.08 157.52 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.82 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 47.8 t -83.73 78.06 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -85.76 85.78 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.097 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -129.32 170.62 13.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.22 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD2' ' CG ' ' A' ' 89' ' ' MET . 1.0 OUTLIER -129.43 171.87 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.587 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -167.5 136.82 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.6 109.33 10.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.378 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -127.7 -170.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.129 0.49 . . . . 0.0 111.98 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 128.14 49.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.416 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 10.1 tp -125.32 91.71 3.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.629 0.728 . . . . 0.0 110.087 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 mt-10 -70.1 165.41 22.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.949 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -83.21 99.18 9.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.98 -26.55 8.77 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.562 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -168.87 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.176 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 t -109.18 30.64 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.65 177.03 20.06 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.358 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -84.54 -43.17 14.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.758 0.313 . . . . 0.0 111.069 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.84 76.61 1.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.784 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.7 p90 -164.72 148.46 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.041 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.2 m -95.97 126.99 41.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.41 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 36.0 pt -115.41 154.73 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.129 0.49 . . . . 0.0 112.019 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 27' ' ' HIS . . . -173.12 118.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . 152.65 29.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.061 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.41 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -58.22 167.13 6.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.41 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 1.2 t -73.03 -31.45 64.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 8.3 t70 -83.84 -51.57 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 111.595 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -119.76 78.4 22.51 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.501 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.87 156.34 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.515 2.143 . . . . 0.0 112.203 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 15.6 t60 -100.81 -19.45 15.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.6 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -108.48 -26.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.666 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.25 32.18 8.5 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.147 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 177.7 39.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -166.56 107.87 0.68 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.897 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 14.2 Cg_exo -69.04 -24.74 32.65 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.684 2.256 . . . . 0.0 112.098 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -74.57 126.29 30.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' HA ' ' C ' ' A' ' 21' ' ' GLY . 0.7 OUTLIER -70.25 148.24 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.201 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -139.83 171.41 14.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.388 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 41.3 mt -99.42 150.57 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.446 ' N ' HG21 ' A' ' 36' ' ' ILE . 22.4 m -108.5 -30.32 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -175.6 148.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 111.455 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.401 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -108.81 141.22 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.983 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 pt -89.69 146.58 35.83 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 58.45 6.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.6 2.2 . . . . 0.0 112.404 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.61 -57.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.02 176.61 1.8 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.54 -24.81 59.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.631 0.253 . . . . 0.0 111.62 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.01 -57.43 10.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.916 0.389 . . . . 0.0 111.292 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.988 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.91 -39.33 69.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 0.0 109.505 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 2.5 m-20 -80.19 -28.39 38.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.31 49.42 0.05 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.278 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -103.56 21.71 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.584 0.23 . . . . 0.0 111.491 -179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.39 163.19 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 158.32 15.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.245 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.701 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 34.2 m -71.16 -44.13 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -58.74 1.25 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' VAL . 55.1 p30 -89.87 163.43 15.01 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.088 -0.383 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -119.26 123.87 45.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.328 . . . . 0.0 111.075 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.1 pt -61.88 94.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' H ' ' HA ' ' A' ' 88' ' ' VAL . 3.6 pp -76.01 -20.57 57.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -158.0 119.58 3.59 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.077 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 HG23 ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -118.33 119.51 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 84' ' ' VAL . 50.7 m-20 52.22 42.5 30.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.185 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.66 30.89 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.09 141.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.31 113.92 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' A' ' 60' ' ' VAL . 14.6 p -146.59 26.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -87.45 6.51 33.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 177.67 50.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.937 0.398 . . . . 0.0 110.088 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.04 144.61 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.623 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.433 ' N ' ' CG2' ' A' ' 23' ' ' THR . 3.9 m -49.93 162.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.766 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.4 t-160 -55.66 -48.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.457 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -50.01 -40.77 45.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.247 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.08 76.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.79 -41.3 68.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.459 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 46.3 t -64.82 -36.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.628 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 6.2 mt-10 -69.3 -30.82 68.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.737 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -36.95 74.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.451 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 pp -82.18 -26.19 33.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -75.99 -32.66 59.56 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.865 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 29.78 7.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.56 -20.53 18.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.19 -131.25 10.28 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.616 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -124.84 16.61 8.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 111.321 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -153.63 94.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG11 ' ND2' ' A' ' 61' ' ' ASN . 0.2 OUTLIER -102.14 136.56 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.08 90.28 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.9 mt -85.12 114.97 22.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.536 0.684 . . . . 0.0 112.764 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -110.02 114.29 27.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 58' ' ' LEU . 34.9 m -123.04 168.37 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.46 ' CG ' ' CD2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -123.26 109.01 13.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.278 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -116.69 138.51 51.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -96.59 131.38 43.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.565 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -86.66 115.76 63.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.591 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.46 110.12 2.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.656 2.237 . . . . 0.0 112.856 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 65.2 Cg_endo -93.84 -154.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.12 2.547 . . . . 0.0 111.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . 97.44 60.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.875 0.47 . . . . 0.0 111.092 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 187' ' ' SER . 4.4 mt-10 74.64 149.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -150.69 165.67 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.923 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.34 120.25 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.82 166.13 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -129.94 106.36 8.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.438 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.29 155.61 20.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.468 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -115.1 137.07 52.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.539 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.428 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 3.1 tt -135.28 118.44 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.2 pt -100.72 144.66 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.011 0.434 . . . . 0.0 111.219 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -76.7 158.47 30.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.52 -164.88 10.06 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.994 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.76 -33.06 4.12 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.258 1.972 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 19.3 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.037 0.446 . . . . 0.0 110.53 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.64 -144.38 15.8 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 112' ' ' PHE . 2.9 mp -86.43 -21.44 27.09 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.108 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.73 46.08 5.83 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.974 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.54 157.64 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 0.0 110.748 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 133' ' ' LYS . 43.9 t -125.15 116.76 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.724 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 8.1 pt -123.05 151.59 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.425 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.426 ' HB2' ' CE1' ' A' ' 122' ' ' HIS . . . -149.87 125.52 10.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.099 0.476 . . . . 0.0 111.696 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.79 -175.29 24.92 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.043 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.22 -144.33 34.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.871 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.67 154.62 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.854 0.359 . . . . 0.0 111.696 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.11 -32.24 7.41 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.236 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 176.54 79.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 0.0 110.163 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -111.07 112.44 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.269 -179.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -57.21 -20.14 25.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.222 0.534 . . . . 0.0 110.892 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.468 HD12 ' CZ ' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -103.09 145.46 30.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.735 -178.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 5.6 Cg_exo -77.52 37.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.998 2.465 . . . . 0.0 112.689 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -122.65 -27.88 1.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.153 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.447 ' CB ' ' HG2' ' A' ' 121' ' ' GLN . 3.2 p30 46.79 28.43 0.82 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.907 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -135.58 -48.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.213 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.4 m -88.66 126.85 35.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.445 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.428 HG13 ' CB ' ' A' ' 161' ' ' GLU . 18.6 mt -83.22 128.75 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.263 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.468 ' CZ ' HD12 ' A' ' 123' ' ' ILE . 17.5 m-85 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.712 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.13 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.05 -45.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -149.43 128.64 12.83 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.916 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.9 mt -120.09 141.7 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 mm -77.18 174.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.624 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -92.19 133.86 35.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.96 25.22 45.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.497 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.84 -171.07 18.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.04 -53.65 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.428 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -69.99 -31.91 69.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -56.84 -60.92 2.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.211 0.529 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -42.42 63.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.117 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -80.85 -59.47 2.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 112.043 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -65.2 -42.13 96.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.053 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.49 21.22 11.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.96 85.03 3.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 169.07 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.598 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.6 mt -47.2 120.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.303 0.573 . . . . 0.0 111.429 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.46 -22.56 5.25 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.335 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.4 OUTLIER -64.06 125.31 24.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.677 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.46 ' HB3' ' CE2' ' A' ' 130' ' ' TYR . 4.1 pttt -109.86 122.53 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.424 ' CD1' ' HB ' ' A' ' 129' ' ' ILE . 0.3 OUTLIER -103.9 130.0 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.57 -0.53 34.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.461 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . -179.9 164.85 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.347 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 57.4 t -115.97 101.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 63.6 m-80 70.56 -58.89 0.54 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 109.778 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.55 21.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -115.33 144.43 22.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.962 0.411 . . . . 0.0 110.983 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.97 71.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.97 30.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 0.0 111.746 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.428 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.85 67.31 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 0.0 110.777 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -176.98 29.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.234 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 2.4 t -123.8 -75.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 7.1 mtm -172.13 -171.38 0.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.921 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.432 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 11.0 p80 -73.23 -30.31 63.39 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.078 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 165' ' ' HIS . 16.4 mt-10 -73.74 -46.94 42.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -66.07 -42.55 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.25 73.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 16.9 t -74.02 -40.34 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.89 -34.53 69.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.84 -29.95 58.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.316 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 3.6 pp -82.09 -37.33 26.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.407 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -75.03 -26.5 59.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.903 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.04 -11.5 60.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.35 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 38.2 p -58.61 -167.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 111.364 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -112.8 172.15 7.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 1.1 m-20 -56.42 -15.13 3.64 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.0 t -147.7 92.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.31 148.19 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.973 0.416 . . . . 0.0 111.962 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 5.5 m-85 -97.24 136.01 38.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.671 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.09 148.73 36.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 0.0 110.258 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 152' ' ' ILE . 13.8 mttp -96.84 114.55 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.7 t -102.03 160.16 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.914 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.47 145.88 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.378 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -103.58 133.07 20.49 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.06 81.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 112.621 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 189' ' ' ALA . 1.1 m 57.95 -156.58 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.089 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 94' ' ' PRO . 7.4 p30 -64.21 71.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.101 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.33 105.21 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' B' ' 4' ' ' PRO . 11.2 t -76.98 -48.15 2.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 3' ' ' VAL . 80.3 Cg_endo -78.4 -179.75 5.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.194 1.929 . . . . 0.0 112.449 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -90.2 168.08 12.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.7 140.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.433 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 2.9 m -131.42 134.92 46.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.4 112.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.772 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.134 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.741 0.305 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.96 87.9 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.017 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 m -78.14 144.8 67.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.8 177.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.575 2.183 . . . . 0.0 112.247 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -70.86 -56.83 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.806 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 179.74 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' SER . . . . . 0.42 ' HB3' HD22 ' A' ' 172' ' ' LEU . 0.8 OUTLIER -106.32 65.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.68 87.67 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.678 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.309 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.79 149.24 25.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 161.52 41.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.727 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -179.33 150.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.233 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 7.1 tt0 -109.2 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.512 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.25 -174.1 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.082 0.467 . . . . 0.0 111.645 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 126.0 45.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.458 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 14.0 tp -123.62 94.49 4.26 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.703 0.764 . . . . 0.0 110.216 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.3 mp0 -68.59 161.85 27.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.687 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 12' ' ' ASN . 15.8 mtt180 -80.63 108.05 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.48 68.4 0.16 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.165 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER 78.81 -78.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.436 0.294 . . . . 0.0 110.549 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -109.53 30.71 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.79 178.01 15.31 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.552 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.524 ' CD2' ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.41 -48.57 9.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.846 0.355 . . . . 0.0 110.979 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.27 76.54 1.3 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.602 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.6 p90 -160.68 152.14 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.558 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.443 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 25.4 m -95.21 126.45 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 34.4 pt -132.74 160.89 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.33 173.74 4.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.61 -128.11 9.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.453 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.83 150.16 10.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.4 t -55.77 -22.41 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.292 . . . . 0.0 111.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -92.61 -44.57 8.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.946 0.403 . . . . 0.0 111.202 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -123.89 77.61 57.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.16 128.31 22.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.587 2.192 . . . . 0.0 112.427 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -66.7 -20.17 65.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.21 -28.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.233 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.82 27.68 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.43 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -170.6 112.85 0.44 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.42 -27.42 47.09 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.721 2.281 . . . . 0.0 112.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.7 t -67.56 141.75 56.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.8 151.47 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.793 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -142.61 160.94 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 110.983 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.626 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 34.6 mt -92.6 147.88 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.2 p -98.81 -41.83 7.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.63 0.253 . . . . 0.0 111.471 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -167.8 152.54 6.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.367 . . . . 0.0 111.262 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -104.35 141.01 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.033 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.7 pt -86.11 120.99 72.85 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.199 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 83.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.113 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.02 -54.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.0 170.47 4.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.546 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.93 -17.76 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.621 0.248 . . . . 0.0 111.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.13 -57.44 11.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.762 0.315 . . . . 0.0 111.154 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.95 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -72.35 -38.1 68.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.512 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 5.0 m-20 -79.18 -30.54 43.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.741 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.62 48.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.524 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.512 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 18.89 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.019 0.409 . . . . 0.0 111.296 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 2.1 pt? -176.11 167.51 2.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.96 0.41 . . . . 0.0 111.679 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 153.57 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.064 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.626 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 27.6 m -70.99 -46.49 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -72.8 15.52 0.19 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -80.56 -167.65 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 104.78 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.9 pt -59.56 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.063 0.459 . . . . 0.0 111.201 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -61.74 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.174 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 64' ' ' ASP . 69.6 m-85 -160.97 160.82 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.54 134.06 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.691 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.6 36.27 5.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.52 29.27 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.9 t -120.76 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 12.8 p-10 -73.74 91.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 60' ' ' VAL . 17.4 t -114.4 34.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -99.75 11.33 39.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.34 40.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m -119.39 148.61 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.163 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.4 m -49.91 156.86 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.336 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.464 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.7 t-160 -54.6 -48.61 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.603 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -57.61 -34.39 69.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.161 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.49 82.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.01 -42.53 66.3 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.289 0.566 . . . . 0.0 109.81 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.464 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 68.3 t -65.32 -36.1 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.781 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 2.9 mt-10 -69.33 -32.33 71.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.766 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.37 -42.76 74.78 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.45 0.643 . . . . 0.0 110.346 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.04 -27.01 48.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.59 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 1.7 tttt -72.94 -37.76 67.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.312 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -103.24 26.39 8.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.634 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.66 -13.47 16.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.514 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -157.13 23.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.592 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.534 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -100.18 21.05 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 111.297 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.4 mt -155.28 95.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.78 140.16 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 112.367 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.8 mtm180 -96.9 95.32 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.759 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mp -93.78 123.84 37.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -104.0 114.46 28.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.01 168.58 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -142.39 108.97 5.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.464 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.19 106.97 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.687 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtm105 -76.94 124.82 28.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.063 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -122.88 49.68 2.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.8 Cg_exo -41.6 -43.17 6.18 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.905 2.404 . . . . 0.0 113.131 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 93' ' ' PRO . 6.6 Cg_exo -74.53 -171.43 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.611 2.207 . . . . 0.0 112.347 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 177.05 34.7 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.431 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 162.73 24.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.903 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -177.4 176.12 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 153.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.51 166.59 23.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 111.322 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.67 106.28 6.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 mm -113.17 155.26 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -122.91 124.81 44.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.42 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.7 tt -126.38 118.91 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -95.4 144.72 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -62.28 160.81 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -141.11 -159.23 7.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.886 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.35 -41.32 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.235 1.957 . . . . 0.0 112.649 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -91.73 21.73 4.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.23 -133.36 11.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.61 -27.09 24.08 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.825 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.92 45.01 4.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.793 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.59 146.6 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -106.68 117.03 32.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.495 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 12.9 pt -129.54 164.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -162.29 124.93 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 111.812 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -154.65 173.42 33.08 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.106 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.81 170.67 13.38 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.473 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 t -92.06 154.84 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.27 6.26 79.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.03 78.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.043 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -93.4 123.07 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.993 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.413 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -48.11 -29.1 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.589 0.709 . . . . 0.0 110.694 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -97.28 146.51 31.47 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.699 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.93 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.564 2.176 . . . . 0.0 112.805 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.84 61.32 1.0 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.353 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.2 m-20 -172.67 90.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 110.825 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.404 ' N ' ' HG2' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -55.82 -22.82 26.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.376 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HA ' ' CG ' ' A' ' 161' ' ' GLU . 38.9 m -47.47 123.12 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.549 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 35.9 mt -59.58 123.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.253 0.549 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.488 ' CE1' ' CB ' ' A' ' 151' ' ' LYS . 3.2 m-85 -121.23 173.53 7.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.784 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -111.16 141.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.166 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.409 HG21 ' CE1' ' A' ' 122' ' ' HIS . 3.3 p -102.74 -60.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 146.89 26.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.513 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.418 HG22 ' CD2' ' A' ' 141' ' ' HIS . 2.6 mt -117.14 141.64 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.429 ' O ' ' CE1' ' A' ' 141' ' ' HIS . 2.4 mm -82.8 173.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.546 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -112.58 36.25 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.99 -29.13 52.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.542 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.89 51.88 0.59 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.59 -84.51 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.17 -31.79 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.233 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.7 m170 -53.47 -56.98 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -50.27 25.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.343 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.33 -59.3 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 0.0 111.696 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -55.37 -56.27 24.28 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.02 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.88 21.78 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -103.77 83.03 2.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.909 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -59.97 166.55 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.587 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 148' ' ' ILE . 31.1 mt -47.86 121.24 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.283 0.563 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 123.02 -19.4 7.79 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.495 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -64.49 126.16 26.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.515 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.488 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.17 124.02 49.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.091 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 182' ' ' LYS . 1.6 mt -98.26 132.51 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.676 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -91.05 -2.04 57.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 153' ' ' LEU . . . 154.58 153.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.217 0.323 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.2 t -103.52 99.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.412 ' OD1' ' CZ ' ' A' ' 180' ' ' TYR . 23.0 m-80 68.32 -59.46 0.44 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.4 p -171.47 31.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.292 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.406 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.6 t -134.87 148.18 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.351 0.595 . . . . 0.0 112.205 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 161' ' ' GLU . . . 91.97 -76.58 1.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 32.12 34.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.258 -0.971 . . . . 0.0 112.284 178.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 159' ' ' GLY . 2.2 pm0 34.37 36.88 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.011 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -116.14 36.24 4.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -149.71 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.943 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.01 166.41 0.93 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 1.9 p80 -53.98 -37.22 63.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.938 0.399 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.07 -40.42 62.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.469 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -76.02 -37.49 58.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.861 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.71 -34.99 72.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.023 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 25.4 t -74.21 -43.1 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.81 69.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.145 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.406 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.11 -26.69 56.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.436 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 3.9 pp -81.41 -36.62 29.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.423 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 11.8 tttp -72.23 -26.9 62.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.306 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -70.5 -9.46 56.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.463 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 16.9 p -49.2 -178.58 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.053 0.454 . . . . 0.0 112.051 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -107.56 171.4 7.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.295 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 6.4 m-20 -53.41 -18.23 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.546 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.1 t -147.38 91.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.494 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.75 147.54 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.026 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 15.7 p90 -111.46 125.99 54.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.224 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.2 158.47 19.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 111.307 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.406 ' O ' HG21 ' A' ' 152' ' ' ILE . 2.0 mptt -100.85 119.76 39.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.353 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 20.8 t -101.74 160.87 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.997 0.427 . . . . 0.0 111.419 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.91 133.21 50.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.84 130.81 53.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.56 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.67 125.82 19.45 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 112.052 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 154.79 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.95 30.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.582 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.123 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.99 129.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 t -75.48 135.92 71.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.58 158.27 54.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.421 2.08 . . . . 0.0 112.241 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -112.5 157.29 21.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.8 m -155.42 157.91 37.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 38.6 t 63.27 -111.03 0.34 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.747 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -63.75 125.69 25.15 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.798 0.332 . . . . 0.0 111.087 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.088 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . 0.416 ' O ' ' CG1' ' C' ' 2' ' ' VAL . 1.7 tp60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.691 0.281 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' C' ' 1' ' ' GLN . 7.2 p 43.84 55.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.551 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 t -107.85 94.74 13.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.083 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.6 170.71 14.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.372 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -149.35 147.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.54 -168.79 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.837 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 41.4 m -107.03 104.88 14.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -80.61 94.31 6.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.013 -179.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.833 0.349 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -86.95 147.66 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.23 153.27 35.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.537 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -170.81 159.46 6.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -110.26 137.34 48.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.632 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.51 ' CG2' ' N ' ' A' ' 7' ' ' THR . 25.3 mt -149.12 164.15 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.127 0.489 . . . . 0.0 111.418 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -123.11 136.73 54.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.074 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 1.5 tp -127.19 89.19 2.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.628 0.728 . . . . 0.0 110.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 tt0 -74.72 134.79 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.244 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -57.5 104.61 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.2 -27.52 5.45 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.636 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -174.8 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -109.29 30.54 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.856 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.22 178.1 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.485 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.27 -50.68 7.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.35 70.4 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.639 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.8 p90 -164.68 157.71 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.56 129.38 56.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.13 160.81 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.353 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.54 12.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.05 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.01 -128.68 9.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.12 147.76 10.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.592 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.4 t -52.2 -25.15 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.685 0.279 . . . . 0.0 111.468 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -89.77 -45.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.531 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -123.87 78.31 57.55 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.573 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.84 134.5 28.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.547 2.164 . . . . 0.0 112.277 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.42 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 38.6 t60 -71.32 -25.71 62.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.193 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.99 -28.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 26.78 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.531 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.7 31.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 110.802 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 5.0 t0 -165.4 95.84 0.84 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 11.4 Cg_endo -54.85 -22.9 31.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.414 2.076 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.72 164.62 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -106.88 146.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.475 ' CE2' HG12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.43 150.13 40.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.456 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 65.6 mt -72.64 151.89 7.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.495 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.456 ' N ' HG21 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -103.23 -35.45 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -169.59 152.24 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.423 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.7 mt -118.23 141.27 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.14 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 pt -85.84 141.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.062 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.27 74.13 3.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.458 2.105 . . . . 0.0 112.391 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.04 -40.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.11 176.29 1.96 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.615 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.36 57.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.557 0.217 . . . . 0.0 111.434 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' HD13 ' A' ' 8' ' ' LEU . . . -47.69 -57.37 5.6 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.43 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.44 69.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.02 -37.08 69.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.312 0.577 . . . . 0.0 109.644 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -82.45 -25.7 33.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.023 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 80.67 51.54 4.81 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.307 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.504 ' NE ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.84 44.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER 33.77 -153.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 150.1 46.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.058 0.456 . . . . 0.0 111.37 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.456 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 33.4 m -71.04 -39.67 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.492 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -51.69 -14.97 0.39 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.369 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HB3' HD13 ' A' ' 51' ' ' LEU . 32.9 p-10 -61.85 156.73 19.95 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.8 m -122.68 124.36 43.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.32 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 3.7 pt -62.92 94.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -23.42 65.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.534 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -158.79 127.09 5.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -123.72 133.12 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.372 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 45.78 33.52 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.405 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 13.8 tt0 67.56 32.46 5.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 18.1 t -120.92 141.78 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.19 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 98.94 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.793 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.24 38.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -103.48 12.55 35.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.58 38.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.2 m -115.86 145.83 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.334 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.457 ' N ' ' CG2' ' A' ' 23' ' ' THR . 2.5 m -49.94 161.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.757 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.453 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 t-160 -55.03 -48.53 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -49.79 -42.34 46.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.862 0.363 . . . . 0.0 111.391 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.18 75.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.031 0.443 . . . . 0.0 110.742 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.53 69.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.614 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.453 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 41.1 t -64.48 -35.34 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.736 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.44 -34.16 74.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.43 -43.42 73.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.328 0.585 . . . . 0.0 110.482 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.25 -26.69 56.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.454 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -70.98 -42.86 69.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.231 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.26 31.4 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.11 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.05 -27.0 26.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.555 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.68 -121.46 6.38 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.579 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 83' ' ' ILE . 88.7 p -137.97 9.8 2.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 82' ' ' SER . 1.6 mt -152.09 94.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -94.84 117.27 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -102.75 91.07 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.3 pp -121.64 154.04 37.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 m-85 -105.04 119.37 38.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.267 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 26.8 m -104.11 167.81 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.249 0.547 . . . . 0.0 112.298 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.88 109.59 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.458 ' HB3' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -121.4 140.56 51.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.85 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.89 123.86 20.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.168 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' CB ' ' CD ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -70.48 178.17 1.19 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.58 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 92' ' ' LYS . 71.1 Cg_exo -49.16 104.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.098 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.45 -156.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.538 2.159 . . . . 0.0 112.108 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.38 28.43 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.429 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 90.23 6.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.66 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -101.68 -175.68 2.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.2 t -132.17 113.12 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 183' ' ' VAL . 2.0 ttm -86.89 166.28 15.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.38 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -133.99 106.75 7.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.149 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.412 ' O ' ' CD1' ' A' ' 180' ' ' TYR . 2.8 mm -114.02 155.53 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -134.86 122.86 22.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.75 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.6 tt -123.25 118.35 27.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.579 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -93.75 144.5 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.547 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 177' ' ' ASP . 2.0 tptm -57.71 141.77 47.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.49 -164.4 11.92 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.949 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -43.43 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.122 1.881 . . . . 0.0 112.228 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -92.52 20.46 6.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.071 0.462 . . . . 0.0 110.115 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.29 -142.37 15.48 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.7 -21.7 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.961 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.5 47.72 6.25 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.41 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' CE2' HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.34 152.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.2 m -116.31 124.83 51.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.442 HD12 ' CE2' ' A' ' 112' ' ' PHE . 20.0 pt -141.63 157.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.726 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.82 125.5 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.581 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.26 -175.08 25.06 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.436 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.02 -179.38 45.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.298 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.04 150.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.742 0.306 . . . . 0.0 111.208 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.74 -19.16 42.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.338 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.423 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 10.7 t-20 -179.53 70.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.034 0.445 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.3 mt-30 -71.55 -7.49 47.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.481 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 61.4 t60 71.82 -57.09 0.62 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.521 0.676 . . . . 0.0 110.975 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -86.56 134.62 37.49 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.7 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.68 77.18 2.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.448 2.098 . . . . 0.0 112.606 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.01 46.55 0.55 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.92 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -172.95 96.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.26 -21.4 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 p -55.26 129.73 39.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.322 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.581 HG12 ' HA3' ' A' ' 116' ' ' GLY . 39.2 mt -66.19 130.84 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 111.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.504 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 2.4 m-85 -123.86 166.73 15.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.334 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 68.8 t -101.9 155.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.377 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.5 p -115.19 -58.99 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.578 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.18 148.7 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.14 141.68 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 mm -79.75 174.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.62 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.91 151.01 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.916 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.53 25.15 54.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -77.06 -169.14 30.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.93 -62.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.381 . . . . 0.0 111.306 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.15 -31.78 69.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.324 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -58.75 -48.69 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -72.58 -49.41 32.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.883 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.23 -59.39 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.853 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -62.96 -33.71 87.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.963 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.84 14.65 9.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.37 144.57 46.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.67 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.072 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 25.8 mt -49.28 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.802 0.811 . . . . 0.0 110.562 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 141.83 -17.9 2.58 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.431 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.07 120.21 13.3 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -105.43 119.77 39.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.946 0.403 . . . . 0.0 111.475 -178.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 182' ' ' LYS . 1.8 mt -92.77 129.75 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.363 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.513 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 1.5 pp -87.08 -0.59 56.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 153' ' ' LEU . . . 166.0 153.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.059 0.224 . . . . 0.0 110.66 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 25.3 t -108.5 99.61 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 72.3 m-80 73.24 -59.84 0.55 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.8 t -169.96 23.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.377 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.465 ' HA ' HD13 ' A' ' 160' ' ' LEU . 2.3 t -135.91 155.24 35.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.714 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . 89.06 -6.9 83.26 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.828 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.505 ' HG ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -68.61 23.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.626 0.77 . . . . 0.0 111.445 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 159' ' ' GLY . 24.0 mt-10 71.31 54.0 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.28 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.873 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -157.18 -83.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.052 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.9 mtm 166.92 162.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.423 ' CG ' ' HB3' ' A' ' 120' ' ' ASN . 11.1 t-160 -53.77 -30.22 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.022 0.439 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -41.16 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.068 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -76.22 -33.88 59.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.06 -38.18 75.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.566 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 39.5 t -74.23 -41.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.484 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.15 62.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.334 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.425 ' CB ' ' CB ' ' A' ' 158' ' ' VAL . . . -72.12 -43.44 64.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.3 pp -67.86 -36.56 80.51 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.429 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 9.2 ttpp -75.3 -26.09 58.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.469 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -48.6 76.52 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.4 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.63 -52.45 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.118 0.485 . . . . 0.0 110.663 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 2.3 t80 66.7 107.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.888 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.567 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t0 82.38 -23.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.895 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.15 93.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.623 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.06 148.43 11.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.107 0.479 . . . . 0.0 111.008 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -124.0 135.83 53.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.975 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.77 136.67 46.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.965 0.412 . . . . 0.0 111.338 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.18 113.83 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 9.2 t -101.79 162.88 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.513 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.53 134.68 34.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.991 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -83.87 136.79 41.25 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.63 125.0 14.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.465 2.11 . . . . 0.0 112.267 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.2 158.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 49.29 30.46 3.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.105 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.06 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.818 0.342 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.09 134.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.501 ' HB ' ' CD ' ' B' ' 4' ' ' PRO . 77.2 t -156.45 -63.09 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.178 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' B' ' 3' ' ' VAL . 36.6 Cg_endo -64.41 121.16 8.67 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.131 1.887 . . . . 0.0 112.249 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.65 31.18 6.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.817 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 p -162.3 178.35 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.41 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -95.75 87.08 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.944 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -85.25 118.62 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.114 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.818 0.342 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.06 109.25 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.21 149.68 43.43 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.15 136.03 30.98 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.628 2.219 . . . . 0.0 112.325 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -103.22 33.33 3.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -175.64 163.72 2.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.73 104.99 16.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.71 103.18 14.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . 0.427 HG22 ' CE1' ' A' ' 112' ' ' PHE . 15.3 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.16 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptm . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.76 149.65 30.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -104.59 178.12 4.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -170.72 155.5 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.014 0.435 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -151.72 100.97 2.73 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -125.87 -171.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 112.133 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.48 125.17 28.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.4 tp -116.68 94.76 4.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 111.048 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -69.53 141.2 53.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.511 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 101.03 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.969 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.9 -26.63 8.63 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.446 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.89 -84.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -109.14 30.54 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.819 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.84 -179.76 20.98 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.314 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.45 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.36 -50.52 7.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.603 0.24 . . . . 0.0 111.397 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.41 30.29 3.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.147 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.426 ' CZ ' HD12 ' A' ' 15' ' ' LEU . 3.5 p90 -123.03 147.96 46.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.368 0.584 . . . . 0.0 110.646 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.6 m -108.03 126.79 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.339 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.97 171.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.865 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.74 139.89 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.39 -121.99 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.62 140.0 7.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.326 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.6 t -54.35 -21.6 9.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.256 . . . . 0.0 111.534 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.09 -56.94 3.63 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -123.74 86.55 53.0 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.394 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.0 129.93 19.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.78 2.32 . . . . 0.0 112.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -61.66 -20.43 63.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.585 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -105.63 -41.86 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.01 0.433 . . . . 0.0 110.843 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.39 24.99 5.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.542 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.49 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 14.3 t70 -158.26 98.34 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.776 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 13.7 Cg_endo -56.52 -29.94 80.48 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.413 2.076 . . . . 0.0 112.001 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -71.06 164.64 25.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.699 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 mt -109.17 155.81 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.34 166.7 23.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 42.6 mt -96.07 154.71 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' N ' HG23 ' A' ' 36' ' ' ILE . 19.0 p -108.7 -42.46 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.47 150.8 9.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.96 141.52 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 HD11 HG23 ' A' ' 40' ' ' ILE . 2.4 mt -84.2 127.81 64.96 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.087 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.1 Cg_exo -65.18 66.9 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.525 2.15 . . . . 0.0 112.254 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.31 -52.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.436 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.68 -178.31 2.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.423 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.86 -20.77 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -60.31 -57.31 13.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -28.04 69.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.05 -43.44 64.92 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.572 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 4.8 t0 -74.39 -31.27 62.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.874 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.83 48.54 0.02 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.425 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.83 18.63 12.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.435 ' CD2' ' NH1' ' A' ' 50' ' ' ARG . 1.7 pt? -175.06 179.81 1.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.995 0.426 . . . . 0.0 111.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 152.71 22.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.341 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 28.0 m -70.95 -38.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.031 0.443 . . . . 0.0 112.17 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.66 15.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -80.11 -158.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 100.61 3.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.758 0.314 . . . . 0.0 110.991 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 3.0 tp -61.97 95.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 110.717 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -70.1 -22.63 63.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.85 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -160.06 130.77 5.64 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.457 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -113.31 117.68 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.167 178.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 46.57 37.82 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 69.44 30.92 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.87 125.86 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -45.85 125.71 6.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.358 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' CG1' HG23 ' A' ' 60' ' ' VAL . 14.2 p -153.12 23.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -94.91 11.76 30.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.354 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 174.82 46.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.981 0.42 . . . . 0.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -111.12 138.07 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.302 0.573 . . . . 0.0 111.983 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.42 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.1 OUTLIER -50.74 166.23 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.607 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.429 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -56.14 -48.55 76.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.062 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -56.2 -42.51 77.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.1 -33.87 75.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.534 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.51 68.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 109.521 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.42 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 50.5 t -64.75 -35.83 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.572 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 -33.34 72.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.832 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 -43.74 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.315 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.71 -26.77 57.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.459 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -71.89 -43.23 65.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.179 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -105.62 31.21 5.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.164 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.27 -28.65 38.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.526 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.95 -103.7 3.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.6 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 74.6 m -151.75 -52.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 18.2 mt -100.82 85.1 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.26 116.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.901 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -75.28 84.56 2.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.4 mt -85.13 139.45 31.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.519 0.676 . . . . 0.0 112.459 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 2.3 m-85 -124.01 114.51 19.84 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 12.9 m -125.53 168.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.4 mtm -127.87 108.99 11.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.244 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -116.53 127.41 54.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 120.98 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.916 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.08 131.54 85.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.1 162.84 40.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 112.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 20.2 Cg_exo -64.98 -159.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.49 2.126 . . . . 0.0 112.299 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . 161.43 86.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.241 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.657 ' HG3' ' HB3' ' A' ' 185' ' ' LYS . 1.1 pm0 -106.58 -176.37 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.288 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HG3' ' C ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -164.01 -70.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.008 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.9 154.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 7.6 tpt -134.55 164.31 27.77 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.699 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.02 106.63 12.62 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' CG2' ' A' ' 183' ' ' VAL . 2.0 mm -120.5 155.66 23.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 180' ' ' TYR . 2.4 mtmp? -115.38 123.26 48.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.358 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 tt -123.0 118.57 28.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -95.64 144.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.24 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 153.14 26.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.955 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 -177.88 15.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.842 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.48 -31.64 21.38 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.063 1.842 . . . . 0.0 112.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -96.79 19.78 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.042 0.449 . . . . 0.0 110.422 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.58 -153.06 17.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.488 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.46 -14.99 41.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.73 50.66 4.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.901 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.474 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.7 155.02 0.79 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.5 m -113.97 116.97 30.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.563 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 7.0 pt -132.79 155.1 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.4 125.04 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.061 0.457 . . . . 0.0 111.99 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.612 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.66 -175.13 25.44 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.273 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 -168.91 40.52 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.126 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 39.4 t -84.51 145.04 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.53 -25.28 16.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.1 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.61 70.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 0.0 109.738 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -72.55 -5.98 40.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.633 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.543 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 59.1 t60 72.04 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.607 0.718 . . . . 0.0 110.561 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 3.4 mt -84.04 144.21 44.05 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.91 63.32 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.548 2.166 . . . . 0.0 112.271 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.08 62.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.36 96.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.988 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -23.72 19.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.18 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 t -55.49 143.79 28.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.03 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.612 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.3 mt -84.33 119.46 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.354 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.464 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 4.5 m-85 -114.93 155.08 27.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.175 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -85.99 155.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 110.896 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.7 p -116.03 -57.3 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -152.65 150.04 29.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.258 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 146' ' ' LEU . 8.0 mt -130.27 141.63 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.054 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 mt -75.98 173.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.98 138.09 35.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.67 27.2 73.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.548 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.06 -173.35 47.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.8 -58.18 3.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 111.168 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -63.93 -31.79 73.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -57.3 -62.18 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -72.94 -38.67 66.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.999 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.43 -59.37 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 112.029 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -72.24 -43.49 46.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.077 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.68 18.64 11.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.309 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -85.96 79.59 9.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -60.47 171.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.5 mt -48.14 127.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 118.43 -25.63 8.08 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.346 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.411 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -58.52 151.07 21.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.748 0.309 . . . . 0.0 110.713 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -138.1 124.45 20.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.147 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.2 130.25 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.627 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.08 -0.98 37.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.322 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 171.22 155.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.875 0.369 . . . . 0.0 111.334 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 21.5 t -111.07 99.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.023 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 67.3 m-80 69.24 -59.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.267 0.556 . . . . 0.0 109.694 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.4 t -164.07 27.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.229 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 11.7 t -101.05 155.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.391 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.38 77.13 0.27 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.417 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.99 24.8 0.49 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -137.14 31.17 2.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.164 0.507 . . . . 0.0 110.763 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.67 27.71 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.059 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -137.61 -76.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.375 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.435 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 2.7 mtm 172.56 165.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.461 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.403 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 51.6 p-80 -53.95 -29.67 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.897 0.38 . . . . 0.0 110.467 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.42 -46.16 50.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.382 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.69 -37.36 73.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.608 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.38 -38.72 74.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.837 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.518 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 9.9 t -70.36 -41.57 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.382 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.431 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.75 -31.31 66.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.077 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.05 -27.23 57.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.657 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.0 pp -81.74 -37.33 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.851 0.358 . . . . 0.0 110.317 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -75.37 -26.54 58.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.714 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.09 -9.79 59.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 78.2 p -52.04 -178.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.947 0.403 . . . . 0.0 111.596 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.1 t80 -100.97 167.1 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.327 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.487 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.4 t70 -50.66 -24.85 3.63 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.214 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 43.0 t -147.75 92.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.71 148.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.26 125.97 38.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.787 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.99 145.09 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 111.332 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -96.38 112.29 24.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.085 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.413 ' CG2' HG13 ' A' ' 101' ' ' ILE . 21.8 t -102.64 162.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.321 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 97' ' ' LYS . . . -121.0 133.15 55.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.122 0.487 . . . . 0.0 110.918 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.657 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -95.46 146.32 31.1 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.343 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 16.7 Cg_exo -68.24 47.84 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.271 . . . . 0.0 113.593 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 t 44.94 -160.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.644 0.259 . . . . 0.0 111.356 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 52.7 p-10 -67.02 66.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.173 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.155 -179.898 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' B' ' 3' ' ' VAL . 0.0 OUTLIER -133.53 -77.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.55 ' CG1' ' HD3' ' B' ' 4' ' ' PRO . 7.0 p 174.42 -36.15 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.55 ' HD3' ' CG1' ' B' ' 3' ' ' VAL . 1.2 Cg_endo -84.39 -74.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.417 2.078 . . . . 0.0 112.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 53.67 24.71 4.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.349 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 21.9 m 55.44 176.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t -159.41 155.67 27.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.81 47.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.095 179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . 0.407 ' O ' ' CG1' ' C' ' 2' ' ' VAL . 1.8 tt0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.622 0.249 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' C' ' 1' ' ' GLN . 13.4 p 44.92 38.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.666 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -134.09 78.78 58.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.006 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.99 134.96 50.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 112.289 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.51 145.56 27.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 47.8 t 63.25 135.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.66 84.62 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 96.5 p -97.83 84.33 3.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.099 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mtm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.821 0.343 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.67 113.22 25.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -109.71 128.88 55.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.393 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -177.73 172.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 111.618 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 1.5 pm0 -90.08 150.48 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.412 ' CD1' ' HG3' ' A' ' 50' ' ' ARG . 8.1 mt -144.18 153.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.281 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -116.91 125.67 51.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.005 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.449 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 8.5 tp -127.05 91.43 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.556 0.693 . . . . 0.0 110.361 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 11.2 mt-10 -77.27 163.16 26.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.786 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -69.56 97.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.592 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -175.28 -85.35 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -109.11 30.53 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.808 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.06 177.73 15.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.358 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.38 -44.83 13.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.804 0.335 . . . . 0.0 111.195 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 90.39 77.15 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.783 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -163.33 155.55 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.788 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.1 t -111.97 126.85 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.1 pt -120.54 163.93 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.883 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.35 156.94 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.28 -126.07 5.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.537 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.45 132.53 5.18 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.448 ' N ' ' HA ' ' A' ' 69' ' ' THR . 1.6 t -48.46 -26.97 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.317 . . . . 0.0 111.345 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.46 -44.31 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -123.77 78.75 56.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.82 134.13 40.85 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.665 2.244 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 27.8 t60 -69.32 -22.93 63.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.18 -30.73 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 27.81 10.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.661 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -172.67 33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.78 111.04 0.47 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.26 -30.14 37.85 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.716 2.277 . . . . 0.0 112.034 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.56 129.27 39.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 152.3 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.3 165.13 28.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.702 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 43.1 mt -94.2 153.79 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.464 ' N ' HG21 ' A' ' 36' ' ' ILE . 15.9 p -106.93 -44.53 4.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.726 0.298 . . . . 0.0 111.494 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -156.59 152.5 27.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 111.39 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -111.01 141.27 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.822 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 40' ' ' ILE . 2.5 mt -86.26 135.83 36.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.82 57.25 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.261 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.09 -53.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.69 -174.83 0.85 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.465 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.64 58.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.47 -51.04 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.324 . . . . 0.0 111.49 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.2 67.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -72.2 -38.97 68.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.749 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -81.56 -31.11 32.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.729 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.56 47.19 0.01 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.503 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -99.15 22.64 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.997 0.399 . . . . 0.0 110.98 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -168.84 -178.14 3.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.49 171.5 8.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.652 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 33.7 m -71.44 -46.67 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -69.39 11.52 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -67.86 -179.74 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -135.75 100.35 4.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.709 0.29 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 57' ' ' ILE . 5.1 pt -61.25 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.414 0.626 . . . . 0.0 110.994 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.85 -24.77 66.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.596 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -160.75 155.53 23.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.642 ' O ' ' N ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -129.66 -176.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.209 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -41.64 78.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.927 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.6 tt0 63.76 21.71 12.78 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.208 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 60' ' ' VAL . 2.2 t -121.44 141.99 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 0.0 111.678 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.37 82.29 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.321 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.4 m -94.72 31.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.583 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.85 -4.39 59.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.345 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 176.64 56.66 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.033 0.444 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.69 142.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.748 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.448 ' HA ' ' N ' ' A' ' 23' ' ' THR . 1.2 m -50.2 161.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.631 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.4 t-160 -53.76 -48.59 69.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.554 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -49.92 -43.72 49.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.06 73.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.61 69.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.604 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 40.0 t -64.4 -35.87 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.644 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.49 -33.74 73.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.57 -43.12 73.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.396 0.617 . . . . 0.0 110.555 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -76.28 -26.74 56.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.486 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.16 -42.53 68.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.196 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -104.16 29.77 5.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.379 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -85.33 -25.78 26.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.435 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.64 -137.36 20.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.488 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.451 ' O ' HG12 ' A' ' 83' ' ' ILE . 35.8 m -121.91 16.43 10.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.572 0.225 . . . . 0.0 111.346 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.17 92.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.2 t -87.22 149.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 111.921 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -137.98 84.86 2.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.723 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -116.67 154.21 30.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.2 t80 -105.66 114.93 29.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.686 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.8 m -121.37 167.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.408 ' HG3' ' HB3' ' A' ' 3' ' ' TYR . 1.1 ttp -121.08 109.61 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.959 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HG2' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -132.39 143.43 49.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' N ' ' HG2' ' A' ' 90' ' ' ARG . 8.5 ttp85 -77.99 135.48 37.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.779 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.45 84.18 23.01 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.146 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -61.85 119.58 6.78 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.701 2.267 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.78 91.76 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.643 2.229 . . . . 0.0 112.252 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.16 44.74 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.627 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.34 125.67 28.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.553 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.51 -177.11 6.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.193 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.19 154.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.0 mmm -128.86 166.68 18.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.236 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -127.86 106.45 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG13 ' CG2' ' A' ' 183' ' ' VAL . 1.8 mm -118.07 155.31 20.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.619 . . . . 0.0 112.606 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -111.93 126.91 55.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.062 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 tt -129.91 118.72 22.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.6 pt -95.97 144.74 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -80.0 156.93 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.998 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 -174.01 13.46 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.86 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.74 -39.72 6.2 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.035 1.823 . . . . 0.0 112.063 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -95.21 22.75 6.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.66 -165.61 12.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.63 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 1.4 mp -80.85 -13.49 58.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.175 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.17 51.84 3.43 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.829 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.94 149.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.665 0.269 . . . . 0.0 110.75 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.413 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 17.0 m -115.31 116.92 29.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.798 0.332 . . . . 0.0 110.674 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 5.5 pt -127.47 152.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -143.49 125.02 14.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.785 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.65 -175.06 25.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.915 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.62 134.71 8.54 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -59.24 153.13 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.58 -32.13 6.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 178.48 76.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 171.61 7.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.103 0.477 . . . . 0.0 110.924 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.53 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 66.9 t60 -49.8 -50.54 44.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.071 0.938 . . . . 0.0 110.516 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -96.58 129.63 32.61 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.836 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.14 78.47 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.307 2.005 . . . . 0.0 112.593 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.47 37.57 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.938 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.33 95.16 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.956 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -52.13 -25.18 8.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.2 m -54.45 115.9 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.785 HG12 ' HA3' ' A' ' 116' ' ' GLY . 11.7 mt -61.8 120.53 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.475 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.2 m-85 -111.98 156.97 21.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.317 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -87.95 153.32 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.823 0.344 . . . . 0.0 110.683 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 113' ' ' SER . 11.6 p -115.54 -58.04 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 147.69 23.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.016 0.436 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.2 mt -125.32 141.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -74.18 173.44 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -90.35 147.24 23.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.82 55.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.44 174.33 53.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.16 -50.17 50.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.422 . . . . 0.0 111.111 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.369 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -54.87 -54.82 37.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -72.87 -51.96 16.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.053 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.56 -59.36 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 111.85 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.6 -52.1 35.12 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.133 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 60.88 19.81 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.401 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -98.57 78.48 2.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.01 174.26 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.703 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.441 HD11 HG23 ' A' ' 148' ' ' ILE . 30.0 mt -48.06 132.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.172 0.51 . . . . 0.0 111.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 112.66 -28.36 9.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.251 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -61.16 145.3 51.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.672 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -132.65 136.85 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.419 ' CD1' ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -105.66 132.4 52.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.713 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -1.65 32.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 173.97 162.98 0.18 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.967 0.413 . . . . 0.0 111.283 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 25.6 t -117.67 99.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.143 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 65.4 m-80 69.2 -59.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.309 0.576 . . . . 0.0 109.817 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.45 26.77 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.353 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 6.3 t -109.23 154.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.26 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.37 76.88 0.26 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.412 ' HB3' ' CB ' ' A' ' 171' ' ' ALA . 0.3 OUTLIER -80.26 24.01 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.72 58.01 1.56 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.1 29.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 2.4 t -136.61 -74.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.3 mtm -174.45 -170.3 0.5 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.453 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -70.86 -32.87 70.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.943 0.401 . . . . 0.0 110.589 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.79 -46.7 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.77 -35.14 69.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 129' ' ' ILE . . . -70.28 -39.01 75.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.315 0.579 . . . . 0.0 109.463 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 t -73.65 -39.95 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.48 71.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.03 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 160' ' ' LEU . . . -78.17 -25.68 47.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.929 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 173' ' ' LYS . 0.4 OUTLIER -81.05 -40.71 23.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.427 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.51 59.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.19 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -12.33 32.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.416 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.53 147.52 0.84 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 111.587 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.2 t80 -86.13 169.54 13.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.419 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 3.2 t70 -46.77 -30.81 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.079 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.8 t -147.91 91.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.649 0.261 . . . . 0.0 110.539 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.83 148.4 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.433 . . . . 0.0 111.734 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.3 m-85 -98.34 128.32 44.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.421 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.54 152.67 28.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -96.56 118.7 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.408 ' CG2' HG13 ' A' ' 101' ' ' ILE . 20.8 t -102.35 161.26 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.352 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -125.92 136.26 52.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.739 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.6 OUTLIER -83.85 137.47 40.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.658 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 4.5 Cg_exo -74.83 48.95 2.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.736 2.29 . . . . 0.0 112.871 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.2 t 53.04 103.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.872 0.368 . . . . 0.0 111.345 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.1 26.85 10.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.146 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.68 0.276 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.423 HG11 ' O ' ' B' ' 2' ' ' VAL . 2.9 p 42.67 93.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.564 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 m -87.23 108.7 20.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.08 -35.56 5.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.396 2.064 . . . . 0.0 112.392 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -165.53 -175.23 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.55 158.92 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 171.31 14.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.969 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -162.6 128.0 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.84 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.073 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.836 0.351 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 24.3 t 63.99 94.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.447 ' HB ' ' HD3' ' C' ' 4' ' ' PRO . 13.3 t -78.8 -47.91 1.73 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.569 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' C' ' 3' ' ' VAL . 96.9 Cg_endo -80.0 -177.91 4.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.301 2.001 . . . . 0.0 112.352 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -177.08 -60.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 3.1 m 61.12 162.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 6.1 t -78.77 94.38 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -90.96 100.26 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.102 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.803 0.335 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.91 162.8 38.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.92 163.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.567 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -174.86 162.17 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.376 . . . . 0.0 111.259 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 6.0 pt-20 -95.97 147.47 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 7' ' ' THR . 27.0 mt -146.78 165.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -129.74 147.17 51.49 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.198 0.523 . . . . 0.0 111.835 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.533 HD22 ' HD3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -135.51 87.33 2.31 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.412 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -79.81 118.85 21.97 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.251 179.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -41.78 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.65 8.05 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.591 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.28 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.31 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -109.23 30.69 6.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.24 177.98 24.72 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.716 -1.23 . . . . 0.0 112.809 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -84.26 -47.33 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.499 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.09 62.14 1.02 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.827 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 11.6 p90 -165.13 169.19 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 111.351 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.56 126.76 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.535 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.0 pt -116.45 157.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.241 0.544 . . . . 0.0 111.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.71 148.09 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.502 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.7 16.9 2.41 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.585 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.06 173.46 0.02 OUTLIER Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.488 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.8 t -77.56 -35.7 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 5.3 t0 -86.38 -42.44 13.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.334 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -123.86 77.25 57.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.429 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.49 171.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.619 2.213 . . . . 0.0 112.275 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 20.7 t60 -111.57 -21.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.339 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.539 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.94 -25.82 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 29.52 7.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.381 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.62 40.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 108.48 2.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.837 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 16.8 Cg_exo -67.43 -22.32 45.53 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -82.92 136.81 34.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.68 145.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.219 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.539 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.7 p90 -142.17 142.95 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.568 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 33.9 mt -69.75 146.87 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.418 ' N ' HG23 ' A' ' 36' ' ' ILE . 3.0 m -101.26 -33.87 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.24 143.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.291 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -107.24 141.45 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.137 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.47 135.13 41.41 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 63.72 4.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.48 -43.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.06 178.5 1.87 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.18 -19.76 58.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . . . -52.92 -57.55 9.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.934 0.397 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.5 69.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.903 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -72.02 -35.02 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.575 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.43 -20.19 25.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.454 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 80.26 1.0 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HD3' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -88.3 22.02 2.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 90' ' ' ARG . 3.2 pp 36.7 -154.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' N ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.11 128.72 38.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 111.158 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.469 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . 26.4 m -57.77 -41.61 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.229 0.538 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -50.45 -17.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.944 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -57.67 150.43 19.5 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -121.7 129.8 53.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -65.82 94.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.1 mt -58.47 -26.89 63.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -162.93 145.45 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.563 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' A' ' 61' ' ' ASN . 1.0 OUTLIER -108.3 -176.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.376 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 60' ' ' VAL . 7.4 m120 -21.78 -52.35 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.943 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.63 25.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HB ' HG11 ' A' ' 60' ' ' VAL . 2.7 t -121.58 142.06 39.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.529 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 8.0 p-10 -79.61 87.13 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 m -94.09 30.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.75 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -82.66 2.03 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.862 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.98 58.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.61 142.8 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.715 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 23' ' ' THR . 5.4 m -49.81 161.94 0.21 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.126 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.1 t-160 -60.34 -48.61 81.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.301 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -37.99 81.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.48 76.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.05 -43.13 65.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.968 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 53.6 t -64.63 -35.71 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.912 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.53 -33.35 72.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.863 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.03 74.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.525 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -77.11 -26.76 53.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.538 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -72.51 -41.1 66.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.399 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 28.45 6.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.878 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.63 -19.13 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.512 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.94 -159.29 16.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.862 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -99.75 10.09 41.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.619 0.247 . . . . 0.0 111.464 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -152.93 94.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 8' ' ' LEU . 26.9 m -90.64 134.89 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -116.7 102.11 9.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -128.82 154.25 46.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.404 0.621 . . . . 0.0 112.546 -178.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -103.77 115.27 30.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.677 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 34.4 m -104.22 167.94 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 112.388 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.4 ttp -126.0 109.62 12.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.844 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HB3' HD11 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -129.51 146.73 51.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.134 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.11 131.16 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 57.94 3.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.15 113.17 2.75 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.606 2.204 . . . . 0.0 112.365 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 188' ' ' ASN . 36.4 Cg_endo -95.8 128.03 0.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.51 2.806 . . . . 0.0 111.681 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.12 21.66 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.617 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -98.24 105.5 17.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.23 124.16 44.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.187 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.0 p -84.66 114.48 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.53 166.69 11.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 111.861 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -135.49 106.5 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.4 mm -114.14 155.27 15.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 3.7 mttp -114.2 120.93 42.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.364 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.9 tt -119.52 118.75 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.369 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -95.14 144.68 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.967 0.413 . . . . 0.0 111.226 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -58.79 151.65 20.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.135 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.93 160.16 23.21 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.646 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -40.54 80.51 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 C-N-CA 122.119 1.879 . . . . 0.0 112.129 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.71 19.69 9.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.05 0.452 . . . . 0.0 110.101 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.4 -144.57 16.0 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 mp -86.56 -20.06 28.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.084 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.33 61.51 3.89 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.92 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 145.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.8 t -109.98 117.4 33.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.412 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 6.3 pt -130.87 154.66 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.65 125.0 10.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 111.755 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.535 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.54 -175.01 25.2 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.516 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.4 -164.17 54.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.195 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.46 150.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 111.149 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.21 -30.51 7.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.973 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -164.66 69.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.053 0.454 . . . . 0.0 109.897 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.9 mt-30 -67.1 -11.24 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.655 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 60.8 t60 72.43 -54.68 0.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.65 0.738 . . . . 0.0 110.944 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -92.38 138.14 24.28 Favored Pre-proline 0 C--N 1.31 -1.117 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.741 -179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.54 60.94 4.3 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.356 2.037 . . . . 0.0 112.563 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 130.74 55.87 0.09 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -175.55 96.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -57.85 -22.13 46.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -58.33 141.92 49.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.535 HG12 ' HA3' ' A' ' 116' ' ' GLY . 14.9 mt -74.65 127.66 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 111.249 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.493 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 5.9 m-85 -122.4 146.52 47.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -76.93 155.59 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 p -119.62 -59.18 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.07 146.69 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.924 0.393 . . . . 0.0 111.157 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 146' ' ' LEU . 17.1 mt -134.4 141.49 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.74 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.672 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.0 153.17 18.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 52.59 31.2 36.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.738 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.36 -167.97 39.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.697 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.02 -60.92 2.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -68.3 -31.94 71.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.273 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.07 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.212 0.529 . . . . 0.0 110.009 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -72.82 -52.99 12.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.772 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.6 -59.24 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.794 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -52.63 -53.34 33.04 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.068 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 64.98 16.46 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.019 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -94.05 78.46 4.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.518 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -61.14 175.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.3 mt -47.94 129.9 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 115.48 -27.04 8.67 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.297 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.0 OUTLIER -64.09 138.33 58.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 110.546 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -126.83 131.31 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.037 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -102.51 134.56 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.884 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.82 -1.92 33.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.923 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 176.15 163.71 0.38 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.46 99.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.224 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.434 ' OD1' ' CG ' ' A' ' 180' ' ' TYR . 66.9 m-80 69.82 -59.91 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.395 0.617 . . . . 0.0 109.762 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.75 27.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.17 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 4.1 t -108.47 154.55 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.295 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.45 77.1 0.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.415 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.93 24.44 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -132.09 30.97 4.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.173 0.511 . . . . 0.0 110.905 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -141.98 28.44 1.73 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.272 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.445 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.5 t -139.93 -78.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.383 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtp -179.14 -169.74 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -70.43 -31.59 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.494 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -47.57 39.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -69.96 -37.12 75.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.84 0.352 . . . . 0.0 110.642 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.14 -38.8 75.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.237 0.542 . . . . 0.0 109.634 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.483 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 13.1 t -72.28 -39.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.411 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.74 -29.73 64.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.016 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.54 55.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.1 pp -81.7 -37.87 26.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.469 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -74.96 -26.44 59.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -15.24 53.29 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.409 ' HB ' ' CG2' ' A' ' 179' ' ' VAL . 25.3 p -50.11 -178.74 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.735 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.486 ' CD1' HG12 ' A' ' 179' ' ' VAL . 9.0 p90 -132.46 -160.41 1.05 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.733 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.519 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 6.3 t0 -53.37 -34.79 59.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.427 ' O ' ' CZ ' ' A' ' 176' ' ' TYR . 35.2 t -147.86 92.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 0.0 111.596 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.486 HG12 ' CD1' ' A' ' 176' ' ' TYR . 0.5 OUTLIER -111.01 131.38 62.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.054 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 10.2 p90 -94.05 124.47 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -109.58 153.87 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 111.374 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -96.93 110.91 23.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.608 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.8 t -102.21 159.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.306 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -140.74 145.24 36.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.54 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -99.08 146.06 31.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.63 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.76 123.76 14.53 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.525 2.15 . . . . 0.0 112.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 t -54.55 -177.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 94' ' ' PRO . 15.6 t-20 -66.24 72.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.168 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.901 0.381 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 27' ' ' HIS . 11.2 p -178.46 49.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 11.4 t -76.16 -48.08 3.45 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.423 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 90.3 Cg_endo -79.01 -31.42 2.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 80.76 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.94 145.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -94.26 95.71 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.38 80.27 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.184 -179.655 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 19.1 t 63.77 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t 64.04 83.23 0.2 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 156.52 12.84 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.594 2.196 . . . . 0.0 112.151 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -97.55 -64.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -103.24 151.33 22.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -75.01 93.72 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -86.49 116.4 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.117 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 mtt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -124.65 168.25 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.27 178.7 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HB2' ' NH2' ' A' ' 90' ' ' ARG . 5.7 tt0 -174.04 142.81 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 8.6 pt-20 -108.86 111.47 23.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.744 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -120.29 -169.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.168 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -140.82 133.36 28.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -113.29 88.93 2.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 111.067 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -82.54 116.79 22.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.377 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -40.63 95.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.406 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.15 -26.87 6.68 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.828 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -169.65 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -109.17 30.66 6.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.82 177.41 23.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.984 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' CD2' ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.28 -45.77 12.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.251 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.54 64.27 1.27 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.682 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 10.1 p90 -164.9 146.38 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.0 110.784 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.407 ' O ' HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -96.01 165.3 12.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.0 pt -152.96 159.63 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.82 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.22 154.95 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.225 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.49 -127.45 6.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.9 144.31 8.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.458 HG23 ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -57.91 -20.01 33.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.349 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB2' HG22 ' A' ' 69' ' ' THR . 19.3 t70 -94.34 -42.1 9.08 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.696 0.284 . . . . 0.0 111.085 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -123.76 77.59 56.82 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -47.46 129.4 16.42 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.715 2.276 . . . . 0.0 112.477 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.406 ' HB3' ' HE1' ' A' ' 35' ' ' PHE . 78.6 t60 -57.22 -72.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.078 0.466 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.407 HD11 ' CE2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -55.9 -42.0 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.551 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.36 23.63 5.07 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.444 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.28 29.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 2.4 m-20 -160.43 103.44 1.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.813 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.8 Cg_endo -55.89 -26.08 56.11 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.465 2.11 . . . . 0.0 111.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -66.71 147.94 52.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.28 151.74 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 111.288 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -142.39 158.07 44.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.717 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 65.4 mt -77.03 148.65 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.31 -30.05 10.38 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.514 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 146.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.45 141.11 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.7 pt -89.65 139.45 27.96 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.17 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.93 64.25 7.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.564 2.176 . . . . 0.0 112.414 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.14 -41.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.14 177.35 15.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 -20.94 57.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.404 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.96 -57.28 10.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.944 0.402 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.76 -28.32 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.87 -40.28 69.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.23 0.538 . . . . 0.0 109.605 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.55 -20.22 43.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.333 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.54 83.85 0.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.443 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -89.37 13.8 12.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.72 0.295 . . . . 0.0 111.16 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.42 -163.68 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.392 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.86 146.85 20.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 111.281 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 6.6 m -63.18 -42.55 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.576 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 35' ' ' PHE . 19.9 m-80 -52.36 -11.81 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.44 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -63.55 152.56 38.32 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 p -119.04 120.22 36.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.009 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.6 pt -60.83 94.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.575 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.409 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -60.7 -26.28 67.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.907 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.417 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.6 m-85 -164.87 140.1 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.381 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -125.13 118.87 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.44 -76.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.9 tt0 -160.44 30.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 17.7 t -120.82 140.73 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.27 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 5.3 p-10 -79.71 107.97 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.1 t -125.57 39.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -95.51 -2.07 49.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -175.77 49.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.172 0.51 . . . . 0.0 109.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.96 142.35 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.638 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.458 ' CG2' HG23 ' A' ' 23' ' ' THR . 66.7 p -49.65 161.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.839 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.446 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.4 t-160 -59.01 -48.71 80.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -58.78 -40.8 85.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.37 68.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.46 69.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.59 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 39.8 t -64.92 -35.3 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.469 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -69.47 -33.51 73.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.763 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.57 73.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -74.77 -26.41 59.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.387 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -41.41 83.37 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.157 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.55 28.24 7.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.688 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.37 -24.74 23.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.36 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.57 -160.49 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.909 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 68.3 m -97.34 -36.54 10.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 mt -112.87 85.1 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 8' ' ' LEU . 17.7 m -90.61 115.15 29.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.091 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.28 101.25 13.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -117.28 154.28 31.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.51 114.99 28.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.328 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.3 m -104.38 159.91 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.195 0.522 . . . . 0.0 112.229 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 109.66 15.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.658 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' NH2' ' HB2' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -128.39 144.81 51.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -68.78 139.65 55.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.641 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -50.34 105.95 0.58 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.296 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.84 179.79 2.51 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.411 2.074 . . . . 0.0 112.015 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' A' ' 188' ' ' ASN . 32.5 Cg_exo -59.18 -151.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.385 2.057 . . . . 0.0 112.307 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 58.16 44.84 18.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.139 0.495 . . . . 0.0 109.74 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 186' ' ' PRO . 4.0 pt-20 179.74 87.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.315 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 187' ' ' SER . 16.9 tttp -96.63 162.61 13.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.4 t -123.61 136.33 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.54 166.64 15.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 111.431 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.97 106.41 6.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mm -114.53 155.21 15.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -108.89 123.73 49.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.226 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.436 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 3.1 tt -126.14 118.57 25.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.755 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -95.46 144.65 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.66 155.77 25.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.66 178.11 18.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.892 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.93 -31.25 38.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.103 1.869 . . . . 0.0 112.006 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -96.89 19.68 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.76 -156.36 16.55 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.539 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.5 -13.27 46.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.12 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.24 49.45 5.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.978 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.2 154.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.808 0.337 . . . . 0.0 111.079 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.2 t -116.84 116.64 27.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 14.3 pt -129.52 157.25 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.44 125.75 7.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.674 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.47 -175.24 25.42 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.19 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.67 -165.76 48.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.182 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.3 t -87.95 148.25 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.172 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.61 -10.97 60.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.516 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.97 65.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.537 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -76.21 -0.61 22.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.908 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 82.4 t60 72.69 -60.99 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.702 0.763 . . . . 0.0 110.568 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.504 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.8 OUTLIER -94.6 107.03 27.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.668 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.49 89.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.394 2.062 . . . . 0.0 112.512 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 108.46 34.4 2.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.402 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -155.47 90.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.977 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -53.9 -23.26 12.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.348 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 m -56.67 137.48 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.674 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.7 mt -78.86 116.22 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.392 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.504 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.9 m-85 -113.06 150.08 32.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.07 155.72 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -128.52 -45.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.34 146.27 32.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.731 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.0 mt -136.81 141.43 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 mt -71.89 173.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 137.28 32.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.844 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.42 27.19 40.03 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.627 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.59 178.43 50.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.14 -54.72 25.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.135 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' CB ' ' HG ' ' A' ' 103' ' ' LEU . . . -70.11 -32.75 70.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -60.0 -55.36 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.239 0.542 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -46.56 52.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.867 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -80.73 -59.47 2.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.032 0.444 . . . . 0.0 112.053 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -60.95 -46.34 94.77 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.247 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.54 17.25 10.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.74 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -91.39 79.2 5.62 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -60.0 170.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.0 mt -47.6 126.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.281 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.99 -23.87 9.12 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.514 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.422 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -65.12 129.12 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.827 0.346 . . . . 0.0 110.517 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -115.62 131.45 56.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.244 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.417 ' CD1' ' CG2' ' A' ' 129' ' ' ILE . 0.3 OUTLIER -104.9 134.61 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.715 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 pp -103.9 -2.07 26.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 176.61 159.9 0.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.896 0.379 . . . . 0.0 111.457 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 11.7 t -115.52 100.19 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 180' ' ' TYR . 20.2 m-80 69.28 -59.5 0.48 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.367 0.604 . . . . 0.0 109.635 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.49 28.96 0.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.989 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.444 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 9.9 t -106.46 154.81 7.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -114.36 76.45 0.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.431 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -78.15 24.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 159' ' ' GLY . 4.2 pt-20 -136.91 35.23 2.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.234 0.54 . . . . 0.0 110.742 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.02 28.59 1.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.4 t -142.04 -77.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.083 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.6 mtm -179.4 -171.59 0.2 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -71.84 -32.67 67.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.301 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.72 -42.4 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.461 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.11 -37.81 66.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.569 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 129' ' ' ILE . . . -70.48 -38.71 74.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 23.8 t -72.69 -43.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.481 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 174' ' ' ASN . . . -71.86 -30.18 65.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.044 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.51 -29.14 56.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.472 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 169' ' ' VAL . 4.2 pp -81.66 -37.58 27.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.55 59.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.937 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -69.99 -13.67 62.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.439 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.7 p -56.84 -168.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 64.0 t80 -106.18 172.46 6.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.428 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 2.2 m-20 -58.28 -15.97 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.202 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.52 92.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.262 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.86 147.91 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.282 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.424 ' CE1' ' HA ' ' A' ' 156' ' ' ASN . 18.4 p90 -100.93 129.71 46.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -108.99 154.37 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 116.93 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.786 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 19.6 t -101.89 162.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.491 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -138.83 117.23 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 0.0 111.936 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 97' ' ' LYS . 4.4 ptpt -113.61 97.82 45.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.599 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.2 Cg_exo -45.76 96.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.756 2.304 . . . . 0.0 113.856 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.7 m -179.81 136.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.438 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . 10.3 p30 42.74 30.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.371 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 96' ' ' GLU . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.095 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.831 0.348 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t -98.68 34.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.09 112.72 5.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 -171.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.438 2.092 . . . . 0.0 112.274 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -150.91 158.24 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 18.6 m -66.08 164.68 14.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -99.42 141.78 31.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -127.19 124.24 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.156 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.0 -47.08 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.16 123.28 30.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.32 105.09 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.491 2.128 . . . . 0.0 112.275 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 62.51 135.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -66.65 -67.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.48 130.81 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.067 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.82 73.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.091 -179.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.93 145.96 37.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.001 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.26 141.1 27.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.584 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 5.7 pt-20 -175.01 165.92 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 111.417 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -109.37 123.47 49.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.771 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -123.62 -172.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.316 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -140.44 127.95 21.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.259 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.492 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 5.8 tp -119.05 91.42 3.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.638 0.732 . . . . 0.0 110.561 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -73.79 138.84 44.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.601 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 82' ' ' SER . 2.5 ptm180 -57.85 103.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.35 -26.91 7.3 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.547 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -168.15 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -109.15 30.71 6.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.725 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.94 174.68 19.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.441 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.33 -50.49 7.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.942 0.401 . . . . 0.0 111.304 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.23 74.64 1.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.69 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.9 p90 -164.65 156.46 15.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.029 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 p -105.93 126.81 52.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 2.4 pp -120.43 154.49 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 0.0 111.945 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.97 147.49 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.754 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.41 19.62 1.34 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.993 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.11 162.92 0.08 OUTLIER Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.542 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.3 t -66.68 -38.73 87.39 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.431 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 12.5 t0 -83.77 -49.17 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 111.631 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.69 76.89 10.77 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.582 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.69 172.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.646 2.23 . . . . 0.0 112.274 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 17.5 t60 -108.8 -21.45 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.212 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.74 -25.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.86 7.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.703 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.89 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.13 101.49 2.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.017 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.15 61.83 2.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.903 2.402 . . . . 0.0 111.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 m -176.86 134.61 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.741 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 145.1 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.52 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.6 p90 -142.24 163.64 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.453 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.615 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 49.2 mt -93.97 148.67 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 110.84 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' N ' HG23 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -106.67 -31.77 8.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.344 -179.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -172.55 148.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -106.95 141.62 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.78 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.05 128.05 64.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.965 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.2 62.14 2.6 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 -43.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.62 -177.26 22.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.94 -21.27 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.631 0.253 . . . . 0.0 111.532 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.0 -57.62 12.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.313 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.13 -28.25 67.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.75 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.21 -36.21 69.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.652 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' GLY . 34.0 m-20 -87.21 -25.98 23.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.327 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 28.47 54.7 0.13 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.148 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' NH1' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -84.16 4.84 28.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -177.76 -177.9 0.68 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.106 0.479 . . . . 0.0 111.547 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 165.19 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.396 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 34.5 m -71.13 -45.51 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.72 17.6 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' VAL . 7.5 p-10 -75.34 -166.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.33 100.05 3.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -60.84 95.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.465 0.65 . . . . 0.0 111.058 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -70.94 -25.68 62.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -154.55 129.84 9.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 2.5 t -137.13 145.87 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.927 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.5 m120 42.24 32.43 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.471 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 65.66 32.7 8.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' VAL . 21.8 t -121.07 141.88 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.46 78.13 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.78 33.26 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.427 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -84.24 3.56 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.05 47.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.039 0.447 . . . . 0.0 109.837 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.71 140.99 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.176 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.434 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.6 OUTLIER -49.67 164.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.905 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.3 t-160 -57.39 -48.49 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.372 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -41.4 63.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.151 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.58 76.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.94 -40.75 68.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.55 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 49.7 t -64.23 -35.83 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.658 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -34.07 73.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.815 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -42.92 74.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 110.477 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.8 pp -76.8 -26.74 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.385 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -45.09 59.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.382 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -103.18 28.82 5.99 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.415 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 77' ' ' LEU . . . -81.56 -27.83 34.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.508 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.09 -124.58 8.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.635 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 83' ' ' ILE . 69.6 p -130.83 4.62 4.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.84 96.73 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 26.6 m -87.41 114.37 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -100.9 110.38 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.47 154.1 51.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.474 ' CE1' ' N ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -107.83 114.68 28.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.219 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.6 m -118.97 168.1 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.113 0.482 . . . . 0.0 112.151 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ptm -124.33 109.53 13.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.155 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -129.14 141.53 51.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -71.61 114.56 9.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -69.89 111.69 9.92 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.06 127.79 3.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.531 2.154 . . . . 0.0 112.479 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.77 86.63 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.525 2.15 . . . . 0.0 111.963 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.18 29.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.112 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.27 146.1 37.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.326 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 -174.82 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 111.433 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.73 152.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.906 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttt -135.31 166.3 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 mm -114.96 155.6 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.603 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' HD2' ' CZ ' ' A' ' 180' ' ' TYR . 1.6 ttpt -113.7 124.53 52.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 tt -125.79 118.4 25.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.87 144.68 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.195 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -65.75 155.24 36.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -134.82 -169.64 11.98 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.68 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.12 -40.13 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.022 1.815 . . . . 0.0 112.322 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 20.2 8.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 110.277 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 106.81 -133.93 11.9 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -86.71 -27.03 23.94 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.935 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.1 40.75 4.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.669 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.526 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.12 154.59 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 111.08 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.5 t -102.23 123.15 45.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.489 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.526 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 16.4 pt -130.1 155.26 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 122' ' ' HIS . . . -162.41 125.47 2.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.051 0.453 . . . . 0.0 111.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.93 -175.48 25.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.622 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.25 34.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.962 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -104.26 154.7 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.853 0.358 . . . . 0.0 111.377 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 -35.83 4.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 175.05 78.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 115.11 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.425 ' CE1' ' HB1' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -58.98 -17.58 26.15 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.537 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 1.1 mt -83.55 122.62 76.88 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.742 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.39 96.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.47 2.114 . . . . 0.0 112.165 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.85 58.31 14.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.93 87.01 1.95 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.571 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -43.53 -28.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t -53.57 168.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.619 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.53 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt -105.86 127.27 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.935 0.398 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.537 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.3 m-30 -117.27 154.67 30.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.502 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.2 t -90.07 152.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 5.9 t -123.62 -50.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.424 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -134.22 142.42 47.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 30.7 mt -136.99 138.46 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -80.16 172.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -91.37 134.52 34.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.922 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.36 26.29 56.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.88 -138.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.4 -72.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 111.19 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -61.47 -31.79 71.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.7 t-160 -56.41 -62.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 110.993 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -72.63 -34.3 67.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.985 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -59.36 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -88.13 -29.23 20.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.844 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 141' ' ' HIS . 1.3 ttm180 67.75 27.8 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.01 0.405 . . . . 0.0 110.527 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -88.64 82.71 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -68.38 176.35 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.87 121.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.299 0.571 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.4 -23.36 5.15 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.059 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 9.3 t0 -57.94 139.51 54.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.773 0.321 . . . . 0.0 110.524 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -130.98 119.51 22.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.146 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.99 131.98 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.092 0.472 . . . . 0.0 110.79 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 pp -104.3 -1.36 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.201 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 179.83 168.68 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 58.6 t -117.88 100.44 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.635 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 66.4 m-80 70.42 -57.45 0.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.072 0.463 . . . . 0.0 110.081 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 m -165.31 21.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.325 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -116.32 132.61 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.165 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.0 68.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.26 28.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.848 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -122.29 37.17 4.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.168 0.508 . . . . 0.0 110.939 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -142.42 29.05 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.8 t -116.08 -76.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.2 mtm -176.45 -170.2 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.744 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -69.99 -34.17 72.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.663 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.7 -45.41 52.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.91 -37.46 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.806 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.93 73.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.061 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.401 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 11.4 t -73.95 -39.97 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.2 -33.6 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.96 -27.04 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -76.18 -36.73 58.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -26.87 60.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.44 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -9.95 55.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.519 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 p -47.73 149.53 1.24 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 0.0 111.442 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -87.58 169.78 11.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t0 -45.12 -35.3 3.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.044 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.8 t -147.85 91.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.95 148.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.661 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.415 ' CZ ' ' HD2' ' A' ' 102' ' ' LYS . 13.2 m-85 -96.42 127.05 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.602 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 mt -104.94 150.71 24.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.954 0.407 . . . . 0.0 110.597 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 152' ' ' ILE . 5.9 tttm -96.8 114.27 25.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.8 t -101.68 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 111.288 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -123.1 141.15 52.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.16 125.89 64.58 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.82 116.27 2.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.242 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.74 142.38 23.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.2 t30 53.19 27.25 5.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.12 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.688 0.28 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 13.3 p 44.07 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.561 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 3.1 t -90.9 -47.23 0.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.492 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 36.0 Cg_endo -90.65 -72.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.823 2.349 . . . . 0.0 112.582 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.88 154.69 3.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.918 0.39 . . . . 0.0 111.008 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -146.06 158.77 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -97.78 108.24 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 111.006 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 71.7 m -103.26 102.81 12.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.678 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.189 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.819 0.342 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.12 30.62 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.19 141.45 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.8 -171.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.425 2.083 . . . . 0.0 112.35 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.13 170.47 22.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 33.0 t -154.78 173.32 16.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 t -103.78 99.83 9.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -80.9 95.82 6.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.108 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.821 0.343 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -112.17 154.33 25.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.9 151.52 20.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -177.07 158.5 1.54 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 111.311 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -113.81 114.71 26.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.727 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -119.27 -176.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 120.979 0.418 . . . . 0.0 111.429 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.13 125.16 38.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.724 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 13.9 tp -124.19 92.73 3.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.683 0.754 . . . . 0.0 109.97 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.16 161.69 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.22 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 15.0 ptm180 -73.14 98.51 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.876 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.87 -26.57 8.48 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.526 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -168.45 -87.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.143 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -109.18 30.73 6.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 177.4 18.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.019 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.496 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.48 -37.08 21.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.187 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 72.47 1.29 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.967 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -156.49 157.11 34.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 178.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.0 m -104.5 126.89 52.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.467 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 35.5 pt -105.4 163.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 0.0 111.74 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . . . -162.36 144.38 10.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.42 -144.75 18.21 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.708 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.09 142.83 5.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.366 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.3 t -48.6 -27.63 2.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -81.58 -45.21 16.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.975 0.417 . . . . 0.0 110.735 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -123.92 84.73 54.44 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -41.99 144.19 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.868 2.379 . . . . 0.0 112.618 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.503 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 72.1 t60 -75.98 -49.61 17.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.637 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.73 -29.26 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.29 23.23 6.13 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.0 30.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -164.06 111.08 0.92 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.639 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.28 -23.68 75.47 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.732 2.288 . . . . 0.0 112.122 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -57.94 175.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mp -104.01 160.81 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 27' ' ' HIS . 3.5 m-85 -132.21 166.28 22.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.189 0.519 . . . . 0.0 111.419 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 11.2 mt -116.71 151.54 18.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.42 ' N ' HG22 ' A' ' 36' ' ' ILE . 32.2 p -109.99 -44.31 3.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.8 158.38 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.196 0.522 . . . . 0.0 112.09 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.08 141.11 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 mt -87.32 129.08 52.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.167 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.0 Cg_exo -65.34 64.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.15 -43.45 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.271 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.56 160.21 52.85 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.319 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.86 -28.79 52.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -58.89 -55.38 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.66 -27.26 68.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -71.71 -42.47 67.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.667 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 3.2 m-20 -77.11 -36.22 55.7 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.394 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 27.3 44.01 0.03 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.391 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' HD2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -76.1 -37.65 57.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -120.33 179.78 4.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 150.91 21.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.769 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -71.25 -35.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.403 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -70.21 14.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 53' ' ' VAL . 32.1 p-10 -83.38 -162.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.84 100.82 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -55.26 96.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 111.191 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 5.1 mt -68.17 -33.85 75.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.892 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 58' ' ' LEU . 69.1 m-85 -157.08 167.7 29.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.295 0.569 . . . . 0.0 111.955 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 62' ' ' GLU . 0.7 OUTLIER -147.15 -177.95 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.013 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -40.32 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 111.592 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 50.32 31.02 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.069 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.94 128.85 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.385 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -95.81 80.26 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -97.17 32.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.43 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -75.88 -5.3 45.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.266 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.62 46.8 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.936 0.398 . . . . 0.0 110.174 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.3 m -117.28 140.4 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.082 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.0 OUTLIER -50.61 166.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.501 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CE1' ' HB2' ' B' ' 7' ' ' SER . 2.3 t-160 -59.73 -48.64 80.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.434 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.56 69.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.53 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.7 -35.23 67.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.014 0.435 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -42.56 65.13 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -64.51 -36.37 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.976 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.4 mt-10 -69.36 -33.68 73.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.65 -41.41 75.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.426 0.632 . . . . 0.0 110.53 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -79.52 -26.9 41.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.457 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -71.49 -36.62 71.19 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.225 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.06 22.91 9.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.811 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.91 16.48 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.192 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.29 103.89 0.88 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.512 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 166.45 -70.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.409 . . . . 0.0 110.602 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -152.44 93.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.859 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 m -93.6 113.71 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -79.3 80.39 5.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.58 132.25 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -109.88 114.54 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.84 168.36 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 0.0 112.234 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.3 ttt -141.63 109.26 5.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.457 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 110.68 21.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -77.76 115.87 17.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.297 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' N ' ' HD3' ' A' ' 93' ' ' PRO . 34.9 mttp -150.42 47.09 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 92' ' ' LYS . 63.1 Cg_endo -86.75 134.96 3.96 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.617 2.212 . . . . 0.0 112.285 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HB2' ' HA ' ' A' ' 188' ' ' ASN . 10.3 Cg_exo -69.23 -155.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.235 1.957 . . . . 0.0 111.783 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 166.32 38.76 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.505 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 185' ' ' LYS . 2.6 tt0 67.54 161.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -177.69 -172.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.678 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.92 147.0 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtm -134.73 166.12 23.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.212 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.04 106.21 6.7 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mm -113.86 155.57 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.425 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -121.57 125.96 47.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.254 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.84 118.78 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.033 0.444 . . . . 0.0 110.733 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.8 pt -93.83 144.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.944 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -69.93 155.49 40.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -135.84 -160.62 8.94 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.58 -42.02 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.184 1.923 . . . . 0.0 112.484 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -92.07 21.37 5.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.025 0.441 . . . . 0.0 110.427 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 107.44 -141.57 15.66 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 HD22 ' CE1' ' A' ' 112' ' ' PHE . 5.1 mp -86.44 -23.0 26.2 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.901 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.95 47.06 4.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.842 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -175.87 153.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 m -111.23 129.9 55.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.463 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 13.5 pt -142.54 156.6 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.9 125.27 5.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.618 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.44 -175.08 25.21 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.104 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.91 -174.08 51.06 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.073 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.35 145.35 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.754 0.312 . . . . 0.0 111.123 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.07 -27.19 9.43 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.201 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.82 68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 109.755 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.537 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -73.4 -4.57 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.537 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 62.1 t60 72.02 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.51 0.671 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' A' ' 130' ' ' TYR . 2.0 mt -88.74 145.56 35.24 Favored Pre-proline 0 C--N 1.313 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.511 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 16.8 Cg_exo -67.26 62.33 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.509 2.14 . . . . 0.0 112.14 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 118.43 60.37 0.28 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.33 94.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.824 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.15 -23.32 20.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 m -60.01 147.71 38.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.618 HG12 ' HA3' ' A' ' 116' ' ' GLY . 1.1 mt -87.57 110.53 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.487 ' CG ' HD11 ' A' ' 123' ' ' ILE . 6.6 m-85 -104.93 150.6 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.2 147.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.7 p -103.06 -56.61 2.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.308 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 147.1 22.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.427 HG23 ' CD2' ' A' ' 141' ' ' HIS . 2.9 mt -114.77 141.58 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.5 mt -80.08 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.738 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.74 30.48 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.82 -28.91 66.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.325 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.22 21.33 8.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.79 -82.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.427 ' CD2' HG23 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -52.79 -56.3 16.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 0.0 110.535 179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.79 -50.39 24.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.264 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.19 -59.42 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.978 0.418 . . . . 0.0 111.888 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -56.07 -57.56 18.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 60.02 26.41 15.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.41 86.43 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -58.91 165.84 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.673 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.3 mt -48.19 115.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 111.288 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.64 -18.19 5.18 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.0 122.24 17.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.878 0.37 . . . . 0.0 110.858 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -110.75 128.63 55.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -101.51 131.73 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.94 -2.91 46.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.086 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 167.38 146.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.86 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 158' ' ' VAL . 95.0 t -101.88 99.66 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.12 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 69.34 -59.66 0.48 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.48 26.14 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.329 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 15.0 t -98.07 155.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.255 0.55 . . . . 0.0 111.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -115.26 77.76 0.27 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.619 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.73 25.69 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.614 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.6 OUTLIER -152.85 53.69 0.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.336 0.589 . . . . 0.0 110.777 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.86 28.24 0.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.6 t -150.64 -74.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtm 175.17 169.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.711 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.411 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 14.5 p-80 -54.96 -29.87 57.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.942 0.401 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -73.41 -48.39 34.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.178 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.62 -36.58 73.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.904 0.383 . . . . 0.0 110.583 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.42 -36.27 73.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.058 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 5.5 t -72.07 -42.55 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.17 -30.81 66.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.627 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.95 49.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.248 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.32 -39.85 24.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.11 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -26.51 58.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.5 -9.89 55.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.405 ' HB ' ' CG2' ' A' ' 179' ' ' VAL . 7.7 p -50.96 -178.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 111.8 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -103.02 169.46 8.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.417 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t70 -52.16 -21.32 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.535 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.58 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.714 0.292 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.24 148.3 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.116 0.484 . . . . 0.0 112.3 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -102.53 124.18 47.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.798 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -104.68 146.22 29.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 0.0 111.334 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.46 115.76 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.8 t -101.83 160.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.145 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.42 ' CB ' ' HD2' ' A' ' 151' ' ' LYS . . . -139.57 132.72 29.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.252 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 7.7 mtpm? -83.89 146.62 49.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.4 155.49 35.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.2 t -79.77 94.93 5.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 12.6 p30 45.36 33.06 1.15 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.41 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.153 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.827 0.346 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 10.3 m -132.53 -45.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.228 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' B' ' 5' ' ' PHE . 11.4 p -98.51 125.54 42.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' B' ' 5' ' ' PHE . 50.0 Cg_exo -53.6 169.37 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.465 2.11 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . 0.414 ' CG ' ' O ' ' B' ' 4' ' ' PRO . 5.0 m-85 -169.72 36.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 m 58.98 167.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.459 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -113.92 120.0 39.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 116.34 31.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.97 -1.014 . . . . 0.0 111.017 179.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.819 0.343 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 m -88.28 123.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.29 80.2 12.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.27 -46.24 32.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.614 2.209 . . . . 0.0 112.408 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -177.12 -31.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.406 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 87.7 p -72.98 174.43 7.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.744 0.307 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -98.81 115.96 29.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.995 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -98.63 105.44 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.041 -179.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -135.26 161.45 35.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -121.64 154.76 36.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 23.8 mm-40 -145.82 118.25 8.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.561 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' CG ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -125.1 95.76 4.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.443 HG13 ' CB ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -126.79 -169.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 111.922 -178.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.69 135.03 54.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.637 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 3.9 tp -128.2 91.35 3.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.785 0.802 . . . . 0.0 110.022 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -72.69 160.64 31.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.12 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -70.5 95.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.11 -25.92 11.44 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.478 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -172.45 -86.85 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -109.35 30.74 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -179.77 21.86 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.419 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 1.2 mp -84.43 -48.74 9.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.805 0.336 . . . . 0.0 111.515 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 76.29 1.31 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.742 -0.742 . . . . 0.0 114.1 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.502 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.5 p90 -164.66 148.68 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.689 0.28 . . . . 0.0 110.756 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.8 m -100.73 126.86 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 111.392 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.9 pt -125.06 164.31 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.07 154.78 7.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.46 -113.54 2.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.281 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.12 22.15 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.544 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.459 ' CG2' ' N ' ' A' ' 69' ' ' THR . 2.8 t -58.21 -18.44 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.9 m-20 -93.44 -49.71 5.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -121.96 79.35 41.82 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.438 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.95 136.9 22.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.606 2.204 . . . . 0.0 112.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -70.38 -21.8 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.108 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.507 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.61 -29.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.935 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.52 29.55 9.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.17 35.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.9 95.97 1.0 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.46 -23.24 30.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.126 . . . . 0.0 112.005 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -76.18 142.53 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.1 mt -93.18 154.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 111.182 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.507 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.9 p90 -142.39 167.82 21.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.299 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 40.5 mt -98.09 152.44 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.47 ' N ' HG22 ' A' ' 36' ' ' ILE . 1.9 p -108.62 -36.34 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.673 0.273 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.81 154.52 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.969 0.414 . . . . 0.0 111.291 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.2 141.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.999 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.8 mt -85.44 123.61 72.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.6 Cg_exo -66.06 64.02 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.68 -52.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.34 166.8 8.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.362 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.03 -23.05 66.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -61.88 -57.37 12.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.167 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.14 -28.1 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.534 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -38.44 69.28 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.999 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 40.7 m-20 -87.56 -25.27 23.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 33.58 70.58 0.13 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.593 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -109.46 -14.06 14.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.541 0.21 . . . . 0.0 111.371 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -141.63 168.87 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.71 165.12 11.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.121 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.744 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 33.9 m -71.54 -47.77 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -62.24 4.63 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -86.99 170.57 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.298 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 m -120.37 116.15 24.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.579 0.228 . . . . 0.0 110.648 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -60.47 94.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.226 0.536 . . . . 0.0 111.19 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 mt -70.07 -28.81 65.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.18 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 143.11 17.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.601 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -152.22 131.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.587 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 52.09 40.47 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.0 26.96 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.81 131.47 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.067 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.3 100.93 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 68' ' ' VAL . 25.0 t -112.71 41.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.012 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.95 9.7 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.655 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -177.76 37.59 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' CG2' HG11 ' A' ' 65' ' ' VAL . 14.9 m -118.96 150.57 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.447 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.9 OUTLIER -49.56 156.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.705 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.473 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.8 t-160 -58.23 -48.56 80.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.554 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -59.45 -34.79 72.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.366 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.98 -37.45 78.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.36 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.37 65.26 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 109.693 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.473 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 78.9 t -64.2 -35.05 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.684 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.3 tt0 -69.19 -33.99 74.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.96 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.466 0.651 . . . . 0.0 110.466 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.92 -27.05 39.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.368 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -70.87 -35.56 72.41 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.141 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 21.64 10.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.655 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.87 16.27 5.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.048 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.52 95.83 0.11 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.781 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.513 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.1 m 169.59 -66.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.79 94.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.249 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.31 140.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -86.87 95.02 9.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 HD23 HG21 ' A' ' 57' ' ' ILE . 2.2 tm? -84.81 115.53 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 0.0 112.067 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CD1' ' CG ' ' A' ' 5' ' ' GLU . 1.3 t80 -121.75 114.44 21.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.3 168.06 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.46 109.08 15.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.631 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -124.08 146.56 48.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.819 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 133.51 37.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -54.7 149.06 23.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.5 Cg_endo -66.14 129.58 22.1 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.557 2.171 . . . . 0.0 112.021 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 16.6 Cg_exo -66.66 -161.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.352 2.035 . . . . 0.0 112.028 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.27 25.19 9.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.56 140.84 39.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.615 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -151.16 -178.92 6.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.1 135.14 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.7 166.73 11.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -135.14 106.41 6.75 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mm -114.15 155.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -113.04 123.28 49.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.257 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 2.0 tt -124.8 118.6 26.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.587 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.6 pt -97.04 144.68 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.115 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -75.17 155.93 36.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.2 -177.85 15.19 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.905 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 -33.43 16.23 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.064 1.843 . . . . 0.0 112.093 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.53 18.22 13.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 0.0 110.416 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' HA3' ' OXT' ' C' ' 9' ' ' VAL . . . 106.4 -148.1 16.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.457 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.57 -18.84 30.47 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.213 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.64 49.95 6.32 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.083 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.76 151.99 0.75 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 110.718 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.2 m -113.48 116.88 30.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -128.78 155.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.607 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.462 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -155.33 125.14 6.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 111.886 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.83 -175.1 25.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.449 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.16 -174.13 21.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.596 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 155.02 4.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 111.4 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.49 -26.77 20.23 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.28 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -173.9 74.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.5 130.76 38.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.006 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.462 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 16.1 t60 -43.28 -34.69 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.049 0.928 . . . . 0.0 110.64 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.446 HD13 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.27 138.3 19.85 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.901 -178.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.21 2.78 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.361 2.041 . . . . 0.0 112.719 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.72 48.76 0.08 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.26 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.42 96.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -58.14 -22.43 51.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 136.87 40.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.575 HG12 ' HA3' ' A' ' 116' ' ' GLY . 4.8 mt -73.85 120.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.999 0.428 . . . . 0.0 111.229 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 151' ' ' LYS . 5.4 m-85 -116.28 147.57 41.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.396 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.4 t -83.96 139.51 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.5 p -97.49 -58.9 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.627 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.15 150.86 27.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 111.468 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 mt -127.87 141.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.767 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.4 mt -74.36 173.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.608 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -87.06 146.29 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.976 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.28 26.1 55.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.1 164.27 45.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.32 66.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 111.201 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.12 -32.01 69.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -56.27 -54.63 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.202 0.525 . . . . 0.0 110.377 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -72.83 -50.75 22.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.092 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.56 -59.58 2.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 111.886 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -55.6 -50.05 62.33 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.169 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.98 19.52 10.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.757 0.313 . . . . 0.0 110.653 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -94.16 79.86 4.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 175.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.4 mt -49.75 129.53 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.159 0.504 . . . . 0.0 111.295 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.5 -24.35 11.35 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.571 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -60.74 129.33 40.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.753 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.9 pttp -117.47 125.28 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.999 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -100.46 132.26 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.116 0.484 . . . . 0.0 110.756 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 -1.28 39.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.158 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 171.35 158.86 0.09 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.831 0.348 . . . . 0.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 20.6 t -116.44 100.07 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.195 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.452 ' OD1' ' CZ ' ' A' ' 180' ' ' TYR . 14.2 m-80 68.84 -59.3 0.47 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.225 0.536 . . . . 0.0 109.814 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 97.4 p -163.4 26.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.385 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 5.6 t -102.47 155.02 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-O 121.07 0.462 . . . . 0.0 111.314 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -118.09 79.05 0.3 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.6 mt -77.61 24.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.92 0.391 . . . . 0.0 112.048 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 159' ' ' GLY . 3.3 mt-10 -139.83 38.68 1.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.099 0.476 . . . . 0.0 110.736 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.77 28.62 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.311 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -145.83 -75.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.388 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 172.84 166.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 169' ' ' VAL . 50.9 t-80 -53.99 -29.92 45.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.79 0.328 . . . . 0.0 110.649 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.31 -46.45 49.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.42 -36.89 68.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.64 -34.97 72.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.443 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.495 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.0 t -72.08 -40.28 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.83 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.92 -36.33 69.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.35 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.42 -26.88 58.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 4.1 pp -82.07 -36.88 27.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.829 0.347 . . . . 0.0 110.377 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 1.0 OUTLIER -75.07 -26.4 59.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.54 -9.59 54.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.188 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.426 ' HB ' HG23 ' A' ' 179' ' ' VAL . 1.2 p -42.34 166.91 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.059 0.457 . . . . 0.0 112.2 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 75.0 t80 -96.95 167.26 11.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -47.83 -29.2 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.315 -179.421 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.9 91.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 110.7 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.68 148.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.686 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 156' ' ' ASN . 27.6 p90 -103.51 125.23 49.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.179 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.414 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -106.75 155.9 19.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.829 -178.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 113.45 24.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.55 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 13.1 t -102.2 164.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.897 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.48 129.05 42.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.64 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -83.72 129.81 58.09 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.812 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.86 142.43 19.36 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.385 2.057 . . . . 0.0 112.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -174.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -65.68 74.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.024 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.171 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.842 0.353 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -177.6 71.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 2.3 t -86.63 -48.45 0.51 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.209 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 7.6 Cg_exo -73.08 -22.1 19.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 65.96 141.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.66 177.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.041 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -108.14 124.52 50.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -99.14 141.0 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.122 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.871 0.367 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.24 -33.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -120.16 121.48 29.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.16 101.76 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.334 2.023 . . . . 0.0 112.358 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -60.42 -30.75 69.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 34.8 t -133.91 149.69 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -106.86 96.46 6.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 125.16 28.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . 0.401 ' OXT' ' HA3' ' A' ' 109' ' ' GLY . 11.6 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.095 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.26 154.12 20.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 3.1 m-85 -135.68 170.65 15.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -178.29 125.79 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.415 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -110.22 106.55 16.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.347 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -122.35 -167.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.008 0.432 . . . . 0.0 111.639 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 135.94 44.65 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -120.32 88.97 3.04 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.6 0.714 . . . . 0.0 110.986 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.21 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.886 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 12' ' ' ASN . 8.5 mtt180 -44.43 105.04 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.82 0.343 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.91 66.11 0.33 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.48 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ARG . 11.2 m-80 77.03 -73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.632 0.253 . . . . 0.0 110.891 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -109.29 30.41 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.67 -176.92 18.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.948 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.27 -51.32 7.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.278 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 97.5 69.12 0.97 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.94 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 5.5 p90 -164.93 155.82 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.9 m -117.53 138.19 52.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.3 pt -127.08 166.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.05 160.7 33.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.51 -132.48 10.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.09 146.95 7.82 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.504 HG22 ' CG2' ' A' ' 69' ' ' THR . 1.3 t -61.76 -16.3 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HB3' HG21 ' A' ' 69' ' ' THR . 30.2 p-10 -102.04 -39.29 7.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.704 0.288 . . . . 0.0 110.92 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.38 76.57 53.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.634 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' CG ' ' HA ' ' A' ' 30' ' ' ASP . 99.8 Cg_exo -43.72 155.55 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.944 2.43 . . . . 0.0 112.344 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 6.0 t60 -122.7 -11.95 8.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.691 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.582 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.16 -58.08 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' ASP . . . -173.74 33.93 0.11 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.088 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' HA ' ' CG ' ' A' ' 26' ' ' PRO . 1.1 t0 81.51 53.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.835 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -118.92 114.8 35.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.695 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 32.3 Cg_exo -59.18 82.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.78 2.32 . . . . 0.0 112.165 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.75 143.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.29 148.27 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -142.61 145.28 33.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.365 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 53' ' ' VAL . 70.9 mt -72.94 144.9 12.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 36' ' ' ILE . 21.8 p -95.49 -43.25 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.655 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 158.46 27.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.202 0.525 . . . . 0.0 111.743 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.437 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -116.92 141.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.85 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.92 133.9 45.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.35 77.82 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.56 2.173 . . . . 0.0 112.189 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.57 -31.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.328 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -61.12 168.95 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.543 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.92 -21.16 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.87 -57.58 11.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.42 69.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -72.05 -37.51 69.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.665 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.74 -20.25 36.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.375 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.05 72.43 1.25 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.985 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.544 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.51 35.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 37.57 -156.91 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.056 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' N ' HD11 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.08 138.09 58.29 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.015 0.436 . . . . 0.0 111.223 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.437 ' CG1' HG13 ' A' ' 39' ' ' ILE . 31.6 m -65.24 -37.85 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.342 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -53.19 -15.27 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.23 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -59.05 170.64 0.83 Allowed 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -123.27 114.11 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 57' ' ' ILE . 14.3 pt -58.6 94.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mt -62.03 -29.0 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.878 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.03 125.55 4.59 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' A' ' 86' ' ' LEU . 4.9 m -114.33 118.59 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.648 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER 53.87 41.99 31.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.002 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 66.91 29.56 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.02 136.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -82.5 111.05 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.55 25.6 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -79.65 5.11 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.21 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -163.96 41.32 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.023 0.44 . . . . 0.0 109.908 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.55 143.24 30.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 112.529 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 23' ' ' THR . 21.5 p -49.52 171.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.131 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.441 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.1 t-160 -70.16 -48.66 56.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.861 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -44.14 74.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.81 73.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.55 68.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.392 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 53.9 t -64.96 -36.83 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.64 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.41 -30.64 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.575 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.7 74.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.299 0.571 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 2.7 pp -82.13 -25.84 34.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.85 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.35 -32.87 58.88 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.104 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.56 29.87 7.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.41 -24.24 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.64 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.06 -135.33 12.07 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.775 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.9 m -131.24 11.46 4.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 111.566 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 82' ' ' SER . 1.7 mt -151.56 92.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 8' ' ' LEU . 3.5 m -104.26 115.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.71 91.92 7.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HG ' ' CG1' ' A' ' 60' ' ' VAL . 1.7 mp -93.16 144.51 25.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 17.7 t80 -122.81 114.38 20.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.97 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 31.4 m -115.25 168.48 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 0.0 112.289 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.9 ttt -138.15 109.05 6.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.491 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -110.78 130.97 55.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -75.26 124.72 27.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -77.05 -49.78 2.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.116 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' LYS . 98.7 Cg_exo -43.83 127.89 6.67 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.594 2.196 . . . . 0.0 112.583 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -93.54 106.7 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.172 2.581 . . . . 0.0 112.361 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' H ' ' HB2' ' A' ' 188' ' ' ASN . . . -96.21 29.67 2.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -44.23 128.64 6.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -112.09 130.6 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.6 p -82.94 133.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.7 mmt -112.27 166.48 11.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.54 106.41 7.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.406 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HG13 ' CG2' ' A' ' 183' ' ' VAL . 3.1 mm -114.95 155.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.515 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 4.8 mptt -113.1 126.97 56.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.0 tt -130.6 118.84 21.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -92.7 144.79 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -69.01 164.42 22.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.159 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.88 -162.52 9.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.786 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.42 -35.28 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.166 1.911 . . . . 0.0 112.554 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 20.54 7.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.957 0.408 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.87 -127.85 9.22 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 1.2 mp -86.77 -30.88 21.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.65 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.69 38.1 3.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.875 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -177.93 160.15 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 111.305 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -110.51 117.06 32.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 45.5 pt -113.43 173.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 111.488 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' O ' HG21 ' A' ' 129' ' ' ILE . . . -99.07 -176.0 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.368 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.429 ' HA3' ' CD2' ' A' ' 165' ' ' HIS . . . -145.72 143.61 11.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.47 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.22 -66.33 2.43 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.061 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.82 153.29 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.62 -9.78 61.26 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.038 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 168.39 81.17 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.845 0.355 . . . . 0.0 110.122 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 4.1 mt-30 -64.54 -15.1 60.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.331 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.546 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.1 t60 71.82 -54.99 0.67 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.6 0.714 . . . . 0.0 110.612 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 3.9 mt -92.02 143.37 27.56 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.659 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.37 77.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.366 2.044 . . . . 0.0 112.247 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 87.77 65.14 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.12 94.0 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -55.13 -23.46 21.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 p -57.92 120.2 8.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 160' ' ' LEU . 21.9 mt -70.56 122.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.456 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.6 m-85 -111.84 151.01 29.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.962 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -86.31 121.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.304 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 p -79.28 -59.06 2.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.649 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -151.12 152.75 33.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 141' ' ' HIS . 2.5 mt -118.19 141.38 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.844 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.454 ' O ' ' CE1' ' A' ' 141' ' ' HIS . 1.5 mt -75.31 172.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -103.7 30.45 5.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.822 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.04 -28.61 58.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.65 10.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.672 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.01 -82.35 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.937 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.06 -31.71 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.3 m170 -52.15 -62.2 1.79 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -42.14 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.577 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.21 -59.36 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -70.84 -41.16 63.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.198 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.37 22.34 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 0.0 110.536 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -95.71 85.45 4.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.92 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.45 166.67 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.523 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.1 mt -47.44 116.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.262 0.553 . . . . 0.0 111.38 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.89 -14.42 6.33 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.666 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.418 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -73.92 120.06 18.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.787 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.45 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -99.96 122.8 43.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.671 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.528 ' HB ' ' CD1' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -101.33 118.54 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.211 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.58 -0.64 47.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.744 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 175.18 159.25 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.513 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 45.6 t -121.73 98.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.276 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' HB ' ' A' ' 179' ' ' VAL . 31.8 m-80 69.27 -57.19 0.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 m -147.01 -20.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -76.16 140.72 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.408 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.73 12.68 33.77 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.897 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 152' ' ' ILE . 24.7 mt 38.96 33.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.229 0.538 . . . . 0.0 111.985 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.52 68.48 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -162.92 26.49 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -161.9 -82.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.674 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.65 170.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.049 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.429 ' CD2' ' HA3' ' A' ' 116' ' ' GLY . 0.2 OUTLIER -54.03 -30.6 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -47.92 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.995 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.37 -32.37 62.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.816 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.7 t -70.03 -40.5 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.559 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.08 -30.43 66.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.672 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.98 -25.83 48.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -40.69 23.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -26.63 58.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.068 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -21.4 65.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 47.7 p -54.73 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -100.88 171.33 7.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.44 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -58.48 -14.51 8.04 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.429 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.4 t -147.55 90.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 0.0 110.288 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.421 ' HB ' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -120.15 148.49 23.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.729 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -100.03 127.62 46.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.23 153.96 22.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.981 0.419 . . . . 0.0 110.671 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -96.59 119.04 34.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.398 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 39.2 t -101.82 164.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.91 140.74 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.691 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.89 146.19 48.54 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.436 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.45 61.17 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.809 2.339 . . . . 0.0 113.119 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.7 p 42.73 -161.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.352 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.446 ' HB2' ' H ' ' A' ' 95' ' ' ALA . 29.2 t-20 -69.37 61.5 0.14 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.832 0.349 . . . . 0.0 110.876 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.054 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 m -126.1 114.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -95.19 133.39 26.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.465 2.11 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -146.09 151.83 38.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -119.02 156.59 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.5 97.75 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -109.28 109.37 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.152 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . 0.41 ' CG2' ' HD2' ' C' ' 4' ' ' PRO . 14.2 p -57.53 152.91 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.465 ' HB ' ' HD3' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -80.17 -61.56 0.43 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.901 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' HB ' ' C' ' 3' ' ' VAL . 53.9 Cg_endo -69.3 119.85 6.77 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.274 1.982 . . . . 0.0 112.092 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -96.65 36.51 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.996 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -128.11 139.33 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' SER . . . . . 0.424 ' OG ' ' CD2' ' A' ' 165' ' ' HIS . 21.8 m -69.54 86.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.846 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 35.9 t -83.63 109.57 17.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.952 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.823 0.345 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -91.02 156.75 17.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -151.46 145.85 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.577 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -176.82 156.27 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.402 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -86.5 167.74 14.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.454 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -164.94 165.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.944 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -137.48 126.34 24.08 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.992 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 50' ' ' ARG . 1.6 tp -122.01 88.58 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.457 0.646 . . . . 0.0 111.367 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pm0 -73.66 152.35 40.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -67.32 93.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.717 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.07 -25.46 10.38 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.638 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.62 -91.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -109.1 30.8 6.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.14 -178.98 25.37 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.135 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.34 -47.59 10.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.816 0.341 . . . . 0.0 111.293 -179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.36 74.18 1.25 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.084 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -164.85 169.34 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.312 . . . . 0.0 110.922 178.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.27 130.8 53.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.459 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.54 164.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -169.77 164.1 9.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.503 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.84 -119.22 4.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.99 145.06 14.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.427 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.508 HG21 ' HA ' ' A' ' 68' ' ' VAL . 1.3 t -53.9 -24.75 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.73 -55.99 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -120.25 83.06 31.67 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.49 132.01 29.0 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.437 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 25.8 t60 -68.05 -21.38 65.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.508 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.72 -28.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.118 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 29.65 12.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.37 33.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -173.03 111.05 0.34 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.92 -27.91 50.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.126 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.79 128.02 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.19 150.34 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.508 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.48 151.09 41.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 53' ' ' VAL . 77.2 mt -77.13 146.17 9.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.257 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.424 ' N ' HG22 ' A' ' 36' ' ' ILE . 66.0 m -99.77 -35.98 9.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.541 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.03 158.29 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.513 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 mt -115.94 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.0 mt -85.76 123.71 71.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -66.18 63.52 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.23 -54.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.485 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.21 -175.77 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 -27.53 57.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 111.369 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -57.56 -29.19 64.22 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.063 0.459 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.86 -27.45 49.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.46 -43.5 66.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.018 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -31.65 15.95 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.17 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 84.48 -27.56 4.64 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER 45.21 30.37 0.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.865 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp 65.17 -173.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 131.1 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.763 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 34.4 m -53.5 -37.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.731 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -62.15 -3.93 1.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.354 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -58.34 175.3 0.24 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 110.671 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.9 t -130.24 102.78 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.02 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 3.2 mt -59.84 -35.39 74.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 1.5 m-85 -158.57 123.57 4.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.409 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -114.16 119.85 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 53.8 37.52 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.67 30.34 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.88 133.74 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' CZ ' ' A' ' 59' ' ' PHE . 1.4 m-20 -72.79 77.64 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HB ' ' CG2' ' A' ' 60' ' ' VAL . 21.1 t -107.65 35.11 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.055 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -101.08 1.04 38.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.083 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -156.1 33.74 0.34 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.758 0.314 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 ' HA ' HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -124.0 158.28 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 23' ' ' THR . 7.3 m -50.07 163.08 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.056 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 t-160 -61.34 -48.56 80.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.834 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 t -52.73 -35.87 56.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.07 77.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.964 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.62 67.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.221 0.534 . . . . 0.0 109.652 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 42.0 t -64.4 -36.01 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.4 -33.39 72.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.815 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.76 75.71 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.435 0.636 . . . . 0.0 110.476 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.69 -26.92 40.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.552 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.63 -37.85 67.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.955 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.34 25.79 7.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.401 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.95 -23.67 23.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.18 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.27 -152.3 22.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 83' ' ' ILE . 3.9 m -101.51 11.74 38.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.497 0.189 . . . . 0.0 111.338 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -151.53 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.5 t -90.59 149.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 102.29 4.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.976 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.9 154.01 50.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE1' ' N ' ' A' ' 4' ' ' GLU . 1.3 t80 -105.68 114.8 29.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.614 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.45 168.03 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.324 0.583 . . . . 0.0 112.414 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.415 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.25 109.66 7.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.134 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.57 106.95 15.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.064 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -67.96 141.06 56.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.934 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.36 66.19 76.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.95 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HB2' ' HD3' ' A' ' 94' ' ' PRO . 39.3 Cg_exo -58.99 -47.39 18.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.45 2.1 . . . . 0.0 112.696 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 93' ' ' PRO . 98.4 Cg_endo -91.68 -167.57 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.775 2.317 . . . . 0.0 112.276 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 26.1 0.6 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.802 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 187' ' ' SER . 70.4 mm-40 -158.13 -173.71 4.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.78 -175.37 5.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.024 0.44 . . . . 0.0 111.29 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.26 144.49 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.268 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.0 166.41 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.424 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -133.19 106.6 7.68 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.2 mm -115.57 155.92 16.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.742 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.95 126.07 54.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.104 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 6.4 tt -126.38 118.54 25.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.4 pt -96.84 144.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.034 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.45 158.44 36.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -136.02 -175.11 13.65 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.869 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.51 -40.75 9.85 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.269 1.98 . . . . 0.0 112.31 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -91.99 19.97 6.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.488 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.02 -141.27 15.22 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 6.6 mp -86.53 -22.35 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.926 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.43 58.39 3.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.887 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.96 155.43 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.7 t -116.38 116.9 28.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 10.3 pt -134.16 154.82 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.091 0.472 . . . . 0.0 112.048 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.573 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.94 -174.99 25.51 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.494 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.63 -176.54 52.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.536 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.0 t -81.45 154.8 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.931 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.06 6.1 81.96 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.19 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -168.69 52.97 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.394 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -33.35 -43.47 0.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 47.6 t60 73.28 -45.53 0.62 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.027 0.918 . . . . 0.0 108.891 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 121' ' ' GLN . 0.6 OUTLIER -122.65 130.85 24.48 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.161 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.24 89.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.445 2.097 . . . . 0.0 112.919 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.95 44.93 4.97 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.217 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.481 ' HB3' HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -150.71 78.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.195 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -53.92 -22.97 11.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.218 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -55.31 145.49 21.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.573 HG12 ' HA3' ' A' ' 116' ' ' GLY . 8.2 mt -80.03 117.43 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.534 ' CD2' HD13 ' A' ' 123' ' ' ILE . 4.1 m-85 -114.92 156.25 25.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.521 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.5 t -95.52 155.63 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.212 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.17 -32.51 1.8 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -160.66 145.63 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.842 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.413 HG22 ' CD2' ' A' ' 141' ' ' HIS . 5.1 mt -131.64 141.8 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.74 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 mm -73.54 175.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -99.47 139.71 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.48 29.18 60.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.583 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.91 -132.45 1.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.578 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.38 -61.29 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.934 0.397 . . . . 0.0 111.184 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -67.15 -31.4 71.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.413 ' CD2' HG22 ' A' ' 134' ' ' ILE . 0.5 OUTLIER -51.81 -60.39 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -46.12 54.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.305 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.48 -59.5 2.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -62.31 -44.93 96.97 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.262 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 145' ' ' ARG . 0.7 OUTLIER 61.26 20.34 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -91.75 82.79 5.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.709 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 169.84 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.751 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.91 121.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.276 0.56 . . . . 0.0 111.235 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.5 -22.5 6.19 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.376 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.442 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -68.85 124.97 25.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -112.73 128.96 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.71 130.72 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.072 0.463 . . . . 0.0 110.538 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.4 pp -98.42 -1.16 42.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.294 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 172.19 152.6 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.719 0.295 . . . . 0.0 111.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 40.2 t -107.4 99.7 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 68.9 m-80 69.18 -59.44 0.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.319 0.58 . . . . 0.0 109.739 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.02 27.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.172 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.478 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 11.5 t -100.6 155.22 4.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.277 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -117.0 77.4 0.28 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.572 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 31.9 mt -79.11 24.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.94 0.4 . . . . 0.0 111.928 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -139.73 32.7 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 110.652 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.79 28.05 1.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -143.29 -77.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 174.74 165.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.605 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.41 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 2.9 p-80 -53.9 -30.7 47.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -45.2 54.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.279 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.66 -37.08 68.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.67 -36.54 73.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.107 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 13.4 t -73.81 -42.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.43 -33.01 69.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.78 -27.71 50.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.465 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -36.72 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -26.85 60.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.519 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.1 -9.89 59.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.293 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 69.9 p -52.59 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.926 0.393 . . . . 0.0 111.515 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -103.61 169.8 8.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t70 -54.31 -18.85 4.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.4 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.58 92.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.94 148.19 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 112.006 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -95.65 127.16 41.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 179.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.87 144.32 33.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 0.0 110.869 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 112.45 24.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.153 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.6 t -101.91 161.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.78 140.09 28.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -96.38 146.32 31.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.75 89.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.172 2.581 . . . . 0.0 112.91 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -58.71 166.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.73 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 8.9 m120 39.74 32.96 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.653 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.118 -179.932 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 m -134.66 -50.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.379 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.46 ' HB ' ' HD3' ' B' ' 4' ' ' PRO . 5.3 t -84.41 -48.02 0.67 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.677 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 88.3 Cg_endo -82.09 157.02 17.64 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.356 2.037 . . . . 0.0 112.402 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -145.46 169.94 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -84.84 160.58 20.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -80.54 117.18 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.975 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 33.6 t -94.16 122.12 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.064 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.33 -58.71 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 8.9 p -163.16 106.92 1.0 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.47 166.54 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.433 2.089 . . . . 0.0 112.38 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.92 141.9 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 13.0 m -149.72 138.93 21.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.96 95.2 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 97.6 p -91.23 119.33 31.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.327 -0.845 . . . . 0.0 111.195 -179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.81 0.338 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -142.83 149.22 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.27 162.69 26.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.7 161.49 2.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.639 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 165.33 14.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.568 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.455 HG22 ' NH2' ' A' ' 50' ' ' ARG . 2.0 tt -164.45 166.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 111.809 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -133.82 138.96 45.97 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.677 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.515 ' HB2' ' NH2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -135.73 86.73 2.26 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.596 0.712 . . . . 0.0 110.99 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -76.63 155.23 33.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.248 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -66.3 86.7 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.85 -26.03 10.41 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.781 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.25 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 m -109.12 30.81 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.0 -179.09 27.05 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -84.33 -42.74 15.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.822 0.344 . . . . 0.0 111.407 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.01 64.81 1.34 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 114.042 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 6.0 p90 -161.78 139.57 8.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 110.594 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.9 m -91.76 130.98 37.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.689 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.56 163.59 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.634 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 164.0 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.371 . . . . 0.0 111.378 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.79 -113.84 2.38 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.534 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.96 141.45 9.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.293 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -56.2 -21.26 22.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.609 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 38.0 t0 -93.53 -43.92 8.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -123.83 78.48 57.27 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.207 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.3 142.15 9.35 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.708 2.272 . . . . 0.0 112.633 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -74.97 -19.41 60.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.495 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.87 -27.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.274 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.09 28.89 9.45 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -171.14 32.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.6 111.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.6 -29.03 52.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.707 2.271 . . . . 0.0 112.009 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -62.26 169.59 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.59 149.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.981 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 10.3 p90 -142.84 144.71 32.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.578 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 57.9 mt -72.69 146.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.119 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.413 ' N ' HG23 ' A' ' 36' ' ' ILE . 16.6 m -101.19 -33.17 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.598 0.237 . . . . 0.0 111.508 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.94 152.67 5.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.447 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -116.36 141.25 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -92.74 141.49 24.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.163 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.78 61.58 6.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.513 2.142 . . . . 0.0 112.392 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.23 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.462 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.99 175.64 23.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.709 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.11 -15.33 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -55.81 -57.46 11.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.95 0.405 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -28.55 69.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.933 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -71.92 -35.72 69.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -84.88 -25.37 28.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.009 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 82.37 56.07 2.91 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.392 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 42.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.2 pp 33.34 -153.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -63.81 144.29 57.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.791 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.469 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 35.2 m -70.61 -37.62 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.515 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -54.86 -13.95 1.26 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -57.45 163.1 2.5 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.6 p -122.16 110.48 15.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.707 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.9 pt -58.99 94.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 5.8 mt -65.14 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.037 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.403 ' O ' ' CB ' ' A' ' 86' ' ' LEU . 9.3 m-85 -146.18 168.6 20.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.105 0.479 . . . . 0.0 111.83 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -147.18 -177.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.547 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -53.96 82.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 110.675 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER 65.5 26.74 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 2.5 t -121.24 141.86 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 111.368 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.49 76.36 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.777 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 m -99.48 31.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.356 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -12.88 59.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -173.37 56.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.117 0.484 . . . . 0.0 109.706 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 19.1 m -117.31 140.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.45 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.5 m -50.25 169.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.201 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 1.8 t-160 -51.08 -48.75 61.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -51.63 -47.9 63.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.862 0.363 . . . . 0.0 111.536 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.403 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -60.24 -32.46 71.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.86 64.46 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.616 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 43.0 t -65.1 -35.22 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.739 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.32 -32.17 71.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.822 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.13 73.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.4 0.619 . . . . 0.0 110.385 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.559 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.08 -39.51 68.93 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.383 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.26 29.06 7.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.628 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.49 34.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.304 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.53 -132.43 11.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.499 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' O ' HG12 ' A' ' 83' ' ' ILE . 5.4 m -125.97 5.72 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.501 0.191 . . . . 0.0 111.397 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -151.06 91.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' THR . 1.7 t -93.75 148.56 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.035 0.445 . . . . 0.0 111.897 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 108.28 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -130.3 153.8 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 112.629 -178.056 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -106.32 115.11 29.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.298 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 27.1 m -104.24 168.07 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.442 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -127.08 109.51 11.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.954 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.5 146.58 46.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.731 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -93.75 133.68 36.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.729 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -141.39 77.16 20.12 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.21 111.86 2.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.797 2.331 . . . . 0.0 113.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.676 ' HB2' ' HA ' ' A' ' 188' ' ' ASN . 11.2 Cg_exo -69.55 -146.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.817 2.345 . . . . 0.0 111.776 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . 161.33 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.516 ' CA ' ' HA ' ' A' ' 187' ' ' SER . 15.0 tt0 -54.39 125.98 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 120.44 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.043 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.96 116.65 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.472 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 tpt -101.31 166.04 10.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.485 0.659 . . . . 0.0 111.942 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -137.32 106.59 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.56 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.459 HG23 ' HA3' ' A' ' 144' ' ' GLY . 3.7 mm -113.22 155.13 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HE3' ' CE2' ' A' ' 180' ' ' TYR . 5.5 tttt -120.89 119.11 31.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.966 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 tt -120.67 118.7 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.48 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -95.13 144.75 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.597 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -55.69 143.63 29.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.975 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -175.46 14.09 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.814 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.59 -38.9 3.98 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 121.978 1.785 . . . . 0.0 112.1 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 18.32 11.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.479 . . . . 0.0 110.302 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.64 11.12 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.5 mp -87.08 -27.31 23.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.886 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.7 47.24 4.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.93 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.07 149.23 0.55 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.922 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -109.2 124.31 50.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.552 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -135.76 155.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -152.39 125.15 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.429 . . . . 0.0 111.868 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.69 -174.99 25.31 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.195 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.11 -179.5 46.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.196 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.4 ' HB ' ' HG2' ' A' ' 164' ' ' MET . 39.5 t -78.99 145.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.758 0.313 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.9 -32.12 5.81 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.624 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 2.7 t-20 -157.11 66.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.67 -4.18 22.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.96 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.545 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.2 t60 72.28 -57.71 0.61 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.449 0.642 . . . . 0.0 110.478 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' A' ' 130' ' ' TYR . 1.3 mt -91.67 128.43 46.35 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.442 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.57 74.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.421 2.08 . . . . 0.0 112.423 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 117.93 47.74 0.43 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.84 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.98 93.75 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.839 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -56.86 -22.08 34.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.308 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -56.02 151.13 12.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.575 HG12 ' HA3' ' A' ' 116' ' ' GLY . 6.4 mt -89.02 119.44 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.335 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.484 ' CD1' HD12 ' A' ' 123' ' ' ILE . 5.2 m-85 -115.77 155.09 28.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.29 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.33 155.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.739 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.4 p -117.62 -57.89 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.486 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 146.28 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 4.7 mt -129.66 141.38 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.883 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -79.29 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.05 143.38 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.05 22.88 65.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.56 -173.82 23.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.37 -69.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -63.28 -31.63 72.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 23.4 t-160 -53.38 -62.1 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.993 0.425 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -38.2 67.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.178 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.33 -59.29 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 145' ' ' ARG . . . -80.81 -18.87 69.16 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.006 -0.616 . . . . 0.0 114.024 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER 50.95 26.99 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.15 0.475 . . . . 0.0 110.791 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.4 81.25 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.59 175.14 3.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.536 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.0 mt -46.85 126.5 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.25 0.548 . . . . 0.0 111.293 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 120.12 -23.21 8.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.514 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.84 159.23 20.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.678 0.275 . . . . 0.0 110.456 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -145.82 138.8 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.004 0.431 . . . . 0.0 111.388 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -105.3 132.22 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.491 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.62 -1.87 37.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.292 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 169.71 154.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.204 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 35.4 t -108.61 99.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.875 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 68.6 m-80 69.53 -59.51 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.404 0.621 . . . . 0.0 109.578 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.9 p -164.33 28.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.028 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.465 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 10.5 t -102.33 155.09 5.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.489 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -114.85 76.74 0.25 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.304 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.424 ' O ' HD13 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -81.09 25.76 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.46 56.2 1.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.333 0.587 . . . . 0.0 110.796 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -165.29 29.37 0.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.352 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.2 t -141.59 -76.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.553 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.4 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 176.62 167.76 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.605 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 120' ' ' ASN . 10.8 t-80 -54.46 -30.11 51.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.69 -49.16 27.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.049 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.453 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.66 -33.12 68.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.033 0.444 . . . . 0.0 110.225 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.23 -41.17 73.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.487 0.66 . . . . 0.0 109.484 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.9 t -69.03 -43.99 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.153 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -32.44 71.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.222 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.42 48.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.983 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.22 -38.47 26.93 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.0 mttp -75.19 -26.66 59.19 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.924 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.53 -9.91 52.25 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.399 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.1 p -42.85 147.21 0.32 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -90.34 170.47 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -44.93 -32.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.9 t -148.22 91.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.389 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.22 148.32 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 0.0 111.925 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.418 ' CE2' ' HE3' ' A' ' 102' ' ' LYS . 7.8 m-85 -101.71 133.35 46.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.771 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -118.98 149.62 41.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.941 0.401 . . . . 0.0 111.092 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -96.52 112.02 23.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.78 159.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.328 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -133.22 146.27 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 146.24 31.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.14 109.71 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.663 2.242 . . . . 0.0 111.922 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.516 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 36.4 t -54.74 161.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.681 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 3.1 m120 -67.27 63.13 0.06 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.335 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.402 ' N ' ' HG2' ' A' ' 94' ' ' PRO . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t 69.91 -64.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.57 121.53 44.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.266 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.26 -71.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.288 1.992 . . . . 0.0 112.032 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.84 -91.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.73 -56.44 3.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.807 0.336 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 7.0 t 74.52 -165.86 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.461 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 9.6 t -59.14 143.63 48.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.697 179.675 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.56 -32.72 59.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t 59.7 84.2 0.2 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.33 -27.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.585 2.19 . . . . 0.0 112.418 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -170.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 54.6 p -116.22 -176.25 2.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.16 88.43 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 98.7 p -86.28 110.77 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.038 179.858 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.22 173.87 7.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.099 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.49 164.04 35.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -179.79 152.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -84.11 148.66 26.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 6' ' ' ILE . 19.3 mt -148.44 152.84 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.239 0.542 . . . . 0.0 111.834 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -116.21 130.28 56.72 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.9 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 3.7 tp -134.98 91.5 2.76 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.608 0.718 . . . . 0.0 110.451 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 mt-10 -69.6 168.86 13.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.721 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 2.6 mtt180 -72.63 104.26 3.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -69.69 65.74 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.108 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 75.83 -76.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.261 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -109.31 30.53 6.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.4 -177.95 17.2 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -84.5 -52.28 6.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.28 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 78.14 1.4 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.845 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.74 155.76 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.74 0.305 . . . . 0.0 110.732 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 m -109.29 126.84 53.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.7 pt -120.73 164.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.755 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.75 157.84 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 0.0 111.305 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.93 -118.11 3.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.265 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 144.46 11.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 69' ' ' THR . 1.9 t -57.37 -19.27 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.555 0.217 . . . . 0.0 111.483 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 3.7 m-20 -88.78 -54.7 4.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.868 0.366 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -120.33 81.83 30.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.9 138.04 21.42 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.643 2.229 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 18.5 t60 -70.02 -19.55 63.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.552 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.29 -30.43 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.49 28.79 8.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.496 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.91 33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.07 112.66 1.04 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 23.7 Cg_exo -64.29 -29.32 63.72 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.739 2.293 . . . . 0.0 112.135 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 176.29 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.789 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 152.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 2.2 p90 -139.79 168.56 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 46.6 mt -95.45 153.44 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.501 ' N ' HG23 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.68 -31.33 7.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 9.7 tmtt? -171.32 150.21 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 0.0 111.594 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.407 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -110.58 141.34 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.846 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.9 mt -85.81 123.5 72.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 20.2 Cg_exo -65.59 64.79 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.558 2.172 . . . . 0.0 112.218 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.17 -51.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.508 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.39 174.08 5.12 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.438 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -59.23 -34.6 72.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 0.0 111.369 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.24 63.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.623 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -71.9 -39.16 69.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.682 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 49' ' ' GLY . 1.2 m-20 -85.96 -28.17 24.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 19.38 59.27 0.01 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.941 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -111.61 -15.35 13.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -118.36 167.72 11.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.061 0.458 . . . . 0.0 111.281 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -107.75 159.05 16.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.049 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.4 m -70.88 -48.25 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 112.023 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.22 1.37 0.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -84.52 160.91 20.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.21 113.22 18.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 110.735 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.539 ' O ' HG13 ' A' ' 57' ' ' ILE . 16.6 pt -56.27 95.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -21.79 66.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.757 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.425 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 2.5 t80 -155.78 145.35 21.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -129.56 117.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.722 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 56.77 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 60' ' ' VAL . 29.1 mt-10 -150.76 30.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 21.4 t -120.86 141.69 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 4.8 m-20 -77.39 90.58 3.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' CG1' HG22 ' A' ' 60' ' ' VAL . 15.0 p -103.2 33.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.423 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 6.04 38.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 173.87 53.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 0.0 110.011 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.5 m -115.64 141.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.004 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.0 OUTLIER -49.95 157.85 0.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.466 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.424 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -51.58 -48.57 63.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.508 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -55.8 -42.69 76.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.37 69.13 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.547 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.406 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 47.5 t -64.6 -35.55 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.649 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -33.71 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.839 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.46 73.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.393 0.616 . . . . 0.0 110.491 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.57 -26.76 55.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.42 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -69.95 -38.56 76.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.067 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.27 27.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.442 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.23 -25.15 25.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.329 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.7 -152.91 30.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.656 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.489 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -101.82 11.09 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.641 0.258 . . . . 0.0 111.438 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -150.64 92.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.8 t -85.23 148.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.401 0.62 . . . . 0.0 111.869 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -138.16 84.13 2.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.562 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 1.7 pp -115.6 154.02 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.397 0.618 . . . . 0.0 112.569 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CE1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -104.84 114.84 29.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.608 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 33.0 m -105.83 167.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.121 0.486 . . . . 0.0 112.193 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.4 ttp -131.62 109.44 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.312 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.2 ttp-105 -120.17 146.52 45.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -52.5 160.94 0.76 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.234 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.24 164.45 61.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.01 171.94 5.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.803 2.335 . . . . 0.0 112.489 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.413 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 37.7 Cg_exo -60.14 -147.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.888 2.392 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . 82.34 53.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.156 0.503 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 185' ' ' LYS . 1.4 mm-40 -64.51 -160.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.492 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.91 -178.96 3.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.94 125.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.84 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.3 mtm -102.18 164.14 11.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.337 0.589 . . . . 0.0 112.08 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -127.98 106.8 9.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.492 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.448 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.2 mm -115.86 155.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 180' ' ' TYR . 9.9 tttp -117.15 118.65 32.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.376 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 7.9 tt -115.69 118.71 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.137 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.5 pt -98.42 144.69 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -74.64 161.18 29.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.965 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.08 -168.66 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.849 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.09 -40.02 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.076 1.851 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -93.75 20.58 7.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.81 -142.83 15.56 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.404 HD22 ' CE1' ' A' ' 112' ' ' PHE . 10.2 mp -86.65 -21.31 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.869 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.84 50.77 8.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.52 148.01 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 111.029 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.3 t -107.01 116.9 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.471 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 48.2 pt -115.38 173.6 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' CB ' ' CB ' ' A' ' 122' ' ' HIS . . . -99.13 -176.53 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.82 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.445 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -143.15 149.14 21.08 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.103 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.47 -94.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.072 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.411 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 34.3 t -87.38 148.63 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.28 -21.19 41.73 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.388 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.93 69.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.259 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -59.83 -19.85 53.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.274 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 49.6 t60 72.51 -52.62 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 110.817 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 3.2 mt -93.3 141.09 23.53 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.839 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.7 83.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.4 2.067 . . . . 0.0 112.233 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 80.01 62.13 2.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.797 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -159.91 93.22 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -55.98 -22.34 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.269 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -54.67 122.88 11.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 110.778 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 160' ' ' LEU . 17.1 mt -72.19 117.8 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.085 0.469 . . . . 0.0 111.744 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.485 ' CD1' ' CB ' ' A' ' 151' ' ' LYS . 3.8 m-85 -111.95 153.9 26.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.05 134.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.25 -45.35 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -122.09 132.59 54.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 111.745 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 56.1 mt -137.36 128.63 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.943 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -74.74 173.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.35 15.19 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.616 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.85 -157.41 3.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.583 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.54 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.17 -31.81 69.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.379 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -55.3 -58.06 9.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.196 0.522 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.8 -47.5 45.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.041 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.69 -59.42 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.24 -35.87 91.55 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.19 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 61.1 20.13 10.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.875 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.72 81.28 3.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.798 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -65.68 176.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.508 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.9 mt -47.82 129.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.214 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 116.28 -24.92 9.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.532 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -63.99 133.44 53.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.349 . . . . 0.0 110.749 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -122.9 130.1 52.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.53 137.03 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.849 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 2.6 pp -98.91 -2.71 36.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.762 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 165.4 147.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.124 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 181' ' ' LEU . 47.5 t -101.36 99.69 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 69.44 -58.73 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 109.666 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.3 p -163.1 25.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.728 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 23.9 t -91.59 156.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-O 121.364 0.602 . . . . 0.0 111.524 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -99.29 74.05 0.51 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.749 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.57 ' O ' HG13 ' A' ' 129' ' ' ILE . 37.7 mt -70.61 24.1 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.717 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.551 ' H ' ' C ' ' A' ' 159' ' ' GLY . 8.3 pt-20 -176.26 56.63 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.3 0.572 . . . . 0.0 110.924 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -161.48 27.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.573 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.451 ' O ' ' HG3' ' A' ' 164' ' ' MET . 0.4 OUTLIER -153.23 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.146 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.5 mtp 173.06 164.48 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.482 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.405 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 2.6 p-80 -53.83 -29.86 42.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.939 0.399 . . . . 0.0 110.446 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.57 -45.41 53.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.151 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.445 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.22 -35.66 66.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.968 0.413 . . . . 0.0 110.604 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.71 73.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.776 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 14.0 t -74.01 -39.94 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.493 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.82 68.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.671 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.36 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -80.79 -36.79 31.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -26.88 60.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.493 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.26 -12.8 60.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.207 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 70.9 p -55.66 -172.59 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 111.341 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -107.68 170.22 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -55.47 -16.96 4.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.347 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.1 t -147.88 92.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.92 148.41 20.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.071 0.463 . . . . 0.0 111.987 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -94.81 131.19 40.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.28 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -118.36 146.99 43.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.13 108.11 20.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.6 t -102.71 157.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.062 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.83 44.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.486 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 7.3 mmtp -123.7 141.95 37.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 97.45 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.753 2.302 . . . . 0.0 112.931 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.3 m -67.84 149.06 50.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 46.34 30.06 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.281 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.058 -179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.723 0.297 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -88.62 51.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.152 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.418 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 22.7 t 56.59 64.39 4.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.426 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' B' ' 3' ' ' VAL . 13.1 Cg_exo -69.66 92.72 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.666 2.244 . . . . 0.0 112.119 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.18 82.08 1.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -164.91 86.46 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 104.5 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 110.73 22.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.12 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.857 0.36 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 31.3 m -71.5 135.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.38 91.81 25.49 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.8 132.87 38.18 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.487 2.125 . . . . 0.0 112.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.44 118.4 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 54.4 m 59.44 162.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 73.9 m -113.65 109.94 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.916 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.7 p -94.22 116.38 28.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.123 179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 ptm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.61 163.49 12.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.33 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.47 25.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 179.28 156.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.54 158.45 35.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.313 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 HG23 ' HG3' ' A' ' 50' ' ' ARG . 3.5 mt -152.78 142.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.294 0.568 . . . . 0.0 111.942 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -122.22 119.38 31.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.965 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 3.1 tp -125.31 93.96 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.637 0.732 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -79.08 165.32 23.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.911 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.9 93.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.67 -25.89 9.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.595 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -173.53 -85.6 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 30.6 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.622 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 177.02 18.59 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.213 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -84.22 -43.45 14.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 -179.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 92.95 71.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.713 . . . . 0.0 114.078 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.77 155.27 14.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.794 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -112.97 126.96 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.446 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.49 164.07 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.26 142.31 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 136.76 -126.89 3.89 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.71 128.47 4.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 69' ' ' THR . 2.2 t -49.58 -25.78 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -91.75 -40.92 10.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.038 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.82 77.24 57.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.67 134.89 34.22 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.644 2.23 . . . . 0.0 112.413 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 28.0 t60 -68.51 -21.41 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.61 -31.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.12 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.02 28.34 8.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.597 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -176.69 36.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 4.7 t0 -162.38 95.67 1.2 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.3 Cg_endo -55.68 -23.71 42.15 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.458 2.106 . . . . 0.0 112.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 159.27 32.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.01 150.77 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.4 p90 -142.53 144.96 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 64.8 mt -74.43 147.25 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' N ' HG21 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -96.59 -46.52 6.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.62 -179.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.44 158.29 39.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.093 0.473 . . . . 0.0 111.671 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -111.09 141.23 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.7 mt -84.5 118.16 70.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.22 76.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.42 2.08 . . . . 0.0 112.099 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . 174.22 -45.62 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.422 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.62 -178.47 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.95 -28.41 57.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.588 0.232 . . . . 0.0 111.396 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -55.74 -43.6 76.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.959 0.409 . . . . 0.0 110.749 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.09 65.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.866 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -71.57 -40.89 69.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.695 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.44 -25.01 25.45 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.273 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.87 -39.24 2.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.597 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 35.23 37.05 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.348 0.594 . . . . 0.0 111.095 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 40.99 -162.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.401 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.32 146.88 54.35 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.243 0.544 . . . . 0.0 111.8 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.443 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . 19.6 m -71.0 -36.0 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.329 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -54.36 -15.12 1.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.103 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -57.17 178.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.477 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 t -136.97 110.45 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.543 ' O ' HG13 ' A' ' 57' ' ' ILE . 14.2 pt -58.96 95.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -21.98 66.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.542 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -157.18 148.36 21.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG1' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -142.69 125.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 45.85 47.94 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 64.69 26.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 16.8 t -120.79 141.76 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.016 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.63 127.47 35.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 34.3 m -143.71 32.52 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.076 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -76.29 2.38 13.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.555 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -173.28 46.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.108 0.48 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 35.6 m -110.6 141.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.754 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.437 ' N ' ' CG2' ' A' ' 23' ' ' THR . 0.0 OUTLIER -50.23 160.89 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.706 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.437 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -50.97 -48.58 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.404 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.61 -40.86 63.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.933 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.84 75.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.373 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.17 69.14 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.429 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.418 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . 47.9 t -64.64 -36.06 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.54 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 7.8 mt-10 -69.54 -33.12 72.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.787 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.34 -42.81 74.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.424 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.84 -26.84 54.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.352 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.65 -44.53 61.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.098 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.27 29.19 5.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.04 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.85 -29.87 58.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.444 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.51 32.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.474 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.48 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -108.76 5.51 24.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.1 mt -155.85 93.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' THR . 30.2 m -95.13 111.46 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 68.64 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . 4.4 pp -89.21 153.97 20.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.636 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.45 120.13 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.476 178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.6 m -117.67 167.87 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 112.458 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.1 ptm -147.89 109.21 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.845 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.419 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 26.1 ttp180 -107.33 111.88 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -73.85 144.97 45.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.397 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.5 71.97 0.28 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -75.65 142.41 25.91 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.476 2.118 . . . . 0.0 112.409 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' CB ' ' HB3' ' A' ' 187' ' ' SER . 10.1 Cg_exo -70.57 -153.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.577 2.184 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.65 12.01 20.3 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 111.6 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 185' ' ' LYS . 1.5 pt-20 170.48 -174.41 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.442 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -179.77 -143.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 121.241 -0.184 . . . . 0.0 111.167 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.31 151.25 4.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 111.833 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.92 166.85 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.858 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -122.46 106.82 11.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.403 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 1.6 mm -119.25 155.55 21.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.519 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 5.1 tttt -111.74 127.16 55.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.687 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 tt -125.43 118.56 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 177' ' ' ASP . 4.2 pt -100.73 144.72 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -65.44 152.77 43.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.798 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -132.37 157.71 22.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.829 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.52 -33.72 69.22 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.046 1.831 . . . . 0.0 112.16 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.05 18.38 13.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.25 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.33 -148.28 16.73 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.56 -17.99 32.63 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.166 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.01 51.95 9.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.081 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.47 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.33 145.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.654 0.264 . . . . 0.0 110.695 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.2 t -110.95 116.75 31.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.737 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.47 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 7.3 pt -126.99 153.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 122' ' ' HIS . . . -149.06 125.02 10.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.0 111.789 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.76 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.71 -175.09 25.44 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.199 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 121' ' ' GLN . . . 111.75 -178.43 19.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.352 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.49 144.4 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.709 0.29 . . . . 0.0 111.349 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.04 -21.17 46.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.541 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 173.0 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.501 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 117' ' ' GLY . 9.7 pm0 -103.4 -179.66 4.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.086 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 115' ' ' ALA . 68.0 t60 -57.95 -50.24 74.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.042 0.925 . . . . 0.0 110.662 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.49 ' CD1' ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -102.61 102.86 28.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.033 -178.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.42 92.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.371 2.047 . . . . 0.0 112.237 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.99 20.87 3.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.935 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -155.64 91.3 1.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -49.99 -25.86 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 p -54.01 116.32 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.76 HG12 ' HA3' ' A' ' 116' ' ' GLY . 5.6 mt -61.61 121.08 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.49 ' CG ' ' CD1' ' A' ' 123' ' ' ILE . 3.2 m-85 -114.34 156.75 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.13 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.1 155.5 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.691 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.5 p -119.87 -57.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -148.87 148.28 29.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.72 139.04 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.56 173.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -90.86 149.52 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.94 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.0 25.33 45.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.4 54.13 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.511 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.64 -60.36 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.03 -32.02 69.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -59.24 -45.74 90.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 110.145 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -72.71 -57.07 4.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.572 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.32 -59.24 2.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.03 -49.16 43.83 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.889 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 63.13 18.11 10.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.597 0.237 . . . . 0.0 111.039 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.416 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER -93.85 78.26 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.73 177.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.1 mt -47.2 134.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.084 0.468 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.44 13.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.539 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.2 m-20 -63.37 140.58 58.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.337 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -125.31 131.74 53.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.054 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.94 127.1 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 pp -96.6 -1.55 46.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.353 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 174.49 158.74 0.17 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 111.223 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.414 ' CG1' ' ND2' ' A' ' 156' ' ' ASN . 22.7 t -118.65 100.07 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.488 HD22 ' HB ' ' A' ' 179' ' ' VAL . 13.0 m-80 70.41 -59.36 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 109.665 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 p -165.57 28.33 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.123 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 4.2 t -103.11 154.81 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.367 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -116.85 78.6 0.29 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.557 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.52 23.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' GLY . 1.0 OUTLIER -140.85 40.3 1.83 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.095 0.474 . . . . 0.0 110.803 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.35 28.38 0.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.459 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.1 t -148.75 -76.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 174.98 169.69 0.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.666 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -55.86 -29.94 60.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.79 38.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.332 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.78 -36.93 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 110.571 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.71 73.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.489 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.3 t -71.5 -39.94 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.93 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.03 -25.98 56.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.304 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -80.32 -36.83 33.72 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -73.0 -26.87 61.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.385 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.82 -9.88 58.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.315 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.8 p -45.56 159.59 0.06 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.633 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -92.6 168.94 10.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.197 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.23 -34.18 6.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.396 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.3 t -148.1 90.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 0.0 110.757 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.488 ' HB ' HD22 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -123.49 148.58 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 111.504 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 36.6 p90 -92.27 132.27 36.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.01 153.86 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.432 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -96.68 114.38 26.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.787 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.02 163.91 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -145.56 149.86 35.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.396 0.617 . . . . 0.0 112.161 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 6.5 mtpt -114.21 146.66 36.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.005 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.38 32.94 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.574 2.183 . . . . 0.0 114.126 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 94' ' ' PRO . 19.6 m 42.3 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.753 0.311 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -65.97 65.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.114 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 m -114.39 -31.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.06 127.95 26.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.079 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.58 115.21 4.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.472 2.114 . . . . 0.0 112.366 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -101.69 33.39 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.84 129.48 34.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.61 106.96 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -89.61 118.6 29.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.406 HG23 ' CE1' ' A' ' 17' ' ' PHE . 23.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.088 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -178.65 -39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 7.8 m -92.69 157.0 40.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.17 -3.29 13.4 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.609 2.206 . . . . 0.0 112.803 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 65.86 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m 62.5 131.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.71 85.58 6.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 36.8 m -85.71 118.64 25.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.362 -0.828 . . . . 0.0 111.086 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.8 mtm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.828 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 156.37 17.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.07 128.2 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -178.03 174.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.414 . . . . 0.0 111.641 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -93.55 149.67 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.632 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.3 mt -148.05 150.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 111.561 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.9 OUTLIER -115.27 119.87 37.78 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.665 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 10.9 tp -121.91 93.62 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.45 0.643 . . . . 0.0 110.097 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -75.27 151.4 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.001 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -72.02 103.87 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.9 -26.89 6.09 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.774 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -169.47 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 p -109.28 30.73 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.39 173.73 17.89 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.519 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.4 -50.02 8.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.753 0.311 . . . . 0.0 111.138 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.93 79.15 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.674 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.503 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -164.7 159.2 18.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.607 178.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HG21 ' A' ' 36' ' ' ILE . 30.8 t -112.74 126.85 55.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.7 pt -118.21 171.71 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.62 149.02 2.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.44 -120.66 4.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.196 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.23 145.68 13.86 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.686 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.489 ' N ' ' HA ' ' A' ' 69' ' ' THR . 1.2 t -50.67 -24.94 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.682 0.277 . . . . 0.0 111.472 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' CB ' ' CG2' ' A' ' 69' ' ' THR . 19.2 t0 -86.68 -48.2 8.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.213 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.89 80.36 56.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 126.64 19.12 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.596 2.197 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 35' ' ' PHE . 17.0 t60 -67.3 -19.42 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.487 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.87 -26.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.14 34.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -168.32 111.56 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.83 -28.73 59.01 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.151 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -72.88 144.21 47.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.0 mt -93.55 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.39 153.5 43.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.544 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 59.9 mt -84.8 150.74 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.473 ' N ' HG22 ' A' ' 36' ' ' ILE . 61.2 p -100.02 -46.61 5.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.871 0.367 . . . . 0.0 111.037 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.07 155.92 31.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.344 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.427 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mt -113.87 141.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.927 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 40' ' ' ILE . 3.8 mt -84.25 134.43 43.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.55 60.38 5.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.094 . . . . 0.0 112.301 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.7 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.65 168.81 26.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.58 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -25.86 67.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 111.506 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.4 -57.54 12.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.2 -28.27 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.956 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -72.1 -41.95 66.68 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -72.61 -33.27 66.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.414 178.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 29.31 39.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.838 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.8 ptm180 -98.69 28.45 4.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -176.43 164.89 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.002 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.89 164.09 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.656 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.8 m -70.93 -47.27 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.015 0.436 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -58.87 -4.85 0.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -62.31 175.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.312 -0.242 . . . . 0.0 110.552 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 p -141.52 106.03 4.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.134 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -54.55 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.429 0.633 . . . . 0.0 111.159 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.32 -25.66 63.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.118 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.5 t80 -163.87 144.03 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.711 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 61' ' ' ASN . 1.1 p -103.92 -176.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.012 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' A' ' 60' ' ' VAL . 7.7 m120 -21.59 -51.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.601 0.563 . . . . 0.0 111.857 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 tt0 -163.72 27.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.702 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.463 ' HB ' HG11 ' A' ' 60' ' ' VAL . 2.8 t -121.59 142.0 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.693 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 23.5 p30 -79.63 84.34 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.058 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.04 26.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.02 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -95.91 9.26 41.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.286 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -166.14 37.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.256 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -118.68 141.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.9 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HA ' ' N ' ' A' ' 23' ' ' THR . 3.8 m -50.34 166.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.426 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.5 t-160 -59.09 -48.71 80.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.2 m -60.73 -36.86 79.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.33 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.976 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.08 -42.32 66.33 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.65 -35.96 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.806 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.49 -33.2 72.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.798 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.53 -42.4 74.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 110.416 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.18 -26.85 47.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.439 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -71.71 -40.03 69.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.072 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.07 26.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.525 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.08 -19.49 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.342 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.37 -120.03 6.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.637 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -137.17 18.13 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.548 0.213 . . . . 0.0 111.244 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.76 94.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 7' ' ' THR . 34.8 m -90.39 112.75 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -101.2 80.9 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 60' ' ' VAL . 1.7 pp -109.79 153.08 24.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.258 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 4.7 t80 -102.04 114.66 28.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.847 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.05 167.98 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.209 0.528 . . . . 0.0 112.172 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 mtp -127.87 109.52 11.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.817 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -121.03 132.9 55.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.87 0.367 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.47 137.21 32.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.908 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 84.94 0.8 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.741 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.33 108.47 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.647 2.232 . . . . 0.0 112.478 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -95.46 109.54 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.258 2.638 . . . . 0.0 112.049 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.54 25.49 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.067 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -91.81 178.26 5.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.1 140.02 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.85 142.59 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.71 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.42 17.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.112 0.482 . . . . 0.0 111.366 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.84 106.21 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.422 HG13 ' CG2' ' A' ' 183' ' ' VAL . 3.2 mm -116.84 155.34 18.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.648 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 17.7 pttm -114.15 126.57 55.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.359 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.407 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 3.9 tt -127.58 118.64 24.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -95.97 144.69 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -72.82 156.28 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.975 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.55 -168.79 12.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.821 -0.705 . . . . 0.0 111.826 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.25 -39.55 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.107 1.871 . . . . 0.0 112.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 19.6 8.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.049 0.452 . . . . 0.0 110.334 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.92 -143.21 15.78 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.275 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.72 -21.5 26.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.184 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.23 4.38 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.701 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.14 148.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -108.6 116.96 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.475 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 27.4 pt -121.79 162.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.636 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 129' ' ' ILE . . . -122.96 127.62 49.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.82 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -80.63 156.8 39.18 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.715 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . -49.58 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.7 t -54.38 134.37 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.822 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.6 -26.14 19.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.92 83.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.549 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -67.44 2.7 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.954 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.627 ' CD2' HG12 ' A' ' 123' ' ' ILE . 79.9 t60 79.63 -60.54 0.33 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.799 0.809 . . . . 0.0 110.497 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.627 HG12 ' CD2' ' A' ' 122' ' ' HIS . 1.5 mm -118.06 101.25 51.77 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.514 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.42 94.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.478 2.119 . . . . 0.0 112.092 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.95 -15.61 1.54 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.774 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.4 84.57 2.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.903 0.382 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -41.65 -28.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -51.8 152.69 2.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.546 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.82 HG12 ' HA2' ' A' ' 116' ' ' GLY . 51.1 mt -75.44 124.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.977 0.418 . . . . 0.0 111.285 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 151' ' ' LYS . 4.9 m-85 -114.71 132.26 56.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.68 155.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.345 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.3 p -118.61 -57.71 2.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.396 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 143.64 25.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.246 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.3 mt -129.96 141.63 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.801 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.39 173.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -93.12 149.1 21.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.99 29.29 51.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.67 -167.55 43.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.54 -55.08 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.13 -31.88 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.267 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.04 -55.67 31.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 0.0 110.316 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -72.8 -48.56 37.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.56 -59.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.891 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -58.5 -49.74 73.81 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.077 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 18.23 11.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.645 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.416 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.17 81.01 3.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.715 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.41 171.2 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.678 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 35.1 mt -46.67 127.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.316 0.579 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.09 -24.81 9.15 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.339 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.2 m-20 -67.95 131.59 45.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -116.87 134.11 55.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.118 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -105.39 131.94 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.71 -4.1 41.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.231 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 169.19 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.435 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 181' ' ' LEU . 38.4 t -103.92 99.7 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.759 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 69.28 -59.41 0.48 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.338 0.59 . . . . 0.0 109.592 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 m -165.02 29.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.941 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 10.0 t -104.26 155.08 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.564 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -110.91 74.57 0.21 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.645 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.05 25.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.984 0.421 . . . . 0.0 111.586 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -155.79 27.87 0.38 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.53 27.74 2.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.441 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.4 t -144.99 -72.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.643 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 174.78 162.58 0.22 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.241 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.409 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -53.54 -30.09 40.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.271 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -45.17 53.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.2 OUTLIER -73.1 -35.37 66.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.918 0.39 . . . . 0.0 110.637 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.92 72.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.167 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 10.5 t -71.93 -44.09 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.99 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.128 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.73 -27.7 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.75 -39.44 24.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.005 0.431 . . . . 0.0 110.192 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -26.69 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.055 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -10.0 59.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.198 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 63.8 p -58.91 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.794 0.331 . . . . 0.0 111.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -102.19 169.95 8.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.26 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.7 -17.41 5.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.361 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.41 91.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.9 148.14 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.733 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.9 m-85 -101.71 125.9 48.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.423 ' HB2' ' CG2' ' A' ' 152' ' ' ILE . 0.1 OUTLIER -111.83 152.72 27.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 120.37 36.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.884 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.422 ' CG2' HG13 ' A' ' 101' ' ' ILE . 18.1 t -102.21 160.67 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -124.87 133.89 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -84.04 146.18 48.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.87 111.81 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.59 2.193 . . . . 0.0 112.16 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 0.8 OUTLIER -58.8 148.91 28.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.183 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 54.6 28.33 9.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.825 0.345 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.78 97.16 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 18.4 m -139.06 123.8 11.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 152.86 21.45 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.485 2.123 . . . . 0.0 112.296 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -115.59 -38.33 3.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 85.8 p -108.85 135.3 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.46 163.7 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -136.72 126.25 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 20.7 t . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.093 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.35 156.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.52 133.71 25.18 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.067 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.78 -159.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.434 2.09 . . . . 0.0 112.267 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -47.42 81.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 11.3 m -124.44 -169.93 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -77.85 128.35 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -117.12 118.01 31.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.34 -0.838 . . . . 0.0 111.111 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.689 0.281 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 90' ' ' ARG . 8.5 tp10 -117.79 155.27 30.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 0.0 111.148 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.426 ' CD2' HD23 ' A' ' 58' ' ' LEU . 4.0 m-85 -110.82 161.39 15.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -176.69 141.34 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.889 0.375 . . . . 0.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 16.3 pt-20 -110.35 154.62 23.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG23 ' CD ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -166.11 159.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 111.972 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 0.8 OUTLIER -107.17 123.44 48.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.364 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.405 ' HG ' ' CD2' ' A' ' 15' ' ' LEU . 2.5 tp -116.1 93.52 4.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.598 0.713 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 11.2 mt-10 -66.66 143.1 57.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.798 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.68 101.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.485 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.22 -27.4 5.39 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.725 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.6 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -109.28 30.63 6.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.883 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.04 -179.65 20.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.008 -1.091 . . . . 0.0 112.248 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -84.47 -63.19 1.38 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.649 0.262 . . . . 0.0 111.309 -179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.79 62.66 0.39 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.599 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 7.9 p90 -149.5 138.9 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.543 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.417 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 5.9 m -79.48 126.69 31.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.5 pt -131.23 155.11 41.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.31 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 152.7 2.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.74 -122.82 2.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.36 128.82 4.46 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.404 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.526 HG23 ' CG2' ' A' ' 69' ' ' THR . 1.9 t -51.84 -27.23 11.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.87 -42.01 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.79 77.45 57.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.26 146.21 13.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.718 2.279 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 20.4 t60 -77.57 -19.38 55.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.53 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.15 -32.74 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 111.007 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.95 26.04 6.53 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.539 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.49 38.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.37 96.64 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.04 -22.68 48.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.485 2.124 . . . . 0.0 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.86 158.66 33.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.74 149.27 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.53 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 7.1 p90 -142.73 163.5 32.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.898 0.38 . . . . 0.0 111.042 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 45.7 mt -94.82 148.49 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.501 ' N ' HG23 ' A' ' 36' ' ' ILE . 1.1 p -104.4 -33.99 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.627 0.251 . . . . 0.0 111.401 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.34 150.93 4.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.38 . . . . 0.0 111.348 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 mt -111.45 141.07 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.997 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 pt -89.63 136.03 30.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.115 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.67 58.2 6.7 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.53 2.153 . . . . 0.0 112.387 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.0 -61.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.618 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.56 -173.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.628 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.04 -26.45 62.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.576 0.227 . . . . 0.0 111.522 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.1 -57.4 11.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.85 67.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.109 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -71.87 -45.68 60.5 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -68.39 -35.49 77.76 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.252 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.07 48.4 0.01 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.203 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.451 ' CD ' HG23 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.96 20.62 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.732 0.266 . . . . 0.0 111.291 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -158.23 162.96 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.334 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.18 158.25 15.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.396 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.616 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 35.2 m -71.2 -46.14 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.83 3.96 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -76.17 174.15 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.9 t -129.8 102.86 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 110.961 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.454 ' HA ' ' CG1' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -55.65 95.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.734 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 HD23 ' CD2' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -73.3 -22.65 60.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.1 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -153.46 155.22 35.88 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.965 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -152.52 130.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.447 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.58 35.07 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.228 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.13 30.96 2.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 t -120.92 141.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -73.34 116.02 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 60' ' ' VAL . 33.4 t -143.98 40.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -100.3 9.24 43.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.153 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 178.5 44.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.928 0.394 . . . . 0.0 110.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.6 m -109.63 147.26 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.562 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.526 ' CG2' HG23 ' A' ' 23' ' ' THR . 65.0 p -49.32 170.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.845 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' B' ' 6' ' ' SER . 2.2 t-160 -63.67 -49.02 74.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.323 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -36.34 83.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -35.53 72.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.23 64.74 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 109.804 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 70' ' ' HIS . 58.4 t -63.99 -36.57 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.52 -32.81 71.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.74 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -43.37 73.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 110.636 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.78 -26.77 54.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.461 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.73 -40.64 72.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.134 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 8.8 tt0 -101.24 27.32 6.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.317 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.77 -23.06 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.423 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.93 -161.81 24.82 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.785 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 9.7 t -86.23 -51.29 6.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 17.0 mt -99.25 84.69 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 13.9 m -85.24 116.26 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.677 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.2 80.5 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -84.89 135.41 34.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.24 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -116.72 114.49 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.391 178.558 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 57' ' ' ILE . 6.1 m -124.89 168.41 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.093 0.473 . . . . 0.0 111.998 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 109.06 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.802 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -122.77 116.52 23.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.675 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 2.4 ptt180 -43.01 137.91 2.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.88 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 15.5 mtpt -156.28 157.66 31.22 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -45.58 97.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.277 2.651 . . . . 0.0 112.613 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 85.5 Cg_endo -98.83 -157.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.607 2.871 . . . . 0.0 112.393 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . 82.37 35.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.821 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' N ' ' HA ' ' A' ' 187' ' ' SER . 4.2 tt0 74.67 164.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -172.18 118.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 111.7 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 0.0 110.755 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 mmm -93.61 166.66 12.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.398 0.618 . . . . 0.0 111.798 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -136.34 106.54 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.443 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 2.7 mm -112.7 155.16 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -110.82 126.13 54.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.304 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 6.7 tt -127.16 118.56 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.6 pt -96.44 144.64 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.43 157.47 30.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.19 -169.38 12.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.921 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.69 -30.78 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.145 1.896 . . . . 0.0 112.283 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.52 18.38 12.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.061 0.458 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.2 -146.34 16.06 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.46 -20.36 28.24 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.908 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.74 46.13 7.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.346 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.58 154.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.687 0.244 . . . . 0.0 110.98 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.31 126.33 51.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.455 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 9.0 pt -134.97 153.18 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.633 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.55 124.91 9.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.854 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.67 -175.11 25.43 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.065 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.38 -169.25 54.8 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.422 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.64 154.56 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.337 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.45 -25.59 17.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.03 77.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.568 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.1 pt20 -72.91 6.83 2.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.384 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 71.2 t60 72.72 -59.17 0.57 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.53 0.681 . . . . 0.0 111.331 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.51 ' CD1' ' CD1' ' A' ' 130' ' ' TYR . 0.4 OUTLIER -87.7 111.58 43.03 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.895 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 79.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.475 2.117 . . . . 0.0 112.243 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 121.68 40.24 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.523 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -175.52 96.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.79 0.328 . . . . 0.0 110.74 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.55 -23.36 50.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 58.3 m -47.44 128.34 12.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.522 HG12 ' HA3' ' A' ' 116' ' ' GLY . 37.7 mt -65.9 123.96 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.934 0.397 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.51 ' CD1' ' CD1' ' A' ' 123' ' ' ILE . 3.0 m-85 -122.89 156.91 33.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.499 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.8 t -89.32 151.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 122' ' ' HIS . 11.3 p -111.44 -58.46 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.496 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 147.91 28.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 147' ' ' GLN . 6.5 mt -128.37 141.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.3 mm -66.06 175.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.623 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.93 133.67 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.857 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.5 25.19 33.87 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.85 -160.72 1.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.513 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.57 -59.72 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.0 111.277 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.13 -31.97 69.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.582 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -53.88 -54.34 40.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.19 0.519 . . . . 0.0 110.392 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -72.9 -53.15 12.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.043 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.74 -59.29 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.153 0.502 . . . . 0.0 111.943 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -49.02 -46.94 32.9 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.453 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 65.76 16.99 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.617 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.431 ' HB2' ' CG ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -106.87 83.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.483 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.96 175.81 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.3 mt -47.46 122.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.354 0.597 . . . . 0.0 111.169 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.06 -21.73 6.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.311 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 8.5 p-10 -64.2 131.99 49.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.882 0.372 . . . . 0.0 110.409 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.497 ' CB ' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -108.24 125.05 51.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.61 133.92 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.046 0.451 . . . . 0.0 110.647 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -93.98 -4.03 50.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 173.52 156.65 0.12 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.936 0.398 . . . . 0.0 110.857 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.92 100.07 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.55 ' ND2' ' HB ' ' A' ' 179' ' ' VAL . 2.1 m-80 56.82 32.21 20.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p 82.92 25.83 0.13 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.856 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.21 146.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-O 121.426 0.631 . . . . 0.0 112.659 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' N ' HD12 ' A' ' 160' ' ' LEU . . . 96.29 -73.54 0.8 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.584 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.425 ' HG ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER 35.83 33.5 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.821 -0.689 . . . . 0.0 111.955 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 128' ' ' SER . 0.9 OUTLIER 35.82 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.926 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -114.43 36.95 3.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -151.17 -71.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.344 0.592 . . . . 0.0 110.607 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.1 mtm 175.42 160.45 0.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.412 ' O ' ' CG2' ' A' ' 169' ' ' VAL . 74.7 t60 -53.68 -31.43 47.71 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.175 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.92 -41.03 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.456 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.58 -38.43 62.65 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.683 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.6 -38.96 74.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.648 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 165' ' ' HIS . 29.3 t -72.99 -46.93 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.092 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.38 69.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.36 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.42 -33.99 58.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.373 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -81.34 -36.85 29.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.945 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -72.94 -26.83 61.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.482 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.29 -10.04 59.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.264 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 31.9 p -60.44 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 111.486 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -114.28 173.12 6.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -13.08 3.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.6 t -147.34 91.11 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.55 ' HB ' ' ND2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -128.93 148.61 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.995 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 39.3 p90 -107.61 135.29 49.31 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-O 121.052 0.453 . . . . 0.0 111.99 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.06 159.3 17.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.677 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -100.28 117.35 34.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.8 t -101.9 159.67 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -126.3 141.04 52.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -102.17 145.83 31.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.63 134.05 42.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.469 ' HA ' ' N ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -76.08 143.29 41.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 t30 47.76 28.91 1.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.17 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.748 0.308 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 m -75.17 133.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.404 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 9.2 p -153.95 63.78 4.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.053 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' B' ' 3' ' ' VAL . 31.1 Cg_exo -59.03 140.57 95.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.619 2.212 . . . . 0.0 112.313 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.23 -72.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.432 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 2.0 t -112.97 -170.73 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.16 -153.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.55 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -52.59 122.09 8.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.066 179.922 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.826 0.346 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -108.16 63.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 m -77.49 126.02 85.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.91 143.04 62.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.354 2.036 . . . . 0.0 112.287 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -137.34 79.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.73 -175.11 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.63 103.4 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 52.9 p -92.63 118.78 31.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.245 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.804 0.335 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -136.24 171.33 14.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.945 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -134.04 166.05 23.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -176.63 159.06 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 13.6 pt-20 -96.05 154.76 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 86' ' ' LEU . 19.2 tt -153.37 164.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.568 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -123.27 122.82 39.32 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.704 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HB2' ' NE ' ' A' ' 50' ' ' ARG . 1.2 tp -125.8 93.04 3.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.752 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -73.65 166.08 23.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.591 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -80.97 95.37 6.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.63 8.03 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.598 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -168.98 -89.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.069 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -109.22 30.85 6.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.51 177.07 24.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.395 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -84.43 -48.66 9.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.766 0.317 . . . . 0.0 111.5 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.24 65.53 0.67 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.77 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.4 p90 -164.69 162.9 21.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.298 . . . . 0.0 110.689 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.75 133.79 54.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.531 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 pt -120.43 171.28 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.8 152.34 3.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.345 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 119.08 -115.25 3.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.49 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 146.23 15.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.257 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 68' ' ' VAL . 1.3 t -54.05 -23.87 15.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.615 0.245 . . . . 0.0 111.475 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.83 0.347 . . . . 0.0 111.443 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.06 77.55 41.63 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 129.14 21.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.401 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.8 t60 -66.57 -20.67 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.32 -27.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.309 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.31 26.51 18.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.628 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -168.69 33.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.29 100.85 0.7 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.754 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.68 -26.85 67.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.401 2.068 . . . . 0.0 112.142 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -66.95 177.94 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.614 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -125.88 153.43 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.0 p90 -142.49 148.89 38.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 73.2 mt -75.15 150.45 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.409 ' N ' HG21 ' A' ' 36' ' ' ILE . 2.5 p -102.88 -40.51 6.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.601 0.239 . . . . 0.0 111.621 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -165.77 146.26 6.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.0 111.437 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -103.52 141.33 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.108 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mm -85.28 136.28 38.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.29 58.79 5.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.212 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.58 -54.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.03 -175.38 0.2 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.86 -31.4 59.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.666 0.269 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 49' ' ' GLY . . . -55.72 -26.25 44.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.542 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.14 -27.49 48.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.574 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.35 -43.75 66.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.954 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.74 -29.02 15.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 89.15 -33.69 4.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.63 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.506 ' NE ' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER 48.32 25.17 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' CD2' ' HG3' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 66.86 -167.58 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.959 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 153.05 25.08 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.097 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' HB ' ' C ' ' A' ' 36' ' ' ILE . 28.5 m -71.16 -36.72 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -52.06 -16.14 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 37.0 p-10 -59.03 156.31 12.01 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 35.6 m -121.55 126.28 48.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 ' HA ' ' CG1' ' A' ' 88' ' ' VAL . 9.4 pt -65.63 94.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.276 0.56 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -76.77 -28.2 55.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.482 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.89 116.15 5.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.432 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.69 125.55 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.9 m120 55.02 36.87 27.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.13 27.49 17.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.25 141.69 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.34 72.04 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 20.2 t -98.04 34.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -9.63 27.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.51 43.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.76 0.314 . . . . 0.0 111.615 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -123.94 155.57 30.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.232 0.539 . . . . 0.0 111.038 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.461 ' N ' ' CG2' ' A' ' 23' ' ' THR . 21.2 m -49.99 161.8 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.901 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.454 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.5 t-160 -58.98 -48.49 81.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.531 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -52.09 -37.53 54.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.401 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.37 80.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.59 66.47 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.264 0.554 . . . . 0.0 109.578 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' CG2' ' CD2' ' A' ' 70' ' ' HIS . 55.0 t -64.81 -35.29 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.682 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 47.4 tt0 -69.65 -32.33 70.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.938 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.36 -41.54 76.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.378 0.609 . . . . 0.0 110.361 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 80' ' ' ALA . 2.7 pp -76.31 -26.22 55.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 4.1 tttt -72.39 -35.21 68.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -113.35 28.76 8.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.203 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 77' ' ' LEU . . . -92.42 -21.44 20.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.63 -137.51 13.39 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' HG12 ' A' ' 83' ' ' ILE . 8.6 t -121.17 17.49 11.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.675 0.274 . . . . 0.0 111.414 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -154.07 95.84 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -102.01 143.38 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.215 0.531 . . . . 0.0 112.429 -178.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 15.9 tpp85 -100.35 93.4 5.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.782 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -88.4 115.36 25.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.347 0.594 . . . . 0.0 112.555 -177.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.5 114.06 27.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.06 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 57' ' ' ILE . 4.5 m -132.21 168.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.3 ttp -107.91 109.23 20.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.492 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HG3' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.4 146.74 52.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.463 . . . . 0.0 111.551 -178.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -71.01 142.09 50.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.183 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -143.74 119.72 6.4 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.696 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 31.4 Cg_exo -57.57 -46.75 25.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.411 2.074 . . . . 0.0 112.546 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 93' ' ' PRO . 96.6 Cg_endo -86.48 -159.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.579 2.186 . . . . 0.0 112.346 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 63.83 28.27 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.883 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' N ' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER 76.89 143.33 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.981 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.62 130.87 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.828 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.78 148.13 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.422 ' HB2' ' HB ' ' A' ' 183' ' ' VAL . 13.9 mtp -124.21 166.73 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 0.0 111.208 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.3 7.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.053 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mm -113.62 155.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.418 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.99 128.43 56.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.989 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 140' ' ' ALA . 6.1 tt -130.39 118.32 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.071 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.73 144.53 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.987 0.422 . . . . 0.0 111.059 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -66.93 149.11 51.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.979 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.08 -174.6 13.65 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.006 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.44 -36.8 14.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.317 2.011 . . . . 0.0 112.317 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -93.84 19.46 8.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.938 0.399 . . . . 0.0 110.498 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.73 -140.97 15.12 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.41 HD21 ' CE1' ' A' ' 112' ' ' PHE . 7.4 mp -86.64 -22.39 26.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.01 46.9 5.2 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.013 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 146.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.611 0.243 . . . . 0.0 110.861 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 m -108.67 116.85 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.46 ' CG2' ' CE2' ' A' ' 112' ' ' PHE . 8.5 pt -129.15 152.9 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.561 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -151.82 125.84 9.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 112.063 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.64 -175.26 25.57 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.882 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.91 176.49 14.49 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.732 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.66 153.65 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.854 0.359 . . . . 0.0 111.357 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.16 -5.89 65.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.72 79.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.87 142.49 27.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.447 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.52 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 8.3 t60 -45.08 -37.85 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.803 0.811 . . . . 0.0 110.517 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 130' ' ' TYR . 1.5 mt -100.43 143.14 25.97 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.583 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.7 83.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.615 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.13 53.49 2.81 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.102 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -154.7 87.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 111.149 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -52.85 -24.4 8.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.9 m -52.12 125.55 16.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.61 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.3 mt -73.69 113.4 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.833 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.455 ' CD1' HD12 ' A' ' 123' ' ' ILE . 4.1 m-85 -106.96 172.83 6.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.722 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.44 148.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.813 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 -29.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 137.65 31.34 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.835 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 43.9 mt -137.12 138.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 mt -82.67 173.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.25 140.94 29.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.876 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.02 26.23 55.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.33 -175.07 9.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.08 -66.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 144' ' ' GLY . . . -70.01 -37.34 75.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.429 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -51.96 -45.85 64.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.038 0.446 . . . . 0.0 110.67 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -57.3 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.038 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.56 -59.59 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.64 -33.6 85.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.176 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 59.94 20.96 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 1.2 pp -83.79 83.79 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.62 170.92 6.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.63 120.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.277 0.56 . . . . 0.0 111.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.28 -19.7 5.97 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -66.29 118.39 9.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.735 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -99.28 123.85 43.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.985 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.473 ' HB ' ' CD1' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -99.86 121.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 110.067 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -0.44 56.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.72 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 158' ' ' VAL . . . 172.97 159.98 0.12 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.562 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.452 ' HB ' ' CG2' ' A' ' 158' ' ' VAL . 36.9 t -117.52 98.85 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.438 ' OD1' ' CE2' ' A' ' 180' ' ' TYR . 7.1 m-80 68.32 -57.72 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.394 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 p -146.01 -18.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -78.02 129.14 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.42 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 154' ' ' ALA . . . -66.68 7.75 1.38 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.547 ' HB3' HG13 ' A' ' 129' ' ' ILE . 20.3 mt 42.71 29.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.469 0.634 . . . . 0.0 112.044 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -178.14 75.36 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -157.68 26.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 1.8 t -157.0 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.923 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 178.63 -172.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -67.45 -37.42 82.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.027 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.469 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.3 -35.55 61.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.854 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.24 76.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.44 -41.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.355 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.28 -29.27 64.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.727 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.94 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.28 -39.45 25.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.109 0.481 . . . . 0.0 109.929 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -75.18 -26.78 59.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.102 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -20.75 23.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.42 ' HB ' ' CG2' ' A' ' 179' ' ' VAL . 76.6 p -54.52 -172.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 178' ' ' VAL . 8.8 p90 -125.03 -162.24 1.08 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.7 m-20 -59.7 -21.6 60.84 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 38.2 t -147.66 91.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 118.728 0.694 . . . . 0.0 111.511 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.92 148.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.919 0.39 . . . . 0.0 111.887 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.438 ' CE2' ' OD1' ' A' ' 156' ' ' ASN . 21.8 p90 -105.23 126.18 51.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.328 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.75 149.05 27.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -96.39 119.16 34.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 152' ' ' ILE . 11.8 t -101.89 161.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -134.78 144.76 47.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.64 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.93 146.21 30.94 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.83 38.53 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.98 2.453 . . . . 0.0 113.229 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.437 ' HA ' ' N ' ' A' ' 96' ' ' GLU . 2.5 p 50.35 -179.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.996 0.427 . . . . 0.0 111.054 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 37.0 34.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.867 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.188 -179.856 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.42 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.066 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -118.8 96.02 49.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.04 91.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.582 2.188 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.11 58.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.78 145.16 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 37.6 m -106.65 150.02 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 29.5 t -133.3 114.69 14.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.102 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.46 146.33 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.501 ' HB ' ' CD ' ' C' ' 4' ' ' PRO . 34.7 t -158.08 -64.36 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' C' ' 3' ' ' VAL . 23.8 Cg_endo -60.91 -165.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.321 2.014 . . . . 0.0 112.171 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 64.21 -169.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 43.9 m -65.58 151.07 47.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -88.36 109.3 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.998 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t -83.47 111.31 18.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.164 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.84 144.15 21.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -179.39 159.01 0.89 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.845 0.355 . . . . 0.0 111.445 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -101.01 156.41 17.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.656 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -158.46 155.19 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.7 OUTLIER -110.22 121.7 45.9 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.854 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.3 tp -116.16 93.3 4.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.429 0.633 . . . . 0.0 110.337 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.28 135.34 42.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.224 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 2.3 mtp180 -56.29 103.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.691 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.13 -28.81 13.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.469 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.07 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.45 . . . . 0.0 109.929 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -109.15 30.67 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.683 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' CA ' ' HG2' ' A' ' 10' ' ' ARG . . . 147.03 171.26 16.06 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.04 -49.36 8.99 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.905 0.384 . . . . 0.0 110.991 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 99.22 80.18 1.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.577 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.9 p90 -164.43 149.91 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.713 0.292 . . . . 0.0 110.483 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 36' ' ' ILE . 18.1 p -105.85 127.01 52.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 111.55 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 36' ' ' ILE . 25.4 pt -119.51 166.0 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.857 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -172.78 153.6 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.234 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.71 -120.45 2.67 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.27 141.02 8.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.172 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -56.91 -18.81 14.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 69' ' ' THR . 12.4 t0 -91.57 -52.51 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -119.5 79.56 21.52 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.26 138.31 23.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 0.0 112.414 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 8.5 t-80 -69.28 -18.63 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.48 -36.98 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 110.985 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.37 24.79 6.05 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.01 40.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -162.15 98.82 1.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 17.7 Cg_endo -57.62 -27.0 75.23 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.09 . . . . 0.0 112.194 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -74.04 141.2 45.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.03 152.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.1 p90 -142.26 166.48 24.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.713 HG12 HG22 ' A' ' 19' ' ' ILE . 53.1 mt -92.19 153.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.15 -39.77 5.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.628 0.251 . . . . 0.0 111.664 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.929 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.28 156.42 14.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.107 0.479 . . . . 0.0 111.644 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -118.42 141.33 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.5 mt -88.14 126.78 59.7 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 16.9 Cg_exo -66.76 63.13 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.141 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.5 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.84 -177.82 0.93 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.466 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -73.82 -18.72 60.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.04 -57.38 13.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.13 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.14 69.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.32 -41.56 66.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' CB ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -76.02 -32.23 59.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.7 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.64 44.61 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 113.901 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HB3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -93.1 21.71 5.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.695 0.247 . . . . 0.0 111.581 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.768 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.8 pt? -176.36 170.11 2.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.999 0.428 . . . . 0.0 111.325 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' NH1' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -101.61 163.44 12.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.499 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.929 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -71.06 -46.54 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 112.04 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.513 ' N ' HG23 ' A' ' 53' ' ' VAL . 15.9 m120 -69.53 11.41 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.5 p-10 -76.92 176.92 8.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -127.87 102.66 6.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.801 HG22 HG12 ' A' ' 88' ' ' VAL . 2.4 pt -57.43 94.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 111.157 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.48 -28.54 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.501 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -163.25 150.57 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -141.28 131.68 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 45.3 38.82 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.192 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 61.6 33.92 18.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 141.68 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.173 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 68' ' ' VAL . 9.0 p-10 -66.93 100.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' A' ' 60' ' ' VAL . 37.9 t -133.1 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.106 0.479 . . . . 0.0 110.911 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -105.06 -14.51 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.93 47.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.813 0.339 . . . . 0.0 111.131 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.62 149.64 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.21 0.528 . . . . 0.0 111.102 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -49.74 154.77 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.937 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -51.81 -48.36 63.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.258 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -49.63 -36.41 24.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.03 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.56 63.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -40.7 68.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.696 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.542 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -65.7 -35.54 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.633 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 3.1 mt-10 -69.59 -32.48 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.875 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.31 76.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.447 0.641 . . . . 0.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.84 -26.5 57.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.47 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -68.82 -35.89 77.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.218 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.64 28.87 8.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.809 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -77.79 -29.25 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.355 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.49 -101.08 2.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.607 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 69.1 m -152.65 -52.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.798 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -98.33 84.93 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -84.63 113.73 23.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.676 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.804 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 ttt85 -92.78 78.83 4.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.075 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.484 ' CB ' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.08 154.03 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.402 -178.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 1.9 t80 -109.51 115.0 29.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.151 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 57' ' ' ILE . 31.6 m -108.46 168.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 112.397 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.25 109.42 7.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.634 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.754 0.312 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 98' ' ' VAL . 14.5 p -103.22 115.71 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.45 166.6 12.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.605 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.96 106.58 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.882 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 181' ' ' LEU . 3.6 mm -114.19 155.36 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.475 ' CG ' ' CD2' ' A' ' 180' ' ' TYR . 2.7 mtmp? -108.02 123.92 49.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.428 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 181' ' ' LEU . 2.5 tt -129.91 118.62 21.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.71 HG22 HG23 ' A' ' 178' ' ' VAL . 4.4 pt -93.96 144.61 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -70.64 152.79 43.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.095 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.62 160.72 23.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.756 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.97 -37.5 86.07 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.094 1.863 . . . . 0.0 112.033 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 20.96 9.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.048 0.451 . . . . 0.0 110.053 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.47 -155.46 17.92 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.283 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.763 HD23 HD13 ' A' ' 103' ' ' LEU . 9.1 mp -86.48 -13.36 46.3 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.075 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.66 63.11 2.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.862 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.684 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.84 150.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.355 . . . . 0.0 110.999 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.72 116.88 32.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 131' ' ' VAL . 8.9 pt -136.52 153.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -151.55 125.0 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.84 -175.13 25.58 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.205 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.9 178.36 51.07 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.442 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 26.0 t -74.08 150.27 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.819 0.342 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.37 -29.46 6.12 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.858 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.71 69.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.48 -4.63 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.688 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.558 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 19.0 t-80 72.48 -58.1 0.6 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.547 0.689 . . . . 0.0 110.578 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.917 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.46 137.56 30.55 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.428 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 123' ' ' ILE . 49.6 Cg_endo -68.71 62.21 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.236 1.957 . . . . 0.0 112.339 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.1 57.29 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.723 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.689 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -174.44 99.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -60.44 -19.72 57.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.324 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -57.31 151.3 16.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 168' ' ' ALA . 2.8 mt -91.03 115.35 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.917 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 m-85 -109.33 153.9 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.62 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 114' ' ' ILE . 75.7 t -90.72 155.72 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.456 ' HA ' HG23 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -136.03 -27.62 1.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 147.96 27.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.982 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.678 HD11 ' O ' ' A' ' 146' ' ' LEU . 42.0 mt -137.21 141.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.51 173.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.585 ' H ' HG22 ' A' ' 135' ' ' ILE . 28.7 mt-10 -93.55 133.15 37.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.844 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.82 26.47 73.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.35 176.77 54.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.63 -53.81 16.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 111.288 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.556 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.25 -34.63 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -51.91 -58.65 5.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.465 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -72.94 -48.69 34.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.467 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.59 -59.6 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -59.68 -44.28 97.04 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.413 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 63.23 17.8 10.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.602 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.678 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -81.52 83.66 6.94 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -65.55 152.58 43.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.656 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 132' ' ' THR . 34.4 mt -46.57 106.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.438 0.637 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 146.41 -14.29 1.62 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.544 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 p-10 -80.45 162.29 24.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.875 0.369 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -142.59 128.31 19.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.549 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.19 133.12 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.114 0.483 . . . . 0.0 110.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 3.2 pp -100.68 -4.13 28.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.101 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 170.35 141.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.772 HG12 HD22 ' A' ' 156' ' ' ASN . 76.6 t -96.74 99.79 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.798 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.772 HD22 HG12 ' A' ' 155' ' ' VAL . 48.9 m-80 69.27 -58.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.084 0.468 . . . . 0.0 109.846 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.1 25.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.799 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 155' ' ' VAL . 24.3 t -92.3 155.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 121.351 0.596 . . . . 0.0 111.367 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -101.93 73.25 0.34 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.759 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.554 ' CD1' HG23 ' A' ' 155' ' ' VAL . 22.1 mt -69.95 20.47 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -163.56 56.49 0.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.268 0.556 . . . . 0.0 110.812 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.58 28.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.555 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.712 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.9 OUTLIER -151.86 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.9 mtp 173.78 164.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.426 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.613 ' O ' HG23 ' A' ' 169' ' ' VAL . 19.7 p-80 -53.77 -30.02 42.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.492 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.73 50.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.305 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.712 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.36 -35.51 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 0.0 110.743 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.17 -35.39 73.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.942 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.742 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.9 t -70.23 -43.5 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.15 -30.35 66.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.9 -25.55 53.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -81.18 -39.91 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.202 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -75.52 -26.55 58.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.02 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -71.04 -10.54 59.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.658 ' HB ' HG21 ' A' ' 179' ' ' VAL . 81.6 p -54.1 -175.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.831 0.348 . . . . 0.0 111.479 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -102.36 168.97 8.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.379 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 t0 -52.03 -23.05 4.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 178' ' ' VAL . 4.0 p -145.18 92.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.383 0.611 . . . . 0.0 110.389 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.51 148.43 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.23 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.475 ' CD2' ' CG ' ' A' ' 102' ' ' LYS . 5.6 m-85 -97.9 120.51 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.752 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -98.08 144.11 27.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.24 109.31 21.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.47 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 152' ' ' ILE . 20.8 t -101.39 161.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -141.89 142.74 33.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.802 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.631 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.62 82.41 4.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.142 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -116.5 153.2 32.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.621 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -157.59 151.22 23.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -142.74 108.91 5.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.853 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.717 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.68 -168.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 111.652 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -143.6 135.95 26.99 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.778 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -113.02 88.84 2.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.475 0.655 . . . . 0.0 110.892 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.4 tt0 -84.73 123.88 30.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.199 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -38.94 96.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -54.39 -24.04 28.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.576 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -176.47 -84.76 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 p -109.28 30.75 6.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.8 179.99 23.32 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.815 -1.184 . . . . 0.0 112.819 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.778 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.34 -50.32 7.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.39 -0.405 . . . . 0.0 111.415 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.8 64.25 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.924 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HE2' HD23 ' A' ' 8' ' ' LEU . 9.2 p90 -164.94 169.03 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -129.72 130.04 44.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.357 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.598 HG22 HG12 ' A' ' 36' ' ' ILE . 3.0 pt -120.21 162.4 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.94 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.294 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.49 -121.61 2.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.27 136.95 5.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 HG23 ' A' ' 69' ' ' THR . 1.2 t -55.77 -19.65 12.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.844 ' HB2' HG22 ' A' ' 69' ' ' THR . 2.6 m-20 -93.2 -52.15 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.188 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -117.86 78.37 12.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.29 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.25 142.62 5.92 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.725 2.283 . . . . 0.0 112.623 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.401 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.0 t60 -74.34 -18.34 60.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.76 -29.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.63 28.16 8.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.526 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.84 37.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -167.46 95.34 0.65 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.76 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 10.6 Cg_endo -53.98 -28.63 50.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -65.06 169.86 4.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.432 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.93 151.99 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.366 . . . . 0.0 111.123 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 5.5 p90 -142.56 144.29 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG22 ' A' ' 19' ' ' ILE . 69.0 mt -70.94 151.78 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.659 ' O ' HG21 ' A' ' 53' ' ' VAL . 28.3 p -99.85 -43.86 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.516 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.46 149.14 6.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.47 . . . . 0.0 111.798 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.458 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -106.19 141.61 21.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.032 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.49 119.94 73.62 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.06 84.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.359 2.039 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.04 -39.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -58.62 175.95 2.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.534 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -76.06 -20.36 57.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -51.02 -57.69 7.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.955 0.407 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.35 69.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -72.09 -34.64 68.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.791 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -89.57 -21.31 22.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.423 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 79.36 0.72 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.276 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.553 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.42 32.0 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 0.0 110.095 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.621 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.1 pp 38.48 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.185 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -58.4 141.43 51.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.035 0.445 . . . . 0.0 111.366 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -69.57 -40.78 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.154 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 53' ' ' VAL . 27.3 p30 -52.73 -16.84 1.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.78 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 20.4 p-10 -59.18 171.69 0.7 Allowed 'General case' 0 C--O 1.23 0.032 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 t -130.17 122.57 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 88' ' ' VAL . 15.2 pt -63.16 94.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.544 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 59' ' ' PHE . 1.3 pp -62.37 -24.31 67.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' A' ' 58' ' ' LEU . 1.3 t80 -164.19 140.35 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.894 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.4 p -101.97 -176.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.702 ' H ' HG22 ' A' ' 60' ' ' VAL . 18.1 m-20 -22.38 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.539 0.524 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -162.79 25.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.6 t -121.71 142.12 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.626 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 7.5 t0 -80.36 84.19 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.114 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 57' ' ' ILE . 16.7 m -94.83 30.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptt85 -89.42 7.63 34.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 179.25 49.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.048 0.451 . . . . 0.0 109.959 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' C ' ' HB ' ' A' ' 23' ' ' THR . 34.8 m -111.73 139.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.257 0.551 . . . . 0.0 112.39 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.844 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -50.06 166.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.547 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -57.06 -48.71 77.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.037 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -41.91 70.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.04 74.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.456 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.76 68.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.541 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.1 t -64.52 -36.13 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.576 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 8.3 mt-10 -69.56 -33.11 72.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.694 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -42.91 74.43 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.37 0.605 . . . . 0.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.541 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.99 -26.88 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.31 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -72.65 -44.2 62.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.005 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.13 28.43 5.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.281 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -80.87 -27.7 36.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.6 -123.04 6.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.371 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' ILE . 13.4 m -135.21 8.15 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.507 HG23 ' HG3' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -156.93 94.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -110.96 119.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HA ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.21 102.32 14.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 57' ' ' ILE . 4.9 mp -103.75 139.78 38.52 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 5' ' ' GLU . 3.7 m-85 -107.8 114.74 28.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.1 m -115.92 168.45 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.308 0.575 . . . . 0.0 112.496 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 mtp -143.29 109.04 5.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 3.6 ptt180 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.808 0.337 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 153' ' ' LEU . 21.6 t -84.94 112.86 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -87.8 166.43 14.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.355 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.81 106.4 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 183' ' ' VAL . 3.0 mm -116.46 155.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -106.23 123.62 48.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.299 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.973 HD12 HD11 ' A' ' 181' ' ' LEU . 2.2 tt -122.85 118.53 28.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.571 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.59 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.3 pt -100.06 144.71 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.029 0.443 . . . . 0.0 111.233 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 110' ' ' LEU . 11.0 tttm -72.01 162.55 29.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -139.22 161.89 26.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.74 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.49 -39.32 91.69 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 122.062 1.841 . . . . 0.0 111.94 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -95.4 21.93 7.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.052 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 105.84 -155.44 16.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.466 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 105' ' ' LYS . 9.3 mp -86.24 -13.38 46.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.868 0.334 . . . . 0.0 111.227 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.26 51.83 7.19 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.56 154.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 132' ' ' THR . 31.1 t -116.08 119.25 35.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.375 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 112' ' ' PHE . 15.5 pt -125.26 156.38 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.901 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -154.91 125.42 6.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.95 165.9 31.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.685 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.06 -131.73 14.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.199 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.2 t -104.46 154.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 114.05 -37.85 3.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.403 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 163.8 82.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 110.276 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 111.43 23.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.161 0.505 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.901 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -57.31 -16.56 8.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.206 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 130' ' ' TYR . 0.3 OUTLIER -87.94 104.78 7.4 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.457 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 123' ' ' ILE . 13.6 Cg_endo -57.08 94.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.534 2.156 . . . . 0.0 112.571 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.68 44.5 8.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.886 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -142.21 85.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.022 0.439 . . . . 0.0 110.85 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -47.82 -26.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -55.89 162.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 160' ' ' LEU . 36.4 mt -96.24 125.31 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.151 0.501 . . . . 0.0 111.387 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.636 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.1 m-85 -116.21 161.33 19.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.229 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 150' ' ' ASP . 49.1 t -92.96 144.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 1.5 t -115.04 -49.21 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.99 144.17 30.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.877 0.37 . . . . 0.0 111.634 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.681 HD11 HG11 ' A' ' 131' ' ' VAL . 31.4 mt -136.89 139.85 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.99 173.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.9 tt0 -91.88 147.31 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.21 27.69 57.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.503 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.01 53.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.31 -59.86 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 111.405 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -69.96 -33.33 71.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.45 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -57.54 -60.2 4.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 0.0 110.24 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -41.7 64.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -80.6 -59.46 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -70.31 -30.81 69.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.215 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.73 21.0 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.726 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -93.37 82.33 4.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -66.71 172.99 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.8 mt -47.54 122.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.305 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.7 -22.6 6.11 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.365 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.754 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.47 134.55 54.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.333 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -119.42 124.72 47.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -104.25 129.45 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 110.717 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -98.55 -0.28 43.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.161 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.57 169.14 1.39 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.897 HG12 ' ND2' ' A' ' 156' ' ' ASN . 57.8 t -126.76 100.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.465 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.897 ' ND2' HG12 ' A' ' 155' ' ' VAL . 25.5 m-80 69.97 -57.7 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.195 0.522 . . . . 0.0 109.977 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.16 27.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.613 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.642 ' HB ' HD21 ' A' ' 160' ' ' LEU . 2.0 t -116.6 154.26 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-O 120.986 0.422 . . . . 0.0 111.332 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.0 77.86 0.24 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -78.21 24.76 0.24 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -127.68 41.35 3.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.382 0.611 . . . . 0.0 110.963 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.19 28.0 0.35 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.039 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.74 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -134.75 -78.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.4 ' CG ' ' HB ' ' A' ' 118' ' ' VAL . 3.2 mtm 173.57 166.87 0.17 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 169' ' ' VAL . 47.2 p-80 -53.88 -29.78 43.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.963 0.411 . . . . 0.0 110.602 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.42 -48.18 35.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.74 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -68.49 -37.85 80.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 160' ' ' LEU . . . -70.27 -38.66 75.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.673 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.5 t -67.25 -46.02 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.369 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.62 67.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.532 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 160' ' ' LEU . . . -77.48 -25.57 50.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.35 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -79.46 -39.97 30.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.177 0.513 . . . . 0.0 109.828 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 169' ' ' VAL . 4.3 mtmt -75.88 -26.58 57.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.07 -33.64 74.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.047 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.722 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -52.72 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.398 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -95.27 169.23 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.488 . . . . 0.0 111.341 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -56.78 -16.75 7.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.615 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.96 90.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.585 0.231 . . . . 0.0 110.934 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.63 148.28 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.129 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 1.4 p90 -95.02 130.42 41.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.627 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.973 HD11 HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.18 155.91 19.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.751 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.53 114.8 26.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.654 HG21 HG13 ' A' ' 101' ' ' ILE . 20.6 t -102.26 161.65 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -119.74 135.78 54.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 0.0 111.349 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 169' ' ' VAL . 47.8 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -85.76 85.78 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.097 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.945 0.402 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD2' ' CG ' ' A' ' 89' ' ' MET . 1.0 OUTLIER -129.43 171.87 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.587 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -167.5 136.82 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.6 109.33 10.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.378 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -127.7 -170.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.129 0.49 . . . . 0.0 111.98 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 128.14 49.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.416 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.1 tp -125.32 91.71 3.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.629 0.728 . . . . 0.0 110.087 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 83' ' ' ILE . 2.3 mt-10 -70.1 165.41 22.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.949 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -83.21 99.18 9.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.98 -26.55 8.77 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -168.87 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.176 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 t -109.18 30.64 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.65 177.03 20.06 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.358 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.54 -43.17 14.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.758 0.313 . . . . 0.0 111.069 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 90.84 76.61 1.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.784 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.7 p90 -164.72 148.46 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.041 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.2 m -95.97 126.99 41.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.41 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 36' ' ' ILE . 36.0 pt -115.41 154.73 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.129 0.49 . . . . 0.0 112.019 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -173.12 118.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . 152.65 29.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.061 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -58.22 167.13 6.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.41 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.74 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -73.03 -31.45 64.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.728 ' CB ' HG23 ' A' ' 69' ' ' THR . 8.3 t70 -83.84 -51.57 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 111.595 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -119.76 78.4 22.51 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.501 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.87 156.34 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.515 2.143 . . . . 0.0 112.203 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.595 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 15.6 t60 -100.81 -19.45 15.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -108.48 -26.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.666 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.25 32.18 8.5 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.147 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 177.7 39.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 3.4 t0 -166.56 107.87 0.68 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.897 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 14.2 Cg_exo -69.04 -24.74 32.65 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.684 2.256 . . . . 0.0 112.098 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -74.57 126.29 30.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -70.25 148.24 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.201 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -139.83 171.41 14.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.388 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 41.3 mt -99.42 150.57 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.4 m -108.5 -30.32 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.838 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.7 tmtt? -175.6 148.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 111.455 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -108.81 141.22 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.983 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 pt -89.69 146.58 35.83 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 58.45 6.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.6 2.2 . . . . 0.0 112.404 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.61 -57.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.02 176.61 1.8 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -74.54 -24.81 59.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.631 0.253 . . . . 0.0 111.62 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -53.01 -57.43 10.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.916 0.389 . . . . 0.0 111.292 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.988 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.91 -39.33 69.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 0.0 109.505 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 2.5 m-20 -80.19 -28.39 38.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.31 49.42 0.05 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.278 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HD3' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -103.56 21.71 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.584 0.23 . . . . 0.0 111.491 -179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.39 163.19 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 158.32 15.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.245 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.838 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.2 m -71.16 -44.13 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 m120 -58.74 1.25 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.688 ' OD2' HG21 ' A' ' 88' ' ' VAL . 55.1 p30 -89.87 163.43 15.01 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.088 -0.383 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -119.26 123.87 45.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.328 . . . . 0.0 111.075 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 7.1 pt -61.88 94.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 59' ' ' PHE . 3.6 pp -76.01 -20.57 57.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.675 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -158.0 119.58 3.59 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.077 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.792 HG22 HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -118.33 119.51 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 52.22 42.5 30.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.185 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.66 30.89 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 60' ' ' VAL . 22.1 t -114.09 141.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.31 113.92 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.792 HG11 HG22 ' A' ' 60' ' ' VAL . 14.6 p -146.59 26.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -87.45 6.51 33.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 177.67 50.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.937 0.398 . . . . 0.0 110.088 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.567 ' CG2' HG23 ' A' ' 65' ' ' VAL . 35.9 m -120.04 144.61 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.623 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.74 ' N ' HG22 ' A' ' 23' ' ' THR . 3.9 m -49.93 162.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.766 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.492 ' ND1' HG23 ' A' ' 74' ' ' VAL . 3.1 t-80 -55.66 -48.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.457 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -50.01 -40.77 45.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.247 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.08 76.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -71.79 -41.3 68.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.459 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 78' ' ' LYS . 46.3 t -64.82 -36.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.628 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 6.2 mt-10 -69.3 -30.82 68.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.737 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.823 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.26 -36.95 74.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.451 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.18 -26.19 33.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -75.99 -32.66 59.56 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.865 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 29.78 7.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.56 -20.53 18.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.19 -131.25 10.28 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.616 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -124.84 16.61 8.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 111.321 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -153.63 94.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -102.14 136.56 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.08 90.28 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.738 HD23 HG12 ' A' ' 60' ' ' VAL . 17.9 mt -85.12 114.97 22.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.536 0.684 . . . . 0.0 112.764 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -110.02 114.29 27.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.193 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.9 m -123.04 168.37 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.468 ' HG3' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -123.26 109.01 13.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.278 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.28 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.34 120.25 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.82 166.13 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -129.94 106.36 8.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.438 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.581 HG13 HG21 ' A' ' 183' ' ' VAL . 2.5 mm -118.29 155.61 20.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.468 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -115.1 137.07 52.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.539 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.823 HD22 HD23 ' A' ' 110' ' ' LEU . 3.1 tt -135.28 118.44 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.72 144.66 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.011 0.434 . . . . 0.0 111.219 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -76.7 158.47 30.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.52 -164.88 10.06 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.994 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.76 -33.06 4.12 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.258 1.972 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 19.3 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.037 0.446 . . . . 0.0 110.53 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.64 -144.38 15.8 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.823 HD23 HD22 ' A' ' 103' ' ' LEU . 2.9 mp -86.43 -21.44 27.09 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.108 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.73 46.08 5.83 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.974 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.54 157.64 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 0.0 110.748 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 133' ' ' LYS . 43.9 t -125.15 116.76 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.724 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 172' ' ' LEU . 8.1 pt -123.05 151.59 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.425 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -149.87 125.52 10.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.099 0.476 . . . . 0.0 111.696 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.79 -175.29 24.92 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.043 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 121' ' ' GLN . . . 73.22 -144.33 34.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.871 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.441 ' H ' ' HA ' ' A' ' 164' ' ' MET . 48.7 t -104.67 154.62 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.854 0.359 . . . . 0.0 111.696 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 107.11 -32.24 7.41 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.236 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 176.54 79.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 0.0 110.163 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -111.07 112.44 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.269 -179.35 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -57.21 -20.14 25.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.222 0.534 . . . . 0.0 110.892 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -103.09 145.46 30.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.735 -178.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 5.6 Cg_exo -77.52 37.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.998 2.465 . . . . 0.0 112.689 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -122.65 -27.88 1.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.153 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 121' ' ' GLN . 3.2 p30 46.79 28.43 0.82 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.907 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -135.58 -48.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.213 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.4 m -88.66 126.85 35.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.445 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.612 ' HB ' HD12 ' A' ' 152' ' ' ILE . 18.6 mt -83.22 128.75 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.263 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.482 ' CD2' HD11 ' A' ' 123' ' ' ILE . 17.5 m-85 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.712 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 150' ' ' ASP . 57.3 t -68.13 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.423 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -131.05 -45.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -149.43 128.64 12.83 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.916 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 146' ' ' LEU . 25.9 mt -120.09 141.7 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.671 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.0 mm -77.18 174.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 135' ' ' ILE . 18.4 tt0 -92.19 133.86 35.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.96 25.22 45.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.497 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.84 -171.07 18.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -74.04 -53.65 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -69.99 -31.91 69.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -56.84 -60.92 2.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.211 0.529 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -42.42 63.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.117 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -80.85 -59.47 2.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 112.043 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.457 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -65.2 -42.13 96.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.053 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.49 21.22 11.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -96.96 85.03 3.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 169.07 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.598 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.6 mt -47.2 120.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.303 0.573 . . . . 0.0 111.429 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.46 -22.56 5.25 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.335 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.06 125.31 24.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.677 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.646 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 4.1 pttt -109.86 122.53 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -103.9 130.0 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.57 -0.53 34.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.461 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.9 164.85 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.347 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.783 HG12 HD22 ' A' ' 156' ' ' ASN . 57.4 t -115.97 101.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.783 HD22 HG12 ' A' ' 155' ' ' VAL . 63.6 m-80 70.56 -58.89 0.54 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 109.778 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.55 21.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.606 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -115.33 144.43 22.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.962 0.411 . . . . 0.0 110.983 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.97 71.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.766 HD21 ' CG2' ' A' ' 155' ' ' VAL . 1.4 pp -91.97 30.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 0.0 111.746 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.424 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.85 67.31 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 0.0 110.777 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -176.98 29.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.234 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.587 HG11 ' OD2' ' A' ' 167' ' ' ASP . 2.4 t -123.8 -75.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HA ' ' H ' ' A' ' 118' ' ' VAL . 7.1 mtm -172.13 -171.38 0.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.921 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.516 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.0 p80 -73.23 -30.31 63.39 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.078 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HG3' ' CE1' ' A' ' 165' ' ' HIS . 16.4 mt-10 -73.74 -46.94 42.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.587 ' OD2' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -66.07 -42.55 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.25 73.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.556 HG22 ' CB ' ' C' ' 7' ' ' SER . 16.9 t -74.02 -40.34 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.402 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.89 -34.53 69.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -75.84 -29.95 58.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 173' ' ' LYS . 3.6 pp -82.09 -37.33 26.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.809 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -75.03 -26.5 59.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.903 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.04 -11.5 60.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.35 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.677 ' HB ' HG21 ' A' ' 179' ' ' VAL . 38.2 p -58.61 -167.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 111.364 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' VAL . 45.2 t80 -112.8 172.15 7.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 1.1 m-20 -56.42 -15.13 3.64 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 104' ' ' ILE . 42.0 t -147.7 92.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.677 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -125.31 148.19 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.973 0.416 . . . . 0.0 111.962 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 5.5 m-85 -97.24 136.01 38.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.671 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.09 148.73 36.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 0.0 110.258 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mttp -96.84 114.55 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.581 HG21 HG13 ' A' ' 101' ' ' ILE . 15.7 t -102.03 160.16 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.914 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -116.47 145.88 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.378 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.798 0.332 . . . . 0.0 111.103 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.68 87.67 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.678 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 110' ' ' LEU . 7.2 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.862 0.363 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 161.52 41.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.727 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -179.33 150.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.233 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 7.1 tt0 -109.2 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.512 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.882 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.25 -174.1 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.082 0.467 . . . . 0.0 111.645 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 126.0 45.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.458 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.915 ' HG ' HD23 ' A' ' 15' ' ' LEU . 14.0 tp -123.62 94.49 4.26 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.703 0.764 . . . . 0.0 110.216 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.797 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.3 mp0 -68.59 161.85 27.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.687 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 12' ' ' ASN . 15.8 mtt180 -80.63 108.05 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.48 68.4 0.16 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.165 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER 78.81 -78.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.436 0.294 . . . . 0.0 110.549 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -109.53 30.71 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.79 178.01 15.31 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.552 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.915 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.41 -48.57 9.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.846 0.355 . . . . 0.0 110.979 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 97.27 76.54 1.3 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.602 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.6 p90 -160.68 152.14 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.558 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 m -95.21 126.45 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 36' ' ' ILE . 34.4 pt -132.74 160.89 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -171.33 173.74 4.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 102.61 -128.11 9.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.453 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.83 150.16 10.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -55.77 -22.41 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.292 . . . . 0.0 111.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.65 ' CB ' HG23 ' A' ' 69' ' ' THR . 11.3 t0 -92.61 -44.57 8.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.946 0.403 . . . . 0.0 111.202 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -123.89 77.61 57.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.16 128.31 22.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.587 2.192 . . . . 0.0 112.427 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 16.9 t-80 -66.7 -20.17 65.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.523 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.21 -28.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.233 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.82 27.68 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.43 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -170.6 112.85 0.44 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.42 -27.42 47.09 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.721 2.281 . . . . 0.0 112.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.7 t -67.56 141.75 56.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -89.8 151.47 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.793 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.523 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -142.61 160.94 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 110.983 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' SER . 34.6 mt -92.6 147.88 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.2 p -98.81 -41.83 7.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.63 0.253 . . . . 0.0 111.471 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HA ' HG11 ' A' ' 53' ' ' VAL . 2.2 tmtp? -167.8 152.54 6.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.367 . . . . 0.0 111.262 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.462 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -104.35 141.01 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.033 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 ' HA2' ' A' ' 16' ' ' GLY . 8.7 pt -86.11 120.99 72.85 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.199 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 83.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.113 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.02 -54.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.0 170.47 4.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.546 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.93 -17.76 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.621 0.248 . . . . 0.0 111.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . -62.13 -57.44 11.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.762 0.315 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.95 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -72.35 -38.1 68.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 5.0 m-20 -79.18 -30.54 43.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.741 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.62 48.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.524 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.882 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.62 18.89 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.019 0.409 . . . . 0.0 111.296 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 51' ' ' LEU . 2.1 pt? -176.11 167.51 2.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.96 0.41 . . . . 0.0 111.679 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 153.57 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.064 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.629 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 27.6 m -70.99 -46.49 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.0 p30 -72.8 15.52 0.19 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -80.56 -167.65 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 104.78 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.755 HG22 HG12 ' A' ' 88' ' ' VAL . 12.9 pt -59.56 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.063 0.459 . . . . 0.0 111.201 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 89' ' ' MET . 0.5 OUTLIER -61.74 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.174 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 69.6 m-85 -160.97 160.82 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.54 134.06 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.691 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.6 36.27 5.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.52 29.27 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.9 t -120.76 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 12.8 p-10 -73.74 91.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 68' ' ' VAL . 17.4 t -114.4 34.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -99.75 11.33 39.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.34 40.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 65' ' ' VAL . 29.0 m -119.39 148.61 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.163 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 1.4 m -49.91 156.86 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.336 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.422 ' CE1' ' CG2' ' A' ' 74' ' ' VAL . 3.7 t-80 -54.6 -48.61 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.603 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -57.61 -34.39 69.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.161 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.49 82.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -72.01 -42.53 66.3 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.289 0.566 . . . . 0.0 109.81 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.498 ' HA ' HD21 ' A' ' 77' ' ' LEU . 68.3 t -65.32 -36.1 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.781 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 2.9 mt-10 -69.33 -32.33 71.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.766 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.37 -42.76 74.78 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.45 0.643 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -78.04 -27.01 48.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.59 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 1.7 tttt -72.94 -37.76 67.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.312 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -103.24 26.39 8.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.634 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -103.66 -13.47 16.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.514 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -157.13 23.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.592 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.56 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -100.18 21.05 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 111.297 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.797 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.4 mt -155.28 95.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.766 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -104.78 140.16 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 112.367 -178.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.8 mtm180 -96.9 95.32 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.759 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mp -93.78 123.84 37.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -104.0 114.46 28.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 57' ' ' ILE . 28.1 m -126.01 168.58 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' HD12 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -142.39 108.97 5.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.464 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.687 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttt . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 153.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.538 ' SD ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.51 166.59 23.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 111.322 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.67 106.28 6.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.628 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -113.17 155.26 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -122.91 124.81 44.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.42 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 140' ' ' ALA . 2.7 tt -126.38 118.91 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.794 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.583 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -95.4 144.72 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -62.28 160.81 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -141.11 -159.23 7.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.886 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.35 -41.32 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.235 1.957 . . . . 0.0 112.649 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -91.73 21.73 4.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.23 -133.36 11.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.503 ' HB2' HG12 ' C' ' 9' ' ' VAL . 4.7 mp -86.61 -27.09 24.08 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.825 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.92 45.01 4.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.793 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.602 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.59 146.6 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -106.68 117.03 32.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.495 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.93 HD11 HD22 ' A' ' 172' ' ' LEU . 12.9 pt -129.54 164.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -162.29 124.93 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 111.812 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -154.65 173.42 33.08 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.106 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.81 170.67 13.38 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.473 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 119' ' ' GLY . 30.7 t -92.06 154.84 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.155 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 75.27 6.26 79.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.696 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.03 78.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.043 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -93.4 123.07 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.993 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -48.11 -29.1 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.589 0.709 . . . . 0.0 110.694 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.777 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -97.28 146.51 31.47 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.699 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.763 ' HD2' HG22 ' A' ' 123' ' ' ILE . 26.3 Cg_exo -62.93 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.564 2.176 . . . . 0.0 112.805 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.84 61.32 1.0 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.353 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.67 90.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 110.825 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' GLN . 4.0 p30 -55.82 -22.82 26.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.43 ' HA ' ' CG ' ' A' ' 161' ' ' GLU . 38.9 m -47.47 123.12 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.588 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 35.9 mt -59.58 123.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.253 0.549 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -121.23 173.53 7.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.784 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 146' ' ' LEU . 44.0 t -111.16 141.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.166 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 148' ' ' ILE . 3.3 p -102.74 -60.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 146.89 26.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.513 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.6 mt -117.14 141.64 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.4 mm -82.8 173.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.546 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.6 pt-20 -112.58 36.25 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.99 -29.13 52.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.542 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.89 51.88 0.59 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.59 -84.51 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.17 -31.79 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.233 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.7 m170 -53.47 -56.98 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -50.27 25.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.343 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.33 -59.3 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 0.0 111.696 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -55.37 -56.27 24.28 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.02 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.88 21.78 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.754 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -103.77 83.03 2.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.909 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -59.97 166.55 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.587 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' THR . 31.1 mt -47.86 121.24 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.283 0.563 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 123.02 -19.4 7.79 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.495 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -64.49 126.16 26.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.515 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -107.17 124.02 49.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.091 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 154' ' ' ALA . 1.6 mt -98.26 132.51 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.676 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.642 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -91.05 -2.04 57.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 154.58 153.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.217 0.323 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG12 ' OD1' ' A' ' 156' ' ' ASN . 15.2 t -103.52 99.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 180' ' ' TYR . 14.0 m120 68.32 -59.46 0.44 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 155' ' ' VAL . 94.4 p -171.47 31.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.292 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.6 t -134.87 148.18 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.351 0.595 . . . . 0.0 112.205 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.744 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 91.97 -76.58 1.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.806 HD13 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER 32.12 34.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.258 -0.971 . . . . 0.0 112.284 178.177 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 159' ' ' GLY . 2.2 pm0 34.37 36.88 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.011 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.806 ' OD2' HD13 ' A' ' 160' ' ' LEU . 31.1 p30 -116.14 36.24 4.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.688 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -149.71 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.943 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.01 166.41 0.93 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.531 ' O ' HG23 ' A' ' 169' ' ' VAL . 8.8 p-80 -53.98 -37.22 63.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.938 0.399 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.07 -40.42 62.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.467 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -76.02 -37.49 58.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.861 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.71 -34.99 72.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.023 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 165' ' ' HIS . 25.4 t -74.21 -43.1 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.81 69.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.145 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.11 -26.69 56.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.436 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.93 HD22 HD11 ' A' ' 114' ' ' ILE . 3.9 pp -81.41 -36.62 29.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.873 ' N ' HD12 ' A' ' 172' ' ' LEU . 11.8 tttp -72.23 -26.9 62.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.306 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -70.5 -9.46 56.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.463 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.611 ' HB ' HG21 ' A' ' 179' ' ' VAL . 16.9 p -49.2 -178.58 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.053 0.454 . . . . 0.0 112.051 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -107.56 171.4 7.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.295 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 6.4 m-20 -53.41 -18.23 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.546 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.583 HG13 HG22 ' A' ' 104' ' ' ILE . 40.1 t -147.38 91.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.494 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.611 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -116.75 147.54 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.026 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.721 ' H ' HD22 ' A' ' 156' ' ' ASN . 15.7 p90 -111.46 125.99 54.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.224 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.2 158.47 19.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 111.307 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.484 ' HB3' HD21 ' A' ' 153' ' ' LEU . 2.0 mptt -100.85 119.76 39.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.353 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.628 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -101.74 160.87 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.997 0.427 . . . . 0.0 111.419 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -126.91 133.21 50.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.56 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.44 ' OG ' HG21 ' A' ' 169' ' ' VAL . 41.4 m . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -80.61 94.31 6.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 110' ' ' LEU . 4.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 3' ' ' TYR . 13.5 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.833 0.349 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.23 153.27 35.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.537 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -170.81 159.46 6.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.475 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -110.26 137.34 48.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.632 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.524 HG22 ' NE ' ' A' ' 50' ' ' ARG . 25.3 mt -149.12 164.15 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.127 0.489 . . . . 0.0 111.418 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.589 HG23 ' HD3' ' A' ' 85' ' ' ARG . 0.3 OUTLIER -123.11 136.73 54.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.074 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.5 tp -127.19 89.19 2.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.628 0.728 . . . . 0.0 110.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' A' ' 83' ' ' ILE . 3.0 tt0 -74.72 134.79 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.244 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -57.5 104.61 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.2 -27.52 5.45 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.636 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -174.8 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -109.29 30.54 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.856 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.22 178.1 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.485 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -50.68 7.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 101.35 70.4 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.639 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.8 p90 -164.68 157.71 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -112.56 129.38 56.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.13 160.81 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.353 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.54 12.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.05 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.01 -128.68 9.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.12 147.76 10.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.592 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -52.2 -25.15 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.685 0.279 . . . . 0.0 111.468 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.598 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.9 t70 -89.77 -45.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.531 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -123.87 78.31 57.55 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.573 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.84 134.5 28.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.547 2.164 . . . . 0.0 112.277 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 38.6 t60 -71.32 -25.71 62.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.193 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.99 -28.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 26.78 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.531 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.7 31.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 110.802 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 5.0 t0 -165.4 95.84 0.84 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 11.4 Cg_endo -54.85 -22.9 31.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.414 2.076 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.72 164.62 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -106.88 146.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.43 150.13 40.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.6 mt -72.64 151.89 7.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.495 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.549 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.23 -35.45 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.644 ' HA ' HG11 ' A' ' 53' ' ' VAL . 5.5 tmmm? -169.59 152.24 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.7 mt -118.23 141.27 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.14 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 pt -85.84 141.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.062 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.27 74.13 3.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.458 2.105 . . . . 0.0 112.391 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.04 -40.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.11 176.29 1.96 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.615 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.85 -27.36 57.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.557 0.217 . . . . 0.0 111.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -47.69 -57.37 5.6 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.43 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.44 69.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.02 -37.08 69.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.312 0.577 . . . . 0.0 109.644 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' HD13 ' A' ' 8' ' ' LEU . 22.2 m-20 -82.45 -25.7 33.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.023 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 80.67 51.54 4.81 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.307 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.524 ' NE ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.84 44.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER 33.77 -153.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 150.1 46.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.058 0.456 . . . . 0.0 111.37 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.4 m -71.04 -39.67 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.492 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 53' ' ' VAL . 22.9 p30 -51.69 -14.97 0.39 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.369 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.9 p-10 -61.85 156.73 19.95 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.8 m -122.68 124.36 43.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.32 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 88' ' ' VAL . 3.7 pt -62.92 94.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -61.08 -23.42 65.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.534 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -158.79 127.09 5.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.536 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.72 133.12 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.372 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 45.78 33.52 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 13.8 tt0 67.56 32.46 5.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 18.1 t -120.92 141.78 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.19 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 98.94 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.793 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG13 ' CG2' ' A' ' 68' ' ' VAL . 21.4 t -130.24 38.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -103.48 12.55 35.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.58 38.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.683 ' CG2' HG13 ' A' ' 65' ' ' VAL . 22.2 m -115.86 145.83 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.741 ' N ' HG22 ' A' ' 23' ' ' THR . 2.5 m -49.94 161.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.757 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.512 ' ND1' HG23 ' A' ' 74' ' ' VAL . 3.4 t-80 -55.03 -48.53 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -49.79 -42.34 46.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.862 0.363 . . . . 0.0 111.391 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.18 75.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.031 0.443 . . . . 0.0 110.742 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.53 69.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.614 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 77' ' ' LEU . 41.1 t -64.48 -35.34 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.736 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.44 -34.16 74.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.764 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.43 -43.42 73.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.328 0.585 . . . . 0.0 110.482 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.25 -26.69 56.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.454 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.1 tttt -70.98 -42.86 69.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.231 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.26 31.4 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.11 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -85.05 -27.0 26.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.555 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.68 -121.46 6.38 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.579 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 83' ' ' ILE . 88.7 p -137.97 9.8 2.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -152.09 94.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.797 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -94.84 117.27 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' HG23 ' A' ' 7' ' ' THR . 1.3 tpp85 -102.75 91.07 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.718 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.3 pp -121.64 154.04 37.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 m-85 -105.04 119.37 38.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.267 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 86' ' ' LEU . 26.8 m -104.11 167.81 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.249 0.547 . . . . 0.0 112.298 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.88 109.59 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.85 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.805 0.336 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.2 t -132.17 113.12 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 183' ' ' VAL . 2.0 ttm -86.89 166.28 15.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.38 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -133.99 106.75 7.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.149 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 144' ' ' GLY . 2.8 mm -114.02 155.53 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 101' ' ' ILE . 24.7 ttmt -134.86 122.86 22.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.75 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.675 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 3.6 tt -123.25 118.35 27.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -93.75 144.5 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.547 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 177' ' ' ASP . 2.0 tptm -57.71 141.77 47.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.49 -164.4 11.92 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.949 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -43.43 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.122 1.881 . . . . 0.0 112.228 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -92.52 20.46 6.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.071 0.462 . . . . 0.0 110.115 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.29 -142.37 15.48 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 103' ' ' LEU . 9.9 mp -86.7 -21.7 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.961 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.5 47.72 6.25 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.41 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.34 152.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.2 m -116.31 124.83 51.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.55 HG22 HG22 ' A' ' 131' ' ' VAL . 20.0 pt -141.63 157.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.726 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -159.82 125.5 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.914 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.597 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.26 -175.08 25.06 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.436 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.02 -179.38 45.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.298 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.04 150.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.742 0.306 . . . . 0.0 111.208 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.74 -19.16 42.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.338 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 10.7 t-20 -179.53 70.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.034 0.445 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.3 mt-30 -71.55 -7.49 47.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.481 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 18.8 t-80 71.82 -57.09 0.62 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.521 0.676 . . . . 0.0 110.975 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -86.56 134.62 37.49 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.7 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.68 77.18 2.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.448 2.098 . . . . 0.0 112.606 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.01 46.55 0.55 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.92 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -172.95 96.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.26 -21.4 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 p -55.26 129.73 39.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.322 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.713 HD11 ' HA3' ' A' ' 159' ' ' GLY . 39.2 mt -66.19 130.84 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 111.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.85 ' CD1' HD11 ' A' ' 123' ' ' ILE . 2.4 m-85 -123.86 166.73 15.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.334 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 68.8 t -101.9 155.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.377 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 148' ' ' ILE . 10.5 p -115.19 -58.99 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.578 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.18 148.7 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 147' ' ' GLN . 16.2 mt -132.14 141.68 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.8 mm -79.75 174.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.62 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.659 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 mt-10 -93.91 151.01 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.53 25.15 54.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -77.06 -169.14 30.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.93 -62.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.381 . . . . 0.0 111.306 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.874 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.15 -31.78 69.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.324 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -58.75 -48.69 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -72.58 -49.41 32.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.883 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.23 -59.39 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.853 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.96 -33.71 87.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.963 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.84 14.65 9.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.874 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -73.37 144.57 46.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.67 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.7 ' HA ' HD12 ' A' ' 134' ' ' ILE . 7.0 mt-30 -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.072 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 132' ' ' THR . 25.8 mt -49.28 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.802 0.811 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 141.83 -17.9 2.58 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.431 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -67.07 120.21 13.3 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.163 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -105.43 119.77 39.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.946 0.403 . . . . 0.0 111.475 -178.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 181' ' ' LEU . 1.8 mt -92.77 129.75 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.363 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.5 pp -87.08 -0.59 56.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 152' ' ' ILE . . . 166.0 153.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.059 0.224 . . . . 0.0 110.66 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.777 HG11 ' HB3' ' A' ' 172' ' ' LEU . 25.3 t -108.5 99.61 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 72.3 m-80 73.24 -59.84 0.55 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.8 t -169.96 23.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.377 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 171' ' ' ALA . 2.3 t -135.91 155.24 35.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.714 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.713 ' HA3' HD11 ' A' ' 129' ' ' ILE . . . 89.06 -6.9 83.26 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.828 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -68.61 23.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.626 0.77 . . . . 0.0 111.445 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 159' ' ' GLY . 24.0 mt-10 71.31 54.0 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.28 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.873 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -157.18 -83.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.052 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.9 mtm 166.92 162.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.1 t-160 -53.77 -30.22 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.022 0.439 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -41.16 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.068 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -76.22 -33.88 59.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' HA2' ' A' ' 159' ' ' GLY . . . -70.06 -38.18 75.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' HIS . 39.5 t -74.23 -41.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.484 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.15 62.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.334 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.746 ' HB2' HG11 ' A' ' 158' ' ' VAL . . . -72.12 -43.44 64.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.3 pp -67.86 -36.56 80.51 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.866 ' N ' HD12 ' A' ' 172' ' ' LEU . 9.2 ttpp -75.3 -26.09 58.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.469 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -56.37 -48.6 76.52 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.4 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -45.63 -52.45 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.118 0.485 . . . . 0.0 110.663 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 2.3 t80 66.7 107.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.888 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t0 82.38 -23.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.895 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.15 93.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.623 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.556 HG22 ' OG1' ' A' ' 175' ' ' THR . 2.2 t -107.06 148.43 11.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.107 0.479 . . . . 0.0 111.008 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -124.0 135.83 53.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.975 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.77 136.67 46.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.965 0.412 . . . . 0.0 111.338 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.83 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 184' ' ' ALA . 9.2 t -101.79 162.88 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.513 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.53 134.68 34.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.991 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.711 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.71 103.18 14.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.16 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.838 0.351 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -104.59 178.12 4.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -170.72 155.5 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.014 0.435 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -151.72 100.97 2.73 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.683 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -125.87 -171.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 112.133 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.48 125.17 28.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.882 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.4 tp -116.68 94.76 4.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 111.048 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -69.53 141.2 53.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.511 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 101.03 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.969 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.9 -26.63 8.63 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.446 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.89 -84.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -109.14 30.54 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.819 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.84 -179.76 20.98 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.314 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.36 -50.52 7.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.603 0.24 . . . . 0.0 111.397 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.41 30.29 3.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.147 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 3.5 p90 -123.03 147.96 46.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.368 0.584 . . . . 0.0 110.646 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.6 m -108.03 126.79 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.339 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.407 HG22 HG12 ' A' ' 36' ' ' ILE . 2.3 pt -106.97 171.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.865 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.74 139.89 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.39 -121.99 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.62 140.0 7.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.326 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.635 HG22 ' CA ' ' A' ' 69' ' ' THR . 1.6 t -54.35 -21.6 9.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.256 . . . . 0.0 111.534 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.5 m-20 -82.09 -56.94 3.63 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -123.74 86.55 53.0 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.394 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.0 129.93 19.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.78 2.32 . . . . 0.0 112.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -61.66 -20.43 63.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.586 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -105.63 -41.86 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.01 0.433 . . . . 0.0 110.843 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.39 24.99 5.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.542 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.49 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 14.3 t70 -158.26 98.34 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.776 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 13.7 Cg_endo -56.52 -29.94 80.48 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.413 2.076 . . . . 0.0 112.001 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -71.06 164.64 25.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.699 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.3 mt -109.17 155.81 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.34 166.7 23.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 42.6 mt -96.07 154.71 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.584 ' O ' HG21 ' A' ' 53' ' ' VAL . 19.0 p -108.7 -42.46 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.47 150.8 9.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 1.1 mt -108.96 141.52 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.4 mt -84.2 127.81 64.96 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.087 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.1 Cg_exo -65.18 66.9 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.525 2.15 . . . . 0.0 112.254 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.31 -52.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.436 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.68 -178.31 2.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.423 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -75.86 -20.77 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.31 -57.31 13.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -28.04 69.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.05 -43.44 64.92 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.572 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 4.8 t0 -74.39 -31.27 62.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.874 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.83 48.54 0.02 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.425 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.683 ' HG3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -95.83 18.63 12.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.7 pt? -175.06 179.81 1.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.995 0.426 . . . . 0.0 111.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 152.71 22.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.341 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 37' ' ' THR . 28.0 m -70.95 -38.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.031 0.443 . . . . 0.0 112.17 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -72.66 15.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.562 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -80.11 -158.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 100.61 3.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.758 0.314 . . . . 0.0 110.991 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.88 HG12 HG13 ' A' ' 60' ' ' VAL . 3.0 tp -61.97 95.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 110.717 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.527 HD23 ' CG ' ' A' ' 89' ' ' MET . 3.2 pp -70.1 -22.63 63.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -160.06 130.77 5.64 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.457 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.88 HG13 HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -113.31 117.68 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.167 178.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.615 HD21 HG12 ' A' ' 84' ' ' VAL . 6.9 m-20 46.57 37.82 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 69.44 30.92 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.87 125.86 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -45.85 125.71 6.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.358 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 57' ' ' ILE . 14.2 p -153.12 23.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -94.91 11.76 30.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.354 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 174.82 46.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.981 0.42 . . . . 0.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -111.12 138.07 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.302 0.573 . . . . 0.0 111.983 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.635 ' CA ' HG22 ' A' ' 23' ' ' THR . 0.1 OUTLIER -50.74 166.23 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.607 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -56.14 -48.55 76.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.062 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -56.2 -42.51 77.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . . . -62.1 -33.87 75.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.534 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.51 68.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 109.521 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 77' ' ' LEU . 50.5 t -64.75 -35.83 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.572 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 -33.34 72.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.832 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.26 -43.74 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.315 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.71 -26.77 57.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.459 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -71.89 -43.23 65.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.179 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -105.62 31.21 5.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.164 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -80.27 -28.65 38.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.526 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.95 -103.7 3.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.6 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 74.6 m -151.75 -52.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 18.2 mt -100.82 85.1 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.839 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 6.8 m -85.26 116.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.901 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -75.28 84.56 2.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.795 ' CD2' HG12 ' A' ' 60' ' ' VAL . 22.4 mt -85.13 139.45 31.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.519 0.676 . . . . 0.0 112.459 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 2.3 m-85 -124.01 114.51 19.84 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.802 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.9 m -125.53 168.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.527 ' CG ' HD23 ' A' ' 58' ' ' LEU . 25.4 mtm -127.87 108.99 11.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.244 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.282 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.857 0.36 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.544 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -121.9 154.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 98' ' ' VAL . 7.6 tpt -134.55 164.31 27.77 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.02 106.63 12.62 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 183' ' ' VAL . 2.0 mm -120.5 155.66 23.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 180' ' ' TYR . 2.4 mtmp? -115.38 123.26 48.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.358 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.763 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.5 tt -123.0 118.57 28.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.701 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.64 144.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.24 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 153.14 26.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.955 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 -177.88 15.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.842 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.48 -31.64 21.38 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.063 1.842 . . . . 0.0 112.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -96.79 19.78 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.042 0.449 . . . . 0.0 110.422 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.58 -153.06 17.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.488 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 mp -86.46 -14.99 41.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.66 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 83.73 50.66 4.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.901 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.7 155.02 0.79 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.5 m -113.97 116.97 30.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.563 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 172' ' ' LEU . 7.0 pt -132.79 155.1 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.4 125.04 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.061 0.457 . . . . 0.0 111.99 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.622 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.66 -175.13 25.44 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.273 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 -168.91 40.52 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.126 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 39.4 t -84.51 145.04 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.53 -25.28 16.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.1 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.61 70.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 0.0 109.738 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -72.55 -5.98 40.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.633 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.527 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 17.5 t-80 72.04 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.607 0.718 . . . . 0.0 110.561 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.949 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.4 mt -84.04 144.21 44.05 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.603 ' HD2' HG22 ' A' ' 123' ' ' ILE . 15.8 Cg_exo -67.91 63.32 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.548 2.166 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.08 62.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -170.36 96.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.988 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -23.72 19.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.18 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 t -55.49 143.79 28.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.03 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.895 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -84.33 119.46 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.354 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.949 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.5 m-85 -114.93 155.08 27.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.175 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 114' ' ' ILE . 46.1 t -85.99 155.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.439 ' N ' HG12 ' A' ' 131' ' ' VAL . 11.7 p -116.03 -57.3 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -152.65 150.04 29.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.258 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.679 HD11 ' O ' ' A' ' 146' ' ' LEU . 8.0 mt -130.27 141.63 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.054 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -75.98 173.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.611 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.98 138.09 35.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.67 27.2 73.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.548 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.06 -173.35 47.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -79.8 -58.18 3.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 111.168 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.568 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -63.93 -31.79 73.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -57.3 -62.18 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -72.94 -38.67 66.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.999 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.43 -59.37 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 112.029 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -72.24 -43.49 46.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.077 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.68 18.64 11.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.309 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.679 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -85.96 79.59 9.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.3 pt20 -60.47 171.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 29.5 mt -48.14 127.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 118.43 -25.63 8.08 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.346 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -58.52 151.07 21.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.748 0.309 . . . . 0.0 110.713 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -138.1 124.45 20.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.147 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.2 130.25 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.627 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.7 OUTLIER -100.08 -0.98 37.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.322 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.22 155.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.875 0.369 . . . . 0.0 111.334 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 158' ' ' VAL . 21.5 t -111.07 99.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.023 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.544 HD22 HG12 ' A' ' 155' ' ' VAL . 67.3 m-80 69.24 -59.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.267 0.556 . . . . 0.0 109.694 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.4 t -164.07 27.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.229 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.7 t -101.05 155.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.391 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -116.38 77.13 0.27 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.417 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.895 HD22 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.99 24.8 0.49 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -137.14 31.17 2.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.164 0.507 . . . . 0.0 110.763 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.67 27.71 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.059 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -137.61 -76.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.375 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.447 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 2.7 mtm 172.56 165.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.461 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 p-80 -53.95 -29.67 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.897 0.38 . . . . 0.0 110.467 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.42 -46.16 50.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.382 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.745 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.69 -37.36 73.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.608 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.38 -38.72 74.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.837 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' C' ' 7' ' ' SER . 9.9 t -70.36 -41.57 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.382 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.75 -31.31 66.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.077 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.05 -27.23 57.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.657 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.0 pp -81.74 -37.33 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.851 0.358 . . . . 0.0 110.317 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.927 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -75.37 -26.54 58.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.714 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.09 -9.79 59.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 179' ' ' VAL . 78.2 p -52.04 -178.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.947 0.403 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.1 t80 -100.97 167.1 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.327 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.4 t70 -50.66 -24.85 3.63 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.214 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.408 HG13 HG22 ' A' ' 104' ' ' ILE . 43.0 t -147.75 92.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -113.71 148.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.26 125.97 38.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.787 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.99 145.09 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 111.332 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.3 mttt -96.38 112.29 24.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.085 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 152' ' ' ILE . 21.8 t -102.64 162.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.321 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.523 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -121.0 133.15 55.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.122 0.487 . . . . 0.0 110.918 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.343 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.633 ' HB2' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.584 ' O ' HG13 ' C' ' 9' ' ' VAL . 96.5 p -97.83 84.33 3.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.584 HG13 ' O ' ' C' ' 8' ' ' SER . 3.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -109.71 128.88 55.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.393 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -177.73 172.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 111.618 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 1.5 pm0 -90.08 150.48 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' A' ' 50' ' ' ARG . 8.1 mt -144.18 153.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.281 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -116.91 125.67 51.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.005 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.5 tp -127.05 91.43 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.556 0.693 . . . . 0.0 110.361 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.855 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -77.27 163.16 26.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.786 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -69.56 97.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -56.04 -23.47 39.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.592 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -175.28 -85.35 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -109.11 30.53 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.808 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.06 177.73 15.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.358 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.921 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.38 -44.83 13.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.804 0.335 . . . . 0.0 111.195 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 90.39 77.15 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.783 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -163.33 155.55 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.788 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.1 t -111.97 126.85 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.723 HG22 HG12 ' A' ' 36' ' ' ILE . 11.1 pt -120.54 163.93 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.883 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.35 156.94 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 126.28 -126.07 5.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.537 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.45 132.53 5.18 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.744 HG22 ' N ' ' A' ' 69' ' ' THR . 1.6 t -48.46 -26.97 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.317 . . . . 0.0 111.345 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.739 ' CB ' HG23 ' A' ' 69' ' ' THR . 27.1 t70 -87.46 -44.31 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -123.77 78.75 56.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.82 134.13 40.85 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.665 2.244 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.414 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 15.8 t-80 -69.32 -22.93 63.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.18 -30.73 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 27.81 10.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.661 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -172.67 33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.78 111.04 0.47 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 17.0 Cg_exo -67.26 -30.14 37.85 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.716 2.277 . . . . 0.0 112.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.56 129.27 39.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 152.3 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.3 165.13 28.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.702 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.723 HG12 HG22 ' A' ' 19' ' ' ILE . 43.1 mt -94.2 153.79 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.497 ' O ' HG21 ' A' ' 53' ' ' VAL . 15.9 p -106.93 -44.53 4.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.726 0.298 . . . . 0.0 111.494 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.927 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -156.59 152.5 27.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 111.39 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -111.01 141.27 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.822 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.26 135.83 36.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.081 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.82 57.25 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.261 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.09 -53.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.69 -174.83 0.85 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.465 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.595 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.03 -29.64 58.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -47.47 -51.04 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.324 . . . . 0.0 111.49 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.2 67.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -72.2 -38.97 68.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.749 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -81.56 -31.11 32.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.729 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.56 47.19 0.01 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.503 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -99.15 22.64 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.997 0.399 . . . . 0.0 110.98 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -168.84 -178.14 3.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HB2' ' HG3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -120.49 171.5 8.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.927 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.7 m -71.44 -46.67 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 53' ' ' VAL . 13.0 m120 -69.39 11.52 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.529 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.2 p-10 -67.86 -179.74 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -135.75 100.35 4.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.709 0.29 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.644 HG22 HG12 ' A' ' 88' ' ' VAL . 5.1 pt -61.25 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.414 0.626 . . . . 0.0 110.994 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 89' ' ' MET . 4.3 mt -66.85 -24.77 66.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.596 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -160.75 155.53 23.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.892 HG12 ' HB ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -129.66 -176.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.209 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.679 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -41.64 78.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.927 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.6 tt0 63.76 21.71 12.78 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.208 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.892 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.2 t -121.44 141.99 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 0.0 111.678 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.37 82.29 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.321 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' HG22 ' A' ' 68' ' ' VAL . 9.4 m -94.72 31.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.583 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.85 -4.39 59.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.345 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 20.0 pt-20 176.64 56.66 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.033 0.444 . . . . 0.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 65' ' ' VAL . 30.5 m -118.69 142.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.748 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.744 ' N ' HG22 ' A' ' 23' ' ' THR . 1.2 m -50.2 161.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.631 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.513 ' ND1' HG23 ' A' ' 74' ' ' VAL . 3.2 t-80 -53.76 -48.59 69.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.554 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -49.92 -43.72 49.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.06 73.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.61 69.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.604 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 77' ' ' LEU . 40.0 t -64.4 -35.87 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.644 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.49 -33.74 73.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -69.57 -43.12 73.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.396 0.617 . . . . 0.0 110.555 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -76.28 -26.74 56.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.486 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -71.16 -42.53 68.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.196 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -104.16 29.77 5.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.379 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -85.33 -25.78 26.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.435 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.64 -137.36 20.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.488 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 83' ' ' ILE . 35.8 m -121.91 16.43 10.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.572 0.225 . . . . 0.0 111.346 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.855 HG23 ' HG2' ' A' ' 9' ' ' GLU . 1.6 mt -152.17 92.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.2 t -87.22 149.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 111.921 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -137.98 84.86 2.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.723 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.711 HD13 HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -116.67 154.21 30.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.2 t80 -105.66 114.93 29.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.686 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.711 HG13 HD13 ' A' ' 86' ' ' LEU . 10.8 m -121.37 167.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 58' ' ' LEU . 1.1 ttp -121.08 109.61 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.959 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.927 0.394 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.727 HG13 HD21 ' A' ' 153' ' ' LEU . 11.2 t -109.19 154.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.0 mmm -128.86 166.68 18.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.236 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -127.86 106.45 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 183' ' ' VAL . 1.8 mm -118.07 155.31 20.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.619 . . . . 0.0 112.606 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -111.93 126.91 55.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.062 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 1.4 tt -129.91 118.72 22.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.809 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.97 144.74 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -80.0 156.93 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.998 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 -174.01 13.46 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.86 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.74 -39.72 6.2 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.035 1.823 . . . . 0.0 112.063 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -95.21 22.75 6.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.66 -165.61 12.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.63 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 103' ' ' LEU . 1.4 mp -80.85 -13.49 58.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.175 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 86.17 51.84 3.43 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.829 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.94 149.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.665 0.269 . . . . 0.0 110.75 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.442 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 17.0 m -115.31 116.92 29.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.798 0.332 . . . . 0.0 110.674 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.626 ' CG1' HD22 ' A' ' 172' ' ' LEU . 5.5 pt -127.47 152.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.91 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -143.49 125.02 14.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.802 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.65 -175.06 25.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.915 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.62 134.71 8.54 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -59.24 153.13 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.58 -32.13 6.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 178.48 76.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 171.61 7.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.103 0.477 . . . . 0.0 110.924 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 21.5 t-80 -49.8 -50.54 44.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.071 0.938 . . . . 0.0 110.516 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.925 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -96.58 129.63 32.61 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.836 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.14 78.47 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.307 2.005 . . . . 0.0 112.593 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.47 37.57 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.938 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.33 95.16 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.956 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -52.13 -25.18 8.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.2 m -54.45 115.9 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.802 HG12 ' HA3' ' A' ' 116' ' ' GLY . 11.7 mt -61.8 120.53 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.925 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -111.98 156.97 21.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.317 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.6 t -87.95 153.32 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.823 0.344 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.678 HG22 ' CD2' ' A' ' 122' ' ' HIS . 11.6 p -115.54 -58.04 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 147.69 23.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.016 0.436 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.798 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.2 mt -125.32 141.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.18 173.44 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -90.35 147.24 23.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.82 55.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.44 174.33 53.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.809 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.16 -50.17 50.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.422 . . . . 0.0 111.111 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.369 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -54.87 -54.82 37.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -72.87 -51.96 16.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.053 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.56 -59.36 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 111.85 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -51.6 -52.1 35.12 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.133 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 60.88 19.81 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -98.57 78.48 2.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.01 174.26 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.703 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 30.0 mt -48.06 132.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.172 0.51 . . . . 0.0 111.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 112.66 -28.36 9.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.251 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -61.16 145.3 51.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.672 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -132.65 136.85 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.66 132.4 52.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.713 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -101.45 -1.65 32.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 182' ' ' LYS . . . 173.97 162.98 0.18 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.967 0.413 . . . . 0.0 111.283 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 156' ' ' ASN . 25.6 t -117.67 99.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.143 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.64 HD22 HG12 ' A' ' 155' ' ' VAL . 65.4 m-80 69.2 -59.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.309 0.576 . . . . 0.0 109.817 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.45 26.77 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.353 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 6.3 t -109.23 154.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.26 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.37 76.88 0.26 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -80.26 24.01 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.72 58.01 1.56 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.1 29.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.543 HG11 ' CG ' ' A' ' 167' ' ' ASP . 2.4 t -136.61 -74.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.3 mtm -174.45 -170.3 0.5 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.453 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' VAL . 70.0 t60 -70.86 -32.87 70.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.943 0.401 . . . . 0.0 110.589 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.79 -46.7 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.543 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.77 -35.14 69.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.28 -39.01 75.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.315 0.579 . . . . 0.0 109.463 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.85 ' HA ' HD23 ' A' ' 172' ' ' LEU . 12.6 t -73.65 -39.95 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.48 71.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.03 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 160' ' ' LEU . . . -78.17 -25.68 47.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.929 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -81.05 -40.71 23.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.51 59.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.19 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -12.33 32.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.416 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.53 147.52 0.84 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 111.587 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.2 t80 -86.13 169.54 13.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.419 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 3.2 t70 -46.77 -30.81 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.079 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 104' ' ' ILE . 41.8 t -147.91 91.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.649 0.261 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -123.83 148.4 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.433 . . . . 0.0 111.734 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.3 m-85 -98.34 128.32 44.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.421 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.54 152.67 28.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 -179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 154' ' ' ALA . 9.6 mttt -96.56 118.7 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -102.35 161.26 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.352 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -125.92 136.26 52.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.739 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.463 ' CB ' HD21 ' A' ' 172' ' ' LEU . 6.1 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -90.96 100.26 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.44 HG23 ' OXT' ' C' ' 9' ' ' VAL . 4.6 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.102 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.821 0.344 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.92 163.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.567 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -174.86 162.17 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.376 . . . . 0.0 111.259 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 6.0 pt-20 -95.97 147.47 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 7' ' ' THR . 27.0 mt -146.78 165.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -129.74 147.17 51.49 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.198 0.523 . . . . 0.0 111.835 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.832 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.51 87.33 2.31 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.412 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -79.81 118.85 21.97 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.251 179.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -41.78 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.69 -26.65 8.05 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.591 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.28 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.31 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -109.23 30.69 6.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.24 177.98 24.72 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.716 -1.23 . . . . 0.0 112.809 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.26 -47.33 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.499 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.09 62.14 1.02 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.827 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.6 p90 -165.13 169.19 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 111.351 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -119.56 126.76 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.535 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.0 pt -116.45 157.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.241 0.544 . . . . 0.0 111.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.71 148.09 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.502 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.7 16.9 2.41 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.585 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -47.06 173.46 0.02 OUTLIER Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.488 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.806 HG22 ' N ' ' A' ' 69' ' ' THR . 1.8 t -77.56 -35.7 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.701 ' CB ' HG23 ' A' ' 69' ' ' THR . 5.3 t0 -86.38 -42.44 13.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.334 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -123.86 77.25 57.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.429 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.49 171.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.619 2.213 . . . . 0.0 112.275 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.2 t-80 -111.57 -21.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.339 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.94 -25.82 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 29.52 7.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.381 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.62 40.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 108.48 2.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.837 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 16.8 Cg_exo -67.43 -22.32 45.53 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -82.92 136.81 34.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -82.68 145.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.219 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.537 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.7 p90 -142.17 142.95 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.568 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 18' ' ' SER . 33.9 mt -69.75 146.87 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 53' ' ' VAL . 3.0 m -101.26 -33.87 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.728 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -172.24 143.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.291 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -107.24 141.45 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.137 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.47 135.13 41.41 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 63.72 4.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.48 -43.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.06 178.5 1.87 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.18 -19.76 58.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -52.92 -57.55 9.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.934 0.397 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.5 69.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.903 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -72.02 -35.02 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.575 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.43 -20.19 25.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.454 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 80.26 1.0 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.613 HH22 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -88.3 22.02 2.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 52' ' ' ARG . 3.2 pp 36.7 -154.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.11 128.72 38.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 111.158 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 38' ' ' LYS . 26.4 m -57.77 -41.61 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.229 0.538 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 53' ' ' VAL . 2.1 m-80 -50.45 -17.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.944 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 33.8 p-10 -57.67 150.43 19.5 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -121.7 129.8 53.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -65.82 94.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.1 mt -58.47 -26.89 63.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -162.93 145.45 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.563 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.0 OUTLIER -108.3 -176.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.376 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.4 m120 -21.78 -52.35 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.943 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.63 25.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.7 t -121.58 142.06 39.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.529 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 8.0 p-10 -79.61 87.13 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.6 m -94.09 30.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.75 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -82.66 2.03 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.862 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.98 58.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG21 HG12 ' A' ' 65' ' ' VAL . 34.9 m -118.61 142.8 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.715 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.806 ' N ' HG22 ' A' ' 23' ' ' THR . 5.4 m -49.81 161.94 0.21 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.126 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.517 ' CE1' HG21 ' A' ' 74' ' ' VAL . 2.4 t-80 -60.34 -48.61 81.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.301 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -37.99 81.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.48 76.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.05 -43.13 65.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.968 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.6 t -64.63 -35.71 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.912 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.53 -33.35 72.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.863 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -43.03 74.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -77.11 -26.76 53.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.538 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -72.51 -41.1 66.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.399 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 28.45 6.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.878 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -96.63 -19.13 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.512 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.94 -159.29 16.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.862 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -99.75 10.09 41.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.619 0.247 . . . . 0.0 111.464 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -152.93 94.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG12 ' CB ' ' A' ' 80' ' ' ALA . 26.9 m -90.64 134.89 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 7' ' ' THR . 3.6 mmt180 -116.7 102.11 9.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -128.82 154.25 46.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.404 0.621 . . . . 0.0 112.546 -178.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -103.77 115.27 30.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.677 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 57' ' ' ILE . 34.4 m -104.22 167.94 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 112.388 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.4 ttp -126.0 109.62 12.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.844 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.134 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.833 0.349 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 98' ' ' VAL . 15.0 p -84.66 114.48 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.53 166.69 11.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 111.861 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -135.49 106.5 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.4 mm -114.14 155.27 15.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 3.7 mttp -114.2 120.93 42.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.364 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -119.52 118.75 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.369 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -95.14 144.68 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.967 0.413 . . . . 0.0 111.226 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -58.79 151.65 20.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.135 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.93 160.16 23.21 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.646 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -40.54 80.51 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 C-N-CA 122.119 1.879 . . . . 0.0 112.129 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.71 19.69 9.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.05 0.452 . . . . 0.0 110.101 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.4 -144.57 16.0 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 103' ' ' LEU . 8.5 mp -86.56 -20.06 28.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.084 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.33 61.51 3.89 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.92 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 145.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.8 t -109.98 117.4 33.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.832 HD11 HD22 ' A' ' 172' ' ' LEU . 6.3 pt -130.87 154.66 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.65 125.0 10.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 111.755 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.54 -175.01 25.2 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.516 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.4 -164.17 54.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.195 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.46 150.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 111.149 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.21 -30.51 7.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.973 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -164.66 69.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.053 0.454 . . . . 0.0 109.897 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.9 mt-30 -67.1 -11.24 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.655 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 18.4 t-80 72.43 -54.68 0.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.65 0.738 . . . . 0.0 110.944 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -92.38 138.14 24.28 Favored Pre-proline 0 C--N 1.31 -1.117 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.741 -179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.2 Cg_endo -73.54 60.94 4.3 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.356 2.037 . . . . 0.0 112.563 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 130.74 55.87 0.09 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -175.55 96.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -57.85 -22.13 46.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -58.33 141.92 49.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 160' ' ' LEU . 14.9 mt -74.65 127.66 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 111.249 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.823 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.9 m-85 -122.4 146.52 47.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.2 t -76.93 155.59 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.434 ' N ' HG12 ' A' ' 131' ' ' VAL . 6.9 p -119.62 -59.18 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.07 146.69 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.924 0.393 . . . . 0.0 111.157 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 147' ' ' GLN . 17.1 mt -134.4 141.49 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.74 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.672 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.1 mt-10 -97.0 153.17 18.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 52.59 31.2 36.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.738 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.36 -167.97 39.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.697 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.02 -60.92 2.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -68.3 -31.94 71.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.273 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.07 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.212 0.529 . . . . 0.0 110.009 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -72.82 -52.99 12.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.772 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.6 -59.24 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.794 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.449 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -52.63 -53.34 33.04 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.068 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 64.98 16.46 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.019 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.507 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.05 78.46 4.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.518 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.8 pt20 -61.14 175.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.3 mt -47.94 129.9 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 115.48 -27.04 8.67 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.297 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -64.09 138.33 58.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 110.546 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.695 ' CE ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -126.83 131.31 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.037 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.639 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.51 134.56 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.884 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -100.82 -1.92 33.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.923 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.15 163.71 0.38 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 158' ' ' VAL . 25.2 t -119.46 99.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.224 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.498 ' ND2' HG12 ' A' ' 155' ' ' VAL . 66.9 m-80 69.82 -59.91 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.395 0.617 . . . . 0.0 109.762 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -164.75 27.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.17 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.1 t -108.47 154.55 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.295 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.45 77.1 0.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.93 24.44 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.194 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -132.09 30.97 4.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.173 0.511 . . . . 0.0 110.905 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -141.98 28.44 1.73 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.272 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.702 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.5 t -139.93 -78.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.383 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtp -179.14 -169.74 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 169' ' ' VAL . 17.0 t60 -70.43 -31.59 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.494 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -47.57 39.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.702 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -69.96 -37.12 75.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.84 0.352 . . . . 0.0 110.642 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 160' ' ' LEU . . . -70.14 -38.8 75.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.237 0.542 . . . . 0.0 109.634 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 13.1 t -72.28 -39.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.428 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.74 -29.73 64.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.016 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.54 55.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.1 pp -81.7 -37.87 26.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -74.96 -26.44 59.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -15.24 53.29 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.602 ' HB ' HG21 ' A' ' 179' ' ' VAL . 25.3 p -50.11 -178.74 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.735 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.493 ' CD1' HG13 ' A' ' 179' ' ' VAL . 9.0 p90 -132.46 -160.41 1.05 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.733 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 6.3 t0 -53.37 -34.79 59.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.427 ' O ' ' CZ ' ' A' ' 176' ' ' TYR . 35.2 t -147.86 92.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 0.0 111.596 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.602 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.5 OUTLIER -111.01 131.38 62.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.054 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 10.2 p90 -94.05 124.47 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -109.58 153.87 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 111.374 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.56 ' O ' HG22 ' A' ' 152' ' ' ILE . 1.1 mptm? -96.93 110.91 23.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.608 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 152' ' ' ILE . 12.8 t -102.21 159.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.695 ' HB3' ' CE ' ' A' ' 151' ' ' LYS . . . -140.74 145.24 36.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.54 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 mttt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.63 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.821 0.343 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -86.49 116.4 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.117 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.794 0.331 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.27 178.7 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.414 ' HB2' ' NH2' ' A' ' 90' ' ' ARG . 5.7 tt0 -174.04 142.81 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.472 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 8.6 pt-20 -108.86 111.47 23.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.744 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -120.29 -169.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.168 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -140.82 133.36 28.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -113.29 88.93 2.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 111.067 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -82.54 116.79 22.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.377 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -40.63 95.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.406 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.15 -26.87 6.68 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.828 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -169.65 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -109.17 30.66 6.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.82 177.41 23.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.984 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.781 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.28 -45.77 12.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.251 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' CA ' HD11 ' A' ' 40' ' ' ILE . . . 89.54 64.27 1.27 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.682 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.54 ' HD2' ' HB2' ' A' ' 45' ' ' ALA . 10.1 p90 -164.9 146.38 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.0 110.784 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.721 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -96.01 165.3 12.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.0 pt -152.96 159.63 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.82 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.22 154.95 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.225 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.49 -127.45 6.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.9 144.31 8.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -57.91 -20.01 33.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.349 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 69' ' ' THR . 19.3 t70 -94.34 -42.1 9.08 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.696 0.284 . . . . 0.0 111.085 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -123.76 77.59 56.82 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -47.46 129.4 16.42 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.715 2.276 . . . . 0.0 112.477 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 35' ' ' PHE . 78.6 t60 -57.22 -72.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.078 0.466 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.475 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -55.9 -42.0 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.551 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.36 23.63 5.07 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.444 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.28 29.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 2.4 m-20 -160.43 103.44 1.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.813 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.8 Cg_endo -55.89 -26.08 56.11 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.465 2.11 . . . . 0.0 111.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -66.71 147.94 52.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -94.28 151.74 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 111.288 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -142.39 158.07 44.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.717 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 18' ' ' SER . 65.4 mt -77.03 148.65 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.31 -30.05 10.38 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.514 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.736 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.64 146.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -116.45 141.11 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.448 HD11 ' CA ' ' A' ' 16' ' ' GLY . 2.7 pt -89.65 139.45 27.96 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.17 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.93 64.25 7.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.564 2.176 . . . . 0.0 112.414 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.14 -41.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.14 177.35 15.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -75.95 -20.94 57.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.404 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -52.96 -57.28 10.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.944 0.402 . . . . 0.0 110.942 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.76 -28.32 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.87 -40.28 69.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.23 0.538 . . . . 0.0 109.605 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD2' HD13 ' A' ' 8' ' ' LEU . 20.4 m-20 -80.55 -20.22 43.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.333 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.54 83.85 0.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.443 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.657 ' NH2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -89.37 13.8 12.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.72 0.295 . . . . 0.0 111.16 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.832 HD22 ' HG3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER 64.42 -163.68 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.392 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.86 146.85 20.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 111.281 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.736 HG11 ' HA ' ' A' ' 38' ' ' LYS . 6.6 m -63.18 -42.55 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.576 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 m120 -52.36 -11.81 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.44 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.405 ' CB ' ' HB3' ' A' ' 90' ' ' ARG . 35.3 p-10 -63.55 152.56 38.32 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 p -119.04 120.22 36.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.009 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.625 HG22 HG12 ' A' ' 88' ' ' VAL . 2.6 pt -60.83 94.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.575 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -60.7 -26.28 67.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.907 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.654 ' HD2' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -164.87 140.1 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.381 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -125.13 118.87 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.44 -76.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.9 tt0 -160.44 30.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 17.7 t -120.82 140.73 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.27 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 5.3 p-10 -79.71 107.97 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 65' ' ' VAL . 24.1 t -125.57 39.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -95.51 -2.07 49.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -175.77 49.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.172 0.51 . . . . 0.0 109.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.598 ' CG2' HG13 ' A' ' 65' ' ' VAL . 35.2 m -115.96 142.35 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.638 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.678 ' CG2' HG22 ' A' ' 23' ' ' THR . 66.7 p -49.65 161.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.839 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.01 -48.71 80.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -58.78 -40.8 85.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.37 68.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.46 69.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.59 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 77' ' ' LEU . 39.8 t -64.92 -35.3 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.469 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 37.6 tp10 -69.47 -33.51 73.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.763 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.57 73.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -74.77 -26.41 59.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.387 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.76 -41.41 83.37 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.157 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.55 28.24 7.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.688 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.37 -24.74 23.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.36 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.57 -160.49 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.909 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 68.3 m -97.34 -36.54 10.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 9' ' ' GLU . 9.0 mt -112.87 85.1 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 84' ' ' VAL . 17.7 m -90.61 115.15 29.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.091 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.441 ' CG ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -91.28 101.25 13.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -117.28 154.28 31.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.51 114.99 28.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.328 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 57' ' ' ILE . 32.3 m -104.38 159.91 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.195 0.522 . . . . 0.0 112.229 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 109.66 15.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.658 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.832 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.4 t -123.61 136.33 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.54 166.64 15.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 111.431 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.97 106.41 6.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 183' ' ' VAL . 3.5 mm -114.53 155.21 15.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -108.89 123.73 49.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.226 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.788 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.1 tt -126.14 118.57 25.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.755 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.663 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.46 144.65 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.66 155.77 25.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.66 178.11 18.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.892 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.93 -31.25 38.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.103 1.869 . . . . 0.0 112.006 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -96.89 19.68 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.76 -156.36 16.55 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.539 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 HD22 ' A' ' 103' ' ' LEU . 6.3 mp -86.5 -13.27 46.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.12 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 81.24 49.45 5.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.978 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.2 154.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.808 0.337 . . . . 0.0 111.079 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.2 t -116.84 116.64 27.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.755 HG22 HG22 ' A' ' 131' ' ' VAL . 14.3 pt -129.52 157.25 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.44 125.75 7.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.47 -175.24 25.42 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.19 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.67 -165.76 48.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.182 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 24.3 t -87.95 148.25 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.61 -10.97 60.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.516 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -179.97 65.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 109.918 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -76.21 -0.61 22.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.908 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.5 t-80 72.69 -60.99 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.702 0.763 . . . . 0.0 110.568 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.937 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.8 OUTLIER -94.6 107.03 27.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.668 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.49 89.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.394 2.062 . . . . 0.0 112.512 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 108.46 34.4 2.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -155.47 90.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.977 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -53.9 -23.26 12.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.348 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 m -56.67 137.48 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.693 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.7 mt -78.86 116.22 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.392 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.937 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.9 m-85 -113.06 150.08 32.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 150' ' ' ASP . 45.2 t -85.07 155.72 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -128.52 -45.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.34 146.27 32.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.731 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 147' ' ' GLN . 24.0 mt -136.81 141.43 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -71.89 173.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.62 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -92.4 137.28 32.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.844 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.42 27.19 40.03 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.627 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.59 178.43 50.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.663 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -65.14 -54.72 25.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.11 -32.75 70.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -60.0 -55.36 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.239 0.542 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -46.56 52.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.867 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -80.73 -59.47 2.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.032 0.444 . . . . 0.0 112.053 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -60.95 -46.34 94.77 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.247 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.54 17.25 10.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.74 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.499 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -91.39 79.2 5.62 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.502 ' HA ' HD12 ' A' ' 134' ' ' ILE . 12.7 pt20 -60.0 170.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.0 mt -47.6 126.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.281 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.99 -23.87 9.12 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.514 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -65.12 129.12 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.827 0.346 . . . . 0.0 110.517 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -115.62 131.45 56.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.244 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -104.9 134.61 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.715 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.553 HD23 ' HB2' ' A' ' 184' ' ' ALA . 2.2 pp -103.9 -2.07 26.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.61 159.9 0.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.896 0.379 . . . . 0.0 111.457 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 158' ' ' VAL . 11.7 t -115.52 100.19 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.737 HD22 ' H ' ' A' ' 180' ' ' TYR . 14.3 m120 69.28 -59.5 0.48 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.367 0.604 . . . . 0.0 109.635 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -165.49 28.96 0.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.989 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 155' ' ' VAL . 9.9 t -106.46 154.81 7.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.36 76.45 0.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.598 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -78.15 24.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.91 35.23 2.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.234 0.54 . . . . 0.0 110.742 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.02 28.59 1.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.762 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -142.04 -77.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.083 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.6 mtm -179.4 -171.59 0.2 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 169' ' ' VAL . 25.5 p80 -71.84 -32.67 67.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.301 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.72 -42.4 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.762 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.11 -37.81 66.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.569 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.71 74.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 165' ' ' HIS . 23.8 t -72.69 -43.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.481 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 174' ' ' ASN . . . -71.86 -30.18 65.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.044 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.51 -29.14 56.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.472 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.2 pp -81.66 -37.58 27.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.55 59.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.937 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -69.99 -13.67 62.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.439 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.686 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.7 p -56.84 -168.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 64.0 t80 -106.18 172.46 6.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.2 m-20 -58.28 -15.97 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.202 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.52 92.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.262 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.86 147.91 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.282 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.737 ' H ' HD22 ' A' ' 156' ' ' ASN . 18.4 p90 -100.93 129.71 46.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.788 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.99 154.37 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.751 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.61 116.93 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.786 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 101' ' ' ILE . 19.6 t -101.89 162.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.491 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.83 117.23 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 0.0 111.936 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.599 178.814 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.402 ' HB3' HG12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.922 0.392 . . . . 0.0 111.067 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' HG13 ' C' ' 9' ' ' VAL . 0.6 OUTLIER -154.82 73.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.545 HG13 ' O ' ' C' ' 8' ' ' SER . 6.7 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.26 141.1 27.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.584 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 5.7 pt-20 -175.01 165.92 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 111.417 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -109.37 123.47 49.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.771 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.62 -172.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.316 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -140.44 127.95 21.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.259 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.88 ' HG ' HD23 ' A' ' 15' ' ' LEU . 5.8 tp -119.05 91.42 3.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.638 0.732 . . . . 0.0 110.561 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -73.79 138.84 44.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.601 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 82' ' ' SER . 2.5 ptm180 -57.85 103.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.35 -26.91 7.3 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.547 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -168.15 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -109.15 30.71 6.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.725 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.94 174.68 19.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.441 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.33 -50.49 7.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.942 0.401 . . . . 0.0 111.304 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.23 74.64 1.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.69 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 39' ' ' ILE . 2.9 p90 -164.65 156.46 15.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.029 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' ILE . 2.1 p -105.93 126.81 52.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 36' ' ' ILE . 2.4 pp -120.43 154.49 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 0.0 111.945 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.97 147.49 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.754 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.41 19.62 1.34 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.993 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.11 162.92 0.08 OUTLIER Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.542 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.752 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -66.68 -38.73 87.39 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.788 ' CB ' HG23 ' A' ' 69' ' ' THR . 12.5 t0 -83.77 -49.17 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 111.631 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.69 76.89 10.77 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.582 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.69 172.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.646 2.23 . . . . 0.0 112.274 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 7.1 t-80 -108.8 -21.45 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.212 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.74 -25.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.86 7.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.703 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.89 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.13 101.49 2.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.017 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.15 61.83 2.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.903 2.402 . . . . 0.0 111.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 m -176.86 134.61 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.741 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 145.1 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.6 p90 -142.24 163.64 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.453 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 19' ' ' ILE . 49.2 mt -93.97 148.67 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 110.84 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -31.77 8.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.344 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.918 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.6 tmmm? -172.55 148.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -106.95 141.62 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.78 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.05 128.05 64.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.965 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.2 62.14 2.6 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 -43.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.62 -177.26 22.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.94 -21.27 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.631 0.253 . . . . 0.0 111.532 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.0 -57.62 12.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.13 -28.25 67.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.75 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.21 -36.21 69.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.652 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' GLY . 34.0 m-20 -87.21 -25.98 23.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.327 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 28.47 54.7 0.13 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.148 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.81 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -84.16 4.84 28.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.958 HD13 HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -177.76 -177.9 0.68 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.106 0.479 . . . . 0.0 111.547 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 165.19 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.396 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.918 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.5 m -71.13 -45.51 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.72 17.6 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 51' ' ' LEU . 7.5 p-10 -75.34 -166.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.33 100.05 3.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.797 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -60.84 95.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.465 0.65 . . . . 0.0 111.058 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.664 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -70.94 -25.68 62.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -154.55 129.84 9.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.5 t -137.13 145.87 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.927 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.5 m120 42.24 32.43 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.471 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 65.66 32.7 8.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' VAL . 21.8 t -121.07 141.88 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.46 78.13 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.701 HG12 HG21 ' A' ' 68' ' ' VAL . 18.8 m -98.78 33.26 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.427 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -84.24 3.56 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.05 47.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.039 0.447 . . . . 0.0 109.837 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 65' ' ' VAL . 29.9 m -118.71 140.99 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.176 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -49.67 164.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.905 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.43 ' ND1' HG23 ' A' ' 74' ' ' VAL . 2.9 t-80 -57.39 -48.49 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.372 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -41.4 63.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.151 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.58 76.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.94 -40.75 68.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.55 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.564 ' HA ' HD21 ' A' ' 77' ' ' LEU . 49.7 t -64.23 -35.83 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.658 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -34.07 73.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.815 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.49 -42.92 74.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 110.477 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.8 -26.74 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.385 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -45.09 59.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.382 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -103.18 28.82 5.99 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.415 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.981 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -81.56 -27.83 34.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.508 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.09 -124.58 8.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.635 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 83' ' ' ILE . 69.6 p -130.83 4.62 4.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.84 96.73 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.981 HG12 ' HB1' ' A' ' 80' ' ' ALA . 26.6 m -87.41 114.37 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -100.9 110.38 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.47 154.1 51.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.664 ' CD1' HD21 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -107.83 114.68 28.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.219 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 51' ' ' LEU . 12.6 m -118.97 168.1 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.113 0.482 . . . . 0.0 112.151 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ptm -124.33 109.53 13.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.155 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' ASP . 1.2 ptt180 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.73 152.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.906 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttt -135.31 166.3 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -114.96 155.6 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.603 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 180' ' ' TYR . 1.6 ttpt -113.7 124.53 52.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 5.8 tt -125.79 118.4 25.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.602 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -94.87 144.68 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.195 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -65.75 155.24 36.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -134.82 -169.64 11.98 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.68 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.12 -40.13 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.022 1.815 . . . . 0.0 112.322 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 20.2 8.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 110.277 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 106.81 -133.93 11.9 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 6.5 mp -86.71 -27.03 23.94 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.935 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.1 40.75 4.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.669 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.12 154.59 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 111.08 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.5 t -102.23 123.15 45.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.489 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.801 HD11 HD22 ' A' ' 172' ' ' LEU . 16.4 pt -130.1 155.26 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -162.41 125.47 2.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.051 0.453 . . . . 0.0 111.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.93 -175.48 25.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.622 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.25 34.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.962 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -104.26 154.7 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.853 0.358 . . . . 0.0 111.377 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 -35.83 4.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 175.05 78.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 115.11 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.775 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -58.98 -17.58 26.15 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 ' CD1' ' A' ' 130' ' ' TYR . 1.1 mt -83.55 122.62 76.88 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.742 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.39 96.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.47 2.114 . . . . 0.0 112.165 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.85 58.31 14.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.93 87.01 1.95 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.571 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -43.53 -28.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t -53.57 168.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.619 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.67 ' HB ' HD12 ' A' ' 152' ' ' ILE . 27.1 mt -105.86 127.27 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.935 0.398 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.3 m-30 -117.27 154.67 30.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.502 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 134' ' ' ILE . 66.2 t -90.07 152.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 133' ' ' LYS . 5.9 t -123.62 -50.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 132' ' ' THR . 0.0 OUTLIER -134.22 142.42 47.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 131' ' ' VAL . 30.7 mt -136.99 138.46 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -80.16 172.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 135' ' ' ILE . 85.8 mt-10 -91.37 134.52 34.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.36 26.29 56.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.88 -138.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' LEU . . . -97.4 -72.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.906 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -61.47 -31.79 71.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.7 t-160 -56.41 -62.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 110.993 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -72.63 -34.3 67.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.985 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -59.36 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -88.13 -29.23 20.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.844 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 141' ' ' HIS . 1.3 ttm180 67.75 27.8 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.01 0.405 . . . . 0.0 110.527 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.906 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -88.64 82.71 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -68.38 176.35 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.87 121.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.299 0.571 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.4 -23.36 5.15 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.059 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 183' ' ' VAL . 9.3 t0 -57.94 139.51 54.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.773 0.321 . . . . 0.0 110.524 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -130.98 119.51 22.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.146 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.99 131.98 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.092 0.472 . . . . 0.0 110.79 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 pp -104.3 -1.36 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.201 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 179.83 168.68 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.718 HG12 HD22 ' A' ' 156' ' ' ASN . 58.6 t -117.88 100.44 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.635 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.718 HD22 HG12 ' A' ' 155' ' ' VAL . 66.4 m-80 70.42 -57.45 0.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.072 0.463 . . . . 0.0 110.081 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 m -165.31 21.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.325 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -116.32 132.61 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.165 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.0 68.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.863 HD22 ' HB1' ' A' ' 171' ' ' ALA . 4.0 pp -87.26 28.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.848 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.414 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -122.29 37.17 4.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.168 0.508 . . . . 0.0 110.939 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -142.42 29.05 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -116.08 -76.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.2 mtm -176.45 -170.2 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.744 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 169' ' ' VAL . 4.0 t-80 -69.99 -34.17 72.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.663 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.7 -45.41 52.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.601 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.91 -37.46 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.806 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.93 73.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.061 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.816 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.4 t -73.95 -39.97 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.2 -33.6 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.863 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -77.96 -27.04 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.816 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -76.18 -36.73 58.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -26.87 60.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.44 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -9.95 55.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.519 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 p -47.73 149.53 1.24 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 0.0 111.442 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -87.58 169.78 11.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t0 -45.12 -35.3 3.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.044 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 104' ' ' ILE . 40.8 t -147.85 91.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.95 148.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.661 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.435 ' CZ ' ' HD2' ' A' ' 102' ' ' LYS . 13.2 m-85 -96.42 127.05 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.602 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 155' ' ' VAL . 1.5 mt -104.94 150.71 24.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.954 0.407 . . . . 0.0 110.597 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.9 tttm -96.8 114.27 25.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 101' ' ' ILE . 18.8 t -101.68 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 111.288 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.608 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -123.1 141.15 52.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.671 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.866 0.365 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -80.9 95.82 6.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.418 HG23 ' OXT' ' C' ' 9' ' ' VAL . 3.5 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.9 151.52 20.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -177.07 158.5 1.54 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 111.311 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -113.81 114.71 26.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.727 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -119.27 -176.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 120.979 0.418 . . . . 0.0 111.429 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.13 125.16 38.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.724 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 15' ' ' LEU . 13.9 tp -124.19 92.73 3.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.683 0.754 . . . . 0.0 109.97 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.16 161.69 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.22 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 15.0 ptm180 -73.14 98.51 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.876 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.87 -26.57 8.48 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.526 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -168.45 -87.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.143 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -109.18 30.73 6.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 177.4 18.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.019 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.974 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.48 -37.08 21.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.187 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 72.47 1.29 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.967 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -156.49 157.11 34.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 178.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.0 m -104.5 126.89 52.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.467 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.586 HD11 ' NE2' ' A' ' 70' ' ' HIS . 35.5 pt -105.4 163.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 0.0 111.74 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . . . -162.36 144.38 10.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.42 -144.75 18.21 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.708 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.09 142.83 5.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.366 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -48.6 -27.63 2.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.725 ' CB ' HG23 ' A' ' 69' ' ' THR . 16.7 t70 -81.58 -45.21 16.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.975 0.417 . . . . 0.0 110.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -123.92 84.73 54.44 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -41.99 144.19 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.868 2.379 . . . . 0.0 112.618 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 72.1 t60 -75.98 -49.61 17.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.637 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.485 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -97.73 -29.26 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.29 23.23 6.13 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.0 30.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -164.06 111.08 0.92 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.639 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.28 -23.68 75.47 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.732 2.288 . . . . 0.0 112.122 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -57.94 175.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.8 mp -104.01 160.81 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 27' ' ' HIS . 3.5 m-85 -132.21 166.28 22.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.189 0.519 . . . . 0.0 111.419 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 18' ' ' SER . 11.2 mt -116.71 151.54 18.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.837 ' O ' HG21 ' A' ' 53' ' ' VAL . 32.2 p -109.99 -44.31 3.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -162.8 158.38 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.196 0.522 . . . . 0.0 112.09 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -112.08 141.11 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.55 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 mt -87.32 129.08 52.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.167 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.0 Cg_exo -65.34 64.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.15 -43.45 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.271 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.56 160.21 52.85 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.319 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -54.86 -28.79 52.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -58.89 -55.38 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 39' ' ' ILE . . . -65.66 -27.26 68.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -71.71 -42.47 67.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.667 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 3.2 m-20 -77.11 -36.22 55.7 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.394 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 27.3 44.01 0.03 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.391 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -76.1 -37.65 57.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -120.33 179.78 4.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 150.91 21.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.769 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.837 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -71.25 -35.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.403 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -70.21 14.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -83.38 -162.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.84 100.82 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -55.26 96.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 111.191 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 89' ' ' MET . 5.1 mt -68.17 -33.85 75.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.892 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 86' ' ' LEU . 69.1 m-85 -157.08 167.7 29.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.295 0.569 . . . . 0.0 111.955 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.926 HG13 ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -147.15 -177.95 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.013 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.0 m-20 -40.32 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 111.592 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 50.32 31.02 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.069 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.2 t -120.94 128.85 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.385 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -95.81 80.26 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG13 HG12 ' A' ' 63' ' ' VAL . 34.5 m -97.17 32.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.43 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -75.88 -5.3 45.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.266 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.62 46.8 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.936 0.398 . . . . 0.0 110.174 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.644 HG21 HG12 ' A' ' 65' ' ' VAL . 23.3 m -117.28 140.4 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.082 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.725 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -50.61 166.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.501 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.586 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.3 t-160 -59.73 -48.64 80.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.434 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.56 69.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.53 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.7 -35.23 67.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.014 0.435 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -72.37 -42.56 65.13 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -64.51 -36.37 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.976 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.4 mt-10 -69.36 -33.68 73.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -69.65 -41.41 75.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.426 0.632 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -79.52 -26.9 41.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.457 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.49 -36.62 71.19 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.225 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.06 22.91 9.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.811 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -129.91 16.48 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.29 103.89 0.88 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 166.45 -70.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.409 . . . . 0.0 110.602 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -152.44 93.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.859 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 8' ' ' LEU . 9.9 m -93.6 113.71 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -79.3 80.39 5.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.926 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -85.58 132.25 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -176.472 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -109.88 114.54 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m -117.84 168.36 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 0.0 112.234 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . 12.3 ttt -141.63 109.26 5.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.457 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.688 0.28 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.92 147.0 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtm -134.73 166.12 23.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.212 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.04 106.21 6.7 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 183' ' ' VAL . 4.3 mm -113.86 155.57 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.425 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -121.57 125.96 47.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.254 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.679 ' HB2' HD11 ' A' ' 181' ' ' LEU . 1.9 tt -130.84 118.78 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.033 0.444 . . . . 0.0 110.733 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG13 ' A' ' 178' ' ' VAL . 4.8 pt -93.83 144.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.944 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 20.4 tttt -69.93 155.49 40.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -135.84 -160.62 8.94 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.58 -42.02 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.184 1.923 . . . . 0.0 112.484 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -92.07 21.37 5.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.025 0.441 . . . . 0.0 110.427 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 107.44 -141.57 15.66 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.44 -23.0 26.2 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.901 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.95 47.06 4.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.842 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.56 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -175.87 153.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 131' ' ' VAL . 9.5 m -111.23 129.9 55.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 172' ' ' LEU . 13.5 pt -142.54 156.6 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -157.9 125.27 5.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.44 -175.08 25.21 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.104 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 83.91 -174.08 51.06 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.073 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 25.7 t -80.35 145.35 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.754 0.312 . . . . 0.0 111.123 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.07 -27.19 9.43 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.201 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.82 68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 109.755 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -73.4 -4.57 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 19.1 t-80 72.02 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.51 0.671 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.74 145.56 35.24 Favored Pre-proline 0 C--N 1.313 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.511 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 123' ' ' ILE . 16.8 Cg_exo -67.26 62.33 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.509 2.14 . . . . 0.0 112.14 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 118.43 60.37 0.28 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.882 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -164.33 94.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.824 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.15 -23.32 20.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 m -60.01 147.71 38.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.718 HD11 ' HB1' ' A' ' 168' ' ' ALA . 1.1 mt -87.57 110.53 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.913 ' CD1' HD11 ' A' ' 123' ' ' ILE . 6.6 m-85 -104.93 150.6 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.9 t -83.2 147.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 148' ' ' ILE . 15.7 p -103.06 -56.61 2.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.308 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 147.1 22.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.9 mt -114.77 141.58 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -80.08 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -106.74 30.48 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.82 -28.91 66.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.325 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.22 21.33 8.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.79 -82.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.79 -56.3 16.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 0.0 110.535 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.79 -50.39 24.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.264 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.19 -59.42 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.978 0.418 . . . . 0.0 111.888 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -56.07 -57.56 18.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 60.02 26.41 15.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.769 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -106.41 86.43 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -58.91 165.84 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.673 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 132' ' ' THR . 32.3 mt -48.19 115.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 111.288 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.64 -18.19 5.18 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -68.0 122.24 17.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.878 0.37 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -110.75 128.63 55.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.51 131.73 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.592 ' CD2' ' HB2' ' A' ' 184' ' ' ALA . 1.0 OUTLIER -95.94 -2.91 46.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.086 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 167.38 146.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.86 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 158' ' ' VAL . 95.0 t -101.88 99.66 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.12 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.441 ' ND2' HG12 ' A' ' 155' ' ' VAL . 69.6 m-80 69.34 -59.66 0.48 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -162.48 26.14 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.329 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 155' ' ' VAL . 15.0 t -98.07 155.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.255 0.55 . . . . 0.0 111.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -115.26 77.76 0.27 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.619 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 168' ' ' ALA . 80.1 mt -76.73 25.69 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.614 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.6 OUTLIER -152.85 53.69 0.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.336 0.589 . . . . 0.0 110.777 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.86 28.24 0.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.6 t -150.64 -74.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtm 175.17 169.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.711 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.52 ' O ' HG23 ' A' ' 169' ' ' VAL . 14.5 p-80 -54.96 -29.87 57.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.942 0.401 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -73.41 -48.39 34.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.178 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.716 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.62 -36.58 73.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.904 0.383 . . . . 0.0 110.583 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.42 -36.27 73.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.058 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.765 ' HA ' HD23 ' A' ' 172' ' ' LEU . 5.5 t -72.07 -42.55 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.17 -30.81 66.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.627 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 160' ' ' LEU . . . -77.68 -25.95 49.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.248 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -81.32 -39.85 24.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.11 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -26.51 58.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -9.89 55.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.669 ' HB ' HG21 ' A' ' 179' ' ' VAL . 7.7 p -50.96 -178.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 111.8 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -103.02 169.46 8.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t70 -52.16 -21.32 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.535 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.499 HG13 HG22 ' A' ' 104' ' ' ILE . 40.4 t -147.58 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.714 0.292 . . . . 0.0 110.341 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.24 148.3 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.116 0.484 . . . . 0.0 112.3 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -102.53 124.18 47.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.798 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -104.68 146.22 29.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 0.0 111.334 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -96.46 115.76 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.233 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 101' ' ' ILE . 17.8 t -101.83 160.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.145 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.834 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -139.57 132.72 29.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.252 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.907 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.778 0.323 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -98.63 105.44 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.546 HG13 ' OXT' ' C' ' 9' ' ' VAL . 11.1 p . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.889 0.376 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -121.64 154.76 36.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 23.8 mm-40 -145.82 118.25 8.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.561 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.457 ' HG2' ' CG ' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -125.1 95.76 4.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.79 -169.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 111.922 -178.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -119.69 135.03 54.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.637 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.9 tp -128.2 91.35 3.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.785 0.802 . . . . 0.0 110.022 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -72.69 160.64 31.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.12 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -70.5 95.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -51.11 -25.92 11.44 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.478 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -172.45 -86.85 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -109.35 30.74 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -179.77 21.86 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.419 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.94 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.2 mp -84.43 -48.74 9.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.805 0.336 . . . . 0.0 111.515 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 76.29 1.31 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.742 -0.742 . . . . 0.0 114.1 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.5 p90 -164.66 148.68 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.689 0.28 . . . . 0.0 110.756 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.8 m -100.73 126.86 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 111.392 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.771 HG22 HG12 ' A' ' 36' ' ' ILE . 2.9 pt -125.06 164.31 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -168.07 154.78 7.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.432 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 120.46 -113.54 2.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.12 22.15 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.544 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 2.8 t -58.21 -18.44 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.837 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.9 m-20 -93.44 -49.71 5.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -121.96 79.35 41.82 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.438 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.95 136.9 22.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.606 2.204 . . . . 0.0 112.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 14.4 t-80 -70.38 -21.8 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.502 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.61 -29.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.935 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.52 29.55 9.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.17 35.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.9 95.97 1.0 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.46 -23.24 30.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.126 . . . . 0.0 112.005 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -76.18 142.53 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' HB ' HD11 ' A' ' 57' ' ' ILE . 9.1 mt -93.18 154.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 111.182 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.9 p90 -142.39 167.82 21.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.299 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.775 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 40.5 mt -98.09 152.44 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 p -108.62 -36.34 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.673 0.273 . . . . 0.0 111.453 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.923 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -163.81 154.52 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.969 0.414 . . . . 0.0 111.291 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.2 141.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.999 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.8 mt -85.44 123.61 72.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.6 Cg_exo -66.06 64.02 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.68 -52.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.34 166.8 8.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.362 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.55 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -62.03 -23.05 66.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.88 -57.37 12.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.167 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.14 -28.1 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.534 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -38.44 69.28 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.999 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 40.7 m-20 -87.56 -25.27 23.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 33.58 70.58 0.13 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.593 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -109.46 -14.06 14.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.541 0.21 . . . . 0.0 111.371 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.648 HD13 HD11 ' A' ' 86' ' ' LEU . 2.1 pt? -141.63 168.87 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -104.71 165.12 11.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.121 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.9 m -71.54 -47.77 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 53' ' ' VAL . 13.6 m-80 -62.24 4.63 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.564 ' OD2' HG21 ' A' ' 88' ' ' VAL . 44.2 p30 -86.99 170.57 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.298 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 m -120.37 116.15 24.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.579 0.228 . . . . 0.0 110.648 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.912 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -60.47 94.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.226 0.536 . . . . 0.0 111.19 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.669 HD11 ' CG ' ' A' ' 89' ' ' MET . 59.6 mt -70.07 -28.81 65.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.18 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 143.11 17.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.601 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.22 131.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.587 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 6.0 t30 52.09 40.47 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.0 26.96 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.5 t -120.81 131.47 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.3 100.93 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.0 t -112.71 41.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.012 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.95 9.7 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.655 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -177.76 37.59 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 65' ' ' VAL . 14.9 m -118.96 150.57 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.447 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.837 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -49.56 156.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.705 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.451 ' CE1' HG21 ' A' ' 74' ' ' VAL . 4.3 t-80 -58.23 -48.56 80.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.554 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -59.45 -34.79 72.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.366 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.98 -37.45 78.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.36 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.37 65.26 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 109.693 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 19' ' ' ILE . 78.9 t -64.2 -35.05 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.684 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.3 tt0 -69.19 -33.99 74.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.96 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.466 0.651 . . . . 0.0 110.466 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -79.92 -27.05 39.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.368 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -70.87 -35.56 72.41 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.141 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 21.64 10.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.655 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.87 16.27 5.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.048 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.52 95.83 0.11 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.781 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.1 m 169.59 -66.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.79 94.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.249 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -101.31 140.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.657 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.87 95.02 9.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.677 HD21 ' CG1' ' A' ' 88' ' ' VAL . 2.2 tm? -84.81 115.53 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 0.0 112.067 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CG ' ' HG2' ' A' ' 5' ' ' GLU . 1.3 t80 -121.75 114.44 21.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.912 HG12 ' HA ' ' A' ' 57' ' ' ILE . 20.7 m -129.3 168.06 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.669 ' CG ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -118.46 109.08 15.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.631 178.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 52' ' ' ARG . 45.7 ttp180 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.819 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.975 0.417 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.1 135.14 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.7 166.73 11.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -135.14 106.41 6.75 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 183' ' ' VAL . 3.7 mm -114.15 155.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -113.04 123.28 49.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.257 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 110' ' ' LEU . 2.0 tt -124.8 118.6 26.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.587 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.528 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -97.04 144.68 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.115 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -75.17 155.93 36.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.2 -177.85 15.19 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.905 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 -33.43 16.23 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.064 1.843 . . . . 0.0 112.093 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.53 18.22 13.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 0.0 110.416 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA3' ' OXT' ' C' ' 9' ' ' VAL . . . 106.4 -148.1 16.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.457 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 103' ' ' LEU . 14.5 mt -86.57 -18.84 30.47 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.213 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.64 49.95 6.32 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.083 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.76 151.99 0.75 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 110.718 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.403 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 67.2 m -113.48 116.88 30.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.942 HD11 HD22 ' A' ' 172' ' ' LEU . 10.4 pt -128.78 155.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.607 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -155.33 125.14 6.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 111.886 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.83 -175.1 25.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.449 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 104.16 -174.13 21.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.596 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.1 t -100.76 155.02 4.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 111.4 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 96.49 -26.77 20.23 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.28 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -173.9 74.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -76.5 130.76 38.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.006 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 3.7 t-80 -43.28 -34.69 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.049 0.928 . . . . 0.0 110.64 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.27 138.3 19.85 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.901 -178.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 123' ' ' ILE . 58.2 Cg_endo -71.52 61.21 2.78 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.361 2.041 . . . . 0.0 112.719 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.72 48.76 0.08 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.26 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.42 96.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -58.14 -22.43 51.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 136.87 40.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.642 ' HB ' HD12 ' A' ' 152' ' ' ILE . 4.8 mt -73.85 120.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.999 0.428 . . . . 0.0 111.229 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.4 m-85 -116.28 147.57 41.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.396 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 150' ' ' ASP . 39.4 t -83.96 139.51 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 148' ' ' ILE . 11.5 p -97.49 -58.9 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.627 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG3' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -155.15 150.86 27.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 111.468 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.9 mt -127.87 141.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.767 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -74.36 173.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.608 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.2 tt0 -87.06 146.29 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.28 26.1 55.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.1 164.27 45.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -58.71 -52.32 66.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 111.201 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.666 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.12 -32.01 69.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -56.27 -54.63 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.202 0.525 . . . . 0.0 110.377 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -72.83 -50.75 22.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.092 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.56 -59.58 2.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 111.886 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -55.6 -50.05 62.33 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.169 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.98 19.52 10.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.757 0.313 . . . . 0.0 110.653 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.625 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.16 79.86 4.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 175.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 132' ' ' THR . 27.4 mt -49.75 129.53 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.159 0.504 . . . . 0.0 111.295 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.5 -24.35 11.35 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.571 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.9 OUTLIER -60.74 129.33 40.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.753 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.839 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 1.9 pttp -117.47 125.28 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.999 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.46 132.26 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.116 0.484 . . . . 0.0 110.756 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -99.41 -1.28 39.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.35 158.86 0.09 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.831 0.348 . . . . 0.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 158' ' ' VAL . 20.6 t -116.44 100.07 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.195 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 180' ' ' TYR . 12.2 m120 68.84 -59.3 0.47 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.225 0.536 . . . . 0.0 109.814 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 97.4 p -163.4 26.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.385 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 5.6 t -102.47 155.02 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-O 121.07 0.462 . . . . 0.0 111.314 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.09 79.05 0.3 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.685 HD13 ' HB3' ' A' ' 172' ' ' LEU . 18.6 mt -77.61 24.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.92 0.391 . . . . 0.0 112.048 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.83 38.68 1.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.099 0.476 . . . . 0.0 110.736 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.77 28.62 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.311 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.731 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -145.83 -75.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.388 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 172.84 166.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 50.9 t-80 -53.99 -29.92 45.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.79 0.328 . . . . 0.0 110.649 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.31 -46.45 49.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.731 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.42 -36.89 68.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.64 -34.97 72.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.511 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.0 t -72.08 -40.28 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.83 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.92 -36.33 69.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.35 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -75.42 -26.88 58.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.942 HD22 HD11 ' A' ' 114' ' ' ILE . 4.1 pp -82.07 -36.88 27.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.829 0.347 . . . . 0.0 110.377 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -75.07 -26.4 59.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.54 -9.59 54.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.188 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 1.2 p -42.34 166.91 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.059 0.457 . . . . 0.0 112.2 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' A' ' 179' ' ' VAL . 75.0 t80 -96.95 167.26 11.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -47.83 -29.2 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.315 -179.421 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 104' ' ' ILE . 41.1 t -147.9 91.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 110.7 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.68 148.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.686 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 156' ' ' ASN . 27.6 p90 -103.51 125.23 49.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.179 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -106.75 155.9 19.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.829 -178.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.88 113.45 24.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.55 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 101' ' ' ILE . 13.1 t -102.2 164.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.839 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -130.48 129.05 42.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.64 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.812 -179.754 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.809 0.338 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 125.16 28.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.402 ' OXT' ' HA3' ' A' ' 109' ' ' GLY . 11.6 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.095 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.748 0.309 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HD2' ' HH ' ' A' ' 87' ' ' TYR . 3.1 m-85 -135.68 170.65 15.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE1' HD12 ' A' ' 6' ' ' ILE . 6.4 tt0 -178.29 125.79 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.415 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 4.8 pt-20 -110.22 106.55 16.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.347 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.665 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -122.35 -167.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.008 0.432 . . . . 0.0 111.639 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 135.94 44.65 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.789 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -120.32 88.97 3.04 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.6 0.714 . . . . 0.0 110.986 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.21 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.886 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASN . 8.5 mtt180 -44.43 105.04 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.82 0.343 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.91 66.11 0.33 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.48 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' ARG . 11.2 m-80 77.03 -73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.632 0.253 . . . . 0.0 110.891 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -109.29 30.41 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.67 -176.92 18.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.948 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -51.32 7.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.278 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 97.5 69.12 0.97 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.94 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 5.5 p90 -164.93 155.82 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 36' ' ' ILE . 12.9 m -117.53 138.19 52.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.551 HG22 HG12 ' A' ' 36' ' ' ILE . 3.3 pt -127.08 166.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.05 160.7 33.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 27' ' ' HIS . . . 112.51 -132.48 10.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.09 146.95 7.82 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -61.76 -16.3 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.689 ' CB ' HG22 ' A' ' 69' ' ' THR . 30.2 p-10 -102.04 -39.29 7.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.704 0.288 . . . . 0.0 110.92 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.38 76.57 53.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.634 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' CG ' ' HA ' ' A' ' 30' ' ' ASP . 99.8 Cg_exo -43.72 155.55 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.944 2.43 . . . . 0.0 112.344 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 2.8 t-80 -122.7 -11.95 8.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.691 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.579 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.16 -58.08 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' ASP . . . -173.74 33.93 0.11 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.088 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HA ' ' CG ' ' A' ' 26' ' ' PRO . 1.1 t0 81.51 53.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.835 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -118.92 114.8 35.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.695 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 32.3 Cg_exo -59.18 82.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.78 2.32 . . . . 0.0 112.165 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.75 143.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.29 148.27 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -142.61 145.28 33.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.365 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 18' ' ' SER . 70.9 mt -72.94 144.9 12.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.641 ' O ' HG21 ' A' ' 53' ' ' VAL . 21.8 p -95.49 -43.25 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.655 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 158.46 27.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.202 0.525 . . . . 0.0 111.743 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -116.92 141.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.85 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.92 133.9 45.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.35 77.82 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.56 2.173 . . . . 0.0 112.189 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.57 -31.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.328 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -61.12 168.95 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.543 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.92 -21.16 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -54.87 -57.58 11.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.42 69.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -72.05 -37.51 69.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.665 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.74 -20.25 36.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.375 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.05 72.43 1.25 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.985 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.51 35.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 88' ' ' VAL . 1.5 pp 37.57 -156.91 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.056 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.08 138.09 58.29 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.015 0.436 . . . . 0.0 111.223 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 37' ' ' THR . 31.6 m -65.24 -37.85 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.342 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -53.19 -15.27 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.23 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 90' ' ' ARG . 25.6 p-10 -59.05 170.64 0.83 Allowed 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -123.27 114.11 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.696 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.3 pt -58.6 94.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.4 mt -62.03 -29.0 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.878 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.03 125.55 4.59 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' HG ' ' A' ' 86' ' ' LEU . 4.9 m -114.33 118.59 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.648 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.408 ' OD1' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER 53.87 41.99 31.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.002 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 66.91 29.56 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.02 136.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -82.5 111.05 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 68' ' ' VAL . 26.9 m -128.55 25.6 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -79.65 5.11 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.21 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' HB2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -163.96 41.32 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.023 0.44 . . . . 0.0 109.908 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 65' ' ' VAL . 35.3 m -118.55 143.24 30.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 112.529 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 21.5 p -49.52 171.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.131 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.16 -48.66 56.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.861 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -44.14 74.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.81 73.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.55 68.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.392 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.511 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.9 t -64.96 -36.83 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.64 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.41 -30.64 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.575 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.25 -36.7 74.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.299 0.571 . . . . 0.0 110.561 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.13 -25.84 34.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.85 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.35 -32.87 58.88 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.104 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.56 29.87 7.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -88.41 -24.24 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.64 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.06 -135.33 12.07 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.775 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.9 m -131.24 11.46 4.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 111.566 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.688 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.7 mt -151.56 92.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 3.5 m -104.26 115.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.71 91.92 7.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.85 ' HG ' HG12 ' A' ' 60' ' ' VAL . 1.7 mp -93.16 144.51 25.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.45 ' HH ' ' HD2' ' A' ' 3' ' ' TYR . 17.7 t80 -122.81 114.38 20.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.97 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 57' ' ' ILE . 31.4 m -115.25 168.48 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 0.0 112.289 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.404 ' HB2' HD12 ' A' ' 58' ' ' LEU . 6.9 ttt -138.15 109.05 6.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.491 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.483 ' CG ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.836 0.35 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.561 HG23 HD21 ' A' ' 153' ' ' LEU . 11.6 p -82.94 133.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.7 mmt -112.27 166.48 11.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.54 106.41 7.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.406 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.618 HG13 HG21 ' A' ' 183' ' ' VAL . 3.1 mm -114.95 155.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.515 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 4.8 mptt -113.1 126.97 56.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.634 HD22 ' HG ' ' A' ' 110' ' ' LEU . 4.0 tt -130.6 118.84 21.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.694 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.522 HG22 HG13 ' A' ' 178' ' ' VAL . 5.1 pt -92.7 144.79 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -69.01 164.42 22.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.159 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.88 -162.52 9.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.786 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.42 -35.28 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.166 1.911 . . . . 0.0 112.554 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 20.54 7.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.957 0.408 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.87 -127.85 9.22 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.696 HD22 HD13 ' A' ' 172' ' ' LEU . 1.2 mp -86.77 -30.88 21.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.65 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 99.69 38.1 3.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.875 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -177.93 160.15 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 111.305 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -110.51 117.06 32.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 172' ' ' LEU . 45.5 pt -113.43 173.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 111.488 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.07 -176.0 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.368 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 165' ' ' HIS . . . -145.72 143.61 11.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.47 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.22 -66.33 2.43 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.061 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.82 153.29 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.62 -9.78 61.26 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.038 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 168.39 81.17 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.845 0.355 . . . . 0.0 110.122 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 4.1 mt-30 -64.54 -15.1 60.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.331 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.559 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 16.4 t-80 71.82 -54.99 0.67 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.6 0.714 . . . . 0.0 110.612 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.9 mt -92.02 143.37 27.56 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.659 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 123' ' ' ILE . 38.4 Cg_exo -60.37 77.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.366 2.044 . . . . 0.0 112.247 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 87.77 65.14 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -162.12 94.0 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -55.13 -23.46 21.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 p -57.92 120.2 8.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 160' ' ' LEU . 21.9 mt -70.56 122.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.859 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.6 m-85 -111.84 151.01 29.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.962 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 150' ' ' ASP . 42.5 t -86.31 121.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.304 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 148' ' ' ILE . 9.2 p -79.28 -59.06 2.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.649 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -151.12 152.75 33.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.597 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.5 mt -118.19 141.38 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.844 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -75.31 172.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.613 ' H ' HG22 ' A' ' 135' ' ' ILE . 64.9 mt-10 -103.7 30.45 5.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.04 -28.61 58.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.65 10.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.672 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.01 -82.35 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.937 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.06 -31.71 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.3 m170 -52.15 -62.2 1.79 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -42.14 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.577 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.21 -59.36 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -70.84 -41.16 63.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.198 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.37 22.34 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 0.0 110.536 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.603 ' CD1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -95.71 85.45 4.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.92 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.45 166.67 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.523 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -47.44 116.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.262 0.553 . . . . 0.0 111.38 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.89 -14.42 6.33 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.666 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -73.92 120.06 18.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.787 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -99.96 122.8 43.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.671 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.33 118.54 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.211 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -82.58 -0.64 47.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.744 -179.107 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 175.18 159.25 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.513 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.897 HG13 HD22 ' A' ' 181' ' ' LEU . 45.6 t -121.73 98.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.276 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.75 ' ND2' HG12 ' A' ' 155' ' ' VAL . 31.8 m-80 69.27 -57.19 0.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 m -147.01 -20.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.688 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -76.16 140.72 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.408 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.73 12.68 33.77 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.897 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 129' ' ' ILE . 24.7 mt 38.96 33.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.229 0.538 . . . . 0.0 111.985 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.52 68.48 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 163' ' ' VAL . 5.9 m-20 -162.92 26.49 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.588 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -161.9 -82.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.674 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.65 170.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.049 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -54.03 -30.6 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -47.92 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.995 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.588 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.37 -32.37 62.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.816 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.762 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.7 t -70.03 -40.5 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.559 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.433 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.08 -30.43 66.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.672 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.98 -25.83 48.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -81.28 -40.69 23.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -75.41 -26.63 58.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.068 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -67.85 -21.4 65.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.918 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.544 ' HB ' HG21 ' A' ' 179' ' ' VAL . 47.7 p -54.73 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -100.88 171.33 7.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -58.48 -14.51 8.04 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.429 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.522 HG13 HG22 ' A' ' 104' ' ' ILE . 41.4 t -147.55 90.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 0.0 110.288 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -120.15 148.49 23.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.729 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -100.03 127.62 46.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.897 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -108.23 153.96 22.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.981 0.419 . . . . 0.0 110.671 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.6 mttt -96.59 119.04 34.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.398 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.618 HG21 HG13 ' A' ' 101' ' ' ILE . 39.2 t -101.82 164.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.536 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -130.91 140.74 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.691 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.436 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.424 ' OG ' ' CD2' ' A' ' 165' ' ' HIS . 21.8 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.862 0.363 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.552 ' O ' HG13 ' C' ' 9' ' ' VAL . 35.9 t -83.63 109.57 17.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 8' ' ' SER . 4.0 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.952 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.907 0.384 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -151.46 145.85 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.577 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -176.82 156.27 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.402 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -86.5 167.74 14.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.454 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.605 HD13 ' HG3' ' A' ' 50' ' ' ARG . 6.9 tt -164.94 165.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.767 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -137.48 126.34 24.08 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.992 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.849 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.6 tp -122.01 88.58 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.457 0.646 . . . . 0.0 111.367 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pm0 -73.66 152.35 40.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 19.4 mtt180 -67.32 93.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.717 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.07 -25.46 10.38 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.638 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.62 -91.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -109.1 30.8 6.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.14 -178.98 25.37 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.135 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.849 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.34 -47.59 10.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.816 0.341 . . . . 0.0 111.293 -179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.36 74.18 1.25 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.084 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -164.85 169.34 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.312 . . . . 0.0 110.922 178.317 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.27 130.8 53.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.459 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HG12 ' A' ' 36' ' ' ILE . 1.2 pt -125.54 164.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -169.77 164.1 9.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.503 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 112.84 -119.22 4.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.481 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.99 145.06 14.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.427 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.76 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -53.9 -24.75 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.587 ' HB2' HG23 ' A' ' 69' ' ' THR . 3.1 t70 -81.73 -55.99 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -120.25 83.06 31.67 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.49 132.01 29.0 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.437 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 18.0 t-80 -68.05 -21.38 65.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.72 -28.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.118 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 29.65 12.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.37 33.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 2.7 m-20 -173.03 111.05 0.34 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 31' ' ' ASP . 21.4 Cg_exo -65.92 -27.91 50.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.126 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.79 128.02 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.19 150.34 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.48 151.09 41.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 18' ' ' SER . 77.2 mt -77.13 146.17 9.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.257 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.547 ' O ' HG21 ' A' ' 53' ' ' VAL . 66.0 m -99.77 -35.98 9.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.541 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.03 158.29 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.513 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -115.94 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.0 mt -85.76 123.71 71.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -66.18 63.52 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.23 -54.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.485 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.21 -175.77 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -27.53 57.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 111.369 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -57.56 -29.19 64.22 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.063 0.459 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.86 -27.45 49.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.46 -43.5 66.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.018 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -31.65 15.95 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.17 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 84.48 -27.56 4.64 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.687 ' NH1' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER 45.21 30.37 0.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.865 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.553 HD23 ' HD3' ' A' ' 90' ' ' ARG . 2.1 mp 65.17 -173.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 131.1 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.763 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.4 m -53.5 -37.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.731 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -62.15 -3.93 1.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.354 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -58.34 175.3 0.24 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 110.671 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.9 t -130.24 102.78 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.02 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 58' ' ' LEU . 3.2 mt -59.84 -35.39 74.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 1.5 m-85 -158.57 123.57 4.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.409 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -114.16 119.85 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 53.8 37.52 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.67 30.34 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.88 133.74 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' CZ ' ' A' ' 59' ' ' PHE . 1.4 m-20 -72.79 77.64 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' HG23 ' A' ' 68' ' ' VAL . 21.1 t -107.65 35.11 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.055 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -101.08 1.04 38.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.083 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -156.1 33.74 0.34 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.758 0.314 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -124.0 158.28 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.76 ' N ' HG22 ' A' ' 23' ' ' THR . 7.3 m -50.07 163.08 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.056 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.637 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -61.34 -48.56 80.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.834 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 t -52.73 -35.87 56.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.07 77.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.964 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -71.96 -41.62 67.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.221 0.534 . . . . 0.0 109.652 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' CD2' ' A' ' 70' ' ' HIS . 42.0 t -64.4 -36.01 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.4 -33.39 72.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.815 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.76 75.71 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.435 0.636 . . . . 0.0 110.476 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -79.69 -26.92 40.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.552 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.63 -37.85 67.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.955 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.34 25.79 7.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.401 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.95 -23.67 23.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.18 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.27 -152.3 22.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 83' ' ' ILE . 3.9 m -101.51 11.74 38.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.497 0.189 . . . . 0.0 111.338 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -151.53 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.5 t -90.59 149.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.767 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -137.67 102.29 4.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.976 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.9 154.01 50.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.3 t80 -105.68 114.8 29.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.614 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.45 168.03 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.324 0.583 . . . . 0.0 112.414 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.427 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.25 109.66 7.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.134 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.553 ' HD3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.064 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 121.024 0.44 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.26 144.49 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.268 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.0 166.41 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.424 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -133.19 106.6 7.68 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.57 155.92 16.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.742 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.95 126.07 54.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.104 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.4 tt -126.38 118.54 25.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.563 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 4.4 pt -96.84 144.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.034 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.45 158.44 36.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -136.02 -175.11 13.65 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.869 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.51 -40.75 9.85 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.269 1.98 . . . . 0.0 112.31 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -91.99 19.97 6.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.488 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.02 -141.27 15.22 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 6.6 mp -86.53 -22.35 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.926 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.43 58.39 3.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.887 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.96 155.43 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.417 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 2.7 t -116.38 116.9 28.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 172' ' ' LEU . 10.3 pt -134.16 154.82 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' CD2' ' A' ' 122' ' ' HIS . . . -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.091 0.472 . . . . 0.0 112.048 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.94 -174.99 25.51 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.494 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.63 -176.54 52.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.536 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 119' ' ' GLY . 26.0 t -81.45 154.8 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 76.06 6.1 81.96 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.19 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 165' ' ' HIS . 1.1 t30 -168.69 52.97 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 7.9 mm-40 -33.35 -43.47 0.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 14.6 t-80 73.28 -45.53 0.62 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.027 0.918 . . . . 0.0 108.891 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.78 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -122.65 130.85 24.48 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.161 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.24 89.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.445 2.097 . . . . 0.0 112.919 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.95 44.93 4.97 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.217 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -150.71 78.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.195 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -53.92 -22.97 11.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.218 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -55.31 145.49 21.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.588 HG12 ' HA3' ' A' ' 116' ' ' GLY . 8.2 mt -80.03 117.43 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.78 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -114.92 156.25 25.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.521 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 47.5 t -95.52 155.63 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.212 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.546 ' O ' HD13 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -130.17 -32.51 1.8 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.417 ' HG3' ' CB ' ' A' ' 113' ' ' SER . 1.8 pttp -160.66 145.63 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.842 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 146' ' ' LEU . 5.1 mt -131.64 141.8 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.74 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.5 mm -73.54 175.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.694 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 tt0 -99.47 139.71 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.48 29.18 60.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.583 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.91 -132.45 1.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.578 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -110.38 -61.29 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.934 0.397 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -67.15 -31.4 71.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -60.39 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -46.12 54.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.305 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.48 -59.5 2.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.564 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.31 -44.93 96.97 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.262 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 145' ' ' ARG . 0.7 OUTLIER 61.26 20.34 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.584 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -91.75 82.79 5.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.709 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 169.84 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.751 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 132' ' ' THR . 33.6 mt -47.91 121.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.276 0.56 . . . . 0.0 111.235 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.5 -22.5 6.19 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.376 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -68.85 124.97 25.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -112.73 128.96 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -102.71 130.72 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.072 0.463 . . . . 0.0 110.538 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.4 pp -98.42 -1.16 42.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.294 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.19 152.6 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.719 0.295 . . . . 0.0 111.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.945 HG13 HD23 ' A' ' 181' ' ' LEU . 40.2 t -107.4 99.7 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.445 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.9 m-80 69.18 -59.44 0.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.319 0.58 . . . . 0.0 109.739 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.02 27.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.172 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.5 t -100.6 155.22 4.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.277 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -117.0 77.4 0.28 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.572 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 31.9 mt -79.11 24.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.94 0.4 . . . . 0.0 111.928 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -139.73 32.7 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 110.652 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.79 28.05 1.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.656 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -143.29 -77.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 0.9 OUTLIER 174.74 165.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.605 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.9 p-80 -53.9 -30.7 47.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -45.2 54.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.279 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.656 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.66 -37.08 68.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.67 -36.54 73.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.107 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.564 ' HA ' HD23 ' A' ' 172' ' ' LEU . 13.4 t -73.81 -42.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.43 -33.01 69.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -77.78 -27.71 50.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.465 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.05 -36.72 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -26.85 60.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.519 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.1 -9.89 59.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.293 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 69.9 p -52.59 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.926 0.393 . . . . 0.0 111.515 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -103.61 169.8 8.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t70 -54.31 -18.85 4.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.4 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.437 HG13 HG22 ' A' ' 104' ' ' ILE . 39.0 t -147.58 92.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.94 148.19 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 112.006 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -95.65 127.16 41.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 179.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.945 HD23 HG13 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -106.87 144.32 33.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 0.0 110.869 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.36 112.45 24.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.153 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.579 HG21 HG13 ' A' ' 101' ' ' ILE . 15.6 t -101.91 161.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.51 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -144.78 140.09 28.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.469 ' O ' HG13 ' C' ' 9' ' ' VAL . 97.6 p -91.23 119.33 31.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' C' ' 8' ' ' SER . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.327 -0.845 . . . . 0.0 111.195 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.27 162.69 26.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.7 161.49 2.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.639 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 165.33 14.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.568 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.502 HG23 ' NH2' ' A' ' 50' ' ' ARG . 2.0 tt -164.45 166.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 111.809 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -133.82 138.96 45.97 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.677 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.776 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.73 86.73 2.26 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.596 0.712 . . . . 0.0 110.99 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -76.63 155.23 33.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.248 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -66.3 86.7 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.85 -26.03 10.41 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.781 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.25 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 m -109.12 30.81 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.0 -179.09 27.05 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.776 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.33 -42.74 15.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.822 0.344 . . . . 0.0 111.407 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 88.01 64.81 1.34 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 114.042 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 6.0 p90 -161.78 139.57 8.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 110.594 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 36' ' ' ILE . 73.9 m -91.76 130.98 37.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.689 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.42 ' CG2' HG12 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -132.56 163.59 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.634 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 164.0 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.371 . . . . 0.0 111.378 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 121.79 -113.84 2.38 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.534 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.96 141.45 9.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.293 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.719 HG22 ' N ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -56.2 -21.26 22.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.609 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.756 ' CB ' HG23 ' A' ' 69' ' ' THR . 38.0 t0 -93.53 -43.92 8.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -123.83 78.48 57.27 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.207 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.3 142.15 9.35 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.708 2.272 . . . . 0.0 112.633 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.7 t60 -74.97 -19.41 60.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.87 -27.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.274 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.09 28.89 9.45 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -171.14 32.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.6 111.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.6 -29.03 52.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.707 2.271 . . . . 0.0 112.009 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -62.26 169.59 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.59 149.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.981 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 10.3 p90 -142.84 144.71 32.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.578 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 18' ' ' SER . 57.9 mt -72.69 146.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.119 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 53' ' ' VAL . 16.6 m -101.19 -33.17 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.598 0.237 . . . . 0.0 111.508 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -168.94 152.67 5.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.427 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -116.36 141.25 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 ' HA2' ' A' ' 16' ' ' GLY . 3.4 pt -92.74 141.49 24.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.78 61.58 6.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.513 2.142 . . . . 0.0 112.392 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.23 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.462 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.99 175.64 23.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.709 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -76.11 -15.33 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.81 -57.46 11.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.95 0.405 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -28.55 69.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.933 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -71.92 -35.72 69.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -84.88 -25.37 28.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.009 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 82.37 56.07 2.91 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.392 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 42.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.633 HD21 HG21 ' A' ' 88' ' ' VAL . 1.2 pp 33.34 -153.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' N ' HD12 ' A' ' 51' ' ' LEU . 4.8 tpm_? -63.81 144.29 57.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.791 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -70.61 -37.62 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.515 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -54.86 -13.95 1.26 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.2 p-10 -57.45 163.1 2.5 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.271 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.6 p -122.16 110.48 15.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.707 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.724 HG22 HG12 ' A' ' 88' ' ' VAL . 2.9 pt -58.99 94.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 5.8 mt -65.14 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.037 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 9.3 m-85 -146.18 168.6 20.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.105 0.479 . . . . 0.0 111.83 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -147.18 -177.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.547 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 60' ' ' VAL . 15.6 p-10 -53.96 82.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER 65.5 26.74 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 2.5 t -121.24 141.86 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 111.368 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.49 76.36 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.777 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.42 HG12 HG21 ' A' ' 68' ' ' VAL . 16.7 m -99.48 31.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.356 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -12.88 59.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -173.37 56.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.117 0.484 . . . . 0.0 109.706 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' C ' ' HB ' ' A' ' 23' ' ' THR . 19.1 m -117.31 140.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.5 m -50.25 169.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.201 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.491 ' H ' HG22 ' A' ' 69' ' ' THR . 1.8 t-80 -51.08 -48.75 61.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -51.63 -47.9 63.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.862 0.363 . . . . 0.0 111.536 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -60.24 -32.46 71.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.86 64.46 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.616 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HA ' HD21 ' A' ' 77' ' ' LEU . 43.0 t -65.1 -35.22 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.739 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.32 -32.17 71.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.822 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.13 73.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.4 0.619 . . . . 0.0 110.385 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.559 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -72.08 -39.51 68.93 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.383 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.26 29.06 7.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.628 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -81.35 -27.49 34.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.304 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.53 -132.43 11.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.499 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.498 ' O ' HG12 ' A' ' 83' ' ' ILE . 5.4 m -125.97 5.72 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.501 0.191 . . . . 0.0 111.397 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -151.06 91.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 80' ' ' ALA . 1.7 t -93.75 148.56 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.035 0.445 . . . . 0.0 111.897 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -133.7 108.28 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -130.3 153.8 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 112.629 -178.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 59' ' ' PHE . 6.6 t80 -106.32 115.11 29.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.298 178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 57' ' ' ILE . 27.1 m -104.24 168.07 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.446 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -127.08 109.51 11.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.954 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.731 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.795 0.331 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 98' ' ' VAL . 10.0 p -82.96 116.65 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.472 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 tpt -101.31 166.04 10.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.485 0.659 . . . . 0.0 111.942 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -137.32 106.59 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.56 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 144' ' ' GLY . 3.7 mm -113.22 155.13 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HE2' ' CZ ' ' A' ' 180' ' ' TYR . 5.5 tttt -120.89 119.11 31.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.966 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.032 HD12 ' HB2' ' A' ' 140' ' ' ALA . 9.6 tt -120.67 118.7 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.48 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -95.13 144.75 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.597 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -55.69 143.63 29.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.975 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -175.46 14.09 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.814 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.59 -38.9 3.98 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 121.978 1.785 . . . . 0.0 112.1 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 18.32 11.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.479 . . . . 0.0 110.302 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.64 11.12 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.5 mp -87.08 -27.31 23.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.886 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.7 47.24 4.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.93 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.07 149.23 0.55 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.922 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 13.6 m -109.2 124.31 50.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.625 HG21 ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -135.76 155.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -152.39 125.15 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.429 . . . . 0.0 111.868 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.587 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.69 -174.99 25.31 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.195 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.11 -179.5 46.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.196 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 164' ' ' MET . 39.5 t -78.99 145.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.758 0.313 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.9 -32.12 5.81 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.624 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 2.7 t-20 -157.11 66.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.67 -4.18 22.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.96 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 16.5 t-80 72.28 -57.71 0.61 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.449 0.642 . . . . 0.0 110.478 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.3 mt -91.67 128.43 46.35 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.442 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.57 74.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.421 2.08 . . . . 0.0 112.423 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 117.93 47.74 0.43 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.84 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.747 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -165.98 93.75 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.839 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -56.86 -22.08 34.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.308 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -56.02 151.13 12.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 160' ' ' LEU . 6.4 mt -89.02 119.44 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.335 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.879 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.2 m-85 -115.77 155.09 28.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.29 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.568 HG22 HG22 ' A' ' 114' ' ' ILE . 47.6 t -84.33 155.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.739 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 148' ' ' ILE . 6.4 p -117.62 -57.89 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.486 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 146.28 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 146' ' ' LEU . 4.7 mt -129.66 141.38 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.883 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -79.29 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 45.3 mt-10 -87.05 143.38 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.05 22.88 65.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.56 -173.82 23.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.37 -69.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.032 ' HB2' HD12 ' A' ' 103' ' ' LEU . . . -63.28 -31.63 72.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 23.4 t-160 -53.38 -62.1 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.993 0.425 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -38.2 67.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.178 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.33 -59.29 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 101' ' ' ILE . . . -80.81 -18.87 69.16 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.006 -0.616 . . . . 0.0 114.024 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER 50.95 26.99 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.15 0.475 . . . . 0.0 110.791 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -87.4 81.25 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.59 175.14 3.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.536 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 132' ' ' THR . 33.0 mt -46.85 126.5 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.25 0.548 . . . . 0.0 111.293 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 120.12 -23.21 8.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.514 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -63.84 159.23 20.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.678 0.275 . . . . 0.0 110.456 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -145.82 138.8 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.004 0.431 . . . . 0.0 111.388 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -105.3 132.22 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.491 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.2 pp -99.62 -1.87 37.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.292 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.71 154.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.204 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 158' ' ' VAL . 35.4 t -108.61 99.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.875 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.542 HD22 HG12 ' A' ' 155' ' ' VAL . 68.6 m-80 69.53 -59.51 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.404 0.621 . . . . 0.0 109.578 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.9 p -164.33 28.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.028 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.5 t -102.33 155.09 5.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.489 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.85 76.74 0.25 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.736 HD22 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -81.09 25.76 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.46 56.2 1.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.333 0.587 . . . . 0.0 110.796 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -165.29 29.37 0.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.352 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.68 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.2 t -141.59 -76.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.553 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.434 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 176.62 167.76 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.605 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 169' ' ' VAL . 10.8 t-80 -54.46 -30.11 51.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.69 -49.16 27.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.049 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.68 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.66 -33.12 68.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.033 0.444 . . . . 0.0 110.225 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.23 -41.17 73.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.487 0.66 . . . . 0.0 109.484 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.818 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.9 t -69.03 -43.99 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.153 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -32.44 71.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.222 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.42 48.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.983 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -81.22 -38.47 26.93 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.868 ' HE3' HG21 ' C' ' 9' ' ' VAL . 4.0 mttp -75.19 -26.66 59.19 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.924 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.53 -9.91 52.25 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.399 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.404 ' CB ' HG21 ' A' ' 179' ' ' VAL . 1.1 p -42.85 147.21 0.32 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -90.34 170.47 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -44.93 -32.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 104' ' ' ILE . 39.9 t -148.22 91.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.404 HG21 ' CB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.22 148.32 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 0.0 111.925 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.439 ' CZ ' ' HE2' ' A' ' 102' ' ' LYS . 7.8 m-85 -101.71 133.35 46.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.771 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -118.98 149.62 41.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.941 0.401 . . . . 0.0 111.092 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 152' ' ' ILE . 22.0 mttt -96.52 112.02 23.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 101' ' ' ILE . 11.5 t -102.78 159.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.328 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.45 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -133.22 146.27 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.921 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.829 0.347 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.591 ' O ' HG13 ' C' ' 9' ' ' VAL . 98.7 p -86.28 110.77 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.868 HG21 ' HE3' ' A' ' 173' ' ' LYS . 3.6 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.038 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.876 0.369 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.49 164.04 35.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -179.79 152.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.454 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -84.11 148.66 26.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 50' ' ' ARG . 19.3 mt -148.44 152.84 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.239 0.542 . . . . 0.0 111.834 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -116.21 130.28 56.72 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.9 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.826 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.7 tp -134.98 91.5 2.76 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.608 0.718 . . . . 0.0 110.451 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 mt-10 -69.6 168.86 13.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.721 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 2.6 mtt180 -72.63 104.26 3.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.796 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -69.69 65.74 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.108 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 75.83 -76.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.261 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -109.31 30.53 6.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.4 -177.95 17.2 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.826 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.5 -52.28 6.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.28 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 78.14 1.4 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.845 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -164.74 155.76 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.74 0.305 . . . . 0.0 110.732 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.5 m -109.29 126.84 53.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.74 HG22 HG12 ' A' ' 36' ' ' ILE . 2.7 pt -120.73 164.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.755 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -171.75 157.84 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 0.0 111.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.93 -118.11 3.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.265 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 144.46 11.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.683 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -57.37 -19.27 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.555 0.217 . . . . 0.0 111.483 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.773 ' HB2' HG22 ' A' ' 69' ' ' THR . 3.7 m-20 -88.78 -54.7 4.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.868 0.366 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -120.33 81.83 30.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.9 138.04 21.42 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.643 2.229 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 13.4 t-80 -70.02 -19.55 63.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.29 -30.43 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.49 28.79 8.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.496 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.91 33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.07 112.66 1.04 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 23.7 Cg_exo -64.29 -29.32 63.72 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.739 2.293 . . . . 0.0 112.135 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 176.29 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.789 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -123.88 152.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 2.2 p90 -139.79 168.56 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.74 HG12 HG22 ' A' ' 19' ' ' ILE . 46.6 mt -95.45 153.44 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.68 -31.33 7.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 9.7 tmtt? -171.32 150.21 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 0.0 111.594 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -110.58 141.34 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.846 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.9 mt -85.81 123.5 72.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 20.2 Cg_exo -65.59 64.79 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.558 2.172 . . . . 0.0 112.218 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.17 -51.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.508 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.39 174.08 5.12 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.438 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.796 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -59.23 -34.6 72.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 0.0 111.369 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.696 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -50.9 -44.47 59.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.24 63.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.623 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -71.9 -39.16 69.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.682 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 49' ' ' GLY . 1.2 m-20 -85.96 -28.17 24.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 19.38 59.27 0.01 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.941 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CG ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.61 -15.35 13.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 51' ' ' LEU . 1.5 pt? -118.36 167.72 11.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.061 0.458 . . . . 0.0 111.281 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -107.75 159.05 16.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.049 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.4 m -70.88 -48.25 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 112.023 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' N ' HG23 ' A' ' 53' ' ' VAL . 10.0 m120 -61.22 1.37 0.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -84.52 160.91 20.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.21 113.22 18.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 110.735 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 88' ' ' VAL . 16.6 pt -56.27 95.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -65.24 -21.79 66.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.757 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.672 ' HA ' HG12 ' A' ' 65' ' ' VAL . 2.5 t80 -155.78 145.35 21.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.64 HG22 ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -129.56 117.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.722 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 56.77 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 60' ' ' VAL . 29.1 mt-10 -150.76 30.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 21.4 t -120.86 141.69 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 4.8 m-20 -77.39 90.58 3.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 57' ' ' ILE . 15.0 p -103.2 33.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.423 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 6.04 38.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 173.87 53.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 0.0 110.011 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.709 ' CG2' HG23 ' A' ' 65' ' ' VAL . 31.5 m -115.64 141.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.004 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.95 157.85 0.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.466 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -51.58 -48.57 63.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.508 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -55.8 -42.69 76.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.37 69.13 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.547 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.561 ' HA ' HD21 ' A' ' 77' ' ' LEU . 47.5 t -64.6 -35.55 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.649 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -69.53 -33.71 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.839 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.46 73.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.393 0.616 . . . . 0.0 110.491 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.57 -26.76 55.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.42 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 4.6 tttm -69.95 -38.56 76.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.067 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.27 27.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.442 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -86.23 -25.15 25.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.329 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.7 -152.91 30.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.656 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.513 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -101.82 11.09 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.641 0.258 . . . . 0.0 111.438 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -150.64 92.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.8 t -85.23 148.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.401 0.62 . . . . 0.0 111.869 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 7' ' ' THR . 2.3 mmt85 -138.16 84.13 2.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.562 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.7 pp -115.6 154.02 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.397 0.618 . . . . 0.0 112.569 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CE1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -104.84 114.84 29.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.608 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 57' ' ' ILE . 33.0 m -105.83 167.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.121 0.486 . . . . 0.0 112.193 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.4 ttp -131.62 109.44 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.312 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 90' ' ' ARG . 21.2 ttp-105 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.742 0.306 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.94 125.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.84 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.3 mtm -102.18 164.14 11.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.337 0.589 . . . . 0.0 112.08 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -127.98 106.8 9.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.492 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.86 155.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.627 ' HE3' HG12 ' A' ' 178' ' ' VAL . 9.9 tttp -117.15 118.65 32.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.376 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.78 ' HB2' HD11 ' A' ' 181' ' ' LEU . 7.9 tt -115.69 118.71 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.137 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 178' ' ' VAL . 4.5 pt -98.42 144.69 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -74.64 161.18 29.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.965 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.08 -168.66 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.849 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.09 -40.02 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.076 1.851 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -93.75 20.58 7.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.81 -142.83 15.56 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.65 -21.31 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.869 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.84 50.77 8.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.52 148.01 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 111.029 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.3 t -107.01 116.9 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.882 HD11 HD22 ' A' ' 172' ' ' LEU . 48.2 pt -115.38 173.6 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.13 -176.53 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.82 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -143.15 149.14 21.08 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.103 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.47 -94.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.072 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 34.3 t -87.38 148.63 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.28 -21.19 41.73 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.388 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.93 69.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.259 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -59.83 -19.85 53.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.274 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 12.5 t-80 72.51 -52.62 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 110.817 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.862 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.2 mt -93.3 141.09 23.53 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.839 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.569 ' HD2' HG22 ' A' ' 123' ' ' ILE . 52.9 Cg_exo -54.7 83.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.4 2.067 . . . . 0.0 112.233 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 80.01 62.13 2.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.797 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.533 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.2 t0 -159.91 93.22 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -55.98 -22.34 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.269 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -54.67 122.88 11.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 110.778 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.805 HD12 ' HB3' ' A' ' 160' ' ' LEU . 17.1 mt -72.19 117.8 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.085 0.469 . . . . 0.0 111.744 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.862 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.8 m-85 -111.95 153.9 26.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 114' ' ' ILE . 60.1 t -91.05 134.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.25 -45.35 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -122.09 132.59 54.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 111.745 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 131' ' ' VAL . 56.1 mt -137.36 128.63 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.943 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.74 173.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.738 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.596 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.0 OUTLIER -92.29 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.35 15.19 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.616 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.85 -157.41 3.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.583 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -83.54 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.277 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.17 -31.81 69.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.379 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -55.3 -58.06 9.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.196 0.522 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.8 -47.5 45.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.041 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.69 -59.42 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' CG2' ' A' ' 101' ' ' ILE . . . -61.24 -35.87 91.55 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.19 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 61.1 20.13 10.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.875 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.72 81.28 3.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.798 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.424 ' HA ' HD12 ' A' ' 134' ' ' ILE . 5.0 pt20 -65.68 176.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.508 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.9 mt -47.82 129.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.214 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 116.28 -24.92 9.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.532 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -63.99 133.44 53.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.349 . . . . 0.0 110.749 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -122.9 130.1 52.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -104.53 137.03 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 2.6 pp -98.91 -2.71 36.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.762 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 165.4 147.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.124 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.739 HG23 HD11 ' A' ' 160' ' ' LEU . 47.5 t -101.36 99.69 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.2 m-80 69.44 -58.73 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 109.666 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 155' ' ' VAL . 81.3 p -163.1 25.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.728 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 155' ' ' VAL . 23.9 t -91.59 156.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-O 121.364 0.602 . . . . 0.0 111.524 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -99.29 74.05 0.51 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.749 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.805 ' HB3' HD12 ' A' ' 129' ' ' ILE . 37.7 mt -70.61 24.1 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.717 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 159' ' ' GLY . 8.3 pt-20 -176.26 56.63 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.3 0.572 . . . . 0.0 110.924 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -161.48 27.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.573 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.678 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -153.23 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.146 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.444 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 5.5 mtp 173.06 164.48 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.482 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.6 p-80 -53.83 -29.86 42.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.939 0.399 . . . . 0.0 110.446 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.57 -45.41 53.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.151 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.678 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.22 -35.66 66.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.968 0.413 . . . . 0.0 110.604 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.71 73.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.776 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 172' ' ' LEU . 14.0 t -74.01 -39.94 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.493 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.82 68.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.671 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.36 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.882 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -80.79 -36.79 31.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -26.88 60.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.493 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.26 -12.8 60.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.207 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.501 ' HB ' HG21 ' A' ' 179' ' ' VAL . 70.9 p -55.66 -172.59 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 111.341 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -107.68 170.22 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -55.47 -16.96 4.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.347 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.627 HG12 ' HE3' ' A' ' 102' ' ' LYS . 39.1 t -147.88 92.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.501 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.92 148.41 20.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.071 0.463 . . . . 0.0 111.987 -178.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.408 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -94.81 131.19 40.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.28 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.36 146.99 43.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.13 108.11 20.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 101' ' ' ILE . 5.6 t -102.71 157.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.062 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.83 44.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.777 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.7 p -94.22 116.38 28.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 112' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -159.41 154.47 25.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 179.28 156.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.54 158.45 35.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.313 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 88' ' ' VAL . 3.5 mt -152.78 142.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.294 0.568 . . . . 0.0 111.942 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -122.22 119.38 31.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.965 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.888 HD21 ' HB2' ' A' ' 45' ' ' ALA . 3.1 tp -125.31 93.96 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.637 0.732 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -79.08 165.32 23.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.911 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.9 93.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.67 -25.89 9.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.595 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -173.53 -85.6 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 30.6 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.622 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 177.02 18.59 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.213 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.804 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.22 -43.45 14.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 -179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 92.95 71.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.713 . . . . 0.0 114.078 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.77 155.27 14.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.794 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.4 m -112.97 126.96 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.446 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.49 164.07 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.26 142.31 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 136.76 -126.89 3.89 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.71 128.47 4.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -49.58 -25.78 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 53.5 t0 -91.75 -40.92 10.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.82 77.24 57.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.67 134.89 34.22 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.644 2.23 . . . . 0.0 112.413 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.425 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.0 t60 -68.51 -21.41 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.61 -31.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.12 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.02 28.34 8.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.597 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -176.69 36.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 4.7 t0 -162.38 95.67 1.2 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.3 Cg_endo -55.68 -23.71 42.15 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.458 2.106 . . . . 0.0 112.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 159.27 32.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.01 150.77 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.52 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.4 p90 -142.53 144.96 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' SER . 64.8 mt -74.43 147.25 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.786 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -96.59 -46.52 6.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.62 -179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.44 158.29 39.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.093 0.473 . . . . 0.0 111.671 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -111.09 141.23 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.7 mt -84.5 118.16 70.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.22 76.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.42 2.08 . . . . 0.0 112.099 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . 174.22 -45.62 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.422 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.62 -178.47 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.561 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -28.41 57.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.588 0.232 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.74 -43.6 76.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.959 0.409 . . . . 0.0 110.749 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.09 65.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.866 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -71.57 -40.89 69.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.695 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.44 -25.01 25.45 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.273 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.87 -39.24 2.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.616 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 35.23 37.05 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.348 0.594 . . . . 0.0 111.095 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 40.99 -162.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.401 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.32 146.88 54.35 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.243 0.544 . . . . 0.0 111.8 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 37' ' ' THR . 19.6 m -71.0 -36.0 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.329 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -54.36 -15.12 1.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.103 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -57.17 178.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.477 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 t -136.97 110.45 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.2 pt -58.96 95.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -64.6 -21.98 66.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.542 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -157.18 148.36 21.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.549 HG12 ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -142.69 125.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.4 m120 45.85 47.94 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 64.69 26.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 16.8 t -120.79 141.76 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.016 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.63 127.47 35.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' HG13 ' A' ' 68' ' ' VAL . 34.3 m -143.71 32.52 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.076 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -76.29 2.38 13.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.555 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -173.28 46.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.108 0.48 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' C ' ' HB ' ' A' ' 23' ' ' THR . 35.6 m -110.6 141.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.754 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.665 ' N ' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -50.23 160.89 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.706 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.41 ' ND1' HG23 ' A' ' 74' ' ' VAL . 3.1 t-80 -50.97 -48.58 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.404 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.61 -40.86 63.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.933 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.84 75.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.373 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.17 69.14 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.429 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HA ' HD21 ' A' ' 77' ' ' LEU . 47.9 t -64.64 -36.06 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.54 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 7.8 mt-10 -69.54 -33.12 72.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.787 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.34 -42.81 74.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.424 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.84 -26.84 54.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.352 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.65 -44.53 61.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.098 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.27 29.19 5.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.04 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -75.85 -29.87 58.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.444 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.51 32.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.474 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -108.76 5.51 24.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.1 mt -155.85 93.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.2 m -95.13 111.46 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 68.64 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.819 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.4 pp -89.21 153.97 20.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.636 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -109.45 120.13 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.476 178.39 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.819 HG13 ' CD1' ' A' ' 86' ' ' LEU . 8.6 m -117.67 167.87 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 112.458 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 5.1 ptm -147.89 109.21 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.845 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 26.1 ttp180 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 111.167 0.062 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.485 HG23 HD21 ' A' ' 153' ' ' LEU . 11.3 p -82.31 151.25 4.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 111.833 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.92 166.85 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.858 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -122.46 106.82 11.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.497 HG13 HG21 ' A' ' 183' ' ' VAL . 1.6 mm -119.25 155.55 21.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.519 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 5.1 tttt -111.74 127.16 55.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.687 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.9 tt -125.43 118.56 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.782 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.73 144.72 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -65.44 152.77 43.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.798 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -132.37 157.71 22.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.829 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.52 -33.72 69.22 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.046 1.831 . . . . 0.0 112.16 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.59 ' HE3' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.05 18.38 13.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.25 178.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.33 -148.28 16.73 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.56 -17.99 32.63 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.166 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 73.01 51.95 9.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.081 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.546 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.33 145.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.654 0.264 . . . . 0.0 110.695 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.2 t -110.95 116.75 31.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.737 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.844 HD11 HD22 ' A' ' 172' ' ' LEU . 7.3 pt -126.99 153.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.924 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.06 125.02 10.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.0 111.789 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.71 -175.09 25.44 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.199 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 121' ' ' GLN . . . 111.75 -178.43 19.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.352 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.49 144.4 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.709 0.29 . . . . 0.0 111.349 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.04 -21.17 46.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.541 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 173.0 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.501 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 117' ' ' GLY . 9.7 pm0 -103.4 -179.66 4.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.086 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.924 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 23.6 t-80 -57.95 -50.24 74.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.042 0.925 . . . . 0.0 110.662 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.943 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -102.61 102.86 28.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.033 -178.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.42 92.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.371 2.047 . . . . 0.0 112.237 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.99 20.87 3.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.935 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -155.64 91.3 1.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -49.99 -25.86 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 p -54.01 116.32 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.765 HG12 ' HA3' ' A' ' 116' ' ' GLY . 5.6 mt -61.61 121.08 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -114.34 156.75 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.13 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 150' ' ' ASP . 53.2 t -84.1 155.5 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.691 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.649 HG22 ' CD2' ' A' ' 122' ' ' HIS . 10.5 p -119.87 -57.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -148.87 148.28 29.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 147' ' ' GLN . 26.5 mt -136.72 139.04 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.59 HD12 ' HE3' ' A' ' 108' ' ' LYS . 1.2 mt -79.56 173.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.4 tt0 -90.86 149.52 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.0 25.33 45.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.4 54.13 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.511 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -68.64 -60.36 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 111.209 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.61 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.03 -32.02 69.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -59.24 -45.74 90.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 110.145 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -72.71 -57.07 4.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.572 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.32 -59.24 2.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.03 -49.16 43.83 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.889 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 63.13 18.11 10.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.597 0.237 . . . . 0.0 111.039 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 144' ' ' GLY . 0.3 OUTLIER -93.85 78.26 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.687 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -62.73 177.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.1 mt -47.2 134.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.084 0.468 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.44 13.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.539 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -63.37 140.58 58.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.337 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -125.31 131.74 53.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.054 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -103.94 127.1 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 184' ' ' ALA . 1.7 pp -96.6 -1.55 46.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.353 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 174.49 158.74 0.17 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 111.223 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.972 HG12 ' ND2' ' A' ' 156' ' ' ASN . 22.7 t -118.65 100.07 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.972 ' ND2' HG12 ' A' ' 155' ' ' VAL . 13.0 m-80 70.41 -59.36 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 109.665 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 p -165.57 28.33 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.123 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.2 t -103.11 154.81 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.367 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.85 78.6 0.29 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.557 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 15.5 mt -76.52 23.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.85 40.3 1.83 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.095 0.474 . . . . 0.0 110.803 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.35 28.38 0.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.459 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.1 t -148.75 -76.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 174.98 169.69 0.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.666 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 169' ' ' VAL . 44.4 t-80 -55.86 -29.94 60.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.79 38.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.332 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.733 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.78 -36.93 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 110.571 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.64 -35.71 73.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.761 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.3 t -71.5 -39.94 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.93 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.56 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -76.03 -25.98 56.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.304 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.844 HD22 HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -80.32 -36.83 33.72 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -73.0 -26.87 61.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.385 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.82 -9.88 58.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.315 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.646 HG22 HG11 ' A' ' 155' ' ' VAL . 5.8 p -45.56 159.59 0.06 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.633 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -92.6 168.94 10.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.197 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.23 -34.18 6.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.396 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 104' ' ' ILE . 41.3 t -148.1 90.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 0.0 110.757 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -123.49 148.58 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 111.504 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 36.6 p90 -92.27 132.27 36.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.846 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -112.01 153.86 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.432 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 152' ' ' ILE . 25.2 mtpp -96.68 114.38 26.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.787 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 101' ' ' ILE . 24.7 t -102.02 163.91 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -145.56 149.86 35.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.396 0.617 . . . . 0.0 112.161 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.005 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 36.8 m -85.71 118.64 25.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.362 -0.828 . . . . 0.0 111.086 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.934 0.397 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.07 128.2 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -178.03 174.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.414 . . . . 0.0 111.641 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -93.55 149.67 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.632 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' HG3' ' A' ' 50' ' ' ARG . 11.3 mt -148.05 150.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 111.561 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.9 OUTLIER -115.27 119.87 37.78 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.665 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.9 tp -121.91 93.62 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.45 0.643 . . . . 0.0 110.097 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -75.27 151.4 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.001 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 82' ' ' SER . 32.3 mtt180 -72.02 103.87 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.9 -26.89 6.09 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.774 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -169.47 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 p -109.28 30.73 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.39 173.73 17.89 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.519 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.896 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.4 -50.02 8.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.753 0.311 . . . . 0.0 111.138 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 100.93 79.15 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.674 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.798 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -164.7 159.2 18.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.607 178.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 36' ' ' ILE . 30.8 t -112.74 126.85 55.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.701 HD11 ' CE1' ' A' ' 70' ' ' HIS . 4.7 pt -118.21 171.71 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.62 149.02 2.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.44 -120.66 4.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.196 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . 105.23 145.68 13.86 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.686 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -50.67 -24.94 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.682 0.277 . . . . 0.0 111.472 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.681 ' CB ' HG23 ' A' ' 69' ' ' THR . 19.2 t0 -86.68 -48.2 8.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.213 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.89 80.36 56.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 126.64 19.12 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.596 2.197 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 35' ' ' PHE . 17.0 t60 -67.3 -19.42 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.87 -26.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.14 34.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -168.32 111.56 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . 23.3 Cg_exo -64.83 -28.73 59.01 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.151 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -72.88 144.21 47.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 35' ' ' PHE . 15.0 mt -93.55 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.478 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.39 153.5 43.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 18' ' ' SER . 59.9 mt -84.8 150.74 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.589 ' O ' HG21 ' A' ' 53' ' ' VAL . 61.2 p -100.02 -46.61 5.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.871 0.367 . . . . 0.0 111.037 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -157.07 155.92 31.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.344 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mt -113.87 141.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.927 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 134.43 43.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.55 60.38 5.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.094 . . . . 0.0 112.301 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.7 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.65 168.81 26.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.58 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -61.73 -25.86 67.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 111.506 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.4 -57.54 12.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.2 -28.27 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.956 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -72.1 -41.95 66.68 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -72.61 -33.27 66.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.414 178.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 29.31 39.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.838 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.808 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.8 ptm180 -98.69 28.45 4.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.645 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -176.43 164.89 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.002 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.89 164.09 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.656 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -70.93 -47.27 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.015 0.436 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' N ' HG23 ' A' ' 53' ' ' VAL . 40.7 m-80 -58.87 -4.85 0.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -62.31 175.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.312 -0.242 . . . . 0.0 110.552 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 p -141.52 106.03 4.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.134 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -54.55 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.429 0.633 . . . . 0.0 111.159 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.32 -25.66 63.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.118 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.5 t80 -163.87 144.03 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.711 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.1 p -103.92 -176.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.012 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.687 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.7 m120 -21.59 -51.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.601 0.563 . . . . 0.0 111.857 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 tt0 -163.72 27.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.702 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.8 t -121.59 142.0 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.693 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 23.5 p30 -79.63 84.34 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.058 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 HG21 ' A' ' 68' ' ' VAL . 5.8 m -91.04 26.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.02 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -95.91 9.26 41.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.286 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' HG2' ' CB ' ' A' ' 32' ' ' PRO . 3.9 mt-10 -166.14 37.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 65' ' ' VAL . 35.9 m -118.68 141.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.9 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.766 ' N ' HG22 ' A' ' 23' ' ' THR . 3.8 m -50.34 166.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.701 ' CE1' HD11 ' A' ' 19' ' ' ILE . 3.2 t-80 -59.09 -48.71 80.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.2 m -60.73 -36.86 79.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.33 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.976 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.08 -42.32 66.33 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 72.8 t -64.65 -35.96 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.806 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.49 -33.2 72.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.798 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.53 -42.4 74.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 110.416 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -78.18 -26.85 47.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.439 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -71.71 -40.03 69.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.072 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.07 26.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.525 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.08 -19.49 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.342 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.37 -120.03 6.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.637 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.541 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -137.17 18.13 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.548 0.213 . . . . 0.0 111.244 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.76 94.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 8' ' ' LEU . 34.8 m -90.39 112.75 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -101.2 80.9 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.964 HD13 HG13 ' A' ' 88' ' ' VAL . 1.7 pp -109.79 153.08 24.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.258 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 4.7 t80 -102.04 114.66 28.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.847 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.964 HG13 HD13 ' A' ' 86' ' ' LEU . 35.3 m -112.05 167.98 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.209 0.528 . . . . 0.0 112.172 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 mtp -127.87 109.52 11.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.817 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 120.87 0.367 . . . . 0.0 111.14 -179.308 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.832 0.349 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.85 142.59 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.71 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.42 17.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.112 0.482 . . . . 0.0 111.366 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.84 106.21 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -116.84 155.34 18.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.648 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 17.7 pttm -114.15 126.57 55.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.359 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.663 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -127.58 118.64 24.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.562 HG22 HG13 ' A' ' 178' ' ' VAL . 4.4 pt -95.97 144.69 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -72.82 156.28 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.975 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.55 -168.79 12.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.821 -0.705 . . . . 0.0 111.826 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.25 -39.55 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.107 1.871 . . . . 0.0 112.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 19.6 8.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.049 0.452 . . . . 0.0 110.334 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.92 -143.21 15.78 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.275 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 103' ' ' LEU . 5.7 mp -86.72 -21.5 26.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.184 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.23 4.38 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.701 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.14 148.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -108.6 116.96 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 172' ' ' LEU . 27.4 pt -121.79 162.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.636 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -122.96 127.62 49.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.838 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -80.63 156.8 39.18 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.715 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . -49.58 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 164' ' ' MET . 15.7 t -54.38 134.37 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.822 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.6 -26.14 19.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.92 83.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -67.44 2.7 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.954 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 25.8 t-80 79.63 -60.54 0.33 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.799 0.809 . . . . 0.0 110.497 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.432 HG12 ' ND1' ' A' ' 122' ' ' HIS . 1.5 mm -118.06 101.25 51.77 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.514 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.42 94.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.478 2.119 . . . . 0.0 112.092 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.95 -15.61 1.54 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.774 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.4 84.57 2.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.903 0.382 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -41.65 -28.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -51.8 152.69 2.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.546 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.838 HG12 ' HA2' ' A' ' 116' ' ' GLY . 51.1 mt -75.44 124.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.977 0.418 . . . . 0.0 111.285 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 151' ' ' LYS . 4.9 m-85 -114.71 132.26 56.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.7 t -61.68 155.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.345 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 148' ' ' ILE . 12.3 p -118.61 -57.71 2.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.396 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 143.64 25.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.246 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 131' ' ' VAL . 5.3 mt -129.96 141.63 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.801 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.39 173.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.603 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.7 mt-10 -93.12 149.1 21.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.99 29.29 51.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.67 -167.55 43.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.54 -55.08 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.565 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.13 -31.88 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.267 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.04 -55.67 31.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 0.0 110.316 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -72.8 -48.56 37.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.56 -59.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.891 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -58.5 -49.74 73.81 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.077 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 18.23 11.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.645 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -96.17 81.01 3.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.715 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.41 171.2 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.678 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -46.67 127.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.316 0.579 . . . . 0.0 111.22 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.09 -24.81 9.15 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.339 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -67.95 131.59 45.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -116.87 134.11 55.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.118 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.39 131.94 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -96.71 -4.1 41.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.231 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.19 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.435 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 158' ' ' VAL . 38.4 t -103.92 99.7 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.759 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.759 ' ND2' HG12 ' A' ' 155' ' ' VAL . 36.5 m-80 69.28 -59.41 0.48 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.338 0.59 . . . . 0.0 109.592 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 m -165.02 29.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.941 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.0 t -104.26 155.08 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.564 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -110.91 74.57 0.21 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.645 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -78.05 25.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.984 0.421 . . . . 0.0 111.586 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -155.79 27.87 0.38 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.307 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.53 27.74 2.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.652 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -144.99 -72.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.643 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.57 ' HG3' HG21 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 174.78 162.58 0.22 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.241 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.8 p-80 -53.54 -30.09 40.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.271 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -45.17 53.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.652 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -73.1 -35.37 66.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.918 0.39 . . . . 0.0 110.637 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.58 -34.92 72.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.167 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.628 ' HA ' HD23 ' A' ' 172' ' ' LEU . 10.5 t -71.93 -44.09 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.99 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.128 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.73 -27.7 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.75 -39.44 24.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.005 0.431 . . . . 0.0 110.192 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -26.69 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.055 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -72.78 -10.0 59.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.535 ' HB ' HG21 ' A' ' 179' ' ' VAL . 63.8 p -58.91 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.794 0.331 . . . . 0.0 111.264 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -102.19 169.95 8.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.26 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.9 t70 -55.7 -17.41 5.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.361 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.41 91.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.535 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.9 148.14 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.733 -179.094 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.9 m-85 -101.71 125.9 48.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -111.83 152.72 27.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.58 120.37 36.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.884 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 101' ' ' ILE . 18.1 t -102.21 160.67 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.493 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -124.87 133.89 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 7' ' ' SER . . . . . 0.4 ' OG ' HG21 ' A' ' 169' ' ' VAL . 1.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.793 0.33 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -117.12 118.01 31.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.445 HG11 HD11 ' A' ' 172' ' ' LEU . 10.4 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.34 -0.838 . . . . 0.0 111.111 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 90' ' ' ARG . 8.5 tp10 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.869 0.366 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.82 161.39 15.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.628 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -176.69 141.34 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.889 0.375 . . . . 0.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 16.3 pt-20 -110.35 154.62 23.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -166.11 159.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 111.972 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.652 HG23 HH11 ' A' ' 85' ' ' ARG . 0.8 OUTLIER -107.17 123.44 48.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.364 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.827 ' HG ' HD23 ' A' ' 15' ' ' LEU . 2.5 tp -116.1 93.52 4.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.598 0.713 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.744 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -66.66 143.1 57.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.798 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.68 101.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.485 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.22 -27.4 5.39 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.725 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.6 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -109.28 30.63 6.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.883 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.04 -179.65 20.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.008 -1.091 . . . . 0.0 112.248 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.47 -63.19 1.38 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.649 0.262 . . . . 0.0 111.309 -179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.79 62.66 0.39 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.599 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.728 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 7.9 p90 -149.5 138.9 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.543 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' ILE . 5.9 m -79.48 126.69 31.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 36' ' ' ILE . 23.5 pt -131.23 155.11 41.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -172.95 152.7 2.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.74 -122.82 2.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.36 128.82 4.46 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.404 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -51.84 -27.23 11.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.87 -42.01 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.79 77.45 57.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.26 146.21 13.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.718 2.279 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 10.8 t-80 -77.57 -19.38 55.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.528 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.15 -32.74 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 111.007 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.95 26.04 6.53 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.539 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.49 38.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.37 96.64 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.04 -22.68 48.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.485 2.124 . . . . 0.0 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.86 158.66 33.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.74 149.27 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 7.1 p90 -142.73 163.5 32.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.898 0.38 . . . . 0.0 111.042 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' SER . 45.7 mt -94.82 148.49 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -104.4 -33.99 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.627 0.251 . . . . 0.0 111.401 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.34 150.93 4.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.38 . . . . 0.0 111.348 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.4 mt -111.45 141.07 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.9 pt -89.63 136.03 30.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.67 58.2 6.7 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.53 2.153 . . . . 0.0 112.387 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.0 -61.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.618 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.56 -173.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.628 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -72.04 -26.45 62.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.576 0.227 . . . . 0.0 111.522 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -54.1 -57.4 11.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -60.08 -27.85 67.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -71.87 -45.68 60.5 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -68.39 -35.49 77.76 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.252 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.07 48.4 0.01 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.203 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.96 20.62 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.732 0.266 . . . . 0.0 111.291 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.494 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -158.23 162.96 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.334 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -98.18 158.25 15.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.396 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -71.2 -46.14 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 p30 -62.83 3.96 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.738 ' OD2' HG21 ' A' ' 88' ' ' VAL . 53.0 p-10 -76.17 174.15 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.9 t -129.8 102.86 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 110.961 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.977 HD11 HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -55.65 95.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.734 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -22.65 60.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.1 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -153.46 155.22 35.88 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.965 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.977 HG13 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -152.52 130.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.447 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.58 35.07 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.228 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.13 30.96 2.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 t -120.92 141.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -73.34 116.02 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 68' ' ' VAL . 33.4 t -143.98 40.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -100.3 9.24 43.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.153 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 178.5 44.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.928 0.394 . . . . 0.0 110.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 65' ' ' VAL . 6.6 m -109.63 147.26 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.562 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.69 ' N ' HG22 ' A' ' 23' ' ' THR . 65.0 p -49.32 170.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.845 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.5 t-80 -63.67 -49.02 74.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.323 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -36.34 83.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -35.53 72.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.23 64.74 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 109.804 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' HD21 ' A' ' 77' ' ' LEU . 58.4 t -63.99 -36.57 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -69.52 -32.81 71.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.74 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -43.37 73.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 110.636 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.78 -26.77 54.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.461 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -70.73 -40.64 72.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.134 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 8.8 tt0 -101.24 27.32 6.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.317 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.77 -23.06 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.423 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.93 -161.81 24.82 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.785 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 9.7 t -86.23 -51.29 6.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.744 HG23 ' HG2' ' A' ' 9' ' ' GLU . 17.0 mt -99.25 84.69 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.9 m -85.24 116.26 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.677 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.652 HH11 HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -77.2 80.5 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.651 ' HB2' HD12 ' A' ' 57' ' ' ILE . 2.4 pp -84.89 135.41 34.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.24 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -116.72 114.49 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.391 178.558 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.1 m -124.89 168.41 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.093 0.473 . . . . 0.0 111.998 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 109.06 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.802 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.675 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 111.7 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 0.0 110.755 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 mmm -93.61 166.66 12.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.398 0.618 . . . . 0.0 111.798 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -136.34 106.54 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 146' ' ' LEU . 2.7 mm -112.7 155.16 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -110.82 126.13 54.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.304 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.837 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.7 tt -127.16 118.56 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -96.44 144.64 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.43 157.47 30.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.19 -169.38 12.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.921 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.69 -30.78 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.145 1.896 . . . . 0.0 112.283 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.52 18.38 12.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.061 0.458 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.2 -146.34 16.06 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.427 ' HB2' HG23 ' C' ' 9' ' ' VAL . 7.4 mp -86.46 -20.36 28.24 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.908 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 80.74 46.13 7.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.346 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.58 154.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.687 0.244 . . . . 0.0 110.98 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.31 126.33 51.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.649 HG22 HG22 ' A' ' 131' ' ' VAL . 9.0 pt -134.97 153.18 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.633 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -150.55 124.91 9.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.854 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.67 -175.11 25.43 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.065 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 161' ' ' GLU . . . 77.38 -169.25 54.8 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.422 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 119' ' ' GLY . 38.9 t -78.64 154.56 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.337 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 92.45 -25.59 17.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.03 77.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.1 pt20 -72.91 6.83 2.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.384 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 25.5 t-80 72.72 -59.17 0.57 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.53 0.681 . . . . 0.0 111.331 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.867 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.4 OUTLIER -87.7 111.58 43.03 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.895 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 79.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.475 2.117 . . . . 0.0 112.243 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 121.68 40.24 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.523 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -175.52 96.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.79 0.328 . . . . 0.0 110.74 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.55 -23.36 50.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 58.3 m -47.44 128.34 12.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.54 HG12 ' HA3' ' A' ' 116' ' ' GLY . 37.7 mt -65.9 123.96 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.934 0.397 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.867 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.0 m-85 -122.89 156.91 33.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.499 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 114' ' ' ILE . 72.8 t -89.32 151.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 148' ' ' ILE . 11.3 p -111.44 -58.46 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.496 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 147.91 28.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' GLY . 6.5 mt -128.37 141.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 136' ' ' GLU . 4.3 mm -66.06 175.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.623 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -92.93 133.67 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.857 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.5 25.19 33.87 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.85 -160.72 1.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.513 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.57 -59.72 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.0 111.277 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.13 -31.97 69.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.582 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -53.88 -54.34 40.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.19 0.519 . . . . 0.0 110.392 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -72.9 -53.15 12.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.043 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.74 -59.29 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.153 0.502 . . . . 0.0 111.943 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -49.02 -46.94 32.9 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.453 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 65.76 16.99 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.617 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.541 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -106.87 83.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.483 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.96 175.81 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 132' ' ' THR . 33.3 mt -47.46 122.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.354 0.597 . . . . 0.0 111.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.06 -21.73 6.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.311 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.611 ' OD1' HG21 ' A' ' 131' ' ' VAL . 8.5 p-10 -64.2 131.99 49.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.882 0.372 . . . . 0.0 110.409 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -108.24 125.05 51.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -104.61 133.92 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.046 0.451 . . . . 0.0 110.647 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -93.98 -4.03 50.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.637 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . 173.52 156.65 0.12 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.936 0.398 . . . . 0.0 110.857 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 39.2 t -109.92 100.07 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 179' ' ' VAL . 2.1 m-80 56.82 32.21 20.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p 82.92 25.83 0.13 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.856 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.8 t -135.21 146.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-O 121.426 0.631 . . . . 0.0 112.659 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 96.29 -73.54 0.8 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.584 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.637 HD23 ' HB2' ' A' ' 154' ' ' ALA . 0.0 OUTLIER 35.83 33.5 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.821 -0.689 . . . . 0.0 111.955 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' SER . 0.9 OUTLIER 35.82 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.926 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -114.43 36.95 3.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.485 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -151.17 -71.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.344 0.592 . . . . 0.0 110.607 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 1.1 mtm 175.42 160.45 0.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 74.7 t60 -53.68 -31.43 47.71 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.175 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.92 -41.03 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.485 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.58 -38.43 62.65 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.683 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.6 -38.96 74.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.648 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.655 ' HA ' HD23 ' A' ' 172' ' ' LEU . 29.3 t -72.99 -46.93 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.092 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.38 69.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.36 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.42 -33.99 58.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.373 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -81.34 -36.85 29.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.945 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' C' ' 9' ' ' VAL . 7.4 mmtt -72.94 -26.83 61.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.482 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -76.29 -10.04 59.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.9 p -60.44 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 111.486 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -114.28 173.12 6.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -13.08 3.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 104' ' ' ILE . 40.6 t -147.34 91.11 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.728 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -128.93 148.61 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.995 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 39.3 p90 -107.61 135.29 49.31 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-O 121.052 0.453 . . . . 0.0 111.99 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -111.06 159.3 17.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.677 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -100.28 117.35 34.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 184' ' ' ALA . 12.8 t -101.9 159.67 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -126.3 141.04 52.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 52.9 p -92.63 118.78 31.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 173' ' ' LYS . 19.5 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.245 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -134.04 166.05 23.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -176.63 159.06 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 13.6 pt-20 -96.05 154.76 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.851 HG22 ' O ' ' A' ' 86' ' ' LEU . 19.2 tt -153.37 164.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.568 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -123.27 122.82 39.32 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.704 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 45' ' ' ALA . 1.2 tp -125.8 93.04 3.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.752 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.761 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -73.65 166.08 23.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.591 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -80.97 95.37 6.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.63 8.03 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.598 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -168.98 -89.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.069 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -109.22 30.85 6.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.51 177.07 24.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.395 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -84.43 -48.66 9.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.766 0.317 . . . . 0.0 111.5 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.24 65.53 0.67 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.77 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.4 p90 -164.69 162.9 21.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.298 . . . . 0.0 110.689 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.75 133.79 54.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.531 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 pt -120.43 171.28 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.8 152.34 3.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.345 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 119.08 -115.25 3.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.49 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 146.23 15.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.257 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -54.05 -23.87 15.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.615 0.245 . . . . 0.0 111.475 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.83 0.347 . . . . 0.0 111.443 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.06 77.55 41.63 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 129.14 21.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.422 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.8 t60 -66.57 -20.67 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.486 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.32 -27.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.309 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.31 26.51 18.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.628 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -168.69 33.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.29 100.85 0.7 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.754 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.68 -26.85 67.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.401 2.068 . . . . 0.0 112.142 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -66.95 177.94 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.614 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -125.88 153.43 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.0 p90 -142.49 148.89 38.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.537 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 73.2 mt -75.15 150.45 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.794 ' O ' HG21 ' A' ' 53' ' ' VAL . 2.5 p -102.88 -40.51 6.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.601 0.239 . . . . 0.0 111.621 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.885 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.77 146.26 6.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.0 111.437 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -103.52 141.33 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.108 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.8 mm -85.28 136.28 38.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 40' ' ' ILE . 72.9 Cg_endo -76.29 58.79 5.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.212 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.58 -54.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.03 -175.38 0.2 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.86 -31.4 59.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.666 0.269 . . . . 0.0 111.224 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.72 -26.25 44.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.542 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -78.14 -27.49 48.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.574 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.35 -43.75 66.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.954 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -93.74 -29.02 15.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.492 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 89.15 -33.69 4.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.63 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 48.32 25.17 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.846 HD13 ' CZ ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 66.86 -167.58 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.959 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 153.05 25.08 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.097 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.885 HG11 ' HA ' ' A' ' 38' ' ' LYS . 28.5 m -71.16 -36.72 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -52.06 -16.14 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.512 ' OD2' HG21 ' A' ' 88' ' ' VAL . 37.0 p-10 -59.03 156.31 12.01 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 35.6 m -121.55 126.28 48.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.954 ' HA ' HG12 ' A' ' 88' ' ' VAL . 9.4 pt -65.63 94.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.276 0.56 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 89' ' ' MET . 24.5 mt -76.77 -28.2 55.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.482 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -150.89 116.15 5.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.432 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' CG1' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -131.69 125.55 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.611 HD21 HG13 ' A' ' 84' ' ' VAL . 28.9 m120 55.02 36.87 27.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.13 27.49 17.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.25 141.69 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.34 72.04 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.2 t -98.04 34.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -9.63 27.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.51 43.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.76 0.314 . . . . 0.0 111.615 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.94 155.57 30.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.232 0.539 . . . . 0.0 111.038 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.775 ' N ' HG22 ' A' ' 23' ' ' THR . 21.2 m -49.99 161.8 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.901 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' CE1' ' CG2' ' A' ' 74' ' ' VAL . 3.3 t-80 -58.98 -48.49 81.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.531 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -52.09 -37.53 54.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.401 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.37 80.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.59 66.47 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.264 0.554 . . . . 0.0 109.578 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 77' ' ' LEU . 55.0 t -64.81 -35.29 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.682 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 47.4 tt0 -69.65 -32.33 70.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.938 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.36 -41.54 76.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.378 0.609 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.31 -26.22 55.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 4.1 tttt -72.39 -35.21 68.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -113.35 28.76 8.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.203 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -92.42 -21.44 20.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.63 -137.51 13.39 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 83' ' ' ILE . 8.6 t -121.17 17.49 11.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.675 0.274 . . . . 0.0 111.414 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.761 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.5 mt -154.07 95.84 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 61' ' ' ASN . 0.9 OUTLIER -102.01 143.38 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.215 0.531 . . . . 0.0 112.429 -178.076 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 15.9 tpp85 -100.35 93.4 5.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.782 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.851 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -88.4 115.36 25.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.347 0.594 . . . . 0.0 112.555 -177.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.5 114.06 27.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.06 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.5 m -132.21 168.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 58' ' ' LEU . 1.3 ttp -107.91 109.23 20.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.492 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.846 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.463 . . . . 0.0 111.551 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.844 0.354 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.63 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -82.78 148.13 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.432 ' HB2' ' HB ' ' A' ' 183' ' ' VAL . 13.9 mtp -124.21 166.73 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 0.0 111.208 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.3 7.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.053 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 183' ' ' VAL . 3.4 mm -113.62 155.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.418 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.99 128.43 56.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.989 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.1 tt -130.39 118.32 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.071 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.73 144.53 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.987 0.422 . . . . 0.0 111.059 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 4.0 tttt -66.93 149.11 51.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.979 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.08 -174.6 13.65 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.006 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.44 -36.8 14.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.317 2.011 . . . . 0.0 112.317 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -93.84 19.46 8.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.938 0.399 . . . . 0.0 110.498 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.73 -140.97 15.12 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HG ' HD22 ' A' ' 103' ' ' LEU . 7.4 mp -86.64 -22.39 26.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.01 46.9 5.2 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.013 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 146.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.611 0.243 . . . . 0.0 110.861 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 m -108.67 116.85 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 131' ' ' VAL . 8.5 pt -129.15 152.9 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.561 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.547 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -151.82 125.84 9.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 112.063 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.626 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.64 -175.26 25.57 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.882 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.91 176.49 14.49 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.732 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.66 153.65 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.854 0.359 . . . . 0.0 111.357 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.16 -5.89 65.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.72 79.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.87 142.49 27.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.447 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.547 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 1.8 t-80 -45.08 -37.85 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.803 0.811 . . . . 0.0 110.517 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.83 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.5 mt -100.43 143.14 25.97 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.583 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 123' ' ' ILE . 45.4 Cg_exo -56.7 83.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.615 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.13 53.49 2.81 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.102 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.5 t70 -154.7 87.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 111.149 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -52.85 -24.4 8.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.9 m -52.12 125.55 16.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -73.69 113.4 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.833 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.83 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -106.96 172.83 6.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.722 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 114' ' ' ILE . 48.3 t -109.44 148.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.813 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 -29.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 137.65 31.34 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.835 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 147' ' ' GLN . 43.9 mt -137.12 138.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.67 173.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -87.25 140.94 29.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.876 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.02 26.23 55.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.33 -175.07 9.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.08 -66.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.829 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.01 -37.34 75.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.429 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -51.96 -45.85 64.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.038 0.446 . . . . 0.0 110.67 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -57.3 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.038 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.56 -59.59 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.64 -33.6 85.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.176 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 59.94 20.96 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.829 HD21 ' HB1' ' A' ' 140' ' ' ALA . 1.2 pp -83.79 83.79 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.437 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -67.62 170.92 6.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.63 120.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.277 0.56 . . . . 0.0 111.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.28 -19.7 5.97 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -66.29 118.39 9.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.735 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.462 ' HB2' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -99.28 123.85 43.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.985 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -99.86 121.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 110.067 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.63 HD21 HG13 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -87.44 -0.44 56.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.72 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.97 159.98 0.12 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.562 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 181' ' ' LEU . 36.9 t -117.52 98.85 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.589 ' ND2' ' CE2' ' A' ' 180' ' ' TYR . 9.7 m120 68.32 -57.72 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.394 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 p -146.01 -18.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.613 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -78.02 129.14 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.42 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.68 7.75 1.38 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 129' ' ' ILE . 20.3 mt 42.71 29.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.469 0.634 . . . . 0.0 112.044 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -178.14 75.36 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 163' ' ' VAL . 1.4 p30 -157.68 26.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -157.0 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.923 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 178.63 -172.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.667 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.9 t-80 -67.45 -37.42 82.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.027 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.738 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.3 -35.55 61.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.854 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.7 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -69.69 -37.24 76.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 172' ' ' LEU . 39.4 t -69.44 -41.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.355 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.28 -29.27 64.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.727 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.94 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.879 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.28 -39.45 25.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.109 0.481 . . . . 0.0 109.929 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.403 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 12.0 pttt -75.18 -26.78 59.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.102 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -20.75 23.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 179' ' ' VAL . 76.6 p -54.52 -172.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 178' ' ' VAL . 8.8 p90 -125.03 -162.24 1.08 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.7 m-20 -59.7 -21.6 60.84 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 38.2 t -147.66 91.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 118.728 0.694 . . . . 0.0 111.511 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.92 148.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.919 0.39 . . . . 0.0 111.887 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.589 ' CE2' ' ND2' ' A' ' 156' ' ' ASN . 21.8 p90 -105.23 126.18 51.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.328 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -106.75 149.05 27.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mtpt -96.39 119.16 34.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 101' ' ' ILE . 11.8 t -101.89 161.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -134.78 144.76 47.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.64 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t -83.47 111.31 18.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.164 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB3' ' CE2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.808 0.337 . . . . 0.0 111.199 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -98.3 156.42 16.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 1' ' ' MET . 0.1 OUTLIER -154.84 144.15 21.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -179.39 159.01 0.89 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.845 0.355 . . . . 0.0 111.445 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -101.01 156.41 17.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.656 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -158.46 155.19 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.7 OUTLIER -110.22 121.7 45.9 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.854 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.3 tp -116.16 93.3 4.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.429 0.633 . . . . 0.0 110.337 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.28 135.34 42.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.224 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 2.3 mtp180 -56.29 103.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.691 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.13 -28.81 13.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.469 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.07 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.45 . . . . 0.0 109.929 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -109.15 30.67 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.683 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' CA ' ' HG2' ' A' ' 10' ' ' ARG . . . 147.03 171.26 16.06 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.04 -49.36 8.99 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.905 0.384 . . . . 0.0 110.991 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 99.22 80.18 1.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.577 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.9 p90 -164.43 149.91 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.713 0.292 . . . . 0.0 110.483 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 36' ' ' ILE . 18.1 p -105.85 127.01 52.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 111.55 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 36' ' ' ILE . 25.4 pt -119.51 166.0 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.857 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -172.78 153.6 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.234 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.71 -120.45 2.67 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.27 141.02 8.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.172 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -56.91 -18.81 14.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 69' ' ' THR . 12.4 t0 -91.57 -52.51 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -119.5 79.56 21.52 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.26 138.31 23.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 0.0 112.414 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 8.5 t-80 -69.28 -18.63 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.48 -36.98 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 110.985 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.37 24.79 6.05 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.01 40.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -162.15 98.82 1.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 17.7 Cg_endo -57.62 -27.0 75.23 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.09 . . . . 0.0 112.194 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -74.04 141.2 45.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.03 152.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.1 p90 -142.26 166.48 24.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.713 HG12 HG22 ' A' ' 19' ' ' ILE . 53.1 mt -92.19 153.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.15 -39.77 5.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.628 0.251 . . . . 0.0 111.664 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.929 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.28 156.42 14.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.107 0.479 . . . . 0.0 111.644 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.425 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -118.42 141.33 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.5 mt -88.14 126.78 59.7 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 16.9 Cg_exo -66.76 63.13 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.141 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.5 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.84 -177.82 0.93 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.466 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -73.82 -18.72 60.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.04 -57.38 13.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.13 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.14 69.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.32 -41.56 66.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' CB ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -76.02 -32.23 59.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.7 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.64 44.61 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 113.901 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HB3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -93.1 21.71 5.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.695 0.247 . . . . 0.0 111.581 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.768 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.8 pt? -176.36 170.11 2.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.999 0.428 . . . . 0.0 111.325 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' NH1' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -101.61 163.44 12.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.499 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.929 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -71.06 -46.54 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 112.04 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.513 ' N ' HG23 ' A' ' 53' ' ' VAL . 15.9 m120 -69.53 11.41 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.5 p-10 -76.92 176.92 8.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -127.87 102.66 6.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.801 HG22 HG12 ' A' ' 88' ' ' VAL . 2.4 pt -57.43 94.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 111.157 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.48 -28.54 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.501 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -163.25 150.57 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -141.28 131.68 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 45.3 38.82 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.192 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 61.6 33.92 18.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 141.68 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.173 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 68' ' ' VAL . 9.0 p-10 -66.93 100.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' A' ' 60' ' ' VAL . 37.9 t -133.1 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.106 0.479 . . . . 0.0 110.911 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -105.06 -14.51 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.93 47.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.813 0.339 . . . . 0.0 111.131 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.62 149.64 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.21 0.528 . . . . 0.0 111.102 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -49.74 154.77 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.937 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -51.81 -48.36 63.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.258 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -49.63 -36.41 24.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.03 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.56 63.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -40.7 68.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.696 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.542 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -65.7 -35.54 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.633 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 3.1 mt-10 -69.59 -32.48 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.875 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.31 76.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.447 0.641 . . . . 0.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.548 HD13 HG21 ' B' ' 9' ' ' VAL . 2.7 pp -75.84 -26.5 57.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.47 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -68.82 -35.89 77.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.218 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.64 28.87 8.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.809 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -77.79 -29.25 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.355 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.49 -101.08 2.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.607 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 69.1 m -152.65 -52.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.798 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -98.33 84.93 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -84.63 113.73 23.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.676 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.804 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 ttt85 -92.78 78.83 4.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.075 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.484 ' CB ' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.08 154.03 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.402 -178.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 1.9 t80 -109.51 115.0 29.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.151 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 57' ' ' ILE . 31.6 m -108.46 168.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 112.397 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.25 109.42 7.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.634 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -113.23 112.75 24.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.93 144.4 56.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.125 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -55.67 164.29 1.65 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.039 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 31.7 Cg_endo -64.13 149.13 91.01 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.487 2.124 . . . . 0.0 112.099 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 16.5 Cg_exo -67.35 -161.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.529 2.153 . . . . 0.0 112.228 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.571 ' HB3' ' H ' ' A' ' 189' ' ' ALA . . . -158.7 28.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.452 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 187' ' ' SER . 41.1 tt0 -86.15 111.88 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 142.19 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 98' ' ' VAL . 14.5 p -103.22 115.71 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.45 166.6 12.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.605 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.96 106.58 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.882 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 181' ' ' LEU . 3.6 mm -114.19 155.36 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' CG ' ' CD2' ' A' ' 180' ' ' TYR . 2.7 mtmp? -108.02 123.92 49.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.428 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 181' ' ' LEU . 2.5 tt -129.91 118.62 21.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.71 HG22 HG23 ' A' ' 178' ' ' VAL . 4.4 pt -93.96 144.61 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -70.64 152.79 43.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.095 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.62 160.72 23.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.756 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.97 -37.5 86.07 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.094 1.863 . . . . 0.0 112.033 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 20.96 9.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.048 0.451 . . . . 0.0 110.053 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.47 -155.46 17.92 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.283 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.763 HD23 HD13 ' A' ' 103' ' ' LEU . 9.1 mp -86.48 -13.36 46.3 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.075 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.66 63.11 2.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.862 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.684 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.84 150.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.355 . . . . 0.0 110.999 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.72 116.88 32.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 131' ' ' VAL . 8.9 pt -136.52 153.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -151.55 125.0 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.84 -175.13 25.58 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.205 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.9 178.36 51.07 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.442 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 26.0 t -74.08 150.27 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.819 0.342 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.37 -29.46 6.12 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.858 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.71 69.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.48 -4.63 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.688 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.558 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 19.0 t-80 72.48 -58.1 0.6 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.547 0.689 . . . . 0.0 110.578 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.917 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.46 137.56 30.55 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.428 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 123' ' ' ILE . 49.6 Cg_endo -68.71 62.21 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.236 1.957 . . . . 0.0 112.339 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.1 57.29 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.723 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.689 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -174.44 99.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -60.44 -19.72 57.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.324 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -57.31 151.3 16.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 168' ' ' ALA . 2.8 mt -91.03 115.35 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.917 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 m-85 -109.33 153.9 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.62 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 114' ' ' ILE . 75.7 t -90.72 155.72 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.456 ' HA ' HG23 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -136.03 -27.62 1.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 147.96 27.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.982 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.678 HD11 ' O ' ' A' ' 146' ' ' LEU . 42.0 mt -137.21 141.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.51 173.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.585 ' H ' HG22 ' A' ' 135' ' ' ILE . 28.7 mt-10 -93.55 133.15 37.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.844 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.82 26.47 73.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.35 176.77 54.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.63 -53.81 16.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 111.288 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.556 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.25 -34.63 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -51.91 -58.65 5.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.465 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -72.94 -48.69 34.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.467 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.59 -59.6 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -59.68 -44.28 97.04 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.413 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 63.23 17.8 10.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.602 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.678 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -81.52 83.66 6.94 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -65.55 152.58 43.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.656 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 132' ' ' THR . 34.4 mt -46.57 106.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.438 0.637 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 146.41 -14.29 1.62 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.544 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 p-10 -80.45 162.29 24.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.875 0.369 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -142.59 128.31 19.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.549 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.19 133.12 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.114 0.483 . . . . 0.0 110.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 3.2 pp -100.68 -4.13 28.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.101 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 170.35 141.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.772 HG12 HD22 ' A' ' 156' ' ' ASN . 76.6 t -96.74 99.79 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.798 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.772 HD22 HG12 ' A' ' 155' ' ' VAL . 48.9 m-80 69.27 -58.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.084 0.468 . . . . 0.0 109.846 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.1 25.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.799 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 155' ' ' VAL . 24.3 t -92.3 155.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 121.351 0.596 . . . . 0.0 111.367 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -101.93 73.25 0.34 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.759 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.554 ' CD1' HG23 ' A' ' 155' ' ' VAL . 22.1 mt -69.95 20.47 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -163.56 56.49 0.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.268 0.556 . . . . 0.0 110.812 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.58 28.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.555 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.712 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.9 OUTLIER -151.86 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.9 mtp 173.78 164.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.426 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.613 ' O ' HG23 ' A' ' 169' ' ' VAL . 19.7 p-80 -53.77 -30.02 42.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.492 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.73 50.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.305 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.712 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.36 -35.51 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 0.0 110.743 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.17 -35.39 73.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.942 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.742 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.9 t -70.23 -43.5 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.15 -30.35 66.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.9 -25.55 53.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -81.18 -39.91 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.202 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -75.52 -26.55 58.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.02 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -71.04 -10.54 59.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.658 ' HB ' HG21 ' A' ' 179' ' ' VAL . 81.6 p -54.1 -175.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.831 0.348 . . . . 0.0 111.479 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -102.36 168.97 8.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.379 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 t0 -52.03 -23.05 4.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 178' ' ' VAL . 4.0 p -145.18 92.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.383 0.611 . . . . 0.0 110.389 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.51 148.43 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.23 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.475 ' CD2' ' CG ' ' A' ' 102' ' ' LYS . 5.6 m-85 -97.9 120.51 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.752 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -98.08 144.11 27.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.24 109.31 21.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.47 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 152' ' ' ILE . 20.8 t -101.39 161.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -141.89 142.74 33.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.802 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 146.25 36.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.631 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.3 107.96 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.576 2.184 . . . . 0.0 112.293 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 96' ' ' GLU . 5.1 m -53.03 154.12 3.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 12.3 m-20 49.94 30.48 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.571 ' H ' ' HB3' ' A' ' 95' ' ' ALA . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.69 HG13 HG23 ' B' ' 3' ' ' VAL . 6.7 p -131.15 -51.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.08 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.69 HG23 HG13 ' B' ' 2' ' ' VAL . 44.3 t -95.19 -47.6 0.26 Allowed Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 89.6 Cg_endo -84.09 136.64 6.97 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.328 2.019 . . . . 0.0 112.56 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.41 176.19 5.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.1 p -63.32 158.16 21.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.7 t -108.33 107.26 17.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.61 90.18 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.55 ' OXT' HD12 ' A' ' 15' ' ' LEU . 30.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.185 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.791 0.329 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -115.97 97.34 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.636 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 14.1 p -84.08 -28.11 0.41 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' C' ' 3' ' ' VAL . 95.8 Cg_endo -81.69 -9.22 12.25 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.945 1.763 . . . . 0.0 112.834 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.31 -38.5 9.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.883 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.5 136.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -81.6 84.52 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.62 82.41 4.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.142 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.796 0.332 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.8 147.4 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -116.5 153.2 32.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.621 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -157.59 151.22 23.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -142.74 108.91 5.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.853 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.717 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.68 -168.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 111.652 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -143.6 135.95 26.99 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.778 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -113.02 88.84 2.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.475 0.655 . . . . 0.0 110.892 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.4 tt0 -84.73 123.88 30.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.199 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -38.94 96.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -54.39 -24.04 28.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.576 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -176.47 -84.76 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 p -109.28 30.75 6.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.8 179.99 23.32 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.815 -1.184 . . . . 0.0 112.819 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.778 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.34 -50.32 7.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.39 -0.405 . . . . 0.0 111.415 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.8 64.25 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.924 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HE2' HD23 ' A' ' 8' ' ' LEU . 9.2 p90 -164.94 169.03 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -129.72 130.04 44.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.357 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.598 HG22 HG12 ' A' ' 36' ' ' ILE . 3.0 pt -120.21 162.4 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.94 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.294 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.49 -121.61 2.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.27 136.95 5.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 HG23 ' A' ' 69' ' ' THR . 1.2 t -55.77 -19.65 12.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.844 ' HB2' HG22 ' A' ' 69' ' ' THR . 2.6 m-20 -93.2 -52.15 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.188 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -117.86 78.37 12.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.29 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.25 142.62 5.92 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.725 2.283 . . . . 0.0 112.623 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.401 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.0 t60 -74.34 -18.34 60.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.76 -29.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.63 28.16 8.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.526 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.84 37.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -167.46 95.34 0.65 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.76 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 10.6 Cg_endo -53.98 -28.63 50.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -65.06 169.86 4.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.432 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.93 151.99 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.366 . . . . 0.0 111.123 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 5.5 p90 -142.56 144.29 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG22 ' A' ' 19' ' ' ILE . 69.0 mt -70.94 151.78 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.659 ' O ' HG21 ' A' ' 53' ' ' VAL . 28.3 p -99.85 -43.86 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.516 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.46 149.14 6.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.47 . . . . 0.0 111.798 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.458 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -106.19 141.61 21.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.032 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.49 119.94 73.62 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.06 84.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.359 2.039 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.04 -39.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -58.62 175.95 2.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.534 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -76.06 -20.36 57.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -51.02 -57.69 7.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.955 0.407 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.35 69.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -72.09 -34.64 68.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.791 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -89.57 -21.31 22.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.423 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 79.36 0.72 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.276 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.553 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.42 32.0 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 0.0 110.095 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.621 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.1 pp 38.48 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.185 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -58.4 141.43 51.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.035 0.445 . . . . 0.0 111.366 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -69.57 -40.78 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.154 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 53' ' ' VAL . 27.3 p30 -52.73 -16.84 1.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.78 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 20.4 p-10 -59.18 171.69 0.7 Allowed 'General case' 0 C--O 1.23 0.032 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 t -130.17 122.57 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 88' ' ' VAL . 15.2 pt -63.16 94.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.544 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 59' ' ' PHE . 1.3 pp -62.37 -24.31 67.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' A' ' 58' ' ' LEU . 1.3 t80 -164.19 140.35 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.894 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.4 p -101.97 -176.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.702 ' H ' HG22 ' A' ' 60' ' ' VAL . 18.1 m-20 -22.38 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.539 0.524 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -162.79 25.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.6 t -121.71 142.12 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.626 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 7.5 t0 -80.36 84.19 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.114 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 57' ' ' ILE . 16.7 m -94.83 30.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptt85 -89.42 7.63 34.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 179.25 49.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.048 0.451 . . . . 0.0 109.959 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' C ' ' HB ' ' A' ' 23' ' ' THR . 34.8 m -111.73 139.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.257 0.551 . . . . 0.0 112.39 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.844 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -50.06 166.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.547 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -57.06 -48.71 77.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.037 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -41.91 70.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.04 74.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.456 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.76 68.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.541 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.1 t -64.52 -36.13 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.576 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 8.3 mt-10 -69.56 -33.11 72.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.694 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -42.91 74.43 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.37 0.605 . . . . 0.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.541 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.99 -26.88 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.31 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -72.65 -44.2 62.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.005 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.13 28.43 5.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.281 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -80.87 -27.7 36.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.6 -123.04 6.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.371 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' ILE . 13.4 m -135.21 8.15 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.507 HG23 ' HG3' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -156.93 94.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -110.96 119.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HA ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.21 102.32 14.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 57' ' ' ILE . 4.9 mp -103.75 139.78 38.52 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 5' ' ' GLU . 3.7 m-85 -107.8 114.74 28.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.1 m -115.92 168.45 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.308 0.575 . . . . 0.0 112.496 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 mtp -143.29 109.04 5.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 3.6 ptt180 -107.61 139.24 42.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.542 ' NH1' ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -77.68 141.59 39.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.953 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.539 ' C ' ' HD3' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -98.93 -53.52 0.19 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.474 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 52.6 Cg_endo -103.21 60.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.406 2.737 . . . . 0.0 113.939 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 94.3 Cg_endo -80.84 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.168 1.912 . . . . 0.0 111.977 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 77.91 43.31 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.457 . . . . 0.0 110.936 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' CG ' ' HA ' ' A' ' 187' ' ' SER . 7.2 mt-10 73.36 134.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -124.74 135.16 52.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.999 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 153' ' ' LEU . 21.6 t -84.94 112.86 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -87.8 166.43 14.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.355 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.81 106.4 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 183' ' ' VAL . 3.0 mm -116.46 155.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -106.23 123.62 48.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.299 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.973 HD12 HD11 ' A' ' 181' ' ' LEU . 2.2 tt -122.85 118.53 28.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.571 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.59 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.3 pt -100.06 144.71 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.029 0.443 . . . . 0.0 111.233 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 110' ' ' LEU . 11.0 tttm -72.01 162.55 29.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -139.22 161.89 26.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.74 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.49 -39.32 91.69 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 122.062 1.841 . . . . 0.0 111.94 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -95.4 21.93 7.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.052 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 105.84 -155.44 16.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.466 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 105' ' ' LYS . 9.3 mp -86.24 -13.38 46.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.868 0.334 . . . . 0.0 111.227 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.26 51.83 7.19 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.56 154.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 132' ' ' THR . 31.1 t -116.08 119.25 35.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.375 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 112' ' ' PHE . 15.5 pt -125.26 156.38 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.901 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -154.91 125.42 6.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.95 165.9 31.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.685 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.06 -131.73 14.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.199 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.2 t -104.46 154.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 114.05 -37.85 3.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.403 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 163.8 82.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 110.276 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 111.43 23.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.161 0.505 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.901 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -57.31 -16.56 8.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.206 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 130' ' ' TYR . 0.3 OUTLIER -87.94 104.78 7.4 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.457 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 123' ' ' ILE . 13.6 Cg_endo -57.08 94.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.534 2.156 . . . . 0.0 112.571 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.68 44.5 8.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.886 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -142.21 85.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.022 0.439 . . . . 0.0 110.85 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -47.82 -26.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -55.89 162.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 160' ' ' LEU . 36.4 mt -96.24 125.31 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.151 0.501 . . . . 0.0 111.387 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.636 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.1 m-85 -116.21 161.33 19.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.229 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 150' ' ' ASP . 49.1 t -92.96 144.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 1.5 t -115.04 -49.21 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.99 144.17 30.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.877 0.37 . . . . 0.0 111.634 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.681 HD11 HG11 ' A' ' 131' ' ' VAL . 31.4 mt -136.89 139.85 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.99 173.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.9 tt0 -91.88 147.31 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.21 27.69 57.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.503 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.01 53.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.31 -59.86 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 111.405 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -69.96 -33.33 71.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.45 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -57.54 -60.2 4.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 0.0 110.24 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -41.7 64.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -80.6 -59.46 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -70.31 -30.81 69.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.215 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.73 21.0 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.726 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -93.37 82.33 4.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -66.71 172.99 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.8 mt -47.54 122.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.305 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.7 -22.6 6.11 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.365 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.754 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.47 134.55 54.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.333 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -119.42 124.72 47.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -104.25 129.45 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 110.717 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -98.55 -0.28 43.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.161 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.57 169.14 1.39 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.897 HG12 ' ND2' ' A' ' 156' ' ' ASN . 57.8 t -126.76 100.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.465 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.897 ' ND2' HG12 ' A' ' 155' ' ' VAL . 25.5 m-80 69.97 -57.7 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.195 0.522 . . . . 0.0 109.977 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.16 27.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.613 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.642 ' HB ' HD21 ' A' ' 160' ' ' LEU . 2.0 t -116.6 154.26 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-O 120.986 0.422 . . . . 0.0 111.332 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.0 77.86 0.24 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -78.21 24.76 0.24 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -127.68 41.35 3.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.382 0.611 . . . . 0.0 110.963 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.19 28.0 0.35 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.039 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.74 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -134.75 -78.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.4 ' CG ' ' HB ' ' A' ' 118' ' ' VAL . 3.2 mtm 173.57 166.87 0.17 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 169' ' ' VAL . 47.2 p-80 -53.88 -29.78 43.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.963 0.411 . . . . 0.0 110.602 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.42 -48.18 35.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.74 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -68.49 -37.85 80.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 160' ' ' LEU . . . -70.27 -38.66 75.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.673 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.5 t -67.25 -46.02 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.369 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.62 67.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.532 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 160' ' ' LEU . . . -77.48 -25.57 50.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.35 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -79.46 -39.97 30.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.177 0.513 . . . . 0.0 109.828 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 169' ' ' VAL . 4.3 mtmt -75.88 -26.58 57.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.07 -33.64 74.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.047 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.722 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -52.72 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.398 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -95.27 169.23 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.488 . . . . 0.0 111.341 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -56.78 -16.75 7.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.615 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.96 90.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.585 0.231 . . . . 0.0 110.934 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.63 148.28 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.129 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 1.4 p90 -95.02 130.42 41.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.627 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.973 HD11 HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.18 155.91 19.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.751 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.53 114.8 26.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.654 HG21 HG13 ' A' ' 101' ' ' ILE . 20.6 t -102.26 161.65 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -119.74 135.78 54.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 0.0 111.349 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 2.1 mtpt -88.4 138.39 30.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 29.9 Cg_exo -61.48 78.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.562 2.175 . . . . 0.0 112.613 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 189' ' ' ALA . 3.1 m 55.1 -145.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.12 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 188' ' ' ASN . 0.7 OUTLIER -65.61 68.2 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.119 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.542 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.209 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.885 0.374 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 2' ' ' VAL . 14.7 p -129.51 33.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.035 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.448 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 1.8 t -87.93 -49.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 6.5 Cg_exo -73.77 -54.32 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.762 2.308 . . . . 0.0 112.203 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' B' ' 2' ' ' VAL . 0.1 OUTLIER 61.39 21.08 11.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.05 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m -165.57 113.13 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.5 143.52 53.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 90.6 p -149.51 112.89 4.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.504 HG13 ' CD1' ' A' ' 15' ' ' LEU . 9.9 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLN . . . . . 0.655 ' O ' HG12 ' C' ' 2' ' ' VAL . 1.9 mp0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.665 0.269 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.655 HG12 ' O ' ' C' ' 1' ' ' GLN . 8.8 p 51.38 161.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.891 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.478 ' N ' HG22 ' C' ' 2' ' ' VAL . 30.9 m -58.15 153.7 34.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.306 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.58 173.29 10.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.57 109.92 21.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.08 157.52 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.82 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 169' ' ' VAL . 47.8 t -83.73 78.06 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -85.76 85.78 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.097 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -129.32 170.62 13.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.22 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD2' ' CG ' ' A' ' 89' ' ' MET . 1.0 OUTLIER -129.43 171.87 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.587 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -167.5 136.82 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.6 109.33 10.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.378 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -127.7 -170.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.129 0.49 . . . . 0.0 111.98 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 128.14 49.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.416 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.1 tp -125.32 91.71 3.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.629 0.728 . . . . 0.0 110.087 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 83' ' ' ILE . 2.3 mt-10 -70.1 165.41 22.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.949 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -83.21 99.18 9.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.98 -26.55 8.77 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -168.87 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.176 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 t -109.18 30.64 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.65 177.03 20.06 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.358 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.54 -43.17 14.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.758 0.313 . . . . 0.0 111.069 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 90.84 76.61 1.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.784 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.7 p90 -164.72 148.46 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.041 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.2 m -95.97 126.99 41.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.41 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 36' ' ' ILE . 36.0 pt -115.41 154.73 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.129 0.49 . . . . 0.0 112.019 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -173.12 118.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . 152.65 29.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.061 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -58.22 167.13 6.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.41 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.74 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -73.03 -31.45 64.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.728 ' CB ' HG23 ' A' ' 69' ' ' THR . 8.3 t70 -83.84 -51.57 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 111.595 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -119.76 78.4 22.51 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.501 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.87 156.34 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.515 2.143 . . . . 0.0 112.203 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.595 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 15.6 t60 -100.81 -19.45 15.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -108.48 -26.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.666 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.25 32.18 8.5 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.147 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 177.7 39.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 3.4 t0 -166.56 107.87 0.68 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.897 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 14.2 Cg_exo -69.04 -24.74 32.65 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.684 2.256 . . . . 0.0 112.098 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -74.57 126.29 30.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -70.25 148.24 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.201 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -139.83 171.41 14.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.388 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 41.3 mt -99.42 150.57 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.4 m -108.5 -30.32 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.838 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.7 tmtt? -175.6 148.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 111.455 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -108.81 141.22 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.983 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 pt -89.69 146.58 35.83 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 58.45 6.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.6 2.2 . . . . 0.0 112.404 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.61 -57.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.02 176.61 1.8 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -74.54 -24.81 59.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.631 0.253 . . . . 0.0 111.62 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -53.01 -57.43 10.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.916 0.389 . . . . 0.0 111.292 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.988 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.91 -39.33 69.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 0.0 109.505 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 2.5 m-20 -80.19 -28.39 38.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.31 49.42 0.05 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.278 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HD3' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -103.56 21.71 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.584 0.23 . . . . 0.0 111.491 -179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.39 163.19 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 158.32 15.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.245 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.838 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.2 m -71.16 -44.13 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 m120 -58.74 1.25 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.688 ' OD2' HG21 ' A' ' 88' ' ' VAL . 55.1 p30 -89.87 163.43 15.01 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.088 -0.383 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -119.26 123.87 45.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.328 . . . . 0.0 111.075 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 7.1 pt -61.88 94.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 59' ' ' PHE . 3.6 pp -76.01 -20.57 57.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.675 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -158.0 119.58 3.59 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.077 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.792 HG22 HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -118.33 119.51 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 52.22 42.5 30.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.185 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.66 30.89 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 60' ' ' VAL . 22.1 t -114.09 141.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.31 113.92 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.792 HG11 HG22 ' A' ' 60' ' ' VAL . 14.6 p -146.59 26.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -87.45 6.51 33.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 177.67 50.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.937 0.398 . . . . 0.0 110.088 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.567 ' CG2' HG23 ' A' ' 65' ' ' VAL . 35.9 m -120.04 144.61 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.623 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.74 ' N ' HG22 ' A' ' 23' ' ' THR . 3.9 m -49.93 162.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.766 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.693 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -55.66 -48.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.457 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -50.01 -40.77 45.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.247 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.08 76.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -71.79 -41.3 68.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.459 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 70' ' ' HIS . 46.3 t -64.82 -36.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.628 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 6.2 mt-10 -69.3 -30.82 68.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.737 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.823 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.26 -36.95 74.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.451 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.18 -26.19 33.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -75.99 -32.66 59.56 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.865 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 29.78 7.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.56 -20.53 18.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.19 -131.25 10.28 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.616 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -124.84 16.61 8.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 111.321 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -153.63 94.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -102.14 136.56 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.08 90.28 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.738 HD23 HG12 ' A' ' 60' ' ' VAL . 17.9 mt -85.12 114.97 22.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.536 0.684 . . . . 0.0 112.764 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -110.02 114.29 27.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.193 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.9 m -123.04 168.37 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.468 ' HG3' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -123.26 109.01 13.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.278 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -116.69 138.51 51.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 1.4 mpt_? -96.59 131.38 43.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.565 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -86.66 115.76 63.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.591 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.46 110.12 2.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.656 2.237 . . . . 0.0 112.856 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 65.2 Cg_endo -93.84 -154.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.12 2.547 . . . . 0.0 111.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 97.44 60.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.875 0.47 . . . . 0.0 111.092 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.442 ' CG ' ' HA ' ' A' ' 187' ' ' SER . 4.4 mt-10 74.64 149.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -150.69 165.67 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.923 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.34 120.25 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.82 166.13 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -129.94 106.36 8.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.438 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.581 HG13 HG21 ' A' ' 183' ' ' VAL . 2.5 mm -118.29 155.61 20.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.468 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -115.1 137.07 52.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.539 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.823 HD22 HD23 ' A' ' 110' ' ' LEU . 3.1 tt -135.28 118.44 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.72 144.66 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.011 0.434 . . . . 0.0 111.219 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -76.7 158.47 30.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.52 -164.88 10.06 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.994 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.76 -33.06 4.12 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.258 1.972 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 19.3 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.037 0.446 . . . . 0.0 110.53 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.64 -144.38 15.8 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.823 HD23 HD22 ' A' ' 103' ' ' LEU . 2.9 mp -86.43 -21.44 27.09 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.108 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.73 46.08 5.83 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.974 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.54 157.64 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 0.0 110.748 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 133' ' ' LYS . 43.9 t -125.15 116.76 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.724 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 172' ' ' LEU . 8.1 pt -123.05 151.59 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.425 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -149.87 125.52 10.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.099 0.476 . . . . 0.0 111.696 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.79 -175.29 24.92 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.043 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 121' ' ' GLN . . . 73.22 -144.33 34.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.871 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.441 ' H ' ' HA ' ' A' ' 164' ' ' MET . 48.7 t -104.67 154.62 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.854 0.359 . . . . 0.0 111.696 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 107.11 -32.24 7.41 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.236 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 176.54 79.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 0.0 110.163 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -111.07 112.44 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.269 -179.35 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -57.21 -20.14 25.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.222 0.534 . . . . 0.0 110.892 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -103.09 145.46 30.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.735 -178.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 5.6 Cg_exo -77.52 37.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.998 2.465 . . . . 0.0 112.689 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -122.65 -27.88 1.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.153 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 121' ' ' GLN . 3.2 p30 46.79 28.43 0.82 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.907 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -135.58 -48.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.213 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.4 m -88.66 126.85 35.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.445 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.612 ' HB ' HD12 ' A' ' 152' ' ' ILE . 18.6 mt -83.22 128.75 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.263 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.482 ' CD2' HD11 ' A' ' 123' ' ' ILE . 17.5 m-85 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.712 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 150' ' ' ASP . 57.3 t -68.13 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.423 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -131.05 -45.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -149.43 128.64 12.83 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.916 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 146' ' ' LEU . 25.9 mt -120.09 141.7 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.671 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.0 mm -77.18 174.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 135' ' ' ILE . 18.4 tt0 -92.19 133.86 35.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.96 25.22 45.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.497 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.84 -171.07 18.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -74.04 -53.65 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -69.99 -31.91 69.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -56.84 -60.92 2.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.211 0.529 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -42.42 63.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.117 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -80.85 -59.47 2.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 112.043 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.457 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -65.2 -42.13 96.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.053 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.49 21.22 11.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -96.96 85.03 3.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 169.07 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.598 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.6 mt -47.2 120.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.303 0.573 . . . . 0.0 111.429 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.46 -22.56 5.25 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.335 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.06 125.31 24.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.677 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.646 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 4.1 pttt -109.86 122.53 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -103.9 130.0 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.57 -0.53 34.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.461 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.9 164.85 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.347 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.783 HG12 HD22 ' A' ' 156' ' ' ASN . 57.4 t -115.97 101.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.783 HD22 HG12 ' A' ' 155' ' ' VAL . 63.6 m-80 70.56 -58.89 0.54 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 109.778 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.55 21.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.606 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -115.33 144.43 22.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.962 0.411 . . . . 0.0 110.983 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.97 71.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.766 HD21 ' CG2' ' A' ' 155' ' ' VAL . 1.4 pp -91.97 30.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 0.0 111.746 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.424 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.85 67.31 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 0.0 110.777 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -176.98 29.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.234 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.587 HG11 ' OD2' ' A' ' 167' ' ' ASP . 2.4 t -123.8 -75.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HA ' ' H ' ' A' ' 118' ' ' VAL . 7.1 mtm -172.13 -171.38 0.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.921 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.516 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.0 p80 -73.23 -30.31 63.39 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.078 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HG3' ' CE1' ' A' ' 165' ' ' HIS . 16.4 mt-10 -73.74 -46.94 42.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.587 ' OD2' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -66.07 -42.55 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.25 73.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.556 HG22 ' CB ' ' C' ' 7' ' ' SER . 16.9 t -74.02 -40.34 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.402 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.89 -34.53 69.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -75.84 -29.95 58.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 173' ' ' LYS . 3.6 pp -82.09 -37.33 26.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.809 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -75.03 -26.5 59.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.903 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.04 -11.5 60.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.35 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.677 ' HB ' HG21 ' A' ' 179' ' ' VAL . 38.2 p -58.61 -167.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 111.364 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' VAL . 45.2 t80 -112.8 172.15 7.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 1.1 m-20 -56.42 -15.13 3.64 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 104' ' ' ILE . 42.0 t -147.7 92.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.677 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -125.31 148.19 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.973 0.416 . . . . 0.0 111.962 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 5.5 m-85 -97.24 136.01 38.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.671 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.09 148.73 36.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 0.0 110.258 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mttp -96.84 114.55 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.581 HG21 HG13 ' A' ' 101' ' ' ILE . 15.7 t -102.03 160.16 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.914 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -116.47 145.88 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.378 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -103.58 133.07 20.49 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.06 81.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 112.621 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.442 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 1.1 m 57.95 -156.58 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.089 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 94' ' ' PRO . 7.4 p30 -64.21 71.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.101 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.33 105.21 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' B' ' 4' ' ' PRO . 11.2 t -76.98 -48.15 2.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' B' ' 3' ' ' VAL . 80.3 Cg_endo -78.4 -179.75 5.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.194 1.929 . . . . 0.0 112.449 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -90.2 168.08 12.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER 63.7 140.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.818 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 2.9 m -131.42 134.92 46.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.4 112.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.772 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.592 ' OXT' HG22 ' B' ' 9' ' ' VAL . 14.1 p . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.741 0.305 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.96 87.9 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.017 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 m -78.14 144.8 67.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.8 177.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.575 2.183 . . . . 0.0 112.247 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -70.86 -56.83 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.806 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -60.45 179.74 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.741 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -106.32 65.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.68 87.67 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.678 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 110' ' ' LEU . 7.2 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.79 149.24 25.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 161.52 41.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.727 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -179.33 150.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.233 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 7.1 tt0 -109.2 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.512 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.882 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.25 -174.1 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.082 0.467 . . . . 0.0 111.645 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 126.0 45.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.458 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.915 ' HG ' HD23 ' A' ' 15' ' ' LEU . 14.0 tp -123.62 94.49 4.26 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.703 0.764 . . . . 0.0 110.216 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.797 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.3 mp0 -68.59 161.85 27.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.687 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 12' ' ' ASN . 15.8 mtt180 -80.63 108.05 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.48 68.4 0.16 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.165 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER 78.81 -78.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.436 0.294 . . . . 0.0 110.549 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -109.53 30.71 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.79 178.01 15.31 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.552 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.915 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.41 -48.57 9.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.846 0.355 . . . . 0.0 110.979 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 97.27 76.54 1.3 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.602 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.814 ' CE1' HG23 ' B' ' 9' ' ' VAL . 2.6 p90 -160.68 152.14 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.558 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 m -95.21 126.45 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 36' ' ' ILE . 34.4 pt -132.74 160.89 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -171.33 173.74 4.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 102.61 -128.11 9.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.453 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.83 150.16 10.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -55.77 -22.41 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.292 . . . . 0.0 111.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.65 ' CB ' HG23 ' A' ' 69' ' ' THR . 11.3 t0 -92.61 -44.57 8.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.946 0.403 . . . . 0.0 111.202 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -123.89 77.61 57.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.16 128.31 22.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.587 2.192 . . . . 0.0 112.427 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 16.9 t-80 -66.7 -20.17 65.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.523 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.21 -28.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.233 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.82 27.68 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.43 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -170.6 112.85 0.44 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.42 -27.42 47.09 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.721 2.281 . . . . 0.0 112.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.7 t -67.56 141.75 56.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -89.8 151.47 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.793 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.523 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -142.61 160.94 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 110.983 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' SER . 34.6 mt -92.6 147.88 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.2 p -98.81 -41.83 7.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.63 0.253 . . . . 0.0 111.471 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HA ' HG11 ' A' ' 53' ' ' VAL . 2.2 tmtp? -167.8 152.54 6.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.367 . . . . 0.0 111.262 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.462 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -104.35 141.01 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.033 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 ' HA2' ' A' ' 16' ' ' GLY . 8.7 pt -86.11 120.99 72.85 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.199 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 83.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.113 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.02 -54.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.0 170.47 4.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.546 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.93 -17.76 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.621 0.248 . . . . 0.0 111.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . -62.13 -57.44 11.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.762 0.315 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.95 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -72.35 -38.1 68.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 5.0 m-20 -79.18 -30.54 43.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.741 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.62 48.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.524 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.882 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.62 18.89 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.019 0.409 . . . . 0.0 111.296 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 51' ' ' LEU . 2.1 pt? -176.11 167.51 2.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.96 0.41 . . . . 0.0 111.679 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 153.57 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.064 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.629 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 27.6 m -70.99 -46.49 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.0 p30 -72.8 15.52 0.19 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -80.56 -167.65 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 104.78 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.755 HG22 HG12 ' A' ' 88' ' ' VAL . 12.9 pt -59.56 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.063 0.459 . . . . 0.0 111.201 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 89' ' ' MET . 0.5 OUTLIER -61.74 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.174 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 69.6 m-85 -160.97 160.82 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.54 134.06 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.691 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.6 36.27 5.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.52 29.27 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.9 t -120.76 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 12.8 p-10 -73.74 91.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 68' ' ' VAL . 17.4 t -114.4 34.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -99.75 11.33 39.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.34 40.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 65' ' ' VAL . 29.0 m -119.39 148.61 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.163 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 1.4 m -49.91 156.86 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.336 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' B' ' 6' ' ' SER . 3.7 t-80 -54.6 -48.61 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.603 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -57.61 -34.39 69.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.161 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.49 82.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -72.01 -42.53 66.3 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.289 0.566 . . . . 0.0 109.81 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.498 ' HA ' HD21 ' A' ' 77' ' ' LEU . 68.3 t -65.32 -36.1 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.781 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 2.9 mt-10 -69.33 -32.33 71.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.766 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.37 -42.76 74.78 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.45 0.643 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -78.04 -27.01 48.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.59 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 1.7 tttt -72.94 -37.76 67.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.312 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -103.24 26.39 8.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.634 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -103.66 -13.47 16.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.514 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -157.13 23.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.592 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.56 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -100.18 21.05 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 111.297 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.797 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.4 mt -155.28 95.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.766 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -104.78 140.16 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 112.367 -178.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.8 mtm180 -96.9 95.32 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.759 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mp -93.78 123.84 37.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -104.0 114.46 28.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 57' ' ' ILE . 28.1 m -126.01 168.58 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' HD12 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -142.39 108.97 5.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.464 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.19 106.97 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.687 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtm105 -76.94 124.82 28.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.063 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -122.88 49.68 2.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.8 Cg_exo -41.6 -43.17 6.18 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.905 2.404 . . . . 0.0 113.131 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 93' ' ' PRO . 6.6 Cg_exo -74.53 -171.43 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.611 2.207 . . . . 0.0 112.347 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HB3' ' OXT' ' A' ' 189' ' ' ALA . . . 177.05 34.7 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.431 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 162.73 24.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.903 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -177.4 176.12 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 153.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.538 ' SD ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.51 166.59 23.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 111.322 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.67 106.28 6.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.628 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -113.17 155.26 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -122.91 124.81 44.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.42 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 140' ' ' ALA . 2.7 tt -126.38 118.91 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.794 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.583 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -95.4 144.72 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -62.28 160.81 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -141.11 -159.23 7.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.886 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.35 -41.32 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.235 1.957 . . . . 0.0 112.649 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -91.73 21.73 4.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.23 -133.36 11.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.503 ' HB2' HG12 ' C' ' 9' ' ' VAL . 4.7 mp -86.61 -27.09 24.08 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.825 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.92 45.01 4.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.793 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.602 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.59 146.6 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -106.68 117.03 32.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.495 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.93 HD11 HD22 ' A' ' 172' ' ' LEU . 12.9 pt -129.54 164.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -162.29 124.93 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 111.812 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -154.65 173.42 33.08 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.106 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.81 170.67 13.38 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.473 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 119' ' ' GLY . 30.7 t -92.06 154.84 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.155 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 75.27 6.26 79.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.696 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.03 78.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.043 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -93.4 123.07 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.993 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -48.11 -29.1 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.589 0.709 . . . . 0.0 110.694 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.777 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -97.28 146.51 31.47 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.699 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.763 ' HD2' HG22 ' A' ' 123' ' ' ILE . 26.3 Cg_exo -62.93 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.564 2.176 . . . . 0.0 112.805 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.84 61.32 1.0 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.353 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.67 90.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 110.825 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' GLN . 4.0 p30 -55.82 -22.82 26.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.376 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.43 ' HA ' ' CG ' ' A' ' 161' ' ' GLU . 38.9 m -47.47 123.12 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.588 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 35.9 mt -59.58 123.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.253 0.549 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -121.23 173.53 7.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.784 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 146' ' ' LEU . 44.0 t -111.16 141.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.166 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 148' ' ' ILE . 3.3 p -102.74 -60.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 146.89 26.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.513 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.6 mt -117.14 141.64 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.4 mm -82.8 173.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.546 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.6 pt-20 -112.58 36.25 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.99 -29.13 52.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.542 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.89 51.88 0.59 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.59 -84.51 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.17 -31.79 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.233 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.7 m170 -53.47 -56.98 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -50.27 25.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.343 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.33 -59.3 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 0.0 111.696 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -55.37 -56.27 24.28 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.02 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.88 21.78 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.754 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -103.77 83.03 2.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.909 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -59.97 166.55 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.587 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' THR . 31.1 mt -47.86 121.24 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.283 0.563 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 123.02 -19.4 7.79 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.495 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -64.49 126.16 26.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.515 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -107.17 124.02 49.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.091 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 154' ' ' ALA . 1.6 mt -98.26 132.51 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.676 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.642 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -91.05 -2.04 57.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 154.58 153.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.217 0.323 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG12 ' OD1' ' A' ' 156' ' ' ASN . 15.2 t -103.52 99.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 180' ' ' TYR . 14.0 m120 68.32 -59.46 0.44 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 155' ' ' VAL . 94.4 p -171.47 31.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.292 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.6 t -134.87 148.18 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.351 0.595 . . . . 0.0 112.205 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.744 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 91.97 -76.58 1.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.806 HD13 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER 32.12 34.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.258 -0.971 . . . . 0.0 112.284 178.177 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 159' ' ' GLY . 2.2 pm0 34.37 36.88 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.011 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.806 ' OD2' HD13 ' A' ' 160' ' ' LEU . 31.1 p30 -116.14 36.24 4.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.688 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -149.71 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.943 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.01 166.41 0.93 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.531 ' O ' HG23 ' A' ' 169' ' ' VAL . 8.8 p-80 -53.98 -37.22 63.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.938 0.399 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.07 -40.42 62.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.467 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -76.02 -37.49 58.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.861 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.71 -34.99 72.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.023 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 165' ' ' HIS . 25.4 t -74.21 -43.1 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.81 69.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.145 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.11 -26.69 56.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.436 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.93 HD22 HD11 ' A' ' 114' ' ' ILE . 3.9 pp -81.41 -36.62 29.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.873 ' N ' HD12 ' A' ' 172' ' ' LEU . 11.8 tttp -72.23 -26.9 62.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.306 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -70.5 -9.46 56.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.463 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.611 ' HB ' HG21 ' A' ' 179' ' ' VAL . 16.9 p -49.2 -178.58 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.053 0.454 . . . . 0.0 112.051 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -107.56 171.4 7.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.295 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 6.4 m-20 -53.41 -18.23 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.546 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.583 HG13 HG22 ' A' ' 104' ' ' ILE . 40.1 t -147.38 91.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.494 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.611 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -116.75 147.54 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.026 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.721 ' H ' HD22 ' A' ' 156' ' ' ASN . 15.7 p90 -111.46 125.99 54.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.224 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.2 158.47 19.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 111.307 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.484 ' HB3' HD21 ' A' ' 153' ' ' LEU . 2.0 mptt -100.85 119.76 39.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.353 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.628 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -101.74 160.87 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.997 0.427 . . . . 0.0 111.419 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -126.91 133.21 50.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.84 130.81 53.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.56 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.604 ' O ' ' HB3' ' A' ' 189' ' ' ALA . 19.4 Cg_endo -58.67 125.82 19.45 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 112.052 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 154.79 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 p-10 41.95 30.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.582 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.123 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.99 129.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' B' ' 4' ' ' PRO . 23.9 t -75.48 135.92 71.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.402 ' HD2' HG13 ' B' ' 3' ' ' VAL . 57.7 Cg_endo -71.58 158.27 54.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.421 2.08 . . . . 0.0 112.241 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -112.5 157.29 21.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.484 ' HA ' ' CE1' ' A' ' 70' ' ' HIS . 6.8 m -155.42 157.91 37.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.527 ' O ' HG22 ' B' ' 9' ' ' VAL . 38.6 t 63.27 -111.03 0.34 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.7 ' O ' HG13 ' B' ' 9' ' ' VAL . 1.3 m -63.75 125.69 25.15 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.798 0.332 . . . . 0.0 111.087 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.814 HG23 ' CE1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.088 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLN . . . . . 0.416 ' O ' ' CG1' ' C' ' 2' ' ' VAL . 1.7 tp60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.691 0.281 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.585 HG22 ' O ' ' C' ' 2' ' ' VAL . 7.2 p 43.84 55.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.551 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 t -107.85 94.74 13.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.083 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.6 170.71 14.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.372 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -149.35 147.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.54 -168.79 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.837 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.44 ' OG ' HG21 ' A' ' 169' ' ' VAL . 41.4 m -107.03 104.88 14.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -80.61 94.31 6.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 110' ' ' LEU . 4.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.833 0.349 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 3' ' ' TYR . 13.5 tt0 -86.95 147.66 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.23 153.27 35.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.537 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -170.81 159.46 6.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.475 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -110.26 137.34 48.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.632 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.524 HG22 ' NE ' ' A' ' 50' ' ' ARG . 25.3 mt -149.12 164.15 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.127 0.489 . . . . 0.0 111.418 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.589 HG23 ' HD3' ' A' ' 85' ' ' ARG . 0.3 OUTLIER -123.11 136.73 54.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.074 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.5 tp -127.19 89.19 2.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.628 0.728 . . . . 0.0 110.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' A' ' 83' ' ' ILE . 3.0 tt0 -74.72 134.79 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.244 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -57.5 104.61 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.2 -27.52 5.45 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.636 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -174.8 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -109.29 30.54 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.856 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.22 178.1 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.485 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -50.68 7.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 101.35 70.4 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.639 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.8 p90 -164.68 157.71 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -112.56 129.38 56.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.13 160.81 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.353 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.54 12.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.05 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.01 -128.68 9.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.12 147.76 10.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.592 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -52.2 -25.15 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.685 0.279 . . . . 0.0 111.468 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.598 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.9 t70 -89.77 -45.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.531 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -123.87 78.31 57.55 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.573 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.84 134.5 28.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.547 2.164 . . . . 0.0 112.277 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 38.6 t60 -71.32 -25.71 62.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.193 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.99 -28.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 26.78 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.531 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.7 31.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 110.802 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 5.0 t0 -165.4 95.84 0.84 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 11.4 Cg_endo -54.85 -22.9 31.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.414 2.076 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.72 164.62 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -106.88 146.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.43 150.13 40.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.6 mt -72.64 151.89 7.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.495 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.549 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.23 -35.45 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.644 ' HA ' HG11 ' A' ' 53' ' ' VAL . 5.5 tmmm? -169.59 152.24 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.7 mt -118.23 141.27 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.14 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 pt -85.84 141.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.062 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.27 74.13 3.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.458 2.105 . . . . 0.0 112.391 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.04 -40.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.11 176.29 1.96 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.615 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.85 -27.36 57.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.557 0.217 . . . . 0.0 111.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -47.69 -57.37 5.6 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.43 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.44 69.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.02 -37.08 69.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.312 0.577 . . . . 0.0 109.644 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' HD13 ' A' ' 8' ' ' LEU . 22.2 m-20 -82.45 -25.7 33.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.023 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 80.67 51.54 4.81 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.307 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.524 ' NE ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.84 44.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER 33.77 -153.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 150.1 46.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.058 0.456 . . . . 0.0 111.37 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.4 m -71.04 -39.67 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.492 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 53' ' ' VAL . 22.9 p30 -51.69 -14.97 0.39 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.369 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.9 p-10 -61.85 156.73 19.95 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.8 m -122.68 124.36 43.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.32 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 88' ' ' VAL . 3.7 pt -62.92 94.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -61.08 -23.42 65.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.534 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -158.79 127.09 5.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.536 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.72 133.12 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.372 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 m120 45.78 33.52 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 13.8 tt0 67.56 32.46 5.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 18.1 t -120.92 141.78 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.19 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 98.94 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.793 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG13 ' CG2' ' A' ' 68' ' ' VAL . 21.4 t -130.24 38.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -103.48 12.55 35.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.58 38.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.683 ' CG2' HG13 ' A' ' 65' ' ' VAL . 22.2 m -115.86 145.83 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.741 ' N ' HG22 ' A' ' 23' ' ' THR . 2.5 m -49.94 161.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.757 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.712 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -55.03 -48.53 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -49.79 -42.34 46.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.862 0.363 . . . . 0.0 111.391 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.18 75.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.031 0.443 . . . . 0.0 110.742 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.53 69.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.614 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.712 HG23 ' CD2' ' A' ' 70' ' ' HIS . 41.1 t -64.48 -35.34 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.736 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.44 -34.16 74.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.764 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.43 -43.42 73.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.328 0.585 . . . . 0.0 110.482 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.89 HD13 HG11 ' B' ' 9' ' ' VAL . 3.0 pp -76.25 -26.69 56.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.454 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.1 tttt -70.98 -42.86 69.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.231 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.26 31.4 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.11 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -85.05 -27.0 26.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.555 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.68 -121.46 6.38 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.579 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 83' ' ' ILE . 88.7 p -137.97 9.8 2.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -152.09 94.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.797 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -94.84 117.27 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' HG23 ' A' ' 7' ' ' THR . 1.3 tpp85 -102.75 91.07 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.718 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.3 pp -121.64 154.04 37.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 m-85 -105.04 119.37 38.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.267 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 86' ' ' LEU . 26.8 m -104.11 167.81 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.249 0.547 . . . . 0.0 112.298 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.88 109.59 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -121.4 140.56 51.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.85 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.89 123.86 20.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.168 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -70.48 178.17 1.19 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.58 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 71.1 Cg_exo -49.16 104.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.098 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.45 -156.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.538 2.159 . . . . 0.0 112.108 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.38 28.43 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.429 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 90.23 6.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.66 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -101.68 -175.68 2.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.2 t -132.17 113.12 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 183' ' ' VAL . 2.0 ttm -86.89 166.28 15.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.38 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -133.99 106.75 7.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.149 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 144' ' ' GLY . 2.8 mm -114.02 155.53 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 101' ' ' ILE . 24.7 ttmt -134.86 122.86 22.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.75 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.675 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 3.6 tt -123.25 118.35 27.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -93.75 144.5 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.547 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 177' ' ' ASP . 2.0 tptm -57.71 141.77 47.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.49 -164.4 11.92 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.949 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -43.43 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.122 1.881 . . . . 0.0 112.228 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -92.52 20.46 6.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.071 0.462 . . . . 0.0 110.115 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.29 -142.37 15.48 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 103' ' ' LEU . 9.9 mp -86.7 -21.7 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.961 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.5 47.72 6.25 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.41 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.34 152.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.2 m -116.31 124.83 51.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.55 HG22 HG22 ' A' ' 131' ' ' VAL . 20.0 pt -141.63 157.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.726 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -159.82 125.5 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.914 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.597 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.26 -175.08 25.06 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.436 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.02 -179.38 45.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.298 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.04 150.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.742 0.306 . . . . 0.0 111.208 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.74 -19.16 42.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.338 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 10.7 t-20 -179.53 70.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.034 0.445 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.3 mt-30 -71.55 -7.49 47.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.481 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 18.8 t-80 71.82 -57.09 0.62 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.521 0.676 . . . . 0.0 110.975 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -86.56 134.62 37.49 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.7 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.68 77.18 2.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.448 2.098 . . . . 0.0 112.606 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.01 46.55 0.55 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.92 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -172.95 96.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.26 -21.4 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 p -55.26 129.73 39.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.322 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.713 HD11 ' HA3' ' A' ' 159' ' ' GLY . 39.2 mt -66.19 130.84 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 111.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.85 ' CD1' HD11 ' A' ' 123' ' ' ILE . 2.4 m-85 -123.86 166.73 15.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.334 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 68.8 t -101.9 155.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.377 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.745 HG21 ' CB ' ' C' ' 6' ' ' SER . 10.5 p -115.19 -58.99 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.578 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.18 148.7 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 147' ' ' GLN . 16.2 mt -132.14 141.68 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.8 mm -79.75 174.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.62 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.659 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 mt-10 -93.91 151.01 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.53 25.15 54.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -77.06 -169.14 30.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.93 -62.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.381 . . . . 0.0 111.306 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.874 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.15 -31.78 69.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.324 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -58.75 -48.69 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -72.58 -49.41 32.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.883 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.23 -59.39 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.853 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.96 -33.71 87.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.963 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.84 14.65 9.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.874 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -73.37 144.57 46.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.67 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.7 ' HA ' HD12 ' A' ' 134' ' ' ILE . 7.0 mt-30 -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.072 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 132' ' ' THR . 25.8 mt -49.28 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.802 0.811 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 141.83 -17.9 2.58 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.431 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -67.07 120.21 13.3 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.163 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -105.43 119.77 39.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.946 0.403 . . . . 0.0 111.475 -178.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 181' ' ' LEU . 1.8 mt -92.77 129.75 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.363 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.5 pp -87.08 -0.59 56.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 152' ' ' ILE . . . 166.0 153.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.059 0.224 . . . . 0.0 110.66 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.777 HG11 ' HB3' ' A' ' 172' ' ' LEU . 25.3 t -108.5 99.61 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 72.3 m-80 73.24 -59.84 0.55 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.8 t -169.96 23.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.377 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 171' ' ' ALA . 2.3 t -135.91 155.24 35.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.714 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.713 ' HA3' HD11 ' A' ' 129' ' ' ILE . . . 89.06 -6.9 83.26 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.828 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -68.61 23.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.626 0.77 . . . . 0.0 111.445 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 159' ' ' GLY . 24.0 mt-10 71.31 54.0 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.28 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.873 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -157.18 -83.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.052 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.9 mtm 166.92 162.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.1 t-160 -53.77 -30.22 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.022 0.439 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -41.16 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.068 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -76.22 -33.88 59.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' HA2' ' A' ' 159' ' ' GLY . . . -70.06 -38.18 75.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' HIS . 39.5 t -74.23 -41.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.484 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.15 62.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.334 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.746 ' HB2' HG11 ' A' ' 158' ' ' VAL . . . -72.12 -43.44 64.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.3 pp -67.86 -36.56 80.51 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.866 ' N ' HD12 ' A' ' 172' ' ' LEU . 9.2 ttpp -75.3 -26.09 58.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.469 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -56.37 -48.6 76.52 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.4 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -45.63 -52.45 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.118 0.485 . . . . 0.0 110.663 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 2.3 t80 66.7 107.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.888 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t0 82.38 -23.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.895 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.15 93.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.623 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.556 HG22 ' OG1' ' A' ' 175' ' ' THR . 2.2 t -107.06 148.43 11.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.107 0.479 . . . . 0.0 111.008 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -124.0 135.83 53.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.975 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.77 136.67 46.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.965 0.412 . . . . 0.0 111.338 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.83 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 184' ' ' ALA . 9.2 t -101.79 162.88 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.513 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.53 134.68 34.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.991 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -83.87 136.79 41.25 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.63 125.0 14.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.465 2.11 . . . . 0.0 112.267 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.2 158.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 49.29 30.46 3.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.105 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.06 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.818 0.342 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.424 ' O ' HG23 ' B' ' 3' ' ' VAL . 21.9 t -85.09 134.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.532 ' HB ' ' HD3' ' B' ' 4' ' ' PRO . 77.2 t -156.45 -63.09 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.178 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 36.6 Cg_endo -64.41 121.16 8.67 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.131 1.887 . . . . 0.0 112.249 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.65 31.18 6.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.817 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 p -162.3 178.35 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.414 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -95.75 87.08 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.944 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -85.25 118.62 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.89 HG11 HD13 ' A' ' 77' ' ' LEU . 10.9 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.818 0.342 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.06 109.25 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.21 149.68 43.43 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.15 136.03 30.98 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.628 2.219 . . . . 0.0 112.325 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -103.22 33.33 3.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.745 ' CB ' HG21 ' A' ' 132' ' ' THR . 50.7 p -175.64 163.72 2.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.73 104.99 16.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.71 103.18 14.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.16 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptm . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.76 149.65 30.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -104.59 178.12 4.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -170.72 155.5 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.014 0.435 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -151.72 100.97 2.73 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.683 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -125.87 -171.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 112.133 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.48 125.17 28.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.882 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.4 tp -116.68 94.76 4.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 111.048 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -69.53 141.2 53.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.511 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 101.03 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.969 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.9 -26.63 8.63 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.446 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.89 -84.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -109.14 30.54 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.819 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.84 -179.76 20.98 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.314 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.36 -50.52 7.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.603 0.24 . . . . 0.0 111.397 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.41 30.29 3.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.147 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 3.5 p90 -123.03 147.96 46.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.368 0.584 . . . . 0.0 110.646 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.6 m -108.03 126.79 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.339 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.407 HG22 HG12 ' A' ' 36' ' ' ILE . 2.3 pt -106.97 171.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.865 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.74 139.89 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.39 -121.99 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.62 140.0 7.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.326 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.635 HG22 ' CA ' ' A' ' 69' ' ' THR . 1.6 t -54.35 -21.6 9.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.256 . . . . 0.0 111.534 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.5 m-20 -82.09 -56.94 3.63 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -123.74 86.55 53.0 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.394 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.0 129.93 19.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.78 2.32 . . . . 0.0 112.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -61.66 -20.43 63.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.586 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -105.63 -41.86 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.01 0.433 . . . . 0.0 110.843 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.39 24.99 5.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.542 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.49 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 14.3 t70 -158.26 98.34 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.776 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 13.7 Cg_endo -56.52 -29.94 80.48 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.413 2.076 . . . . 0.0 112.001 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -71.06 164.64 25.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.699 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.3 mt -109.17 155.81 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.34 166.7 23.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 42.6 mt -96.07 154.71 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.584 ' O ' HG21 ' A' ' 53' ' ' VAL . 19.0 p -108.7 -42.46 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.47 150.8 9.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 1.1 mt -108.96 141.52 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.4 mt -84.2 127.81 64.96 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.087 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.1 Cg_exo -65.18 66.9 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.525 2.15 . . . . 0.0 112.254 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.31 -52.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.436 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.68 -178.31 2.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.423 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -75.86 -20.77 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.31 -57.31 13.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -28.04 69.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.05 -43.44 64.92 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.572 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 4.8 t0 -74.39 -31.27 62.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.874 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.83 48.54 0.02 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.425 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.683 ' HG3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -95.83 18.63 12.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.7 pt? -175.06 179.81 1.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.995 0.426 . . . . 0.0 111.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 152.71 22.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.341 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 37' ' ' THR . 28.0 m -70.95 -38.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.031 0.443 . . . . 0.0 112.17 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -72.66 15.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.562 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -80.11 -158.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 100.61 3.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.758 0.314 . . . . 0.0 110.991 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.88 HG12 HG13 ' A' ' 60' ' ' VAL . 3.0 tp -61.97 95.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 110.717 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.527 HD23 ' CG ' ' A' ' 89' ' ' MET . 3.2 pp -70.1 -22.63 63.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -160.06 130.77 5.64 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.457 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.88 HG13 HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -113.31 117.68 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.167 178.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.615 HD21 HG12 ' A' ' 84' ' ' VAL . 6.9 m-20 46.57 37.82 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 69.44 30.92 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.87 125.86 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -45.85 125.71 6.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.358 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 57' ' ' ILE . 14.2 p -153.12 23.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -94.91 11.76 30.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.354 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 174.82 46.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.981 0.42 . . . . 0.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -111.12 138.07 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.302 0.573 . . . . 0.0 111.983 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.635 ' CA ' HG22 ' A' ' 23' ' ' THR . 0.1 OUTLIER -50.74 166.23 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.607 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -56.14 -48.55 76.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.062 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -56.2 -42.51 77.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . . . -62.1 -33.87 75.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.534 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.51 68.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 109.521 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 77' ' ' LEU . 50.5 t -64.75 -35.83 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.572 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 -33.34 72.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.832 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.26 -43.74 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.315 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.727 ' HB2' HG21 ' B' ' 9' ' ' VAL . 2.7 pp -75.71 -26.77 57.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.459 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -71.89 -43.23 65.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.179 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -105.62 31.21 5.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.164 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -80.27 -28.65 38.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.526 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.95 -103.7 3.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.6 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 74.6 m -151.75 -52.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 18.2 mt -100.82 85.1 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.839 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 6.8 m -85.26 116.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.901 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -75.28 84.56 2.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.795 ' CD2' HG12 ' A' ' 60' ' ' VAL . 22.4 mt -85.13 139.45 31.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.519 0.676 . . . . 0.0 112.459 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 2.3 m-85 -124.01 114.51 19.84 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.802 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.9 m -125.53 168.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.527 ' CG ' HD23 ' A' ' 58' ' ' LEU . 25.4 mtm -127.87 108.99 11.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.244 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -116.53 127.41 54.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 120.98 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.916 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.08 131.54 85.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.1 162.84 40.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 112.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 20.2 Cg_exo -64.98 -159.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.49 2.126 . . . . 0.0 112.299 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 161.43 86.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.241 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HG3' ' HB3' ' A' ' 185' ' ' LYS . 1.1 pm0 -106.58 -176.37 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.288 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.459 ' HG3' ' C ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -164.01 -70.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.008 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.544 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -121.9 154.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 98' ' ' VAL . 7.6 tpt -134.55 164.31 27.77 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.02 106.63 12.62 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 183' ' ' VAL . 2.0 mm -120.5 155.66 23.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 180' ' ' TYR . 2.4 mtmp? -115.38 123.26 48.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.358 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.763 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.5 tt -123.0 118.57 28.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.701 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.64 144.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.24 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 153.14 26.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.955 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 -177.88 15.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.842 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.48 -31.64 21.38 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.063 1.842 . . . . 0.0 112.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -96.79 19.78 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.042 0.449 . . . . 0.0 110.422 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.58 -153.06 17.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.488 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 mp -86.46 -14.99 41.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.66 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 83.73 50.66 4.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.901 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.7 155.02 0.79 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.5 m -113.97 116.97 30.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.563 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 172' ' ' LEU . 7.0 pt -132.79 155.1 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.4 125.04 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.061 0.457 . . . . 0.0 111.99 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.622 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.66 -175.13 25.44 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.273 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 -168.91 40.52 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.126 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 39.4 t -84.51 145.04 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.53 -25.28 16.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.1 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.61 70.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 0.0 109.738 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -72.55 -5.98 40.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.633 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.527 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 17.5 t-80 72.04 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.607 0.718 . . . . 0.0 110.561 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.949 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.4 mt -84.04 144.21 44.05 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.603 ' HD2' HG22 ' A' ' 123' ' ' ILE . 15.8 Cg_exo -67.91 63.32 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.548 2.166 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.08 62.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -170.36 96.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.988 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -23.72 19.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.18 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 t -55.49 143.79 28.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.03 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.895 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -84.33 119.46 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.354 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.949 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.5 m-85 -114.93 155.08 27.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.175 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 114' ' ' ILE . 46.1 t -85.99 155.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.439 ' N ' HG12 ' A' ' 131' ' ' VAL . 11.7 p -116.03 -57.3 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -152.65 150.04 29.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.258 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.679 HD11 ' O ' ' A' ' 146' ' ' LEU . 8.0 mt -130.27 141.63 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.054 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -75.98 173.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.611 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.98 138.09 35.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.67 27.2 73.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.548 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.06 -173.35 47.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -79.8 -58.18 3.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 111.168 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.568 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -63.93 -31.79 73.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -57.3 -62.18 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -72.94 -38.67 66.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.999 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.43 -59.37 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 112.029 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -72.24 -43.49 46.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.077 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.68 18.64 11.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.309 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.679 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -85.96 79.59 9.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.3 pt20 -60.47 171.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 29.5 mt -48.14 127.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 118.43 -25.63 8.08 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.346 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -58.52 151.07 21.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.748 0.309 . . . . 0.0 110.713 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -138.1 124.45 20.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.147 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.2 130.25 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.627 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.7 OUTLIER -100.08 -0.98 37.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.322 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.22 155.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.875 0.369 . . . . 0.0 111.334 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 158' ' ' VAL . 21.5 t -111.07 99.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.023 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.544 HD22 HG12 ' A' ' 155' ' ' VAL . 67.3 m-80 69.24 -59.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.267 0.556 . . . . 0.0 109.694 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.4 t -164.07 27.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.229 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.7 t -101.05 155.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.391 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -116.38 77.13 0.27 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.417 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.895 HD22 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.99 24.8 0.49 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -137.14 31.17 2.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.164 0.507 . . . . 0.0 110.763 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.67 27.71 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.059 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -137.61 -76.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.375 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.447 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 2.7 mtm 172.56 165.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.461 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 p-80 -53.95 -29.67 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.897 0.38 . . . . 0.0 110.467 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.42 -46.16 50.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.382 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.745 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.69 -37.36 73.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.608 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.38 -38.72 74.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.837 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' C' ' 7' ' ' SER . 9.9 t -70.36 -41.57 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.382 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.75 -31.31 66.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.077 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.05 -27.23 57.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.657 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.0 pp -81.74 -37.33 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.851 0.358 . . . . 0.0 110.317 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.927 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -75.37 -26.54 58.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.714 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.09 -9.79 59.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 179' ' ' VAL . 78.2 p -52.04 -178.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.947 0.403 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.1 t80 -100.97 167.1 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.327 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.4 t70 -50.66 -24.85 3.63 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.214 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.408 HG13 HG22 ' A' ' 104' ' ' ILE . 43.0 t -147.75 92.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -113.71 148.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.26 125.97 38.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.787 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.99 145.09 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 111.332 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.3 mttt -96.38 112.29 24.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.085 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 152' ' ' ILE . 21.8 t -102.64 162.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.321 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.523 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -121.0 133.15 55.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.122 0.487 . . . . 0.0 110.918 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.676 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -95.46 146.32 31.1 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.343 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 16.7 Cg_exo -68.24 47.84 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.271 . . . . 0.0 113.593 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 189' ' ' ALA . 25.9 t 44.94 -160.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.644 0.259 . . . . 0.0 111.356 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 52.7 p-10 -67.02 66.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.173 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.155 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' B' ' 3' ' ' VAL . 0.0 OUTLIER -133.53 -77.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' B' ' 4' ' ' PRO . 7.0 p 174.42 -36.15 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' B' ' 3' ' ' VAL . 1.2 Cg_endo -84.39 -74.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.417 2.078 . . . . 0.0 112.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 53.67 24.71 4.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.349 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 21.9 m 55.44 176.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t -159.41 155.67 27.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.81 47.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.727 HG21 ' HB2' ' A' ' 77' ' ' LEU . 10.8 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLN . . . . . 0.916 ' O ' HG23 ' C' ' 3' ' ' VAL . 1.8 tt0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.622 0.249 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 2' ' ' VAL . 13.4 p 44.92 38.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.666 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.916 HG23 ' O ' ' C' ' 1' ' ' GLN . 44.0 t -134.09 78.78 58.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.006 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.99 134.96 50.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 112.289 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.51 145.56 27.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 47.8 t 63.25 135.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.633 ' HB2' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -79.66 84.62 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.584 ' O ' HG13 ' C' ' 9' ' ' VAL . 96.5 p -97.83 84.33 3.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.584 HG13 ' O ' ' C' ' 8' ' ' SER . 3.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mtm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.821 0.343 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.67 113.22 25.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -109.71 128.88 55.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.393 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -177.73 172.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 111.618 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 1.5 pm0 -90.08 150.48 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' A' ' 50' ' ' ARG . 8.1 mt -144.18 153.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.281 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -116.91 125.67 51.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.005 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.5 tp -127.05 91.43 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.556 0.693 . . . . 0.0 110.361 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.855 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -77.27 163.16 26.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.786 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -69.56 97.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -56.04 -23.47 39.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.592 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -175.28 -85.35 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -109.11 30.53 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.808 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.06 177.73 15.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.358 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.921 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.38 -44.83 13.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.804 0.335 . . . . 0.0 111.195 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 90.39 77.15 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.783 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -163.33 155.55 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.788 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.1 t -111.97 126.85 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.723 HG22 HG12 ' A' ' 36' ' ' ILE . 11.1 pt -120.54 163.93 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.883 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.35 156.94 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 126.28 -126.07 5.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.537 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.45 132.53 5.18 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.744 HG22 ' N ' ' A' ' 69' ' ' THR . 1.6 t -48.46 -26.97 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.317 . . . . 0.0 111.345 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.739 ' CB ' HG23 ' A' ' 69' ' ' THR . 27.1 t70 -87.46 -44.31 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -123.77 78.75 56.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.82 134.13 40.85 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.665 2.244 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.414 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 15.8 t-80 -69.32 -22.93 63.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.18 -30.73 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 27.81 10.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.661 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -172.67 33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.78 111.04 0.47 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 17.0 Cg_exo -67.26 -30.14 37.85 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.716 2.277 . . . . 0.0 112.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.56 129.27 39.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 152.3 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.3 165.13 28.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.702 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.723 HG12 HG22 ' A' ' 19' ' ' ILE . 43.1 mt -94.2 153.79 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.497 ' O ' HG21 ' A' ' 53' ' ' VAL . 15.9 p -106.93 -44.53 4.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.726 0.298 . . . . 0.0 111.494 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.927 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -156.59 152.5 27.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 111.39 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -111.01 141.27 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.822 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.26 135.83 36.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.081 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.82 57.25 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.261 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.09 -53.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.69 -174.83 0.85 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.465 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.595 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.03 -29.64 58.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -47.47 -51.04 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.324 . . . . 0.0 111.49 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.2 67.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -72.2 -38.97 68.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.749 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -81.56 -31.11 32.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.729 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.56 47.19 0.01 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.503 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -99.15 22.64 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.997 0.399 . . . . 0.0 110.98 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -168.84 -178.14 3.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HB2' ' HG3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -120.49 171.5 8.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.927 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.7 m -71.44 -46.67 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 53' ' ' VAL . 13.0 m120 -69.39 11.52 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.529 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.2 p-10 -67.86 -179.74 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -135.75 100.35 4.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.709 0.29 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.644 HG22 HG12 ' A' ' 88' ' ' VAL . 5.1 pt -61.25 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.414 0.626 . . . . 0.0 110.994 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 89' ' ' MET . 4.3 mt -66.85 -24.77 66.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.596 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -160.75 155.53 23.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.892 HG12 ' HB ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -129.66 -176.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.209 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.679 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -41.64 78.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.927 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.6 tt0 63.76 21.71 12.78 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.208 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.892 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.2 t -121.44 141.99 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 0.0 111.678 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.37 82.29 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.321 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' HG22 ' A' ' 68' ' ' VAL . 9.4 m -94.72 31.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.583 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.85 -4.39 59.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.345 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 20.0 pt-20 176.64 56.66 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.033 0.444 . . . . 0.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 65' ' ' VAL . 30.5 m -118.69 142.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.748 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.744 ' N ' HG22 ' A' ' 23' ' ' THR . 1.2 m -50.2 161.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.631 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' ND1' HG23 ' A' ' 74' ' ' VAL . 3.2 t-80 -53.76 -48.59 69.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.554 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -49.92 -43.72 49.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.06 73.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.61 69.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.604 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.559 ' HA ' HD21 ' A' ' 77' ' ' LEU . 40.0 t -64.4 -35.87 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.644 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.49 -33.74 73.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -69.57 -43.12 73.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.396 0.617 . . . . 0.0 110.555 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.653 HD13 HG21 ' B' ' 9' ' ' VAL . 3.2 pp -76.28 -26.74 56.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.486 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -71.16 -42.53 68.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.196 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -104.16 29.77 5.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.379 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -85.33 -25.78 26.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.435 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.64 -137.36 20.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.488 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 83' ' ' ILE . 35.8 m -121.91 16.43 10.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.572 0.225 . . . . 0.0 111.346 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.855 HG23 ' HG2' ' A' ' 9' ' ' GLU . 1.6 mt -152.17 92.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.2 t -87.22 149.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 111.921 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -137.98 84.86 2.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.723 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.711 HD13 HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -116.67 154.21 30.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.2 t80 -105.66 114.93 29.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.686 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.711 HG13 HD13 ' A' ' 86' ' ' LEU . 10.8 m -121.37 167.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 58' ' ' LEU . 1.1 ttp -121.08 109.61 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.959 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -132.39 143.43 49.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 ttp85 -77.99 135.48 37.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.45 84.18 23.01 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.146 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -61.85 119.58 6.78 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.701 2.267 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.78 91.76 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.643 2.229 . . . . 0.0 112.252 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.16 44.74 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.627 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.34 125.67 28.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.553 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.51 -177.11 6.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.193 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.727 HG13 HD21 ' A' ' 153' ' ' LEU . 11.2 t -109.19 154.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.0 mmm -128.86 166.68 18.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.236 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -127.86 106.45 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 183' ' ' VAL . 1.8 mm -118.07 155.31 20.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.619 . . . . 0.0 112.606 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -111.93 126.91 55.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.062 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 1.4 tt -129.91 118.72 22.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.809 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.97 144.74 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -80.0 156.93 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.998 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 -174.01 13.46 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.86 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.74 -39.72 6.2 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.035 1.823 . . . . 0.0 112.063 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -95.21 22.75 6.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.66 -165.61 12.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.63 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 103' ' ' LEU . 1.4 mp -80.85 -13.49 58.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.175 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 86.17 51.84 3.43 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.829 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.94 149.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.665 0.269 . . . . 0.0 110.75 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.442 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 17.0 m -115.31 116.92 29.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.798 0.332 . . . . 0.0 110.674 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.626 ' CG1' HD22 ' A' ' 172' ' ' LEU . 5.5 pt -127.47 152.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.91 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -143.49 125.02 14.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.802 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.65 -175.06 25.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.915 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.62 134.71 8.54 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -59.24 153.13 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.58 -32.13 6.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 178.48 76.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 171.61 7.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.103 0.477 . . . . 0.0 110.924 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 21.5 t-80 -49.8 -50.54 44.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.071 0.938 . . . . 0.0 110.516 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.925 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -96.58 129.63 32.61 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.836 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.14 78.47 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.307 2.005 . . . . 0.0 112.593 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.47 37.57 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.938 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.33 95.16 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.956 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -52.13 -25.18 8.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.2 m -54.45 115.9 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.802 HG12 ' HA3' ' A' ' 116' ' ' GLY . 11.7 mt -61.8 120.53 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.925 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -111.98 156.97 21.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.317 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.6 t -87.95 153.32 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.823 0.344 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.678 HG22 ' CD2' ' A' ' 122' ' ' HIS . 11.6 p -115.54 -58.04 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 147.69 23.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.016 0.436 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.798 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.2 mt -125.32 141.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.18 173.44 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -90.35 147.24 23.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.82 55.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.44 174.33 53.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.809 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.16 -50.17 50.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.422 . . . . 0.0 111.111 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.369 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -54.87 -54.82 37.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -72.87 -51.96 16.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.053 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.56 -59.36 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 111.85 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -51.6 -52.1 35.12 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.133 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 60.88 19.81 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -98.57 78.48 2.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.01 174.26 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.703 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 30.0 mt -48.06 132.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.172 0.51 . . . . 0.0 111.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 112.66 -28.36 9.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.251 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -61.16 145.3 51.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.672 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -132.65 136.85 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.66 132.4 52.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.713 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -101.45 -1.65 32.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 182' ' ' LYS . . . 173.97 162.98 0.18 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.967 0.413 . . . . 0.0 111.283 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 156' ' ' ASN . 25.6 t -117.67 99.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.143 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.64 HD22 HG12 ' A' ' 155' ' ' VAL . 65.4 m-80 69.2 -59.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.309 0.576 . . . . 0.0 109.817 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.45 26.77 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.353 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 6.3 t -109.23 154.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.26 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.37 76.88 0.26 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -80.26 24.01 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.72 58.01 1.56 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.1 29.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.543 HG11 ' CG ' ' A' ' 167' ' ' ASP . 2.4 t -136.61 -74.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.3 mtm -174.45 -170.3 0.5 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.453 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' VAL . 70.0 t60 -70.86 -32.87 70.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.943 0.401 . . . . 0.0 110.589 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.79 -46.7 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.543 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.77 -35.14 69.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.28 -39.01 75.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.315 0.579 . . . . 0.0 109.463 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.85 ' HA ' HD23 ' A' ' 172' ' ' LEU . 12.6 t -73.65 -39.95 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.48 71.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.03 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 160' ' ' LEU . . . -78.17 -25.68 47.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.929 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -81.05 -40.71 23.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.51 59.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.19 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -12.33 32.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.416 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.53 147.52 0.84 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 111.587 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.2 t80 -86.13 169.54 13.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.419 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 3.2 t70 -46.77 -30.81 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.079 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 104' ' ' ILE . 41.8 t -147.91 91.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.649 0.261 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -123.83 148.4 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.433 . . . . 0.0 111.734 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.3 m-85 -98.34 128.32 44.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.421 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.54 152.67 28.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 -179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 154' ' ' ALA . 9.6 mttt -96.56 118.7 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -102.35 161.26 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.352 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -125.92 136.26 52.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.739 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.6 OUTLIER -83.85 137.47 40.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.658 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.684 ' HD2' ' HB3' ' A' ' 189' ' ' ALA . 4.5 Cg_exo -74.83 48.95 2.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.736 2.29 . . . . 0.0 112.871 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.2 t 53.04 103.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.872 0.368 . . . . 0.0 111.345 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.1 26.85 10.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.146 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.68 0.276 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.415 ' O ' HG13 ' B' ' 2' ' ' VAL . 2.9 p 42.67 93.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.564 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.44 ' O ' HG23 ' B' ' 3' ' ' VAL . 8.9 m -87.23 108.7 20.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.08 -35.56 5.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.396 2.064 . . . . 0.0 112.392 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -165.53 -175.23 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.55 158.92 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 171.31 14.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.969 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -162.6 128.0 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.84 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 77' ' ' LEU . 9.7 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.073 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.836 0.351 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 24.3 t 63.99 94.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' C' ' 4' ' ' PRO . 13.3 t -78.8 -47.91 1.73 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.569 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' C' ' 3' ' ' VAL . 96.9 Cg_endo -80.0 -177.91 4.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.301 2.001 . . . . 0.0 112.352 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -177.08 -60.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 3.1 m 61.12 162.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.463 ' CB ' HD21 ' A' ' 172' ' ' LEU . 6.1 t -78.77 94.38 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -90.96 100.26 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.44 HG23 ' OXT' ' C' ' 9' ' ' VAL . 4.6 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.102 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.803 0.335 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.91 162.8 38.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.92 163.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.567 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -174.86 162.17 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.376 . . . . 0.0 111.259 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 6.0 pt-20 -95.97 147.47 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 7' ' ' THR . 27.0 mt -146.78 165.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -129.74 147.17 51.49 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.198 0.523 . . . . 0.0 111.835 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.832 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.51 87.33 2.31 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.412 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -79.81 118.85 21.97 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.251 179.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -41.78 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.69 -26.65 8.05 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.591 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.28 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.31 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -109.23 30.69 6.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.24 177.98 24.72 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.716 -1.23 . . . . 0.0 112.809 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.26 -47.33 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.499 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.09 62.14 1.02 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.827 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.6 p90 -165.13 169.19 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 111.351 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -119.56 126.76 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.535 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.0 pt -116.45 157.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.241 0.544 . . . . 0.0 111.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.71 148.09 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.502 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.7 16.9 2.41 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.585 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -47.06 173.46 0.02 OUTLIER Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.488 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.806 HG22 ' N ' ' A' ' 69' ' ' THR . 1.8 t -77.56 -35.7 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.701 ' CB ' HG23 ' A' ' 69' ' ' THR . 5.3 t0 -86.38 -42.44 13.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.334 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -123.86 77.25 57.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.429 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.49 171.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.619 2.213 . . . . 0.0 112.275 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.621 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.2 t-80 -111.57 -21.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.339 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.94 -25.82 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 29.52 7.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.381 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.62 40.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 108.48 2.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.837 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 16.8 Cg_exo -67.43 -22.32 45.53 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -82.92 136.81 34.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -82.68 145.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.219 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.537 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.7 p90 -142.17 142.95 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.568 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 18' ' ' SER . 33.9 mt -69.75 146.87 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 53' ' ' VAL . 3.0 m -101.26 -33.87 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.728 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -172.24 143.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.291 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -107.24 141.45 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.137 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.47 135.13 41.41 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 63.72 4.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.48 -43.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.06 178.5 1.87 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.18 -19.76 58.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -52.92 -57.55 9.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.934 0.397 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.5 69.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.903 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -72.02 -35.02 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.575 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.43 -20.19 25.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.454 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 80.26 1.0 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.613 HH22 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -88.3 22.02 2.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 52' ' ' ARG . 3.2 pp 36.7 -154.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.11 128.72 38.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 111.158 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 38' ' ' LYS . 26.4 m -57.77 -41.61 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.229 0.538 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 53' ' ' VAL . 2.1 m-80 -50.45 -17.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.944 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 33.8 p-10 -57.67 150.43 19.5 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -121.7 129.8 53.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -65.82 94.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.1 mt -58.47 -26.89 63.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -162.93 145.45 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.563 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.0 OUTLIER -108.3 -176.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.376 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.4 m120 -21.78 -52.35 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.943 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.63 25.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.7 t -121.58 142.06 39.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.529 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 8.0 p-10 -79.61 87.13 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.6 m -94.09 30.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.75 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -82.66 2.03 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.862 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.98 58.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG21 HG12 ' A' ' 65' ' ' VAL . 34.9 m -118.61 142.8 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.715 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.806 ' N ' HG22 ' A' ' 23' ' ' THR . 5.4 m -49.81 161.94 0.21 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.126 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.1 t-160 -60.34 -48.61 81.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.301 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -37.99 81.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.48 76.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.05 -43.13 65.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.968 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.6 t -64.63 -35.71 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.912 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.53 -33.35 72.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.863 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -43.03 74.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -77.11 -26.76 53.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.538 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -72.51 -41.1 66.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.399 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 28.45 6.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.878 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -96.63 -19.13 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.512 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.94 -159.29 16.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.862 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -99.75 10.09 41.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.619 0.247 . . . . 0.0 111.464 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -152.93 94.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG12 ' CB ' ' A' ' 80' ' ' ALA . 26.9 m -90.64 134.89 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 7' ' ' THR . 3.6 mmt180 -116.7 102.11 9.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -128.82 154.25 46.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.404 0.621 . . . . 0.0 112.546 -178.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -103.77 115.27 30.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.677 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 57' ' ' ILE . 34.4 m -104.22 167.94 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 112.388 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.4 ttp -126.0 109.62 12.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.844 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -129.51 146.73 51.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.134 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.11 131.16 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 57.94 3.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.1 Cg_endo -67.15 113.17 2.75 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.606 2.204 . . . . 0.0 112.365 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.508 ' HA ' ' HB2' ' A' ' 188' ' ' ASN . 36.4 Cg_endo -95.8 128.03 0.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.51 2.806 . . . . 0.0 111.681 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.12 21.66 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.617 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -98.24 105.5 17.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.23 124.16 44.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.187 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 98' ' ' VAL . 15.0 p -84.66 114.48 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.53 166.69 11.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 111.861 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -135.49 106.5 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.4 mm -114.14 155.27 15.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 3.7 mttp -114.2 120.93 42.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.364 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -119.52 118.75 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.369 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -95.14 144.68 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.967 0.413 . . . . 0.0 111.226 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -58.79 151.65 20.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.135 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.93 160.16 23.21 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.646 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -40.54 80.51 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 C-N-CA 122.119 1.879 . . . . 0.0 112.129 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.71 19.69 9.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.05 0.452 . . . . 0.0 110.101 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.4 -144.57 16.0 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 103' ' ' LEU . 8.5 mp -86.56 -20.06 28.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.084 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.33 61.51 3.89 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.92 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 145.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.8 t -109.98 117.4 33.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.832 HD11 HD22 ' A' ' 172' ' ' LEU . 6.3 pt -130.87 154.66 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.65 125.0 10.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 111.755 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.54 -175.01 25.2 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.516 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.4 -164.17 54.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.195 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.46 150.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 111.149 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.21 -30.51 7.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.973 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -164.66 69.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.053 0.454 . . . . 0.0 109.897 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.9 mt-30 -67.1 -11.24 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.655 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 18.4 t-80 72.43 -54.68 0.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.65 0.738 . . . . 0.0 110.944 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -92.38 138.14 24.28 Favored Pre-proline 0 C--N 1.31 -1.117 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.741 -179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.2 Cg_endo -73.54 60.94 4.3 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.356 2.037 . . . . 0.0 112.563 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 130.74 55.87 0.09 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -175.55 96.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -57.85 -22.13 46.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -58.33 141.92 49.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 160' ' ' LEU . 14.9 mt -74.65 127.66 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 111.249 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.823 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.9 m-85 -122.4 146.52 47.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.2 t -76.93 155.59 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.592 HG21 ' OG ' ' C' ' 6' ' ' SER . 6.9 p -119.62 -59.18 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.07 146.69 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.924 0.393 . . . . 0.0 111.157 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 147' ' ' GLN . 17.1 mt -134.4 141.49 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.74 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.672 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.1 mt-10 -97.0 153.17 18.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 52.59 31.2 36.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.738 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.36 -167.97 39.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.697 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.02 -60.92 2.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -68.3 -31.94 71.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.273 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.07 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.212 0.529 . . . . 0.0 110.009 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -72.82 -52.99 12.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.772 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.6 -59.24 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.794 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.449 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -52.63 -53.34 33.04 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.068 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 64.98 16.46 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.019 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.507 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.05 78.46 4.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.518 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.8 pt20 -61.14 175.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.3 mt -47.94 129.9 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 115.48 -27.04 8.67 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.297 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -64.09 138.33 58.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 110.546 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.695 ' CE ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -126.83 131.31 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.037 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.639 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.51 134.56 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.884 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -100.82 -1.92 33.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.923 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.15 163.71 0.38 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 158' ' ' VAL . 25.2 t -119.46 99.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.224 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.498 ' ND2' HG12 ' A' ' 155' ' ' VAL . 66.9 m-80 69.82 -59.91 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.395 0.617 . . . . 0.0 109.762 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -164.75 27.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.17 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.1 t -108.47 154.55 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.295 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.45 77.1 0.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.93 24.44 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.194 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -132.09 30.97 4.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.173 0.511 . . . . 0.0 110.905 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -141.98 28.44 1.73 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.272 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.702 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.5 t -139.93 -78.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.383 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtp -179.14 -169.74 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 169' ' ' VAL . 17.0 t60 -70.43 -31.59 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.494 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -47.57 39.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.702 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -69.96 -37.12 75.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.84 0.352 . . . . 0.0 110.642 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 160' ' ' LEU . . . -70.14 -38.8 75.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.237 0.542 . . . . 0.0 109.634 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 13.1 t -72.28 -39.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.428 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.74 -29.73 64.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.016 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.54 55.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.1 pp -81.7 -37.87 26.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -74.96 -26.44 59.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -15.24 53.29 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.602 ' HB ' HG21 ' A' ' 179' ' ' VAL . 25.3 p -50.11 -178.74 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.735 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.493 ' CD1' HG13 ' A' ' 179' ' ' VAL . 9.0 p90 -132.46 -160.41 1.05 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.733 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 6.3 t0 -53.37 -34.79 59.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.427 ' O ' ' CZ ' ' A' ' 176' ' ' TYR . 35.2 t -147.86 92.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 0.0 111.596 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.602 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.5 OUTLIER -111.01 131.38 62.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.054 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 10.2 p90 -94.05 124.47 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -109.58 153.87 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 111.374 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.56 ' O ' HG22 ' A' ' 152' ' ' ILE . 1.1 mptm? -96.93 110.91 23.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.608 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 152' ' ' ILE . 12.8 t -102.21 159.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.695 ' HB3' ' CE ' ' A' ' 151' ' ' LYS . . . -140.74 145.24 36.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.54 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -99.08 146.06 31.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.63 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.76 123.76 14.53 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.525 2.15 . . . . 0.0 112.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 t -54.55 -177.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 94' ' ' PRO . 15.6 t-20 -66.24 72.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.168 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.901 0.381 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 2' ' ' VAL . 11.2 p -178.46 49.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' B' ' 4' ' ' PRO . 11.4 t -76.16 -48.08 3.45 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.423 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 3' ' ' VAL . 90.3 Cg_endo -79.01 -31.42 2.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 80.76 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.94 145.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.44 ' HB3' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -94.26 95.71 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.38 80.27 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.473 ' OXT' HG12 ' B' ' 9' ' ' VAL . 29.5 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.184 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.786 HG12 HG23 ' C' ' 3' ' ' VAL . 19.1 t 63.77 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.786 HG23 HG12 ' C' ' 2' ' ' VAL . 25.7 t 64.04 83.23 0.2 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 156.52 12.84 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.594 2.196 . . . . 0.0 112.151 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -97.55 -64.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.592 ' OG ' HG21 ' A' ' 132' ' ' THR . 49.3 m -103.24 151.33 22.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -75.01 93.72 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -86.49 116.4 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.117 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 mtt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -124.65 168.25 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.27 178.7 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' HB2' ' NH2' ' A' ' 90' ' ' ARG . 5.7 tt0 -174.04 142.81 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 8.6 pt-20 -108.86 111.47 23.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.744 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -120.29 -169.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.168 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -140.82 133.36 28.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -113.29 88.93 2.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 111.067 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -82.54 116.79 22.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.377 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -40.63 95.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.406 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.15 -26.87 6.68 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.828 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -169.65 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -109.17 30.66 6.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.82 177.41 23.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.984 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.781 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.28 -45.77 12.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.251 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' CA ' HD11 ' A' ' 40' ' ' ILE . . . 89.54 64.27 1.27 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.682 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.54 ' HD2' ' HB2' ' A' ' 45' ' ' ALA . 10.1 p90 -164.9 146.38 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.0 110.784 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.721 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -96.01 165.3 12.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.0 pt -152.96 159.63 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.82 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.22 154.95 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.225 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.49 -127.45 6.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.9 144.31 8.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -57.91 -20.01 33.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.349 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 69' ' ' THR . 19.3 t70 -94.34 -42.1 9.08 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.696 0.284 . . . . 0.0 111.085 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -123.76 77.59 56.82 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -47.46 129.4 16.42 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.715 2.276 . . . . 0.0 112.477 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 35' ' ' PHE . 78.6 t60 -57.22 -72.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.078 0.466 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.475 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -55.9 -42.0 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.551 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.36 23.63 5.07 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.444 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.28 29.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 2.4 m-20 -160.43 103.44 1.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.813 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.8 Cg_endo -55.89 -26.08 56.11 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.465 2.11 . . . . 0.0 111.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -66.71 147.94 52.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -94.28 151.74 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 111.288 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -142.39 158.07 44.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.717 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 18' ' ' SER . 65.4 mt -77.03 148.65 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.31 -30.05 10.38 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.514 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.736 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.64 146.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -116.45 141.11 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.448 HD11 ' CA ' ' A' ' 16' ' ' GLY . 2.7 pt -89.65 139.45 27.96 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.17 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.93 64.25 7.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.564 2.176 . . . . 0.0 112.414 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.14 -41.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.14 177.35 15.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -75.95 -20.94 57.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.404 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -52.96 -57.28 10.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.944 0.402 . . . . 0.0 110.942 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.76 -28.32 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.87 -40.28 69.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.23 0.538 . . . . 0.0 109.605 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD2' HD13 ' A' ' 8' ' ' LEU . 20.4 m-20 -80.55 -20.22 43.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.333 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.54 83.85 0.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.443 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.657 ' NH2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -89.37 13.8 12.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.72 0.295 . . . . 0.0 111.16 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.832 HD22 ' HG3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER 64.42 -163.68 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.392 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.86 146.85 20.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 111.281 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.736 HG11 ' HA ' ' A' ' 38' ' ' LYS . 6.6 m -63.18 -42.55 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.576 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 m120 -52.36 -11.81 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.44 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.405 ' CB ' ' HB3' ' A' ' 90' ' ' ARG . 35.3 p-10 -63.55 152.56 38.32 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 p -119.04 120.22 36.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.009 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.625 HG22 HG12 ' A' ' 88' ' ' VAL . 2.6 pt -60.83 94.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.575 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -60.7 -26.28 67.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.907 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.654 ' HD2' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -164.87 140.1 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.381 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -125.13 118.87 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.44 -76.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.9 tt0 -160.44 30.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 17.7 t -120.82 140.73 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.27 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 5.3 p-10 -79.71 107.97 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 65' ' ' VAL . 24.1 t -125.57 39.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -95.51 -2.07 49.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -175.77 49.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.172 0.51 . . . . 0.0 109.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' CG2' HG13 ' A' ' 65' ' ' VAL . 35.2 m -115.96 142.35 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.638 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.678 ' CG2' HG22 ' A' ' 23' ' ' THR . 66.7 p -49.65 161.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.839 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.01 -48.71 80.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -58.78 -40.8 85.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.37 68.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.46 69.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.59 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 77' ' ' LEU . 39.8 t -64.92 -35.3 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.469 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 37.6 tp10 -69.47 -33.51 73.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.763 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.57 73.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -74.77 -26.41 59.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.387 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.76 -41.41 83.37 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.157 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.55 28.24 7.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.688 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.37 -24.74 23.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.36 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.57 -160.49 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.909 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 68.3 m -97.34 -36.54 10.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 9' ' ' GLU . 9.0 mt -112.87 85.1 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 84' ' ' VAL . 17.7 m -90.61 115.15 29.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.091 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.441 ' CG ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -91.28 101.25 13.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -117.28 154.28 31.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.51 114.99 28.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.328 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 57' ' ' ILE . 32.3 m -104.38 159.91 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.195 0.522 . . . . 0.0 112.229 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 109.66 15.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.658 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.832 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.39 144.81 51.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -68.78 139.65 55.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.641 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -50.34 105.95 0.58 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.296 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 43.4 Cg_endo -67.84 179.79 2.51 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.411 2.074 . . . . 0.0 112.015 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.723 ' HA ' ' HB2' ' A' ' 189' ' ' ALA . 32.5 Cg_exo -59.18 -151.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.385 2.057 . . . . 0.0 112.307 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 187' ' ' SER . . . 58.16 44.84 18.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.139 0.495 . . . . 0.0 109.74 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.948 ' HA ' ' HA ' ' A' ' 186' ' ' PRO . 4.0 pt-20 179.74 87.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.315 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 187' ' ' SER . 16.9 tttp -96.63 162.61 13.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.4 t -123.61 136.33 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.54 166.64 15.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 111.431 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.97 106.41 6.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 183' ' ' VAL . 3.5 mm -114.53 155.21 15.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -108.89 123.73 49.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.226 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.788 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.1 tt -126.14 118.57 25.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.755 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.663 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.46 144.65 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.66 155.77 25.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.66 178.11 18.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.892 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.93 -31.25 38.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.103 1.869 . . . . 0.0 112.006 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -96.89 19.68 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.76 -156.36 16.55 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.539 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 HD22 ' A' ' 103' ' ' LEU . 6.3 mp -86.5 -13.27 46.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.12 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 81.24 49.45 5.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.978 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.2 154.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.808 0.337 . . . . 0.0 111.079 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.2 t -116.84 116.64 27.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.755 HG22 HG22 ' A' ' 131' ' ' VAL . 14.3 pt -129.52 157.25 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.44 125.75 7.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.47 -175.24 25.42 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.19 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.67 -165.76 48.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.182 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 24.3 t -87.95 148.25 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.61 -10.97 60.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.516 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -179.97 65.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 109.918 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -76.21 -0.61 22.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.908 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.5 t-80 72.69 -60.99 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.702 0.763 . . . . 0.0 110.568 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.937 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.8 OUTLIER -94.6 107.03 27.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.668 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.49 89.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.394 2.062 . . . . 0.0 112.512 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 108.46 34.4 2.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -155.47 90.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.977 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -53.9 -23.26 12.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.348 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 m -56.67 137.48 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.693 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.7 mt -78.86 116.22 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.392 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.937 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.9 m-85 -113.06 150.08 32.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 150' ' ' ASP . 45.2 t -85.07 155.72 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -128.52 -45.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.34 146.27 32.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.731 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 147' ' ' GLN . 24.0 mt -136.81 141.43 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -71.89 173.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.62 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -92.4 137.28 32.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.844 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.42 27.19 40.03 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.627 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.59 178.43 50.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.663 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -65.14 -54.72 25.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.11 -32.75 70.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -60.0 -55.36 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.239 0.542 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -46.56 52.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.867 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -80.73 -59.47 2.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.032 0.444 . . . . 0.0 112.053 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -60.95 -46.34 94.77 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.247 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.54 17.25 10.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.74 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.499 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -91.39 79.2 5.62 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.502 ' HA ' HD12 ' A' ' 134' ' ' ILE . 12.7 pt20 -60.0 170.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.0 mt -47.6 126.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.281 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.99 -23.87 9.12 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.514 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -65.12 129.12 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.827 0.346 . . . . 0.0 110.517 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -115.62 131.45 56.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.244 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -104.9 134.61 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.715 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.553 HD23 ' HB2' ' A' ' 184' ' ' ALA . 2.2 pp -103.9 -2.07 26.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.61 159.9 0.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.896 0.379 . . . . 0.0 111.457 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 158' ' ' VAL . 11.7 t -115.52 100.19 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.737 HD22 ' H ' ' A' ' 180' ' ' TYR . 14.3 m120 69.28 -59.5 0.48 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.367 0.604 . . . . 0.0 109.635 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -165.49 28.96 0.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.989 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 155' ' ' VAL . 9.9 t -106.46 154.81 7.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.36 76.45 0.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.598 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -78.15 24.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.91 35.23 2.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.234 0.54 . . . . 0.0 110.742 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.02 28.59 1.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.762 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -142.04 -77.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.083 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.6 mtm -179.4 -171.59 0.2 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 169' ' ' VAL . 25.5 p80 -71.84 -32.67 67.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.301 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.72 -42.4 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.762 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.11 -37.81 66.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.569 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.71 74.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 165' ' ' HIS . 23.8 t -72.69 -43.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.481 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 174' ' ' ASN . . . -71.86 -30.18 65.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.044 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.51 -29.14 56.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.472 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.2 pp -81.66 -37.58 27.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.55 59.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.937 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -69.99 -13.67 62.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.439 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.686 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.7 p -56.84 -168.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 64.0 t80 -106.18 172.46 6.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.2 m-20 -58.28 -15.97 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.202 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.52 92.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.262 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.86 147.91 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.282 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.737 ' H ' HD22 ' A' ' 156' ' ' ASN . 18.4 p90 -100.93 129.71 46.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.788 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.99 154.37 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.751 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.61 116.93 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.786 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 101' ' ' ILE . 19.6 t -101.89 162.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.491 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.83 117.23 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 0.0 111.936 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -113.61 97.82 45.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.599 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.948 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.2 Cg_exo -45.76 96.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.756 2.304 . . . . 0.0 113.856 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.7 m -179.81 136.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . 10.3 p30 42.74 30.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.371 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 94' ' ' PRO . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.095 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.831 0.348 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.573 ' O ' HG12 ' B' ' 2' ' ' VAL . 17.0 t -98.68 34.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.09 112.72 5.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 -171.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.438 2.092 . . . . 0.0 112.274 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -150.91 158.24 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 18.6 m -66.08 164.68 14.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -99.42 141.78 31.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -127.19 124.24 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.491 ' OXT' HD12 ' A' ' 15' ' ' LEU . 8.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.0 -47.08 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.16 123.28 30.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.32 105.09 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.491 2.128 . . . . 0.0 112.275 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 62.51 135.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -66.65 -67.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.402 ' HB3' HG12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -109.48 130.81 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.067 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' HG13 ' C' ' 9' ' ' VAL . 0.6 OUTLIER -154.82 73.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.545 HG13 ' O ' ' C' ' 8' ' ' SER . 6.7 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.93 145.96 37.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.001 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.26 141.1 27.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.584 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 5.7 pt-20 -175.01 165.92 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 111.417 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -109.37 123.47 49.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.771 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.62 -172.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.316 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -140.44 127.95 21.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.259 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.88 ' HG ' HD23 ' A' ' 15' ' ' LEU . 5.8 tp -119.05 91.42 3.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.638 0.732 . . . . 0.0 110.561 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -73.79 138.84 44.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.601 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 82' ' ' SER . 2.5 ptm180 -57.85 103.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.35 -26.91 7.3 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.547 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -168.15 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -109.15 30.71 6.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.725 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.94 174.68 19.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.441 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.33 -50.49 7.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.942 0.401 . . . . 0.0 111.304 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.23 74.64 1.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.69 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 39' ' ' ILE . 2.9 p90 -164.65 156.46 15.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.029 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' ILE . 2.1 p -105.93 126.81 52.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 36' ' ' ILE . 2.4 pp -120.43 154.49 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 0.0 111.945 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.97 147.49 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.754 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.41 19.62 1.34 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.993 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.11 162.92 0.08 OUTLIER Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.542 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.752 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -66.68 -38.73 87.39 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.788 ' CB ' HG23 ' A' ' 69' ' ' THR . 12.5 t0 -83.77 -49.17 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 111.631 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.69 76.89 10.77 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.582 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.69 172.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.646 2.23 . . . . 0.0 112.274 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 17.5 t60 -108.8 -21.45 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.212 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.74 -25.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.86 7.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.703 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.89 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.13 101.49 2.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.017 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.15 61.83 2.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.903 2.402 . . . . 0.0 111.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 m -176.86 134.61 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.741 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 145.1 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.6 p90 -142.24 163.64 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.453 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 19' ' ' ILE . 49.2 mt -93.97 148.67 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 110.84 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -31.77 8.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.344 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.918 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.6 tmmm? -172.55 148.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -106.95 141.62 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.78 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.05 128.05 64.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.965 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.2 62.14 2.6 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 -43.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.62 -177.26 22.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.94 -21.27 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.631 0.253 . . . . 0.0 111.532 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.0 -57.62 12.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.13 -28.25 67.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.75 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.21 -36.21 69.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.652 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' GLY . 34.0 m-20 -87.21 -25.98 23.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.327 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 28.47 54.7 0.13 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.148 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.81 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -84.16 4.84 28.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.958 HD13 HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -177.76 -177.9 0.68 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.106 0.479 . . . . 0.0 111.547 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 165.19 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.396 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.918 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.5 m -71.13 -45.51 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.72 17.6 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 51' ' ' LEU . 7.5 p-10 -75.34 -166.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.33 100.05 3.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.797 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -60.84 95.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.465 0.65 . . . . 0.0 111.058 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.664 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -70.94 -25.68 62.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -154.55 129.84 9.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.5 t -137.13 145.87 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.927 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.5 m120 42.24 32.43 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.471 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 65.66 32.7 8.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' VAL . 21.8 t -121.07 141.88 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.46 78.13 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.701 HG12 HG21 ' A' ' 68' ' ' VAL . 18.8 m -98.78 33.26 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.427 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -84.24 3.56 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.05 47.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.039 0.447 . . . . 0.0 109.837 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 65' ' ' VAL . 29.9 m -118.71 140.99 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.176 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -49.67 164.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.905 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.3 t-160 -57.39 -48.49 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.372 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -41.4 63.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.151 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.58 76.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.94 -40.75 68.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.55 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 ' CD2' ' A' ' 70' ' ' HIS . 49.7 t -64.23 -35.83 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.658 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -34.07 73.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.815 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.49 -42.92 74.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 110.477 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.648 HD13 HG21 ' B' ' 9' ' ' VAL . 2.8 pp -76.8 -26.74 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.385 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -45.09 59.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.382 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -103.18 28.82 5.99 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.415 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.981 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -81.56 -27.83 34.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.508 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.09 -124.58 8.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.635 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 83' ' ' ILE . 69.6 p -130.83 4.62 4.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.84 96.73 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.981 HG12 ' HB1' ' A' ' 80' ' ' ALA . 26.6 m -87.41 114.37 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -100.9 110.38 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.47 154.1 51.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.664 ' CD1' HD21 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -107.83 114.68 28.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.219 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 51' ' ' LEU . 12.6 m -118.97 168.1 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.113 0.482 . . . . 0.0 112.151 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ptm -124.33 109.53 13.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.155 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' ASP . 1.2 ptt180 -129.14 141.53 51.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.75 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -71.61 114.56 9.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -69.89 111.69 9.92 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.06 127.79 3.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.531 2.154 . . . . 0.0 112.479 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.77 86.63 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.525 2.15 . . . . 0.0 111.963 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.18 29.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.112 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.27 146.1 37.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.326 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 -174.82 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 111.433 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.73 152.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.906 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttt -135.31 166.3 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -114.96 155.6 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.603 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 180' ' ' TYR . 1.6 ttpt -113.7 124.53 52.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 5.8 tt -125.79 118.4 25.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.602 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -94.87 144.68 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.195 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -65.75 155.24 36.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -134.82 -169.64 11.98 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.68 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.12 -40.13 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.022 1.815 . . . . 0.0 112.322 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 20.2 8.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 110.277 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 106.81 -133.93 11.9 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 6.5 mp -86.71 -27.03 23.94 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.935 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.1 40.75 4.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.669 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.12 154.59 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 111.08 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.5 t -102.23 123.15 45.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.489 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.801 HD11 HD22 ' A' ' 172' ' ' LEU . 16.4 pt -130.1 155.26 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -162.41 125.47 2.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.051 0.453 . . . . 0.0 111.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.93 -175.48 25.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.622 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.25 34.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.962 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -104.26 154.7 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.853 0.358 . . . . 0.0 111.377 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 -35.83 4.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.05 78.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 110.608 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 115.11 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.775 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -58.98 -17.58 26.15 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 ' CD1' ' A' ' 130' ' ' TYR . 1.1 mt -83.55 122.62 76.88 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.742 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.39 96.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.47 2.114 . . . . 0.0 112.165 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.85 58.31 14.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.93 87.01 1.95 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.571 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -43.53 -28.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t -53.57 168.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.619 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.67 ' HB ' HD12 ' A' ' 152' ' ' ILE . 27.1 mt -105.86 127.27 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.935 0.398 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.3 m-30 -117.27 154.67 30.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.502 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 134' ' ' ILE . 66.2 t -90.07 152.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 133' ' ' LYS . 5.9 t -123.62 -50.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 132' ' ' THR . 0.0 OUTLIER -134.22 142.42 47.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 131' ' ' VAL . 30.7 mt -136.99 138.46 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -80.16 172.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 135' ' ' ILE . 85.8 mt-10 -91.37 134.52 34.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.36 26.29 56.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.88 -138.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' LEU . . . -97.4 -72.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.906 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -61.47 -31.79 71.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.7 t-160 -56.41 -62.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 110.993 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -72.63 -34.3 67.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.985 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -59.36 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -88.13 -29.23 20.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.844 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 141' ' ' HIS . 1.3 ttm180 67.75 27.8 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.01 0.405 . . . . 0.0 110.527 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.906 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -88.64 82.71 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -68.38 176.35 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.87 121.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.299 0.571 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.4 -23.36 5.15 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.059 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 183' ' ' VAL . 9.3 t0 -57.94 139.51 54.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.773 0.321 . . . . 0.0 110.524 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -130.98 119.51 22.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.146 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.99 131.98 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.092 0.472 . . . . 0.0 110.79 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 pp -104.3 -1.36 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.201 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 179.83 168.68 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.718 HG12 HD22 ' A' ' 156' ' ' ASN . 58.6 t -117.88 100.44 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.635 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.718 HD22 HG12 ' A' ' 155' ' ' VAL . 66.4 m-80 70.42 -57.45 0.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.072 0.463 . . . . 0.0 110.081 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 m -165.31 21.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.325 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -116.32 132.61 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.165 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.0 68.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.863 HD22 ' HB1' ' A' ' 171' ' ' ALA . 4.0 pp -87.26 28.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.848 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.414 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -122.29 37.17 4.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.168 0.508 . . . . 0.0 110.939 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -142.42 29.05 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -116.08 -76.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.2 mtm -176.45 -170.2 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.744 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 169' ' ' VAL . 4.0 t-80 -69.99 -34.17 72.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.663 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.7 -45.41 52.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.601 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.91 -37.46 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.806 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.93 73.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.061 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.816 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.4 t -73.95 -39.97 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.2 -33.6 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.863 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -77.96 -27.04 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.816 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -76.18 -36.73 58.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -26.87 60.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.44 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -9.95 55.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.519 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 p -47.73 149.53 1.24 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 0.0 111.442 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -87.58 169.78 11.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t0 -45.12 -35.3 3.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.044 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 104' ' ' ILE . 40.8 t -147.85 91.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.95 148.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.661 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.435 ' CZ ' ' HD2' ' A' ' 102' ' ' LYS . 13.2 m-85 -96.42 127.05 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.602 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 155' ' ' VAL . 1.5 mt -104.94 150.71 24.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.954 0.407 . . . . 0.0 110.597 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.9 tttm -96.8 114.27 25.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 101' ' ' ILE . 18.8 t -101.68 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 111.288 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.608 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -123.1 141.15 52.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.16 125.89 64.58 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 189' ' ' ALA . 54.2 Cg_exo -51.82 116.27 2.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.242 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.74 142.38 23.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.2 t30 53.19 27.25 5.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLN . . . . . 0.454 ' O ' HG12 ' B' ' 2' ' ' VAL . 2.7 mm-40 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.688 0.28 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.62 HG22 ' O ' ' B' ' 2' ' ' VAL . 13.3 p 44.07 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.561 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 3.1 t -90.9 -47.23 0.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.492 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 36.0 Cg_endo -90.65 -72.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.823 2.349 . . . . 0.0 112.582 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.88 154.69 3.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.918 0.39 . . . . 0.0 111.008 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -146.06 158.77 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -97.78 108.24 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 111.006 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 71.7 m -103.26 102.81 12.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.678 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 77' ' ' LEU . 14.1 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.189 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.819 0.342 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.12 30.62 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.19 141.45 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.8 -171.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.425 2.083 . . . . 0.0 112.35 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.13 170.47 22.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 33.0 t -154.78 173.32 16.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 t -103.78 99.83 9.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -80.9 95.82 6.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.418 HG23 ' OXT' ' C' ' 9' ' ' VAL . 3.5 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.821 0.343 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -112.17 154.33 25.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.9 151.52 20.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -177.07 158.5 1.54 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 111.311 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -113.81 114.71 26.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.727 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -119.27 -176.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 120.979 0.418 . . . . 0.0 111.429 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.13 125.16 38.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.724 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 15' ' ' LEU . 13.9 tp -124.19 92.73 3.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.683 0.754 . . . . 0.0 109.97 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.16 161.69 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.22 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 15.0 ptm180 -73.14 98.51 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.876 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.87 -26.57 8.48 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.526 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -168.45 -87.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.143 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -109.18 30.73 6.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 177.4 18.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.019 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.974 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.48 -37.08 21.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.187 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 72.47 1.29 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.967 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -156.49 157.11 34.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 178.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.0 m -104.5 126.89 52.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.467 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.586 HD11 ' NE2' ' A' ' 70' ' ' HIS . 35.5 pt -105.4 163.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 0.0 111.74 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . . . -162.36 144.38 10.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.42 -144.75 18.21 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.708 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.09 142.83 5.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.366 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -48.6 -27.63 2.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.725 ' CB ' HG23 ' A' ' 69' ' ' THR . 16.7 t70 -81.58 -45.21 16.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.975 0.417 . . . . 0.0 110.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -123.92 84.73 54.44 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -41.99 144.19 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.868 2.379 . . . . 0.0 112.618 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 72.1 t60 -75.98 -49.61 17.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.637 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.485 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -97.73 -29.26 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.29 23.23 6.13 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.0 30.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -164.06 111.08 0.92 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.639 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.28 -23.68 75.47 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.732 2.288 . . . . 0.0 112.122 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -57.94 175.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.8 mp -104.01 160.81 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 27' ' ' HIS . 3.5 m-85 -132.21 166.28 22.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.189 0.519 . . . . 0.0 111.419 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 18' ' ' SER . 11.2 mt -116.71 151.54 18.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.837 ' O ' HG21 ' A' ' 53' ' ' VAL . 32.2 p -109.99 -44.31 3.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -162.8 158.38 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.196 0.522 . . . . 0.0 112.09 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -112.08 141.11 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.55 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 mt -87.32 129.08 52.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.167 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.0 Cg_exo -65.34 64.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.15 -43.45 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.271 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.56 160.21 52.85 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.319 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -54.86 -28.79 52.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -58.89 -55.38 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 39' ' ' ILE . . . -65.66 -27.26 68.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -71.71 -42.47 67.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.667 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 3.2 m-20 -77.11 -36.22 55.7 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.394 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 27.3 44.01 0.03 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.391 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -76.1 -37.65 57.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -120.33 179.78 4.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 150.91 21.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.769 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.837 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -71.25 -35.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.403 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -70.21 14.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -83.38 -162.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.84 100.82 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -55.26 96.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 111.191 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 89' ' ' MET . 5.1 mt -68.17 -33.85 75.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.892 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 86' ' ' LEU . 69.1 m-85 -157.08 167.7 29.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.295 0.569 . . . . 0.0 111.955 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.926 HG13 ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -147.15 -177.95 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.013 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.0 m-20 -40.32 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 111.592 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 50.32 31.02 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.069 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.2 t -120.94 128.85 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.385 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -95.81 80.26 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG13 HG12 ' A' ' 63' ' ' VAL . 34.5 m -97.17 32.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.43 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -75.88 -5.3 45.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.266 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.62 46.8 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.936 0.398 . . . . 0.0 110.174 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.644 HG21 HG12 ' A' ' 65' ' ' VAL . 23.3 m -117.28 140.4 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.082 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.725 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -50.61 166.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.501 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.586 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.3 t-160 -59.73 -48.64 80.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.434 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.56 69.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.53 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.7 -35.23 67.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.014 0.435 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -72.37 -42.56 65.13 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -64.51 -36.37 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.976 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.4 mt-10 -69.36 -33.68 73.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -69.65 -41.41 75.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.426 0.632 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.786 HD13 HG21 ' B' ' 9' ' ' VAL . 3.2 pp -79.52 -26.9 41.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.457 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.49 -36.62 71.19 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.225 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.06 22.91 9.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.811 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -129.91 16.48 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.29 103.89 0.88 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 166.45 -70.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.409 . . . . 0.0 110.602 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -152.44 93.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.859 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 8' ' ' LEU . 9.9 m -93.6 113.71 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -79.3 80.39 5.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.926 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -85.58 132.25 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -176.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -109.88 114.54 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m -117.84 168.36 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 0.0 112.234 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . 12.3 ttt -141.63 109.26 5.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.457 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 110.68 21.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' HG2' ' CD ' ' A' ' 93' ' ' PRO . 20.5 ttm180 -77.76 115.87 17.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.297 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' N ' ' HD3' ' A' ' 93' ' ' PRO . 34.9 mttp -150.42 47.09 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 92' ' ' LYS . 63.1 Cg_endo -86.75 134.96 3.96 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.617 2.212 . . . . 0.0 112.285 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.581 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 10.3 Cg_exo -69.23 -155.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.235 1.957 . . . . 0.0 111.783 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 166.32 38.76 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.505 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 185' ' ' LYS . 2.6 tt0 67.54 161.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -177.69 -172.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.678 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.92 147.0 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtm -134.73 166.12 23.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.212 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.04 106.21 6.7 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 183' ' ' VAL . 4.3 mm -113.86 155.57 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.425 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -121.57 125.96 47.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.254 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.679 ' HB2' HD11 ' A' ' 181' ' ' LEU . 1.9 tt -130.84 118.78 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.033 0.444 . . . . 0.0 110.733 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG13 ' A' ' 178' ' ' VAL . 4.8 pt -93.83 144.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.944 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 20.4 tttt -69.93 155.49 40.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -135.84 -160.62 8.94 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.58 -42.02 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.184 1.923 . . . . 0.0 112.484 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -92.07 21.37 5.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.025 0.441 . . . . 0.0 110.427 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 107.44 -141.57 15.66 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.44 -23.0 26.2 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.901 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.95 47.06 4.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.842 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.56 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -175.87 153.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 131' ' ' VAL . 9.5 m -111.23 129.9 55.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 172' ' ' LEU . 13.5 pt -142.54 156.6 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -157.9 125.27 5.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.44 -175.08 25.21 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.104 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 83.91 -174.08 51.06 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.073 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 25.7 t -80.35 145.35 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.754 0.312 . . . . 0.0 111.123 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.07 -27.19 9.43 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.201 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.82 68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 109.755 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -73.4 -4.57 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 19.1 t-80 72.02 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.51 0.671 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.74 145.56 35.24 Favored Pre-proline 0 C--N 1.313 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.511 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 123' ' ' ILE . 16.8 Cg_exo -67.26 62.33 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.509 2.14 . . . . 0.0 112.14 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 118.43 60.37 0.28 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.882 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -164.33 94.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.824 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.15 -23.32 20.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 m -60.01 147.71 38.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.718 HD11 ' HB1' ' A' ' 168' ' ' ALA . 1.1 mt -87.57 110.53 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.913 ' CD1' HD11 ' A' ' 123' ' ' ILE . 6.6 m-85 -104.93 150.6 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.9 t -83.2 147.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.531 HG21 ' CB ' ' C' ' 6' ' ' SER . 15.7 p -103.06 -56.61 2.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.308 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 147.1 22.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.9 mt -114.77 141.58 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -80.08 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -106.74 30.48 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.82 -28.91 66.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.325 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.22 21.33 8.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.79 -82.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.79 -56.3 16.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 0.0 110.535 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.79 -50.39 24.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.264 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.19 -59.42 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.978 0.418 . . . . 0.0 111.888 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -56.07 -57.56 18.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 60.02 26.41 15.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.769 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -106.41 86.43 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -58.91 165.84 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.673 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 132' ' ' THR . 32.3 mt -48.19 115.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 111.288 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.64 -18.19 5.18 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -68.0 122.24 17.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.878 0.37 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -110.75 128.63 55.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.51 131.73 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.592 ' CD2' ' HB2' ' A' ' 184' ' ' ALA . 1.0 OUTLIER -95.94 -2.91 46.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.086 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 167.38 146.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.86 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 158' ' ' VAL . 95.0 t -101.88 99.66 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.12 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.441 ' ND2' HG12 ' A' ' 155' ' ' VAL . 69.6 m-80 69.34 -59.66 0.48 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -162.48 26.14 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.329 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 155' ' ' VAL . 15.0 t -98.07 155.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.255 0.55 . . . . 0.0 111.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -115.26 77.76 0.27 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.619 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 168' ' ' ALA . 80.1 mt -76.73 25.69 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.614 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.6 OUTLIER -152.85 53.69 0.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.336 0.589 . . . . 0.0 110.777 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.86 28.24 0.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.6 t -150.64 -74.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtm 175.17 169.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.711 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.52 ' O ' HG23 ' A' ' 169' ' ' VAL . 14.5 p-80 -54.96 -29.87 57.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.942 0.401 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -73.41 -48.39 34.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.178 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.716 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.62 -36.58 73.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.904 0.383 . . . . 0.0 110.583 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.42 -36.27 73.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.058 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.765 ' HA ' HD23 ' A' ' 172' ' ' LEU . 5.5 t -72.07 -42.55 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.17 -30.81 66.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.627 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 160' ' ' LEU . . . -77.68 -25.95 49.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.248 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -81.32 -39.85 24.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.11 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -26.51 58.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.5 -9.89 55.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.669 ' HB ' HG21 ' A' ' 179' ' ' VAL . 7.7 p -50.96 -178.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 111.8 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -103.02 169.46 8.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t70 -52.16 -21.32 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.535 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.499 HG13 HG22 ' A' ' 104' ' ' ILE . 40.4 t -147.58 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.714 0.292 . . . . 0.0 110.341 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.24 148.3 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.116 0.484 . . . . 0.0 112.3 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -102.53 124.18 47.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.798 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -104.68 146.22 29.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 0.0 111.334 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -96.46 115.76 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.233 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 101' ' ' ILE . 17.8 t -101.83 160.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.145 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.834 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -139.57 132.72 29.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.252 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 7.7 mtpm? -83.89 146.62 49.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 31.9 Cg_exo -58.4 155.49 35.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.2 t -79.77 94.93 5.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 1.8 p-10 45.36 33.06 1.15 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.41 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.153 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.827 0.346 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.423 HG23 ' N ' ' B' ' 3' ' ' VAL . 10.3 m -132.53 -45.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.228 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.425 HG13 ' O ' ' B' ' 3' ' ' VAL . 11.4 p -98.51 125.54 42.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' B' ' 5' ' ' PHE . 50.0 Cg_exo -53.6 169.37 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.465 2.11 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.414 ' CG ' ' O ' ' B' ' 4' ' ' PRO . 5.0 m-85 -169.72 36.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 m 58.98 167.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -113.92 120.0 39.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 116.34 31.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.786 HG21 HD13 ' A' ' 77' ' ' LEU . 11.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.97 -1.014 . . . . 0.0 111.017 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.819 0.343 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 m -88.28 123.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.452 HG23 ' O ' ' C' ' 3' ' ' VAL . 10.9 m -117.29 80.2 12.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.27 -46.24 32.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.614 2.209 . . . . 0.0 112.408 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -177.12 -31.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.406 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.531 ' CB ' HG21 ' A' ' 132' ' ' THR . 87.7 p -72.98 174.43 7.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.744 0.307 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -98.81 115.96 29.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.995 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -98.63 105.44 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.546 HG13 ' OXT' ' C' ' 9' ' ' VAL . 11.1 p . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -135.26 161.45 35.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -121.64 154.76 36.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 23.8 mm-40 -145.82 118.25 8.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.561 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.457 ' HG2' ' CG ' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -125.1 95.76 4.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.79 -169.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 111.922 -178.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -119.69 135.03 54.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.637 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.9 tp -128.2 91.35 3.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.785 0.802 . . . . 0.0 110.022 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -72.69 160.64 31.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.12 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -70.5 95.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -51.11 -25.92 11.44 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.478 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -172.45 -86.85 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -109.35 30.74 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -179.77 21.86 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.419 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.94 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.2 mp -84.43 -48.74 9.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.805 0.336 . . . . 0.0 111.515 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 76.29 1.31 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.742 -0.742 . . . . 0.0 114.1 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.5 p90 -164.66 148.68 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.689 0.28 . . . . 0.0 110.756 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.8 m -100.73 126.86 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 111.392 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.771 HG22 HG12 ' A' ' 36' ' ' ILE . 2.9 pt -125.06 164.31 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -168.07 154.78 7.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.432 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 120.46 -113.54 2.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.12 22.15 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.544 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 2.8 t -58.21 -18.44 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.837 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.9 m-20 -93.44 -49.71 5.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -121.96 79.35 41.82 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.438 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.95 136.9 22.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.606 2.204 . . . . 0.0 112.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 14.4 t-80 -70.38 -21.8 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.502 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.61 -29.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.935 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.52 29.55 9.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.17 35.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.9 95.97 1.0 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.46 -23.24 30.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.126 . . . . 0.0 112.005 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -76.18 142.53 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' HB ' HD11 ' A' ' 57' ' ' ILE . 9.1 mt -93.18 154.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 111.182 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.9 p90 -142.39 167.82 21.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.299 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.775 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 40.5 mt -98.09 152.44 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 p -108.62 -36.34 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.673 0.273 . . . . 0.0 111.453 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.923 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -163.81 154.52 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.969 0.414 . . . . 0.0 111.291 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.2 141.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.999 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' B' ' 8' ' ' SER . 2.8 mt -85.44 123.61 72.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.6 Cg_exo -66.06 64.02 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.68 -52.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.34 166.8 8.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.362 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.55 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -62.03 -23.05 66.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.88 -57.37 12.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.167 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.14 -28.1 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.534 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -38.44 69.28 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.999 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 40.7 m-20 -87.56 -25.27 23.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 33.58 70.58 0.13 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.593 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -109.46 -14.06 14.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.541 0.21 . . . . 0.0 111.371 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.648 HD13 HD11 ' A' ' 86' ' ' LEU . 2.1 pt? -141.63 168.87 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -104.71 165.12 11.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.121 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.9 m -71.54 -47.77 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 53' ' ' VAL . 13.6 m-80 -62.24 4.63 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.564 ' OD2' HG21 ' A' ' 88' ' ' VAL . 44.2 p30 -86.99 170.57 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.298 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 m -120.37 116.15 24.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.579 0.228 . . . . 0.0 110.648 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.912 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -60.47 94.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.226 0.536 . . . . 0.0 111.19 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.669 HD11 ' CG ' ' A' ' 89' ' ' MET . 59.6 mt -70.07 -28.81 65.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.18 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 143.11 17.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.601 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.22 131.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.587 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 6.0 t30 52.09 40.47 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.0 26.96 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.5 t -120.81 131.47 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.3 100.93 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.0 t -112.71 41.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.012 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.95 9.7 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.655 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -177.76 37.59 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 65' ' ' VAL . 14.9 m -118.96 150.57 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.447 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.837 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -49.56 156.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.705 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.451 ' CE1' HG21 ' A' ' 74' ' ' VAL . 4.3 t-80 -58.23 -48.56 80.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.554 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -59.45 -34.79 72.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.366 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.98 -37.45 78.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.36 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.37 65.26 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 109.693 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 19' ' ' ILE . 78.9 t -64.2 -35.05 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.684 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.3 tt0 -69.19 -33.99 74.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.96 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.466 0.651 . . . . 0.0 110.466 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -79.92 -27.05 39.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.368 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -70.87 -35.56 72.41 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.141 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 21.64 10.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.655 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.87 16.27 5.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.048 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.52 95.83 0.11 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.781 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.1 m 169.59 -66.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.79 94.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.249 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -101.31 140.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.657 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.87 95.02 9.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.677 HD21 ' CG1' ' A' ' 88' ' ' VAL . 2.2 tm? -84.81 115.53 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 0.0 112.067 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CG ' ' HG2' ' A' ' 5' ' ' GLU . 1.3 t80 -121.75 114.44 21.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.912 HG12 ' HA ' ' A' ' 57' ' ' ILE . 20.7 m -129.3 168.06 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.669 ' CG ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -118.46 109.08 15.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.631 178.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 52' ' ' ARG . 45.7 ttp180 -124.08 146.56 48.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.819 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 133.51 37.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -54.7 149.06 23.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.5 Cg_endo -66.14 129.58 22.1 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.557 2.171 . . . . 0.0 112.021 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 16.6 Cg_exo -66.66 -161.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.352 2.035 . . . . 0.0 112.028 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.27 25.19 9.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.56 140.84 39.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.615 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -151.16 -178.92 6.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.1 135.14 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.7 166.73 11.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -135.14 106.41 6.75 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 183' ' ' VAL . 3.7 mm -114.15 155.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -113.04 123.28 49.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.257 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 110' ' ' LEU . 2.0 tt -124.8 118.6 26.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.587 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.528 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -97.04 144.68 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.115 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -75.17 155.93 36.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.2 -177.85 15.19 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.905 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 -33.43 16.23 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.064 1.843 . . . . 0.0 112.093 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.53 18.22 13.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 0.0 110.416 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA3' ' OXT' ' C' ' 9' ' ' VAL . . . 106.4 -148.1 16.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.457 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 103' ' ' LEU . 14.5 mt -86.57 -18.84 30.47 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.213 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.64 49.95 6.32 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.083 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.76 151.99 0.75 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 110.718 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.403 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 67.2 m -113.48 116.88 30.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.942 HD11 HD22 ' A' ' 172' ' ' LEU . 10.4 pt -128.78 155.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.607 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -155.33 125.14 6.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 111.886 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.83 -175.1 25.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.449 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 104.16 -174.13 21.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.596 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.1 t -100.76 155.02 4.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 111.4 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 96.49 -26.77 20.23 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.28 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -173.9 74.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -76.5 130.76 38.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.006 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 3.7 t-80 -43.28 -34.69 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.049 0.928 . . . . 0.0 110.64 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.27 138.3 19.85 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.901 -178.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 123' ' ' ILE . 58.2 Cg_endo -71.52 61.21 2.78 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.361 2.041 . . . . 0.0 112.719 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.72 48.76 0.08 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.26 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.42 96.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -58.14 -22.43 51.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 136.87 40.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.642 ' HB ' HD12 ' A' ' 152' ' ' ILE . 4.8 mt -73.85 120.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.999 0.428 . . . . 0.0 111.229 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.4 m-85 -116.28 147.57 41.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.396 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 150' ' ' ASP . 39.4 t -83.96 139.51 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.589 HG21 ' OG ' ' C' ' 6' ' ' SER . 11.5 p -97.49 -58.9 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.627 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG3' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -155.15 150.86 27.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 111.468 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.9 mt -127.87 141.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.767 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -74.36 173.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.608 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.2 tt0 -87.06 146.29 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.28 26.1 55.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.1 164.27 45.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -58.71 -52.32 66.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 111.201 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.666 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.12 -32.01 69.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -56.27 -54.63 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.202 0.525 . . . . 0.0 110.377 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -72.83 -50.75 22.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.092 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.56 -59.58 2.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 111.886 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -55.6 -50.05 62.33 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.169 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.98 19.52 10.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.757 0.313 . . . . 0.0 110.653 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.625 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.16 79.86 4.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 175.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 132' ' ' THR . 27.4 mt -49.75 129.53 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.159 0.504 . . . . 0.0 111.295 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.5 -24.35 11.35 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.571 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.9 OUTLIER -60.74 129.33 40.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.753 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.839 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 1.9 pttp -117.47 125.28 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.999 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.46 132.26 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.116 0.484 . . . . 0.0 110.756 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -99.41 -1.28 39.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.35 158.86 0.09 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.831 0.348 . . . . 0.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 158' ' ' VAL . 20.6 t -116.44 100.07 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.195 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 180' ' ' TYR . 12.2 m120 68.84 -59.3 0.47 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.225 0.536 . . . . 0.0 109.814 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 97.4 p -163.4 26.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.385 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 5.6 t -102.47 155.02 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-O 121.07 0.462 . . . . 0.0 111.314 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.09 79.05 0.3 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.685 HD13 ' HB3' ' A' ' 172' ' ' LEU . 18.6 mt -77.61 24.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.92 0.391 . . . . 0.0 112.048 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.83 38.68 1.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.099 0.476 . . . . 0.0 110.736 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.77 28.62 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.311 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.731 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -145.83 -75.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.388 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 172.84 166.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 50.9 t-80 -53.99 -29.92 45.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.79 0.328 . . . . 0.0 110.649 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.31 -46.45 49.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.731 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.42 -36.89 68.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.64 -34.97 72.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.511 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.0 t -72.08 -40.28 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.83 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.92 -36.33 69.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.35 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -75.42 -26.88 58.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.942 HD22 HD11 ' A' ' 114' ' ' ILE . 4.1 pp -82.07 -36.88 27.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.829 0.347 . . . . 0.0 110.377 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -75.07 -26.4 59.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.54 -9.59 54.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.188 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 1.2 p -42.34 166.91 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.059 0.457 . . . . 0.0 112.2 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' A' ' 179' ' ' VAL . 75.0 t80 -96.95 167.26 11.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -47.83 -29.2 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.315 -179.421 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 104' ' ' ILE . 41.1 t -147.9 91.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 110.7 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.68 148.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.686 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 156' ' ' ASN . 27.6 p90 -103.51 125.23 49.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.179 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -106.75 155.9 19.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.829 -178.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.88 113.45 24.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.55 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 101' ' ' ILE . 13.1 t -102.2 164.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.839 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -130.48 129.05 42.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.64 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -83.72 129.81 58.09 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.812 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.86 142.43 19.36 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.385 2.057 . . . . 0.0 112.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -174.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -65.68 74.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.024 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.171 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.842 0.353 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.609 ' O ' HG13 ' B' ' 2' ' ' VAL . 9.1 p -177.6 71.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 2.3 t -86.63 -48.45 0.51 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.209 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 7.6 Cg_exo -73.08 -22.1 19.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 65.96 141.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.66 177.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.041 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -108.14 124.52 50.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.675 ' HB2' HD11 ' A' ' 40' ' ' ILE . 61.7 p -99.14 141.0 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.525 HG23 ' CE1' ' A' ' 17' ' ' PHE . 14.4 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.871 0.367 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.24 -33.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.486 ' O ' HG13 ' C' ' 3' ' ' VAL . 12.4 p -120.16 121.48 29.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.16 101.76 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.334 2.023 . . . . 0.0 112.358 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -60.42 -30.75 69.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.589 ' OG ' HG21 ' A' ' 132' ' ' THR . 34.8 t -133.91 149.69 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -106.86 96.46 6.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 125.16 28.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.402 ' OXT' ' HA3' ' A' ' 109' ' ' GLY . 11.6 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.095 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.26 154.12 20.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HD2' ' HH ' ' A' ' 87' ' ' TYR . 3.1 m-85 -135.68 170.65 15.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE1' HD12 ' A' ' 6' ' ' ILE . 6.4 tt0 -178.29 125.79 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.415 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 4.8 pt-20 -110.22 106.55 16.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.347 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.665 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -122.35 -167.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.008 0.432 . . . . 0.0 111.639 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 135.94 44.65 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.789 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -120.32 88.97 3.04 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.6 0.714 . . . . 0.0 110.986 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.21 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.886 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASN . 8.5 mtt180 -44.43 105.04 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.82 0.343 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.91 66.11 0.33 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.48 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' ARG . 11.2 m-80 77.03 -73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.632 0.253 . . . . 0.0 110.891 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -109.29 30.41 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.67 -176.92 18.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.948 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -51.32 7.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.278 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 97.5 69.12 0.97 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.94 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 5.5 p90 -164.93 155.82 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 36' ' ' ILE . 12.9 m -117.53 138.19 52.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.551 HG22 HG12 ' A' ' 36' ' ' ILE . 3.3 pt -127.08 166.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.05 160.7 33.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 27' ' ' HIS . . . 112.51 -132.48 10.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.09 146.95 7.82 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -61.76 -16.3 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.689 ' CB ' HG22 ' A' ' 69' ' ' THR . 30.2 p-10 -102.04 -39.29 7.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.704 0.288 . . . . 0.0 110.92 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.38 76.57 53.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.634 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' CG ' ' HA ' ' A' ' 30' ' ' ASP . 99.8 Cg_exo -43.72 155.55 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.944 2.43 . . . . 0.0 112.344 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 2.8 t-80 -122.7 -11.95 8.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.691 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.579 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.16 -58.08 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' ASP . . . -173.74 33.93 0.11 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.088 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HA ' ' CG ' ' A' ' 26' ' ' PRO . 1.1 t0 81.51 53.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.835 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -118.92 114.8 35.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.695 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 32.3 Cg_exo -59.18 82.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.78 2.32 . . . . 0.0 112.165 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.75 143.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.29 148.27 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -142.61 145.28 33.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.365 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 18' ' ' SER . 70.9 mt -72.94 144.9 12.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.641 ' O ' HG21 ' A' ' 53' ' ' VAL . 21.8 p -95.49 -43.25 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.655 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 158.46 27.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.202 0.525 . . . . 0.0 111.743 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -116.92 141.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.85 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.92 133.9 45.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.35 77.82 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.56 2.173 . . . . 0.0 112.189 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.57 -31.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.328 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -61.12 168.95 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.543 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.92 -21.16 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -54.87 -57.58 11.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.42 69.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -72.05 -37.51 69.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.665 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.74 -20.25 36.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.375 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.05 72.43 1.25 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.985 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.51 35.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 88' ' ' VAL . 1.5 pp 37.57 -156.91 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.056 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.08 138.09 58.29 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.015 0.436 . . . . 0.0 111.223 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 37' ' ' THR . 31.6 m -65.24 -37.85 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.342 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -53.19 -15.27 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.23 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 90' ' ' ARG . 25.6 p-10 -59.05 170.64 0.83 Allowed 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -123.27 114.11 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.696 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.3 pt -58.6 94.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.4 mt -62.03 -29.0 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.878 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.03 125.55 4.59 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' HG ' ' A' ' 86' ' ' LEU . 4.9 m -114.33 118.59 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.648 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.408 ' OD1' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER 53.87 41.99 31.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.002 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 66.91 29.56 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.02 136.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -82.5 111.05 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 68' ' ' VAL . 26.9 m -128.55 25.6 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -79.65 5.11 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.21 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' HB2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -163.96 41.32 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.023 0.44 . . . . 0.0 109.908 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 65' ' ' VAL . 35.3 m -118.55 143.24 30.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 112.529 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 21.5 p -49.52 171.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.131 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.551 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.1 t-160 -70.16 -48.66 56.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.861 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -44.14 74.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.81 73.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.55 68.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.392 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG23 ' CD2' ' A' ' 70' ' ' HIS . 53.9 t -64.96 -36.83 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.64 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.41 -30.64 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.575 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.25 -36.7 74.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.299 0.571 . . . . 0.0 110.561 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.13 -25.84 34.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.85 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.35 -32.87 58.88 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.104 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.56 29.87 7.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -88.41 -24.24 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.64 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.06 -135.33 12.07 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.775 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.9 m -131.24 11.46 4.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 111.566 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.688 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.7 mt -151.56 92.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 3.5 m -104.26 115.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.71 91.92 7.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.85 ' HG ' HG12 ' A' ' 60' ' ' VAL . 1.7 mp -93.16 144.51 25.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.45 ' HH ' ' HD2' ' A' ' 3' ' ' TYR . 17.7 t80 -122.81 114.38 20.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.97 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 57' ' ' ILE . 31.4 m -115.25 168.48 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 0.0 112.289 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.404 ' HB2' HD12 ' A' ' 58' ' ' LEU . 6.9 ttt -138.15 109.05 6.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.491 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.483 ' CG ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -110.78 130.97 55.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -75.26 124.72 27.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -77.05 -49.78 2.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.116 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' LYS . 98.7 Cg_exo -43.83 127.89 6.67 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.594 2.196 . . . . 0.0 112.583 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -93.54 106.7 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.172 2.581 . . . . 0.0 112.361 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' H ' ' HB2' ' A' ' 188' ' ' ASN . . . -96.21 29.67 2.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -44.23 128.64 6.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -112.09 130.6 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.561 HG23 HD21 ' A' ' 153' ' ' LEU . 11.6 p -82.94 133.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.7 mmt -112.27 166.48 11.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.54 106.41 7.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.406 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.618 HG13 HG21 ' A' ' 183' ' ' VAL . 3.1 mm -114.95 155.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.515 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 4.8 mptt -113.1 126.97 56.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.634 HD22 ' HG ' ' A' ' 110' ' ' LEU . 4.0 tt -130.6 118.84 21.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.694 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.522 HG22 HG13 ' A' ' 178' ' ' VAL . 5.1 pt -92.7 144.79 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -69.01 164.42 22.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.159 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.88 -162.52 9.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.786 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.42 -35.28 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.166 1.911 . . . . 0.0 112.554 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 20.54 7.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.957 0.408 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.87 -127.85 9.22 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.696 HD22 HD13 ' A' ' 172' ' ' LEU . 1.2 mp -86.77 -30.88 21.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.65 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 99.69 38.1 3.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.875 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -177.93 160.15 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 111.305 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -110.51 117.06 32.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 172' ' ' LEU . 45.5 pt -113.43 173.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 111.488 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.07 -176.0 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.368 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 165' ' ' HIS . . . -145.72 143.61 11.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.47 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.22 -66.33 2.43 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.061 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.82 153.29 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.62 -9.78 61.26 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.038 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 168.39 81.17 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.845 0.355 . . . . 0.0 110.122 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 4.1 mt-30 -64.54 -15.1 60.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.331 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.559 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 16.4 t-80 71.82 -54.99 0.67 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.6 0.714 . . . . 0.0 110.612 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.9 mt -92.02 143.37 27.56 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.659 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 123' ' ' ILE . 38.4 Cg_exo -60.37 77.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.366 2.044 . . . . 0.0 112.247 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 87.77 65.14 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -162.12 94.0 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -55.13 -23.46 21.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 p -57.92 120.2 8.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 160' ' ' LEU . 21.9 mt -70.56 122.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.859 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.6 m-85 -111.84 151.01 29.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.962 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 150' ' ' ASP . 42.5 t -86.31 121.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.304 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 148' ' ' ILE . 9.2 p -79.28 -59.06 2.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.649 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -151.12 152.75 33.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.597 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.5 mt -118.19 141.38 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.844 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -75.31 172.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.613 ' H ' HG22 ' A' ' 135' ' ' ILE . 64.9 mt-10 -103.7 30.45 5.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.04 -28.61 58.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.65 10.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.672 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.01 -82.35 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.937 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.06 -31.71 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.3 m170 -52.15 -62.2 1.79 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -42.14 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.577 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.21 -59.36 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -70.84 -41.16 63.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.198 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.37 22.34 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 0.0 110.536 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.603 ' CD1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -95.71 85.45 4.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.92 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.45 166.67 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.523 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -47.44 116.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.262 0.553 . . . . 0.0 111.38 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.89 -14.42 6.33 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.666 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -73.92 120.06 18.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.787 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -99.96 122.8 43.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.671 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.33 118.54 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.211 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -82.58 -0.64 47.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.744 -179.107 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 175.18 159.25 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.513 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.897 HG13 HD22 ' A' ' 181' ' ' LEU . 45.6 t -121.73 98.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.276 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.75 ' ND2' HG12 ' A' ' 155' ' ' VAL . 31.8 m-80 69.27 -57.19 0.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 m -147.01 -20.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.688 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -76.16 140.72 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.408 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.73 12.68 33.77 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.897 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 129' ' ' ILE . 24.7 mt 38.96 33.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.229 0.538 . . . . 0.0 111.985 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.52 68.48 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 163' ' ' VAL . 5.9 m-20 -162.92 26.49 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.588 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -161.9 -82.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.674 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.65 170.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.049 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -54.03 -30.6 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -47.92 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.995 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.588 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.37 -32.37 62.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.816 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.762 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.7 t -70.03 -40.5 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.559 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.433 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.08 -30.43 66.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.672 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.98 -25.83 48.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -81.28 -40.69 23.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -75.41 -26.63 58.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.068 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -67.85 -21.4 65.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.918 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.544 ' HB ' HG21 ' A' ' 179' ' ' VAL . 47.7 p -54.73 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -100.88 171.33 7.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -58.48 -14.51 8.04 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.429 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.522 HG13 HG22 ' A' ' 104' ' ' ILE . 41.4 t -147.55 90.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 0.0 110.288 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -120.15 148.49 23.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.729 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -100.03 127.62 46.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.897 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -108.23 153.96 22.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.981 0.419 . . . . 0.0 110.671 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.6 mttt -96.59 119.04 34.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.398 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.618 HG21 HG13 ' A' ' 101' ' ' ILE . 39.2 t -101.82 164.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.536 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -130.91 140.74 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.691 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.89 146.19 48.54 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.436 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.45 61.17 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.809 2.339 . . . . 0.0 113.119 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.7 p 42.73 -161.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.352 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.492 ' HB2' ' H ' ' A' ' 95' ' ' ALA . 29.2 t-20 -69.37 61.5 0.14 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.832 0.349 . . . . 0.0 110.876 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.054 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 2' ' ' VAL . 30.9 m -126.1 114.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.6 HG13 ' CE1' ' B' ' 5' ' ' PHE . 11.8 p -95.19 133.39 26.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.465 2.11 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' PHE . . . . . 0.6 ' CE1' HG13 ' B' ' 3' ' ' VAL . 78.4 m-85 -146.09 151.83 38.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -119.02 156.59 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.5 97.75 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -109.28 109.37 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.547 ' OXT' HG22 ' B' ' 9' ' ' VAL . 13.4 p . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.152 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.693 HG22 ' HD2' ' C' ' 4' ' ' PRO . 14.2 p -57.53 152.91 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -80.17 -61.56 0.43 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.901 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.693 ' HD2' HG22 ' C' ' 2' ' ' VAL . 53.9 Cg_endo -69.3 119.85 6.77 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.274 1.982 . . . . 0.0 112.092 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -96.65 36.51 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.996 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -128.11 139.33 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.424 ' OG ' ' CD2' ' A' ' 165' ' ' HIS . 21.8 m -69.54 86.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.846 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.552 ' O ' HG13 ' C' ' 9' ' ' VAL . 35.9 t -83.63 109.57 17.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 8' ' ' SER . 4.0 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.952 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.823 0.345 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -91.02 156.75 17.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -151.46 145.85 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.577 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -176.82 156.27 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.402 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -86.5 167.74 14.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.454 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.605 HD13 ' HG3' ' A' ' 50' ' ' ARG . 6.9 tt -164.94 165.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.767 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -137.48 126.34 24.08 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.992 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.849 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.6 tp -122.01 88.58 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.457 0.646 . . . . 0.0 111.367 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pm0 -73.66 152.35 40.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 19.4 mtt180 -67.32 93.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.717 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.07 -25.46 10.38 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.638 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.62 -91.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -109.1 30.8 6.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.14 -178.98 25.37 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.135 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.849 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.34 -47.59 10.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.816 0.341 . . . . 0.0 111.293 -179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.36 74.18 1.25 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.084 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -164.85 169.34 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.312 . . . . 0.0 110.922 178.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.27 130.8 53.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.459 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HG12 ' A' ' 36' ' ' ILE . 1.2 pt -125.54 164.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -169.77 164.1 9.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.503 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 112.84 -119.22 4.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.481 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.99 145.06 14.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.427 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.76 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -53.9 -24.75 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.587 ' HB2' HG23 ' A' ' 69' ' ' THR . 3.1 t70 -81.73 -55.99 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -120.25 83.06 31.67 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.49 132.01 29.0 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.437 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 18.0 t-80 -68.05 -21.38 65.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.72 -28.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.118 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 29.65 12.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.37 33.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 2.7 m-20 -173.03 111.05 0.34 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 31' ' ' ASP . 21.4 Cg_exo -65.92 -27.91 50.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.126 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.79 128.02 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.19 150.34 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.48 151.09 41.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 18' ' ' SER . 77.2 mt -77.13 146.17 9.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.257 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.547 ' O ' HG21 ' A' ' 53' ' ' VAL . 66.0 m -99.77 -35.98 9.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.541 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.03 158.29 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.513 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -115.94 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 HD11 ' OG ' ' B' ' 8' ' ' SER . 3.0 mt -85.76 123.71 71.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -66.18 63.52 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.23 -54.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.485 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.21 -175.77 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -27.53 57.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 111.369 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -57.56 -29.19 64.22 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.063 0.459 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.86 -27.45 49.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.46 -43.5 66.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.018 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -31.65 15.95 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.17 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 84.48 -27.56 4.64 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.687 ' NH1' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER 45.21 30.37 0.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.865 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.553 HD23 ' HD3' ' A' ' 90' ' ' ARG . 2.1 mp 65.17 -173.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 131.1 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.763 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.4 m -53.5 -37.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.731 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -62.15 -3.93 1.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.354 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -58.34 175.3 0.24 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 110.671 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.9 t -130.24 102.78 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.02 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 58' ' ' LEU . 3.2 mt -59.84 -35.39 74.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 1.5 m-85 -158.57 123.57 4.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.409 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -114.16 119.85 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 53.8 37.52 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.67 30.34 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.88 133.74 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' CZ ' ' A' ' 59' ' ' PHE . 1.4 m-20 -72.79 77.64 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' HG23 ' A' ' 68' ' ' VAL . 21.1 t -107.65 35.11 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.055 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -101.08 1.04 38.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.083 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -156.1 33.74 0.34 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.758 0.314 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -124.0 158.28 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.76 ' N ' HG22 ' A' ' 23' ' ' THR . 7.3 m -50.07 163.08 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.056 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.637 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -61.34 -48.56 80.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.834 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 t -52.73 -35.87 56.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.07 77.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.964 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -71.96 -41.62 67.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.221 0.534 . . . . 0.0 109.652 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' CD2' ' A' ' 70' ' ' HIS . 42.0 t -64.4 -36.01 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.4 -33.39 72.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.815 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.76 75.71 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.435 0.636 . . . . 0.0 110.476 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -79.69 -26.92 40.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.552 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.63 -37.85 67.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.955 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.34 25.79 7.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.401 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.95 -23.67 23.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.18 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.27 -152.3 22.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 83' ' ' ILE . 3.9 m -101.51 11.74 38.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.497 0.189 . . . . 0.0 111.338 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -151.53 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.5 t -90.59 149.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.767 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -137.67 102.29 4.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.976 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.9 154.01 50.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.3 t80 -105.68 114.8 29.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.614 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.45 168.03 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.324 0.583 . . . . 0.0 112.414 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.427 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.25 109.66 7.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.134 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.553 ' HD3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -112.57 106.95 15.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.064 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -67.96 141.06 56.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.934 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.36 66.19 76.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.95 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 39.3 Cg_exo -58.99 -47.39 18.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.45 2.1 . . . . 0.0 112.696 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 188' ' ' ASN . 98.4 Cg_endo -91.68 -167.57 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.775 2.317 . . . . 0.0 112.276 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 26.1 0.6 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.802 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 187' ' ' SER . 70.4 mm-40 -158.13 -173.71 4.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.78 -175.37 5.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.024 0.44 . . . . 0.0 111.29 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.26 144.49 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.268 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.0 166.41 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.424 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -133.19 106.6 7.68 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.57 155.92 16.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.742 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.95 126.07 54.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.104 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.4 tt -126.38 118.54 25.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.563 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 4.4 pt -96.84 144.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.034 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.45 158.44 36.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -136.02 -175.11 13.65 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.869 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.51 -40.75 9.85 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.269 1.98 . . . . 0.0 112.31 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -91.99 19.97 6.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.488 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.02 -141.27 15.22 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 6.6 mp -86.53 -22.35 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.926 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.43 58.39 3.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.887 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.96 155.43 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.417 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 2.7 t -116.38 116.9 28.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 172' ' ' LEU . 10.3 pt -134.16 154.82 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' CD2' ' A' ' 122' ' ' HIS . . . -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.091 0.472 . . . . 0.0 112.048 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.94 -174.99 25.51 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.494 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.63 -176.54 52.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.536 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 119' ' ' GLY . 26.0 t -81.45 154.8 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 76.06 6.1 81.96 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.19 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 165' ' ' HIS . 1.1 t30 -168.69 52.97 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 7.9 mm-40 -33.35 -43.47 0.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 14.6 t-80 73.28 -45.53 0.62 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.027 0.918 . . . . 0.0 108.891 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.78 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -122.65 130.85 24.48 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.161 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.24 89.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.445 2.097 . . . . 0.0 112.919 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.95 44.93 4.97 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.217 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -150.71 78.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.195 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -53.92 -22.97 11.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.218 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -55.31 145.49 21.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.588 HG12 ' HA3' ' A' ' 116' ' ' GLY . 8.2 mt -80.03 117.43 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.78 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -114.92 156.25 25.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.521 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 47.5 t -95.52 155.63 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.212 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.546 ' O ' HD13 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -130.17 -32.51 1.8 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.417 ' HG3' ' CB ' ' A' ' 113' ' ' SER . 1.8 pttp -160.66 145.63 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.842 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 146' ' ' LEU . 5.1 mt -131.64 141.8 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.74 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.5 mm -73.54 175.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.694 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 tt0 -99.47 139.71 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.48 29.18 60.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.583 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.91 -132.45 1.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.578 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -110.38 -61.29 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.934 0.397 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -67.15 -31.4 71.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -60.39 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -46.12 54.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.305 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.48 -59.5 2.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.564 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.31 -44.93 96.97 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.262 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 145' ' ' ARG . 0.7 OUTLIER 61.26 20.34 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.584 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -91.75 82.79 5.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.709 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 169.84 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.751 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 132' ' ' THR . 33.6 mt -47.91 121.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.276 0.56 . . . . 0.0 111.235 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.5 -22.5 6.19 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.376 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -68.85 124.97 25.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -112.73 128.96 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -102.71 130.72 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.072 0.463 . . . . 0.0 110.538 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.4 pp -98.42 -1.16 42.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.294 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.19 152.6 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.719 0.295 . . . . 0.0 111.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.945 HG13 HD23 ' A' ' 181' ' ' LEU . 40.2 t -107.4 99.7 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.445 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.9 m-80 69.18 -59.44 0.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.319 0.58 . . . . 0.0 109.739 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.02 27.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.172 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.5 t -100.6 155.22 4.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.277 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -117.0 77.4 0.28 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.572 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 31.9 mt -79.11 24.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.94 0.4 . . . . 0.0 111.928 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -139.73 32.7 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 110.652 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.79 28.05 1.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.656 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -143.29 -77.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 0.9 OUTLIER 174.74 165.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.605 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.9 p-80 -53.9 -30.7 47.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -45.2 54.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.279 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.656 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.66 -37.08 68.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.67 -36.54 73.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.107 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.564 ' HA ' HD23 ' A' ' 172' ' ' LEU . 13.4 t -73.81 -42.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.43 -33.01 69.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -77.78 -27.71 50.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.465 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.05 -36.72 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -26.85 60.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.519 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.1 -9.89 59.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.293 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 69.9 p -52.59 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.926 0.393 . . . . 0.0 111.515 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -103.61 169.8 8.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t70 -54.31 -18.85 4.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.4 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.437 HG13 HG22 ' A' ' 104' ' ' ILE . 39.0 t -147.58 92.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.94 148.19 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 112.006 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -95.65 127.16 41.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 179.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.945 HD23 HG13 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -106.87 144.32 33.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 0.0 110.869 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.36 112.45 24.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.153 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.579 HG21 HG13 ' A' ' 101' ' ' ILE . 15.6 t -101.91 161.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.51 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -144.78 140.09 28.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.455 ' CB ' ' HB3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -96.38 146.32 31.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.75 89.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.172 2.581 . . . . 0.0 112.91 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.515 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -58.71 166.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.73 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 8.9 m120 39.74 32.96 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.653 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.118 -179.932 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.657 HG23 HG23 ' B' ' 3' ' ' VAL . 4.8 m -134.66 -50.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.379 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.657 HG23 HG23 ' B' ' 2' ' ' VAL . 5.3 t -84.41 -48.02 0.67 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.677 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 88.3 Cg_endo -82.09 157.02 17.64 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.356 2.037 . . . . 0.0 112.402 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -145.46 169.94 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -84.84 160.58 20.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -80.54 117.18 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.975 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 40' ' ' ILE . 33.6 t -94.16 122.12 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 8' ' ' SER . 14.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.33 -58.71 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.611 ' O ' HG13 ' C' ' 3' ' ' VAL . 8.9 p -163.16 106.92 1.0 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.47 166.54 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.433 2.089 . . . . 0.0 112.38 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.92 141.9 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 13.0 m -149.72 138.93 21.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.96 95.2 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.469 ' O ' HG13 ' C' ' 9' ' ' VAL . 97.6 p -91.23 119.33 31.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' C' ' 8' ' ' SER . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.327 -0.845 . . . . 0.0 111.195 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.81 0.338 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -142.83 149.22 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.27 162.69 26.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.7 161.49 2.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.639 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 165.33 14.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.568 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.502 HG23 ' NH2' ' A' ' 50' ' ' ARG . 2.0 tt -164.45 166.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 111.809 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -133.82 138.96 45.97 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.677 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.776 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.73 86.73 2.26 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.596 0.712 . . . . 0.0 110.99 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -76.63 155.23 33.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.248 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -66.3 86.7 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.85 -26.03 10.41 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.781 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.25 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 m -109.12 30.81 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.0 -179.09 27.05 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.776 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.33 -42.74 15.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.822 0.344 . . . . 0.0 111.407 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 88.01 64.81 1.34 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 114.042 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 6.0 p90 -161.78 139.57 8.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 110.594 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 36' ' ' ILE . 73.9 m -91.76 130.98 37.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.689 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.42 ' CG2' HG12 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -132.56 163.59 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.634 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 164.0 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.371 . . . . 0.0 111.378 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 121.79 -113.84 2.38 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.534 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.96 141.45 9.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.293 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.719 HG22 ' N ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -56.2 -21.26 22.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.609 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.756 ' CB ' HG23 ' A' ' 69' ' ' THR . 38.0 t0 -93.53 -43.92 8.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -123.83 78.48 57.27 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.207 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.3 142.15 9.35 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.708 2.272 . . . . 0.0 112.633 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.7 t60 -74.97 -19.41 60.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.87 -27.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.274 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.09 28.89 9.45 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -171.14 32.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.6 111.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.6 -29.03 52.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.707 2.271 . . . . 0.0 112.009 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -62.26 169.59 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.59 149.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.981 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 10.3 p90 -142.84 144.71 32.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.578 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 18' ' ' SER . 57.9 mt -72.69 146.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.119 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 53' ' ' VAL . 16.6 m -101.19 -33.17 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.598 0.237 . . . . 0.0 111.508 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -168.94 152.67 5.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.427 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -116.36 141.25 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 ' HA2' ' A' ' 16' ' ' GLY . 3.4 pt -92.74 141.49 24.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.78 61.58 6.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.513 2.142 . . . . 0.0 112.392 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.23 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.462 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.99 175.64 23.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.709 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -76.11 -15.33 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.81 -57.46 11.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.95 0.405 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -28.55 69.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.933 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -71.92 -35.72 69.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -84.88 -25.37 28.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.009 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 82.37 56.07 2.91 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.392 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 42.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.633 HD21 HG21 ' A' ' 88' ' ' VAL . 1.2 pp 33.34 -153.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' N ' HD12 ' A' ' 51' ' ' LEU . 4.8 tpm_? -63.81 144.29 57.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.791 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -70.61 -37.62 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.515 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -54.86 -13.95 1.26 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.2 p-10 -57.45 163.1 2.5 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.271 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.6 p -122.16 110.48 15.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.707 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.724 HG22 HG12 ' A' ' 88' ' ' VAL . 2.9 pt -58.99 94.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 5.8 mt -65.14 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.037 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 9.3 m-85 -146.18 168.6 20.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.105 0.479 . . . . 0.0 111.83 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -147.18 -177.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.547 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 60' ' ' VAL . 15.6 p-10 -53.96 82.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER 65.5 26.74 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 2.5 t -121.24 141.86 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 111.368 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.49 76.36 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.777 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG12 HG21 ' A' ' 68' ' ' VAL . 16.7 m -99.48 31.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.356 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -12.88 59.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -173.37 56.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.117 0.484 . . . . 0.0 109.706 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' C ' ' HB ' ' A' ' 23' ' ' THR . 19.1 m -117.31 140.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.5 m -50.25 169.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.201 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.491 ' H ' HG22 ' A' ' 69' ' ' THR . 1.8 t-80 -51.08 -48.75 61.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -51.63 -47.9 63.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.862 0.363 . . . . 0.0 111.536 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -60.24 -32.46 71.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.86 64.46 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.616 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' HA ' HD21 ' A' ' 77' ' ' LEU . 43.0 t -65.1 -35.22 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.739 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.32 -32.17 71.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.822 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.13 73.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.4 0.619 . . . . 0.0 110.385 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.559 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -72.08 -39.51 68.93 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.383 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.26 29.06 7.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.628 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -81.35 -27.49 34.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.304 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.53 -132.43 11.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.499 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.498 ' O ' HG12 ' A' ' 83' ' ' ILE . 5.4 m -125.97 5.72 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.501 0.191 . . . . 0.0 111.397 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -151.06 91.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 80' ' ' ALA . 1.7 t -93.75 148.56 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.035 0.445 . . . . 0.0 111.897 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -133.7 108.28 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -130.3 153.8 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 112.629 -178.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 59' ' ' PHE . 6.6 t80 -106.32 115.11 29.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.298 178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 57' ' ' ILE . 27.1 m -104.24 168.07 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.446 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -127.08 109.51 11.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.954 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.5 146.58 46.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.731 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -93.75 133.68 36.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.729 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 90' ' ' ARG . 1.2 mmmt -141.39 77.16 20.12 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.21 111.86 2.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.797 2.331 . . . . 0.0 113.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.686 ' HB2' ' HA ' ' A' ' 188' ' ' ASN . 11.2 Cg_exo -69.55 -146.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.817 2.345 . . . . 0.0 111.776 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 161.33 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.531 ' CA ' ' HA ' ' A' ' 187' ' ' SER . 15.0 tt0 -54.39 125.98 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 120.44 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.043 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 98' ' ' VAL . 10.0 p -82.96 116.65 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.472 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 tpt -101.31 166.04 10.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.485 0.659 . . . . 0.0 111.942 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -137.32 106.59 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.56 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 144' ' ' GLY . 3.7 mm -113.22 155.13 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HE2' ' CZ ' ' A' ' 180' ' ' TYR . 5.5 tttt -120.89 119.11 31.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.966 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.032 HD12 ' HB2' ' A' ' 140' ' ' ALA . 9.6 tt -120.67 118.7 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.48 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -95.13 144.75 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.597 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -55.69 143.63 29.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.975 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -175.46 14.09 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.814 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.59 -38.9 3.98 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 121.978 1.785 . . . . 0.0 112.1 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 18.32 11.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.479 . . . . 0.0 110.302 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.64 11.12 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.5 mp -87.08 -27.31 23.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.886 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.7 47.24 4.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.93 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.07 149.23 0.55 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.922 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 13.6 m -109.2 124.31 50.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.625 HG21 ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -135.76 155.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' C' ' 6' ' ' SER . . . -152.39 125.15 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.429 . . . . 0.0 111.868 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.587 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.69 -174.99 25.31 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.195 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.11 -179.5 46.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.196 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 164' ' ' MET . 39.5 t -78.99 145.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.758 0.313 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.9 -32.12 5.81 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.624 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 2.7 t-20 -157.11 66.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.67 -4.18 22.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.96 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 16.5 t-80 72.28 -57.71 0.61 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.449 0.642 . . . . 0.0 110.478 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.3 mt -91.67 128.43 46.35 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.442 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.57 74.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.421 2.08 . . . . 0.0 112.423 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 117.93 47.74 0.43 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.84 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.747 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -165.98 93.75 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.839 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -56.86 -22.08 34.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.308 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -56.02 151.13 12.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 160' ' ' LEU . 6.4 mt -89.02 119.44 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.335 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.879 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.2 m-85 -115.77 155.09 28.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.29 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.568 HG22 HG22 ' A' ' 114' ' ' ILE . 47.6 t -84.33 155.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.739 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 148' ' ' ILE . 6.4 p -117.62 -57.89 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.486 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 146.28 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 146' ' ' LEU . 4.7 mt -129.66 141.38 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.883 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -79.29 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 45.3 mt-10 -87.05 143.38 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.05 22.88 65.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.56 -173.82 23.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.37 -69.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.032 ' HB2' HD12 ' A' ' 103' ' ' LEU . . . -63.28 -31.63 72.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 23.4 t-160 -53.38 -62.1 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.993 0.425 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -38.2 67.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.178 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.33 -59.29 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 101' ' ' ILE . . . -80.81 -18.87 69.16 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.006 -0.616 . . . . 0.0 114.024 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER 50.95 26.99 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.15 0.475 . . . . 0.0 110.791 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -87.4 81.25 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.59 175.14 3.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.536 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 132' ' ' THR . 33.0 mt -46.85 126.5 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.25 0.548 . . . . 0.0 111.293 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 120.12 -23.21 8.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.514 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -63.84 159.23 20.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.678 0.275 . . . . 0.0 110.456 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -145.82 138.8 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.004 0.431 . . . . 0.0 111.388 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -105.3 132.22 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.491 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.2 pp -99.62 -1.87 37.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.292 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.71 154.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.204 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 158' ' ' VAL . 35.4 t -108.61 99.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.875 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.542 HD22 HG12 ' A' ' 155' ' ' VAL . 68.6 m-80 69.53 -59.51 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.404 0.621 . . . . 0.0 109.578 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.9 p -164.33 28.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.028 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.5 t -102.33 155.09 5.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.489 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.85 76.74 0.25 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.736 HD22 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -81.09 25.76 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.46 56.2 1.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.333 0.587 . . . . 0.0 110.796 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -165.29 29.37 0.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.352 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.68 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.2 t -141.59 -76.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.553 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.434 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 176.62 167.76 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.605 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 169' ' ' VAL . 10.8 t-80 -54.46 -30.11 51.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.69 -49.16 27.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.049 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.68 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.66 -33.12 68.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.033 0.444 . . . . 0.0 110.225 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.23 -41.17 73.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.487 0.66 . . . . 0.0 109.484 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.818 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.9 t -69.03 -43.99 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.153 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -32.44 71.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.222 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.42 48.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.983 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -81.22 -38.47 26.93 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.868 ' HE3' HG21 ' C' ' 9' ' ' VAL . 4.0 mttp -75.19 -26.66 59.19 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.924 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.53 -9.91 52.25 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.399 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.404 ' CB ' HG21 ' A' ' 179' ' ' VAL . 1.1 p -42.85 147.21 0.32 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -90.34 170.47 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -44.93 -32.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 104' ' ' ILE . 39.9 t -148.22 91.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.404 HG21 ' CB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.22 148.32 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 0.0 111.925 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.439 ' CZ ' ' HE2' ' A' ' 102' ' ' LYS . 7.8 m-85 -101.71 133.35 46.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.771 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -118.98 149.62 41.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.941 0.401 . . . . 0.0 111.092 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 152' ' ' ILE . 22.0 mttt -96.52 112.02 23.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 101' ' ' ILE . 11.5 t -102.78 159.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.328 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.45 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -133.22 146.27 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.921 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 146.24 31.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.14 109.71 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.663 2.242 . . . . 0.0 111.922 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.531 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 36.4 t -54.74 161.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.681 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.686 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 3.1 m120 -67.27 63.13 0.06 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.335 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.408 ' N ' ' HG2' ' A' ' 94' ' ' PRO . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t 69.91 -64.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' B' ' 7' ' ' SER . 7.4 p -56.57 121.53 44.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.266 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.26 -71.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.288 1.992 . . . . 0.0 112.032 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.84 -91.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.73 -56.44 3.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.807 0.336 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.782 ' HB2' HG23 ' B' ' 3' ' ' VAL . 7.0 t 74.52 -165.86 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.461 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 9.6 t -59.14 143.63 48.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.518 ' OXT' HD12 ' A' ' 15' ' ' LEU . 25.1 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.697 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.56 -32.72 59.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t 59.7 84.2 0.2 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.33 -27.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.585 2.19 . . . . 0.0 112.418 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -170.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . 54.6 p -116.22 -176.25 2.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.16 88.43 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.591 ' O ' HG13 ' C' ' 9' ' ' VAL . 98.7 p -86.28 110.77 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.868 HG21 ' HE3' ' A' ' 173' ' ' LYS . 3.6 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.038 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG3' ' HG2' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.22 173.87 7.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.099 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.49 164.04 35.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -179.79 152.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -84.11 148.66 26.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 50' ' ' ARG . 19.3 mt -148.44 152.84 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.239 0.542 . . . . 0.0 111.834 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -116.21 130.28 56.72 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.9 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.826 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.7 tp -134.98 91.5 2.76 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.608 0.718 . . . . 0.0 110.451 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 mt-10 -69.6 168.86 13.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.721 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 2.6 mtt180 -72.63 104.26 3.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.796 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -69.69 65.74 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.108 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 75.83 -76.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.261 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -109.31 30.53 6.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.4 -177.95 17.2 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.826 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.5 -52.28 6.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.28 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 78.14 1.4 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.845 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -164.74 155.76 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.74 0.305 . . . . 0.0 110.732 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.5 m -109.29 126.84 53.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.74 HG22 HG12 ' A' ' 36' ' ' ILE . 2.7 pt -120.73 164.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.755 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -171.75 157.84 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 0.0 111.305 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.93 -118.11 3.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.265 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 144.46 11.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.683 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -57.37 -19.27 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.555 0.217 . . . . 0.0 111.483 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.773 ' HB2' HG22 ' A' ' 69' ' ' THR . 3.7 m-20 -88.78 -54.7 4.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.868 0.366 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -120.33 81.83 30.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.9 138.04 21.42 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.643 2.229 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 13.4 t-80 -70.02 -19.55 63.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.29 -30.43 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.49 28.79 8.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.496 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.91 33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.07 112.66 1.04 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 23.7 Cg_exo -64.29 -29.32 63.72 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.739 2.293 . . . . 0.0 112.135 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 176.29 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.789 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -123.88 152.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 2.2 p90 -139.79 168.56 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.74 HG12 HG22 ' A' ' 19' ' ' ILE . 46.6 mt -95.45 153.44 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.68 -31.33 7.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 9.7 tmtt? -171.32 150.21 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 0.0 111.594 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -110.58 141.34 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.846 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.9 mt -85.81 123.5 72.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 20.2 Cg_exo -65.59 64.79 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.558 2.172 . . . . 0.0 112.218 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.17 -51.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.508 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.39 174.08 5.12 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.438 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.796 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -59.23 -34.6 72.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 0.0 111.369 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.696 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -50.9 -44.47 59.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.24 63.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.623 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -71.9 -39.16 69.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.682 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 49' ' ' GLY . 1.2 m-20 -85.96 -28.17 24.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 19.38 59.27 0.01 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.941 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CG ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.61 -15.35 13.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 51' ' ' LEU . 1.5 pt? -118.36 167.72 11.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.061 0.458 . . . . 0.0 111.281 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -107.75 159.05 16.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.049 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.4 m -70.88 -48.25 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 112.023 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' N ' HG23 ' A' ' 53' ' ' VAL . 10.0 m120 -61.22 1.37 0.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -84.52 160.91 20.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.21 113.22 18.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 110.735 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 88' ' ' VAL . 16.6 pt -56.27 95.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -65.24 -21.79 66.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.757 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.672 ' HA ' HG12 ' A' ' 65' ' ' VAL . 2.5 t80 -155.78 145.35 21.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.64 HG22 ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -129.56 117.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.722 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 56.77 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 60' ' ' VAL . 29.1 mt-10 -150.76 30.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 21.4 t -120.86 141.69 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 4.8 m-20 -77.39 90.58 3.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 57' ' ' ILE . 15.0 p -103.2 33.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.423 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 6.04 38.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 173.87 53.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 0.0 110.011 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.709 ' CG2' HG23 ' A' ' 65' ' ' VAL . 31.5 m -115.64 141.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.004 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.95 157.85 0.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.466 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -51.58 -48.57 63.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.508 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -55.8 -42.69 76.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.37 69.13 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.547 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.561 ' HA ' HD21 ' A' ' 77' ' ' LEU . 47.5 t -64.6 -35.55 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.649 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -69.53 -33.71 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.839 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.46 73.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.393 0.616 . . . . 0.0 110.491 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.57 -26.76 55.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.42 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 4.6 tttm -69.95 -38.56 76.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.067 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.27 27.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.442 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -86.23 -25.15 25.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.329 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.7 -152.91 30.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.656 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.513 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -101.82 11.09 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.641 0.258 . . . . 0.0 111.438 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -150.64 92.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.8 t -85.23 148.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.401 0.62 . . . . 0.0 111.869 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 7' ' ' THR . 2.3 mmt85 -138.16 84.13 2.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.562 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.7 pp -115.6 154.02 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.397 0.618 . . . . 0.0 112.569 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CE1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -104.84 114.84 29.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.608 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 57' ' ' ILE . 33.0 m -105.83 167.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.121 0.486 . . . . 0.0 112.193 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.4 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 29.4 ttp -131.62 109.44 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.312 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 90' ' ' ARG . 21.2 ttp-105 -120.17 146.52 45.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -52.5 160.94 0.76 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.234 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.24 164.45 61.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.01 171.94 5.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.803 2.335 . . . . 0.0 112.489 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.586 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 37.7 Cg_exo -60.14 -147.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.888 2.392 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 82.34 53.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.156 0.503 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' HG3' ' HB3' ' A' ' 185' ' ' LYS . 1.4 mm-40 -64.51 -160.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.492 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.91 -178.96 3.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.94 125.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.84 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.3 mtm -102.18 164.14 11.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.337 0.589 . . . . 0.0 112.08 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -127.98 106.8 9.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.492 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.86 155.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.627 ' HE3' HG12 ' A' ' 178' ' ' VAL . 9.9 tttp -117.15 118.65 32.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.376 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.78 ' HB2' HD11 ' A' ' 181' ' ' LEU . 7.9 tt -115.69 118.71 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.137 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 178' ' ' VAL . 4.5 pt -98.42 144.69 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -74.64 161.18 29.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.965 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.08 -168.66 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.849 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.09 -40.02 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.076 1.851 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -93.75 20.58 7.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.81 -142.83 15.56 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.65 -21.31 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.869 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.84 50.77 8.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.52 148.01 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 111.029 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.3 t -107.01 116.9 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.882 HD11 HD22 ' A' ' 172' ' ' LEU . 48.2 pt -115.38 173.6 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.13 -176.53 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.82 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -143.15 149.14 21.08 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.103 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.47 -94.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.072 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 34.3 t -87.38 148.63 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.28 -21.19 41.73 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.388 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.93 69.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.259 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -59.83 -19.85 53.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.274 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 12.5 t-80 72.51 -52.62 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 110.817 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.862 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.2 mt -93.3 141.09 23.53 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.839 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.569 ' HD2' HG22 ' A' ' 123' ' ' ILE . 52.9 Cg_exo -54.7 83.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.4 2.067 . . . . 0.0 112.233 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 80.01 62.13 2.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.797 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.533 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.2 t0 -159.91 93.22 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -55.98 -22.34 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.269 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -54.67 122.88 11.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 110.778 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.805 HD12 ' HB3' ' A' ' 160' ' ' LEU . 17.1 mt -72.19 117.8 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.085 0.469 . . . . 0.0 111.744 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.862 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.8 m-85 -111.95 153.9 26.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 114' ' ' ILE . 60.1 t -91.05 134.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.25 -45.35 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -122.09 132.59 54.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 111.745 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 131' ' ' VAL . 56.1 mt -137.36 128.63 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.943 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.74 173.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.738 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.596 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.0 OUTLIER -92.29 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.35 15.19 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.616 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.85 -157.41 3.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.583 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -83.54 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.277 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.17 -31.81 69.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.379 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -55.3 -58.06 9.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.196 0.522 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.8 -47.5 45.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.041 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.69 -59.42 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' CG2' ' A' ' 101' ' ' ILE . . . -61.24 -35.87 91.55 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.19 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 61.1 20.13 10.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.875 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.72 81.28 3.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.798 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' HA ' HD12 ' A' ' 134' ' ' ILE . 5.0 pt20 -65.68 176.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.508 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.9 mt -47.82 129.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.214 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 116.28 -24.92 9.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.532 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -63.99 133.44 53.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.349 . . . . 0.0 110.749 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -122.9 130.1 52.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -104.53 137.03 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 2.6 pp -98.91 -2.71 36.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.762 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 165.4 147.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.124 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.739 HG23 HD11 ' A' ' 160' ' ' LEU . 47.5 t -101.36 99.69 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.2 m-80 69.44 -58.73 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 109.666 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 155' ' ' VAL . 81.3 p -163.1 25.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.728 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 155' ' ' VAL . 23.9 t -91.59 156.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-O 121.364 0.602 . . . . 0.0 111.524 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -99.29 74.05 0.51 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.749 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.805 ' HB3' HD12 ' A' ' 129' ' ' ILE . 37.7 mt -70.61 24.1 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.717 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 159' ' ' GLY . 8.3 pt-20 -176.26 56.63 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.3 0.572 . . . . 0.0 110.924 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -161.48 27.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.573 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.678 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -153.23 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.146 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.444 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 5.5 mtp 173.06 164.48 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.482 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.6 p-80 -53.83 -29.86 42.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.939 0.399 . . . . 0.0 110.446 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.57 -45.41 53.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.151 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.678 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.22 -35.66 66.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.968 0.413 . . . . 0.0 110.604 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.71 73.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.776 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 172' ' ' LEU . 14.0 t -74.01 -39.94 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.493 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.82 68.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.671 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.36 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.882 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -80.79 -36.79 31.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -26.88 60.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.493 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.26 -12.8 60.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.207 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.501 ' HB ' HG21 ' A' ' 179' ' ' VAL . 70.9 p -55.66 -172.59 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 111.341 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -107.68 170.22 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -55.47 -16.96 4.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.347 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.627 HG12 ' HE3' ' A' ' 102' ' ' LYS . 39.1 t -147.88 92.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.501 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.92 148.41 20.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.071 0.463 . . . . 0.0 111.987 -178.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.408 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -94.81 131.19 40.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.28 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.36 146.99 43.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.13 108.11 20.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 101' ' ' ILE . 5.6 t -102.71 157.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.062 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.83 44.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.505 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 7.3 mmtp -123.7 141.95 37.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 97.45 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.753 2.302 . . . . 0.0 112.931 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.3 m -67.84 149.06 50.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 46.34 30.06 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.281 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.058 -179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.723 0.297 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.577 HG22 ' O ' ' B' ' 2' ' ' VAL . 10.7 p -88.62 51.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.152 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.418 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 22.7 t 56.59 64.39 4.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.426 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' B' ' 3' ' ' VAL . 13.1 Cg_exo -69.66 92.72 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.666 2.244 . . . . 0.0 112.119 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.18 82.08 1.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -164.91 86.46 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 104.5 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 110.73 22.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.772 ' OXT' HD12 ' A' ' 15' ' ' LEU . 26.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.12 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.857 0.36 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 31.3 m -71.5 135.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.38 91.81 25.49 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.8 132.87 38.18 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.487 2.125 . . . . 0.0 112.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.44 118.4 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 54.4 m 59.44 162.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 73.9 m -113.65 109.94 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.916 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.7 p -94.22 116.38 28.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 112' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 ptm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.61 163.49 12.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.33 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -159.41 154.47 25.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 179.28 156.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.54 158.45 35.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.313 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 88' ' ' VAL . 3.5 mt -152.78 142.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.294 0.568 . . . . 0.0 111.942 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -122.22 119.38 31.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.965 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.888 HD21 ' HB2' ' A' ' 45' ' ' ALA . 3.1 tp -125.31 93.96 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.637 0.732 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -79.08 165.32 23.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.911 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.9 93.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.67 -25.89 9.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.595 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -173.53 -85.6 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 30.6 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.622 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 177.02 18.59 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.213 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.804 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.22 -43.45 14.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 -179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 92.95 71.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.713 . . . . 0.0 114.078 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.77 155.27 14.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.794 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.4 m -112.97 126.96 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.446 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.49 164.07 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.26 142.31 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 136.76 -126.89 3.89 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.71 128.47 4.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -49.58 -25.78 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 53.5 t0 -91.75 -40.92 10.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.82 77.24 57.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.67 134.89 34.22 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.644 2.23 . . . . 0.0 112.413 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.425 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.0 t60 -68.51 -21.41 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.61 -31.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.12 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.02 28.34 8.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.597 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -176.69 36.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 4.7 t0 -162.38 95.67 1.2 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.3 Cg_endo -55.68 -23.71 42.15 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.458 2.106 . . . . 0.0 112.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 159.27 32.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.01 150.77 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.52 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.4 p90 -142.53 144.96 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' SER . 64.8 mt -74.43 147.25 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.786 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -96.59 -46.52 6.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.62 -179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.44 158.29 39.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.093 0.473 . . . . 0.0 111.671 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -111.09 141.23 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.7 mt -84.5 118.16 70.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.22 76.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.42 2.08 . . . . 0.0 112.099 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . 174.22 -45.62 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.422 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.62 -178.47 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.561 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -28.41 57.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.588 0.232 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.74 -43.6 76.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.959 0.409 . . . . 0.0 110.749 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.09 65.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.866 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -71.57 -40.89 69.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.695 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.44 -25.01 25.45 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.273 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.87 -39.24 2.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.616 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 35.23 37.05 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.348 0.594 . . . . 0.0 111.095 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 40.99 -162.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.401 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.32 146.88 54.35 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.243 0.544 . . . . 0.0 111.8 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 37' ' ' THR . 19.6 m -71.0 -36.0 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.329 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -54.36 -15.12 1.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.103 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -57.17 178.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.477 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 t -136.97 110.45 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.2 pt -58.96 95.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -64.6 -21.98 66.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.542 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -157.18 148.36 21.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.549 HG12 ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -142.69 125.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.4 m120 45.85 47.94 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 64.69 26.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 16.8 t -120.79 141.76 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.016 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.63 127.47 35.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' HG13 ' A' ' 68' ' ' VAL . 34.3 m -143.71 32.52 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.076 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -76.29 2.38 13.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.555 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -173.28 46.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.108 0.48 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' C ' ' HB ' ' A' ' 23' ' ' THR . 35.6 m -110.6 141.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.754 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.665 ' N ' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -50.23 160.89 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.706 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.41 ' ND1' HG23 ' A' ' 74' ' ' VAL . 3.1 t-80 -50.97 -48.58 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.404 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.61 -40.86 63.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.933 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.84 75.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.373 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.17 69.14 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.429 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HA ' HD21 ' A' ' 77' ' ' LEU . 47.9 t -64.64 -36.06 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.54 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 7.8 mt-10 -69.54 -33.12 72.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.787 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.34 -42.81 74.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.424 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.828 HD13 HG11 ' B' ' 9' ' ' VAL . 3.0 pp -76.84 -26.84 54.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.352 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.65 -44.53 61.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.098 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.27 29.19 5.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.04 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -75.85 -29.87 58.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.444 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.51 32.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.474 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -108.76 5.51 24.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.1 mt -155.85 93.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.2 m -95.13 111.46 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 68.64 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.819 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.4 pp -89.21 153.97 20.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.636 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -109.45 120.13 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.476 178.39 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.819 HG13 ' CD1' ' A' ' 86' ' ' LEU . 8.6 m -117.67 167.87 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 112.458 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 5.1 ptm -147.89 109.21 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.845 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 26.1 ttp180 -107.33 111.88 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 93' ' ' PRO . 2.8 mtm180 -73.85 144.97 45.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.397 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.5 71.97 0.28 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 75.4 Cg_endo -75.65 142.41 25.91 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.476 2.118 . . . . 0.0 112.409 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 10.1 Cg_exo -70.57 -153.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.577 2.184 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 188' ' ' ASN . . . -90.65 12.01 20.3 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 111.6 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 185' ' ' LYS . 1.5 pt-20 170.48 -174.41 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.442 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -179.77 -143.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 121.241 -0.184 . . . . 0.0 111.167 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.485 HG23 HD21 ' A' ' 153' ' ' LEU . 11.3 p -82.31 151.25 4.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 111.833 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.92 166.85 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.858 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -122.46 106.82 11.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.497 HG13 HG21 ' A' ' 183' ' ' VAL . 1.6 mm -119.25 155.55 21.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.519 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 5.1 tttt -111.74 127.16 55.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.687 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.9 tt -125.43 118.56 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.782 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.73 144.72 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -65.44 152.77 43.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.798 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -132.37 157.71 22.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.829 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.52 -33.72 69.22 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.046 1.831 . . . . 0.0 112.16 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.59 ' HE3' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.05 18.38 13.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.25 178.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.33 -148.28 16.73 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.56 -17.99 32.63 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.166 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 73.01 51.95 9.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.081 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.546 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.33 145.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.654 0.264 . . . . 0.0 110.695 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.2 t -110.95 116.75 31.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.737 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.844 HD11 HD22 ' A' ' 172' ' ' LEU . 7.3 pt -126.99 153.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.924 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.06 125.02 10.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.0 111.789 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.71 -175.09 25.44 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.199 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 121' ' ' GLN . . . 111.75 -178.43 19.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.352 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.49 144.4 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.709 0.29 . . . . 0.0 111.349 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.04 -21.17 46.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.541 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 173.0 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.501 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 117' ' ' GLY . 9.7 pm0 -103.4 -179.66 4.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.086 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.924 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 23.6 t-80 -57.95 -50.24 74.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.042 0.925 . . . . 0.0 110.662 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.943 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -102.61 102.86 28.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.033 -178.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.42 92.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.371 2.047 . . . . 0.0 112.237 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.99 20.87 3.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.935 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -155.64 91.3 1.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -49.99 -25.86 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 p -54.01 116.32 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.765 HG12 ' HA3' ' A' ' 116' ' ' GLY . 5.6 mt -61.61 121.08 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -114.34 156.75 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.13 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 150' ' ' ASP . 53.2 t -84.1 155.5 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.691 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.649 HG22 ' CD2' ' A' ' 122' ' ' HIS . 10.5 p -119.87 -57.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -148.87 148.28 29.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 147' ' ' GLN . 26.5 mt -136.72 139.04 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.59 HD12 ' HE3' ' A' ' 108' ' ' LYS . 1.2 mt -79.56 173.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.4 tt0 -90.86 149.52 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.0 25.33 45.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.4 54.13 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.511 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -68.64 -60.36 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 111.209 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.61 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.03 -32.02 69.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -59.24 -45.74 90.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 110.145 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -72.71 -57.07 4.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.572 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.32 -59.24 2.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.03 -49.16 43.83 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.889 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 63.13 18.11 10.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.597 0.237 . . . . 0.0 111.039 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 144' ' ' GLY . 0.3 OUTLIER -93.85 78.26 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.687 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -62.73 177.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.1 mt -47.2 134.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.084 0.468 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.44 13.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.539 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -63.37 140.58 58.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.337 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -125.31 131.74 53.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.054 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -103.94 127.1 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 184' ' ' ALA . 1.7 pp -96.6 -1.55 46.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.353 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 174.49 158.74 0.17 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 111.223 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.972 HG12 ' ND2' ' A' ' 156' ' ' ASN . 22.7 t -118.65 100.07 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.972 ' ND2' HG12 ' A' ' 155' ' ' VAL . 13.0 m-80 70.41 -59.36 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 109.665 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 p -165.57 28.33 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.123 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.2 t -103.11 154.81 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.367 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.85 78.6 0.29 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.557 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 15.5 mt -76.52 23.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.85 40.3 1.83 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.095 0.474 . . . . 0.0 110.803 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.35 28.38 0.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.459 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.1 t -148.75 -76.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 174.98 169.69 0.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.666 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 169' ' ' VAL . 44.4 t-80 -55.86 -29.94 60.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.79 38.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.332 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.733 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.78 -36.93 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 110.571 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.64 -35.71 73.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.761 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.3 t -71.5 -39.94 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.93 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.56 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -76.03 -25.98 56.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.304 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.844 HD22 HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -80.32 -36.83 33.72 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -73.0 -26.87 61.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.385 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.82 -9.88 58.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.315 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.646 HG22 HG11 ' A' ' 155' ' ' VAL . 5.8 p -45.56 159.59 0.06 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.633 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -92.6 168.94 10.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.197 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.23 -34.18 6.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.396 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 104' ' ' ILE . 41.3 t -148.1 90.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 0.0 110.757 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -123.49 148.58 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 111.504 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 36.6 p90 -92.27 132.27 36.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.846 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -112.01 153.86 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.432 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 152' ' ' ILE . 25.2 mtpp -96.68 114.38 26.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.787 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 101' ' ' ILE . 24.7 t -102.02 163.91 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -145.56 149.86 35.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.396 0.617 . . . . 0.0 112.161 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 6.5 mtpt -114.21 146.66 36.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.005 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.38 32.94 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.574 2.183 . . . . 0.0 114.126 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 19.6 m 42.3 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.753 0.311 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.715 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 26.0 p-10 -65.97 65.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.114 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 m -114.39 -31.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.06 127.95 26.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.079 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.58 115.21 4.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.472 2.114 . . . . 0.0 112.366 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -101.69 33.39 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.84 129.48 34.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.61 106.96 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -89.61 118.6 29.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 77' ' ' LEU . 23.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.088 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.418 HG13 HG13 ' C' ' 3' ' ' VAL . 10.7 p -178.65 -39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.418 HG13 HG13 ' C' ' 2' ' ' VAL . 7.8 m -92.69 157.0 40.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.17 -3.29 13.4 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.609 2.206 . . . . 0.0 112.803 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 65.86 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.404 ' OG ' HG21 ' A' ' 132' ' ' THR . 3.4 m 62.5 131.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.71 85.58 6.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 36.8 m -85.71 118.64 25.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.362 -0.828 . . . . 0.0 111.086 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.8 mtm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.828 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 156.37 17.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.07 128.2 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -178.03 174.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.414 . . . . 0.0 111.641 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -93.55 149.67 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.632 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' HG3' ' A' ' 50' ' ' ARG . 11.3 mt -148.05 150.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 111.561 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.9 OUTLIER -115.27 119.87 37.78 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.665 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.9 tp -121.91 93.62 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.45 0.643 . . . . 0.0 110.097 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -75.27 151.4 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.001 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 82' ' ' SER . 32.3 mtt180 -72.02 103.87 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.9 -26.89 6.09 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.774 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -169.47 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 p -109.28 30.73 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.39 173.73 17.89 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.519 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.896 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.4 -50.02 8.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.753 0.311 . . . . 0.0 111.138 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 100.93 79.15 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.674 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.798 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -164.7 159.2 18.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.607 178.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 36' ' ' ILE . 30.8 t -112.74 126.85 55.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 36' ' ' ILE . 4.7 pt -118.21 171.71 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.62 149.02 2.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.44 -120.66 4.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.196 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . 105.23 145.68 13.86 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.686 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -50.67 -24.94 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.682 0.277 . . . . 0.0 111.472 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.681 ' CB ' HG23 ' A' ' 69' ' ' THR . 19.2 t0 -86.68 -48.2 8.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.213 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.89 80.36 56.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 126.64 19.12 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.596 2.197 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 35' ' ' PHE . 17.0 t60 -67.3 -19.42 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.87 -26.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.14 34.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -168.32 111.56 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . 23.3 Cg_exo -64.83 -28.73 59.01 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.151 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -72.88 144.21 47.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 35' ' ' PHE . 15.0 mt -93.55 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.478 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.39 153.5 43.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 18' ' ' SER . 59.9 mt -84.8 150.74 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.589 ' O ' HG21 ' A' ' 53' ' ' VAL . 61.2 p -100.02 -46.61 5.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.871 0.367 . . . . 0.0 111.037 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -157.07 155.92 31.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.344 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mt -113.87 141.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.927 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 134.43 43.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.55 60.38 5.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.094 . . . . 0.0 112.301 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.7 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.65 168.81 26.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.58 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -61.73 -25.86 67.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 111.506 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.4 -57.54 12.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.2 -28.27 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.956 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -72.1 -41.95 66.68 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -72.61 -33.27 66.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.414 178.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 29.31 39.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.838 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.808 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.8 ptm180 -98.69 28.45 4.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.645 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -176.43 164.89 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.002 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.89 164.09 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.656 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -70.93 -47.27 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.015 0.436 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' N ' HG23 ' A' ' 53' ' ' VAL . 40.7 m-80 -58.87 -4.85 0.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -62.31 175.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.312 -0.242 . . . . 0.0 110.552 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 p -141.52 106.03 4.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.134 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -54.55 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.429 0.633 . . . . 0.0 111.159 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.32 -25.66 63.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.118 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.5 t80 -163.87 144.03 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.711 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.1 p -103.92 -176.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.012 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.687 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.7 m120 -21.59 -51.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.601 0.563 . . . . 0.0 111.857 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 tt0 -163.72 27.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.702 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.8 t -121.59 142.0 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.693 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 23.5 p30 -79.63 84.34 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.058 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 HG21 ' A' ' 68' ' ' VAL . 5.8 m -91.04 26.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.02 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -95.91 9.26 41.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.286 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' HG2' ' CB ' ' A' ' 32' ' ' PRO . 3.9 mt-10 -166.14 37.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 65' ' ' VAL . 35.9 m -118.68 141.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.9 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.766 ' N ' HG22 ' A' ' 23' ' ' THR . 3.8 m -50.34 166.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.501 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.5 t-160 -59.09 -48.71 80.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.2 m -60.73 -36.86 79.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.33 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.976 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.08 -42.32 66.33 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 72.8 t -64.65 -35.96 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.806 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.49 -33.2 72.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.798 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.53 -42.4 74.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 110.416 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -78.18 -26.85 47.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.439 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -71.71 -40.03 69.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.072 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.07 26.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.525 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.08 -19.49 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.342 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.37 -120.03 6.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.637 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.541 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -137.17 18.13 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.548 0.213 . . . . 0.0 111.244 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.76 94.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 8' ' ' LEU . 34.8 m -90.39 112.75 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -101.2 80.9 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.964 HD13 HG13 ' A' ' 88' ' ' VAL . 1.7 pp -109.79 153.08 24.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.258 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 4.7 t80 -102.04 114.66 28.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.847 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.964 HG13 HD13 ' A' ' 86' ' ' LEU . 35.3 m -112.05 167.98 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.209 0.528 . . . . 0.0 112.172 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 mtp -127.87 109.52 11.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.817 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -121.03 132.9 55.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.87 0.367 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.47 137.21 32.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.908 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 84.94 0.8 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.741 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.33 108.47 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.647 2.232 . . . . 0.0 112.478 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -95.46 109.54 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.258 2.638 . . . . 0.0 112.049 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.717 ' HB3' ' CA ' ' A' ' 188' ' ' ASN . . . -86.54 25.49 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.067 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -91.81 178.26 5.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.1 140.02 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.85 142.59 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.71 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.42 17.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.112 0.482 . . . . 0.0 111.366 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.84 106.21 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -116.84 155.34 18.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.648 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 17.7 pttm -114.15 126.57 55.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.359 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.663 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -127.58 118.64 24.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.562 HG22 HG13 ' A' ' 178' ' ' VAL . 4.4 pt -95.97 144.69 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -72.82 156.28 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.975 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.55 -168.79 12.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.821 -0.705 . . . . 0.0 111.826 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.25 -39.55 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.107 1.871 . . . . 0.0 112.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 19.6 8.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.049 0.452 . . . . 0.0 110.334 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.92 -143.21 15.78 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.275 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 103' ' ' LEU . 5.7 mp -86.72 -21.5 26.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.184 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.23 4.38 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.701 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.14 148.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -108.6 116.96 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 172' ' ' LEU . 27.4 pt -121.79 162.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.636 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -122.96 127.62 49.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.838 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -80.63 156.8 39.18 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.715 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . -49.58 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 164' ' ' MET . 15.7 t -54.38 134.37 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.822 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.6 -26.14 19.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.92 83.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -67.44 2.7 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.954 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 25.8 t-80 79.63 -60.54 0.33 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.799 0.809 . . . . 0.0 110.497 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.432 HG12 ' ND1' ' A' ' 122' ' ' HIS . 1.5 mm -118.06 101.25 51.77 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.514 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.42 94.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.478 2.119 . . . . 0.0 112.092 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.95 -15.61 1.54 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.774 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.4 84.57 2.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.903 0.382 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -41.65 -28.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -51.8 152.69 2.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.546 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.838 HG12 ' HA2' ' A' ' 116' ' ' GLY . 51.1 mt -75.44 124.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.977 0.418 . . . . 0.0 111.285 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 151' ' ' LYS . 4.9 m-85 -114.71 132.26 56.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.7 t -61.68 155.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.345 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 148' ' ' ILE . 12.3 p -118.61 -57.71 2.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.396 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 143.64 25.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.246 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 131' ' ' VAL . 5.3 mt -129.96 141.63 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.801 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.39 173.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.603 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.7 mt-10 -93.12 149.1 21.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.99 29.29 51.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.67 -167.55 43.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.54 -55.08 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.565 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.13 -31.88 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.267 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.04 -55.67 31.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 0.0 110.316 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -72.8 -48.56 37.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.56 -59.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.891 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -58.5 -49.74 73.81 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.077 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 18.23 11.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.645 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -96.17 81.01 3.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.715 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.41 171.2 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.678 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -46.67 127.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.316 0.579 . . . . 0.0 111.22 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.09 -24.81 9.15 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.339 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -67.95 131.59 45.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -116.87 134.11 55.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.118 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.39 131.94 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -96.71 -4.1 41.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.231 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.19 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.435 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 158' ' ' VAL . 38.4 t -103.92 99.7 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.759 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.759 ' ND2' HG12 ' A' ' 155' ' ' VAL . 36.5 m-80 69.28 -59.41 0.48 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.338 0.59 . . . . 0.0 109.592 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 m -165.02 29.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.941 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.0 t -104.26 155.08 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.564 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -110.91 74.57 0.21 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.645 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -78.05 25.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.984 0.421 . . . . 0.0 111.586 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -155.79 27.87 0.38 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.307 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.53 27.74 2.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.652 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -144.99 -72.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.643 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.57 ' HG3' HG21 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 174.78 162.58 0.22 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.241 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.8 p-80 -53.54 -30.09 40.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.271 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -45.17 53.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.652 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -73.1 -35.37 66.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.918 0.39 . . . . 0.0 110.637 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.58 -34.92 72.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.167 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.628 ' HA ' HD23 ' A' ' 172' ' ' LEU . 10.5 t -71.93 -44.09 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.99 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.128 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.73 -27.7 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.75 -39.44 24.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.005 0.431 . . . . 0.0 110.192 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -26.69 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.055 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -72.78 -10.0 59.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.535 ' HB ' HG21 ' A' ' 179' ' ' VAL . 63.8 p -58.91 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.794 0.331 . . . . 0.0 111.264 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -102.19 169.95 8.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.26 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.9 t70 -55.7 -17.41 5.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.361 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.41 91.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.535 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.9 148.14 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.733 -179.094 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.9 m-85 -101.71 125.9 48.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -111.83 152.72 27.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.58 120.37 36.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.884 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 101' ' ' ILE . 18.1 t -102.21 160.67 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.493 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -124.87 133.89 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -84.04 146.18 48.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 189' ' ' ALA . 9.8 Cg_endo -52.87 111.81 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.59 2.193 . . . . 0.0 112.16 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 0.8 OUTLIER -58.8 148.91 28.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.183 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . 0.717 ' CA ' ' HB3' ' A' ' 95' ' ' ALA . 1.4 t-20 54.6 28.33 9.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.825 0.345 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 2' ' ' VAL . 5.6 m -130.78 97.16 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 18.4 m -139.06 123.8 11.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 152.86 21.45 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.485 2.123 . . . . 0.0 112.296 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -115.59 -38.33 3.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 85.8 p -108.85 135.3 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.46 163.7 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -136.72 126.25 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.575 ' OXT' HG12 ' B' ' 9' ' ' VAL . 20.7 t . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.454 HG22 ' N ' ' C' ' 3' ' ' VAL . 11.8 p -116.35 156.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.454 ' N ' HG22 ' C' ' 2' ' ' VAL . 21.7 t -130.52 133.71 25.18 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.067 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.78 -159.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.434 2.09 . . . . 0.0 112.267 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -47.42 81.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 11.3 m -124.44 -169.93 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' SER . . . . . 0.4 ' OG ' HG21 ' A' ' 169' ' ' VAL . 1.3 m -77.85 128.35 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -117.12 118.01 31.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.445 HG11 HD11 ' A' ' 172' ' ' LEU . 10.4 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.34 -0.838 . . . . 0.0 111.111 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.689 0.281 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 90' ' ' ARG . 8.5 tp10 -117.79 155.27 30.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 0.0 111.148 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.82 161.39 15.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.628 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -176.69 141.34 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.889 0.375 . . . . 0.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 16.3 pt-20 -110.35 154.62 23.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -166.11 159.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 111.972 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.652 HG23 HH11 ' A' ' 85' ' ' ARG . 0.8 OUTLIER -107.17 123.44 48.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.364 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.827 ' HG ' HD23 ' A' ' 15' ' ' LEU . 2.5 tp -116.1 93.52 4.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.598 0.713 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.744 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -66.66 143.1 57.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.798 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.68 101.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.485 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.22 -27.4 5.39 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.725 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.6 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -109.28 30.63 6.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.883 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.04 -179.65 20.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.008 -1.091 . . . . 0.0 112.248 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.47 -63.19 1.38 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.649 0.262 . . . . 0.0 111.309 -179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.79 62.66 0.39 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.599 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.728 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 7.9 p90 -149.5 138.9 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.543 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' ILE . 5.9 m -79.48 126.69 31.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 36' ' ' ILE . 23.5 pt -131.23 155.11 41.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -172.95 152.7 2.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.74 -122.82 2.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.36 128.82 4.46 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.404 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -51.84 -27.23 11.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.87 -42.01 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.79 77.45 57.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.26 146.21 13.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.718 2.279 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.445 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 10.8 t-80 -77.57 -19.38 55.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.528 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.15 -32.74 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 111.007 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.95 26.04 6.53 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.539 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.49 38.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.37 96.64 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.04 -22.68 48.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.485 2.124 . . . . 0.0 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.86 158.66 33.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.74 149.27 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 7.1 p90 -142.73 163.5 32.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.898 0.38 . . . . 0.0 111.042 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' SER . 45.7 mt -94.82 148.49 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -104.4 -33.99 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.627 0.251 . . . . 0.0 111.401 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.34 150.93 4.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.38 . . . . 0.0 111.348 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.4 mt -111.45 141.07 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.9 pt -89.63 136.03 30.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.67 58.2 6.7 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.53 2.153 . . . . 0.0 112.387 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.0 -61.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.618 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.56 -173.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.628 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -72.04 -26.45 62.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.576 0.227 . . . . 0.0 111.522 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -54.1 -57.4 11.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -60.08 -27.85 67.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -71.87 -45.68 60.5 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -68.39 -35.49 77.76 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.252 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.07 48.4 0.01 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.203 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.96 20.62 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.732 0.266 . . . . 0.0 111.291 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.494 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -158.23 162.96 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.334 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -98.18 158.25 15.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.396 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -71.2 -46.14 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 p30 -62.83 3.96 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.738 ' OD2' HG21 ' A' ' 88' ' ' VAL . 53.0 p-10 -76.17 174.15 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.9 t -129.8 102.86 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 110.961 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.977 HD11 HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -55.65 95.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.734 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -22.65 60.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.1 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -153.46 155.22 35.88 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.965 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.977 HG13 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -152.52 130.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.447 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.58 35.07 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.228 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.13 30.96 2.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 t -120.92 141.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -73.34 116.02 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 68' ' ' VAL . 33.4 t -143.98 40.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -100.3 9.24 43.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.153 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 178.5 44.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.928 0.394 . . . . 0.0 110.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 65' ' ' VAL . 6.6 m -109.63 147.26 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.562 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.69 ' N ' HG22 ' A' ' 23' ' ' THR . 65.0 p -49.32 170.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.845 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.5 t-80 -63.67 -49.02 74.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.323 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -36.34 83.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -35.53 72.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.23 64.74 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 109.804 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' HD21 ' A' ' 77' ' ' LEU . 58.4 t -63.99 -36.57 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -69.52 -32.81 71.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.74 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -43.37 73.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 110.636 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.78 -26.77 54.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.461 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -70.73 -40.64 72.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.134 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 8.8 tt0 -101.24 27.32 6.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.317 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.77 -23.06 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.423 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.93 -161.81 24.82 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.785 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 9.7 t -86.23 -51.29 6.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.744 HG23 ' HG2' ' A' ' 9' ' ' GLU . 17.0 mt -99.25 84.69 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.9 m -85.24 116.26 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.677 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.652 HH11 HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -77.2 80.5 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.651 ' HB2' HD12 ' A' ' 57' ' ' ILE . 2.4 pp -84.89 135.41 34.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.24 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -116.72 114.49 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.391 178.558 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.1 m -124.89 168.41 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.093 0.473 . . . . 0.0 111.998 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 109.06 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.802 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -122.77 116.52 23.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.675 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 2.4 ptt180 -43.01 137.91 2.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.88 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -156.28 157.66 31.22 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -45.58 97.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.277 2.651 . . . . 0.0 112.613 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.581 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 85.5 Cg_endo -98.83 -157.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.607 2.871 . . . . 0.0 112.393 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 82.37 35.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.821 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' N ' ' HA ' ' A' ' 187' ' ' SER . 4.2 tt0 74.67 164.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -172.18 118.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 111.7 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 0.0 110.755 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 mmm -93.61 166.66 12.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.398 0.618 . . . . 0.0 111.798 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -136.34 106.54 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 146' ' ' LEU . 2.7 mm -112.7 155.16 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -110.82 126.13 54.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.304 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.837 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.7 tt -127.16 118.56 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -96.44 144.64 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.43 157.47 30.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.19 -169.38 12.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.921 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.69 -30.78 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.145 1.896 . . . . 0.0 112.283 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.52 18.38 12.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.061 0.458 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.2 -146.34 16.06 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.427 ' HB2' HG23 ' C' ' 9' ' ' VAL . 7.4 mp -86.46 -20.36 28.24 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.908 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 80.74 46.13 7.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.346 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.58 154.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.687 0.244 . . . . 0.0 110.98 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.31 126.33 51.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.649 HG22 HG22 ' A' ' 131' ' ' VAL . 9.0 pt -134.97 153.18 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.633 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -150.55 124.91 9.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.854 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.67 -175.11 25.43 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.065 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 161' ' ' GLU . . . 77.38 -169.25 54.8 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.422 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 119' ' ' GLY . 38.9 t -78.64 154.56 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.337 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 92.45 -25.59 17.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.03 77.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.1 pt20 -72.91 6.83 2.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.384 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 25.5 t-80 72.72 -59.17 0.57 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.53 0.681 . . . . 0.0 111.331 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.867 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.4 OUTLIER -87.7 111.58 43.03 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.895 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 79.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.475 2.117 . . . . 0.0 112.243 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 121.68 40.24 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.523 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -175.52 96.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.79 0.328 . . . . 0.0 110.74 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.55 -23.36 50.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 58.3 m -47.44 128.34 12.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.54 HG12 ' HA3' ' A' ' 116' ' ' GLY . 37.7 mt -65.9 123.96 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.934 0.397 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.867 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.0 m-85 -122.89 156.91 33.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.499 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 114' ' ' ILE . 72.8 t -89.32 151.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 148' ' ' ILE . 11.3 p -111.44 -58.46 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.496 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 147.91 28.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' GLY . 6.5 mt -128.37 141.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 136' ' ' GLU . 4.3 mm -66.06 175.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.623 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -92.93 133.67 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.857 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.5 25.19 33.87 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.85 -160.72 1.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.513 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.57 -59.72 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.0 111.277 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.13 -31.97 69.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.582 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -53.88 -54.34 40.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.19 0.519 . . . . 0.0 110.392 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -72.9 -53.15 12.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.043 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.74 -59.29 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.153 0.502 . . . . 0.0 111.943 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -49.02 -46.94 32.9 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.453 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 65.76 16.99 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.617 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.541 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -106.87 83.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.483 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.96 175.81 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 132' ' ' THR . 33.3 mt -47.46 122.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.354 0.597 . . . . 0.0 111.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.06 -21.73 6.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.311 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.611 ' OD1' HG21 ' A' ' 131' ' ' VAL . 8.5 p-10 -64.2 131.99 49.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.882 0.372 . . . . 0.0 110.409 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -108.24 125.05 51.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -104.61 133.92 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.046 0.451 . . . . 0.0 110.647 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -93.98 -4.03 50.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.637 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . 173.52 156.65 0.12 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.936 0.398 . . . . 0.0 110.857 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 39.2 t -109.92 100.07 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 179' ' ' VAL . 2.1 m-80 56.82 32.21 20.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p 82.92 25.83 0.13 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.856 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.8 t -135.21 146.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-O 121.426 0.631 . . . . 0.0 112.659 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 96.29 -73.54 0.8 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.584 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.637 HD23 ' HB2' ' A' ' 154' ' ' ALA . 0.0 OUTLIER 35.83 33.5 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.821 -0.689 . . . . 0.0 111.955 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' SER . 0.9 OUTLIER 35.82 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.926 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -114.43 36.95 3.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.485 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -151.17 -71.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.344 0.592 . . . . 0.0 110.607 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 1.1 mtm 175.42 160.45 0.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 74.7 t60 -53.68 -31.43 47.71 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.175 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.92 -41.03 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.485 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.58 -38.43 62.65 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.683 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.6 -38.96 74.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.648 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.655 ' HA ' HD23 ' A' ' 172' ' ' LEU . 29.3 t -72.99 -46.93 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.092 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.38 69.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.36 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.42 -33.99 58.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.373 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -81.34 -36.85 29.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.945 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' C' ' 9' ' ' VAL . 7.4 mmtt -72.94 -26.83 61.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.482 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -76.29 -10.04 59.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.264 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.9 p -60.44 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 111.486 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -114.28 173.12 6.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -13.08 3.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 104' ' ' ILE . 40.6 t -147.34 91.11 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.728 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -128.93 148.61 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.995 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 39.3 p90 -107.61 135.29 49.31 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-O 121.052 0.453 . . . . 0.0 111.99 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -111.06 159.3 17.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.677 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -100.28 117.35 34.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 184' ' ' ALA . 12.8 t -101.9 159.67 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -126.3 141.04 52.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -102.17 145.83 31.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 24.1 Cg_exo -63.63 134.05 42.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -76.08 143.29 41.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 t30 47.76 28.91 1.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.17 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.748 0.308 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 m -75.17 133.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.56 HG13 ' O ' ' B' ' 3' ' ' VAL . 9.2 p -153.95 63.78 4.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.053 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' B' ' 3' ' ' VAL . 31.1 Cg_exo -59.03 140.57 95.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.619 2.212 . . . . 0.0 112.313 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.23 -72.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.437 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 2.0 t -112.97 -170.73 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.16 -153.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.55 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.48 ' O ' HG13 ' B' ' 9' ' ' VAL . 2.2 p -52.59 122.09 8.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 8' ' ' SER . 14.2 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.066 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.826 0.346 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.569 ' O ' HG13 ' C' ' 2' ' ' VAL . 10.9 p -108.16 63.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 m -77.49 126.02 85.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.91 143.04 62.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.354 2.036 . . . . 0.0 112.287 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -137.34 79.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -168.73 -175.11 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.63 103.4 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 52.9 p -92.63 118.78 31.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 173' ' ' LYS . 19.5 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.245 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.804 0.335 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.54 ' OE2' ' HB3' ' A' ' 95' ' ' ALA . 17.7 mt-10 -136.24 171.33 14.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -134.04 166.05 23.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -176.63 159.06 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 13.6 pt-20 -96.05 154.76 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.851 HG22 ' O ' ' A' ' 86' ' ' LEU . 19.2 tt -153.37 164.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.568 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -123.27 122.82 39.32 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.704 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 45' ' ' ALA . 1.2 tp -125.8 93.04 3.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.752 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.761 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -73.65 166.08 23.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.591 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -80.97 95.37 6.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.63 8.03 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.598 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -168.98 -89.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.069 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -109.22 30.85 6.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.51 177.07 24.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.395 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -84.43 -48.66 9.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.766 0.317 . . . . 0.0 111.5 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.24 65.53 0.67 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.77 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.4 p90 -164.69 162.9 21.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.298 . . . . 0.0 110.689 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.75 133.79 54.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.531 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 pt -120.43 171.28 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.8 152.34 3.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.345 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 119.08 -115.25 3.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.49 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 146.23 15.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.257 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -54.05 -23.87 15.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.615 0.245 . . . . 0.0 111.475 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.83 0.347 . . . . 0.0 111.443 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.06 77.55 41.63 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.414 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 129.14 21.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.422 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.8 t60 -66.57 -20.67 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.32 -27.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.309 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.31 26.51 18.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.628 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -168.69 33.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.29 100.85 0.7 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.754 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.68 -26.85 67.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.401 2.068 . . . . 0.0 112.142 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -66.95 177.94 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.614 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -125.88 153.43 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.0 p90 -142.49 148.89 38.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.537 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 73.2 mt -75.15 150.45 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.794 ' O ' HG21 ' A' ' 53' ' ' VAL . 2.5 p -102.88 -40.51 6.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.601 0.239 . . . . 0.0 111.621 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.885 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.77 146.26 6.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.0 111.437 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -103.52 141.33 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.108 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.8 mm -85.28 136.28 38.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 40' ' ' ILE . 72.9 Cg_endo -76.29 58.79 5.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.212 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.58 -54.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.03 -175.38 0.2 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.86 -31.4 59.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.666 0.269 . . . . 0.0 111.224 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.72 -26.25 44.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.542 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -78.14 -27.49 48.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.574 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.35 -43.75 66.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.954 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -93.74 -29.02 15.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.492 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 89.15 -33.69 4.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.63 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 48.32 25.17 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.846 HD13 ' CZ ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 66.86 -167.58 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.959 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 153.05 25.08 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.097 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.885 HG11 ' HA ' ' A' ' 38' ' ' LYS . 28.5 m -71.16 -36.72 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -52.06 -16.14 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.512 ' OD2' HG21 ' A' ' 88' ' ' VAL . 37.0 p-10 -59.03 156.31 12.01 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 35.6 m -121.55 126.28 48.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.954 ' HA ' HG12 ' A' ' 88' ' ' VAL . 9.4 pt -65.63 94.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.276 0.56 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 89' ' ' MET . 24.5 mt -76.77 -28.2 55.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.482 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -150.89 116.15 5.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.432 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' CG1' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -131.69 125.55 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.611 HD21 HG13 ' A' ' 84' ' ' VAL . 28.9 m120 55.02 36.87 27.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.13 27.49 17.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.25 141.69 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.34 72.04 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.2 t -98.04 34.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -9.63 27.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.51 43.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.76 0.314 . . . . 0.0 111.615 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.94 155.57 30.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.232 0.539 . . . . 0.0 111.038 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.775 ' N ' HG22 ' A' ' 23' ' ' THR . 21.2 m -49.99 161.8 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.901 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -58.98 -48.49 81.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.531 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -52.09 -37.53 54.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.401 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.37 80.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.59 66.47 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.264 0.554 . . . . 0.0 109.578 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 70' ' ' HIS . 55.0 t -64.81 -35.29 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.682 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 47.4 tt0 -69.65 -32.33 70.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.938 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.36 -41.54 76.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.378 0.609 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.31 -26.22 55.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 4.1 tttt -72.39 -35.21 68.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -113.35 28.76 8.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.203 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -92.42 -21.44 20.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.63 -137.51 13.39 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 83' ' ' ILE . 8.6 t -121.17 17.49 11.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.675 0.274 . . . . 0.0 111.414 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.761 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.5 mt -154.07 95.84 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 61' ' ' ASN . 0.9 OUTLIER -102.01 143.38 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.215 0.531 . . . . 0.0 112.429 -178.076 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 15.9 tpp85 -100.35 93.4 5.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.782 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.851 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -88.4 115.36 25.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.347 0.594 . . . . 0.0 112.555 -177.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.5 114.06 27.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.06 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.5 m -132.21 168.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 58' ' ' LEU . 1.3 ttp -107.91 109.23 20.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.492 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.846 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.4 146.74 52.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.463 . . . . 0.0 111.551 -178.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -71.01 142.09 50.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.183 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -143.74 119.72 6.4 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.696 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 31.4 Cg_exo -57.57 -46.75 25.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.411 2.074 . . . . 0.0 112.546 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 93' ' ' PRO . 96.6 Cg_endo -86.48 -159.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.579 2.186 . . . . 0.0 112.346 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' ' OE2' ' A' ' 2' ' ' GLU . . . 63.83 28.27 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.883 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' N ' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER 76.89 143.33 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.981 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.62 130.87 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.828 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.63 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -82.78 148.13 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.432 ' HB2' ' HB ' ' A' ' 183' ' ' VAL . 13.9 mtp -124.21 166.73 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 0.0 111.208 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.3 7.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.053 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 183' ' ' VAL . 3.4 mm -113.62 155.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.418 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.99 128.43 56.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.989 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.1 tt -130.39 118.32 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.071 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.73 144.53 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.987 0.422 . . . . 0.0 111.059 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 4.0 tttt -66.93 149.11 51.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.979 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.08 -174.6 13.65 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.006 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.44 -36.8 14.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.317 2.011 . . . . 0.0 112.317 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -93.84 19.46 8.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.938 0.399 . . . . 0.0 110.498 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.73 -140.97 15.12 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HG ' HD22 ' A' ' 103' ' ' LEU . 7.4 mp -86.64 -22.39 26.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.01 46.9 5.2 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.013 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 146.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.611 0.243 . . . . 0.0 110.861 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 m -108.67 116.85 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 131' ' ' VAL . 8.5 pt -129.15 152.9 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.561 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' C' ' 6' ' ' SER . . . -151.82 125.84 9.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 112.063 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.626 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.64 -175.26 25.57 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.882 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.91 176.49 14.49 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.732 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.66 153.65 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.854 0.359 . . . . 0.0 111.357 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.16 -5.89 65.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.72 79.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.87 142.49 27.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.447 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.547 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 1.8 t-80 -45.08 -37.85 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.803 0.811 . . . . 0.0 110.517 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.83 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.5 mt -100.43 143.14 25.97 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.583 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 123' ' ' ILE . 45.4 Cg_exo -56.7 83.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.615 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.13 53.49 2.81 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.102 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.5 t70 -154.7 87.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 111.149 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -52.85 -24.4 8.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.9 m -52.12 125.55 16.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -73.69 113.4 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.833 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.83 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -106.96 172.83 6.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.722 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 114' ' ' ILE . 48.3 t -109.44 148.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.813 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 -29.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 137.65 31.34 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.835 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 147' ' ' GLN . 43.9 mt -137.12 138.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.67 173.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -87.25 140.94 29.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.876 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.02 26.23 55.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.33 -175.07 9.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.08 -66.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.829 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.01 -37.34 75.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.429 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -51.96 -45.85 64.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.038 0.446 . . . . 0.0 110.67 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -57.3 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.038 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.56 -59.59 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.64 -33.6 85.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.176 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 59.94 20.96 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.829 HD21 ' HB1' ' A' ' 140' ' ' ALA . 1.2 pp -83.79 83.79 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.437 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -67.62 170.92 6.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.63 120.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.277 0.56 . . . . 0.0 111.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.28 -19.7 5.97 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -66.29 118.39 9.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.735 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.462 ' HB2' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -99.28 123.85 43.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.985 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -99.86 121.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 110.067 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.63 HD21 HG13 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -87.44 -0.44 56.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.72 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.97 159.98 0.12 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.562 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 181' ' ' LEU . 36.9 t -117.52 98.85 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.589 ' ND2' ' CE2' ' A' ' 180' ' ' TYR . 9.7 m120 68.32 -57.72 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.394 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 p -146.01 -18.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.613 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -78.02 129.14 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.42 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.68 7.75 1.38 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 129' ' ' ILE . 20.3 mt 42.71 29.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.469 0.634 . . . . 0.0 112.044 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -178.14 75.36 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 163' ' ' VAL . 1.4 p30 -157.68 26.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -157.0 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.923 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 178.63 -172.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.667 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.9 t-80 -67.45 -37.42 82.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.027 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.738 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.3 -35.55 61.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.854 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.7 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -69.69 -37.24 76.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 172' ' ' LEU . 39.4 t -69.44 -41.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.355 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.28 -29.27 64.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.727 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.94 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.879 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.28 -39.45 25.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.109 0.481 . . . . 0.0 109.929 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.403 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 12.0 pttt -75.18 -26.78 59.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.102 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -20.75 23.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 179' ' ' VAL . 76.6 p -54.52 -172.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 178' ' ' VAL . 8.8 p90 -125.03 -162.24 1.08 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.7 m-20 -59.7 -21.6 60.84 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 38.2 t -147.66 91.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 118.728 0.694 . . . . 0.0 111.511 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.92 148.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.919 0.39 . . . . 0.0 111.887 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.589 ' CE2' ' ND2' ' A' ' 156' ' ' ASN . 21.8 p90 -105.23 126.18 51.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.328 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -106.75 149.05 27.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mtpt -96.39 119.16 34.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 101' ' ' ILE . 11.8 t -101.89 161.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -134.78 144.76 47.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.64 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.4 OUTLIER -94.93 146.21 30.94 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 3.2 Cg_exo -77.83 38.53 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.98 2.453 . . . . 0.0 113.229 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.449 ' HA ' ' N ' ' A' ' 96' ' ' GLU . 2.5 p 50.35 -179.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.996 0.427 . . . . 0.0 111.054 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 37.0 34.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.867 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.188 -179.856 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.42 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.066 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.522 ' O ' HG23 ' B' ' 3' ' ' VAL . 14.5 m -118.8 96.02 49.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.04 91.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.582 2.188 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.11 58.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.78 145.16 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 37.6 m -106.65 150.02 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.533 ' O ' HG13 ' B' ' 9' ' ' VAL . 29.5 t -133.3 114.69 14.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.533 HG13 ' O ' ' B' ' 8' ' ' SER . 6.0 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.102 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' VAL . . . . . 0.547 ' O ' HG23 ' C' ' 3' ' ' VAL . 21.6 t -98.46 146.33 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.547 HG23 ' O ' ' C' ' 2' ' ' VAL . 34.7 t -158.08 -64.36 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 4' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' C' ' 3' ' ' VAL . 23.8 Cg_endo -60.91 -165.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.321 2.014 . . . . 0.0 112.171 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 64.21 -169.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 6' ' ' SER . . . . . 0.626 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 43.9 m -65.58 151.07 47.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -88.36 109.3 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.998 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t -83.47 111.31 18.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.164 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.84 144.15 21.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -179.39 159.01 0.89 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.845 0.355 . . . . 0.0 111.445 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -101.01 156.41 17.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.656 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -158.46 155.19 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.7 OUTLIER -110.22 121.7 45.9 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.854 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.3 tp -116.16 93.3 4.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.429 0.633 . . . . 0.0 110.337 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.28 135.34 42.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.224 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 2.3 mtp180 -56.29 103.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.691 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.13 -28.81 13.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.469 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.07 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.45 . . . . 0.0 109.929 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -109.15 30.67 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.683 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' CA ' ' HG2' ' A' ' 10' ' ' ARG . . . 147.03 171.26 16.06 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.04 -49.36 8.99 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.905 0.384 . . . . 0.0 110.991 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 99.22 80.18 1.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.577 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.9 p90 -164.43 149.91 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.713 0.292 . . . . 0.0 110.483 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 36' ' ' ILE . 18.1 p -105.85 127.01 52.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 111.55 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 36' ' ' ILE . 25.4 pt -119.51 166.0 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.857 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.78 153.6 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.71 -120.45 2.67 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.27 141.02 8.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.172 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -56.91 -18.81 14.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 69' ' ' THR . 12.4 t0 -91.57 -52.51 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -119.5 79.56 21.52 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.26 138.31 23.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 0.0 112.414 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -69.28 -18.63 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.48 -36.98 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 110.985 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.37 24.79 6.05 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.01 40.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -162.15 98.82 1.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 17.7 Cg_endo -57.62 -27.0 75.23 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.09 . . . . 0.0 112.194 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -74.04 141.2 45.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.03 152.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.1 p90 -142.26 166.48 24.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.713 HG12 HG22 ' A' ' 19' ' ' ILE . 53.1 mt -92.19 153.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.15 -39.77 5.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.628 0.251 . . . . 0.0 111.664 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.929 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.28 156.42 14.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.107 0.479 . . . . 0.0 111.644 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -118.42 141.33 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.5 mt -88.14 126.78 59.7 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 16.9 Cg_exo -66.76 63.13 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.141 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.5 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.84 -177.82 0.93 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.466 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -73.82 -18.72 60.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.04 -57.38 13.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.13 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.14 69.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.32 -41.56 66.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' CB ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -76.02 -32.23 59.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.7 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.64 44.61 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 113.901 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HB3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -93.1 21.71 5.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.695 0.247 . . . . 0.0 111.581 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.768 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.8 pt? -176.36 170.11 2.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.999 0.428 . . . . 0.0 111.325 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' NH1' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -101.61 163.44 12.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.499 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.929 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -71.06 -46.54 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 112.04 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.513 ' N ' HG23 ' A' ' 53' ' ' VAL . 29.1 m-80 -69.53 11.41 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.5 p-10 -76.92 176.92 8.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -127.87 102.66 6.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.801 HG22 HG12 ' A' ' 88' ' ' VAL . 2.4 pt -57.43 94.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 111.157 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.48 -28.54 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.501 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -163.25 150.57 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -141.28 131.68 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 45.3 38.82 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.192 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 61.6 33.92 18.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 141.68 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.173 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 68' ' ' VAL . 9.0 p-10 -66.93 100.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' A' ' 60' ' ' VAL . 37.9 t -133.1 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.106 0.479 . . . . 0.0 110.911 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -105.06 -14.51 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.93 47.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.813 0.339 . . . . 0.0 111.131 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.62 149.64 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.21 0.528 . . . . 0.0 111.102 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -49.74 154.77 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.937 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -51.81 -48.36 63.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.258 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -49.63 -36.41 24.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.03 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.56 63.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -40.7 68.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.696 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.542 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -65.7 -35.54 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.633 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 3.1 mt-10 -69.59 -32.48 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.875 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.31 76.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.447 0.641 . . . . 0.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.84 -26.5 57.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.47 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -68.82 -35.89 77.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.218 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.64 28.87 8.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.809 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -77.79 -29.25 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.355 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.49 -101.08 2.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.607 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 69.1 m -152.65 -52.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.798 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -98.33 84.93 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -84.63 113.73 23.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.676 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.804 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 ttt85 -92.78 78.83 4.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.075 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.484 ' CB ' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.08 154.03 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.402 -178.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 1.9 t80 -109.51 115.0 29.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.151 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 57' ' ' ILE . 31.6 m -108.46 168.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 112.397 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.25 109.42 7.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.634 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -179.676 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.754 0.312 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 98' ' ' VAL . 14.5 p -103.22 115.71 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.45 166.6 12.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.605 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.96 106.58 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.882 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 181' ' ' LEU . 3.6 mm -114.19 155.36 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.475 ' CG ' ' CD2' ' A' ' 180' ' ' TYR . 2.7 mtmp? -108.02 123.92 49.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.428 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 181' ' ' LEU . 2.5 tt -129.91 118.62 21.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.71 HG22 HG23 ' A' ' 178' ' ' VAL . 4.4 pt -93.96 144.61 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -70.64 152.79 43.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.095 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.62 160.72 23.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.756 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.97 -37.5 86.07 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.094 1.863 . . . . 0.0 112.033 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 20.96 9.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.048 0.451 . . . . 0.0 110.053 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.47 -155.46 17.92 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.283 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.763 HD23 HD13 ' A' ' 103' ' ' LEU . 9.1 mp -86.48 -13.36 46.3 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.075 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.66 63.11 2.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.862 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.684 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.84 150.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.355 . . . . 0.0 110.999 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.72 116.88 32.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 131' ' ' VAL . 8.9 pt -136.52 153.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -151.55 125.0 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.84 -175.13 25.58 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.205 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.9 178.36 51.07 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.442 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 26.0 t -74.08 150.27 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.819 0.342 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.37 -29.46 6.12 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.858 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.71 69.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.48 -4.63 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.688 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.558 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 62.6 t60 72.48 -58.1 0.6 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.547 0.689 . . . . 0.0 110.578 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.917 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.46 137.56 30.55 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.428 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 123' ' ' ILE . 49.6 Cg_endo -68.71 62.21 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.236 1.957 . . . . 0.0 112.339 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.1 57.29 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.723 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.689 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -174.44 99.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -60.44 -19.72 57.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.324 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -57.31 151.3 16.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 168' ' ' ALA . 2.8 mt -91.03 115.35 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.917 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 m-85 -109.33 153.9 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.62 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 114' ' ' ILE . 75.7 t -90.72 155.72 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.456 ' HA ' HG23 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -136.03 -27.62 1.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 147.96 27.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.982 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.678 HD11 ' O ' ' A' ' 146' ' ' LEU . 42.0 mt -137.21 141.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.51 173.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.585 ' H ' HG22 ' A' ' 135' ' ' ILE . 28.7 mt-10 -93.55 133.15 37.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.844 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.82 26.47 73.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.35 176.77 54.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.63 -53.81 16.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 111.288 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.556 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.25 -34.63 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -51.91 -58.65 5.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.465 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -72.94 -48.69 34.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.467 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.59 -59.6 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -59.68 -44.28 97.04 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.413 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 63.23 17.8 10.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.602 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.678 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -81.52 83.66 6.94 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -65.55 152.58 43.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.656 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 132' ' ' THR . 34.4 mt -46.57 106.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.438 0.637 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 146.41 -14.29 1.62 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.544 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 p-10 -80.45 162.29 24.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.875 0.369 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -142.59 128.31 19.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.549 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.19 133.12 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.114 0.483 . . . . 0.0 110.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 3.2 pp -100.68 -4.13 28.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.101 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 170.35 141.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.772 HG12 HD22 ' A' ' 156' ' ' ASN . 76.6 t -96.74 99.79 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.798 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.772 HD22 HG12 ' A' ' 155' ' ' VAL . 48.9 m-80 69.27 -58.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.084 0.468 . . . . 0.0 109.846 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.1 25.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.799 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 155' ' ' VAL . 24.3 t -92.3 155.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 121.351 0.596 . . . . 0.0 111.367 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -101.93 73.25 0.34 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.759 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.554 ' CD1' HG23 ' A' ' 155' ' ' VAL . 22.1 mt -69.95 20.47 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -163.56 56.49 0.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.268 0.556 . . . . 0.0 110.812 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.58 28.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.555 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.712 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.9 OUTLIER -151.86 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.9 mtp 173.78 164.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.426 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.613 ' O ' HG23 ' A' ' 169' ' ' VAL . 19.7 p-80 -53.77 -30.02 42.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.492 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.73 50.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.305 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.712 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.36 -35.51 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 0.0 110.743 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.17 -35.39 73.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.942 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.742 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.9 t -70.23 -43.5 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.15 -30.35 66.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.9 -25.55 53.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -81.18 -39.91 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.202 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -75.52 -26.55 58.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.02 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.04 -10.54 59.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.658 ' HB ' HG21 ' A' ' 179' ' ' VAL . 81.6 p -54.1 -175.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.831 0.348 . . . . 0.0 111.479 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -102.36 168.97 8.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.379 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 t0 -52.03 -23.05 4.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 178' ' ' VAL . 4.0 p -145.18 92.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.383 0.611 . . . . 0.0 110.389 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.51 148.43 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.23 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.475 ' CD2' ' CG ' ' A' ' 102' ' ' LYS . 5.6 m-85 -97.9 120.51 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.752 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -98.08 144.11 27.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.24 109.31 21.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.47 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 152' ' ' ILE . 20.8 t -101.39 161.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -141.89 142.74 33.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.802 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.631 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.62 82.41 4.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.142 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.9 0.381 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -116.5 153.2 32.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.621 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -157.59 151.22 23.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -142.74 108.91 5.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.853 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.717 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.68 -168.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 111.652 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -143.6 135.95 26.99 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.778 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -113.02 88.84 2.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.475 0.655 . . . . 0.0 110.892 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.4 tt0 -84.73 123.88 30.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.199 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -38.94 96.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -54.39 -24.04 28.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.576 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -176.47 -84.76 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 p -109.28 30.75 6.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.8 179.99 23.32 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.815 -1.184 . . . . 0.0 112.819 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.778 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.34 -50.32 7.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.39 -0.405 . . . . 0.0 111.415 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.8 64.25 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.924 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HE2' HD23 ' A' ' 8' ' ' LEU . 9.2 p90 -164.94 169.03 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -129.72 130.04 44.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.357 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.598 HG22 HG12 ' A' ' 36' ' ' ILE . 3.0 pt -120.21 162.4 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.94 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.294 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.49 -121.61 2.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.27 136.95 5.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 HG23 ' A' ' 69' ' ' THR . 1.2 t -55.77 -19.65 12.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.844 ' HB2' HG22 ' A' ' 69' ' ' THR . 2.6 m-20 -93.2 -52.15 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.188 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -117.86 78.37 12.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.29 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.25 142.62 5.92 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.725 2.283 . . . . 0.0 112.623 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.401 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.0 t60 -74.34 -18.34 60.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.76 -29.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.63 28.16 8.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.526 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.84 37.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -167.46 95.34 0.65 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.76 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 10.6 Cg_endo -53.98 -28.63 50.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -65.06 169.86 4.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.432 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.93 151.99 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.366 . . . . 0.0 111.123 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 5.5 p90 -142.56 144.29 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG22 ' A' ' 19' ' ' ILE . 69.0 mt -70.94 151.78 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.659 ' O ' HG21 ' A' ' 53' ' ' VAL . 28.3 p -99.85 -43.86 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.516 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.46 149.14 6.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.47 . . . . 0.0 111.798 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.458 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -106.19 141.61 21.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.032 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.49 119.94 73.62 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.06 84.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.359 2.039 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.04 -39.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -58.62 175.95 2.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.534 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -76.06 -20.36 57.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -51.02 -57.69 7.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.955 0.407 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.35 69.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -72.09 -34.64 68.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.791 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -89.57 -21.31 22.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.423 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 79.36 0.72 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.276 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.553 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.42 32.0 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 0.0 110.095 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.621 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.1 pp 38.48 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.185 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -58.4 141.43 51.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.035 0.445 . . . . 0.0 111.366 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -69.57 -40.78 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.154 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 53' ' ' VAL . 27.3 p30 -52.73 -16.84 1.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.78 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 20.4 p-10 -59.18 171.69 0.7 Allowed 'General case' 0 C--O 1.23 0.032 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 t -130.17 122.57 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 88' ' ' VAL . 15.2 pt -63.16 94.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.544 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 59' ' ' PHE . 1.3 pp -62.37 -24.31 67.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' A' ' 58' ' ' LEU . 1.3 t80 -164.19 140.35 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.894 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.4 p -101.97 -176.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.702 ' H ' HG22 ' A' ' 60' ' ' VAL . 18.1 m-20 -22.38 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.539 0.524 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -162.79 25.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.6 t -121.71 142.12 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.626 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 7.5 t0 -80.36 84.19 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.114 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 57' ' ' ILE . 16.7 m -94.83 30.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptt85 -89.42 7.63 34.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 179.25 49.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.048 0.451 . . . . 0.0 109.959 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.405 ' C ' ' HB ' ' A' ' 23' ' ' THR . 34.8 m -111.73 139.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.257 0.551 . . . . 0.0 112.39 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.844 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -50.06 166.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.547 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.562 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.3 t-160 -57.06 -48.71 77.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.037 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -41.91 70.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.04 74.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.456 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.76 68.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 ' CD2' ' A' ' 70' ' ' HIS . 53.1 t -64.52 -36.13 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.576 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 8.3 mt-10 -69.56 -33.11 72.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.694 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -42.91 74.43 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.37 0.605 . . . . 0.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.541 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.99 -26.88 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.31 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -72.65 -44.2 62.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.005 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.13 28.43 5.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.281 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -80.87 -27.7 36.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.6 -123.04 6.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.371 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' ILE . 13.4 m -135.21 8.15 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.507 HG23 ' HG3' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -156.93 94.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -110.96 119.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HA ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.21 102.32 14.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 57' ' ' ILE . 4.9 mp -103.75 139.78 38.52 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 5' ' ' GLU . 3.7 m-85 -107.8 114.74 28.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.1 m -115.92 168.45 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.308 0.575 . . . . 0.0 112.496 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 mtp -143.29 109.04 5.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 3.6 ptt180 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.808 0.337 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 153' ' ' LEU . 21.6 t -84.94 112.86 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -87.8 166.43 14.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.355 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.81 106.4 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 183' ' ' VAL . 3.0 mm -116.46 155.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -106.23 123.62 48.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.299 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.973 HD12 HD11 ' A' ' 181' ' ' LEU . 2.2 tt -122.85 118.53 28.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.571 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.59 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.3 pt -100.06 144.71 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.029 0.443 . . . . 0.0 111.233 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 110' ' ' LEU . 11.0 tttm -72.01 162.55 29.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -139.22 161.89 26.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.74 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.49 -39.32 91.69 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 122.062 1.841 . . . . 0.0 111.94 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -95.4 21.93 7.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.052 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 105.84 -155.44 16.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.466 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 105' ' ' LYS . 9.3 mp -86.24 -13.38 46.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.868 0.334 . . . . 0.0 111.227 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.26 51.83 7.19 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.56 154.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 132' ' ' THR . 31.1 t -116.08 119.25 35.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.375 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 112' ' ' PHE . 15.5 pt -125.26 156.38 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.901 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -154.91 125.42 6.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.95 165.9 31.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.685 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.06 -131.73 14.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.199 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.2 t -104.46 154.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 114.05 -37.85 3.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.403 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 163.8 82.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 111.43 23.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.161 0.505 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.901 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -57.31 -16.56 8.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.206 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 130' ' ' TYR . 0.3 OUTLIER -87.94 104.78 7.4 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.457 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 123' ' ' ILE . 13.6 Cg_endo -57.08 94.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.534 2.156 . . . . 0.0 112.571 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.68 44.5 8.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.886 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -142.21 85.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.022 0.439 . . . . 0.0 110.85 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -47.82 -26.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -55.89 162.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 160' ' ' LEU . 36.4 mt -96.24 125.31 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.151 0.501 . . . . 0.0 111.387 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.636 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.1 m-85 -116.21 161.33 19.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.229 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 150' ' ' ASP . 49.1 t -92.96 144.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 1.5 t -115.04 -49.21 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.99 144.17 30.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.877 0.37 . . . . 0.0 111.634 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.681 HD11 HG11 ' A' ' 131' ' ' VAL . 31.4 mt -136.89 139.85 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.99 173.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.9 tt0 -91.88 147.31 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.21 27.69 57.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.503 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.01 53.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.31 -59.86 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 111.405 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -69.96 -33.33 71.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.45 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -57.54 -60.2 4.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 0.0 110.24 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -41.7 64.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -80.6 -59.46 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -70.31 -30.81 69.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.215 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.73 21.0 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.726 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -93.37 82.33 4.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -66.71 172.99 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.8 mt -47.54 122.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.305 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.7 -22.6 6.11 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.365 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.754 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.47 134.55 54.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.333 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -119.42 124.72 47.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -104.25 129.45 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 110.717 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -98.55 -0.28 43.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.161 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.57 169.14 1.39 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.897 HG12 ' ND2' ' A' ' 156' ' ' ASN . 57.8 t -126.76 100.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.465 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.897 ' ND2' HG12 ' A' ' 155' ' ' VAL . 25.5 m-80 69.97 -57.7 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.195 0.522 . . . . 0.0 109.977 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.16 27.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.613 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.642 ' HB ' HD21 ' A' ' 160' ' ' LEU . 2.0 t -116.6 154.26 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-O 120.986 0.422 . . . . 0.0 111.332 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.0 77.86 0.24 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -78.21 24.76 0.24 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -127.68 41.35 3.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.382 0.611 . . . . 0.0 110.963 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.19 28.0 0.35 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.039 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.74 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -134.75 -78.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.4 ' CG ' ' HB ' ' A' ' 118' ' ' VAL . 3.2 mtm 173.57 166.87 0.17 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 169' ' ' VAL . 47.2 p-80 -53.88 -29.78 43.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.963 0.411 . . . . 0.0 110.602 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.42 -48.18 35.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.74 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -68.49 -37.85 80.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 160' ' ' LEU . . . -70.27 -38.66 75.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.673 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.5 t -67.25 -46.02 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.369 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.62 67.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.532 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 160' ' ' LEU . . . -77.48 -25.57 50.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.35 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -79.46 -39.97 30.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.177 0.513 . . . . 0.0 109.828 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 169' ' ' VAL . 4.3 mtmt -75.88 -26.58 57.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.07 -33.64 74.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.047 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.722 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -52.72 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.398 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -95.27 169.23 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.488 . . . . 0.0 111.341 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -56.78 -16.75 7.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.615 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.96 90.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.585 0.231 . . . . 0.0 110.934 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.63 148.28 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.129 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 1.4 p90 -95.02 130.42 41.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.627 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.973 HD11 HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.18 155.91 19.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.751 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.53 114.8 26.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.654 HG21 HG13 ' A' ' 101' ' ' ILE . 20.6 t -102.26 161.65 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -119.74 135.78 54.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 0.0 111.349 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 169' ' ' VAL . 47.8 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -85.76 85.78 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.097 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.945 0.402 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD2' ' CG ' ' A' ' 89' ' ' MET . 1.0 OUTLIER -129.43 171.87 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.587 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -167.5 136.82 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.6 109.33 10.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.378 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -127.7 -170.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.129 0.49 . . . . 0.0 111.98 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 128.14 49.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.416 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.1 tp -125.32 91.71 3.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.629 0.728 . . . . 0.0 110.087 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 83' ' ' ILE . 2.3 mt-10 -70.1 165.41 22.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.949 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -83.21 99.18 9.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.98 -26.55 8.77 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -168.87 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.176 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 t -109.18 30.64 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.65 177.03 20.06 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.358 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.54 -43.17 14.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.758 0.313 . . . . 0.0 111.069 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 90.84 76.61 1.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.784 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.7 p90 -164.72 148.46 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.041 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.2 m -95.97 126.99 41.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.41 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 36' ' ' ILE . 36.0 pt -115.41 154.73 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.129 0.49 . . . . 0.0 112.019 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -173.12 118.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . 152.65 29.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.061 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -58.22 167.13 6.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.41 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.74 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -73.03 -31.45 64.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.728 ' CB ' HG23 ' A' ' 69' ' ' THR . 8.3 t70 -83.84 -51.57 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 111.595 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -119.76 78.4 22.51 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.501 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.87 156.34 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.515 2.143 . . . . 0.0 112.203 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.595 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 15.6 t60 -100.81 -19.45 15.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -108.48 -26.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.666 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.25 32.18 8.5 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.147 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 177.7 39.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 3.4 t0 -166.56 107.87 0.68 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.897 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 14.2 Cg_exo -69.04 -24.74 32.65 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.684 2.256 . . . . 0.0 112.098 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -74.57 126.29 30.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -70.25 148.24 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.201 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -139.83 171.41 14.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.388 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 41.3 mt -99.42 150.57 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.4 m -108.5 -30.32 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.838 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.7 tmtt? -175.6 148.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 111.455 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -108.81 141.22 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.983 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 pt -89.69 146.58 35.83 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 58.45 6.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.6 2.2 . . . . 0.0 112.404 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.61 -57.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.02 176.61 1.8 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -74.54 -24.81 59.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.631 0.253 . . . . 0.0 111.62 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -53.01 -57.43 10.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.916 0.389 . . . . 0.0 111.292 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.988 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.91 -39.33 69.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 0.0 109.505 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 2.5 m-20 -80.19 -28.39 38.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.31 49.42 0.05 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.278 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HD3' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -103.56 21.71 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.584 0.23 . . . . 0.0 111.491 -179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.39 163.19 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 158.32 15.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.245 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.838 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.2 m -71.16 -44.13 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 53' ' ' VAL . 19.3 m-80 -58.74 1.25 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.688 ' OD2' HG21 ' A' ' 88' ' ' VAL . 55.1 p30 -89.87 163.43 15.01 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.088 -0.383 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -119.26 123.87 45.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.328 . . . . 0.0 111.075 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 7.1 pt -61.88 94.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 59' ' ' PHE . 3.6 pp -76.01 -20.57 57.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.675 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -158.0 119.58 3.59 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.077 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.792 HG22 HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -118.33 119.51 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 52.22 42.5 30.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.185 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.66 30.89 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 60' ' ' VAL . 22.1 t -114.09 141.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.31 113.92 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.792 HG11 HG22 ' A' ' 60' ' ' VAL . 14.6 p -146.59 26.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -87.45 6.51 33.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 177.67 50.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.937 0.398 . . . . 0.0 110.088 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.567 ' CG2' HG23 ' A' ' 65' ' ' VAL . 35.9 m -120.04 144.61 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.623 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.74 ' N ' HG22 ' A' ' 23' ' ' THR . 3.9 m -49.93 162.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.766 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.693 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -55.66 -48.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.457 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -50.01 -40.77 45.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.247 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.08 76.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -71.79 -41.3 68.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.459 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 70' ' ' HIS . 46.3 t -64.82 -36.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.628 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 6.2 mt-10 -69.3 -30.82 68.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.737 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.823 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.26 -36.95 74.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.451 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.18 -26.19 33.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -75.99 -32.66 59.56 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.865 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 29.78 7.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.56 -20.53 18.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.19 -131.25 10.28 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.616 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -124.84 16.61 8.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 111.321 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -153.63 94.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -102.14 136.56 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.08 90.28 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.738 HD23 HG12 ' A' ' 60' ' ' VAL . 17.9 mt -85.12 114.97 22.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.536 0.684 . . . . 0.0 112.764 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -110.02 114.29 27.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.9 m -123.04 168.37 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.468 ' HG3' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -123.26 109.01 13.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.278 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.28 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.34 120.25 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.82 166.13 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -129.94 106.36 8.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.438 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.581 HG13 HG21 ' A' ' 183' ' ' VAL . 2.5 mm -118.29 155.61 20.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.468 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -115.1 137.07 52.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.539 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.823 HD22 HD23 ' A' ' 110' ' ' LEU . 3.1 tt -135.28 118.44 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.72 144.66 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.011 0.434 . . . . 0.0 111.219 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -76.7 158.47 30.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.52 -164.88 10.06 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.994 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.76 -33.06 4.12 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.258 1.972 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 19.3 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.037 0.446 . . . . 0.0 110.53 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.64 -144.38 15.8 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.823 HD23 HD22 ' A' ' 103' ' ' LEU . 2.9 mp -86.43 -21.44 27.09 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.108 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.73 46.08 5.83 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.974 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.54 157.64 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 0.0 110.748 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 133' ' ' LYS . 43.9 t -125.15 116.76 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.724 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 172' ' ' LEU . 8.1 pt -123.05 151.59 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.425 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -149.87 125.52 10.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.099 0.476 . . . . 0.0 111.696 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.79 -175.29 24.92 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.043 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 121' ' ' GLN . . . 73.22 -144.33 34.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.871 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.441 ' H ' ' HA ' ' A' ' 164' ' ' MET . 48.7 t -104.67 154.62 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.854 0.359 . . . . 0.0 111.696 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 107.11 -32.24 7.41 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.236 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 176.54 79.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 0.0 110.163 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -111.07 112.44 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.269 -179.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -57.21 -20.14 25.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.222 0.534 . . . . 0.0 110.892 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -103.09 145.46 30.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.735 -178.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 5.6 Cg_exo -77.52 37.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.998 2.465 . . . . 0.0 112.689 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -122.65 -27.88 1.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.153 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 121' ' ' GLN . 3.2 p30 46.79 28.43 0.82 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.907 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -135.58 -48.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.213 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.4 m -88.66 126.85 35.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.445 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.612 ' HB ' HD12 ' A' ' 152' ' ' ILE . 18.6 mt -83.22 128.75 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.263 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.482 ' CD2' HD11 ' A' ' 123' ' ' ILE . 17.5 m-85 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.712 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 150' ' ' ASP . 57.3 t -68.13 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.423 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -131.05 -45.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -149.43 128.64 12.83 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.916 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 146' ' ' LEU . 25.9 mt -120.09 141.7 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.671 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.0 mm -77.18 174.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 135' ' ' ILE . 18.4 tt0 -92.19 133.86 35.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.96 25.22 45.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.497 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.84 -171.07 18.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -74.04 -53.65 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -69.99 -31.91 69.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -56.84 -60.92 2.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.211 0.529 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -42.42 63.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.117 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -80.85 -59.47 2.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 112.043 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.457 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -65.2 -42.13 96.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.053 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.49 21.22 11.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -96.96 85.03 3.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 169.07 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.598 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.6 mt -47.2 120.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.303 0.573 . . . . 0.0 111.429 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.46 -22.56 5.25 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.335 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.06 125.31 24.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.677 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.646 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 4.1 pttt -109.86 122.53 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -103.9 130.0 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.57 -0.53 34.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.461 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.9 164.85 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.347 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.783 HG12 HD22 ' A' ' 156' ' ' ASN . 57.4 t -115.97 101.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.783 HD22 HG12 ' A' ' 155' ' ' VAL . 63.6 m-80 70.56 -58.89 0.54 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 109.778 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.55 21.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.606 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -115.33 144.43 22.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.962 0.411 . . . . 0.0 110.983 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.97 71.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.766 HD21 ' CG2' ' A' ' 155' ' ' VAL . 1.4 pp -91.97 30.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 0.0 111.746 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.424 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.85 67.31 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 0.0 110.777 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -176.98 29.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.234 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.587 HG11 ' OD2' ' A' ' 167' ' ' ASP . 2.4 t -123.8 -75.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HA ' ' H ' ' A' ' 118' ' ' VAL . 7.1 mtm -172.13 -171.38 0.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.921 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.516 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.0 p80 -73.23 -30.31 63.39 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.078 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HG3' ' CE1' ' A' ' 165' ' ' HIS . 16.4 mt-10 -73.74 -46.94 42.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.587 ' OD2' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -66.07 -42.55 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.25 73.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.556 HG22 ' CB ' ' C' ' 7' ' ' SER . 16.9 t -74.02 -40.34 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.402 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.89 -34.53 69.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -75.84 -29.95 58.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 173' ' ' LYS . 3.6 pp -82.09 -37.33 26.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.809 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -75.03 -26.5 59.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.903 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.04 -11.5 60.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.35 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.677 ' HB ' HG21 ' A' ' 179' ' ' VAL . 38.2 p -58.61 -167.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 111.364 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' VAL . 45.2 t80 -112.8 172.15 7.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 1.1 m-20 -56.42 -15.13 3.64 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 104' ' ' ILE . 42.0 t -147.7 92.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.677 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -125.31 148.19 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.973 0.416 . . . . 0.0 111.962 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 5.5 m-85 -97.24 136.01 38.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.671 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.09 148.73 36.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 0.0 110.258 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mttp -96.84 114.55 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.581 HG21 HG13 ' A' ' 101' ' ' ILE . 15.7 t -102.03 160.16 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.914 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -116.47 145.88 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.378 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.8 mttt . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.798 0.332 . . . . 0.0 111.103 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.68 87.67 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.678 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 110' ' ' LEU . 7.2 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.862 0.363 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 161.52 41.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.727 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -179.33 150.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.233 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 7.1 tt0 -109.2 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.512 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.882 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.25 -174.1 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.082 0.467 . . . . 0.0 111.645 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 126.0 45.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.458 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.915 ' HG ' HD23 ' A' ' 15' ' ' LEU . 14.0 tp -123.62 94.49 4.26 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.703 0.764 . . . . 0.0 110.216 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.797 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.3 mp0 -68.59 161.85 27.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.687 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 12' ' ' ASN . 15.8 mtt180 -80.63 108.05 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.48 68.4 0.16 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.165 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER 78.81 -78.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.436 0.294 . . . . 0.0 110.549 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -109.53 30.71 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.79 178.01 15.31 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.552 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.915 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.41 -48.57 9.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.846 0.355 . . . . 0.0 110.979 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 97.27 76.54 1.3 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.602 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.608 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.6 p90 -160.68 152.14 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.558 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 m -95.21 126.45 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 36' ' ' ILE . 34.4 pt -132.74 160.89 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -171.33 173.74 4.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 102.61 -128.11 9.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.453 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.83 150.16 10.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -55.77 -22.41 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.292 . . . . 0.0 111.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.65 ' CB ' HG23 ' A' ' 69' ' ' THR . 11.3 t0 -92.61 -44.57 8.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.946 0.403 . . . . 0.0 111.202 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -123.89 77.61 57.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.16 128.31 22.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.587 2.192 . . . . 0.0 112.427 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -66.7 -20.17 65.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.523 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.21 -28.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.233 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.82 27.68 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.43 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -170.6 112.85 0.44 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.42 -27.42 47.09 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.721 2.281 . . . . 0.0 112.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.7 t -67.56 141.75 56.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -89.8 151.47 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.793 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.523 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -142.61 160.94 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 110.983 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' SER . 34.6 mt -92.6 147.88 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.2 p -98.81 -41.83 7.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.63 0.253 . . . . 0.0 111.471 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HA ' HG11 ' A' ' 53' ' ' VAL . 2.2 tmtp? -167.8 152.54 6.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.367 . . . . 0.0 111.262 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.462 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -104.35 141.01 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.033 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 ' HA2' ' A' ' 16' ' ' GLY . 8.7 pt -86.11 120.99 72.85 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.199 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 83.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.113 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.02 -54.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.0 170.47 4.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.546 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.93 -17.76 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.621 0.248 . . . . 0.0 111.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . -62.13 -57.44 11.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.762 0.315 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.95 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -72.35 -38.1 68.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 5.0 m-20 -79.18 -30.54 43.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.741 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.62 48.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.524 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.882 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.62 18.89 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.019 0.409 . . . . 0.0 111.296 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 51' ' ' LEU . 2.1 pt? -176.11 167.51 2.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.96 0.41 . . . . 0.0 111.679 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 153.57 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.064 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.629 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 27.6 m -70.99 -46.49 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.0 p30 -72.8 15.52 0.19 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -80.56 -167.65 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 104.78 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.755 HG22 HG12 ' A' ' 88' ' ' VAL . 12.9 pt -59.56 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.063 0.459 . . . . 0.0 111.201 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 89' ' ' MET . 0.5 OUTLIER -61.74 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.174 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 69.6 m-85 -160.97 160.82 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.54 134.06 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.691 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.6 36.27 5.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.52 29.27 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.9 t -120.76 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 12.8 p-10 -73.74 91.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 68' ' ' VAL . 17.4 t -114.4 34.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -99.75 11.33 39.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.34 40.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 65' ' ' VAL . 29.0 m -119.39 148.61 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.163 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 1.4 m -49.91 156.86 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.336 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.7 t-160 -54.6 -48.61 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.603 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -57.61 -34.39 69.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.161 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.49 82.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -72.01 -42.53 66.3 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.289 0.566 . . . . 0.0 109.81 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 70' ' ' HIS . 68.3 t -65.32 -36.1 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.781 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 2.9 mt-10 -69.33 -32.33 71.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.766 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.37 -42.76 74.78 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.45 0.643 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -78.04 -27.01 48.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.59 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 1.7 tttt -72.94 -37.76 67.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.312 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -103.24 26.39 8.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.634 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -103.66 -13.47 16.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.514 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -157.13 23.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.592 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.56 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -100.18 21.05 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 111.297 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.797 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.4 mt -155.28 95.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.766 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -104.78 140.16 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 112.367 -178.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.8 mtm180 -96.9 95.32 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.759 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mp -93.78 123.84 37.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -104.0 114.46 28.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 57' ' ' ILE . 28.1 m -126.01 168.58 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' HD12 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -142.39 108.97 5.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.464 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.687 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttt . . . . . 0 CA--C 1.527 0.087 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 153.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.538 ' SD ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.51 166.59 23.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 111.322 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.67 106.28 6.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.628 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -113.17 155.26 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -122.91 124.81 44.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.42 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 140' ' ' ALA . 2.7 tt -126.38 118.91 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.794 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.583 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -95.4 144.72 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -62.28 160.81 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -141.11 -159.23 7.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.886 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.35 -41.32 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.235 1.957 . . . . 0.0 112.649 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -91.73 21.73 4.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.23 -133.36 11.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.503 ' HB2' HG12 ' C' ' 9' ' ' VAL . 4.7 mp -86.61 -27.09 24.08 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.825 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.92 45.01 4.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.793 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.602 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.59 146.6 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -106.68 117.03 32.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.495 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.93 HD11 HD22 ' A' ' 172' ' ' LEU . 12.9 pt -129.54 164.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -162.29 124.93 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 111.812 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -154.65 173.42 33.08 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.106 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.81 170.67 13.38 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.473 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 119' ' ' GLY . 30.7 t -92.06 154.84 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.155 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 75.27 6.26 79.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.696 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.03 78.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.043 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -93.4 123.07 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.993 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -48.11 -29.1 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.589 0.709 . . . . 0.0 110.694 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.777 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -97.28 146.51 31.47 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.699 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.763 ' HD2' HG22 ' A' ' 123' ' ' ILE . 26.3 Cg_exo -62.93 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.564 2.176 . . . . 0.0 112.805 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.84 61.32 1.0 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.353 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.67 90.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 110.825 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -55.82 -22.82 26.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.376 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.43 ' HA ' ' CG ' ' A' ' 161' ' ' GLU . 38.9 m -47.47 123.12 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.588 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 35.9 mt -59.58 123.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.253 0.549 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -121.23 173.53 7.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.784 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 146' ' ' LEU . 44.0 t -111.16 141.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.166 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 148' ' ' ILE . 3.3 p -102.74 -60.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 146.89 26.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.513 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.6 mt -117.14 141.64 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.4 mm -82.8 173.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.546 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.6 pt-20 -112.58 36.25 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.99 -29.13 52.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.542 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.89 51.88 0.59 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.59 -84.51 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.17 -31.79 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.233 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.7 m170 -53.47 -56.98 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -50.27 25.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.343 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.33 -59.3 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 0.0 111.696 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -55.37 -56.27 24.28 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.02 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.88 21.78 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.754 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -103.77 83.03 2.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.909 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -59.97 166.55 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.587 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' THR . 31.1 mt -47.86 121.24 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.283 0.563 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 123.02 -19.4 7.79 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.495 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -64.49 126.16 26.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.515 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -107.17 124.02 49.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.091 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 154' ' ' ALA . 1.6 mt -98.26 132.51 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.676 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.642 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -91.05 -2.04 57.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 154.58 153.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.217 0.323 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.773 HG12 HD22 ' A' ' 156' ' ' ASN . 15.2 t -103.52 99.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.773 HD22 HG12 ' A' ' 155' ' ' VAL . 23.0 m-80 68.32 -59.46 0.44 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 155' ' ' VAL . 94.4 p -171.47 31.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.292 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.6 t -134.87 148.18 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.351 0.595 . . . . 0.0 112.205 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.744 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 91.97 -76.58 1.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.806 HD13 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER 32.12 34.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.258 -0.971 . . . . 0.0 112.284 178.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 159' ' ' GLY . 2.2 pm0 34.37 36.88 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.011 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.806 ' OD2' HD13 ' A' ' 160' ' ' LEU . 31.1 p30 -116.14 36.24 4.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.688 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -149.71 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.943 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.01 166.41 0.93 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.531 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.9 p80 -53.98 -37.22 63.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.938 0.399 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.07 -40.42 62.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.467 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -76.02 -37.49 58.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.861 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.71 -34.99 72.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.023 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 165' ' ' HIS . 25.4 t -74.21 -43.1 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.81 69.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.145 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.11 -26.69 56.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.436 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.93 HD22 HD11 ' A' ' 114' ' ' ILE . 3.9 pp -81.41 -36.62 29.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.873 ' N ' HD12 ' A' ' 172' ' ' LEU . 11.8 tttp -72.23 -26.9 62.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.306 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -70.5 -9.46 56.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.463 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.611 ' HB ' HG21 ' A' ' 179' ' ' VAL . 16.9 p -49.2 -178.58 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.053 0.454 . . . . 0.0 112.051 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -107.56 171.4 7.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.295 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 6.4 m-20 -53.41 -18.23 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.546 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.583 HG13 HG22 ' A' ' 104' ' ' ILE . 40.1 t -147.38 91.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.494 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.611 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -116.75 147.54 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.026 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 15.7 p90 -111.46 125.99 54.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.224 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.2 158.47 19.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 111.307 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.484 ' HB3' HD21 ' A' ' 153' ' ' LEU . 2.0 mptt -100.85 119.76 39.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.353 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.628 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -101.74 160.87 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.997 0.427 . . . . 0.0 111.419 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -126.91 133.21 50.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.56 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.44 ' OG ' HG21 ' A' ' 169' ' ' VAL . 41.4 m . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.78 0.324 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -80.61 94.31 6.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 110' ' ' LEU . 4.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 3' ' ' TYR . 13.5 tt0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.833 0.349 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.23 153.27 35.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.537 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -170.81 159.46 6.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.475 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -110.26 137.34 48.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.632 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.524 HG22 ' NE ' ' A' ' 50' ' ' ARG . 25.3 mt -149.12 164.15 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.127 0.489 . . . . 0.0 111.418 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.589 HG23 ' HD3' ' A' ' 85' ' ' ARG . 0.3 OUTLIER -123.11 136.73 54.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.074 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.5 tp -127.19 89.19 2.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.628 0.728 . . . . 0.0 110.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' A' ' 83' ' ' ILE . 3.0 tt0 -74.72 134.79 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.244 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -57.5 104.61 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.2 -27.52 5.45 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.636 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -174.8 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -109.29 30.54 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.856 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.22 178.1 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.485 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -50.68 7.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 101.35 70.4 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.639 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.8 p90 -164.68 157.71 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -112.56 129.38 56.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.13 160.81 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.353 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.54 12.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.05 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.01 -128.68 9.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.12 147.76 10.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.592 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -52.2 -25.15 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.685 0.279 . . . . 0.0 111.468 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.598 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.9 t70 -89.77 -45.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.531 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -123.87 78.31 57.55 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.573 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.84 134.5 28.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.547 2.164 . . . . 0.0 112.277 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 38.6 t60 -71.32 -25.71 62.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.193 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.99 -28.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 26.78 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.531 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.7 31.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 110.802 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 5.0 t0 -165.4 95.84 0.84 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 11.4 Cg_endo -54.85 -22.9 31.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.414 2.076 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.72 164.62 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -106.88 146.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.43 150.13 40.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.6 mt -72.64 151.89 7.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.495 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.549 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.23 -35.45 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.644 ' HA ' HG11 ' A' ' 53' ' ' VAL . 5.5 tmmm? -169.59 152.24 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.7 mt -118.23 141.27 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.14 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 pt -85.84 141.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.062 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.27 74.13 3.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.458 2.105 . . . . 0.0 112.391 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.04 -40.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.11 176.29 1.96 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.615 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.85 -27.36 57.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.557 0.217 . . . . 0.0 111.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -47.69 -57.37 5.6 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.43 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.44 69.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.02 -37.08 69.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.312 0.577 . . . . 0.0 109.644 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' HD13 ' A' ' 8' ' ' LEU . 22.2 m-20 -82.45 -25.7 33.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.023 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 80.67 51.54 4.81 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.307 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.524 ' NE ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.84 44.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER 33.77 -153.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 150.1 46.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.058 0.456 . . . . 0.0 111.37 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.4 m -71.04 -39.67 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.492 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 53' ' ' VAL . 22.9 p30 -51.69 -14.97 0.39 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.369 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.9 p-10 -61.85 156.73 19.95 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.8 m -122.68 124.36 43.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.32 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 88' ' ' VAL . 3.7 pt -62.92 94.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -61.08 -23.42 65.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.534 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -158.79 127.09 5.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.536 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.72 133.12 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.372 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.452 HD21 HG12 ' A' ' 84' ' ' VAL . 2.9 m-80 45.78 33.52 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 13.8 tt0 67.56 32.46 5.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 18.1 t -120.92 141.78 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.19 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 98.94 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.793 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.683 HG13 ' CG2' ' A' ' 68' ' ' VAL . 21.4 t -130.24 38.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -103.48 12.55 35.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.58 38.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.683 ' CG2' HG13 ' A' ' 65' ' ' VAL . 22.2 m -115.86 145.83 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.741 ' N ' HG22 ' A' ' 23' ' ' THR . 2.5 m -49.94 161.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.757 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.712 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -55.03 -48.53 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -49.79 -42.34 46.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.862 0.363 . . . . 0.0 111.391 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.18 75.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.031 0.443 . . . . 0.0 110.742 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.53 69.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.614 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.712 HG23 ' CD2' ' A' ' 70' ' ' HIS . 41.1 t -64.48 -35.34 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.736 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.44 -34.16 74.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.764 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.43 -43.42 73.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.328 0.585 . . . . 0.0 110.482 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.25 -26.69 56.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.454 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.1 tttt -70.98 -42.86 69.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.231 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.26 31.4 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.11 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -85.05 -27.0 26.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.555 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.68 -121.46 6.38 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.579 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 83' ' ' ILE . 88.7 p -137.97 9.8 2.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -152.09 94.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.797 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -94.84 117.27 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' HG23 ' A' ' 7' ' ' THR . 1.3 tpp85 -102.75 91.07 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.718 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.3 pp -121.64 154.04 37.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 m-85 -105.04 119.37 38.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.267 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 86' ' ' LEU . 26.8 m -104.11 167.81 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.249 0.547 . . . . 0.0 112.298 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.88 109.59 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.85 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.805 0.336 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.2 t -132.17 113.12 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 183' ' ' VAL . 2.0 ttm -86.89 166.28 15.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.38 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -133.99 106.75 7.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.149 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 144' ' ' GLY . 2.8 mm -114.02 155.53 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 101' ' ' ILE . 24.7 ttmt -134.86 122.86 22.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.75 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.675 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 3.6 tt -123.25 118.35 27.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -93.75 144.5 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.547 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 177' ' ' ASP . 2.0 tptm -57.71 141.77 47.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.49 -164.4 11.92 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.949 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -43.43 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.122 1.881 . . . . 0.0 112.228 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -92.52 20.46 6.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.071 0.462 . . . . 0.0 110.115 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.29 -142.37 15.48 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 103' ' ' LEU . 9.9 mp -86.7 -21.7 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.961 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.5 47.72 6.25 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.41 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.34 152.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.2 m -116.31 124.83 51.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.55 HG22 HG22 ' A' ' 131' ' ' VAL . 20.0 pt -141.63 157.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.726 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -159.82 125.5 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.914 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.597 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.26 -175.08 25.06 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.436 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.02 -179.38 45.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.298 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.04 150.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.742 0.306 . . . . 0.0 111.208 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.74 -19.16 42.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.338 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 10.7 t-20 -179.53 70.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.034 0.445 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.3 mt-30 -71.55 -7.49 47.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.481 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 61.4 t60 71.82 -57.09 0.62 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.521 0.676 . . . . 0.0 110.975 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -86.56 134.62 37.49 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.7 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.68 77.18 2.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.448 2.098 . . . . 0.0 112.606 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.01 46.55 0.55 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.92 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -172.95 96.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.26 -21.4 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 p -55.26 129.73 39.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.322 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.713 HD11 ' HA3' ' A' ' 159' ' ' GLY . 39.2 mt -66.19 130.84 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 111.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.85 ' CD1' HD11 ' A' ' 123' ' ' ILE . 2.4 m-85 -123.86 166.73 15.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.334 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 68.8 t -101.9 155.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.377 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.589 HG22 ' CE1' ' A' ' 122' ' ' HIS . 10.5 p -115.19 -58.99 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.578 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.18 148.7 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 147' ' ' GLN . 16.2 mt -132.14 141.68 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.8 mm -79.75 174.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.62 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.659 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 mt-10 -93.91 151.01 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.53 25.15 54.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -77.06 -169.14 30.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.93 -62.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.381 . . . . 0.0 111.306 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.874 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.15 -31.78 69.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.324 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -58.75 -48.69 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -72.58 -49.41 32.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.883 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.23 -59.39 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.853 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.96 -33.71 87.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.963 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.84 14.65 9.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.874 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -73.37 144.57 46.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.67 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.7 ' HA ' HD12 ' A' ' 134' ' ' ILE . 7.0 mt-30 -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.072 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 132' ' ' THR . 25.8 mt -49.28 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.802 0.811 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 141.83 -17.9 2.58 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.431 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -67.07 120.21 13.3 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.163 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -105.43 119.77 39.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.946 0.403 . . . . 0.0 111.475 -178.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 181' ' ' LEU . 1.8 mt -92.77 129.75 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.363 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.5 pp -87.08 -0.59 56.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 152' ' ' ILE . . . 166.0 153.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.059 0.224 . . . . 0.0 110.66 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.777 HG11 ' HB3' ' A' ' 172' ' ' LEU . 25.3 t -108.5 99.61 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 72.3 m-80 73.24 -59.84 0.55 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.8 t -169.96 23.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.377 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 171' ' ' ALA . 2.3 t -135.91 155.24 35.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.714 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.713 ' HA3' HD11 ' A' ' 129' ' ' ILE . . . 89.06 -6.9 83.26 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.828 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -68.61 23.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.626 0.77 . . . . 0.0 111.445 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 159' ' ' GLY . 24.0 mt-10 71.31 54.0 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.28 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.873 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -157.18 -83.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.052 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.9 mtm 166.92 162.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.1 t-160 -53.77 -30.22 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.022 0.439 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -41.16 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.068 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -76.22 -33.88 59.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' HA2' ' A' ' 159' ' ' GLY . . . -70.06 -38.18 75.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' HIS . 39.5 t -74.23 -41.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.484 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.15 62.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.334 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.746 ' HB2' HG11 ' A' ' 158' ' ' VAL . . . -72.12 -43.44 64.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.3 pp -67.86 -36.56 80.51 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.866 ' N ' HD12 ' A' ' 172' ' ' LEU . 9.2 ttpp -75.3 -26.09 58.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.469 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -56.37 -48.6 76.52 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.4 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -45.63 -52.45 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.118 0.485 . . . . 0.0 110.663 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 2.3 t80 66.7 107.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.888 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t0 82.38 -23.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.895 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.15 93.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.623 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.556 HG22 ' OG1' ' A' ' 175' ' ' THR . 2.2 t -107.06 148.43 11.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.107 0.479 . . . . 0.0 111.008 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -124.0 135.83 53.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.975 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.77 136.67 46.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.965 0.412 . . . . 0.0 111.338 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.83 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 184' ' ' ALA . 9.2 t -101.79 162.88 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.513 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.53 134.68 34.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.991 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.711 -179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.751 0.31 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.71 103.18 14.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.16 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.838 0.351 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -104.59 178.12 4.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -170.72 155.5 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.014 0.435 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -151.72 100.97 2.73 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.683 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -125.87 -171.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 112.133 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.48 125.17 28.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.882 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.4 tp -116.68 94.76 4.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 111.048 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -69.53 141.2 53.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.511 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 101.03 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.969 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.9 -26.63 8.63 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.446 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.89 -84.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -109.14 30.54 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.819 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.84 -179.76 20.98 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.314 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.36 -50.52 7.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.603 0.24 . . . . 0.0 111.397 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.41 30.29 3.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.147 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 3.5 p90 -123.03 147.96 46.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.368 0.584 . . . . 0.0 110.646 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.6 m -108.03 126.79 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.339 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.407 HG22 HG12 ' A' ' 36' ' ' ILE . 2.3 pt -106.97 171.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.865 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.74 139.89 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.39 -121.99 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.62 140.0 7.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.326 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.635 HG22 ' CA ' ' A' ' 69' ' ' THR . 1.6 t -54.35 -21.6 9.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.256 . . . . 0.0 111.534 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.5 m-20 -82.09 -56.94 3.63 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -123.74 86.55 53.0 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.394 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.0 129.93 19.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.78 2.32 . . . . 0.0 112.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -61.66 -20.43 63.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.586 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -105.63 -41.86 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.01 0.433 . . . . 0.0 110.843 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.39 24.99 5.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.542 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.49 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 14.3 t70 -158.26 98.34 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.776 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 13.7 Cg_endo -56.52 -29.94 80.48 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.413 2.076 . . . . 0.0 112.001 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -71.06 164.64 25.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.699 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.3 mt -109.17 155.81 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.34 166.7 23.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 42.6 mt -96.07 154.71 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.584 ' O ' HG21 ' A' ' 53' ' ' VAL . 19.0 p -108.7 -42.46 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.47 150.8 9.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 1.1 mt -108.96 141.52 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.4 mt -84.2 127.81 64.96 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.087 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.1 Cg_exo -65.18 66.9 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.525 2.15 . . . . 0.0 112.254 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.31 -52.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.436 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.68 -178.31 2.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.423 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -75.86 -20.77 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.31 -57.31 13.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -28.04 69.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.05 -43.44 64.92 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.572 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 4.8 t0 -74.39 -31.27 62.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.874 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.83 48.54 0.02 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.425 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.683 ' HG3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -95.83 18.63 12.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.7 pt? -175.06 179.81 1.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.995 0.426 . . . . 0.0 111.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 152.71 22.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.341 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 37' ' ' THR . 28.0 m -70.95 -38.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.031 0.443 . . . . 0.0 112.17 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.66 15.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.562 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -80.11 -158.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 100.61 3.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.758 0.314 . . . . 0.0 110.991 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.88 HG12 HG13 ' A' ' 60' ' ' VAL . 3.0 tp -61.97 95.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 110.717 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.527 HD23 ' CG ' ' A' ' 89' ' ' MET . 3.2 pp -70.1 -22.63 63.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -160.06 130.77 5.64 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.457 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.88 HG13 HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -113.31 117.68 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.167 178.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.615 HD21 HG12 ' A' ' 84' ' ' VAL . 6.9 m-20 46.57 37.82 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 69.44 30.92 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.87 125.86 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -45.85 125.71 6.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.358 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 57' ' ' ILE . 14.2 p -153.12 23.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -94.91 11.76 30.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.354 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 174.82 46.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.981 0.42 . . . . 0.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -111.12 138.07 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.302 0.573 . . . . 0.0 111.983 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.635 ' CA ' HG22 ' A' ' 23' ' ' THR . 0.1 OUTLIER -50.74 166.23 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.607 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -56.14 -48.55 76.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.062 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -56.2 -42.51 77.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . . . -62.1 -33.87 75.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.534 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.51 68.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 109.521 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 77' ' ' LEU . 50.5 t -64.75 -35.83 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.572 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 -33.34 72.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.832 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.26 -43.74 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.315 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -75.71 -26.77 57.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.459 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -71.89 -43.23 65.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.179 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -105.62 31.21 5.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.164 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -80.27 -28.65 38.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.526 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.95 -103.7 3.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.6 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 74.6 m -151.75 -52.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 18.2 mt -100.82 85.1 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.839 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 6.8 m -85.26 116.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.901 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -75.28 84.56 2.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.795 ' CD2' HG12 ' A' ' 60' ' ' VAL . 22.4 mt -85.13 139.45 31.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.519 0.676 . . . . 0.0 112.459 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 2.3 m-85 -124.01 114.51 19.84 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.802 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.9 m -125.53 168.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.527 ' CG ' HD23 ' A' ' 58' ' ' LEU . 25.4 mtm -127.87 108.99 11.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.244 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.282 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.857 0.36 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.544 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -121.9 154.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 98' ' ' VAL . 7.6 tpt -134.55 164.31 27.77 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.02 106.63 12.62 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 183' ' ' VAL . 2.0 mm -120.5 155.66 23.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 180' ' ' TYR . 2.4 mtmp? -115.38 123.26 48.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.358 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.763 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.5 tt -123.0 118.57 28.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.701 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.64 144.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.24 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 153.14 26.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.955 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 -177.88 15.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.842 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.48 -31.64 21.38 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.063 1.842 . . . . 0.0 112.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -96.79 19.78 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.042 0.449 . . . . 0.0 110.422 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.58 -153.06 17.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.488 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 mp -86.46 -14.99 41.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.66 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 83.73 50.66 4.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.901 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.7 155.02 0.79 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.5 m -113.97 116.97 30.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.563 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 172' ' ' LEU . 7.0 pt -132.79 155.1 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.4 125.04 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.061 0.457 . . . . 0.0 111.99 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.622 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.66 -175.13 25.44 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.273 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 -168.91 40.52 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.126 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 39.4 t -84.51 145.04 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.53 -25.28 16.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.1 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.61 70.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 0.0 109.738 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -72.55 -5.98 40.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.633 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.527 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 59.1 t60 72.04 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.607 0.718 . . . . 0.0 110.561 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.949 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.4 mt -84.04 144.21 44.05 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.603 ' HD2' HG22 ' A' ' 123' ' ' ILE . 15.8 Cg_exo -67.91 63.32 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.548 2.166 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.08 62.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -170.36 96.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.988 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -23.72 19.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.18 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 t -55.49 143.79 28.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.03 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.895 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -84.33 119.46 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.354 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.949 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.5 m-85 -114.93 155.08 27.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.175 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 114' ' ' ILE . 46.1 t -85.99 155.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.526 HG22 ' CE1' ' A' ' 122' ' ' HIS . 11.7 p -116.03 -57.3 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -152.65 150.04 29.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.258 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.679 HD11 ' O ' ' A' ' 146' ' ' LEU . 8.0 mt -130.27 141.63 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.054 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -75.98 173.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.611 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.98 138.09 35.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.67 27.2 73.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.548 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.06 -173.35 47.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -79.8 -58.18 3.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 111.168 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.568 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -63.93 -31.79 73.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -57.3 -62.18 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -72.94 -38.67 66.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.999 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.43 -59.37 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 112.029 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -72.24 -43.49 46.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.077 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.68 18.64 11.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.309 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.679 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -85.96 79.59 9.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.3 pt20 -60.47 171.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 29.5 mt -48.14 127.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 118.43 -25.63 8.08 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.346 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -58.52 151.07 21.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.748 0.309 . . . . 0.0 110.713 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -138.1 124.45 20.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.147 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.2 130.25 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.627 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.7 OUTLIER -100.08 -0.98 37.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.322 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.22 155.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.875 0.369 . . . . 0.0 111.334 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 158' ' ' VAL . 21.5 t -111.07 99.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.023 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.544 HD22 HG12 ' A' ' 155' ' ' VAL . 67.3 m-80 69.24 -59.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.267 0.556 . . . . 0.0 109.694 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.4 t -164.07 27.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.229 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.7 t -101.05 155.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.391 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -116.38 77.13 0.27 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.417 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.895 HD22 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.99 24.8 0.49 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -137.14 31.17 2.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.164 0.507 . . . . 0.0 110.763 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.67 27.71 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.059 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -137.61 -76.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.375 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.447 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 2.7 mtm 172.56 165.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.461 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 p-80 -53.95 -29.67 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.897 0.38 . . . . 0.0 110.467 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.42 -46.16 50.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.382 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.745 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.69 -37.36 73.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.608 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.38 -38.72 74.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.837 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' C' ' 7' ' ' SER . 9.9 t -70.36 -41.57 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.382 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.75 -31.31 66.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.077 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.05 -27.23 57.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.657 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.0 pp -81.74 -37.33 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.851 0.358 . . . . 0.0 110.317 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.927 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -75.37 -26.54 58.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.714 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.09 -9.79 59.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 179' ' ' VAL . 78.2 p -52.04 -178.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.947 0.403 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.1 t80 -100.97 167.1 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.327 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.4 t70 -50.66 -24.85 3.63 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.214 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.408 HG13 HG22 ' A' ' 104' ' ' ILE . 43.0 t -147.75 92.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -113.71 148.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.26 125.97 38.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.787 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.99 145.09 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 111.332 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.3 mttt -96.38 112.29 24.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.085 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 152' ' ' ILE . 21.8 t -102.64 162.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.321 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.523 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -121.0 133.15 55.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.122 0.487 . . . . 0.0 110.918 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.343 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.633 ' HB2' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.584 ' O ' HG13 ' C' ' 9' ' ' VAL . 96.5 p -97.83 84.33 3.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.584 HG13 ' O ' ' C' ' 8' ' ' SER . 3.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.792 0.329 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -109.71 128.88 55.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.393 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -177.73 172.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 111.618 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 1.5 pm0 -90.08 150.48 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' A' ' 50' ' ' ARG . 8.1 mt -144.18 153.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.281 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -116.91 125.67 51.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.005 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.5 tp -127.05 91.43 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.556 0.693 . . . . 0.0 110.361 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.855 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -77.27 163.16 26.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.786 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -69.56 97.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -56.04 -23.47 39.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.592 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -175.28 -85.35 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -109.11 30.53 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.808 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.06 177.73 15.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.358 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.921 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.38 -44.83 13.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.804 0.335 . . . . 0.0 111.195 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 90.39 77.15 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.783 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -163.33 155.55 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.788 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.1 t -111.97 126.85 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.723 HG22 HG12 ' A' ' 36' ' ' ILE . 11.1 pt -120.54 163.93 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.883 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.35 156.94 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 126.28 -126.07 5.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.537 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.45 132.53 5.18 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.744 HG22 ' N ' ' A' ' 69' ' ' THR . 1.6 t -48.46 -26.97 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.317 . . . . 0.0 111.345 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.739 ' CB ' HG23 ' A' ' 69' ' ' THR . 27.1 t70 -87.46 -44.31 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -123.77 78.75 56.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.82 134.13 40.85 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.665 2.244 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.414 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 27.8 t60 -69.32 -22.93 63.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.18 -30.73 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 27.81 10.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.661 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -172.67 33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.78 111.04 0.47 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 17.0 Cg_exo -67.26 -30.14 37.85 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.716 2.277 . . . . 0.0 112.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.56 129.27 39.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 152.3 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.3 165.13 28.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.702 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.723 HG12 HG22 ' A' ' 19' ' ' ILE . 43.1 mt -94.2 153.79 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.497 ' O ' HG21 ' A' ' 53' ' ' VAL . 15.9 p -106.93 -44.53 4.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.726 0.298 . . . . 0.0 111.494 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.927 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -156.59 152.5 27.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 111.39 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -111.01 141.27 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.822 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.26 135.83 36.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.081 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.82 57.25 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.261 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.09 -53.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.69 -174.83 0.85 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.465 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.595 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.03 -29.64 58.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -47.47 -51.04 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.324 . . . . 0.0 111.49 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.2 67.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -72.2 -38.97 68.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.749 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -81.56 -31.11 32.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.729 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.56 47.19 0.01 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.503 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -99.15 22.64 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.997 0.399 . . . . 0.0 110.98 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -168.84 -178.14 3.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HB2' ' HG3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -120.49 171.5 8.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.927 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.7 m -71.44 -46.67 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 53' ' ' VAL . 20.0 m-80 -69.39 11.52 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.529 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.2 p-10 -67.86 -179.74 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -135.75 100.35 4.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.709 0.29 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.644 HG22 HG12 ' A' ' 88' ' ' VAL . 5.1 pt -61.25 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.414 0.626 . . . . 0.0 110.994 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 89' ' ' MET . 4.3 mt -66.85 -24.77 66.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.596 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -160.75 155.53 23.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.892 HG12 ' HB ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -129.66 -176.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.209 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.679 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -41.64 78.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.927 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.6 tt0 63.76 21.71 12.78 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.208 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.892 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.2 t -121.44 141.99 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 0.0 111.678 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.37 82.29 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.321 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' HG22 ' A' ' 68' ' ' VAL . 9.4 m -94.72 31.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.583 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.85 -4.39 59.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.345 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 20.0 pt-20 176.64 56.66 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.033 0.444 . . . . 0.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 65' ' ' VAL . 30.5 m -118.69 142.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.748 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.744 ' N ' HG22 ' A' ' 23' ' ' THR . 1.2 m -50.2 161.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.631 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.713 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -53.76 -48.59 69.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.554 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -49.92 -43.72 49.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.06 73.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.61 69.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.604 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.713 HG23 ' CD2' ' A' ' 70' ' ' HIS . 40.0 t -64.4 -35.87 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.644 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.49 -33.74 73.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -69.57 -43.12 73.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.396 0.617 . . . . 0.0 110.555 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -76.28 -26.74 56.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.486 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -71.16 -42.53 68.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.196 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -104.16 29.77 5.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.379 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -85.33 -25.78 26.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.435 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.64 -137.36 20.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.488 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 83' ' ' ILE . 35.8 m -121.91 16.43 10.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.572 0.225 . . . . 0.0 111.346 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.855 HG23 ' HG2' ' A' ' 9' ' ' GLU . 1.6 mt -152.17 92.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.2 t -87.22 149.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 111.921 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -137.98 84.86 2.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.723 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.711 HD13 HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -116.67 154.21 30.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.2 t80 -105.66 114.93 29.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.686 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.711 HG13 HD13 ' A' ' 86' ' ' LEU . 10.8 m -121.37 167.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 58' ' ' LEU . 1.1 ttp -121.08 109.61 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.959 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.927 0.394 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.727 HG13 HD21 ' A' ' 153' ' ' LEU . 11.2 t -109.19 154.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.0 mmm -128.86 166.68 18.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.236 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -127.86 106.45 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 183' ' ' VAL . 1.8 mm -118.07 155.31 20.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.619 . . . . 0.0 112.606 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -111.93 126.91 55.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.062 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 1.4 tt -129.91 118.72 22.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.809 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.97 144.74 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -80.0 156.93 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.998 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 -174.01 13.46 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.86 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.74 -39.72 6.2 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.035 1.823 . . . . 0.0 112.063 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -95.21 22.75 6.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.66 -165.61 12.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.63 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 103' ' ' LEU . 1.4 mp -80.85 -13.49 58.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.175 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 86.17 51.84 3.43 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.829 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.94 149.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.665 0.269 . . . . 0.0 110.75 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.442 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 17.0 m -115.31 116.92 29.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.798 0.332 . . . . 0.0 110.674 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.626 ' CG1' HD22 ' A' ' 172' ' ' LEU . 5.5 pt -127.47 152.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.91 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -143.49 125.02 14.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.802 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.65 -175.06 25.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.915 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.62 134.71 8.54 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -59.24 153.13 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.58 -32.13 6.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 178.48 76.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 171.61 7.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.103 0.477 . . . . 0.0 110.924 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 66.9 t60 -49.8 -50.54 44.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.071 0.938 . . . . 0.0 110.516 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.925 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -96.58 129.63 32.61 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.836 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.14 78.47 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.307 2.005 . . . . 0.0 112.593 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.47 37.57 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.938 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.33 95.16 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.956 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -52.13 -25.18 8.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.2 m -54.45 115.9 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.802 HG12 ' HA3' ' A' ' 116' ' ' GLY . 11.7 mt -61.8 120.53 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.925 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -111.98 156.97 21.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.317 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.6 t -87.95 153.32 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.823 0.344 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.479 HG22 ' ND1' ' A' ' 122' ' ' HIS . 11.6 p -115.54 -58.04 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 147.69 23.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.016 0.436 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.798 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.2 mt -125.32 141.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.18 173.44 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -90.35 147.24 23.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.82 55.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.44 174.33 53.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.809 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.16 -50.17 50.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.422 . . . . 0.0 111.111 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.369 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -54.87 -54.82 37.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -72.87 -51.96 16.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.053 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.56 -59.36 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 111.85 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -51.6 -52.1 35.12 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.133 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 60.88 19.81 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -98.57 78.48 2.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.01 174.26 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.703 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 30.0 mt -48.06 132.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.172 0.51 . . . . 0.0 111.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 112.66 -28.36 9.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.251 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -61.16 145.3 51.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.672 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -132.65 136.85 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.66 132.4 52.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.713 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -101.45 -1.65 32.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 182' ' ' LYS . . . 173.97 162.98 0.18 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.967 0.413 . . . . 0.0 111.283 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 156' ' ' ASN . 25.6 t -117.67 99.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.143 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.64 HD22 HG12 ' A' ' 155' ' ' VAL . 65.4 m-80 69.2 -59.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.309 0.576 . . . . 0.0 109.817 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.45 26.77 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.353 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 6.3 t -109.23 154.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.26 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.37 76.88 0.26 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -80.26 24.01 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.72 58.01 1.56 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.1 29.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.543 HG11 ' CG ' ' A' ' 167' ' ' ASP . 2.4 t -136.61 -74.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.3 mtm -174.45 -170.3 0.5 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.453 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' VAL . 70.0 t60 -70.86 -32.87 70.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.943 0.401 . . . . 0.0 110.589 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.79 -46.7 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.543 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.77 -35.14 69.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.28 -39.01 75.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.315 0.579 . . . . 0.0 109.463 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.85 ' HA ' HD23 ' A' ' 172' ' ' LEU . 12.6 t -73.65 -39.95 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.48 71.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.03 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 160' ' ' LEU . . . -78.17 -25.68 47.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.929 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -81.05 -40.71 23.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.51 59.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.19 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -12.33 32.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.416 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.53 147.52 0.84 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 111.587 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.2 t80 -86.13 169.54 13.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.419 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 3.2 t70 -46.77 -30.81 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.079 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 104' ' ' ILE . 41.8 t -147.91 91.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.649 0.261 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -123.83 148.4 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.433 . . . . 0.0 111.734 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.3 m-85 -98.34 128.32 44.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.421 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.54 152.67 28.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 -179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 154' ' ' ALA . 9.6 mttt -96.56 118.7 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -102.35 161.26 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.352 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -125.92 136.26 52.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.739 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.658 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.463 ' CB ' HD21 ' A' ' 172' ' ' LEU . 6.1 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.847 0.356 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -90.96 100.26 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.44 HG23 ' OXT' ' C' ' 9' ' ' VAL . 4.6 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.102 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.821 0.344 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.92 163.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.567 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -174.86 162.17 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.376 . . . . 0.0 111.259 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 6.0 pt-20 -95.97 147.47 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 7' ' ' THR . 27.0 mt -146.78 165.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -129.74 147.17 51.49 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.198 0.523 . . . . 0.0 111.835 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.832 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.51 87.33 2.31 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.412 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -79.81 118.85 21.97 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.251 179.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -41.78 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.69 -26.65 8.05 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.591 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.28 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.31 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -109.23 30.69 6.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.24 177.98 24.72 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.716 -1.23 . . . . 0.0 112.809 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.26 -47.33 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.499 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.09 62.14 1.02 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.827 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.6 p90 -165.13 169.19 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 111.351 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -119.56 126.76 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.535 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.0 pt -116.45 157.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.241 0.544 . . . . 0.0 111.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.71 148.09 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.502 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.7 16.9 2.41 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.585 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -47.06 173.46 0.02 OUTLIER Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.488 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.806 HG22 ' N ' ' A' ' 69' ' ' THR . 1.8 t -77.56 -35.7 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.701 ' CB ' HG23 ' A' ' 69' ' ' THR . 5.3 t0 -86.38 -42.44 13.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.334 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -123.86 77.25 57.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.429 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.49 171.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.619 2.213 . . . . 0.0 112.275 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.621 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 20.7 t60 -111.57 -21.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.339 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.94 -25.82 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 29.52 7.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.381 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.62 40.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 108.48 2.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.837 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 16.8 Cg_exo -67.43 -22.32 45.53 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -82.92 136.81 34.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -82.68 145.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.219 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.537 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.7 p90 -142.17 142.95 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.568 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 18' ' ' SER . 33.9 mt -69.75 146.87 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 53' ' ' VAL . 3.0 m -101.26 -33.87 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.728 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -172.24 143.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.291 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -107.24 141.45 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.137 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.47 135.13 41.41 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 63.72 4.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.48 -43.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.06 178.5 1.87 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.18 -19.76 58.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -52.92 -57.55 9.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.934 0.397 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.5 69.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.903 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -72.02 -35.02 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.575 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.43 -20.19 25.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.454 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 80.26 1.0 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.613 HH22 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -88.3 22.02 2.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 52' ' ' ARG . 3.2 pp 36.7 -154.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.11 128.72 38.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 111.158 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 38' ' ' LYS . 26.4 m -57.77 -41.61 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.229 0.538 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 53' ' ' VAL . 2.1 m-80 -50.45 -17.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.944 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 33.8 p-10 -57.67 150.43 19.5 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -121.7 129.8 53.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -65.82 94.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.1 mt -58.47 -26.89 63.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -162.93 145.45 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.563 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.0 OUTLIER -108.3 -176.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.376 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.4 m120 -21.78 -52.35 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.943 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.63 25.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.7 t -121.58 142.06 39.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.529 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 8.0 p-10 -79.61 87.13 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.6 m -94.09 30.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.75 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -82.66 2.03 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.862 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.98 58.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG21 HG12 ' A' ' 65' ' ' VAL . 34.9 m -118.61 142.8 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.715 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.806 ' N ' HG22 ' A' ' 23' ' ' THR . 5.4 m -49.81 161.94 0.21 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.126 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.1 t-160 -60.34 -48.61 81.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.301 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -37.99 81.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.48 76.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.05 -43.13 65.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.968 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.6 t -64.63 -35.71 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.912 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.53 -33.35 72.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.863 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -43.03 74.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -77.11 -26.76 53.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.538 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -72.51 -41.1 66.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.399 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 28.45 6.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.878 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -96.63 -19.13 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.512 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.94 -159.29 16.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.862 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -99.75 10.09 41.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.619 0.247 . . . . 0.0 111.464 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -152.93 94.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 HG12 ' CB ' ' A' ' 80' ' ' ALA . 26.9 m -90.64 134.89 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 7' ' ' THR . 3.6 mmt180 -116.7 102.11 9.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -128.82 154.25 46.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.404 0.621 . . . . 0.0 112.546 -178.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -103.77 115.27 30.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.677 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 57' ' ' ILE . 34.4 m -104.22 167.94 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 112.388 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.4 ttp -126.0 109.62 12.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.844 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.134 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.833 0.349 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 98' ' ' VAL . 15.0 p -84.66 114.48 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.53 166.69 11.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 111.861 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -135.49 106.5 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.4 mm -114.14 155.27 15.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 3.7 mttp -114.2 120.93 42.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.364 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -119.52 118.75 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.369 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -95.14 144.68 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.967 0.413 . . . . 0.0 111.226 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -58.79 151.65 20.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.135 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.93 160.16 23.21 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.646 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -40.54 80.51 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 C-N-CA 122.119 1.879 . . . . 0.0 112.129 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.71 19.69 9.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.05 0.452 . . . . 0.0 110.101 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.4 -144.57 16.0 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 103' ' ' LEU . 8.5 mp -86.56 -20.06 28.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.084 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.33 61.51 3.89 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.92 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 145.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.8 t -109.98 117.4 33.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.832 HD11 HD22 ' A' ' 172' ' ' LEU . 6.3 pt -130.87 154.66 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.65 125.0 10.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 111.755 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.54 -175.01 25.2 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.516 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.4 -164.17 54.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.195 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.46 150.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 111.149 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.21 -30.51 7.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.973 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -164.66 69.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.053 0.454 . . . . 0.0 109.897 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.9 mt-30 -67.1 -11.24 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.655 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 60.8 t60 72.43 -54.68 0.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.65 0.738 . . . . 0.0 110.944 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -92.38 138.14 24.28 Favored Pre-proline 0 C--N 1.31 -1.117 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.741 -179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.2 Cg_endo -73.54 60.94 4.3 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.356 2.037 . . . . 0.0 112.563 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 130.74 55.87 0.09 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -175.55 96.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -57.85 -22.13 46.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -58.33 141.92 49.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 160' ' ' LEU . 14.9 mt -74.65 127.66 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 111.249 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.823 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.9 m-85 -122.4 146.52 47.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.2 t -76.93 155.59 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.434 ' N ' HG12 ' A' ' 131' ' ' VAL . 6.9 p -119.62 -59.18 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.07 146.69 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.924 0.393 . . . . 0.0 111.157 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 147' ' ' GLN . 17.1 mt -134.4 141.49 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.74 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.672 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.1 mt-10 -97.0 153.17 18.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 52.59 31.2 36.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.738 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.36 -167.97 39.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.697 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.02 -60.92 2.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -68.3 -31.94 71.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.273 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.07 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.212 0.529 . . . . 0.0 110.009 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -72.82 -52.99 12.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.772 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.6 -59.24 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.794 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.449 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -52.63 -53.34 33.04 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.068 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 64.98 16.46 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.019 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.507 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.05 78.46 4.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.518 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.8 pt20 -61.14 175.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.3 mt -47.94 129.9 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 115.48 -27.04 8.67 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.297 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -64.09 138.33 58.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 110.546 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.695 ' CE ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -126.83 131.31 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.037 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.639 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.51 134.56 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.884 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -100.82 -1.92 33.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.923 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.15 163.71 0.38 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 158' ' ' VAL . 25.2 t -119.46 99.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.224 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.498 ' ND2' HG12 ' A' ' 155' ' ' VAL . 66.9 m-80 69.82 -59.91 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.395 0.617 . . . . 0.0 109.762 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -164.75 27.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.17 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.1 t -108.47 154.55 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.295 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.45 77.1 0.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.93 24.44 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -132.09 30.97 4.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.173 0.511 . . . . 0.0 110.905 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -141.98 28.44 1.73 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.272 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.702 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.5 t -139.93 -78.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.383 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtp -179.14 -169.74 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 169' ' ' VAL . 17.0 t60 -70.43 -31.59 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.494 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -47.57 39.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.702 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -69.96 -37.12 75.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.84 0.352 . . . . 0.0 110.642 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 160' ' ' LEU . . . -70.14 -38.8 75.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.237 0.542 . . . . 0.0 109.634 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 13.1 t -72.28 -39.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.428 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.74 -29.73 64.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.016 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.54 55.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.1 pp -81.7 -37.87 26.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -74.96 -26.44 59.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -15.24 53.29 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.602 ' HB ' HG21 ' A' ' 179' ' ' VAL . 25.3 p -50.11 -178.74 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.735 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.493 ' CD1' HG13 ' A' ' 179' ' ' VAL . 9.0 p90 -132.46 -160.41 1.05 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.733 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 6.3 t0 -53.37 -34.79 59.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.427 ' O ' ' CZ ' ' A' ' 176' ' ' TYR . 35.2 t -147.86 92.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 0.0 111.596 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.602 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.5 OUTLIER -111.01 131.38 62.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.054 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 10.2 p90 -94.05 124.47 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -109.58 153.87 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 111.374 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.56 ' O ' HG22 ' A' ' 152' ' ' ILE . 1.1 mptm? -96.93 110.91 23.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.608 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 152' ' ' ILE . 12.8 t -102.21 159.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.695 ' HB3' ' CE ' ' A' ' 151' ' ' LYS . . . -140.74 145.24 36.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.54 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 mttt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.63 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.821 0.343 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -86.49 116.4 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.117 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.794 0.331 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.27 178.7 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.414 ' HB2' ' NH2' ' A' ' 90' ' ' ARG . 5.7 tt0 -174.04 142.81 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.472 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 8.6 pt-20 -108.86 111.47 23.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.744 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -120.29 -169.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.168 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -140.82 133.36 28.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -113.29 88.93 2.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 111.067 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -82.54 116.79 22.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.377 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -40.63 95.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.406 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.15 -26.87 6.68 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.828 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -169.65 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -109.17 30.66 6.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.82 177.41 23.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.984 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.781 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.28 -45.77 12.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.251 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' CA ' HD11 ' A' ' 40' ' ' ILE . . . 89.54 64.27 1.27 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.682 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.54 ' HD2' ' HB2' ' A' ' 45' ' ' ALA . 10.1 p90 -164.9 146.38 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.0 110.784 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.721 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -96.01 165.3 12.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.0 pt -152.96 159.63 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.82 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.22 154.95 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.225 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.49 -127.45 6.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.9 144.31 8.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -57.91 -20.01 33.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.349 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 69' ' ' THR . 19.3 t70 -94.34 -42.1 9.08 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.696 0.284 . . . . 0.0 111.085 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -123.76 77.59 56.82 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -47.46 129.4 16.42 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.715 2.276 . . . . 0.0 112.477 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 35' ' ' PHE . 78.6 t60 -57.22 -72.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.078 0.466 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.475 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -55.9 -42.0 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.551 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.36 23.63 5.07 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.444 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.28 29.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 2.4 m-20 -160.43 103.44 1.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.813 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.8 Cg_endo -55.89 -26.08 56.11 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.465 2.11 . . . . 0.0 111.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -66.71 147.94 52.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -94.28 151.74 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 111.288 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -142.39 158.07 44.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.717 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 18' ' ' SER . 65.4 mt -77.03 148.65 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.31 -30.05 10.38 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.514 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.736 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.64 146.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -116.45 141.11 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.448 HD11 ' CA ' ' A' ' 16' ' ' GLY . 2.7 pt -89.65 139.45 27.96 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.17 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.93 64.25 7.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.564 2.176 . . . . 0.0 112.414 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.14 -41.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.14 177.35 15.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -75.95 -20.94 57.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.404 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -52.96 -57.28 10.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.944 0.402 . . . . 0.0 110.942 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.76 -28.32 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.87 -40.28 69.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.23 0.538 . . . . 0.0 109.605 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD2' HD13 ' A' ' 8' ' ' LEU . 20.4 m-20 -80.55 -20.22 43.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.333 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.54 83.85 0.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.443 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.657 ' NH2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -89.37 13.8 12.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.72 0.295 . . . . 0.0 111.16 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.832 HD22 ' HG3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER 64.42 -163.68 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.392 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.86 146.85 20.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 111.281 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.736 HG11 ' HA ' ' A' ' 38' ' ' LYS . 6.6 m -63.18 -42.55 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.576 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 53' ' ' VAL . 19.9 m-80 -52.36 -11.81 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.44 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.405 ' CB ' ' HB3' ' A' ' 90' ' ' ARG . 35.3 p-10 -63.55 152.56 38.32 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 p -119.04 120.22 36.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.009 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.625 HG22 HG12 ' A' ' 88' ' ' VAL . 2.6 pt -60.83 94.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.575 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -60.7 -26.28 67.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.907 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.654 ' HD2' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -164.87 140.1 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.381 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -125.13 118.87 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.44 -76.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.9 tt0 -160.44 30.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 17.7 t -120.82 140.73 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.27 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 5.3 p-10 -79.71 107.97 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 65' ' ' VAL . 24.1 t -125.57 39.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -95.51 -2.07 49.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -175.77 49.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.172 0.51 . . . . 0.0 109.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.598 ' CG2' HG13 ' A' ' 65' ' ' VAL . 35.2 m -115.96 142.35 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.638 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.678 ' CG2' HG22 ' A' ' 23' ' ' THR . 66.7 p -49.65 161.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.839 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.513 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -59.01 -48.71 80.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -58.78 -40.8 85.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.37 68.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.46 69.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.59 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 77' ' ' LEU . 39.8 t -64.92 -35.3 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.469 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 37.6 tp10 -69.47 -33.51 73.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.763 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.57 73.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -74.77 -26.41 59.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.387 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.76 -41.41 83.37 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.157 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.55 28.24 7.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.688 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.37 -24.74 23.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.36 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.57 -160.49 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.909 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 68.3 m -97.34 -36.54 10.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 9' ' ' GLU . 9.0 mt -112.87 85.1 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 84' ' ' VAL . 17.7 m -90.61 115.15 29.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.091 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.441 ' CG ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -91.28 101.25 13.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -117.28 154.28 31.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.51 114.99 28.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.328 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 57' ' ' ILE . 32.3 m -104.38 159.91 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.195 0.522 . . . . 0.0 112.229 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 109.66 15.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.658 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.832 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.4 t -123.61 136.33 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.54 166.64 15.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 111.431 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.97 106.41 6.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 183' ' ' VAL . 3.5 mm -114.53 155.21 15.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -108.89 123.73 49.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.226 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.788 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.1 tt -126.14 118.57 25.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.755 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.663 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.46 144.65 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.66 155.77 25.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.66 178.11 18.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.892 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.93 -31.25 38.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.103 1.869 . . . . 0.0 112.006 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -96.89 19.68 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.76 -156.36 16.55 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.539 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 HD22 ' A' ' 103' ' ' LEU . 6.3 mp -86.5 -13.27 46.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.12 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 81.24 49.45 5.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.978 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.2 154.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.808 0.337 . . . . 0.0 111.079 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.2 t -116.84 116.64 27.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.755 HG22 HG22 ' A' ' 131' ' ' VAL . 14.3 pt -129.52 157.25 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.44 125.75 7.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.47 -175.24 25.42 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.19 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.67 -165.76 48.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.182 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 24.3 t -87.95 148.25 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.61 -10.97 60.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.516 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.97 65.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -76.21 -0.61 22.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.908 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 82.4 t60 72.69 -60.99 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.702 0.763 . . . . 0.0 110.568 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.937 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.8 OUTLIER -94.6 107.03 27.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.668 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.49 89.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.394 2.062 . . . . 0.0 112.512 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 108.46 34.4 2.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -155.47 90.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.977 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -53.9 -23.26 12.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.348 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 m -56.67 137.48 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.693 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.7 mt -78.86 116.22 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.392 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.937 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.9 m-85 -113.06 150.08 32.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 150' ' ' ASP . 45.2 t -85.07 155.72 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -128.52 -45.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.34 146.27 32.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.731 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 147' ' ' GLN . 24.0 mt -136.81 141.43 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -71.89 173.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.62 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -92.4 137.28 32.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.844 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.42 27.19 40.03 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.627 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.59 178.43 50.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.663 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -65.14 -54.72 25.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.11 -32.75 70.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -60.0 -55.36 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.239 0.542 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -46.56 52.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.867 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -80.73 -59.47 2.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.032 0.444 . . . . 0.0 112.053 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -60.95 -46.34 94.77 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.247 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.54 17.25 10.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.74 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.499 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -91.39 79.2 5.62 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.502 ' HA ' HD12 ' A' ' 134' ' ' ILE . 12.7 pt20 -60.0 170.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.0 mt -47.6 126.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.281 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.99 -23.87 9.12 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.514 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -65.12 129.12 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.827 0.346 . . . . 0.0 110.517 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -115.62 131.45 56.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.244 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -104.9 134.61 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.715 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.553 HD23 ' HB2' ' A' ' 184' ' ' ALA . 2.2 pp -103.9 -2.07 26.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.61 159.9 0.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.896 0.379 . . . . 0.0 111.457 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.802 HG12 HD22 ' A' ' 156' ' ' ASN . 11.7 t -115.52 100.19 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.802 HD22 HG12 ' A' ' 155' ' ' VAL . 20.2 m-80 69.28 -59.5 0.48 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.367 0.604 . . . . 0.0 109.635 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -165.49 28.96 0.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.989 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 155' ' ' VAL . 9.9 t -106.46 154.81 7.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.36 76.45 0.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.598 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -78.15 24.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.91 35.23 2.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.234 0.54 . . . . 0.0 110.742 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.02 28.59 1.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.762 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -142.04 -77.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.083 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.6 mtm -179.4 -171.59 0.2 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 169' ' ' VAL . 25.5 p80 -71.84 -32.67 67.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.301 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.72 -42.4 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.762 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.11 -37.81 66.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.569 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.71 74.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 165' ' ' HIS . 23.8 t -72.69 -43.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.481 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 174' ' ' ASN . . . -71.86 -30.18 65.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.044 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.51 -29.14 56.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.472 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.2 pp -81.66 -37.58 27.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.55 59.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.937 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -69.99 -13.67 62.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.439 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.686 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.7 p -56.84 -168.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 64.0 t80 -106.18 172.46 6.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.2 m-20 -58.28 -15.97 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.202 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.52 92.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.262 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.86 147.91 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.282 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.445 ' CE1' ' HA ' ' A' ' 156' ' ' ASN . 18.4 p90 -100.93 129.71 46.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.788 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.99 154.37 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.751 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.61 116.93 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.786 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 101' ' ' ILE . 19.6 t -101.89 162.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.491 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.83 117.23 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 0.0 111.936 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.599 178.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.402 ' HB3' HG12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.922 0.392 . . . . 0.0 111.067 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' HG13 ' C' ' 9' ' ' VAL . 0.6 OUTLIER -154.82 73.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.545 HG13 ' O ' ' C' ' 8' ' ' SER . 6.7 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.871 0.367 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.26 141.1 27.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.584 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 5.7 pt-20 -175.01 165.92 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 111.417 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -109.37 123.47 49.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.771 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.62 -172.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.316 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -140.44 127.95 21.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.259 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.88 ' HG ' HD23 ' A' ' 15' ' ' LEU . 5.8 tp -119.05 91.42 3.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.638 0.732 . . . . 0.0 110.561 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -73.79 138.84 44.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.601 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 82' ' ' SER . 2.5 ptm180 -57.85 103.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.35 -26.91 7.3 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.547 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -168.15 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -109.15 30.71 6.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.725 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.94 174.68 19.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.441 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.33 -50.49 7.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.942 0.401 . . . . 0.0 111.304 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.23 74.64 1.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.69 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 39' ' ' ILE . 2.9 p90 -164.65 156.46 15.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.029 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' ILE . 2.1 p -105.93 126.81 52.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 36' ' ' ILE . 2.4 pp -120.43 154.49 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 0.0 111.945 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.97 147.49 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.754 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.41 19.62 1.34 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.993 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.11 162.92 0.08 OUTLIER Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.542 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.752 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -66.68 -38.73 87.39 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.788 ' CB ' HG23 ' A' ' 69' ' ' THR . 12.5 t0 -83.77 -49.17 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 111.631 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.69 76.89 10.77 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.582 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.69 172.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.646 2.23 . . . . 0.0 112.274 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 17.5 t60 -108.8 -21.45 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.212 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.74 -25.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.86 7.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.703 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.89 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.13 101.49 2.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.017 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.15 61.83 2.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.903 2.402 . . . . 0.0 111.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 m -176.86 134.61 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.741 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 145.1 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.6 p90 -142.24 163.64 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.453 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 19' ' ' ILE . 49.2 mt -93.97 148.67 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 110.84 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -31.77 8.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.344 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.918 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.6 tmmm? -172.55 148.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -106.95 141.62 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.78 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.05 128.05 64.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.965 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.2 62.14 2.6 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 -43.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.62 -177.26 22.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.94 -21.27 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.631 0.253 . . . . 0.0 111.532 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.0 -57.62 12.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.13 -28.25 67.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.75 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.21 -36.21 69.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.652 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' GLY . 34.0 m-20 -87.21 -25.98 23.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.327 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 28.47 54.7 0.13 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.148 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.81 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -84.16 4.84 28.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.958 HD13 HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -177.76 -177.9 0.68 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.106 0.479 . . . . 0.0 111.547 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 165.19 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.396 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.918 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.5 m -71.13 -45.51 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.72 17.6 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 51' ' ' LEU . 7.5 p-10 -75.34 -166.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.33 100.05 3.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.797 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -60.84 95.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.465 0.65 . . . . 0.0 111.058 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.664 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -70.94 -25.68 62.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -154.55 129.84 9.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.5 t -137.13 145.87 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.927 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.5 m120 42.24 32.43 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.471 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 65.66 32.7 8.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' VAL . 21.8 t -121.07 141.88 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.46 78.13 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.701 HG12 HG21 ' A' ' 68' ' ' VAL . 18.8 m -98.78 33.26 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.427 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -84.24 3.56 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.05 47.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.039 0.447 . . . . 0.0 109.837 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 65' ' ' VAL . 29.9 m -118.71 140.99 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.176 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -49.67 164.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.905 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.3 t-160 -57.39 -48.49 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.372 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -41.4 63.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.151 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.58 76.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.94 -40.75 68.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.55 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 ' CD2' ' A' ' 70' ' ' HIS . 49.7 t -64.23 -35.83 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.658 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -34.07 73.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.815 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.49 -42.92 74.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 110.477 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.8 -26.74 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.385 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -45.09 59.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.382 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -103.18 28.82 5.99 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.415 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.981 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -81.56 -27.83 34.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.508 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.09 -124.58 8.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.635 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 83' ' ' ILE . 69.6 p -130.83 4.62 4.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.84 96.73 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.981 HG12 ' HB1' ' A' ' 80' ' ' ALA . 26.6 m -87.41 114.37 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -100.9 110.38 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.47 154.1 51.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.664 ' CD1' HD21 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -107.83 114.68 28.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.219 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 51' ' ' LEU . 12.6 m -118.97 168.1 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.113 0.482 . . . . 0.0 112.151 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ptm -124.33 109.53 13.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.155 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' ASP . 1.2 ptt180 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.75 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.73 152.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.906 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttt -135.31 166.3 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -114.96 155.6 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.603 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 180' ' ' TYR . 1.6 ttpt -113.7 124.53 52.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 5.8 tt -125.79 118.4 25.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.602 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -94.87 144.68 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.195 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -65.75 155.24 36.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -134.82 -169.64 11.98 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.68 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.12 -40.13 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.022 1.815 . . . . 0.0 112.322 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 20.2 8.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 110.277 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 106.81 -133.93 11.9 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 6.5 mp -86.71 -27.03 23.94 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.935 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.1 40.75 4.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.669 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.12 154.59 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 111.08 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.5 t -102.23 123.15 45.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.489 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.801 HD11 HD22 ' A' ' 172' ' ' LEU . 16.4 pt -130.1 155.26 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -162.41 125.47 2.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.051 0.453 . . . . 0.0 111.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.93 -175.48 25.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.622 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.25 34.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.962 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -104.26 154.7 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.853 0.358 . . . . 0.0 111.377 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 -35.83 4.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 175.05 78.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 115.11 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.775 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -58.98 -17.58 26.15 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 ' CD1' ' A' ' 130' ' ' TYR . 1.1 mt -83.55 122.62 76.88 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.742 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.39 96.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.47 2.114 . . . . 0.0 112.165 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.85 58.31 14.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.93 87.01 1.95 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.571 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -43.53 -28.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t -53.57 168.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.619 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.67 ' HB ' HD12 ' A' ' 152' ' ' ILE . 27.1 mt -105.86 127.27 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.935 0.398 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.3 m-30 -117.27 154.67 30.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.502 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 134' ' ' ILE . 66.2 t -90.07 152.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 133' ' ' LYS . 5.9 t -123.62 -50.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 132' ' ' THR . 0.0 OUTLIER -134.22 142.42 47.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 131' ' ' VAL . 30.7 mt -136.99 138.46 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -80.16 172.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 135' ' ' ILE . 85.8 mt-10 -91.37 134.52 34.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.36 26.29 56.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.88 -138.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' LEU . . . -97.4 -72.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.906 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -61.47 -31.79 71.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.7 t-160 -56.41 -62.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 110.993 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -72.63 -34.3 67.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.985 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -59.36 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -88.13 -29.23 20.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.844 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 141' ' ' HIS . 1.3 ttm180 67.75 27.8 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.01 0.405 . . . . 0.0 110.527 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.906 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -88.64 82.71 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -68.38 176.35 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.87 121.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.299 0.571 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.4 -23.36 5.15 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.059 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 183' ' ' VAL . 9.3 t0 -57.94 139.51 54.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.773 0.321 . . . . 0.0 110.524 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -130.98 119.51 22.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.146 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.99 131.98 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.092 0.472 . . . . 0.0 110.79 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 pp -104.3 -1.36 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.201 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 179.83 168.68 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.718 HG12 HD22 ' A' ' 156' ' ' ASN . 58.6 t -117.88 100.44 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.635 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.718 HD22 HG12 ' A' ' 155' ' ' VAL . 66.4 m-80 70.42 -57.45 0.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.072 0.463 . . . . 0.0 110.081 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 m -165.31 21.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.325 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -116.32 132.61 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.165 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.0 68.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.863 HD22 ' HB1' ' A' ' 171' ' ' ALA . 4.0 pp -87.26 28.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.848 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.414 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -122.29 37.17 4.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.168 0.508 . . . . 0.0 110.939 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -142.42 29.05 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -116.08 -76.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.2 mtm -176.45 -170.2 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.744 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 169' ' ' VAL . 4.0 t-80 -69.99 -34.17 72.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.663 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.7 -45.41 52.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.601 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.91 -37.46 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.806 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.93 73.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.061 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.816 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.4 t -73.95 -39.97 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.2 -33.6 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.863 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -77.96 -27.04 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.816 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -76.18 -36.73 58.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -26.87 60.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.44 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -9.95 55.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.519 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 p -47.73 149.53 1.24 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 0.0 111.442 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -87.58 169.78 11.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t0 -45.12 -35.3 3.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.044 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 104' ' ' ILE . 40.8 t -147.85 91.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.95 148.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.661 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.435 ' CZ ' ' HD2' ' A' ' 102' ' ' LYS . 13.2 m-85 -96.42 127.05 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.602 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 155' ' ' VAL . 1.5 mt -104.94 150.71 24.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.954 0.407 . . . . 0.0 110.597 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.9 tttm -96.8 114.27 25.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 101' ' ' ILE . 18.8 t -101.68 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 111.288 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.608 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -123.1 141.15 52.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.671 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.866 0.365 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -80.9 95.82 6.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.418 HG23 ' OXT' ' C' ' 9' ' ' VAL . 3.5 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.831 0.348 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.9 151.52 20.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -177.07 158.5 1.54 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 111.311 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -113.81 114.71 26.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.727 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -119.27 -176.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 120.979 0.418 . . . . 0.0 111.429 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.13 125.16 38.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.724 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 15' ' ' LEU . 13.9 tp -124.19 92.73 3.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.683 0.754 . . . . 0.0 109.97 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.16 161.69 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.22 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 15.0 ptm180 -73.14 98.51 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.876 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.87 -26.57 8.48 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.526 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -168.45 -87.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.143 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -109.18 30.73 6.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 177.4 18.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.019 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.974 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.48 -37.08 21.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.187 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 72.47 1.29 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.967 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -156.49 157.11 34.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 178.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.0 m -104.5 126.89 52.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.467 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.586 HD11 ' NE2' ' A' ' 70' ' ' HIS . 35.5 pt -105.4 163.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 0.0 111.74 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . . . -162.36 144.38 10.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.42 -144.75 18.21 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.708 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.09 142.83 5.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.366 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -48.6 -27.63 2.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.725 ' CB ' HG23 ' A' ' 69' ' ' THR . 16.7 t70 -81.58 -45.21 16.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.975 0.417 . . . . 0.0 110.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -123.92 84.73 54.44 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -41.99 144.19 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.868 2.379 . . . . 0.0 112.618 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 72.1 t60 -75.98 -49.61 17.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.637 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.485 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -97.73 -29.26 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.29 23.23 6.13 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.0 30.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -164.06 111.08 0.92 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.639 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.28 -23.68 75.47 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.732 2.288 . . . . 0.0 112.122 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -57.94 175.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.8 mp -104.01 160.81 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 27' ' ' HIS . 3.5 m-85 -132.21 166.28 22.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.189 0.519 . . . . 0.0 111.419 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 18' ' ' SER . 11.2 mt -116.71 151.54 18.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.837 ' O ' HG21 ' A' ' 53' ' ' VAL . 32.2 p -109.99 -44.31 3.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -162.8 158.38 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.196 0.522 . . . . 0.0 112.09 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -112.08 141.11 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.55 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 mt -87.32 129.08 52.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.167 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.0 Cg_exo -65.34 64.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.15 -43.45 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.271 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.56 160.21 52.85 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.319 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -54.86 -28.79 52.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -58.89 -55.38 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 39' ' ' ILE . . . -65.66 -27.26 68.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -71.71 -42.47 67.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.667 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 3.2 m-20 -77.11 -36.22 55.7 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.394 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 27.3 44.01 0.03 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.391 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -76.1 -37.65 57.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -120.33 179.78 4.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 150.91 21.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.769 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.837 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -71.25 -35.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.403 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -70.21 14.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -83.38 -162.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.84 100.82 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -55.26 96.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 111.191 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 89' ' ' MET . 5.1 mt -68.17 -33.85 75.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.892 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 86' ' ' LEU . 69.1 m-85 -157.08 167.7 29.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.295 0.569 . . . . 0.0 111.955 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.926 HG13 ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -147.15 -177.95 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.013 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.0 m-20 -40.32 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 111.592 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 50.32 31.02 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.069 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.2 t -120.94 128.85 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.385 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -95.81 80.26 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG13 HG12 ' A' ' 63' ' ' VAL . 34.5 m -97.17 32.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.43 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -75.88 -5.3 45.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.266 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.62 46.8 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.936 0.398 . . . . 0.0 110.174 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.644 HG21 HG12 ' A' ' 65' ' ' VAL . 23.3 m -117.28 140.4 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.082 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.725 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -50.61 166.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.501 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.586 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.3 t-160 -59.73 -48.64 80.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.434 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.56 69.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.53 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.7 -35.23 67.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.014 0.435 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -72.37 -42.56 65.13 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -64.51 -36.37 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.976 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.4 mt-10 -69.36 -33.68 73.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -69.65 -41.41 75.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.426 0.632 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.518 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.2 pp -79.52 -26.9 41.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.457 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.49 -36.62 71.19 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.225 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.06 22.91 9.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.811 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -129.91 16.48 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.29 103.89 0.88 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 166.45 -70.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.409 . . . . 0.0 110.602 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -152.44 93.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.859 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 8' ' ' LEU . 9.9 m -93.6 113.71 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -79.3 80.39 5.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.926 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -85.58 132.25 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -176.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -109.88 114.54 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m -117.84 168.36 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 0.0 112.234 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . 12.3 ttt -141.63 109.26 5.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.457 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.688 0.28 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.92 147.0 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtm -134.73 166.12 23.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.212 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.04 106.21 6.7 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 183' ' ' VAL . 4.3 mm -113.86 155.57 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.425 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -121.57 125.96 47.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.254 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.679 ' HB2' HD11 ' A' ' 181' ' ' LEU . 1.9 tt -130.84 118.78 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.033 0.444 . . . . 0.0 110.733 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG13 ' A' ' 178' ' ' VAL . 4.8 pt -93.83 144.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.944 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 20.4 tttt -69.93 155.49 40.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -135.84 -160.62 8.94 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.58 -42.02 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.184 1.923 . . . . 0.0 112.484 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -92.07 21.37 5.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.025 0.441 . . . . 0.0 110.427 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 107.44 -141.57 15.66 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.44 -23.0 26.2 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.901 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.95 47.06 4.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.842 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.56 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -175.87 153.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 131' ' ' VAL . 9.5 m -111.23 129.9 55.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 172' ' ' LEU . 13.5 pt -142.54 156.6 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -157.9 125.27 5.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.44 -175.08 25.21 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.104 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 83.91 -174.08 51.06 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.073 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 25.7 t -80.35 145.35 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.754 0.312 . . . . 0.0 111.123 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.07 -27.19 9.43 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.201 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.82 68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 109.755 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -73.4 -4.57 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 62.1 t60 72.02 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.51 0.671 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.74 145.56 35.24 Favored Pre-proline 0 C--N 1.313 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.511 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 123' ' ' ILE . 16.8 Cg_exo -67.26 62.33 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.509 2.14 . . . . 0.0 112.14 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 118.43 60.37 0.28 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.882 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -164.33 94.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.824 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.15 -23.32 20.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 m -60.01 147.71 38.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.718 HD11 ' HB1' ' A' ' 168' ' ' ALA . 1.1 mt -87.57 110.53 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.913 ' CD1' HD11 ' A' ' 123' ' ' ILE . 6.6 m-85 -104.93 150.6 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.9 t -83.2 147.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 148' ' ' ILE . 15.7 p -103.06 -56.61 2.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.308 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 147.1 22.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.9 mt -114.77 141.58 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -80.08 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -106.74 30.48 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.82 -28.91 66.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.325 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.22 21.33 8.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.79 -82.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.79 -56.3 16.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 0.0 110.535 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.79 -50.39 24.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.264 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.19 -59.42 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.978 0.418 . . . . 0.0 111.888 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -56.07 -57.56 18.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 60.02 26.41 15.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.769 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -106.41 86.43 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -58.91 165.84 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.673 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 132' ' ' THR . 32.3 mt -48.19 115.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 111.288 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.64 -18.19 5.18 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -68.0 122.24 17.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.878 0.37 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -110.75 128.63 55.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.51 131.73 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.592 ' CD2' ' HB2' ' A' ' 184' ' ' ALA . 1.0 OUTLIER -95.94 -2.91 46.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.086 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 167.38 146.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.86 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 158' ' ' VAL . 95.0 t -101.88 99.66 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.12 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.441 ' ND2' HG12 ' A' ' 155' ' ' VAL . 69.6 m-80 69.34 -59.66 0.48 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -162.48 26.14 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.329 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 155' ' ' VAL . 15.0 t -98.07 155.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.255 0.55 . . . . 0.0 111.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -115.26 77.76 0.27 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.619 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 168' ' ' ALA . 80.1 mt -76.73 25.69 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.614 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.6 OUTLIER -152.85 53.69 0.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.336 0.589 . . . . 0.0 110.777 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.86 28.24 0.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.6 t -150.64 -74.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtm 175.17 169.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.711 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.52 ' O ' HG23 ' A' ' 169' ' ' VAL . 14.5 p-80 -54.96 -29.87 57.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.942 0.401 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -73.41 -48.39 34.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.178 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.716 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.62 -36.58 73.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.904 0.383 . . . . 0.0 110.583 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.42 -36.27 73.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.058 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.765 ' HA ' HD23 ' A' ' 172' ' ' LEU . 5.5 t -72.07 -42.55 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.17 -30.81 66.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.627 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 160' ' ' LEU . . . -77.68 -25.95 49.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.248 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -81.32 -39.85 24.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.11 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -26.51 58.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.5 -9.89 55.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.669 ' HB ' HG21 ' A' ' 179' ' ' VAL . 7.7 p -50.96 -178.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 111.8 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -103.02 169.46 8.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t70 -52.16 -21.32 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.535 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.499 HG13 HG22 ' A' ' 104' ' ' ILE . 40.4 t -147.58 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.714 0.292 . . . . 0.0 110.341 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.24 148.3 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.116 0.484 . . . . 0.0 112.3 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -102.53 124.18 47.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.798 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -104.68 146.22 29.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 0.0 111.334 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -96.46 115.76 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.233 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 101' ' ' ILE . 17.8 t -101.83 160.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.145 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.834 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -139.57 132.72 29.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.252 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.907 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.778 0.323 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -98.63 105.44 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.546 HG13 ' OXT' ' C' ' 9' ' ' VAL . 11.1 p . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.889 0.376 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -121.64 154.76 36.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 23.8 mm-40 -145.82 118.25 8.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.561 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.457 ' HG2' ' CG ' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -125.1 95.76 4.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.79 -169.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 111.922 -178.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -119.69 135.03 54.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.637 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.9 tp -128.2 91.35 3.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.785 0.802 . . . . 0.0 110.022 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -72.69 160.64 31.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.12 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -70.5 95.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -51.11 -25.92 11.44 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.478 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -172.45 -86.85 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -109.35 30.74 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -179.77 21.86 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.419 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.94 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.2 mp -84.43 -48.74 9.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.805 0.336 . . . . 0.0 111.515 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 76.29 1.31 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.742 -0.742 . . . . 0.0 114.1 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.5 p90 -164.66 148.68 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.689 0.28 . . . . 0.0 110.756 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.8 m -100.73 126.86 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 111.392 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.771 HG22 HG12 ' A' ' 36' ' ' ILE . 2.9 pt -125.06 164.31 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.07 154.78 7.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 120.46 -113.54 2.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.12 22.15 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.544 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 2.8 t -58.21 -18.44 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.837 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.9 m-20 -93.44 -49.71 5.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -121.96 79.35 41.82 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.438 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.95 136.9 22.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.606 2.204 . . . . 0.0 112.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.409 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 26.8 t60 -70.38 -21.8 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.502 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.61 -29.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.935 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.52 29.55 9.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.17 35.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.9 95.97 1.0 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.46 -23.24 30.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.126 . . . . 0.0 112.005 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -76.18 142.53 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' HB ' HD11 ' A' ' 57' ' ' ILE . 9.1 mt -93.18 154.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 111.182 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.9 p90 -142.39 167.82 21.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.299 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.775 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 40.5 mt -98.09 152.44 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 p -108.62 -36.34 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.673 0.273 . . . . 0.0 111.453 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.923 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -163.81 154.52 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.969 0.414 . . . . 0.0 111.291 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.2 141.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.999 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.8 mt -85.44 123.61 72.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.6 Cg_exo -66.06 64.02 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.68 -52.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.34 166.8 8.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.362 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.55 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -62.03 -23.05 66.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.88 -57.37 12.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.167 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.14 -28.1 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.534 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -38.44 69.28 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.999 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 40.7 m-20 -87.56 -25.27 23.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 33.58 70.58 0.13 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.593 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -109.46 -14.06 14.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.541 0.21 . . . . 0.0 111.371 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.648 HD13 HD11 ' A' ' 86' ' ' LEU . 2.1 pt? -141.63 168.87 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -104.71 165.12 11.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.121 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.9 m -71.54 -47.77 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 53' ' ' VAL . 13.6 m-80 -62.24 4.63 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.564 ' OD2' HG21 ' A' ' 88' ' ' VAL . 44.2 p30 -86.99 170.57 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.298 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 m -120.37 116.15 24.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.579 0.228 . . . . 0.0 110.648 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.912 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -60.47 94.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.226 0.536 . . . . 0.0 111.19 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.669 HD11 ' CG ' ' A' ' 89' ' ' MET . 59.6 mt -70.07 -28.81 65.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.18 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 143.11 17.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.601 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.22 131.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.587 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 1.1 t-20 52.09 40.47 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.0 26.96 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.5 t -120.81 131.47 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.3 100.93 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.0 t -112.71 41.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.012 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.95 9.7 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.655 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -177.76 37.59 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 65' ' ' VAL . 14.9 m -118.96 150.57 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.447 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.837 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -49.56 156.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.705 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.473 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.8 t-160 -58.23 -48.56 80.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.554 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -59.45 -34.79 72.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.366 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.98 -37.45 78.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.36 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.37 65.26 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 109.693 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 19' ' ' ILE . 78.9 t -64.2 -35.05 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.684 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.3 tt0 -69.19 -33.99 74.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.96 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.466 0.651 . . . . 0.0 110.466 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -79.92 -27.05 39.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.368 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -70.87 -35.56 72.41 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.141 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 21.64 10.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.655 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.87 16.27 5.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.048 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.52 95.83 0.11 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.781 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.1 m 169.59 -66.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.79 94.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.249 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -101.31 140.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.657 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.87 95.02 9.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.677 HD21 ' CG1' ' A' ' 88' ' ' VAL . 2.2 tm? -84.81 115.53 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 0.0 112.067 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CG ' ' HG2' ' A' ' 5' ' ' GLU . 1.3 t80 -121.75 114.44 21.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.912 HG12 ' HA ' ' A' ' 57' ' ' ILE . 20.7 m -129.3 168.06 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.669 ' CG ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -118.46 109.08 15.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.631 178.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 52' ' ' ARG . 45.7 ttp180 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.819 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.975 0.417 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.1 135.14 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.7 166.73 11.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -135.14 106.41 6.75 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 183' ' ' VAL . 3.7 mm -114.15 155.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -113.04 123.28 49.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.257 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 110' ' ' LEU . 2.0 tt -124.8 118.6 26.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.587 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.528 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -97.04 144.68 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.115 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -75.17 155.93 36.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.2 -177.85 15.19 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.905 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 -33.43 16.23 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.064 1.843 . . . . 0.0 112.093 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.53 18.22 13.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 0.0 110.416 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA3' ' OXT' ' C' ' 9' ' ' VAL . . . 106.4 -148.1 16.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.457 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 103' ' ' LEU . 14.5 mt -86.57 -18.84 30.47 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.213 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.64 49.95 6.32 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.083 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.76 151.99 0.75 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 110.718 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.403 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 67.2 m -113.48 116.88 30.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.942 HD11 HD22 ' A' ' 172' ' ' LEU . 10.4 pt -128.78 155.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.607 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -155.33 125.14 6.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 111.886 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.83 -175.1 25.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.449 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 104.16 -174.13 21.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.596 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.1 t -100.76 155.02 4.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 111.4 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 96.49 -26.77 20.23 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.28 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -173.9 74.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -76.5 130.76 38.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.006 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 16.1 t60 -43.28 -34.69 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.049 0.928 . . . . 0.0 110.64 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.27 138.3 19.85 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.901 -178.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 123' ' ' ILE . 58.2 Cg_endo -71.52 61.21 2.78 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.361 2.041 . . . . 0.0 112.719 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.72 48.76 0.08 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.26 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.42 96.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -58.14 -22.43 51.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 136.87 40.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.642 ' HB ' HD12 ' A' ' 152' ' ' ILE . 4.8 mt -73.85 120.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.999 0.428 . . . . 0.0 111.229 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.4 m-85 -116.28 147.57 41.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.396 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 150' ' ' ASP . 39.4 t -83.96 139.51 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.482 HG22 ' CE1' ' A' ' 122' ' ' HIS . 11.5 p -97.49 -58.9 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.627 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG3' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -155.15 150.86 27.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 111.468 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.9 mt -127.87 141.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.767 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -74.36 173.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.608 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.2 tt0 -87.06 146.29 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.28 26.1 55.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.1 164.27 45.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -58.71 -52.32 66.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 111.201 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.666 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.12 -32.01 69.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -56.27 -54.63 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.202 0.525 . . . . 0.0 110.377 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -72.83 -50.75 22.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.092 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.56 -59.58 2.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 111.886 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.476 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -55.6 -50.05 62.33 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.169 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.98 19.52 10.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.757 0.313 . . . . 0.0 110.653 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.625 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.16 79.86 4.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 175.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 132' ' ' THR . 27.4 mt -49.75 129.53 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.159 0.504 . . . . 0.0 111.295 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.5 -24.35 11.35 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.571 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.9 OUTLIER -60.74 129.33 40.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.753 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.839 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 1.9 pttp -117.47 125.28 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.999 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.46 132.26 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.116 0.484 . . . . 0.0 110.756 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -99.41 -1.28 39.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.35 158.86 0.09 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.831 0.348 . . . . 0.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.742 HG12 HD22 ' A' ' 156' ' ' ASN . 20.6 t -116.44 100.07 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.195 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.742 HD22 HG12 ' A' ' 155' ' ' VAL . 14.2 m-80 68.84 -59.3 0.47 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.225 0.536 . . . . 0.0 109.814 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 97.4 p -163.4 26.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.385 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 5.6 t -102.47 155.02 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-O 121.07 0.462 . . . . 0.0 111.314 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.09 79.05 0.3 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.685 HD13 ' HB3' ' A' ' 172' ' ' LEU . 18.6 mt -77.61 24.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.92 0.391 . . . . 0.0 112.048 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.83 38.68 1.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.099 0.476 . . . . 0.0 110.736 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.77 28.62 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.311 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.731 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -145.83 -75.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.388 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 172.84 166.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 50.9 t-80 -53.99 -29.92 45.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.79 0.328 . . . . 0.0 110.649 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.31 -46.45 49.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.731 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.42 -36.89 68.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.64 -34.97 72.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.511 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.0 t -72.08 -40.28 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.83 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.92 -36.33 69.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.35 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -75.42 -26.88 58.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.942 HD22 HD11 ' A' ' 114' ' ' ILE . 4.1 pp -82.07 -36.88 27.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.829 0.347 . . . . 0.0 110.377 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -75.07 -26.4 59.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.54 -9.59 54.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.188 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 1.2 p -42.34 166.91 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.059 0.457 . . . . 0.0 112.2 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' A' ' 179' ' ' VAL . 75.0 t80 -96.95 167.26 11.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -47.83 -29.2 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.315 -179.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 104' ' ' ILE . 41.1 t -147.9 91.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 110.7 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.68 148.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.686 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 156' ' ' ASN . 27.6 p90 -103.51 125.23 49.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.179 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -106.75 155.9 19.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.829 -178.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.88 113.45 24.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.55 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 101' ' ' ILE . 13.1 t -102.2 164.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.839 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -130.48 129.05 42.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.64 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.812 -179.754 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.809 0.338 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 125.16 28.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.402 ' OXT' ' HA3' ' A' ' 109' ' ' GLY . 11.6 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.095 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.748 0.309 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HD2' ' HH ' ' A' ' 87' ' ' TYR . 3.1 m-85 -135.68 170.65 15.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE1' HD12 ' A' ' 6' ' ' ILE . 6.4 tt0 -178.29 125.79 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.415 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 4.8 pt-20 -110.22 106.55 16.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.347 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.665 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -122.35 -167.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.008 0.432 . . . . 0.0 111.639 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 135.94 44.65 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.789 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -120.32 88.97 3.04 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.6 0.714 . . . . 0.0 110.986 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.21 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.886 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASN . 8.5 mtt180 -44.43 105.04 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.82 0.343 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.91 66.11 0.33 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.48 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' ARG . 11.2 m-80 77.03 -73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.632 0.253 . . . . 0.0 110.891 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -109.29 30.41 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.67 -176.92 18.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.948 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -51.32 7.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.278 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 97.5 69.12 0.97 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.94 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 5.5 p90 -164.93 155.82 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 36' ' ' ILE . 12.9 m -117.53 138.19 52.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.551 HG22 HG12 ' A' ' 36' ' ' ILE . 3.3 pt -127.08 166.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.05 160.7 33.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 27' ' ' HIS . . . 112.51 -132.48 10.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.09 146.95 7.82 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -61.76 -16.3 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.689 ' CB ' HG22 ' A' ' 69' ' ' THR . 30.2 p-10 -102.04 -39.29 7.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.704 0.288 . . . . 0.0 110.92 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.38 76.57 53.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.634 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' CG ' ' HA ' ' A' ' 30' ' ' ASP . 99.8 Cg_exo -43.72 155.55 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.944 2.43 . . . . 0.0 112.344 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 6.0 t60 -122.7 -11.95 8.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.691 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.579 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.16 -58.08 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' ASP . . . -173.74 33.93 0.11 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.088 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HA ' ' CG ' ' A' ' 26' ' ' PRO . 1.1 t0 81.51 53.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.835 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -118.92 114.8 35.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.695 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 32.3 Cg_exo -59.18 82.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.78 2.32 . . . . 0.0 112.165 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.75 143.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.29 148.27 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -142.61 145.28 33.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.365 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 18' ' ' SER . 70.9 mt -72.94 144.9 12.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.641 ' O ' HG21 ' A' ' 53' ' ' VAL . 21.8 p -95.49 -43.25 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.655 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 158.46 27.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.202 0.525 . . . . 0.0 111.743 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -116.92 141.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.85 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.92 133.9 45.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.35 77.82 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.56 2.173 . . . . 0.0 112.189 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.57 -31.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.328 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -61.12 168.95 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.543 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.92 -21.16 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -54.87 -57.58 11.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.42 69.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -72.05 -37.51 69.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.665 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.74 -20.25 36.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.375 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.05 72.43 1.25 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.985 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.51 35.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 88' ' ' VAL . 1.5 pp 37.57 -156.91 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.056 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.08 138.09 58.29 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.015 0.436 . . . . 0.0 111.223 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 37' ' ' THR . 31.6 m -65.24 -37.85 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.342 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -53.19 -15.27 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.23 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 90' ' ' ARG . 25.6 p-10 -59.05 170.64 0.83 Allowed 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -123.27 114.11 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.696 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.3 pt -58.6 94.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.4 mt -62.03 -29.0 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.878 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.03 125.55 4.59 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' HG ' ' A' ' 86' ' ' LEU . 4.9 m -114.33 118.59 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.648 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.683 HD22 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER 53.87 41.99 31.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.002 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 66.91 29.56 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.02 136.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -82.5 111.05 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 68' ' ' VAL . 26.9 m -128.55 25.6 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -79.65 5.11 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.21 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' HB2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -163.96 41.32 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.023 0.44 . . . . 0.0 109.908 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 65' ' ' VAL . 35.3 m -118.55 143.24 30.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 112.529 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 21.5 p -49.52 171.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.131 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.551 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.1 t-160 -70.16 -48.66 56.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.861 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -44.14 74.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.81 73.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.55 68.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.392 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG23 ' CD2' ' A' ' 70' ' ' HIS . 53.9 t -64.96 -36.83 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.64 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.41 -30.64 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.575 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.25 -36.7 74.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.299 0.571 . . . . 0.0 110.561 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.13 -25.84 34.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.85 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.35 -32.87 58.88 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.104 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.56 29.87 7.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -88.41 -24.24 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.64 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.06 -135.33 12.07 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.775 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.9 m -131.24 11.46 4.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 111.566 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.688 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.7 mt -151.56 92.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 3.5 m -104.26 115.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.71 91.92 7.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.85 ' HG ' HG12 ' A' ' 60' ' ' VAL . 1.7 mp -93.16 144.51 25.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.45 ' HH ' ' HD2' ' A' ' 3' ' ' TYR . 17.7 t80 -122.81 114.38 20.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.97 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 57' ' ' ILE . 31.4 m -115.25 168.48 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 0.0 112.289 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.404 ' HB2' HD12 ' A' ' 58' ' ' LEU . 6.9 ttt -138.15 109.05 6.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.491 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.483 ' CG ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.836 0.35 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.561 HG23 HD21 ' A' ' 153' ' ' LEU . 11.6 p -82.94 133.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.7 mmt -112.27 166.48 11.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.54 106.41 7.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.406 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.618 HG13 HG21 ' A' ' 183' ' ' VAL . 3.1 mm -114.95 155.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.515 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 4.8 mptt -113.1 126.97 56.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.634 HD22 ' HG ' ' A' ' 110' ' ' LEU . 4.0 tt -130.6 118.84 21.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.694 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.522 HG22 HG13 ' A' ' 178' ' ' VAL . 5.1 pt -92.7 144.79 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -69.01 164.42 22.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.159 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.88 -162.52 9.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.786 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.42 -35.28 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.166 1.911 . . . . 0.0 112.554 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 20.54 7.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.957 0.408 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.87 -127.85 9.22 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.696 HD22 HD13 ' A' ' 172' ' ' LEU . 1.2 mp -86.77 -30.88 21.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.65 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 99.69 38.1 3.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.875 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -177.93 160.15 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 111.305 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -110.51 117.06 32.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 172' ' ' LEU . 45.5 pt -113.43 173.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 111.488 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.07 -176.0 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.368 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 165' ' ' HIS . . . -145.72 143.61 11.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.47 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.22 -66.33 2.43 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.061 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.82 153.29 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.62 -9.78 61.26 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.038 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 168.39 81.17 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.845 0.355 . . . . 0.0 110.122 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 4.1 mt-30 -64.54 -15.1 60.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.331 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.559 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.1 t60 71.82 -54.99 0.67 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.6 0.714 . . . . 0.0 110.612 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.9 mt -92.02 143.37 27.56 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.659 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 123' ' ' ILE . 38.4 Cg_exo -60.37 77.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.366 2.044 . . . . 0.0 112.247 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 87.77 65.14 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -162.12 94.0 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -55.13 -23.46 21.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 p -57.92 120.2 8.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 160' ' ' LEU . 21.9 mt -70.56 122.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.859 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.6 m-85 -111.84 151.01 29.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.962 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 150' ' ' ASP . 42.5 t -86.31 121.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.304 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 148' ' ' ILE . 9.2 p -79.28 -59.06 2.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.649 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -151.12 152.75 33.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.597 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.5 mt -118.19 141.38 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.844 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -75.31 172.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.613 ' H ' HG22 ' A' ' 135' ' ' ILE . 64.9 mt-10 -103.7 30.45 5.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.04 -28.61 58.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.65 10.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.672 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.01 -82.35 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.937 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.06 -31.71 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.3 m170 -52.15 -62.2 1.79 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -42.14 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.577 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.21 -59.36 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -70.84 -41.16 63.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.198 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.37 22.34 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 0.0 110.536 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.603 ' CD1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -95.71 85.45 4.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.92 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.45 166.67 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.523 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -47.44 116.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.262 0.553 . . . . 0.0 111.38 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.89 -14.42 6.33 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.666 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -73.92 120.06 18.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.787 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -99.96 122.8 43.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.671 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.33 118.54 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.211 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -82.58 -0.64 47.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.744 -179.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 175.18 159.25 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.513 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.897 HG13 HD22 ' A' ' 181' ' ' LEU . 45.6 t -121.73 98.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.276 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.75 ' ND2' HG12 ' A' ' 155' ' ' VAL . 31.8 m-80 69.27 -57.19 0.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 m -147.01 -20.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.688 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -76.16 140.72 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.408 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.73 12.68 33.77 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.897 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 129' ' ' ILE . 24.7 mt 38.96 33.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.229 0.538 . . . . 0.0 111.985 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.52 68.48 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 163' ' ' VAL . 5.9 m-20 -162.92 26.49 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.588 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -161.9 -82.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.674 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.65 170.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.049 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -54.03 -30.6 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -47.92 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.995 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.588 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.37 -32.37 62.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.816 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.762 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.7 t -70.03 -40.5 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.559 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.433 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.08 -30.43 66.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.672 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.98 -25.83 48.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -81.28 -40.69 23.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -75.41 -26.63 58.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.068 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -21.4 65.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.544 ' HB ' HG21 ' A' ' 179' ' ' VAL . 47.7 p -54.73 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -100.88 171.33 7.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -58.48 -14.51 8.04 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.429 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.522 HG13 HG22 ' A' ' 104' ' ' ILE . 41.4 t -147.55 90.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 0.0 110.288 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -120.15 148.49 23.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.729 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -100.03 127.62 46.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.897 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -108.23 153.96 22.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.981 0.419 . . . . 0.0 110.671 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.6 mttt -96.59 119.04 34.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.398 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.618 HG21 HG13 ' A' ' 101' ' ' ILE . 39.2 t -101.82 164.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.536 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -130.91 140.74 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.691 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.436 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.424 ' OG ' ' CD2' ' A' ' 165' ' ' HIS . 21.8 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.862 0.363 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.552 ' O ' HG13 ' C' ' 9' ' ' VAL . 35.9 t -83.63 109.57 17.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 8' ' ' SER . 4.0 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.952 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.907 0.384 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -151.46 145.85 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.577 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -176.82 156.27 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.402 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -86.5 167.74 14.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.454 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.605 HD13 ' HG3' ' A' ' 50' ' ' ARG . 6.9 tt -164.94 165.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.767 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -137.48 126.34 24.08 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.992 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.849 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.6 tp -122.01 88.58 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.457 0.646 . . . . 0.0 111.367 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pm0 -73.66 152.35 40.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 19.4 mtt180 -67.32 93.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.717 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.07 -25.46 10.38 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.638 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.62 -91.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -109.1 30.8 6.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.14 -178.98 25.37 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.135 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.849 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.34 -47.59 10.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.816 0.341 . . . . 0.0 111.293 -179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.36 74.18 1.25 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.084 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -164.85 169.34 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.312 . . . . 0.0 110.922 178.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.27 130.8 53.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.459 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HG12 ' A' ' 36' ' ' ILE . 1.2 pt -125.54 164.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 70' ' ' HIS . . . -169.77 164.1 9.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.503 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 112.84 -119.22 4.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.481 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.99 145.06 14.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.427 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.76 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -53.9 -24.75 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.587 ' HB2' HG23 ' A' ' 69' ' ' THR . 3.1 t70 -81.73 -55.99 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -120.25 83.06 31.67 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.49 132.01 29.0 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.437 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 25.8 t60 -68.05 -21.38 65.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.72 -28.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.118 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 29.65 12.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.37 33.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 2.7 m-20 -173.03 111.05 0.34 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 31' ' ' ASP . 21.4 Cg_exo -65.92 -27.91 50.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.126 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.79 128.02 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.19 150.34 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.48 151.09 41.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 18' ' ' SER . 77.2 mt -77.13 146.17 9.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.257 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.547 ' O ' HG21 ' A' ' 53' ' ' VAL . 66.0 m -99.77 -35.98 9.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.541 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.03 158.29 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.513 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -115.94 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.0 mt -85.76 123.71 71.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -66.18 63.52 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.23 -54.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.485 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.21 -175.77 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -27.53 57.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 111.369 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -57.56 -29.19 64.22 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.063 0.459 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.86 -27.45 49.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.46 -43.5 66.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.018 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -31.65 15.95 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.17 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 84.48 -27.56 4.64 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.687 ' NH1' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER 45.21 30.37 0.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.865 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.553 HD23 ' HD3' ' A' ' 90' ' ' ARG . 2.1 mp 65.17 -173.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 131.1 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.763 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.4 m -53.5 -37.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.731 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -62.15 -3.93 1.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.354 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -58.34 175.3 0.24 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 110.671 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.9 t -130.24 102.78 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.02 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 58' ' ' LEU . 3.2 mt -59.84 -35.39 74.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 1.5 m-85 -158.57 123.57 4.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.409 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -114.16 119.85 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 53.8 37.52 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.67 30.34 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.88 133.74 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' CZ ' ' A' ' 59' ' ' PHE . 1.4 m-20 -72.79 77.64 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' HG23 ' A' ' 68' ' ' VAL . 21.1 t -107.65 35.11 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.055 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -101.08 1.04 38.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.083 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -156.1 33.74 0.34 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.758 0.314 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -124.0 158.28 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.76 ' N ' HG22 ' A' ' 23' ' ' THR . 7.3 m -50.07 163.08 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.056 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.637 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -61.34 -48.56 80.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.834 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 t -52.73 -35.87 56.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.07 77.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.964 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -71.96 -41.62 67.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.221 0.534 . . . . 0.0 109.652 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' CD2' ' A' ' 70' ' ' HIS . 42.0 t -64.4 -36.01 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.4 -33.39 72.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.815 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.76 75.71 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.435 0.636 . . . . 0.0 110.476 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -79.69 -26.92 40.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.552 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.63 -37.85 67.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.955 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.34 25.79 7.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.401 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.95 -23.67 23.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.18 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.27 -152.3 22.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 83' ' ' ILE . 3.9 m -101.51 11.74 38.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.497 0.189 . . . . 0.0 111.338 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -151.53 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.5 t -90.59 149.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.767 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -137.67 102.29 4.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.976 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.9 154.01 50.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.3 t80 -105.68 114.8 29.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.614 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.45 168.03 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.324 0.583 . . . . 0.0 112.414 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.427 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.25 109.66 7.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.134 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.553 ' HD3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.064 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 121.024 0.44 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.26 144.49 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.268 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.0 166.41 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.424 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -133.19 106.6 7.68 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.57 155.92 16.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.742 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.95 126.07 54.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.104 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.4 tt -126.38 118.54 25.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.563 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 4.4 pt -96.84 144.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.034 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.45 158.44 36.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -136.02 -175.11 13.65 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.869 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.51 -40.75 9.85 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.269 1.98 . . . . 0.0 112.31 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -91.99 19.97 6.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.488 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.02 -141.27 15.22 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 6.6 mp -86.53 -22.35 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.926 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.43 58.39 3.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.887 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.96 155.43 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.417 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 2.7 t -116.38 116.9 28.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 172' ' ' LEU . 10.3 pt -134.16 154.82 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.091 0.472 . . . . 0.0 112.048 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.94 -174.99 25.51 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.494 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.63 -176.54 52.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.536 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 119' ' ' GLY . 26.0 t -81.45 154.8 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 76.06 6.1 81.96 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.19 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 165' ' ' HIS . 1.1 t30 -168.69 52.97 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -33.35 -43.47 0.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 47.6 t60 73.28 -45.53 0.62 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.027 0.918 . . . . 0.0 108.891 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.78 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -122.65 130.85 24.48 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.161 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.24 89.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.445 2.097 . . . . 0.0 112.919 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.95 44.93 4.97 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.217 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -150.71 78.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.195 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -53.92 -22.97 11.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.218 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -55.31 145.49 21.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.588 HG12 ' HA3' ' A' ' 116' ' ' GLY . 8.2 mt -80.03 117.43 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.78 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -114.92 156.25 25.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.521 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 47.5 t -95.52 155.63 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.212 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.546 ' O ' HD13 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -130.17 -32.51 1.8 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.417 ' HG3' ' CB ' ' A' ' 113' ' ' SER . 1.8 pttp -160.66 145.63 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.842 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 146' ' ' LEU . 5.1 mt -131.64 141.8 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.74 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.5 mm -73.54 175.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.694 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 tt0 -99.47 139.71 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.48 29.18 60.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.583 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.91 -132.45 1.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.578 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -110.38 -61.29 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.934 0.397 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -67.15 -31.4 71.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -60.39 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -46.12 54.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.305 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.48 -59.5 2.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.564 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.31 -44.93 96.97 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.262 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 145' ' ' ARG . 0.7 OUTLIER 61.26 20.34 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.584 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -91.75 82.79 5.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.709 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 169.84 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.751 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 132' ' ' THR . 33.6 mt -47.91 121.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.276 0.56 . . . . 0.0 111.235 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.5 -22.5 6.19 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.376 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -68.85 124.97 25.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -112.73 128.96 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -102.71 130.72 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.072 0.463 . . . . 0.0 110.538 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.4 pp -98.42 -1.16 42.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.294 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.19 152.6 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.719 0.295 . . . . 0.0 111.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.945 HG13 HD23 ' A' ' 181' ' ' LEU . 40.2 t -107.4 99.7 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.445 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.9 m-80 69.18 -59.44 0.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.319 0.58 . . . . 0.0 109.739 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.02 27.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.172 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.5 t -100.6 155.22 4.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.277 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -117.0 77.4 0.28 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.572 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 31.9 mt -79.11 24.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.94 0.4 . . . . 0.0 111.928 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -139.73 32.7 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 110.652 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.79 28.05 1.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.656 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -143.29 -77.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 0.9 OUTLIER 174.74 165.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.605 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.9 p-80 -53.9 -30.7 47.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -45.2 54.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.279 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.656 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.66 -37.08 68.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.67 -36.54 73.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.107 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.564 ' HA ' HD23 ' A' ' 172' ' ' LEU . 13.4 t -73.81 -42.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.43 -33.01 69.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -77.78 -27.71 50.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.465 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.05 -36.72 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -26.85 60.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.519 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.1 -9.89 59.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.293 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 69.9 p -52.59 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.926 0.393 . . . . 0.0 111.515 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -103.61 169.8 8.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t70 -54.31 -18.85 4.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.4 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.437 HG13 HG22 ' A' ' 104' ' ' ILE . 39.0 t -147.58 92.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.94 148.19 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 112.006 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -95.65 127.16 41.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 179.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.945 HD23 HG13 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -106.87 144.32 33.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 0.0 110.869 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.36 112.45 24.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.153 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.579 HG21 HG13 ' A' ' 101' ' ' ILE . 15.6 t -101.91 161.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.51 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -144.78 140.09 28.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.818 0.342 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.469 ' O ' HG13 ' C' ' 9' ' ' VAL . 97.6 p -91.23 119.33 31.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' C' ' 8' ' ' SER . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.327 -0.845 . . . . 0.0 111.195 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.952 0.406 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.27 162.69 26.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.7 161.49 2.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.639 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 165.33 14.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.568 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.502 HG23 ' NH2' ' A' ' 50' ' ' ARG . 2.0 tt -164.45 166.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 111.809 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -133.82 138.96 45.97 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.677 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.776 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.73 86.73 2.26 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.596 0.712 . . . . 0.0 110.99 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -76.63 155.23 33.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.248 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -66.3 86.7 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.85 -26.03 10.41 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.781 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.25 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 m -109.12 30.81 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.0 -179.09 27.05 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.776 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.33 -42.74 15.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.822 0.344 . . . . 0.0 111.407 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 88.01 64.81 1.34 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 114.042 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 6.0 p90 -161.78 139.57 8.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 110.594 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 36' ' ' ILE . 73.9 m -91.76 130.98 37.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.689 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.42 ' CG2' HG12 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -132.56 163.59 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.634 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 164.0 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.371 . . . . 0.0 111.378 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 121.79 -113.84 2.38 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.534 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.96 141.45 9.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.293 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.719 HG22 ' N ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -56.2 -21.26 22.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.609 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.756 ' CB ' HG23 ' A' ' 69' ' ' THR . 38.0 t0 -93.53 -43.92 8.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -123.83 78.48 57.27 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.207 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.3 142.15 9.35 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.708 2.272 . . . . 0.0 112.633 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.7 t60 -74.97 -19.41 60.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.87 -27.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.274 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.09 28.89 9.45 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -171.14 32.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.6 111.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.6 -29.03 52.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.707 2.271 . . . . 0.0 112.009 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -62.26 169.59 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.59 149.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.981 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 10.3 p90 -142.84 144.71 32.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.578 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 18' ' ' SER . 57.9 mt -72.69 146.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.119 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 53' ' ' VAL . 16.6 m -101.19 -33.17 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.598 0.237 . . . . 0.0 111.508 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -168.94 152.67 5.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.427 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -116.36 141.25 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 ' HA2' ' A' ' 16' ' ' GLY . 3.4 pt -92.74 141.49 24.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.78 61.58 6.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.513 2.142 . . . . 0.0 112.392 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.23 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.462 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.99 175.64 23.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.709 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -76.11 -15.33 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.81 -57.46 11.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.95 0.405 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -28.55 69.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.933 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -71.92 -35.72 69.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -84.88 -25.37 28.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.009 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 82.37 56.07 2.91 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.392 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 42.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.633 HD21 HG21 ' A' ' 88' ' ' VAL . 1.2 pp 33.34 -153.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' N ' HD12 ' A' ' 51' ' ' LEU . 4.8 tpm_? -63.81 144.29 57.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.791 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -70.61 -37.62 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.515 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -54.86 -13.95 1.26 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.2 p-10 -57.45 163.1 2.5 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.271 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.6 p -122.16 110.48 15.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.707 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.724 HG22 HG12 ' A' ' 88' ' ' VAL . 2.9 pt -58.99 94.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 5.8 mt -65.14 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.037 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 9.3 m-85 -146.18 168.6 20.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.105 0.479 . . . . 0.0 111.83 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -147.18 -177.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.547 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 60' ' ' VAL . 15.6 p-10 -53.96 82.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER 65.5 26.74 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 2.5 t -121.24 141.86 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 111.368 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.49 76.36 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.777 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.42 HG12 HG21 ' A' ' 68' ' ' VAL . 16.7 m -99.48 31.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.356 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -12.88 59.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -173.37 56.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.117 0.484 . . . . 0.0 109.706 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' C ' ' HB ' ' A' ' 23' ' ' THR . 19.1 m -117.31 140.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.5 m -50.25 169.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.201 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.612 ' CD2' HG23 ' A' ' 74' ' ' VAL . 1.8 t-160 -51.08 -48.75 61.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -51.63 -47.9 63.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.862 0.363 . . . . 0.0 111.536 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -60.24 -32.46 71.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.86 64.46 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.616 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 ' CD2' ' A' ' 70' ' ' HIS . 43.0 t -65.1 -35.22 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.739 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.32 -32.17 71.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.822 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.13 73.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.4 0.619 . . . . 0.0 110.385 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.559 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -72.08 -39.51 68.93 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.383 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.26 29.06 7.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.628 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -81.35 -27.49 34.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.304 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.53 -132.43 11.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.499 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.498 ' O ' HG12 ' A' ' 83' ' ' ILE . 5.4 m -125.97 5.72 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.501 0.191 . . . . 0.0 111.397 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -151.06 91.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 80' ' ' ALA . 1.7 t -93.75 148.56 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.035 0.445 . . . . 0.0 111.897 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -133.7 108.28 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -130.3 153.8 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 112.629 -178.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 59' ' ' PHE . 6.6 t80 -106.32 115.11 29.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.298 178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 57' ' ' ILE . 27.1 m -104.24 168.07 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.446 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -127.08 109.51 11.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.954 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.731 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.795 0.331 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 98' ' ' VAL . 10.0 p -82.96 116.65 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.472 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 tpt -101.31 166.04 10.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.485 0.659 . . . . 0.0 111.942 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -137.32 106.59 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.56 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 144' ' ' GLY . 3.7 mm -113.22 155.13 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HE2' ' CZ ' ' A' ' 180' ' ' TYR . 5.5 tttt -120.89 119.11 31.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.966 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.032 HD12 ' HB2' ' A' ' 140' ' ' ALA . 9.6 tt -120.67 118.7 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.48 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -95.13 144.75 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.597 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -55.69 143.63 29.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.975 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -175.46 14.09 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.814 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.59 -38.9 3.98 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 121.978 1.785 . . . . 0.0 112.1 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 18.32 11.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.479 . . . . 0.0 110.302 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.64 11.12 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.5 mp -87.08 -27.31 23.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.886 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.7 47.24 4.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.93 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.07 149.23 0.55 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.922 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 13.6 m -109.2 124.31 50.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.625 HG21 ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -135.76 155.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -152.39 125.15 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.429 . . . . 0.0 111.868 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.587 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.69 -174.99 25.31 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.195 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.11 -179.5 46.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.196 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 164' ' ' MET . 39.5 t -78.99 145.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.758 0.313 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.9 -32.12 5.81 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.624 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 2.7 t-20 -157.11 66.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.67 -4.18 22.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.96 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.2 t60 72.28 -57.71 0.61 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.449 0.642 . . . . 0.0 110.478 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.3 mt -91.67 128.43 46.35 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.442 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.57 74.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.421 2.08 . . . . 0.0 112.423 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 117.93 47.74 0.43 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.84 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.747 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -165.98 93.75 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.839 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -56.86 -22.08 34.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.308 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -56.02 151.13 12.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 160' ' ' LEU . 6.4 mt -89.02 119.44 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.335 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.879 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.2 m-85 -115.77 155.09 28.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.29 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.568 HG22 HG22 ' A' ' 114' ' ' ILE . 47.6 t -84.33 155.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.739 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 148' ' ' ILE . 6.4 p -117.62 -57.89 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.486 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 146.28 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 146' ' ' LEU . 4.7 mt -129.66 141.38 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.883 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -79.29 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 45.3 mt-10 -87.05 143.38 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.05 22.88 65.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.56 -173.82 23.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.37 -69.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.032 ' HB2' HD12 ' A' ' 103' ' ' LEU . . . -63.28 -31.63 72.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 23.4 t-160 -53.38 -62.1 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.993 0.425 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -38.2 67.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.178 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.33 -59.29 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 101' ' ' ILE . . . -80.81 -18.87 69.16 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.006 -0.616 . . . . 0.0 114.024 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER 50.95 26.99 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.15 0.475 . . . . 0.0 110.791 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -87.4 81.25 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.59 175.14 3.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.536 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 132' ' ' THR . 33.0 mt -46.85 126.5 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.25 0.548 . . . . 0.0 111.293 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 120.12 -23.21 8.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.514 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -63.84 159.23 20.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.678 0.275 . . . . 0.0 110.456 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -145.82 138.8 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.004 0.431 . . . . 0.0 111.388 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -105.3 132.22 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.491 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.2 pp -99.62 -1.87 37.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.292 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.71 154.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.204 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 158' ' ' VAL . 35.4 t -108.61 99.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.875 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.542 HD22 HG12 ' A' ' 155' ' ' VAL . 68.6 m-80 69.53 -59.51 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.404 0.621 . . . . 0.0 109.578 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.9 p -164.33 28.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.028 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.5 t -102.33 155.09 5.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.489 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.85 76.74 0.25 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.736 HD22 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -81.09 25.76 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.46 56.2 1.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.333 0.587 . . . . 0.0 110.796 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -165.29 29.37 0.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.352 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.68 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.2 t -141.59 -76.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.553 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.434 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 176.62 167.76 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.605 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 169' ' ' VAL . 10.8 t-80 -54.46 -30.11 51.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.69 -49.16 27.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.049 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.68 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.66 -33.12 68.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.033 0.444 . . . . 0.0 110.225 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.23 -41.17 73.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.487 0.66 . . . . 0.0 109.484 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.818 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.9 t -69.03 -43.99 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.153 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -32.44 71.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.222 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.42 48.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.983 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -81.22 -38.47 26.93 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.868 ' HE3' HG21 ' C' ' 9' ' ' VAL . 4.0 mttp -75.19 -26.66 59.19 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.924 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.53 -9.91 52.25 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.399 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.404 ' CB ' HG21 ' A' ' 179' ' ' VAL . 1.1 p -42.85 147.21 0.32 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -90.34 170.47 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -44.93 -32.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 104' ' ' ILE . 39.9 t -148.22 91.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.404 HG21 ' CB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.22 148.32 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 0.0 111.925 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.439 ' CZ ' ' HE2' ' A' ' 102' ' ' LYS . 7.8 m-85 -101.71 133.35 46.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.771 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -118.98 149.62 41.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.941 0.401 . . . . 0.0 111.092 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 152' ' ' ILE . 22.0 mttt -96.52 112.02 23.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 101' ' ' ILE . 11.5 t -102.78 159.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.328 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.45 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -133.22 146.27 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.921 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.829 0.347 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.591 ' O ' HG13 ' C' ' 9' ' ' VAL . 98.7 p -86.28 110.77 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.868 HG21 ' HE3' ' A' ' 173' ' ' LYS . 3.6 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.038 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.876 0.369 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.49 164.04 35.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -179.79 152.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.454 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -84.11 148.66 26.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 50' ' ' ARG . 19.3 mt -148.44 152.84 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.239 0.542 . . . . 0.0 111.834 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -116.21 130.28 56.72 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.9 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.826 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.7 tp -134.98 91.5 2.76 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.608 0.718 . . . . 0.0 110.451 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 mt-10 -69.6 168.86 13.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.721 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 2.6 mtt180 -72.63 104.26 3.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.796 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -69.69 65.74 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.108 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 75.83 -76.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.261 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -109.31 30.53 6.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.4 -177.95 17.2 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.826 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.5 -52.28 6.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.28 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 78.14 1.4 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.845 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -164.74 155.76 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.74 0.305 . . . . 0.0 110.732 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.5 m -109.29 126.84 53.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.74 HG22 HG12 ' A' ' 36' ' ' ILE . 2.7 pt -120.73 164.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.755 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.75 157.84 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 0.0 111.305 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.93 -118.11 3.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.265 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 144.46 11.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.683 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -57.37 -19.27 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.555 0.217 . . . . 0.0 111.483 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.773 ' HB2' HG22 ' A' ' 69' ' ' THR . 3.7 m-20 -88.78 -54.7 4.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.868 0.366 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -120.33 81.83 30.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.9 138.04 21.42 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.643 2.229 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 18.5 t60 -70.02 -19.55 63.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.29 -30.43 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.49 28.79 8.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.496 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.91 33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.07 112.66 1.04 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 23.7 Cg_exo -64.29 -29.32 63.72 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.739 2.293 . . . . 0.0 112.135 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 176.29 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.789 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -123.88 152.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 2.2 p90 -139.79 168.56 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.74 HG12 HG22 ' A' ' 19' ' ' ILE . 46.6 mt -95.45 153.44 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.68 -31.33 7.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 9.7 tmtt? -171.32 150.21 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 0.0 111.594 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -110.58 141.34 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.846 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.9 mt -85.81 123.5 72.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 20.2 Cg_exo -65.59 64.79 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.558 2.172 . . . . 0.0 112.218 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.17 -51.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.508 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.39 174.08 5.12 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.438 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.796 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -59.23 -34.6 72.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 0.0 111.369 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.696 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -50.9 -44.47 59.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.24 63.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.623 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -71.9 -39.16 69.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.682 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 49' ' ' GLY . 1.2 m-20 -85.96 -28.17 24.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 19.38 59.27 0.01 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.941 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CG ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.61 -15.35 13.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 51' ' ' LEU . 1.5 pt? -118.36 167.72 11.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.061 0.458 . . . . 0.0 111.281 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -107.75 159.05 16.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.049 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.4 m -70.88 -48.25 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 112.023 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' N ' HG23 ' A' ' 53' ' ' VAL . 15.9 m-80 -61.22 1.37 0.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -84.52 160.91 20.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.21 113.22 18.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 110.735 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 88' ' ' VAL . 16.6 pt -56.27 95.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -65.24 -21.79 66.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.757 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.672 ' HA ' HG12 ' A' ' 65' ' ' VAL . 2.5 t80 -155.78 145.35 21.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.64 HG22 ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -129.56 117.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.722 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 56.77 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 60' ' ' VAL . 29.1 mt-10 -150.76 30.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 21.4 t -120.86 141.69 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 4.8 m-20 -77.39 90.58 3.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 57' ' ' ILE . 15.0 p -103.2 33.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.423 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 6.04 38.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 173.87 53.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 0.0 110.011 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.709 ' CG2' HG23 ' A' ' 65' ' ' VAL . 31.5 m -115.64 141.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.004 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.95 157.85 0.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.466 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -51.58 -48.57 63.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.508 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -55.8 -42.69 76.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.37 69.13 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.547 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.561 ' HA ' HD21 ' A' ' 77' ' ' LEU . 47.5 t -64.6 -35.55 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.649 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -69.53 -33.71 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.839 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.46 73.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.393 0.616 . . . . 0.0 110.491 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.57 -26.76 55.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.42 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 4.6 tttm -69.95 -38.56 76.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.067 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.27 27.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.442 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -86.23 -25.15 25.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.329 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.7 -152.91 30.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.656 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.513 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -101.82 11.09 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.641 0.258 . . . . 0.0 111.438 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -150.64 92.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.8 t -85.23 148.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.401 0.62 . . . . 0.0 111.869 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 7' ' ' THR . 2.3 mmt85 -138.16 84.13 2.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.562 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.7 pp -115.6 154.02 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.397 0.618 . . . . 0.0 112.569 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CE1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -104.84 114.84 29.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.608 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 57' ' ' ILE . 33.0 m -105.83 167.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.121 0.486 . . . . 0.0 112.193 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.4 ttp -131.62 109.44 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.312 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 90' ' ' ARG . 21.2 ttp-105 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.742 0.306 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.94 125.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.84 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.3 mtm -102.18 164.14 11.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.337 0.589 . . . . 0.0 112.08 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -127.98 106.8 9.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.492 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.86 155.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.627 ' HE3' HG12 ' A' ' 178' ' ' VAL . 9.9 tttp -117.15 118.65 32.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.376 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.78 ' HB2' HD11 ' A' ' 181' ' ' LEU . 7.9 tt -115.69 118.71 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.137 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 178' ' ' VAL . 4.5 pt -98.42 144.69 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -74.64 161.18 29.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.965 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.08 -168.66 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.849 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.09 -40.02 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.076 1.851 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -93.75 20.58 7.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.81 -142.83 15.56 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.65 -21.31 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.869 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.84 50.77 8.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.52 148.01 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 111.029 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.3 t -107.01 116.9 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.882 HD11 HD22 ' A' ' 172' ' ' LEU . 48.2 pt -115.38 173.6 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.13 -176.53 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.82 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -143.15 149.14 21.08 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.103 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.47 -94.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.072 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 34.3 t -87.38 148.63 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.28 -21.19 41.73 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.388 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.93 69.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.259 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -59.83 -19.85 53.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.274 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 49.6 t60 72.51 -52.62 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 110.817 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.862 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.2 mt -93.3 141.09 23.53 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.839 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.569 ' HD2' HG22 ' A' ' 123' ' ' ILE . 52.9 Cg_exo -54.7 83.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.4 2.067 . . . . 0.0 112.233 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 80.01 62.13 2.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.797 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.533 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.2 t0 -159.91 93.22 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -55.98 -22.34 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.269 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -54.67 122.88 11.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 110.778 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.805 HD12 ' HB3' ' A' ' 160' ' ' LEU . 17.1 mt -72.19 117.8 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.085 0.469 . . . . 0.0 111.744 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.862 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.8 m-85 -111.95 153.9 26.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 114' ' ' ILE . 60.1 t -91.05 134.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.25 -45.35 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -122.09 132.59 54.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 111.745 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 131' ' ' VAL . 56.1 mt -137.36 128.63 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.943 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.74 173.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.738 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.596 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.0 OUTLIER -92.29 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.35 15.19 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.616 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.85 -157.41 3.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.583 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -83.54 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.277 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.17 -31.81 69.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.379 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -55.3 -58.06 9.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.196 0.522 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.8 -47.5 45.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.041 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.69 -59.42 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' CG2' ' A' ' 101' ' ' ILE . . . -61.24 -35.87 91.55 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.19 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 61.1 20.13 10.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.875 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.72 81.28 3.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.798 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.424 ' HA ' HD12 ' A' ' 134' ' ' ILE . 5.0 pt20 -65.68 176.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.508 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.9 mt -47.82 129.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.214 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 116.28 -24.92 9.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.532 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -63.99 133.44 53.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.349 . . . . 0.0 110.749 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -122.9 130.1 52.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -104.53 137.03 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 2.6 pp -98.91 -2.71 36.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.762 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 165.4 147.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.124 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.739 HG23 HD11 ' A' ' 160' ' ' LEU . 47.5 t -101.36 99.69 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.2 m-80 69.44 -58.73 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 109.666 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 155' ' ' VAL . 81.3 p -163.1 25.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.728 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 155' ' ' VAL . 23.9 t -91.59 156.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-O 121.364 0.602 . . . . 0.0 111.524 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -99.29 74.05 0.51 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.749 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.805 ' HB3' HD12 ' A' ' 129' ' ' ILE . 37.7 mt -70.61 24.1 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.717 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 159' ' ' GLY . 8.3 pt-20 -176.26 56.63 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.3 0.572 . . . . 0.0 110.924 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -161.48 27.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.573 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.678 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -153.23 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.146 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.444 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 5.5 mtp 173.06 164.48 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.482 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.6 p-80 -53.83 -29.86 42.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.939 0.399 . . . . 0.0 110.446 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.57 -45.41 53.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.151 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.678 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.22 -35.66 66.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.968 0.413 . . . . 0.0 110.604 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.71 73.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.776 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 172' ' ' LEU . 14.0 t -74.01 -39.94 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.493 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.82 68.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.671 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.36 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.882 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -80.79 -36.79 31.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -26.88 60.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.493 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.26 -12.8 60.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.207 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.501 ' HB ' HG21 ' A' ' 179' ' ' VAL . 70.9 p -55.66 -172.59 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 111.341 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -107.68 170.22 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -55.47 -16.96 4.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.347 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.627 HG12 ' HE3' ' A' ' 102' ' ' LYS . 39.1 t -147.88 92.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.501 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.92 148.41 20.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.071 0.463 . . . . 0.0 111.987 -178.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.408 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -94.81 131.19 40.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.28 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.36 146.99 43.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.13 108.11 20.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 101' ' ' ILE . 5.6 t -102.71 157.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.062 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.83 44.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.3 mmtp . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.7 p -94.22 116.38 28.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 112' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -159.41 154.47 25.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 179.28 156.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.54 158.45 35.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.313 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 88' ' ' VAL . 3.5 mt -152.78 142.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.294 0.568 . . . . 0.0 111.942 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -122.22 119.38 31.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.965 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.888 HD21 ' HB2' ' A' ' 45' ' ' ALA . 3.1 tp -125.31 93.96 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.637 0.732 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -79.08 165.32 23.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.911 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.9 93.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.67 -25.89 9.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.595 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -173.53 -85.6 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 30.6 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.622 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 177.02 18.59 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.213 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.804 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.22 -43.45 14.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 -179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 92.95 71.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.713 . . . . 0.0 114.078 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.77 155.27 14.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.794 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.4 m -112.97 126.96 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.446 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.49 164.07 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.26 142.31 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 136.76 -126.89 3.89 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.71 128.47 4.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -49.58 -25.78 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 53.5 t0 -91.75 -40.92 10.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.82 77.24 57.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.67 134.89 34.22 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.644 2.23 . . . . 0.0 112.413 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.425 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.0 t60 -68.51 -21.41 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.61 -31.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.12 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.02 28.34 8.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.597 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -176.69 36.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 4.7 t0 -162.38 95.67 1.2 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.3 Cg_endo -55.68 -23.71 42.15 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.458 2.106 . . . . 0.0 112.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 159.27 32.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.01 150.77 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.52 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.4 p90 -142.53 144.96 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' SER . 64.8 mt -74.43 147.25 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.786 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -96.59 -46.52 6.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.62 -179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.44 158.29 39.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.093 0.473 . . . . 0.0 111.671 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -111.09 141.23 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.7 mt -84.5 118.16 70.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.22 76.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.42 2.08 . . . . 0.0 112.099 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . 174.22 -45.62 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.422 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.62 -178.47 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.561 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -28.41 57.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.588 0.232 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.74 -43.6 76.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.959 0.409 . . . . 0.0 110.749 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.09 65.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.866 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -71.57 -40.89 69.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.695 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.44 -25.01 25.45 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.273 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.87 -39.24 2.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.616 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 35.23 37.05 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.348 0.594 . . . . 0.0 111.095 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 40.99 -162.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.401 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.32 146.88 54.35 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.243 0.544 . . . . 0.0 111.8 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 37' ' ' THR . 19.6 m -71.0 -36.0 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.329 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -54.36 -15.12 1.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.103 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -57.17 178.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.477 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 t -136.97 110.45 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.2 pt -58.96 95.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -64.6 -21.98 66.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.542 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -157.18 148.36 21.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.549 HG12 ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -142.69 125.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.522 HD21 HG12 ' A' ' 84' ' ' VAL . 31.7 m-20 45.85 47.94 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 64.69 26.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 16.8 t -120.79 141.76 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.016 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.63 127.47 35.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' HG13 ' A' ' 68' ' ' VAL . 34.3 m -143.71 32.52 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.076 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -76.29 2.38 13.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.555 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -173.28 46.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.108 0.48 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' C ' ' HB ' ' A' ' 23' ' ' THR . 35.6 m -110.6 141.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.754 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.665 ' N ' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -50.23 160.89 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.706 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.603 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -50.97 -48.58 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.404 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.61 -40.86 63.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.933 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.84 75.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.373 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.17 69.14 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.429 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.603 HG23 ' CD2' ' A' ' 70' ' ' HIS . 47.9 t -64.64 -36.06 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.54 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 7.8 mt-10 -69.54 -33.12 72.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.787 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.34 -42.81 74.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.424 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -76.84 -26.84 54.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.352 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.65 -44.53 61.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.098 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.27 29.19 5.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.04 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -75.85 -29.87 58.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.444 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.51 32.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.474 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -108.76 5.51 24.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.1 mt -155.85 93.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.2 m -95.13 111.46 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 68.64 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.819 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.4 pp -89.21 153.97 20.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.636 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -109.45 120.13 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.476 178.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.819 HG13 ' CD1' ' A' ' 86' ' ' LEU . 8.6 m -117.67 167.87 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 112.458 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 5.1 ptm -147.89 109.21 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.845 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 26.1 ttp180 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 111.167 0.062 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.485 HG23 HD21 ' A' ' 153' ' ' LEU . 11.3 p -82.31 151.25 4.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 111.833 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.92 166.85 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.858 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -122.46 106.82 11.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.497 HG13 HG21 ' A' ' 183' ' ' VAL . 1.6 mm -119.25 155.55 21.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.519 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 5.1 tttt -111.74 127.16 55.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.687 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.9 tt -125.43 118.56 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.782 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.73 144.72 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -65.44 152.77 43.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.798 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -132.37 157.71 22.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.829 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.52 -33.72 69.22 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.046 1.831 . . . . 0.0 112.16 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.59 ' HE3' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.05 18.38 13.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.25 178.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.33 -148.28 16.73 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.56 -17.99 32.63 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.166 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 73.01 51.95 9.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.081 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.546 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.33 145.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.654 0.264 . . . . 0.0 110.695 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.2 t -110.95 116.75 31.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.737 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.844 HD11 HD22 ' A' ' 172' ' ' LEU . 7.3 pt -126.99 153.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.924 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.06 125.02 10.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.0 111.789 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.71 -175.09 25.44 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.199 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 121' ' ' GLN . . . 111.75 -178.43 19.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.352 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.49 144.4 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.709 0.29 . . . . 0.0 111.349 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.04 -21.17 46.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.541 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 173.0 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.501 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 117' ' ' GLY . 9.7 pm0 -103.4 -179.66 4.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.086 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.924 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 68.0 t60 -57.95 -50.24 74.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.042 0.925 . . . . 0.0 110.662 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.943 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -102.61 102.86 28.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.033 -178.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.42 92.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.371 2.047 . . . . 0.0 112.237 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.99 20.87 3.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.935 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -155.64 91.3 1.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -49.99 -25.86 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 p -54.01 116.32 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.765 HG12 ' HA3' ' A' ' 116' ' ' GLY . 5.6 mt -61.61 121.08 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -114.34 156.75 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.13 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 150' ' ' ASP . 53.2 t -84.1 155.5 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.691 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.476 HG22 ' CE1' ' A' ' 122' ' ' HIS . 10.5 p -119.87 -57.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -148.87 148.28 29.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 147' ' ' GLN . 26.5 mt -136.72 139.04 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.59 HD12 ' HE3' ' A' ' 108' ' ' LYS . 1.2 mt -79.56 173.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.4 tt0 -90.86 149.52 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.0 25.33 45.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.4 54.13 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.511 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -68.64 -60.36 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 111.209 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.61 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.03 -32.02 69.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -59.24 -45.74 90.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 110.145 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -72.71 -57.07 4.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.572 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.32 -59.24 2.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.03 -49.16 43.83 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.889 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 63.13 18.11 10.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.597 0.237 . . . . 0.0 111.039 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 144' ' ' GLY . 0.3 OUTLIER -93.85 78.26 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.687 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -62.73 177.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.1 mt -47.2 134.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.084 0.468 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.44 13.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.539 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -63.37 140.58 58.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.337 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -125.31 131.74 53.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.054 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -103.94 127.1 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 184' ' ' ALA . 1.7 pp -96.6 -1.55 46.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.353 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 174.49 158.74 0.17 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 111.223 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.972 HG12 ' ND2' ' A' ' 156' ' ' ASN . 22.7 t -118.65 100.07 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.972 ' ND2' HG12 ' A' ' 155' ' ' VAL . 13.0 m-80 70.41 -59.36 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 109.665 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 p -165.57 28.33 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.123 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.2 t -103.11 154.81 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.367 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.85 78.6 0.29 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.557 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 15.5 mt -76.52 23.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.85 40.3 1.83 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.095 0.474 . . . . 0.0 110.803 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.35 28.38 0.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.459 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.1 t -148.75 -76.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 174.98 169.69 0.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.666 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 169' ' ' VAL . 44.4 t-80 -55.86 -29.94 60.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.79 38.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.332 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.733 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.78 -36.93 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 110.571 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.64 -35.71 73.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.761 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.3 t -71.5 -39.94 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.93 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.56 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -76.03 -25.98 56.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.304 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.844 HD22 HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -80.32 -36.83 33.72 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -73.0 -26.87 61.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.385 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.82 -9.88 58.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.315 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.646 HG22 HG11 ' A' ' 155' ' ' VAL . 5.8 p -45.56 159.59 0.06 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.633 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -92.6 168.94 10.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.197 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.23 -34.18 6.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.396 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 104' ' ' ILE . 41.3 t -148.1 90.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 0.0 110.757 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -123.49 148.58 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 111.504 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 36.6 p90 -92.27 132.27 36.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.846 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -112.01 153.86 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.432 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 152' ' ' ILE . 25.2 mtpp -96.68 114.38 26.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.787 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 101' ' ' ILE . 24.7 t -102.02 163.91 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -145.56 149.86 35.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.396 0.617 . . . . 0.0 112.161 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.005 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 36.8 m -85.71 118.64 25.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.362 -0.828 . . . . 0.0 111.086 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.934 0.397 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.07 128.2 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -178.03 174.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.414 . . . . 0.0 111.641 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -93.55 149.67 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.632 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' HG3' ' A' ' 50' ' ' ARG . 11.3 mt -148.05 150.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 111.561 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.9 OUTLIER -115.27 119.87 37.78 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.665 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.9 tp -121.91 93.62 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.45 0.643 . . . . 0.0 110.097 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -75.27 151.4 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.001 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 82' ' ' SER . 32.3 mtt180 -72.02 103.87 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.9 -26.89 6.09 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.774 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -169.47 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 p -109.28 30.73 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.39 173.73 17.89 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.519 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.896 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.4 -50.02 8.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.753 0.311 . . . . 0.0 111.138 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 100.93 79.15 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.674 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.798 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -164.7 159.2 18.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.607 178.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 36' ' ' ILE . 30.8 t -112.74 126.85 55.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 36' ' ' ILE . 4.7 pt -118.21 171.71 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.62 149.02 2.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.44 -120.66 4.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.196 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . 105.23 145.68 13.86 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.686 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -50.67 -24.94 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.682 0.277 . . . . 0.0 111.472 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.681 ' CB ' HG23 ' A' ' 69' ' ' THR . 19.2 t0 -86.68 -48.2 8.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.213 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.89 80.36 56.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 126.64 19.12 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.596 2.197 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 35' ' ' PHE . 17.0 t60 -67.3 -19.42 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.87 -26.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.14 34.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -168.32 111.56 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . 23.3 Cg_exo -64.83 -28.73 59.01 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.151 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -72.88 144.21 47.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 35' ' ' PHE . 15.0 mt -93.55 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.478 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.39 153.5 43.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 18' ' ' SER . 59.9 mt -84.8 150.74 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.589 ' O ' HG21 ' A' ' 53' ' ' VAL . 61.2 p -100.02 -46.61 5.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.871 0.367 . . . . 0.0 111.037 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -157.07 155.92 31.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.344 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mt -113.87 141.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.927 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 134.43 43.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.55 60.38 5.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.094 . . . . 0.0 112.301 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.7 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.65 168.81 26.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.58 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -61.73 -25.86 67.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 111.506 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.4 -57.54 12.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.2 -28.27 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.956 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -72.1 -41.95 66.68 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -72.61 -33.27 66.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.414 178.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 29.31 39.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.838 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.808 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.8 ptm180 -98.69 28.45 4.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.645 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -176.43 164.89 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.002 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.89 164.09 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.656 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -70.93 -47.27 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.015 0.436 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' N ' HG23 ' A' ' 53' ' ' VAL . 40.7 m-80 -58.87 -4.85 0.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -62.31 175.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.312 -0.242 . . . . 0.0 110.552 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 p -141.52 106.03 4.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.134 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -54.55 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.429 0.633 . . . . 0.0 111.159 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.32 -25.66 63.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.118 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.5 t80 -163.87 144.03 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.711 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.1 p -103.92 -176.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.012 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.687 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.7 m120 -21.59 -51.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.601 0.563 . . . . 0.0 111.857 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 tt0 -163.72 27.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.702 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.8 t -121.59 142.0 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.693 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 23.5 p30 -79.63 84.34 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.058 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 HG21 ' A' ' 68' ' ' VAL . 5.8 m -91.04 26.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.02 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -95.91 9.26 41.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.286 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' HG2' ' CB ' ' A' ' 32' ' ' PRO . 3.9 mt-10 -166.14 37.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 65' ' ' VAL . 35.9 m -118.68 141.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.9 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.766 ' N ' HG22 ' A' ' 23' ' ' THR . 3.8 m -50.34 166.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.501 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.5 t-160 -59.09 -48.71 80.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.2 m -60.73 -36.86 79.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.33 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.976 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.08 -42.32 66.33 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 72.8 t -64.65 -35.96 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.806 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.49 -33.2 72.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.798 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.53 -42.4 74.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 110.416 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -78.18 -26.85 47.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.439 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -71.71 -40.03 69.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.072 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.07 26.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.525 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.08 -19.49 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.342 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.37 -120.03 6.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.637 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.541 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -137.17 18.13 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.548 0.213 . . . . 0.0 111.244 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.76 94.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 8' ' ' LEU . 34.8 m -90.39 112.75 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -101.2 80.9 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.964 HD13 HG13 ' A' ' 88' ' ' VAL . 1.7 pp -109.79 153.08 24.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.258 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 4.7 t80 -102.04 114.66 28.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.847 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.964 HG13 HD13 ' A' ' 86' ' ' LEU . 35.3 m -112.05 167.98 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.209 0.528 . . . . 0.0 112.172 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 mtp -127.87 109.52 11.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.817 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 120.87 0.367 . . . . 0.0 111.14 -179.308 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.832 0.349 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.85 142.59 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.71 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.42 17.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.112 0.482 . . . . 0.0 111.366 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.84 106.21 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -116.84 155.34 18.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.648 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 17.7 pttm -114.15 126.57 55.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.359 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.663 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -127.58 118.64 24.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.562 HG22 HG13 ' A' ' 178' ' ' VAL . 4.4 pt -95.97 144.69 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -72.82 156.28 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.975 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.55 -168.79 12.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.821 -0.705 . . . . 0.0 111.826 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.25 -39.55 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.107 1.871 . . . . 0.0 112.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 19.6 8.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.049 0.452 . . . . 0.0 110.334 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.92 -143.21 15.78 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.275 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 103' ' ' LEU . 5.7 mp -86.72 -21.5 26.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.184 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.23 4.38 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.701 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.14 148.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -108.6 116.96 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 172' ' ' LEU . 27.4 pt -121.79 162.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.636 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -122.96 127.62 49.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.838 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -80.63 156.8 39.18 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.715 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . -49.58 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 164' ' ' MET . 15.7 t -54.38 134.37 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.822 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.6 -26.14 19.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.92 83.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -67.44 2.7 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.954 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 79.9 t60 79.63 -60.54 0.33 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.799 0.809 . . . . 0.0 110.497 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.633 HG12 ' CD2' ' A' ' 122' ' ' HIS . 1.5 mm -118.06 101.25 51.77 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.514 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.42 94.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.478 2.119 . . . . 0.0 112.092 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.95 -15.61 1.54 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.774 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.4 84.57 2.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.903 0.382 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -41.65 -28.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -51.8 152.69 2.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.546 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.838 HG12 ' HA2' ' A' ' 116' ' ' GLY . 51.1 mt -75.44 124.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.977 0.418 . . . . 0.0 111.285 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 151' ' ' LYS . 4.9 m-85 -114.71 132.26 56.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.7 t -61.68 155.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.345 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 148' ' ' ILE . 12.3 p -118.61 -57.71 2.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.396 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 143.64 25.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.246 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 131' ' ' VAL . 5.3 mt -129.96 141.63 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.801 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.39 173.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.603 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.7 mt-10 -93.12 149.1 21.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.99 29.29 51.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.67 -167.55 43.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.54 -55.08 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.565 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.13 -31.88 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.267 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.04 -55.67 31.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 0.0 110.316 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -72.8 -48.56 37.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.56 -59.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.891 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -58.5 -49.74 73.81 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.077 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 18.23 11.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.645 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -96.17 81.01 3.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.715 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.41 171.2 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.678 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -46.67 127.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.316 0.579 . . . . 0.0 111.22 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.09 -24.81 9.15 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.339 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -67.95 131.59 45.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -116.87 134.11 55.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.118 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.39 131.94 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -96.71 -4.1 41.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.231 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.19 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.435 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 158' ' ' VAL . 38.4 t -103.92 99.7 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.759 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.759 ' ND2' HG12 ' A' ' 155' ' ' VAL . 36.5 m-80 69.28 -59.41 0.48 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.338 0.59 . . . . 0.0 109.592 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 m -165.02 29.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.941 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.0 t -104.26 155.08 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.564 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -110.91 74.57 0.21 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.645 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -78.05 25.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.984 0.421 . . . . 0.0 111.586 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -155.79 27.87 0.38 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.53 27.74 2.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.652 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -144.99 -72.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.643 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.57 ' HG3' HG21 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 174.78 162.58 0.22 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.241 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.3 OUTLIER -53.54 -30.09 40.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.271 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -45.17 53.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.652 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -73.1 -35.37 66.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.918 0.39 . . . . 0.0 110.637 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.58 -34.92 72.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.167 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.628 ' HA ' HD23 ' A' ' 172' ' ' LEU . 10.5 t -71.93 -44.09 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.99 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.128 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.73 -27.7 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.75 -39.44 24.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.005 0.431 . . . . 0.0 110.192 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -26.69 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.055 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -10.0 59.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.198 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.535 ' HB ' HG21 ' A' ' 179' ' ' VAL . 63.8 p -58.91 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.794 0.331 . . . . 0.0 111.264 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -102.19 169.95 8.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.26 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.9 t70 -55.7 -17.41 5.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.361 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.41 91.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.535 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.9 148.14 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.733 -179.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.9 m-85 -101.71 125.9 48.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -111.83 152.72 27.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.58 120.37 36.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.884 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 101' ' ' ILE . 18.1 t -102.21 160.67 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.493 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -124.87 133.89 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . 0.4 ' OG ' HG21 ' A' ' 169' ' ' VAL . 1.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.793 0.33 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -117.12 118.01 31.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.445 HG11 HD11 ' A' ' 172' ' ' LEU . 10.4 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.34 -0.838 . . . . 0.0 111.111 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 90' ' ' ARG . 8.5 tp10 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.869 0.366 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.82 161.39 15.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.628 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -176.69 141.34 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.889 0.375 . . . . 0.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 16.3 pt-20 -110.35 154.62 23.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -166.11 159.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 111.972 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.652 HG23 HH11 ' A' ' 85' ' ' ARG . 0.8 OUTLIER -107.17 123.44 48.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.364 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.827 ' HG ' HD23 ' A' ' 15' ' ' LEU . 2.5 tp -116.1 93.52 4.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.598 0.713 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.744 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -66.66 143.1 57.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.798 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.68 101.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.485 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.22 -27.4 5.39 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.725 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.6 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -109.28 30.63 6.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.883 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.04 -179.65 20.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.008 -1.091 . . . . 0.0 112.248 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.827 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.47 -63.19 1.38 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.649 0.262 . . . . 0.0 111.309 -179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.79 62.66 0.39 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.599 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.728 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 7.9 p90 -149.5 138.9 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.543 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' ILE . 5.9 m -79.48 126.69 31.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 36' ' ' ILE . 23.5 pt -131.23 155.11 41.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 152.7 2.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.74 -122.82 2.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.36 128.82 4.46 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.404 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -51.84 -27.23 11.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.87 -42.01 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.79 77.45 57.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.26 146.21 13.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.718 2.279 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -77.57 -19.38 55.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.002 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.528 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.15 -32.74 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 111.007 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.95 26.04 6.53 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.539 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.49 38.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.37 96.64 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.04 -22.68 48.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.485 2.124 . . . . 0.0 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.86 158.66 33.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.74 149.27 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 7.1 p90 -142.73 163.5 32.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.898 0.38 . . . . 0.0 111.042 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' SER . 45.7 mt -94.82 148.49 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -104.4 -33.99 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.627 0.251 . . . . 0.0 111.401 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.34 150.93 4.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.38 . . . . 0.0 111.348 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.4 mt -111.45 141.07 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.9 pt -89.63 136.03 30.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.67 58.2 6.7 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.53 2.153 . . . . 0.0 112.387 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.0 -61.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.618 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.56 -173.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.628 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -72.04 -26.45 62.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.576 0.227 . . . . 0.0 111.522 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -54.1 -57.4 11.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -60.08 -27.85 67.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -71.87 -45.68 60.5 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -68.39 -35.49 77.76 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.252 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.07 48.4 0.01 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.203 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.96 20.62 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.732 0.266 . . . . 0.0 111.291 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.494 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -158.23 162.96 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.334 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -98.18 158.25 15.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.396 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -71.2 -46.14 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.507 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 p30 -62.83 3.96 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.738 ' OD2' HG21 ' A' ' 88' ' ' VAL . 53.0 p-10 -76.17 174.15 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.9 t -129.8 102.86 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 110.961 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.977 HD11 HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -55.65 95.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.734 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -22.65 60.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.1 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -153.46 155.22 35.88 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.965 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.977 HG13 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -152.52 130.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.447 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.58 35.07 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.228 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.13 30.96 2.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 t -120.92 141.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -73.34 116.02 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 68' ' ' VAL . 33.4 t -143.98 40.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -100.3 9.24 43.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.153 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 178.5 44.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.928 0.394 . . . . 0.0 110.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 65' ' ' VAL . 6.6 m -109.63 147.26 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.562 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.69 ' N ' HG22 ' A' ' 23' ' ' THR . 65.0 p -49.32 170.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.845 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.2 t-160 -63.67 -49.02 74.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.323 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -36.34 83.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -35.53 72.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.23 64.74 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 109.804 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' HD21 ' A' ' 77' ' ' LEU . 58.4 t -63.99 -36.57 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -69.52 -32.81 71.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.74 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -43.37 73.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 110.636 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.78 -26.77 54.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.461 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -70.73 -40.64 72.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.134 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 8.8 tt0 -101.24 27.32 6.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.317 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.77 -23.06 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.423 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.93 -161.81 24.82 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.785 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 9.7 t -86.23 -51.29 6.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.744 HG23 ' HG2' ' A' ' 9' ' ' GLU . 17.0 mt -99.25 84.69 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.9 m -85.24 116.26 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.677 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.652 HH11 HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -77.2 80.5 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.651 ' HB2' HD12 ' A' ' 57' ' ' ILE . 2.4 pp -84.89 135.41 34.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.24 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -116.72 114.49 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.391 178.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.1 m -124.89 168.41 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.093 0.473 . . . . 0.0 111.998 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 109.06 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.802 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.675 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.808 0.337 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 111.7 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 0.0 110.755 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 mmm -93.61 166.66 12.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.398 0.618 . . . . 0.0 111.798 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -136.34 106.54 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 146' ' ' LEU . 2.7 mm -112.7 155.16 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -110.82 126.13 54.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.304 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.837 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.7 tt -127.16 118.56 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -96.44 144.64 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.43 157.47 30.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.19 -169.38 12.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.921 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.69 -30.78 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.145 1.896 . . . . 0.0 112.283 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.52 18.38 12.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.061 0.458 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.2 -146.34 16.06 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.427 ' HB2' HG23 ' C' ' 9' ' ' VAL . 7.4 mp -86.46 -20.36 28.24 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.908 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 80.74 46.13 7.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.346 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.58 154.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.687 0.244 . . . . 0.0 110.98 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.31 126.33 51.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.649 HG22 HG22 ' A' ' 131' ' ' VAL . 9.0 pt -134.97 153.18 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.633 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -150.55 124.91 9.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.854 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.67 -175.11 25.43 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.065 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 161' ' ' GLU . . . 77.38 -169.25 54.8 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.422 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 119' ' ' GLY . 38.9 t -78.64 154.56 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.337 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 92.45 -25.59 17.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.03 77.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.1 pt20 -72.91 6.83 2.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.384 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 71.2 t60 72.72 -59.17 0.57 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.53 0.681 . . . . 0.0 111.331 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.867 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.4 OUTLIER -87.7 111.58 43.03 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.895 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 79.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.475 2.117 . . . . 0.0 112.243 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 121.68 40.24 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.523 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -175.52 96.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.79 0.328 . . . . 0.0 110.74 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.55 -23.36 50.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 58.3 m -47.44 128.34 12.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.54 HG12 ' HA3' ' A' ' 116' ' ' GLY . 37.7 mt -65.9 123.96 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.934 0.397 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.867 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.0 m-85 -122.89 156.91 33.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.499 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 114' ' ' ILE . 72.8 t -89.32 151.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 122' ' ' HIS . 11.3 p -111.44 -58.46 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.496 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 147.91 28.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' GLY . 6.5 mt -128.37 141.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 136' ' ' GLU . 4.3 mm -66.06 175.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.623 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -92.93 133.67 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.857 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.5 25.19 33.87 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.85 -160.72 1.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.513 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.57 -59.72 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.0 111.277 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.13 -31.97 69.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.582 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -53.88 -54.34 40.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.19 0.519 . . . . 0.0 110.392 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -72.9 -53.15 12.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.043 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.74 -59.29 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.153 0.502 . . . . 0.0 111.943 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -49.02 -46.94 32.9 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.453 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 65.76 16.99 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.617 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.541 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -106.87 83.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.483 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.96 175.81 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 132' ' ' THR . 33.3 mt -47.46 122.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.354 0.597 . . . . 0.0 111.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.06 -21.73 6.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.311 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.611 ' OD1' HG21 ' A' ' 131' ' ' VAL . 8.5 p-10 -64.2 131.99 49.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.882 0.372 . . . . 0.0 110.409 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -108.24 125.05 51.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -104.61 133.92 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.046 0.451 . . . . 0.0 110.647 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -93.98 -4.03 50.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.637 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . 173.52 156.65 0.12 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.936 0.398 . . . . 0.0 110.857 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 39.2 t -109.92 100.07 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 179' ' ' VAL . 2.1 m-80 56.82 32.21 20.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p 82.92 25.83 0.13 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.856 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.8 t -135.21 146.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-O 121.426 0.631 . . . . 0.0 112.659 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 96.29 -73.54 0.8 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.584 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.637 HD23 ' HB2' ' A' ' 154' ' ' ALA . 0.0 OUTLIER 35.83 33.5 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.821 -0.689 . . . . 0.0 111.955 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' SER . 0.9 OUTLIER 35.82 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.926 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -114.43 36.95 3.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.485 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -151.17 -71.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.344 0.592 . . . . 0.0 110.607 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 1.1 mtm 175.42 160.45 0.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 74.7 t60 -53.68 -31.43 47.71 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.175 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.92 -41.03 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.485 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.58 -38.43 62.65 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.683 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.6 -38.96 74.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.648 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.655 ' HA ' HD23 ' A' ' 172' ' ' LEU . 29.3 t -72.99 -46.93 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.092 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.38 69.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.36 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.42 -33.99 58.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.373 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -81.34 -36.85 29.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.945 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' C' ' 9' ' ' VAL . 7.4 mmtt -72.94 -26.83 61.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.482 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.29 -10.04 59.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.264 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.9 p -60.44 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 111.486 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -114.28 173.12 6.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -13.08 3.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 104' ' ' ILE . 40.6 t -147.34 91.11 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.728 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -128.93 148.61 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.995 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 39.3 p90 -107.61 135.29 49.31 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-O 121.052 0.453 . . . . 0.0 111.99 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -111.06 159.3 17.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.677 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -100.28 117.35 34.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 184' ' ' ALA . 12.8 t -101.9 159.67 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -126.3 141.04 52.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 52.9 p -92.63 118.78 31.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 173' ' ' LYS . 19.5 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.245 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -134.04 166.05 23.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -176.63 159.06 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 13.6 pt-20 -96.05 154.76 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.851 HG22 ' O ' ' A' ' 86' ' ' LEU . 19.2 tt -153.37 164.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.568 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -123.27 122.82 39.32 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.704 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 45' ' ' ALA . 1.2 tp -125.8 93.04 3.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.752 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.761 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -73.65 166.08 23.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.591 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -80.97 95.37 6.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.63 8.03 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.598 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -168.98 -89.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.069 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -109.22 30.85 6.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.51 177.07 24.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.395 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -84.43 -48.66 9.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.766 0.317 . . . . 0.0 111.5 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.24 65.53 0.67 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.77 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.4 p90 -164.69 162.9 21.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.298 . . . . 0.0 110.689 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.75 133.79 54.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.531 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 pt -120.43 171.28 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.8 152.34 3.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.345 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 119.08 -115.25 3.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.49 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 146.23 15.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.257 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -54.05 -23.87 15.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.615 0.245 . . . . 0.0 111.475 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.83 0.347 . . . . 0.0 111.443 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.06 77.55 41.63 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 129.14 21.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.422 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.8 t60 -66.57 -20.67 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.486 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.32 -27.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.309 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.31 26.51 18.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.628 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -168.69 33.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.29 100.85 0.7 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.754 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.68 -26.85 67.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.401 2.068 . . . . 0.0 112.142 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -66.95 177.94 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.614 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -125.88 153.43 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.0 p90 -142.49 148.89 38.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.537 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 73.2 mt -75.15 150.45 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.794 ' O ' HG21 ' A' ' 53' ' ' VAL . 2.5 p -102.88 -40.51 6.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.601 0.239 . . . . 0.0 111.621 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.885 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.77 146.26 6.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.0 111.437 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -103.52 141.33 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.108 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.8 mm -85.28 136.28 38.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 40' ' ' ILE . 72.9 Cg_endo -76.29 58.79 5.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.212 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.58 -54.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.03 -175.38 0.2 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.86 -31.4 59.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.666 0.269 . . . . 0.0 111.224 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.72 -26.25 44.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.542 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -78.14 -27.49 48.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.574 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.35 -43.75 66.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.954 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -93.74 -29.02 15.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.492 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 89.15 -33.69 4.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.63 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 48.32 25.17 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.846 HD13 ' CZ ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 66.86 -167.58 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.959 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 153.05 25.08 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.097 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.885 HG11 ' HA ' ' A' ' 38' ' ' LYS . 28.5 m -71.16 -36.72 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -52.06 -16.14 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.512 ' OD2' HG21 ' A' ' 88' ' ' VAL . 37.0 p-10 -59.03 156.31 12.01 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 35.6 m -121.55 126.28 48.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.954 ' HA ' HG12 ' A' ' 88' ' ' VAL . 9.4 pt -65.63 94.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.276 0.56 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 89' ' ' MET . 24.5 mt -76.77 -28.2 55.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.482 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -150.89 116.15 5.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.432 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' CG1' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -131.69 125.55 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.611 HD21 HG13 ' A' ' 84' ' ' VAL . 28.9 m120 55.02 36.87 27.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.13 27.49 17.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.25 141.69 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.34 72.04 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.2 t -98.04 34.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -9.63 27.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.51 43.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.76 0.314 . . . . 0.0 111.615 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.94 155.57 30.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.232 0.539 . . . . 0.0 111.038 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.775 ' N ' HG22 ' A' ' 23' ' ' THR . 21.2 m -49.99 161.8 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.901 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -58.98 -48.49 81.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.531 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -52.09 -37.53 54.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.401 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.37 80.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.59 66.47 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.264 0.554 . . . . 0.0 109.578 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 70' ' ' HIS . 55.0 t -64.81 -35.29 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.682 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 47.4 tt0 -69.65 -32.33 70.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.938 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.36 -41.54 76.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.378 0.609 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.31 -26.22 55.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 4.1 tttt -72.39 -35.21 68.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -113.35 28.76 8.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.203 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -92.42 -21.44 20.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.63 -137.51 13.39 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 83' ' ' ILE . 8.6 t -121.17 17.49 11.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.675 0.274 . . . . 0.0 111.414 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.761 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.5 mt -154.07 95.84 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 61' ' ' ASN . 0.9 OUTLIER -102.01 143.38 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.215 0.531 . . . . 0.0 112.429 -178.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 15.9 tpp85 -100.35 93.4 5.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.782 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.851 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -88.4 115.36 25.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.347 0.594 . . . . 0.0 112.555 -177.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.5 114.06 27.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.5 m -132.21 168.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 58' ' ' LEU . 1.3 ttp -107.91 109.23 20.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.492 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.846 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.463 . . . . 0.0 111.551 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.844 0.354 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.63 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -82.78 148.13 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.432 ' HB2' ' HB ' ' A' ' 183' ' ' VAL . 13.9 mtp -124.21 166.73 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 0.0 111.208 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.3 7.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.053 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 183' ' ' VAL . 3.4 mm -113.62 155.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.418 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.99 128.43 56.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.989 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.1 tt -130.39 118.32 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.071 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.73 144.53 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.987 0.422 . . . . 0.0 111.059 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 4.0 tttt -66.93 149.11 51.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.979 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.08 -174.6 13.65 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.006 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.44 -36.8 14.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.317 2.011 . . . . 0.0 112.317 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -93.84 19.46 8.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.938 0.399 . . . . 0.0 110.498 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.73 -140.97 15.12 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HG ' HD22 ' A' ' 103' ' ' LEU . 7.4 mp -86.64 -22.39 26.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.01 46.9 5.2 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.013 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 146.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.611 0.243 . . . . 0.0 110.861 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 m -108.67 116.85 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 131' ' ' VAL . 8.5 pt -129.15 152.9 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.561 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.547 ' O ' ' HB3' ' A' ' 122' ' ' HIS . . . -151.82 125.84 9.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 112.063 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.626 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.64 -175.26 25.57 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.882 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.91 176.49 14.49 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.732 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.66 153.65 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.854 0.359 . . . . 0.0 111.357 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.16 -5.89 65.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.72 79.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.87 142.49 27.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.447 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.547 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 8.3 t60 -45.08 -37.85 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.803 0.811 . . . . 0.0 110.517 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.83 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.5 mt -100.43 143.14 25.97 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.583 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 123' ' ' ILE . 45.4 Cg_exo -56.7 83.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.615 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.13 53.49 2.81 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.102 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.5 t70 -154.7 87.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 111.149 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -52.85 -24.4 8.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.9 m -52.12 125.55 16.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -73.69 113.4 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.833 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.83 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -106.96 172.83 6.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.722 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 114' ' ' ILE . 48.3 t -109.44 148.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.813 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 -29.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 137.65 31.34 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.835 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 147' ' ' GLN . 43.9 mt -137.12 138.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.67 173.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -87.25 140.94 29.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.876 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.02 26.23 55.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.33 -175.07 9.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.08 -66.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.829 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.01 -37.34 75.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.429 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -51.96 -45.85 64.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.038 0.446 . . . . 0.0 110.67 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -57.3 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.038 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.56 -59.59 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.64 -33.6 85.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.176 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 59.94 20.96 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.829 HD21 ' HB1' ' A' ' 140' ' ' ALA . 1.2 pp -83.79 83.79 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.437 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -67.62 170.92 6.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.63 120.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.277 0.56 . . . . 0.0 111.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.28 -19.7 5.97 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -66.29 118.39 9.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.735 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.462 ' HB2' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -99.28 123.85 43.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.985 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -99.86 121.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 110.067 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.63 HD21 HG13 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -87.44 -0.44 56.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.72 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.97 159.98 0.12 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.562 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 181' ' ' LEU . 36.9 t -117.52 98.85 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.661 HD22 HG12 ' A' ' 155' ' ' VAL . 7.1 m-80 68.32 -57.72 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.394 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 p -146.01 -18.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.613 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -78.02 129.14 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.42 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.68 7.75 1.38 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 129' ' ' ILE . 20.3 mt 42.71 29.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.469 0.634 . . . . 0.0 112.044 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -178.14 75.36 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 163' ' ' VAL . 1.4 p30 -157.68 26.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -157.0 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.923 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 178.63 -172.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.667 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.9 t-80 -67.45 -37.42 82.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.027 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.738 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.3 -35.55 61.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.854 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.7 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -69.69 -37.24 76.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 172' ' ' LEU . 39.4 t -69.44 -41.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.355 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.28 -29.27 64.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.727 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.94 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.879 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.28 -39.45 25.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.109 0.481 . . . . 0.0 109.929 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.403 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 12.0 pttt -75.18 -26.78 59.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.102 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -20.75 23.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 179' ' ' VAL . 76.6 p -54.52 -172.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 178' ' ' VAL . 8.8 p90 -125.03 -162.24 1.08 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.7 m-20 -59.7 -21.6 60.84 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 38.2 t -147.66 91.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 118.728 0.694 . . . . 0.0 111.511 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.92 148.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.919 0.39 . . . . 0.0 111.887 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 156' ' ' ASN . 21.8 p90 -105.23 126.18 51.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.328 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -106.75 149.05 27.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mtpt -96.39 119.16 34.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 101' ' ' ILE . 11.8 t -101.89 161.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -134.78 144.76 47.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.64 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t -83.47 111.31 18.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.164 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB3' ' CE2' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.808 0.337 . . . . 0.0 111.199 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -98.3 156.42 16.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 1' ' ' MET . 0.1 OUTLIER -154.84 144.15 21.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.598 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -179.39 159.01 0.89 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.845 0.355 . . . . 0.0 111.445 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -101.01 156.41 17.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.656 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -158.46 155.19 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.7 OUTLIER -110.22 121.7 45.9 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.854 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.853 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.3 tp -116.16 93.3 4.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.429 0.633 . . . . 0.0 110.337 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.28 135.34 42.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.224 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 2.3 mtp180 -56.29 103.74 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.691 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.13 -28.81 13.93 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.469 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.07 -86.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.45 . . . . 0.0 109.929 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.7 m -109.15 30.67 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.683 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' CA ' ' HG2' ' A' ' 10' ' ' ARG . . . 147.03 171.26 16.06 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.04 -49.36 8.99 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.905 0.384 . . . . 0.0 110.991 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 99.22 80.18 1.51 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.636 -0.793 . . . . 0.0 113.577 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.571 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.9 p90 -164.43 149.91 10.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.713 0.292 . . . . 0.0 110.483 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 36' ' ' ILE . 18.1 p -105.85 127.01 52.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.961 0.41 . . . . 0.0 111.55 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 36' ' ' ILE . 25.4 pt -119.51 166.0 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.857 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.78 153.6 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.234 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.71 -120.45 2.67 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.597 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.27 141.02 8.45 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.172 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -56.91 -18.81 14.68 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 69' ' ' THR . 12.4 t0 -91.57 -52.51 4.74 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 111.002 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -119.5 79.56 21.52 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.26 138.31 23.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.646 2.231 . . . . 0.0 112.414 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -69.28 -18.63 63.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -108.48 -36.98 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 110.985 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.37 24.79 6.05 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.01 40.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.5 OUTLIER -162.15 98.82 1.16 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 17.7 Cg_endo -57.62 -27.0 75.23 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.436 2.09 . . . . 0.0 112.194 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -74.04 141.2 45.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.03 152.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.117 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.1 p90 -142.26 166.48 24.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.713 HG12 HG22 ' A' ' 19' ' ' ILE . 53.1 mt -92.19 153.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.527 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.15 -39.77 5.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.628 0.251 . . . . 0.0 111.664 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.929 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.28 156.42 14.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.107 0.479 . . . . 0.0 111.644 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.425 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -118.42 141.33 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.748 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.5 mt -88.14 126.78 59.7 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.107 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 16.9 Cg_exo -66.76 63.13 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.483 2.122 . . . . 0.0 112.141 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.5 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.84 -177.82 0.93 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.466 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -73.82 -18.72 60.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.04 -57.38 13.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 111.13 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.14 69.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -72.32 -41.56 66.42 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' CB ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -76.02 -32.23 59.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.7 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.64 44.61 0.02 OUTLIER Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.399 -0.818 . . . . 0.0 113.901 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HB3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -93.1 21.71 5.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.695 0.247 . . . . 0.0 111.581 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.768 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.8 pt? -176.36 170.11 2.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.999 0.428 . . . . 0.0 111.325 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' NH1' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -101.61 163.44 12.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.499 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.929 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -71.06 -46.54 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 112.04 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.513 ' N ' HG23 ' A' ' 53' ' ' VAL . 29.1 m-80 -69.53 11.41 0.26 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.768 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.5 p-10 -76.92 176.92 8.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -127.87 102.66 6.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.473 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.801 HG22 HG12 ' A' ' 88' ' ' VAL . 2.4 pt -57.43 94.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 111.157 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.48 -28.54 65.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.501 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -163.25 150.57 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -141.28 131.68 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.84 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 45.3 38.82 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.192 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 61.6 33.92 18.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.678 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 141.68 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.173 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 68' ' ' VAL . 9.0 p-10 -66.93 100.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.566 ' CG2' HG23 ' A' ' 60' ' ' VAL . 37.9 t -133.1 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.106 0.479 . . . . 0.0 110.911 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -105.06 -14.51 15.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.93 47.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.813 0.339 . . . . 0.0 111.131 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.62 149.64 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.21 0.528 . . . . 0.0 111.102 179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -49.74 154.77 0.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.937 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 2.4 t-160 -51.81 -48.36 63.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.258 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -49.63 -36.41 24.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.03 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.56 63.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.007 0.432 . . . . 0.0 110.544 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.96 -40.7 68.47 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.696 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.542 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -65.7 -35.54 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.633 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 3.1 mt-10 -69.59 -32.48 71.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.875 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.18 -42.31 76.03 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.447 0.641 . . . . 0.0 110.315 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.548 HD13 HG21 ' B' ' 9' ' ' VAL . 2.7 pp -75.84 -26.5 57.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.47 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -68.82 -35.89 77.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.218 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.64 28.87 8.13 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.733 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.809 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -77.79 -29.25 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.355 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.49 -101.08 2.74 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.607 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 69.1 m -152.65 -52.32 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.798 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -98.33 84.93 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.809 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 34.7 m -84.63 113.73 23.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.676 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.804 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 ttt85 -92.78 78.83 4.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.075 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.484 ' CB ' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -99.08 154.03 18.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.402 -178.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 1.9 t80 -109.51 115.0 29.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.151 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 57' ' ' ILE . 31.6 m -108.46 168.03 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 112.397 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ttm -136.25 109.42 7.76 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.634 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -113.23 112.75 24.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.93 144.4 56.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.125 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -55.67 164.29 1.65 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.039 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 31.7 Cg_endo -64.13 149.13 91.01 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.487 2.124 . . . . 0.0 112.099 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 16.5 Cg_exo -67.35 -161.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.529 2.153 . . . . 0.0 112.228 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.571 ' HB3' ' H ' ' A' ' 189' ' ' ALA . . . -158.7 28.31 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.452 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 187' ' ' SER . 41.1 tt0 -86.15 111.88 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.81 142.19 28.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.846 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 98' ' ' VAL . 14.5 p -103.22 115.71 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.269 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.45 166.6 12.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.605 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -134.96 106.58 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.882 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.511 ' HB ' HD12 ' A' ' 181' ' ' LEU . 3.6 mm -114.19 155.36 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' CG ' ' CD2' ' A' ' 180' ' ' TYR . 2.7 mtmp? -108.02 123.92 49.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.428 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' A' ' 181' ' ' LEU . 2.5 tt -129.91 118.62 21.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.553 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.71 HG22 HG23 ' A' ' 178' ' ' VAL . 4.4 pt -93.96 144.61 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -70.64 152.79 43.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.095 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.62 160.72 23.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.756 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.97 -37.5 86.07 Favored 'Trans proline' 0 CA--C 1.517 -0.346 0 C-N-CA 122.094 1.863 . . . . 0.0 112.033 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 20.96 9.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.048 0.451 . . . . 0.0 110.053 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.47 -155.46 17.92 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.283 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.763 HD23 HD13 ' A' ' 103' ' ' LEU . 9.1 mp -86.48 -13.36 46.3 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.075 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.66 63.11 2.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.862 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.684 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.84 150.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.355 . . . . 0.0 110.999 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.72 116.88 32.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.55 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 131' ' ' VAL . 8.9 pt -136.52 153.22 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -151.55 125.0 8.87 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.84 -175.13 25.58 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.205 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.9 178.36 51.07 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.442 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 26.0 t -74.08 150.27 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.819 0.342 . . . . 0.0 111.039 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.37 -29.46 6.12 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.858 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.71 69.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.48 -4.63 23.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.688 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.558 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 62.6 t60 72.48 -58.1 0.6 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.547 0.689 . . . . 0.0 110.578 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.917 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.46 137.56 30.55 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.428 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 123' ' ' ILE . 49.6 Cg_endo -68.71 62.21 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.236 1.957 . . . . 0.0 112.339 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 127.1 57.29 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.723 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.689 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -174.44 99.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -60.44 -19.72 57.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.324 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -57.31 151.3 16.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.797 0.332 . . . . 0.0 111.051 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.696 HD11 ' HB1' ' A' ' 168' ' ' ALA . 2.8 mt -91.03 115.35 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.917 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.2 m-85 -109.33 153.9 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.62 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 114' ' ' ILE . 75.7 t -90.72 155.72 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.43 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.456 ' HA ' HG23 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -136.03 -27.62 1.1 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 147.96 27.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.982 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.678 HD11 ' O ' ' A' ' 146' ' ' LEU . 42.0 mt -137.21 141.63 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.011 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.51 173.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.604 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.585 ' H ' HG22 ' A' ' 135' ' ' ILE . 28.7 mt-10 -93.55 133.15 37.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.844 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.82 26.47 73.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.449 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.35 176.77 54.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.63 -53.81 16.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.965 0.412 . . . . 0.0 111.288 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.556 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.25 -34.63 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.377 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -51.91 -58.65 5.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.465 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -72.94 -48.69 34.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.467 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -80.59 -59.6 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.439 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -59.68 -44.28 97.04 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.413 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 63.23 17.8 10.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.602 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.678 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.1 OUTLIER -81.52 83.66 6.94 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -65.55 152.58 43.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.656 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 132' ' ' THR . 34.4 mt -46.57 106.46 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.438 0.637 . . . . 0.0 111.205 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 146.41 -14.29 1.62 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.544 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.505 ' CG ' ' HB2' ' A' ' 146' ' ' LEU . 9.4 p-10 -80.45 162.29 24.48 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.875 0.369 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.753 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -142.59 128.31 19.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.549 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.753 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.19 133.12 46.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.114 0.483 . . . . 0.0 110.814 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 3.2 pp -100.68 -4.13 28.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.101 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 170.35 141.92 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.772 HG12 HD22 ' A' ' 156' ' ' ASN . 76.6 t -96.74 99.79 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.798 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.772 HD22 HG12 ' A' ' 155' ' ' VAL . 48.9 m-80 69.27 -58.48 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.084 0.468 . . . . 0.0 109.846 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.1 25.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.799 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 155' ' ' VAL . 24.3 t -92.3 155.71 3.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 121.351 0.596 . . . . 0.0 111.367 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -101.93 73.25 0.34 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.759 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.554 ' CD1' HG23 ' A' ' 155' ' ' VAL . 22.1 mt -69.95 20.47 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.2 OUTLIER -163.56 56.49 0.17 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.268 0.556 . . . . 0.0 110.812 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.58 28.46 0.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.555 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.712 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.9 OUTLIER -151.86 -74.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.969 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.423 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.9 mtp 173.78 164.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.426 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.613 ' O ' HG23 ' A' ' 169' ' ' VAL . 19.7 p-80 -53.77 -30.02 42.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.492 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.67 -45.73 50.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.305 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.712 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.36 -35.51 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.809 0.338 . . . . 0.0 110.743 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.17 -35.39 73.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.942 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.742 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.9 t -70.23 -43.5 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.406 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.15 -30.35 66.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.809 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.9 -25.55 53.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -81.18 -39.91 24.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.202 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -75.52 -26.55 58.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.02 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.04 -10.54 59.93 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.391 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.658 ' HB ' HG21 ' A' ' 179' ' ' VAL . 81.6 p -54.1 -175.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.831 0.348 . . . . 0.0 111.479 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -102.36 168.97 8.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.379 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.3 t0 -52.03 -23.05 4.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 178' ' ' VAL . 4.0 p -145.18 92.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.383 0.611 . . . . 0.0 110.389 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.51 148.43 22.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.23 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.475 ' CD2' ' CG ' ' A' ' 102' ' ' LYS . 5.6 m-85 -97.9 120.51 38.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.752 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -98.08 144.11 27.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.955 0.407 . . . . 0.0 110.82 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.753 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.24 109.31 21.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.47 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.547 HG22 HG23 ' A' ' 152' ' ' ILE . 20.8 t -101.39 161.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.242 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -141.89 142.74 33.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.802 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 146.25 36.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.631 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.3 107.96 0.33 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.576 2.184 . . . . 0.0 112.293 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 96' ' ' GLU . 5.1 m -53.03 154.12 3.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 12.3 m-20 49.94 30.48 4.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.571 ' H ' ' HB3' ' A' ' 95' ' ' ALA . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.085 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.756 0.312 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.69 HG13 HG23 ' B' ' 3' ' ' VAL . 6.7 p -131.15 -51.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.08 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.69 HG23 HG13 ' B' ' 2' ' ' VAL . 44.3 t -95.19 -47.6 0.26 Allowed Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.487 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 89.6 Cg_endo -84.09 136.64 6.97 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.328 2.019 . . . . 0.0 112.56 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.41 176.19 5.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 84.1 p -63.32 158.16 21.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 2.7 t -108.33 107.26 17.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.61 90.18 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.55 ' OXT' HD12 ' A' ' 15' ' ' LEU . 30.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.185 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.791 0.329 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 3.2 m -115.97 97.34 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.636 ' N ' ' CD ' ' C' ' 4' ' ' PRO . 14.1 p -84.08 -28.11 0.41 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' C' ' 3' ' ' VAL . 95.8 Cg_endo -81.69 -9.22 12.25 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 121.945 1.763 . . . . 0.0 112.834 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.31 -38.5 9.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.883 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.5 136.58 0.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -81.6 84.52 6.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.62 82.41 4.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.142 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.796 0.332 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.8 147.4 35.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -116.5 153.2 32.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.434 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.621 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -157.59 151.22 23.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 111.55 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -142.74 108.91 5.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.853 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.717 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.68 -168.05 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 121.033 0.444 . . . . 0.0 111.652 -178.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -143.6 135.95 26.99 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 -179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.778 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -113.02 88.84 2.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.475 0.655 . . . . 0.0 110.892 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.507 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.4 tt0 -84.73 123.88 30.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.199 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -38.94 96.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.625 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.59 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -54.39 -24.04 28.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.576 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -176.47 -84.76 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.3 p -109.28 30.75 6.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.8 179.99 23.32 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 119.815 -1.184 . . . . 0.0 112.819 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.778 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.34 -50.32 7.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.39 -0.405 . . . . 0.0 111.415 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.8 64.25 1.0 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.924 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' HE2' HD23 ' A' ' 8' ' ' LEU . 9.2 p90 -164.94 169.03 16.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.978 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -129.72 130.04 44.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.357 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.598 HG22 HG12 ' A' ' 36' ' ' ILE . 3.0 pt -120.21 162.4 18.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.94 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.294 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.49 -121.61 2.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.495 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.27 136.95 5.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 HG23 ' A' ' 69' ' ' THR . 1.2 t -55.77 -19.65 12.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.844 ' HB2' HG22 ' A' ' 69' ' ' THR . 2.6 m-20 -93.2 -52.15 4.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.188 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -117.86 78.37 12.5 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.29 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -45.25 142.62 5.92 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.725 2.283 . . . . 0.0 112.623 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.401 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.0 t60 -74.34 -18.34 60.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.76 -29.32 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 111.16 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.63 28.16 8.09 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.526 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.84 37.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -167.46 95.34 0.65 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.76 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 10.6 Cg_endo -53.98 -28.63 50.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.45 2.1 . . . . 0.0 111.992 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m -65.06 169.86 4.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.432 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.93 151.99 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.366 . . . . 0.0 111.123 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 5.5 p90 -142.56 144.29 32.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG22 ' A' ' 19' ' ' ILE . 69.0 mt -70.94 151.78 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.409 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.659 ' O ' HG21 ' A' ' 53' ' ' VAL . 28.3 p -99.85 -43.86 6.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.516 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.46 149.14 6.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.088 0.47 . . . . 0.0 111.798 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.458 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -106.19 141.61 21.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.032 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -84.49 119.94 73.62 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.06 84.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.359 2.039 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.04 -39.29 0.34 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -58.62 175.95 2.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.534 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -76.06 -20.36 57.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -51.02 -57.69 7.97 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.955 0.407 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.35 69.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -72.09 -34.64 68.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.791 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -89.57 -21.31 22.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.423 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 79.36 0.72 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.276 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.553 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.42 32.0 2.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 0.0 110.095 179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.621 HD22 ' HG3' ' A' ' 4' ' ' GLU . 2.1 pp 38.48 -156.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.185 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -58.4 141.43 51.45 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.035 0.445 . . . . 0.0 111.366 -178.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -69.57 -40.78 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.154 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' N ' HG23 ' A' ' 53' ' ' VAL . 27.3 p30 -52.73 -16.84 1.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.78 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 20.4 p-10 -59.18 171.69 0.7 Allowed 'General case' 0 C--O 1.23 0.032 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 t -130.17 122.57 28.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 0.0 111.386 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.79 ' HA ' HG12 ' A' ' 88' ' ' VAL . 15.2 pt -63.16 94.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.011 0.434 . . . . 0.0 110.544 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 59' ' ' PHE . 1.3 pp -62.37 -24.31 67.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' HB2' HD12 ' A' ' 58' ' ' LEU . 1.3 t80 -164.19 140.35 6.32 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.894 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.4 p -101.97 -176.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.889 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.702 ' H ' HG22 ' A' ' 60' ' ' VAL . 18.1 m-20 -22.38 -50.54 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.539 0.524 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -162.79 25.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.6 t -121.71 142.12 39.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.626 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 59' ' ' PHE . 7.5 t0 -80.36 84.19 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.114 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 57' ' ' ILE . 16.7 m -94.83 30.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.769 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.8 ptt85 -89.42 7.63 34.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.021 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 179.25 49.79 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.048 0.451 . . . . 0.0 109.959 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.405 ' C ' ' HB ' ' A' ' 23' ' ' THR . 34.8 m -111.73 139.97 33.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.257 0.551 . . . . 0.0 112.39 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.844 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -50.06 166.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.547 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.562 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.3 t-160 -57.06 -48.71 77.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.037 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.59 -41.91 70.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.9 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.6 -34.04 74.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.456 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.76 68.86 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 ' CD2' ' A' ' 70' ' ' HIS . 53.1 t -64.52 -36.13 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.576 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 8.3 mt-10 -69.56 -33.11 72.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.694 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -42.91 74.43 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.37 0.605 . . . . 0.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.541 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.99 -26.88 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.31 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -72.65 -44.2 62.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.005 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.13 28.43 5.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.281 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -80.87 -27.7 36.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.6 -123.04 6.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.371 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 83' ' ' ILE . 13.4 m -135.21 8.15 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.507 HG23 ' HG3' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -156.93 94.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -110.96 119.1 58.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HA ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.21 102.32 14.69 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 57' ' ' ILE . 4.9 mp -103.75 139.78 38.52 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 5' ' ' GLU . 3.7 m-85 -107.8 114.74 28.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.1 m -115.92 168.45 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.308 0.575 . . . . 0.0 112.496 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 mtp -143.29 109.04 5.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.469 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 3.6 ptt180 -107.61 139.24 42.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.979 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.542 ' NH1' ' HB2' ' A' ' 189' ' ' ALA . 0.2 OUTLIER -77.68 141.59 39.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.953 -179.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.539 ' C ' ' HD3' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -98.93 -53.52 0.19 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.474 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 52.6 Cg_endo -103.21 60.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.406 2.737 . . . . 0.0 113.939 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 94.3 Cg_endo -80.84 -157.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.168 1.912 . . . . 0.0 111.977 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 77.91 43.31 0.1 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.457 . . . . 0.0 110.936 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' CG ' ' HA ' ' A' ' 187' ' ' SER . 7.2 mt-10 73.36 134.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -124.74 135.16 52.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.999 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.609 HG13 HD21 ' A' ' 153' ' ' LEU . 21.6 t -84.94 112.86 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -87.8 166.43 14.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.355 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.81 106.4 7.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 183' ' ' VAL . 3.0 mm -116.46 155.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -106.23 123.62 48.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.299 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.973 HD12 HD11 ' A' ' 181' ' ' LEU . 2.2 tt -122.85 118.53 28.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.571 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.59 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.3 pt -100.06 144.71 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.029 0.443 . . . . 0.0 111.233 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 110' ' ' LEU . 11.0 tttm -72.01 162.55 29.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -139.22 161.89 26.02 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.74 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.49 -39.32 91.69 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 122.062 1.841 . . . . 0.0 111.94 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -95.4 21.93 7.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.028 0.442 . . . . 0.0 110.052 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 105.84 -155.44 16.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.466 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 105' ' ' LYS . 9.3 mp -86.24 -13.38 46.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.868 0.334 . . . . 0.0 111.227 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.26 51.83 7.19 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.56 154.67 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 132' ' ' THR . 31.1 t -116.08 119.25 35.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.375 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.535 HG21 ' CE2' ' A' ' 112' ' ' PHE . 15.5 pt -125.26 156.38 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.901 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -154.91 125.42 6.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.95 165.9 31.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.685 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.06 -131.73 14.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.199 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.2 t -104.46 154.93 6.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 114.05 -37.85 3.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.403 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.447 ' ND2' ' CG ' ' C' ' 5' ' ' PHE . 2.1 m-80 163.8 82.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 110.276 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.21 111.43 23.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.161 0.505 . . . . 0.0 111.192 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.901 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -57.31 -16.56 8.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.206 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.636 HD13 ' CD1' ' A' ' 130' ' ' TYR . 0.3 OUTLIER -87.94 104.78 7.4 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.457 -179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 123' ' ' ILE . 13.6 Cg_endo -57.08 94.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.534 2.156 . . . . 0.0 112.571 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.68 44.5 8.42 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.886 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 123' ' ' ILE . 0.4 OUTLIER -142.21 85.43 1.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.022 0.439 . . . . 0.0 110.85 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -47.82 -26.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.0 m -55.89 162.53 1.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.521 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.57 HD11 ' O ' ' A' ' 160' ' ' LEU . 36.4 mt -96.24 125.31 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.151 0.501 . . . . 0.0 111.387 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.636 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.1 m-85 -116.21 161.33 19.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.229 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 150' ' ' ASP . 49.1 t -92.96 144.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 133' ' ' LYS . 1.5 t -115.04 -49.21 2.8 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.99 144.17 30.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.877 0.37 . . . . 0.0 111.634 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.681 HD11 HG11 ' A' ' 131' ' ' VAL . 31.4 mt -136.89 139.85 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.99 173.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.9 tt0 -91.88 147.31 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.84 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.21 27.69 57.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.503 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.37 179.01 53.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.31 -59.86 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 111.405 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -69.96 -33.33 71.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.45 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -57.54 -60.2 4.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.183 0.516 . . . . 0.0 110.24 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.89 -41.7 64.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -80.6 -59.46 2.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.539 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -70.31 -30.81 69.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.215 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.73 21.0 9.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.726 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.539 HD23 ' HA3' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -93.37 82.33 4.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.7 OUTLIER -66.71 172.99 3.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.8 mt -47.54 122.49 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.35 0.595 . . . . 0.0 111.305 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.7 -22.6 6.11 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.365 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.754 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.47 134.55 54.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.798 0.333 . . . . 0.0 110.579 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -119.42 124.72 47.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -104.25 129.45 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 110.717 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.609 HD21 HG13 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -98.55 -0.28 43.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.161 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.57 169.14 1.39 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.897 HG12 ' ND2' ' A' ' 156' ' ' ASN . 57.8 t -126.76 100.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.465 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.897 ' ND2' HG12 ' A' ' 155' ' ' VAL . 25.5 m-80 69.97 -57.7 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.195 0.522 . . . . 0.0 109.977 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.16 27.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.613 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.642 ' HB ' HD21 ' A' ' 160' ' ' LEU . 2.0 t -116.6 154.26 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 CA-C-O 120.986 0.422 . . . . 0.0 111.332 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.0 77.86 0.24 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' A' ' 158' ' ' VAL . 0.3 OUTLIER -78.21 24.76 0.24 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -127.68 41.35 3.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.382 0.611 . . . . 0.0 110.963 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.19 28.0 0.35 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.039 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.74 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -134.75 -78.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.488 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.4 ' CG ' ' HB ' ' A' ' 118' ' ' VAL . 3.2 mtm 173.57 166.87 0.17 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 169' ' ' VAL . 47.2 p-80 -53.88 -29.78 43.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.963 0.411 . . . . 0.0 110.602 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.42 -48.18 35.9 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.74 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -68.49 -37.85 80.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.87 0.367 . . . . 0.0 110.76 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 160' ' ' LEU . . . -70.27 -38.66 75.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.187 0.518 . . . . 0.0 110.025 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.673 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.5 t -67.25 -46.02 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.369 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.62 67.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.532 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 160' ' ' LEU . . . -77.48 -25.57 50.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.35 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -79.46 -39.97 30.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.177 0.513 . . . . 0.0 109.828 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 169' ' ' VAL . 4.3 mtmt -75.88 -26.58 57.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.07 -33.64 74.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.047 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.722 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -52.72 -177.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.398 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -95.27 169.23 10.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.124 0.488 . . . . 0.0 111.341 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -56.78 -16.75 7.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.615 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.96 90.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.585 0.231 . . . . 0.0 110.934 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.63 148.28 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.129 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 1.4 p90 -95.02 130.42 41.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.627 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.973 HD11 HD12 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.18 155.91 19.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.751 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.53 114.8 26.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.985 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.654 HG21 HG13 ' A' ' 101' ' ' ILE . 20.6 t -102.26 161.65 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.492 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -119.74 135.78 54.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.844 0.354 . . . . 0.0 111.349 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 2.1 mtpt -88.4 138.39 30.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 29.9 Cg_exo -61.48 78.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.562 2.175 . . . . 0.0 112.613 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 189' ' ' ALA . 3.1 m 55.1 -145.19 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.12 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 94' ' ' PRO . 10.7 p30 -65.61 68.2 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.881 0.372 . . . . 0.0 111.119 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.542 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.209 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.885 0.374 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 2' ' ' VAL . 14.7 p -129.51 33.56 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.035 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.448 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 1.8 t -87.93 -49.44 0.44 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.22 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 6.5 Cg_exo -73.77 -54.32 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.762 2.308 . . . . 0.0 112.203 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' B' ' 2' ' ' VAL . 0.1 OUTLIER 61.39 21.08 11.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.05 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m -165.57 113.13 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.763 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.5 143.52 53.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 90.6 p -149.51 112.89 4.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.504 HG13 ' CD1' ' A' ' 15' ' ' LEU . 9.9 p . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.164 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . 0.655 ' O ' HG12 ' C' ' 2' ' ' VAL . 1.9 mp0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.665 0.269 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.655 HG12 ' O ' ' C' ' 1' ' ' GLN . 8.8 p 51.38 161.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.891 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.478 ' N ' HG22 ' C' ' 2' ' ' VAL . 30.9 m -58.15 153.7 34.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.306 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.58 173.29 10.1 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.645 2.23 . . . . 0.0 112.366 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . 0.447 ' CG ' ' ND2' ' A' ' 120' ' ' ASN . 1.7 m-85 -101.57 109.92 21.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.08 157.52 1.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.82 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.498 ' OG ' HG22 ' A' ' 169' ' ' VAL . 47.8 t -83.73 78.06 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -85.76 85.78 7.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.097 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -129.32 170.62 13.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.22 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD2' ' CG ' ' A' ' 89' ' ' MET . 1.0 OUTLIER -129.43 171.87 12.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.587 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -167.5 136.82 2.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.459 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -129.6 109.33 10.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.378 179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -127.7 -170.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.129 0.49 . . . . 0.0 111.98 -178.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 128.14 49.39 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.416 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.1 tp -125.32 91.71 3.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.629 0.728 . . . . 0.0 110.087 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.614 ' HG3' HG23 ' A' ' 83' ' ' ILE . 2.3 mt-10 -70.1 165.41 22.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.949 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -83.21 99.18 9.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.98 -26.55 8.77 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.562 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -168.87 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.176 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.8 t -109.18 30.64 6.39 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.65 177.03 20.06 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.358 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.54 -43.17 14.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.758 0.313 . . . . 0.0 111.069 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 90.84 76.61 1.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.784 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 2.7 p90 -164.72 148.46 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 111.041 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.2 m -95.97 126.99 41.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.41 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 36' ' ' ILE . 36.0 pt -115.41 154.73 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.129 0.49 . . . . 0.0 112.019 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -173.12 118.43 0.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . 152.65 29.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.061 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -58.22 167.13 6.24 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.41 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.74 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -73.03 -31.45 64.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.724 0.297 . . . . 0.0 111.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.728 ' CB ' HG23 ' A' ' 69' ' ' THR . 8.3 t70 -83.84 -51.57 7.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 0.0 111.595 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -119.76 78.4 22.51 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.501 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.87 156.34 3.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.515 2.143 . . . . 0.0 112.203 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.595 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 15.6 t60 -100.81 -19.45 15.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.345 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -108.48 -26.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.666 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.25 32.18 8.5 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.147 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 177.7 39.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.085 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 3.4 t0 -166.56 107.87 0.68 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.897 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 14.2 Cg_exo -69.04 -24.74 32.65 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.684 2.256 . . . . 0.0 112.098 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -74.57 126.29 30.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -70.25 148.24 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.201 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -139.83 171.41 14.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.388 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 41.3 mt -99.42 150.57 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.4 m -108.5 -30.32 8.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.158 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.838 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.7 tmtt? -175.6 148.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 111.455 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -108.81 141.22 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.983 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 pt -89.69 146.58 35.83 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.92 58.45 6.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.6 2.2 . . . . 0.0 112.404 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.61 -57.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.02 176.61 1.8 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -74.54 -24.81 59.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.631 0.253 . . . . 0.0 111.62 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -53.01 -57.43 10.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.916 0.389 . . . . 0.0 111.292 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.17 69.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.988 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -71.91 -39.33 69.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.273 0.559 . . . . 0.0 109.505 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HB3' ' HG2' ' A' ' 50' ' ' ARG . 2.5 m-20 -80.19 -28.39 38.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.919 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 26.31 49.42 0.05 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.278 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.495 ' HD3' ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -103.56 21.71 15.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.584 0.23 . . . . 0.0 111.491 -179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -172.39 163.19 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.996 0.427 . . . . 0.0 111.439 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 158.32 15.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.245 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.838 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.2 m -71.16 -44.13 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 53' ' ' VAL . 19.3 m-80 -58.74 1.25 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.688 ' OD2' HG21 ' A' ' 88' ' ' VAL . 55.1 p30 -89.87 163.43 15.01 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.088 -0.383 . . . . 0.0 110.041 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.8 m -119.26 123.87 45.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.79 0.328 . . . . 0.0 111.075 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 7.1 pt -61.88 94.79 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 59' ' ' PHE . 3.6 pp -76.01 -20.57 57.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.892 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.675 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -158.0 119.58 3.59 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.077 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.792 HG22 HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -118.33 119.51 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.681 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 52.22 42.5 30.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 111.185 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.66 30.89 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.939 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 60' ' ' VAL . 22.1 t -114.09 141.69 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -66.31 113.92 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.792 HG11 HG22 ' A' ' 60' ' ' VAL . 14.6 p -146.59 26.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.078 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -87.45 6.51 33.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 177.67 50.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.937 0.398 . . . . 0.0 110.088 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.567 ' CG2' HG23 ' A' ' 65' ' ' VAL . 35.9 m -120.04 144.61 28.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.623 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.74 ' N ' HG22 ' A' ' 23' ' ' THR . 3.9 m -49.93 162.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.766 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.693 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -55.66 -48.44 75.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.457 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.9 m -50.01 -40.77 45.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.247 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.08 76.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.738 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -71.79 -41.3 68.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.459 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 70' ' ' HIS . 46.3 t -64.82 -36.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.628 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 6.2 mt-10 -69.3 -30.82 68.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.737 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.823 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.26 -36.95 74.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.451 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.18 -26.19 33.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -75.99 -32.66 59.56 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.865 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.84 29.78 7.74 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.56 -20.53 18.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.19 -131.25 10.28 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.616 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.555 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -124.84 16.61 8.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.602 0.239 . . . . 0.0 111.321 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.614 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -153.63 94.38 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -102.14 136.56 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.08 90.28 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.738 HD23 HG12 ' A' ' 60' ' ' VAL . 17.9 mt -85.12 114.97 22.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.536 0.684 . . . . 0.0 112.764 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -110.02 114.29 27.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.804 HG12 ' HA ' ' A' ' 57' ' ' ILE . 34.9 m -123.04 168.37 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.468 ' HG3' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -123.26 109.01 13.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.278 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -116.69 138.51 51.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.806 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 1.4 mpt_? -96.59 131.38 43.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.565 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -86.66 115.76 63.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.591 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.46 110.12 2.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.656 2.237 . . . . 0.0 112.856 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 65.2 Cg_endo -93.84 -154.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.12 2.547 . . . . 0.0 111.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 97.44 60.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.875 0.47 . . . . 0.0 111.092 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.442 ' CG ' ' HA ' ' A' ' 187' ' ' SER . 4.4 mt-10 74.64 149.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.035 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -150.69 165.67 32.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.923 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -116.34 120.25 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.207 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.82 166.13 15.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -129.94 106.36 8.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.438 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.581 HG13 HG21 ' A' ' 183' ' ' VAL . 2.5 mm -118.29 155.61 20.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.468 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -115.1 137.07 52.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.539 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.823 HD22 HD23 ' A' ' 110' ' ' LEU . 3.1 tt -135.28 118.44 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.469 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.72 144.66 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 121.011 0.434 . . . . 0.0 111.219 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -76.7 158.47 30.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.52 -164.88 10.06 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.994 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.76 -33.06 4.12 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.258 1.972 . . . . 0.0 112.355 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 19.3 9.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.037 0.446 . . . . 0.0 110.53 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.64 -144.38 15.8 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.823 HD23 HD22 ' A' ' 103' ' ' LEU . 2.9 mp -86.43 -21.44 27.09 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.108 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.73 46.08 5.83 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.974 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.54 157.64 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 0.0 110.748 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 133' ' ' LYS . 43.9 t -125.15 116.76 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.724 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.595 HD11 HD22 ' A' ' 172' ' ' LEU . 8.1 pt -123.05 151.59 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.425 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.913 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -149.87 125.52 10.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.099 0.476 . . . . 0.0 111.696 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.79 -175.29 24.92 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.043 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 121' ' ' GLN . . . 73.22 -144.33 34.44 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.871 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.441 ' H ' ' HA ' ' A' ' 164' ' ' MET . 48.7 t -104.67 154.62 6.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.854 0.359 . . . . 0.0 111.696 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 107.11 -32.24 7.41 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.236 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 176.54 79.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.954 0.407 . . . . 0.0 110.163 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -111.07 112.44 24.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.269 -179.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.913 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -57.21 -20.14 25.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.222 0.534 . . . . 0.0 110.892 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -103.09 145.46 30.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.735 -178.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 123' ' ' ILE . 5.6 Cg_exo -77.52 37.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.998 2.465 . . . . 0.0 112.689 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -122.65 -27.88 1.52 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.153 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 121' ' ' GLN . 3.2 p30 46.79 28.43 0.82 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.907 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -135.58 -48.59 0.7 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.213 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.4 m -88.66 126.85 35.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.445 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.612 ' HB ' HD12 ' A' ' 152' ' ' ILE . 18.6 mt -83.22 128.75 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.263 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.482 ' CD2' HD11 ' A' ' 123' ' ' ILE . 17.5 m-85 -118.43 146.5 44.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.712 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 150' ' ' ASP . 57.3 t -68.13 155.77 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.423 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -131.05 -45.22 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 113' ' ' SER . 0.1 OUTLIER -149.43 128.64 12.83 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.916 -179.321 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 146' ' ' LEU . 25.9 mt -120.09 141.7 39.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.843 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.671 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.0 mm -77.18 174.6 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.624 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.671 ' H ' HG22 ' A' ' 135' ' ' ILE . 18.4 tt0 -92.19 133.86 35.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.96 25.22 45.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.497 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.84 -171.07 18.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.675 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -74.04 -53.65 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -69.99 -31.91 69.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -56.84 -60.92 2.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.211 0.529 . . . . 0.0 110.289 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -42.42 63.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.117 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -80.85 -59.47 2.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.955 0.407 . . . . 0.0 112.043 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.457 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -65.2 -42.13 96.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.053 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.49 21.22 11.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.575 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 144' ' ' GLY . 0.4 OUTLIER -96.96 85.03 3.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 169.07 6.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.598 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.6 mt -47.2 120.29 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.303 0.573 . . . . 0.0 111.429 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.46 -22.56 5.25 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.335 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -64.06 125.31 24.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.94 0.4 . . . . 0.0 110.677 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.646 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 4.1 pttt -109.86 122.53 47.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.943 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -103.9 130.0 55.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.08 0.467 . . . . 0.0 110.502 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -101.57 -0.53 34.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.461 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . -179.9 164.85 1.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.347 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.783 HG12 HD22 ' A' ' 156' ' ' ASN . 57.4 t -115.97 101.57 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.783 HD22 HG12 ' A' ' 155' ' ' VAL . 63.6 m-80 70.56 -58.89 0.54 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 109.778 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.55 21.85 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.098 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.606 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -115.33 144.43 22.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 CA-C-O 120.962 0.411 . . . . 0.0 110.983 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -103.97 71.24 0.26 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.766 HD21 ' CG2' ' A' ' 155' ' ' VAL . 1.4 pp -91.97 30.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.856 0.36 . . . . 0.0 111.746 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.424 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -127.85 67.31 1.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.389 0.614 . . . . 0.0 110.777 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -176.98 29.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.234 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.587 HG11 ' OD2' ' A' ' 167' ' ' ASP . 2.4 t -123.8 -75.05 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 111.396 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HA ' ' H ' ' A' ' 118' ' ' VAL . 7.1 mtm -172.13 -171.38 0.84 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.921 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.516 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.0 p80 -73.23 -30.31 63.39 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.078 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HG3' ' CE1' ' A' ' 165' ' ' HIS . 16.4 mt-10 -73.74 -46.94 42.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.587 ' OD2' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -66.07 -42.55 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.34 -35.25 73.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.434 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.556 HG22 ' CB ' ' C' ' 7' ' ' SER . 16.9 t -74.02 -40.34 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.402 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.89 -34.53 69.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.274 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -75.84 -29.95 58.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 173' ' ' LYS . 3.6 pp -82.09 -37.33 26.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.478 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.809 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -75.03 -26.5 59.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.903 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.04 -11.5 60.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.35 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.677 ' HB ' HG21 ' A' ' 179' ' ' VAL . 38.2 p -58.61 -167.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 111.364 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 179' ' ' VAL . 45.2 t80 -112.8 172.15 7.1 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 1.1 m-20 -56.42 -15.13 3.64 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.361 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 HG22 ' A' ' 104' ' ' ILE . 42.0 t -147.7 92.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.677 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -125.31 148.19 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.973 0.416 . . . . 0.0 111.962 -178.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 5.5 m-85 -97.24 136.01 38.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.671 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -114.09 148.73 36.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 0.0 110.258 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.727 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mttp -96.84 114.55 26.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.577 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.581 HG21 HG13 ' A' ' 101' ' ' ILE . 15.7 t -102.03 160.16 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.914 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.646 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -116.47 145.88 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.378 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -103.58 133.07 20.49 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.06 81.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.595 2.196 . . . . 0.0 112.621 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.442 ' HA ' ' CG ' ' A' ' 96' ' ' GLU . 1.1 m 57.95 -156.58 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.089 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 94' ' ' PRO . 7.4 p30 -64.21 71.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 111.134 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.101 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -84.33 105.21 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.067 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' B' ' 4' ' ' PRO . 11.2 t -76.98 -48.15 2.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.559 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' B' ' 3' ' ' VAL . 80.3 Cg_endo -78.4 -179.75 5.75 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.194 1.929 . . . . 0.0 112.449 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -90.2 168.08 12.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.996 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER 63.7 140.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.818 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 2.9 m -131.42 134.92 46.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.4 112.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.772 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.592 ' OXT' HG22 ' B' ' 9' ' ' VAL . 14.1 p . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.134 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.741 0.305 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 23.9 t -126.96 87.9 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.017 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 m -78.14 144.8 67.89 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.8 177.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.575 2.183 . . . . 0.0 112.247 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -70.86 -56.83 5.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.806 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 115' ' ' ALA . 0.1 OUTLIER -60.45 179.74 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.741 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.556 ' CB ' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -106.32 65.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.103 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.68 87.67 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.678 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 110' ' ' LEU . 7.2 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.828 0.346 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.79 149.24 25.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.76 161.52 41.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.727 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -179.33 150.43 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.233 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.467 ' HB2' ' CD2' ' A' ' 87' ' ' TYR . 7.1 tt0 -109.2 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.512 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.882 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.25 -174.1 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-O 121.082 0.467 . . . . 0.0 111.645 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 126.0 45.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.458 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.915 ' HG ' HD23 ' A' ' 15' ' ' LEU . 14.0 tp -123.62 94.49 4.26 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.703 0.764 . . . . 0.0 110.216 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.797 ' HG3' HG23 ' A' ' 83' ' ' ILE . 10.3 mp0 -68.59 161.85 27.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.687 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 12' ' ' ASN . 15.8 mtt180 -80.63 108.05 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.905 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.48 68.4 0.16 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.165 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.3 OUTLIER 78.81 -78.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.436 0.294 . . . . 0.0 110.549 -178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 t -109.53 30.71 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.79 178.01 15.31 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.552 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.915 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.41 -48.57 9.51 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.846 0.355 . . . . 0.0 110.979 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 97.27 76.54 1.3 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.602 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.814 ' CE1' HG23 ' B' ' 9' ' ' VAL . 2.6 p90 -160.68 152.14 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.696 0.284 . . . . 0.0 110.558 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' ILE . 25.4 m -95.21 126.45 40.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.573 HG22 HG12 ' A' ' 36' ' ' ILE . 34.4 pt -132.74 160.89 42.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -171.33 173.74 4.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 102.61 -128.11 9.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.453 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.83 150.16 10.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.542 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -55.77 -22.41 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.712 0.292 . . . . 0.0 111.42 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.65 ' CB ' HG23 ' A' ' 69' ' ' THR . 11.3 t0 -92.61 -44.57 8.52 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.946 0.403 . . . . 0.0 111.202 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -123.89 77.61 57.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.185 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.16 128.31 22.16 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.587 2.192 . . . . 0.0 112.427 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -66.7 -20.17 65.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.523 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.21 -28.98 2.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.233 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.82 27.68 16.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.43 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -170.6 112.85 0.44 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.42 -27.42 47.09 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.721 2.281 . . . . 0.0 112.187 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.7 t -67.56 141.75 56.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -89.8 151.47 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.793 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.523 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.9 p90 -142.61 160.94 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.974 0.416 . . . . 0.0 110.983 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' SER . 34.6 mt -92.6 147.88 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.2 p -98.81 -41.83 7.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.63 0.253 . . . . 0.0 111.471 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HA ' HG11 ' A' ' 53' ' ' VAL . 2.2 tmtp? -167.8 152.54 6.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.872 0.367 . . . . 0.0 111.262 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.462 HG13 ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -104.35 141.01 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.033 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD11 ' HA2' ' A' ' 16' ' ' GLY . 8.7 pt -86.11 120.99 72.85 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.199 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.52 83.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.426 2.084 . . . . 0.0 112.113 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.02 -54.81 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.0 170.47 4.16 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.546 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.93 -17.76 64.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.621 0.248 . . . . 0.0 111.438 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 16' ' ' GLY . . . -62.13 -57.44 11.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.762 0.315 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.87 -28.95 68.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -72.35 -38.1 68.67 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 5.0 m-20 -79.18 -30.54 43.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.741 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.62 48.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.524 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.882 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -92.62 18.89 8.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.019 0.409 . . . . 0.0 111.296 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.589 ' N ' HD23 ' A' ' 51' ' ' LEU . 2.1 pt? -176.11 167.51 2.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.96 0.41 . . . . 0.0 111.679 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 153.57 18.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.064 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.629 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 27.6 m -70.99 -46.49 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.0 p30 -72.8 15.52 0.19 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -80.56 -167.65 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 104.78 6.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 110.523 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.755 HG22 HG12 ' A' ' 88' ' ' VAL . 12.9 pt -59.56 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.063 0.459 . . . . 0.0 111.201 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD12 ' HB3' ' A' ' 89' ' ' MET . 0.5 OUTLIER -61.74 -32.18 72.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.174 179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 69.6 m-85 -160.97 160.82 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.54 134.06 5.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.691 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.6 36.27 5.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.52 29.27 11.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.9 t -120.76 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.17 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 12.8 p-10 -73.74 91.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG13 ' CG2' ' A' ' 68' ' ' VAL . 17.4 t -114.4 34.43 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -99.75 11.33 39.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.169 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.34 40.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.376 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' HG13 ' A' ' 65' ' ' VAL . 29.0 m -119.39 148.61 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.163 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 1.4 m -49.91 156.86 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.336 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.7 t-160 -54.6 -48.61 71.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.603 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -57.61 -34.39 69.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.161 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.49 82.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -72.01 -42.53 66.3 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.289 0.566 . . . . 0.0 109.81 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 70' ' ' HIS . 68.3 t -65.32 -36.1 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.781 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 2.9 mt-10 -69.33 -32.33 71.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.766 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.682 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.37 -42.76 74.78 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.45 0.643 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -78.04 -27.01 48.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.59 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 1.7 tttt -72.94 -37.76 67.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.312 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -103.24 26.39 8.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.634 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.766 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -103.66 -13.47 16.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.514 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.93 -157.13 23.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.592 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.56 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -100.18 21.05 13.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 111.297 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.797 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.4 mt -155.28 95.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.766 HG13 ' HB1' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -104.78 140.16 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.344 0.592 . . . . 0.0 112.367 -178.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 2.8 mtm180 -96.9 95.32 7.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.759 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.9 mp -93.78 123.84 37.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -104.0 114.46 28.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.755 HG12 HG22 ' A' ' 57' ' ' ILE . 28.1 m -126.01 168.58 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' HD12 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -142.39 108.97 5.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.464 179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.19 106.97 17.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.687 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.5 mtm105 -76.94 124.82 28.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.063 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -122.88 49.68 2.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.8 Cg_exo -41.6 -43.17 6.18 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.905 2.404 . . . . 0.0 113.131 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 93' ' ' PRO . 6.6 Cg_exo -74.53 -171.43 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.611 2.207 . . . . 0.0 112.347 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HB3' ' OXT' ' A' ' 189' ' ' ALA . . . 177.05 34.7 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.431 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.19 162.73 24.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.903 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -177.4 176.12 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.32 153.79 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.538 ' SD ' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -136.51 166.59 23.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.012 0.434 . . . . 0.0 111.322 -179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -135.67 106.28 6.51 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.628 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -113.17 155.26 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -122.91 124.81 44.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.42 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 140' ' ' ALA . 2.7 tt -126.38 118.91 25.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.794 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.583 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -95.4 144.72 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.994 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -62.28 160.81 12.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.996 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -141.11 -159.23 7.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.886 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.35 -41.32 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.235 1.957 . . . . 0.0 112.649 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -91.73 21.73 4.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.23 -133.36 11.47 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.503 ' HB2' HG12 ' C' ' 9' ' ' VAL . 4.7 mp -86.61 -27.09 24.08 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.825 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.92 45.01 4.96 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.793 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.602 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.59 146.6 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.339 . . . . 0.0 111.09 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.1 m -106.68 117.03 32.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.495 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.93 HD11 HD22 ' A' ' 172' ' ' LEU . 12.9 pt -129.54 164.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.959 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -162.29 124.93 2.87 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 111.812 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -154.65 173.42 33.08 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.106 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 123.81 170.67 13.38 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.473 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 119' ' ' GLY . 30.7 t -92.06 154.84 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.44 -0.38 . . . . 0.0 111.155 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 75.27 6.26 79.46 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.696 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 172.03 78.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.953 0.406 . . . . 0.0 110.043 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -93.4 123.07 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.993 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.653 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -48.11 -29.1 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.589 0.709 . . . . 0.0 110.694 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.777 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -97.28 146.51 31.47 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.699 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.763 ' HD2' HG22 ' A' ' 123' ' ' ILE . 26.3 Cg_exo -62.93 72.63 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.564 2.176 . . . . 0.0 112.805 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.84 61.32 1.0 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.353 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -172.67 90.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.359 . . . . 0.0 110.825 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' GLN . 0.5 OUTLIER -55.82 -22.82 26.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.376 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.43 ' HA ' ' CG ' ' A' ' 161' ' ' GLU . 38.9 m -47.47 123.12 5.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.588 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 35.9 mt -59.58 123.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.253 0.549 . . . . 0.0 111.357 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -121.23 173.53 7.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.784 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 146' ' ' LEU . 44.0 t -111.16 141.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.166 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 148' ' ' ILE . 3.3 p -102.74 -60.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 146.89 26.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.899 0.38 . . . . 0.0 111.513 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.754 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.6 mt -117.14 141.64 34.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.4 mm -82.8 173.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.546 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.626 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.6 pt-20 -112.58 36.25 3.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.99 -29.13 52.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.542 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.89 51.88 0.59 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.642 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.59 -84.51 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.17 -31.79 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.233 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.429 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.7 m170 -53.47 -56.98 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -50.27 25.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.343 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.33 -59.3 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.049 0.452 . . . . 0.0 111.696 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -55.37 -56.27 24.28 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.02 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.88 21.78 10.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.991 0.424 . . . . 0.0 110.383 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.754 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -103.77 83.03 2.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.909 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -59.97 166.55 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.587 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' THR . 31.1 mt -47.86 121.24 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.283 0.563 . . . . 0.0 111.22 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 123.02 -19.4 7.79 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.495 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -64.49 126.16 26.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.885 0.374 . . . . 0.0 110.515 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -107.17 124.02 49.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.091 -179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.571 HG22 ' H ' ' A' ' 154' ' ' ALA . 1.6 mt -98.26 132.51 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.676 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.642 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -91.05 -2.04 57.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.983 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 154.58 153.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.217 0.323 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.773 HG12 HD22 ' A' ' 156' ' ' ASN . 15.2 t -103.52 99.29 8.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.773 HD22 HG12 ' A' ' 155' ' ' VAL . 23.0 m-80 68.32 -59.46 0.44 Allowed 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 155' ' ' VAL . 94.4 p -171.47 31.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.292 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.6 t -134.87 148.18 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 121.351 0.595 . . . . 0.0 112.205 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.744 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 91.97 -76.58 1.34 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.806 HD13 ' OD2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER 32.12 34.02 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.258 -0.971 . . . . 0.0 112.284 178.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 159' ' ' GLY . 2.2 pm0 34.37 36.88 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.011 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.806 ' OD2' HD13 ' A' ' 160' ' ' LEU . 31.1 p30 -116.14 36.24 4.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.688 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -149.71 -82.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.943 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.01 166.41 0.93 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.531 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.9 p80 -53.98 -37.22 63.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.938 0.399 . . . . 0.0 110.787 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.07 -40.42 62.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.467 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -76.02 -37.49 58.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.861 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.71 -34.99 72.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.023 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 165' ' ' HIS . 25.4 t -74.21 -43.1 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.97 -35.81 69.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.145 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.11 -26.69 56.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.436 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.93 HD22 HD11 ' A' ' 114' ' ' ILE . 3.9 pp -81.41 -36.62 29.27 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.873 ' N ' HD12 ' A' ' 172' ' ' LEU . 11.8 tttp -72.23 -26.9 62.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.306 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -70.5 -9.46 56.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.463 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.611 ' HB ' HG21 ' A' ' 179' ' ' VAL . 16.9 p -49.2 -178.58 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 121.053 0.454 . . . . 0.0 112.051 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -107.56 171.4 7.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.295 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 6.4 m-20 -53.41 -18.23 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.546 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.583 HG13 HG22 ' A' ' 104' ' ' ILE . 40.1 t -147.38 91.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 110.494 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.611 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -116.75 147.54 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.026 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 15.7 p90 -111.46 125.99 54.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.224 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.2 158.47 19.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 111.307 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.484 ' HB3' HD21 ' A' ' 153' ' ' LEU . 2.0 mptt -100.85 119.76 39.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.353 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.628 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -101.74 160.87 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.997 0.427 . . . . 0.0 111.419 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -126.91 133.21 50.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.84 130.81 53.85 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.56 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.604 ' O ' ' HB3' ' A' ' 189' ' ' ALA . 19.4 Cg_endo -58.67 125.82 19.45 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.408 2.072 . . . . 0.0 112.052 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.62 154.79 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.012 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 p-10 41.95 30.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.582 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.123 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.99 129.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' B' ' 4' ' ' PRO . 23.9 t -75.48 135.92 71.89 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.402 ' HD2' HG13 ' B' ' 3' ' ' VAL . 57.7 Cg_endo -71.58 158.27 54.08 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.421 2.08 . . . . 0.0 112.241 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -112.5 157.29 21.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.8 m -155.42 157.91 37.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.709 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.527 ' O ' HG22 ' B' ' 9' ' ' VAL . 38.6 t 63.27 -111.03 0.34 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.747 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.7 ' O ' HG13 ' B' ' 9' ' ' VAL . 1.3 m -63.75 125.69 25.15 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.798 0.332 . . . . 0.0 111.087 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.814 HG23 ' CE1' ' A' ' 17' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.088 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . 0.416 ' O ' ' CG1' ' C' ' 2' ' ' VAL . 1.7 tp60 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.691 0.281 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.585 HG22 ' O ' ' C' ' 2' ' ' VAL . 7.2 p 43.84 55.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.551 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 t -107.85 94.74 13.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.083 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.6 170.71 14.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.372 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -149.35 147.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.54 -168.79 2.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.837 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.44 ' OG ' HG21 ' A' ' 169' ' ' VAL . 41.4 m -107.03 104.88 14.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.926 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 12.3 p -80.61 94.31 6.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 110' ' ' LEU . 4.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.833 0.349 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 3' ' ' TYR . 13.5 tt0 -86.95 147.66 25.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.23 153.27 35.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.537 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -170.81 159.46 6.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.951 0.405 . . . . 0.0 111.45 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.475 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -110.26 137.34 48.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.632 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.524 HG22 ' NE ' ' A' ' 50' ' ' ARG . 25.3 mt -149.12 164.15 4.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.127 0.489 . . . . 0.0 111.418 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.589 HG23 ' HD3' ' A' ' 85' ' ' ARG . 0.3 OUTLIER -123.11 136.73 54.92 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.074 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.839 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.5 tp -127.19 89.19 2.93 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.628 0.728 . . . . 0.0 110.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.691 ' HG3' HG23 ' A' ' 83' ' ' ILE . 3.0 tt0 -74.72 134.79 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.244 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -57.5 104.61 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.2 -27.52 5.45 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.636 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -174.8 -77.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.127 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 t -109.29 30.54 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.856 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.22 178.1 19.64 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.485 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.839 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -50.68 7.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.86 0.362 . . . . 0.0 111.175 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 101.35 70.4 0.89 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.639 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.649 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 2.8 p90 -164.68 157.71 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -112.56 129.38 56.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.881 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.13 160.81 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.353 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.54 12.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.05 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.01 -128.68 9.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.12 147.76 10.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.592 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 69' ' ' THR . 1.4 t -52.2 -25.15 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.685 0.279 . . . . 0.0 111.468 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.598 ' HB2' HG23 ' A' ' 69' ' ' THR . 1.9 t70 -89.77 -45.84 9.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.531 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -123.87 78.31 57.55 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.573 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -48.84 134.5 28.39 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.547 2.164 . . . . 0.0 112.277 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 38.6 t60 -71.32 -25.71 62.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.193 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.99 -28.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.076 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 26.78 11.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.531 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.7 31.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 110.802 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 5.0 t0 -165.4 95.84 0.84 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 11.4 Cg_endo -54.85 -22.9 31.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.414 2.076 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.72 164.62 16.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -106.88 146.02 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.43 150.13 40.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.524 -179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.528 HG22 ' HB ' ' A' ' 53' ' ' VAL . 65.6 mt -72.64 151.89 7.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.495 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.549 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.23 -35.45 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.213 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.644 ' HA ' HG11 ' A' ' 53' ' ' VAL . 5.5 tmmm? -169.59 152.24 4.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.001 0.429 . . . . 0.0 111.486 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.7 mt -118.23 141.27 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.14 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 pt -85.84 141.72 36.08 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.062 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.27 74.13 3.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.458 2.105 . . . . 0.0 112.391 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.04 -40.73 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.11 176.29 1.96 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.615 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.85 -27.36 57.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.557 0.217 . . . . 0.0 111.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -47.69 -57.37 5.6 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.43 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.44 69.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -72.02 -37.08 69.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.312 0.577 . . . . 0.0 109.644 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' OD2' HD13 ' A' ' 8' ' ' LEU . 22.2 m-20 -82.45 -25.7 33.36 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.023 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 80.67 51.54 4.81 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.307 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.524 ' NE ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.84 44.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER 33.77 -153.36 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 150.1 46.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.058 0.456 . . . . 0.0 111.37 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.4 m -71.04 -39.67 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.492 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 53' ' ' VAL . 22.9 p30 -51.69 -14.97 0.39 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.369 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.9 p-10 -61.85 156.73 19.95 Favored 'General case' 0 C--O 1.23 0.054 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.8 m -122.68 124.36 43.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 111.32 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.664 HG22 HG12 ' A' ' 88' ' ' VAL . 3.7 pt -62.92 94.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.61 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -61.08 -23.42 65.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.534 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -158.79 127.09 5.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.901 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.536 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.72 133.12 70.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.88 0.372 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.452 HD21 HG12 ' A' ' 84' ' ' VAL . 2.9 m-80 45.78 33.52 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.248 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 13.8 tt0 67.56 32.46 5.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 18.1 t -120.92 141.78 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.19 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.44 98.94 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.793 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.683 HG13 ' CG2' ' A' ' 68' ' ' VAL . 21.4 t -130.24 38.39 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -103.48 12.55 35.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -176.58 38.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.5 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.683 ' CG2' HG13 ' A' ' 65' ' ' VAL . 22.2 m -115.86 145.83 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.741 ' N ' HG22 ' A' ' 23' ' ' THR . 2.5 m -49.94 161.34 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.757 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.712 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -55.03 -48.53 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.695 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -49.79 -42.34 46.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.862 0.363 . . . . 0.0 111.391 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -34.18 75.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.031 0.443 . . . . 0.0 110.742 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.74 -40.53 69.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.614 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.712 HG23 ' CD2' ' A' ' 70' ' ' HIS . 41.1 t -64.48 -35.34 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.736 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.44 -34.16 74.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.764 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.43 -43.42 73.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.328 0.585 . . . . 0.0 110.482 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.89 HD13 HG11 ' B' ' 9' ' ' VAL . 3.0 pp -76.25 -26.69 56.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.454 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.1 tttt -70.98 -42.86 69.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.231 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -105.26 31.4 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.11 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -85.05 -27.0 26.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.555 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.68 -121.46 6.38 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.579 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 83' ' ' ILE . 88.7 p -137.97 9.8 2.81 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.691 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.6 mt -152.09 94.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.797 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -94.84 117.27 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' HG23 ' A' ' 7' ' ' THR . 1.3 tpp85 -102.75 91.07 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.718 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.3 pp -121.64 154.04 37.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.6 m-85 -105.04 119.37 38.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.267 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 86' ' ' LEU . 26.8 m -104.11 167.81 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.249 0.547 . . . . 0.0 112.298 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.88 109.59 11.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -121.4 140.56 51.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.85 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.89 123.86 20.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.168 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HG2' ' HD2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -70.48 178.17 1.19 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.58 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 71.1 Cg_exo -49.16 104.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.098 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.45 -156.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.538 2.159 . . . . 0.0 112.108 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.38 28.43 4.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.429 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 90.23 6.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.66 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mtmm -101.68 -175.68 2.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 29.2 t -132.17 113.12 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 183' ' ' VAL . 2.0 ttm -86.89 166.28 15.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.38 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -133.99 106.75 7.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.149 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.504 HD12 ' CA ' ' A' ' 144' ' ' GLY . 2.8 mm -114.02 155.53 15.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 101' ' ' ILE . 24.7 ttmt -134.86 122.86 22.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.75 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.675 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 3.6 tt -123.25 118.35 27.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.579 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 5.1 pt -93.75 144.5 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.547 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 177' ' ' ASP . 2.0 tptm -57.71 141.77 47.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.49 -164.4 11.92 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.949 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.76 -43.43 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.122 1.881 . . . . 0.0 112.228 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -92.52 20.46 6.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.071 0.462 . . . . 0.0 110.115 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.29 -142.37 15.48 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.645 ' HG ' HD22 ' A' ' 103' ' ' LEU . 9.9 mp -86.7 -21.7 26.48 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.961 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.5 47.72 6.25 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.41 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.34 152.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 179.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.2 m -116.31 124.83 51.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.124 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.55 HG22 HG22 ' A' ' 131' ' ' VAL . 20.0 pt -141.63 157.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.726 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -159.82 125.5 4.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.976 0.417 . . . . 0.0 111.914 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.597 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.26 -175.08 25.06 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.436 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.02 -179.38 45.17 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.298 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.04 150.3 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.742 0.306 . . . . 0.0 111.208 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.74 -19.16 42.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.338 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 10.7 t-20 -179.53 70.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.034 0.445 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.3 mt-30 -71.55 -7.49 47.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.481 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.663 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 61.4 t60 71.82 -57.09 0.62 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.521 0.676 . . . . 0.0 110.975 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -86.56 134.62 37.49 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.7 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.68 77.18 2.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.448 2.098 . . . . 0.0 112.606 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.01 46.55 0.55 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.92 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -172.95 96.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -58.26 -21.4 48.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.5 p -55.26 129.73 39.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.775 0.322 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.713 HD11 ' HA3' ' A' ' 159' ' ' GLY . 39.2 mt -66.19 130.84 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 111.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.85 ' CD1' HD11 ' A' ' 123' ' ' ILE . 2.4 m-85 -123.86 166.73 15.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.334 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 68.8 t -101.9 155.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.377 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.745 HG21 ' CB ' ' C' ' 6' ' ' SER . 10.5 p -115.19 -58.99 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.578 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.18 148.7 29.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.187 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 147' ' ' GLN . 16.2 mt -132.14 141.68 44.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 136' ' ' GLU . 2.8 mm -79.75 174.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.62 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.659 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 mt-10 -93.91 151.01 19.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.916 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.53 25.15 54.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -77.06 -169.14 30.91 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.93 -62.35 1.59 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.381 . . . . 0.0 111.306 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.874 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.15 -31.78 69.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.324 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -58.75 -48.69 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -72.58 -49.41 32.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.883 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.23 -59.39 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.853 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.505 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.96 -33.71 87.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.963 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 66.84 14.65 9.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.874 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -73.37 144.57 46.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.67 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.7 ' HA ' HD12 ' A' ' 134' ' ' ILE . 7.0 mt-30 -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.072 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 132' ' ' THR . 25.8 mt -49.28 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-O 121.802 0.811 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 141.83 -17.9 2.58 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.389 -1.278 . . . . 0.0 111.431 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -67.07 120.21 13.3 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.163 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -105.43 119.77 39.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.946 0.403 . . . . 0.0 111.475 -178.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 181' ' ' LEU . 1.8 mt -92.77 129.75 42.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.363 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.5 pp -87.08 -0.59 56.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.001 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.564 ' H ' HG22 ' A' ' 152' ' ' ILE . . . 166.0 153.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.059 0.224 . . . . 0.0 110.66 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.777 HG11 ' HB3' ' A' ' 172' ' ' LEU . 25.3 t -108.5 99.61 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 72.3 m-80 73.24 -59.84 0.55 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.8 t -169.96 23.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.377 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 171' ' ' ALA . 2.3 t -135.91 155.24 35.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.714 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.713 ' HA3' HD11 ' A' ' 129' ' ' ILE . . . 89.06 -6.9 83.26 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.828 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.57 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -68.61 23.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.626 0.77 . . . . 0.0 111.445 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 159' ' ' GLY . 24.0 mt-10 71.31 54.0 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.072 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.28 26.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.873 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -157.18 -83.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.052 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.9 mtm 166.92 162.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 11.1 t-160 -53.77 -30.22 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.022 0.439 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -41.16 62.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.068 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -76.22 -33.88 59.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' HB2' ' HA2' ' A' ' 159' ' ' GLY . . . -70.06 -38.18 75.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' HIS . 39.5 t -74.23 -41.92 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.484 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.67 -26.15 62.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.334 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.746 ' HB2' HG11 ' A' ' 158' ' ' VAL . . . -72.12 -43.44 64.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.3 pp -67.86 -36.56 80.51 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.866 ' N ' HD12 ' A' ' 172' ' ' LEU . 9.2 ttpp -75.3 -26.09 58.41 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.469 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -56.37 -48.6 76.52 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.4 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.556 ' OG1' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -45.63 -52.45 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.118 0.485 . . . . 0.0 110.663 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' O ' ' CB ' ' A' ' 177' ' ' ASP . 2.3 t80 66.7 107.15 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.888 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t0 82.38 -23.87 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.895 177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.15 93.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.623 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.556 HG22 ' OG1' ' A' ' 175' ' ' THR . 2.2 t -107.06 148.43 11.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.107 0.479 . . . . 0.0 111.008 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 156' ' ' ASN . 0.2 OUTLIER -124.0 135.83 53.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.502 -0.772 . . . . 0.0 108.975 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -132.77 136.67 46.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.965 0.412 . . . . 0.0 111.338 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.83 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 184' ' ' ALA . 9.2 t -101.79 162.88 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.513 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.53 134.68 34.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.991 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -83.87 136.79 41.25 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.711 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.63 125.0 14.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.465 2.11 . . . . 0.0 112.267 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.2 158.62 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 49.29 30.46 3.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.105 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.06 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.818 0.342 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.424 ' O ' HG23 ' B' ' 3' ' ' VAL . 21.9 t -85.09 134.54 26.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.213 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.532 ' HB ' ' HD3' ' B' ' 4' ' ' PRO . 77.2 t -156.45 -63.09 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.178 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 36.6 Cg_endo -64.41 121.16 8.67 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.131 1.887 . . . . 0.0 112.249 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.65 31.18 6.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.817 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 p -162.3 178.35 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.414 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -95.75 87.08 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.944 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -85.25 118.62 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.89 HG11 HD13 ' A' ' 77' ' ' LEU . 10.9 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.818 0.342 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.06 109.25 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 31.0 m -89.21 149.68 43.43 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.15 136.03 30.98 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.628 2.219 . . . . 0.0 112.325 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -103.22 33.33 3.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.745 ' CB ' HG21 ' A' ' 132' ' ' THR . 50.7 p -175.64 163.72 2.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.73 104.99 16.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.71 103.18 14.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.16 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptm . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.793 0.33 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.76 149.65 30.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -104.59 178.12 4.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -170.72 155.5 4.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.014 0.435 . . . . 0.0 111.387 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -151.72 100.97 2.73 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.111 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.683 HG21 ' HG3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -125.87 -171.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 112.133 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.48 125.17 28.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.877 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.882 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.4 tp -116.68 94.76 4.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.594 0.712 . . . . 0.0 111.048 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -69.53 141.2 53.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.511 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 101.03 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.969 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.9 -26.63 8.63 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.446 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.89 -84.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 m -109.14 30.54 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.819 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.84 -179.76 20.98 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.314 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -84.36 -50.52 7.73 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.603 0.24 . . . . 0.0 111.397 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.41 30.29 3.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.147 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.919 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 3.5 p90 -123.03 147.96 46.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.368 0.584 . . . . 0.0 110.646 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.6 m -108.03 126.79 53.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.339 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.407 HG22 HG12 ' A' ' 36' ' ' ILE . 2.3 pt -106.97 171.86 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.865 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.74 139.89 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.212 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 134.39 -121.99 2.83 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.62 140.0 7.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.326 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.635 HG22 ' CA ' ' A' ' 69' ' ' THR . 1.6 t -54.35 -21.6 9.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.639 0.256 . . . . 0.0 111.534 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.5 m-20 -82.09 -56.94 3.63 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.897 0.38 . . . . 0.0 111.206 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -123.74 86.55 53.0 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.394 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -48.0 129.93 19.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.78 2.32 . . . . 0.0 112.482 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 14.9 t60 -61.66 -20.43 63.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.586 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -105.63 -41.86 6.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.01 0.433 . . . . 0.0 110.843 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.39 24.99 5.43 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.542 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.49 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 14.3 t70 -158.26 98.34 1.79 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.776 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 13.7 Cg_endo -56.52 -29.94 80.48 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.413 2.076 . . . . 0.0 112.001 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -71.06 164.64 25.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.699 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.3 mt -109.17 155.81 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.129 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.34 166.7 23.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 ' HB ' ' CA ' ' A' ' 53' ' ' VAL . 42.6 mt -96.07 154.71 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.585 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.584 ' O ' HG21 ' A' ' 53' ' ' VAL . 19.0 p -108.7 -42.46 4.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.611 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.47 150.8 9.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.014 0.435 . . . . 0.0 111.619 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.409 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 1.1 mt -108.96 141.52 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.4 mt -84.2 127.81 64.96 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.087 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.1 Cg_exo -65.18 66.9 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.525 2.15 . . . . 0.0 112.254 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.31 -52.22 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.436 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.68 -178.31 2.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.423 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -75.86 -20.77 57.84 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -60.31 -57.31 13.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.14 -28.04 69.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -72.05 -43.44 64.92 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.572 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 4.8 t0 -74.39 -31.27 62.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.874 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 23.83 48.54 0.02 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.425 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.683 ' HG3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -95.83 18.63 12.77 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' OD2' ' A' ' 55' ' ' ASP . 1.7 pt? -175.06 179.81 1.51 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.995 0.426 . . . . 0.0 111.91 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.22 152.71 22.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.341 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 37' ' ' THR . 28.0 m -70.95 -38.27 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.031 0.443 . . . . 0.0 112.17 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.66 15.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.562 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -80.11 -158.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 100.61 3.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.758 0.314 . . . . 0.0 110.991 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.88 HG12 HG13 ' A' ' 60' ' ' VAL . 3.0 tp -61.97 95.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 110.717 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.527 HD23 ' CG ' ' A' ' 89' ' ' MET . 3.2 pp -70.1 -22.63 63.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.85 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -160.06 130.77 5.64 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.457 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.88 HG13 HG12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -113.31 117.68 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.167 178.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.615 HD21 HG12 ' A' ' 84' ' ' VAL . 6.9 m-20 46.57 37.82 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.798 0.332 . . . . 0.0 111.031 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 69.44 30.92 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.87 125.86 74.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -45.85 125.71 6.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.358 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 57' ' ' ILE . 14.2 p -153.12 23.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -94.91 11.76 30.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.354 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 174.82 46.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.981 0.42 . . . . 0.0 110.294 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -111.12 138.07 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.302 0.573 . . . . 0.0 111.983 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.635 ' CA ' HG22 ' A' ' 23' ' ' THR . 0.1 OUTLIER -50.74 166.23 0.09 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.607 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -56.14 -48.55 76.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.062 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 p -56.2 -42.51 77.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . . . -62.1 -33.87 75.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.534 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.51 68.82 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.332 0.587 . . . . 0.0 109.521 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HA ' HD21 ' A' ' 77' ' ' LEU . 50.5 t -64.75 -35.83 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.572 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 -33.34 72.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.832 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.26 -43.74 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.315 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.727 ' HB2' HG21 ' B' ' 9' ' ' VAL . 2.7 pp -75.71 -26.77 57.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.459 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -71.89 -43.23 65.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.179 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -105.62 31.21 5.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.164 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -80.27 -28.65 38.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.526 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.95 -103.7 3.08 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.6 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 74.6 m -151.75 -52.43 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 18.2 mt -100.82 85.1 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.839 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 6.8 m -85.26 116.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.337 -1.302 . . . . 0.0 112.901 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -75.28 84.56 2.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.795 ' CD2' HG12 ' A' ' 60' ' ' VAL . 22.4 mt -85.13 139.45 31.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.519 0.676 . . . . 0.0 112.459 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 2.3 m-85 -124.01 114.51 19.84 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.802 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.9 m -125.53 168.5 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.527 ' CG ' HD23 ' A' ' 58' ' ' LEU . 25.4 mtm -127.87 108.99 11.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.244 178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -116.53 127.41 54.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.018 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.71 120.98 13.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.916 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.08 131.54 85.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.1 162.84 40.75 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.381 2.054 . . . . 0.0 112.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 20.2 Cg_exo -64.98 -159.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.49 2.126 . . . . 0.0 112.299 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 161.43 86.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.241 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HG3' ' HB3' ' A' ' 185' ' ' LYS . 1.1 pm0 -106.58 -176.37 3.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.288 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.459 ' HG3' ' C ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -164.01 -70.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.008 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.544 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -121.9 154.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 98' ' ' VAL . 7.6 tpt -134.55 164.31 27.77 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.699 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.02 106.63 12.62 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG13 HG21 ' A' ' 183' ' ' VAL . 2.0 mm -120.5 155.66 23.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 180' ' ' TYR . 2.4 mtmp? -115.38 123.26 48.21 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.358 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.763 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.5 tt -123.0 118.57 28.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.701 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.64 144.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.24 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.67 153.14 26.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.955 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 -177.88 15.26 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.842 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.48 -31.64 21.38 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.063 1.842 . . . . 0.0 112.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -96.79 19.78 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.042 0.449 . . . . 0.0 110.422 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.58 -153.06 17.22 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.488 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.642 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 mp -86.46 -14.99 41.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.66 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 83.73 50.66 4.34 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.901 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.7 155.02 0.79 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.776 0.322 . . . . 0.0 111.196 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.5 m -113.97 116.97 30.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.563 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 172' ' ' LEU . 7.0 pt -132.79 155.1 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.956 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.4 125.04 7.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.061 0.457 . . . . 0.0 111.99 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.622 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.66 -175.13 25.44 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.273 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.54 -168.91 40.52 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.126 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 39.4 t -84.51 145.04 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 111.045 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.53 -25.28 16.15 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.1 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -164.61 70.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.103 0.478 . . . . 0.0 109.738 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.7 OUTLIER -72.55 -5.98 40.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.633 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.527 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 59.1 t60 72.04 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.607 0.718 . . . . 0.0 110.561 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.949 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.4 mt -84.04 144.21 44.05 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.603 ' HD2' HG22 ' A' ' 123' ' ' ILE . 15.8 Cg_exo -67.91 63.32 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.548 2.166 . . . . 0.0 112.271 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.08 62.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.787 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.728 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.3 OUTLIER -170.36 96.6 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.988 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.79 -23.72 19.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.18 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 t -55.49 143.79 28.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.03 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.895 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -84.33 119.46 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.354 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.949 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.5 m-85 -114.93 155.08 27.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.175 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 114' ' ' ILE . 46.1 t -85.99 155.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 110.896 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.526 HG22 ' CE1' ' A' ' 122' ' ' HIS . 11.7 p -116.03 -57.3 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.501 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -152.65 150.04 29.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.258 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.679 HD11 ' O ' ' A' ' 146' ' ' LEU . 8.0 mt -130.27 141.63 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.054 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -75.98 173.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.453 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.611 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.98 138.09 35.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 110.996 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 69.67 27.2 73.6 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.548 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.06 -173.35 47.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -79.8 -58.18 3.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 111.168 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.568 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -63.93 -31.79 73.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -57.3 -62.18 1.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 110.444 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -72.94 -38.67 66.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.999 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.43 -59.37 2.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 112.029 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -72.24 -43.49 46.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.077 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.68 18.64 11.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.748 0.309 . . . . 0.0 110.939 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.679 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -85.96 79.59 9.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.561 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.3 pt20 -60.47 171.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 29.5 mt -48.14 127.59 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 118.43 -25.63 8.08 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.346 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 1.3 m-20 -58.52 151.07 21.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.748 0.309 . . . . 0.0 110.713 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -138.1 124.45 20.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.147 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.628 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.2 130.25 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.627 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.7 OUTLIER -100.08 -0.98 37.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.322 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.22 155.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.875 0.369 . . . . 0.0 111.334 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 158' ' ' VAL . 21.5 t -111.07 99.86 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.023 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.544 HD22 HG12 ' A' ' 155' ' ' VAL . 67.3 m-80 69.24 -59.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.267 0.556 . . . . 0.0 109.694 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.4 t -164.07 27.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.229 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.7 t -101.05 155.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.391 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -116.38 77.13 0.27 Allowed Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.417 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.895 HD22 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.99 24.8 0.49 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -137.14 31.17 2.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.164 0.507 . . . . 0.0 110.763 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.67 27.71 1.33 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.059 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.745 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -137.61 -76.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.375 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.447 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 2.7 mtm 172.56 165.48 0.12 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.461 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 p-80 -53.95 -29.67 43.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.897 0.38 . . . . 0.0 110.467 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.42 -46.16 50.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.382 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.745 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.69 -37.36 73.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.608 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.523 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.38 -38.72 74.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.837 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.633 HG22 ' HB2' ' C' ' 7' ' ' SER . 9.9 t -70.36 -41.57 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.382 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.75 -31.31 66.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.077 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.05 -27.23 57.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.657 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.927 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.0 pp -81.74 -37.33 27.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.851 0.358 . . . . 0.0 110.317 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.927 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -75.37 -26.54 58.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.714 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -78.09 -9.79 59.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.674 ' HB ' HG21 ' A' ' 179' ' ' VAL . 78.2 p -52.04 -178.26 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.947 0.403 . . . . 0.0 111.596 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.1 t80 -100.97 167.1 10.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.327 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.494 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.4 t70 -50.66 -24.85 3.63 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.214 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.408 HG13 HG22 ' A' ' 104' ' ' ILE . 43.0 t -147.75 92.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -113.71 148.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.26 125.97 38.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.787 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -114.99 145.09 42.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 111.332 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.3 mttt -96.38 112.29 24.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.085 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 152' ' ' ILE . 21.8 t -102.64 162.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.321 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.523 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -121.0 133.15 55.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.122 0.487 . . . . 0.0 110.918 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.676 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -95.46 146.32 31.1 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.343 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 16.7 Cg_exo -68.24 47.84 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.271 . . . . 0.0 113.593 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 189' ' ' ALA . 25.9 t 44.94 -160.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.644 0.259 . . . . 0.0 111.356 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 52.7 p-10 -67.02 66.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.173 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.155 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.821 0.343 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' B' ' 3' ' ' VAL . 0.0 OUTLIER -133.53 -77.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.666 HG12 ' HD3' ' B' ' 4' ' ' PRO . 7.0 p 174.42 -36.15 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.666 ' HD3' HG12 ' B' ' 3' ' ' VAL . 1.2 Cg_endo -84.39 -74.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.417 2.078 . . . . 0.0 112.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 53.67 24.71 4.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.349 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 21.9 m 55.44 176.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 27.6 t -159.41 155.67 27.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.69 147.81 47.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.727 HG21 ' HB2' ' A' ' 77' ' ' LEU . 10.8 p . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.095 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . 0.916 ' O ' HG23 ' C' ' 3' ' ' VAL . 1.8 tt0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.622 0.249 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 2' ' ' VAL . 13.4 p 44.92 38.58 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.666 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.916 HG23 ' O ' ' C' ' 1' ' ' GLN . 44.0 t -134.09 78.78 58.26 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.006 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.99 134.96 50.62 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 112.289 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -148.51 145.56 27.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 47.8 t 63.25 135.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.633 ' HB2' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -79.66 84.62 5.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.584 ' O ' HG13 ' C' ' 9' ' ' VAL . 96.5 p -97.83 84.33 3.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.584 HG13 ' O ' ' C' ' 8' ' ' SER . 3.9 m . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mtm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.821 0.343 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.67 113.22 25.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -109.71 128.88 55.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.393 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -177.73 172.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.035 0.445 . . . . 0.0 111.618 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 1.5 pm0 -90.08 150.48 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.487 HD13 ' HG3' ' A' ' 50' ' ' ARG . 8.1 mt -144.18 153.32 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.065 0.459 . . . . 0.0 111.281 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -116.91 125.67 51.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.005 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.921 ' HG ' HD23 ' A' ' 15' ' ' LEU . 8.5 tp -127.05 91.43 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.556 0.693 . . . . 0.0 110.361 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.855 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -77.27 163.16 26.75 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.786 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -69.56 97.27 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -56.04 -23.47 39.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.592 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -175.28 -85.35 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.9 m -109.11 30.53 6.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.808 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.06 177.73 15.21 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.358 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.921 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.38 -44.83 13.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.804 0.335 . . . . 0.0 111.195 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 90.39 77.15 1.33 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.783 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -163.33 155.55 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.788 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.1 t -111.97 126.85 55.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 111.446 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.723 HG22 HG12 ' A' ' 36' ' ' ILE . 11.1 pt -120.54 163.93 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.883 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.35 156.94 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 126.28 -126.07 5.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.537 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.45 132.53 5.18 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.526 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.744 HG22 ' N ' ' A' ' 69' ' ' THR . 1.6 t -48.46 -26.97 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.317 . . . . 0.0 111.345 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.739 ' CB ' HG23 ' A' ' 69' ' ' THR . 27.1 t70 -87.46 -44.31 11.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -123.77 78.75 56.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.82 134.13 40.85 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.665 2.244 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.414 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 27.8 t60 -69.32 -22.93 63.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.18 -30.73 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.74 27.81 10.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.661 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -172.67 33.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.78 111.04 0.47 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 17.0 Cg_exo -67.26 -30.14 37.85 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.716 2.277 . . . . 0.0 112.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.56 129.27 39.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 152.3 4.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.031 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.3 165.13 28.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.702 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.723 HG12 HG22 ' A' ' 19' ' ' ILE . 43.1 mt -94.2 153.79 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.497 ' O ' HG21 ' A' ' 53' ' ' VAL . 15.9 p -106.93 -44.53 4.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.726 0.298 . . . . 0.0 111.494 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.927 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -156.59 152.5 27.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 111.39 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -111.01 141.27 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.822 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 mt -86.26 135.83 36.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.081 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.82 57.25 5.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.261 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.09 -53.22 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.69 -174.83 0.85 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.465 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.595 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.03 -29.64 58.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.532 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -47.47 -51.04 21.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.324 . . . . 0.0 111.49 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.2 67.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.968 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -72.2 -38.97 68.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.749 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -81.56 -31.11 32.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.729 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.56 47.19 0.01 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.307 -0.86 . . . . 0.0 114.503 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -99.15 22.64 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.997 0.399 . . . . 0.0 110.98 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -168.84 -178.14 3.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HB2' ' HG3' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -120.49 171.5 8.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.535 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.927 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.7 m -71.44 -46.67 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 53' ' ' VAL . 20.0 m-80 -69.39 11.52 0.23 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.529 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.2 p-10 -67.86 -179.74 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -135.75 100.35 4.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.709 0.29 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.644 HG22 HG12 ' A' ' 88' ' ' VAL . 5.1 pt -61.25 94.95 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 121.414 0.626 . . . . 0.0 110.994 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 89' ' ' MET . 4.3 mt -66.85 -24.77 66.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.596 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -160.75 155.53 23.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.282 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.892 HG12 ' HB ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -129.66 -176.43 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.209 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.679 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -41.64 78.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.927 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.6 tt0 63.76 21.71 12.78 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.208 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.892 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.2 t -121.44 141.99 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 0.0 111.678 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.37 82.29 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.321 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HA ' HG22 ' A' ' 68' ' ' VAL . 9.4 m -94.72 31.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.583 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.85 -4.39 59.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.345 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 20.0 pt-20 176.64 56.66 0.0 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.033 0.444 . . . . 0.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 65' ' ' VAL . 30.5 m -118.69 142.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.748 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.744 ' N ' HG22 ' A' ' 23' ' ' THR . 1.2 m -50.2 161.31 0.29 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.631 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.713 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -53.76 -48.59 69.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.554 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 m -49.92 -43.72 49.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.873 0.368 . . . . 0.0 111.26 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.06 73.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.629 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.61 69.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.604 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.713 HG23 ' CD2' ' A' ' 70' ' ' HIS . 40.0 t -64.4 -35.87 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.644 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.49 -33.74 73.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.797 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -69.57 -43.12 73.5 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.396 0.617 . . . . 0.0 110.555 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.653 HD13 HG21 ' B' ' 9' ' ' VAL . 3.2 pp -76.28 -26.74 56.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.486 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -71.16 -42.53 68.99 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.196 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -104.16 29.77 5.72 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.379 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -85.33 -25.78 26.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.435 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.64 -137.36 20.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.488 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 83' ' ' ILE . 35.8 m -121.91 16.43 10.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.572 0.225 . . . . 0.0 111.346 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.855 HG23 ' HG2' ' A' ' 9' ' ' GLU . 1.6 mt -152.17 92.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.2 t -87.22 149.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 111.921 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -137.98 84.86 2.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.723 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.711 HD13 HG13 ' A' ' 88' ' ' VAL . 0.5 OUTLIER -116.67 154.21 30.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.2 t80 -105.66 114.93 29.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.686 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.711 HG13 HD13 ' A' ' 86' ' ' LEU . 10.8 m -121.37 167.97 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 58' ' ' LEU . 1.1 ttp -121.08 109.61 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.959 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HG3' ' HB2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -132.39 143.43 49.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.033 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.5 ttp85 -77.99 135.48 37.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.779 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.45 84.18 23.01 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.146 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -61.85 119.58 6.78 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.701 2.267 . . . . 0.0 112.208 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.78 91.76 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.643 2.229 . . . . 0.0 112.252 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.16 44.74 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.627 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.34 125.67 28.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.553 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.51 -177.11 6.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.193 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.727 HG13 HD21 ' A' ' 153' ' ' LEU . 11.2 t -109.19 154.28 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 76.0 mmm -128.86 166.68 18.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.129 0.49 . . . . 0.0 111.236 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -127.86 106.45 9.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 183' ' ' VAL . 1.8 mm -118.07 155.31 20.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.619 . . . . 0.0 112.606 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -111.93 126.91 55.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.062 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 140' ' ' ALA . 1.4 tt -129.91 118.72 22.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.809 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.97 144.74 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -80.0 156.93 26.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.998 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 -174.01 13.46 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.86 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.74 -39.72 6.2 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.035 1.823 . . . . 0.0 112.063 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -95.21 22.75 6.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.66 -165.61 12.67 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.63 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD23 HD22 ' A' ' 103' ' ' LEU . 1.4 mp -80.85 -13.49 58.89 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.175 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.798 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 86.17 51.84 3.43 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.829 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.94 149.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.665 0.269 . . . . 0.0 110.75 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.442 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 17.0 m -115.31 116.92 29.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.798 0.332 . . . . 0.0 110.674 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.626 ' CG1' HD22 ' A' ' 172' ' ' LEU . 5.5 pt -127.47 152.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.91 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -143.49 125.02 14.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.802 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.65 -175.06 25.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.915 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.62 134.71 8.54 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.203 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.5 t -59.24 153.13 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.237 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.58 -32.13 6.83 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 178.48 76.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 171.61 7.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.103 0.477 . . . . 0.0 110.924 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.91 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 66.9 t60 -49.8 -50.54 44.54 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.071 0.938 . . . . 0.0 110.516 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.925 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -96.58 129.63 32.61 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 113.616 -1.629 . . . . 0.0 110.836 -178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.14 78.47 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.307 2.005 . . . . 0.0 112.593 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.47 37.57 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.938 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.33 95.16 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.956 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -52.13 -25.18 8.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.2 m -54.45 115.9 2.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.684 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.802 HG12 ' HA3' ' A' ' 116' ' ' GLY . 11.7 mt -61.8 120.53 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.298 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.925 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -111.98 156.97 21.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.317 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.6 t -87.95 153.32 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.823 0.344 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.479 HG22 ' ND1' ' A' ' 122' ' ' HIS . 11.6 p -115.54 -58.04 2.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.402 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.82 147.69 23.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.016 0.436 . . . . 0.0 111.472 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.798 HG23 ' O ' ' A' ' 111' ' ' GLY . 4.2 mt -125.32 141.58 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.18 173.44 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.671 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -90.35 147.24 23.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.82 55.25 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.44 174.33 53.26 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.809 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.16 -50.17 50.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.422 . . . . 0.0 111.111 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 103' ' ' LEU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.369 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -54.87 -54.82 37.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.218 0.532 . . . . 0.0 110.309 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -72.87 -51.96 16.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.053 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -80.56 -59.36 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 111.85 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -51.6 -52.1 35.12 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.133 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 60.88 19.81 10.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 0.0 110.794 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -98.57 78.48 2.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.01 174.26 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.703 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 132' ' ' THR . 30.0 mt -48.06 132.34 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.172 0.51 . . . . 0.0 111.18 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 112.66 -28.36 9.04 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.251 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.739 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -61.16 145.3 51.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.672 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -132.65 136.85 46.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.66 132.4 52.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.713 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.727 HD21 HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -101.45 -1.65 32.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.241 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 182' ' ' LYS . . . 173.97 162.98 0.18 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.967 0.413 . . . . 0.0 111.283 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.64 HG12 HD22 ' A' ' 156' ' ' ASN . 25.6 t -117.67 99.95 9.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.143 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.64 HD22 HG12 ' A' ' 155' ' ' VAL . 65.4 m-80 69.2 -59.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.309 0.576 . . . . 0.0 109.817 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.45 26.77 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.353 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 6.3 t -109.23 154.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.26 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.37 76.88 0.26 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.68 HD13 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -80.26 24.01 0.46 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.72 58.01 1.56 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.201 0.524 . . . . 0.0 110.77 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.1 29.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.543 HG11 ' CG ' ' A' ' 167' ' ' ASP . 2.4 t -136.61 -74.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.132 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 4.3 mtm -174.45 -170.3 0.5 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.453 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 169' ' ' VAL . 70.0 t60 -70.86 -32.87 70.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.943 0.401 . . . . 0.0 110.589 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.79 -46.7 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.543 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.77 -35.14 69.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 -179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.28 -39.01 75.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.315 0.579 . . . . 0.0 109.463 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.85 ' HA ' HD23 ' A' ' 172' ' ' LEU . 12.6 t -73.65 -39.95 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.48 71.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.03 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 160' ' ' LEU . . . -78.17 -25.68 47.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.929 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -81.05 -40.71 23.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.51 59.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.19 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -12.33 32.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.416 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.53 147.52 0.84 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.877 0.37 . . . . 0.0 111.587 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.419 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 69.2 t80 -86.13 169.54 13.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.978 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.419 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 3.2 t70 -46.77 -30.81 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.079 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.55 HG13 HG22 ' A' ' 104' ' ' ILE . 41.8 t -147.91 91.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.649 0.261 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 176' ' ' TYR . 0.0 OUTLIER -123.83 148.4 27.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.008 0.433 . . . . 0.0 111.734 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.3 m-85 -98.34 128.32 44.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.421 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -112.54 152.67 28.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 -179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.718 ' HD2' ' HB3' ' A' ' 154' ' ' ALA . 9.6 mttt -96.56 118.7 33.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.495 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HG13 ' A' ' 101' ' ' ILE . 20.8 t -102.35 161.26 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.352 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.502 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -125.92 136.26 52.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.739 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.6 OUTLIER -83.85 137.47 40.87 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.658 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.684 ' HD2' ' HB3' ' A' ' 189' ' ' ALA . 4.5 Cg_exo -74.83 48.95 2.08 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.736 2.29 . . . . 0.0 112.871 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.2 t 53.04 103.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.872 0.368 . . . . 0.0 111.345 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.1 26.85 10.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.146 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.68 0.276 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.415 ' O ' HG13 ' B' ' 2' ' ' VAL . 2.9 p 42.67 93.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.564 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.44 ' O ' HG23 ' B' ' 3' ' ' VAL . 8.9 m -87.23 108.7 20.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.08 -35.56 5.14 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.396 2.064 . . . . 0.0 112.392 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -165.53 -175.23 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.55 158.92 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.66 171.31 14.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.969 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -162.6 128.0 3.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.84 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 77' ' ' LEU . 9.7 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.073 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.836 0.351 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 24.3 t 63.99 94.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' C' ' 4' ' ' PRO . 13.3 t -78.8 -47.91 1.73 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.569 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' C' ' 3' ' ' VAL . 96.9 Cg_endo -80.0 -177.91 4.15 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.301 2.001 . . . . 0.0 112.352 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -177.08 -60.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 3.1 m 61.12 162.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.463 ' CB ' HD21 ' A' ' 172' ' ' LEU . 6.1 t -78.77 94.38 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.1 t -90.96 100.26 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.44 HG23 ' OXT' ' C' ' 9' ' ' VAL . 4.6 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.102 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.803 0.335 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.91 162.8 38.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.02 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.92 163.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.567 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -174.86 162.17 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.376 . . . . 0.0 111.259 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 6.0 pt-20 -95.97 147.47 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.727 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 7' ' ' THR . 27.0 mt -146.78 165.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.751 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.602 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -129.74 147.17 51.49 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.198 0.523 . . . . 0.0 111.835 -178.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.832 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -135.51 87.33 2.31 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.412 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -79.81 118.85 21.97 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.251 179.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -41.78 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.396 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.69 -26.65 8.05 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.591 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.28 -85.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.31 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 m -109.23 30.69 6.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.24 177.98 24.72 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 119.716 -1.23 . . . . 0.0 112.809 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.26 -47.33 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.462 -0.369 . . . . 0.0 111.499 -179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.09 62.14 1.02 Allowed Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.827 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.6 p90 -165.13 169.19 16.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.963 0.381 . . . . 0.0 111.351 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -119.56 126.76 52.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.535 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 14.0 pt -116.45 157.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.241 0.544 . . . . 0.0 111.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.71 148.09 1.85 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.502 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.7 16.9 2.41 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.585 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 34' ' ' ILE . . . -47.06 173.46 0.02 OUTLIER Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.548 -0.358 . . . . 0.0 113.488 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.806 HG22 ' N ' ' A' ' 69' ' ' THR . 1.8 t -77.56 -35.7 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.701 ' CB ' HG23 ' A' ' 69' ' ' THR . 5.3 t0 -86.38 -42.44 13.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.334 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -123.86 77.25 57.66 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.429 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.49 171.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.619 2.213 . . . . 0.0 112.275 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.744 ' CE1' HG11 ' B' ' 2' ' ' VAL . 20.7 t60 -111.57 -21.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.339 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.537 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -106.94 -25.82 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.452 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 29.52 7.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.381 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.62 40.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.794 0.33 . . . . 0.0 111.185 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.66 108.48 2.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.837 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' THR . 16.8 Cg_exo -67.43 -22.32 45.53 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -82.92 136.81 34.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' HA2' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -82.68 145.96 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.219 179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.537 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.7 p90 -142.17 142.95 32.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 0.0 110.568 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 18' ' ' SER . 33.9 mt -69.75 146.87 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.753 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 53' ' ' VAL . 3.0 m -101.26 -33.87 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.076 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.728 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -172.24 143.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.291 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.6 OUTLIER -107.24 141.45 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.137 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.47 135.13 41.41 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 63.72 4.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.48 -43.32 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.599 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.06 178.5 1.87 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.656 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -76.18 -19.76 58.15 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' N ' HD11 ' A' ' 8' ' ' LEU . . . -52.92 -57.55 9.9 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.934 0.397 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -28.5 69.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.903 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -72.02 -35.02 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.575 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.43 -20.19 25.55 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.454 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.17 80.26 1.0 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.613 HH22 HD11 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -88.3 22.02 2.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 52' ' ' ARG . 3.2 pp 36.7 -154.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.11 128.72 38.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 111.158 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 38' ' ' LYS . 26.4 m -57.77 -41.61 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.229 0.538 . . . . 0.0 111.322 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 53' ' ' VAL . 2.1 m-80 -50.45 -17.19 0.44 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.944 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 33.8 p-10 -57.67 150.43 19.5 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -121.7 129.8 53.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -65.82 94.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.1 mt -58.47 -26.89 63.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.514 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -162.93 145.45 10.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.563 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.0 OUTLIER -108.3 -176.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.376 179.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.4 m120 -21.78 -52.35 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.943 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.63 25.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.945 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.7 t -121.58 142.06 39.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.529 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 8.0 p-10 -79.61 87.13 5.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.228 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.6 m -94.09 30.4 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.75 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -82.66 2.03 35.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.862 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 175.98 58.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG21 HG12 ' A' ' 65' ' ' VAL . 34.9 m -118.61 142.8 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.715 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.806 ' N ' HG22 ' A' ' 23' ' ' THR . 5.4 m -49.81 161.94 0.21 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.126 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.468 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.1 t-160 -60.34 -48.61 81.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.301 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -37.99 81.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.252 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.43 -36.48 76.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.05 -43.13 65.42 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.968 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 77' ' ' LEU . 53.6 t -64.63 -35.71 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.912 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.53 -33.35 72.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.863 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.747 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.41 -43.03 74.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.525 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -77.11 -26.76 53.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.538 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -72.51 -41.1 66.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.399 179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 28.45 6.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.878 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -96.63 -19.13 19.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.512 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.94 -159.29 16.62 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.862 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -99.75 10.09 41.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.619 0.247 . . . . 0.0 111.464 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -152.93 94.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 HG12 ' CB ' ' A' ' 80' ' ' ALA . 26.9 m -90.64 134.89 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.602 ' HG2' HG22 ' A' ' 7' ' ' THR . 3.6 mmt180 -116.7 102.11 9.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD13 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -128.82 154.25 46.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.404 0.621 . . . . 0.0 112.546 -178.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER -103.77 115.27 30.16 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.677 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 57' ' ' ILE . 34.4 m -104.22 167.94 2.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 112.388 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.4 ttp -126.0 109.62 12.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.844 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -129.51 146.73 51.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.134 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.11 131.16 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 57.94 3.2 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.619 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.1 Cg_endo -67.15 113.17 2.75 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.606 2.204 . . . . 0.0 112.365 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.508 ' HA ' ' HB2' ' A' ' 188' ' ' ASN . 36.4 Cg_endo -95.8 128.03 0.38 Allowed 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 123.51 2.806 . . . . 0.0 111.681 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.12 21.66 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.617 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -98.24 105.5 17.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.525 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.23 124.16 44.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.187 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 98' ' ' VAL . 15.0 p -84.66 114.48 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.888 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.53 166.69 11.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.256 0.55 . . . . 0.0 111.861 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -135.49 106.5 6.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' CG2' ' HA2' ' A' ' 144' ' ' GLY . 3.4 mm -114.14 155.27 15.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 3.7 mttp -114.2 120.93 42.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.364 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.786 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -119.52 118.75 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.369 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.3 pt -95.14 144.68 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 120.967 0.413 . . . . 0.0 111.226 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -58.79 151.65 20.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.135 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.93 160.16 23.21 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.646 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.95 -40.54 80.51 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 C-N-CA 122.119 1.879 . . . . 0.0 112.129 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.71 19.69 9.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.05 0.452 . . . . 0.0 110.101 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.4 -144.57 16.0 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.786 HD23 HD13 ' A' ' 103' ' ' LEU . 8.5 mp -86.56 -20.06 28.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.084 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.33 61.51 3.89 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.92 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 145.75 0.45 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.875 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.8 t -109.98 117.4 33.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.832 HD11 HD22 ' A' ' 172' ' ' LEU . 6.3 pt -130.87 154.66 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.004 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.65 125.0 10.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.022 0.439 . . . . 0.0 111.755 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.552 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.54 -175.01 25.2 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.516 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.4 -164.17 54.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.195 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.46 150.05 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 111.149 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.21 -30.51 7.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.973 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -164.66 69.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.053 0.454 . . . . 0.0 109.897 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.569 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 2.9 mt-30 -67.1 -11.24 56.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.655 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 60.8 t60 72.43 -54.68 0.68 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.65 0.738 . . . . 0.0 110.944 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.823 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -92.38 138.14 24.28 Favored Pre-proline 0 C--N 1.31 -1.117 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.741 -179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.2 Cg_endo -73.54 60.94 4.3 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.356 2.037 . . . . 0.0 112.563 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 130.74 55.87 0.09 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.904 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -175.55 96.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -57.85 -22.13 46.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.254 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -58.33 141.92 49.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 160' ' ' LEU . 14.9 mt -74.65 127.66 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.944 0.402 . . . . 0.0 111.249 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.823 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.9 m-85 -122.4 146.52 47.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.26 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.2 t -76.93 155.59 5.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.592 HG21 ' OG ' ' C' ' 6' ' ' SER . 6.9 p -119.62 -59.18 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.07 146.69 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.924 0.393 . . . . 0.0 111.157 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 147' ' ' GLN . 17.1 mt -134.4 141.49 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.74 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.672 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.1 mt-10 -97.0 153.17 18.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 52.59 31.2 36.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.738 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.36 -167.97 39.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.697 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.02 -60.92 2.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.41 . . . . 0.0 111.253 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -68.3 -31.94 71.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.273 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -59.07 -51.11 71.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.212 0.529 . . . . 0.0 110.009 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -72.82 -52.99 12.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.772 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.6 -59.24 2.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.794 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.449 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -52.63 -53.34 33.04 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.068 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 28.4 mmm-85 64.98 16.46 10.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.019 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.507 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.05 78.46 4.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.518 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.583 ' HA ' HD12 ' A' ' 134' ' ' ILE . 2.8 pt20 -61.14 175.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.3 mt -47.94 129.9 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.196 0.522 . . . . 0.0 111.175 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 115.48 -27.04 8.67 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.297 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -64.09 138.33 58.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.359 . . . . 0.0 110.546 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.695 ' CE ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -126.83 131.31 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.037 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.639 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -102.51 134.56 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.884 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -100.82 -1.92 33.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.923 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.15 163.71 0.38 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.908 0.385 . . . . 0.0 111.08 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 158' ' ' VAL . 25.2 t -119.46 99.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.224 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.498 ' ND2' HG12 ' A' ' 155' ' ' VAL . 66.9 m-80 69.82 -59.91 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.395 0.617 . . . . 0.0 109.762 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -164.75 27.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.17 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.1 t -108.47 154.55 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.295 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.45 77.1 0.28 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -80.93 24.44 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -132.09 30.97 4.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.173 0.511 . . . . 0.0 110.905 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -141.98 28.44 1.73 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.272 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.702 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.5 t -139.93 -78.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.383 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtp -179.14 -169.74 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 169' ' ' VAL . 17.0 t60 -70.43 -31.59 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.494 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -47.57 39.62 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.702 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -69.96 -37.12 75.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.84 0.352 . . . . 0.0 110.642 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 160' ' ' LEU . . . -70.14 -38.8 75.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.237 0.542 . . . . 0.0 109.634 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 172' ' ' LEU . 13.1 t -72.28 -39.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.428 ' HA ' ' CG ' ' A' ' 173' ' ' LYS . . . -71.74 -29.73 64.84 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.016 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.54 55.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.1 pp -81.7 -37.87 26.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -74.96 -26.44 59.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.854 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.81 -15.24 53.29 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.602 ' HB ' HG21 ' A' ' 179' ' ' VAL . 25.3 p -50.11 -178.74 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.735 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.493 ' CD1' HG13 ' A' ' 179' ' ' VAL . 9.0 p90 -132.46 -160.41 1.05 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.733 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.527 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 6.3 t0 -53.37 -34.79 59.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.427 ' O ' ' CZ ' ' A' ' 176' ' ' TYR . 35.2 t -147.86 92.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 0.0 111.596 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.602 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.5 OUTLIER -111.01 131.38 62.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.054 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 10.2 p90 -94.05 124.47 38.08 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -109.58 153.87 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 111.374 -178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.56 ' O ' HG22 ' A' ' 152' ' ' ILE . 1.1 mptm? -96.93 110.91 23.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.608 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 152' ' ' ILE . 12.8 t -102.21 159.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.306 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.695 ' HB3' ' CE ' ' A' ' 151' ' ' LYS . . . -140.74 145.24 36.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.54 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -99.08 146.06 31.05 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.63 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.76 123.76 14.53 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.525 2.15 . . . . 0.0 112.103 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.3 t -54.55 -177.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 94' ' ' PRO . 15.6 t-20 -66.24 72.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.168 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.901 0.381 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.744 HG11 ' CE1' ' A' ' 27' ' ' HIS . 11.2 p -178.46 49.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' B' ' 4' ' ' PRO . 11.4 t -76.16 -48.08 3.45 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.423 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 3' ' ' VAL . 90.3 Cg_endo -79.01 -31.42 2.29 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.26 1.973 . . . . 0.0 112.465 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.6 80.76 5.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.934 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.94 145.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.473 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.44 ' HB3' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -94.26 95.71 9.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.943 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.38 80.27 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.473 ' OXT' HG12 ' B' ' 9' ' ' VAL . 29.5 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.184 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.786 HG12 HG23 ' C' ' 3' ' ' VAL . 19.1 t 63.77 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.786 HG23 HG12 ' C' ' 2' ' ' VAL . 25.7 t 64.04 83.23 0.2 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 156.52 12.84 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.594 2.196 . . . . 0.0 112.151 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -97.55 -64.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.592 ' OG ' HG21 ' A' ' 132' ' ' THR . 49.3 m -103.24 151.33 22.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -75.01 93.72 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -86.49 116.4 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.117 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 mtt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -124.65 168.25 13.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.27 178.7 7.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' HB2' ' NH2' ' A' ' 90' ' ' ARG . 5.7 tt0 -174.04 142.81 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.472 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 8.6 pt-20 -108.86 111.47 23.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.744 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.632 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -120.29 -169.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.168 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -140.82 133.36 28.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.397 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -113.29 88.93 2.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.417 0.627 . . . . 0.0 111.067 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HB3' HG23 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -82.54 116.79 22.12 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.377 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 mtt180 -40.63 95.25 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.406 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.15 -26.87 6.68 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.828 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -169.65 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.677 0.275 . . . . 0.0 110.632 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.3 t -109.17 30.66 6.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.82 177.41 23.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.984 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.781 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.28 -45.77 12.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.251 -179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' CA ' HD11 ' A' ' 40' ' ' ILE . . . 89.54 64.27 1.27 Allowed Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.682 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.54 ' HD2' ' HB2' ' A' ' 45' ' ' ALA . 10.1 p90 -164.9 146.38 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.92 0.391 . . . . 0.0 110.784 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.721 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -96.01 165.3 12.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.101 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.0 pt -152.96 159.63 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.82 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -167.22 154.95 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.225 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.49 -127.45 6.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.9 144.31 8.39 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.287 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.678 HG22 ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -57.91 -20.01 33.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.349 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' HG22 ' A' ' 69' ' ' THR . 19.3 t70 -94.34 -42.1 9.08 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.696 0.284 . . . . 0.0 111.085 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -123.76 77.59 56.82 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.41 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -47.46 129.4 16.42 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.715 2.276 . . . . 0.0 112.477 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 35' ' ' PHE . 78.6 t60 -57.22 -72.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.078 0.466 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.475 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -55.9 -42.0 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.551 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.36 23.63 5.07 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.444 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.28 29.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 2.4 m-20 -160.43 103.44 1.35 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.813 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.8 Cg_endo -55.89 -26.08 56.11 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.465 2.11 . . . . 0.0 111.998 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -66.71 147.94 52.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -94.28 151.74 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 111.288 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -142.39 158.07 44.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.717 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 18' ' ' SER . 65.4 mt -77.03 148.65 6.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.601 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.31 -30.05 10.38 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.514 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.736 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.64 146.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 111.269 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -116.45 141.11 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.766 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.448 HD11 ' CA ' ' A' ' 16' ' ' GLY . 2.7 pt -89.65 139.45 27.96 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.17 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.93 64.25 7.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.564 2.176 . . . . 0.0 112.414 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.14 -41.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.642 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.14 177.35 15.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.594 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -75.95 -20.94 57.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.631 0.253 . . . . 0.0 111.404 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -52.96 -57.28 10.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.944 0.402 . . . . 0.0 110.942 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.76 -28.32 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -71.87 -40.28 69.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.23 0.538 . . . . 0.0 109.605 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' OD2' HD13 ' A' ' 8' ' ' LEU . 20.4 m-20 -80.55 -20.22 43.93 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.333 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.54 83.85 0.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.443 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.657 ' NH2' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -89.37 13.8 12.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.72 0.295 . . . . 0.0 111.16 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.832 HD22 ' HG3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER 64.42 -163.68 0.26 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.392 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.86 146.85 20.69 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 111.281 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.736 HG11 ' HA ' ' A' ' 38' ' ' LYS . 6.6 m -63.18 -42.55 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.576 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' N ' HG23 ' A' ' 53' ' ' VAL . 19.9 m-80 -52.36 -11.81 0.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.44 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.405 ' CB ' ' HB3' ' A' ' 90' ' ' ARG . 35.3 p-10 -63.55 152.56 38.32 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.3 p -119.04 120.22 36.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.009 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.625 HG22 HG12 ' A' ' 88' ' ' VAL . 2.6 pt -60.83 94.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.575 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -60.7 -26.28 67.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.907 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.654 ' HD2' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -164.87 140.1 5.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.381 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -125.13 118.87 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.649 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.44 -76.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.706 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.9 tt0 -160.44 30.64 0.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.415 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 59' ' ' PHE . 17.7 t -120.82 140.73 44.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.27 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 5.3 p-10 -79.71 107.97 12.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.76 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 65' ' ' VAL . 24.1 t -125.57 39.69 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -95.51 -2.07 49.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -175.77 49.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.172 0.51 . . . . 0.0 109.938 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' CG2' HG13 ' A' ' 65' ' ' VAL . 35.2 m -115.96 142.35 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.638 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.678 ' CG2' HG22 ' A' ' 23' ' ' THR . 66.7 p -49.65 161.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.839 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -59.01 -48.71 80.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.079 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.0 t -58.78 -40.8 85.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.989 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -32.37 68.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.46 69.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.59 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' HA ' HD21 ' A' ' 77' ' ' LEU . 39.8 t -64.92 -35.3 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.469 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 78' ' ' LYS . 37.6 tp10 -69.47 -33.51 73.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.763 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.57 73.07 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.317 0.58 . . . . 0.0 110.563 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -74.77 -26.41 59.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.387 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -67.76 -41.41 83.37 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.157 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -104.55 28.24 7.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.688 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.37 -24.74 23.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.36 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.57 -160.49 18.97 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.909 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 68.3 m -97.34 -36.54 10.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 110.96 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.638 HG23 ' HB3' ' A' ' 9' ' ' GLU . 9.0 mt -112.87 85.1 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 84' ' ' VAL . 17.7 m -90.61 115.15 29.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.091 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.441 ' CG ' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -91.28 101.25 13.95 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -117.28 154.28 31.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.51 114.99 28.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.328 178.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 57' ' ' ILE . 32.3 m -104.38 159.91 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.195 0.522 . . . . 0.0 112.229 -178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.68 109.66 15.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.658 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.832 ' HG3' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.39 144.81 51.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.214 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -68.78 139.65 55.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.641 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -50.34 105.95 0.58 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.296 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 43.4 Cg_endo -67.84 179.79 2.51 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.411 2.074 . . . . 0.0 112.015 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.723 ' HA ' ' HB2' ' A' ' 189' ' ' ALA . 32.5 Cg_exo -59.18 -151.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.385 2.057 . . . . 0.0 112.307 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 187' ' ' SER . . . 58.16 44.84 18.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.139 0.495 . . . . 0.0 109.74 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.948 ' HA ' ' HA ' ' A' ' 186' ' ' PRO . 4.0 pt-20 179.74 87.91 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.315 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 187' ' ' SER . 16.9 tttp -96.63 162.61 13.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 111.065 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.4 t -123.61 136.33 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.54 166.64 15.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.179 0.514 . . . . 0.0 111.431 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.97 106.41 6.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.638 HG13 HG21 ' A' ' 183' ' ' VAL . 3.5 mm -114.53 155.21 15.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -108.89 123.73 49.53 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.226 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.788 ' CB ' HD21 ' A' ' 181' ' ' LEU . 3.1 tt -126.14 118.57 25.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.755 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.663 HG12 ' HB1' ' A' ' 139' ' ' ALA . 4.6 pt -95.46 144.65 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.66 155.77 25.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.032 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.66 178.11 18.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.892 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.93 -31.25 38.35 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.103 1.869 . . . . 0.0 112.006 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -96.89 19.68 12.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.019 0.438 . . . . 0.0 110.413 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.76 -156.36 16.55 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.539 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD23 HD22 ' A' ' 103' ' ' LEU . 6.3 mp -86.5 -13.27 46.53 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.12 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 81.24 49.45 5.53 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.978 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.2 154.32 0.84 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.808 0.337 . . . . 0.0 111.079 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.2 t -116.84 116.64 27.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.974 0.416 . . . . 0.0 110.684 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.755 HG22 HG22 ' A' ' 131' ' ' VAL . 14.3 pt -129.52 157.25 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.538 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -154.44 125.75 7.37 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.47 -175.24 25.42 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.19 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.67 -165.76 48.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.182 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 24.3 t -87.95 148.25 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.172 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.61 -10.97 60.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.516 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.97 65.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 109.918 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -76.21 -0.61 22.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.908 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 82.4 t60 72.69 -60.99 0.52 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.702 0.763 . . . . 0.0 110.568 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.937 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.8 OUTLIER -94.6 107.03 27.48 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.668 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.49 89.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.394 2.062 . . . . 0.0 112.512 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 108.46 34.4 2.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -155.47 90.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.977 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -53.9 -23.26 12.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.348 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 m -56.67 137.48 54.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.693 HG12 ' HA3' ' A' ' 116' ' ' GLY . 3.7 mt -78.86 116.22 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.392 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.937 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.9 m-85 -113.06 150.08 32.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.631 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 150' ' ' ASP . 45.2 t -85.07 155.72 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.422 ' N ' HG12 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -128.52 -45.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.405 ' N ' ' CG2' ' A' ' 132' ' ' THR . 0.0 OUTLIER -144.34 146.27 32.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.731 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 147' ' ' GLN . 24.0 mt -136.81 141.43 40.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.999 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -71.89 173.41 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.62 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -92.4 137.28 32.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.844 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.42 27.19 40.03 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.627 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.59 178.43 50.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.661 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.663 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -65.14 -54.72 25.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.135 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.11 -32.75 70.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -60.0 -55.36 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.239 0.542 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -46.56 52.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.867 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -80.73 -59.47 2.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.032 0.444 . . . . 0.0 112.053 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -60.95 -46.34 94.77 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.247 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.54 17.25 10.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.786 0.327 . . . . 0.0 110.74 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.499 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -91.39 79.2 5.62 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.722 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.502 ' HA ' HD12 ' A' ' 134' ' ' ILE . 12.7 pt20 -60.0 170.98 1.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.0 mt -47.6 126.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.149 0.5 . . . . 0.0 111.281 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.99 -23.87 9.12 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.514 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.808 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -65.12 129.12 38.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.827 0.346 . . . . 0.0 110.517 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.903 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -115.62 131.45 56.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.244 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -104.9 134.61 45.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.715 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.553 HD23 ' HB2' ' A' ' 184' ' ' ALA . 2.2 pp -103.9 -2.07 26.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.137 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 176.61 159.9 0.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.896 0.379 . . . . 0.0 111.457 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.802 HG12 HD22 ' A' ' 156' ' ' ASN . 11.7 t -115.52 100.19 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.988 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.802 HD22 HG12 ' A' ' 155' ' ' VAL . 20.2 m-80 69.28 -59.5 0.48 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.367 0.604 . . . . 0.0 109.635 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.3 OUTLIER -165.49 28.96 0.05 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.989 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 155' ' ' VAL . 9.9 t -106.46 154.81 7.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.42 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.36 76.45 0.25 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.183 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.598 ' O ' HD11 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -78.15 24.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.91 35.23 2.61 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.234 0.54 . . . . 0.0 110.742 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -143.02 28.59 1.54 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.582 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.762 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -142.04 -77.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.083 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.6 mtm -179.4 -171.59 0.2 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 169' ' ' VAL . 25.5 p80 -71.84 -32.67 67.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.007 0.432 . . . . 0.0 110.301 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -73.72 -42.4 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.762 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.11 -37.81 66.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.906 0.384 . . . . 0.0 110.569 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.71 74.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 165' ' ' HIS . 23.8 t -72.69 -43.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.481 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 174' ' ' ASN . . . -71.86 -30.18 65.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.044 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.51 -29.14 56.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.472 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 173' ' ' LYS . 4.2 pp -81.66 -37.58 27.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.022 0.439 . . . . 0.0 110.211 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.915 ' N ' HD12 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -75.15 -26.55 59.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.937 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -69.99 -13.67 62.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.439 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.686 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.7 p -56.84 -168.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 177' ' ' ASP . 64.0 t80 -106.18 172.46 6.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.2 m-20 -58.28 -15.97 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.202 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.7 t -147.52 92.23 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.262 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -124.86 147.91 29.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.282 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.445 ' CE1' ' HA ' ' A' ' 156' ' ' ASN . 18.4 p90 -100.93 129.71 46.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.788 HD21 ' CB ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -108.99 154.37 22.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.121 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.751 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.61 116.93 29.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.786 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.638 HG21 HG13 ' A' ' 101' ' ' ILE . 19.6 t -101.89 162.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.491 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.903 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -138.83 117.23 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.055 0.455 . . . . 0.0 111.936 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -113.61 97.82 45.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.599 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.948 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 80.2 Cg_exo -45.76 96.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.756 2.304 . . . . 0.0 113.856 -178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 1.7 m -179.81 136.25 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 94' ' ' PRO . 10.3 p30 42.74 30.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.371 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 94' ' ' PRO . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.216 -0.897 . . . . 0.0 111.095 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.831 0.348 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.573 ' O ' HG12 ' B' ' 2' ' ' VAL . 17.0 t -98.68 34.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.02 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 5.1 m -144.09 112.72 5.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.15 -171.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.438 2.092 . . . . 0.0 112.274 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -150.91 158.24 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 18.6 m -66.08 164.68 14.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -99.42 141.78 31.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -127.19 124.24 38.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.491 ' OXT' HD12 ' A' ' 15' ' ' LEU . 8.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.0 -47.08 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.16 123.28 30.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.32 105.09 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.491 2.128 . . . . 0.0 112.275 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 62.51 135.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -66.65 -67.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.402 ' HB3' HG12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -109.48 130.81 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.067 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' HG13 ' C' ' 9' ' ' VAL . 0.6 OUTLIER -154.82 73.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.69 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.545 HG13 ' O ' ' C' ' 8' ' ' SER . 6.7 m . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.091 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.93 145.96 37.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.001 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.26 141.1 27.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.584 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 5.7 pt-20 -175.01 165.92 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 111.417 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -109.37 123.47 49.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.771 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -123.62 -172.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.316 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.1 OUTLIER -140.44 127.95 21.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.259 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.88 ' HG ' HD23 ' A' ' 15' ' ' LEU . 5.8 tp -119.05 91.42 3.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.638 0.732 . . . . 0.0 110.561 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -73.79 138.84 44.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.601 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 82' ' ' SER . 2.5 ptm180 -57.85 103.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.35 -26.91 7.3 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.43 -0.891 . . . . 0.0 111.547 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -168.15 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -109.15 30.71 6.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.725 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.94 174.68 19.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.441 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.33 -50.49 7.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.942 0.401 . . . . 0.0 111.304 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.23 74.64 1.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.69 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 39' ' ' ILE . 2.9 p90 -164.65 156.46 15.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.799 0.333 . . . . 0.0 111.029 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' ILE . 2.1 p -105.93 126.81 52.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.896 HG22 HG12 ' A' ' 36' ' ' ILE . 2.4 pp -120.43 154.49 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 0.0 111.945 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -172.97 147.49 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.754 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.41 19.62 1.34 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.993 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.11 162.92 0.08 OUTLIER Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.542 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.752 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -66.68 -38.73 87.39 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.788 ' CB ' HG23 ' A' ' 69' ' ' THR . 12.5 t0 -83.77 -49.17 9.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 111.631 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -117.69 76.89 10.77 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.582 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.69 172.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.646 2.23 . . . . 0.0 112.274 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.641 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 17.5 t60 -108.8 -21.45 12.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.212 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -104.74 -25.23 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.281 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.86 7.71 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.703 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 167.89 50.37 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.76 0.314 . . . . 0.0 111.178 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.13 101.49 2.82 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.017 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.15 61.83 2.55 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.903 2.402 . . . . 0.0 111.914 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 m -176.86 134.61 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.741 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.35 145.1 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.572 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 13.6 p90 -142.24 163.64 32.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.453 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 19' ' ' ILE . 49.2 mt -93.97 148.67 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.893 0.378 . . . . 0.0 110.84 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.67 -31.77 8.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.344 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.918 ' HA ' HG11 ' A' ' 53' ' ' VAL . 1.6 tmmm? -172.55 148.0 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.761 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.5 OUTLIER -106.95 141.62 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.78 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 mt -84.05 128.05 64.31 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.965 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.2 62.14 2.6 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.453 2.102 . . . . 0.0 112.23 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 -43.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.62 -177.26 22.87 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.521 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.94 -21.27 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.631 0.253 . . . . 0.0 111.532 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.0 -57.62 12.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 111.313 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.13 -28.25 67.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 0.0 110.75 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.21 -36.21 69.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.652 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 49' ' ' GLY . 34.0 m-20 -87.21 -25.98 23.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.327 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 28.47 54.7 0.13 Allowed Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.148 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.81 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -84.16 4.84 28.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.958 HD13 HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -177.76 -177.9 0.68 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.106 0.479 . . . . 0.0 111.547 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 165.19 11.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.396 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.918 HG11 ' HA ' ' A' ' 38' ' ' LYS . 34.5 m -71.13 -45.51 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' N ' HG23 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.72 17.6 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.564 ' CG ' HD12 ' A' ' 51' ' ' LEU . 7.5 p-10 -75.34 -166.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.33 100.05 3.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.881 0.372 . . . . 0.0 110.759 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.797 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -60.84 95.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.465 0.65 . . . . 0.0 111.058 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.664 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -70.94 -25.68 62.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.552 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -154.55 129.84 9.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.295 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.859 HG13 ' HB3' ' A' ' 86' ' ' LEU . 2.5 t -137.13 145.87 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.927 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.5 m120 42.24 32.43 0.32 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.471 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 65.66 32.7 8.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.75 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 60' ' ' VAL . 21.8 t -121.07 141.88 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.46 78.13 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.701 HG12 HG21 ' A' ' 68' ' ' VAL . 18.8 m -98.78 33.26 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.427 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -84.24 3.56 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.126 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -173.05 47.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.039 0.447 . . . . 0.0 109.837 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 65' ' ' VAL . 29.9 m -118.71 140.99 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.176 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -49.67 164.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.905 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.63 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.3 t-160 -57.39 -48.49 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.372 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -41.4 63.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.151 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.85 -34.58 76.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.94 -40.75 68.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.55 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 ' CD2' ' A' ' 70' ' ' HIS . 49.7 t -64.23 -35.83 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.658 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.39 -34.07 73.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.815 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.49 -42.92 74.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.305 0.574 . . . . 0.0 110.477 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.648 HD13 HG21 ' B' ' 9' ' ' VAL . 2.8 pp -76.8 -26.74 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.385 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -45.09 59.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.382 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -103.18 28.82 5.99 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.415 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.981 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -81.56 -27.83 34.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.508 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.09 -124.58 8.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.635 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG12 ' A' ' 83' ' ' ILE . 69.6 p -130.83 4.62 4.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -152.84 96.73 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.981 HG12 ' HB1' ' A' ' 80' ' ' ALA . 26.6 m -87.41 114.37 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -100.9 110.38 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.859 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -135.47 154.1 51.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.664 ' CD1' HD21 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -107.83 114.68 28.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.219 178.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 51' ' ' LEU . 12.6 m -118.97 168.1 11.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.113 0.482 . . . . 0.0 112.151 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.5 ptm -124.33 109.53 13.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.155 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 55' ' ' ASP . 1.2 ptt180 -129.14 141.53 51.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.75 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -71.61 114.56 9.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -69.89 111.69 9.92 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.06 127.79 3.55 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.531 2.154 . . . . 0.0 112.479 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.77 86.63 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.525 2.15 . . . . 0.0 111.963 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.18 29.28 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.112 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.27 146.1 37.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.326 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 -174.82 4.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 111.433 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.73 152.82 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.906 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.3 ttt -135.31 166.3 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 183' ' ' VAL . 3.9 mm -114.96 155.6 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.603 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 180' ' ' TYR . 1.6 ttpt -113.7 124.53 52.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.343 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.754 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 5.8 tt -125.79 118.4 25.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.638 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.602 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -94.87 144.68 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.195 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -65.75 155.24 36.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -134.82 -169.64 11.98 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.68 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.12 -40.13 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.022 1.815 . . . . 0.0 112.322 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 20.2 8.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.985 0.422 . . . . 0.0 110.277 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 106.81 -133.93 11.9 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.223 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 139' ' ' ALA . 6.5 mp -86.71 -27.03 23.94 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.935 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.1 40.75 4.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.669 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.12 154.59 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.062 0.458 . . . . 0.0 111.08 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.5 t -102.23 123.15 45.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.489 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.801 HD11 HD22 ' A' ' 172' ' ' LEU . 16.4 pt -130.1 155.26 41.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.505 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.775 ' HB3' ' CE1' ' A' ' 122' ' ' HIS . . . -162.41 125.47 2.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.051 0.453 . . . . 0.0 111.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 129' ' ' ILE . . . -153.93 -175.48 25.24 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.622 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.25 34.85 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.962 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.2 t -104.26 154.7 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.853 0.358 . . . . 0.0 111.377 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.72 -35.83 4.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.733 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 t30 175.05 78.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 110.608 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.13 115.11 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.158 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.775 ' CE1' ' HB3' ' A' ' 115' ' ' ALA . 0.6 OUTLIER -58.98 -17.58 26.15 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 ' CD1' ' A' ' 130' ' ' TYR . 1.1 mt -83.55 122.62 76.88 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.742 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.39 96.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.47 2.114 . . . . 0.0 112.165 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 59.85 58.31 14.85 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.356 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.93 87.01 1.95 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.571 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -43.53 -28.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.6 t -53.57 168.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.619 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.67 ' HB ' HD12 ' A' ' 152' ' ' ILE . 27.1 mt -105.86 127.27 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.935 0.398 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 123' ' ' ILE . 3.3 m-30 -117.27 154.67 30.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.502 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 134' ' ' ILE . 66.2 t -90.07 152.26 3.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.463 HG23 ' N ' ' A' ' 133' ' ' LYS . 5.9 t -123.62 -50.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' N ' HG23 ' A' ' 132' ' ' THR . 0.0 OUTLIER -134.22 142.42 47.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.682 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 131' ' ' VAL . 30.7 mt -136.99 138.46 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -80.16 172.93 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 135' ' ' ILE . 85.8 mt-10 -91.37 134.52 34.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.36 26.29 56.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.88 -138.79 0.12 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 110' ' ' LEU . . . -97.4 -72.77 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.906 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -61.47 -31.79 71.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.205 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 13.7 t-160 -56.41 -62.24 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 110.993 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -72.63 -34.3 67.23 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.985 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -59.36 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -88.13 -29.23 20.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.844 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 141' ' ' HIS . 1.3 ttm180 67.75 27.8 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.01 0.405 . . . . 0.0 110.527 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.906 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.3 OUTLIER -88.64 82.71 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.77 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -68.38 176.35 2.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.6 mt -47.87 121.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.299 0.571 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 128.4 -23.36 5.15 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.059 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 183' ' ' VAL . 9.3 t0 -57.94 139.51 54.19 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.773 0.321 . . . . 0.0 110.524 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -130.98 119.51 22.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.146 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.3 OUTLIER -102.99 131.98 50.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.092 0.472 . . . . 0.0 110.79 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 pp -104.3 -1.36 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.201 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 179.83 168.68 1.21 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.908 0.385 . . . . 0.0 111.295 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.718 HG12 HD22 ' A' ' 156' ' ' ASN . 58.6 t -117.88 100.44 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.635 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.718 HD22 HG12 ' A' ' 155' ' ' VAL . 66.4 m-80 70.42 -57.45 0.58 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.072 0.463 . . . . 0.0 110.081 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 m -165.31 21.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.325 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -116.32 132.61 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 111.165 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -95.0 68.38 1.19 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.863 HD22 ' HB1' ' A' ' 171' ' ' ALA . 4.0 pp -87.26 28.71 0.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.848 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.414 ' CB ' HG13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -122.29 37.17 4.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.168 0.508 . . . . 0.0 110.939 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -142.42 29.05 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.677 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -116.08 -76.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.443 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 5.2 mtm -176.45 -170.2 0.33 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.744 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.483 ' O ' HG23 ' A' ' 169' ' ' VAL . 4.0 t-80 -69.99 -34.17 72.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.663 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -73.7 -45.41 52.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.601 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.91 -37.46 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.879 0.371 . . . . 0.0 110.806 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.93 73.2 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.061 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.816 ' HA ' HD23 ' A' ' 172' ' ' LEU . 11.4 t -73.95 -39.97 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.708 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.2 -33.6 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.814 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.863 ' HB1' HD22 ' A' ' 160' ' ' LEU . . . -77.96 -27.04 49.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.816 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -76.18 -36.73 58.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.49 -26.87 60.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.44 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -9.95 55.87 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.519 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.8 p -47.73 149.53 1.24 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.753 0.311 . . . . 0.0 111.442 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -87.58 169.78 11.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.422 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t0 -45.12 -35.3 3.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.044 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 104' ' ' ILE . 40.8 t -147.85 91.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.95 148.04 22.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.661 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.435 ' CZ ' ' HD2' ' A' ' 102' ' ' LYS . 13.2 m-85 -96.42 127.05 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.602 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.647 HD23 HG13 ' A' ' 155' ' ' VAL . 1.5 mt -104.94 150.71 24.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.954 0.407 . . . . 0.0 110.597 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.9 tttm -96.8 114.27 25.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.658 HG21 HG13 ' A' ' 101' ' ' ILE . 18.8 t -101.68 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.967 0.413 . . . . 0.0 111.288 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.608 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -123.1 141.15 52.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.148 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.16 125.89 64.58 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 189' ' ' ALA . 54.2 Cg_exo -51.82 116.27 2.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.242 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.74 142.38 23.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.2 t30 53.19 27.25 5.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . 0.454 ' O ' HG12 ' B' ' 2' ' ' VAL . 2.7 mm-40 . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.688 0.28 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.62 HG22 ' O ' ' B' ' 2' ' ' VAL . 13.3 p 44.07 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.561 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 3.1 t -90.9 -47.23 0.37 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.492 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 36.0 Cg_endo -90.65 -72.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.823 2.349 . . . . 0.0 112.582 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.88 154.69 3.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.918 0.39 . . . . 0.0 111.008 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 6.8 p -146.06 158.77 43.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -97.78 108.24 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 111.006 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 71.7 m -103.26 102.81 12.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.678 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 77' ' ' LEU . 14.1 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.189 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.819 0.342 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 m -131.12 30.62 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.19 141.45 22.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.8 -171.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.425 2.083 . . . . 0.0 112.35 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.13 170.47 22.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 33.0 t -154.78 173.32 16.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.6 t -103.78 99.83 9.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -80.9 95.82 6.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.418 HG23 ' OXT' ' C' ' 9' ' ' VAL . 3.5 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.821 0.343 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -112.17 154.33 25.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -159.9 151.52 20.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -177.07 158.5 1.54 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 111.311 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -113.81 114.71 26.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.727 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -119.27 -176.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 120.979 0.418 . . . . 0.0 111.429 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.13 125.16 38.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.724 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 15' ' ' LEU . 13.9 tp -124.19 92.73 3.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.683 0.754 . . . . 0.0 109.97 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.16 161.69 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.22 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 15.0 ptm180 -73.14 98.51 2.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.876 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -49.87 -26.57 8.48 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.526 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -168.45 -87.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.529 -0.335 . . . . 0.0 110.143 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -109.18 30.73 6.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.23 177.4 18.16 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.019 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.974 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.48 -37.08 21.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.187 -179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 72.47 1.29 Allowed Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.967 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.55 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -156.49 157.11 34.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 178.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 36' ' ' ILE . 50.0 m -104.5 126.89 52.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.467 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.586 HD11 ' NE2' ' A' ' 70' ' ' HIS . 35.5 pt -105.4 163.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 0.0 111.74 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . . . -162.36 144.38 10.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.843 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.42 -144.75 18.21 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.708 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.09 142.83 5.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.366 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.675 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -48.6 -27.63 2.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 111.443 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.725 ' CB ' HG23 ' A' ' 69' ' ' THR . 16.7 t70 -81.58 -45.21 16.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.975 0.417 . . . . 0.0 110.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -123.92 84.73 54.44 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.043 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -41.99 144.19 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.868 2.379 . . . . 0.0 112.618 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 72.1 t60 -75.98 -49.61 17.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.637 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.485 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -97.73 -29.26 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.187 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.29 23.23 6.13 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.0 30.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -164.06 111.08 0.92 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.639 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.28 -23.68 75.47 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.732 2.288 . . . . 0.0 112.122 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -57.94 175.56 0.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.8 mp -104.01 160.81 4.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 27' ' ' HIS . 3.5 m-85 -132.21 166.28 22.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.189 0.519 . . . . 0.0 111.419 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 18' ' ' SER . 11.2 mt -116.71 151.54 18.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.837 ' O ' HG21 ' A' ' 53' ' ' VAL . 32.2 p -109.99 -44.31 3.82 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.532 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -162.8 158.38 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.196 0.522 . . . . 0.0 112.09 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -112.08 141.11 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.55 179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 mt -87.32 129.08 52.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.167 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 21.0 Cg_exo -65.34 64.64 0.35 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.537 2.158 . . . . 0.0 112.231 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.15 -43.45 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.271 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.56 160.21 52.85 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.319 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.471 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -54.86 -28.79 52.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.595 0.236 . . . . 0.0 111.455 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -58.89 -55.38 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 39' ' ' ILE . . . -65.66 -27.26 68.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.641 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -71.71 -42.47 67.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.667 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 3.2 m-20 -77.11 -36.22 55.7 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.394 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 27.3 44.01 0.03 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.391 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -76.1 -37.65 57.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.899 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -120.33 179.78 4.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 150.91 21.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.769 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.837 HG21 ' O ' ' A' ' 37' ' ' THR . 35.8 m -71.25 -35.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.403 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -70.21 14.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -83.38 -162.71 0.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.84 100.82 3.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -55.26 96.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 111.191 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 89' ' ' MET . 5.1 mt -68.17 -33.85 75.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.892 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.57 ' O ' HD23 ' A' ' 86' ' ' LEU . 69.1 m-85 -157.08 167.7 29.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.295 0.569 . . . . 0.0 111.955 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.926 HG13 ' HG ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -147.15 -177.95 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.013 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.81 ' O ' HG23 ' A' ' 63' ' ' VAL . 3.0 m-20 -40.32 91.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 111.592 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 50.32 31.02 4.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.069 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.2 t -120.94 128.85 76.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.883 0.373 . . . . 0.0 111.385 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -95.81 80.26 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.527 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG13 HG12 ' A' ' 63' ' ' VAL . 34.5 m -97.17 32.87 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.43 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -75.88 -5.3 45.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.266 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.62 46.8 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.936 0.398 . . . . 0.0 110.174 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.644 HG21 HG12 ' A' ' 65' ' ' VAL . 23.3 m -117.28 140.4 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.082 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.725 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.0 OUTLIER -50.61 166.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.501 -179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.586 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.3 t-160 -59.73 -48.64 80.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.434 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.56 69.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.53 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.7 -35.23 67.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.014 0.435 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -72.37 -42.56 65.13 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.163 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -64.51 -36.37 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.976 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.4 mt-10 -69.36 -33.68 73.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.922 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -69.65 -41.41 75.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.426 0.632 . . . . 0.0 110.53 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.786 HD13 HG21 ' B' ' 9' ' ' VAL . 3.2 pp -79.52 -26.9 41.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.457 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.49 -36.62 71.19 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.225 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -99.06 22.91 9.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.811 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB1' HG12 ' A' ' 84' ' ' VAL . . . -129.91 16.48 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.192 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.29 103.89 0.88 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.965 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.54 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER 166.45 -70.77 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.409 . . . . 0.0 110.602 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -152.44 93.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.859 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 8' ' ' LEU . 9.9 m -93.6 113.71 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -79.3 80.39 5.66 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.926 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -85.58 132.25 34.21 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -176.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -109.88 114.54 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m -117.84 168.36 9.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 0.0 112.234 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.449 ' HB2' HD12 ' A' ' 58' ' ' LEU . 12.3 ttt -141.63 109.26 5.66 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.457 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 110.68 21.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' HG2' ' CD ' ' A' ' 93' ' ' PRO . 20.5 ttm180 -77.76 115.87 17.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.297 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' N ' ' HD3' ' A' ' 93' ' ' PRO . 34.9 mttp -150.42 47.09 0.43 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.391 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 92' ' ' LYS . 63.1 Cg_endo -86.75 134.96 3.96 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.617 2.212 . . . . 0.0 112.285 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.581 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 10.3 Cg_exo -69.23 -155.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.235 1.957 . . . . 0.0 111.783 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 166.32 38.76 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.505 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 185' ' ' LYS . 2.6 tt0 67.54 161.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -177.69 -172.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.678 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.92 147.0 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.12 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 mtm -134.73 166.12 23.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.212 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.04 106.21 6.7 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 183' ' ' VAL . 4.3 mm -113.86 155.57 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.425 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -121.57 125.96 47.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.254 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.679 ' HB2' HD11 ' A' ' 181' ' ' LEU . 1.9 tt -130.84 118.78 21.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.033 0.444 . . . . 0.0 110.733 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG22 HG13 ' A' ' 178' ' ' VAL . 4.8 pt -93.83 144.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.944 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 20.4 tttt -69.93 155.49 40.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -135.84 -160.62 8.94 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.58 -42.02 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.184 1.923 . . . . 0.0 112.484 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -92.07 21.37 5.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.025 0.441 . . . . 0.0 110.427 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 107.44 -141.57 15.66 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.44 -23.0 26.2 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.901 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 88.95 47.06 4.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.842 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.56 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -175.87 153.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.48 ' O ' HG13 ' A' ' 131' ' ' VAL . 9.5 m -111.23 129.9 55.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.806 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 172' ' ' LEU . 13.5 pt -142.54 156.6 18.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -157.9 125.27 5.12 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.62 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.44 -175.08 25.21 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.104 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 83.91 -174.08 51.06 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.073 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 25.7 t -80.35 145.35 9.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.754 0.312 . . . . 0.0 111.123 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.07 -27.19 9.43 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.201 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.82 68.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.126 0.489 . . . . 0.0 109.755 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.0 OUTLIER -73.4 -4.57 34.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.594 -179.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 62.1 t60 72.02 -58.56 0.58 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.51 0.671 . . . . 0.0 110.578 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.913 HD11 ' CD1' ' A' ' 130' ' ' TYR . 2.0 mt -88.74 145.56 35.24 Favored Pre-proline 0 C--N 1.313 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.511 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 123' ' ' ILE . 16.8 Cg_exo -67.26 62.33 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.509 2.14 . . . . 0.0 112.14 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 118.43 60.37 0.28 Allowed Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.64 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.882 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -164.33 94.04 0.7 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.851 0.358 . . . . 0.0 110.824 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -55.15 -23.32 20.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 m -60.01 147.71 38.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.821 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.718 HD11 ' HB1' ' A' ' 168' ' ' ALA . 1.1 mt -87.57 110.53 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.429 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.913 ' CD1' HD11 ' A' ' 123' ' ' ILE . 6.6 m-85 -104.93 150.6 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 150' ' ' ASP . 46.9 t -83.2 147.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.831 0.348 . . . . 0.0 110.935 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.531 HG21 ' CB ' ' C' ' 6' ' ' SER . 15.7 p -103.06 -56.61 2.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.308 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 147.1 22.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.322 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.769 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.9 mt -114.77 141.58 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -80.08 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.738 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.63 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -106.74 30.48 6.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.82 -28.91 66.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.325 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.22 21.33 8.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.799 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.79 -82.86 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.791 0.329 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.79 -56.3 16.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.207 0.527 . . . . 0.0 110.535 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.79 -50.39 24.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.264 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.19 -59.42 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.978 0.418 . . . . 0.0 111.888 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -56.07 -57.56 18.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.948 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 60.02 26.41 15.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.769 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -106.41 86.43 2.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -58.91 165.84 2.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.673 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 132' ' ' THR . 32.3 mt -48.19 115.55 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 111.288 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 130.64 -18.19 5.18 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.729 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -68.0 122.24 17.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.878 0.37 . . . . 0.0 110.858 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -110.75 128.63 55.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.944 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.51 131.73 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.592 ' CD2' ' HB2' ' A' ' 184' ' ' ALA . 1.0 OUTLIER -95.94 -2.91 46.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.086 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 167.38 146.76 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.86 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 158' ' ' VAL . 95.0 t -101.88 99.66 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.12 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.441 ' ND2' HG12 ' A' ' 155' ' ' VAL . 69.6 m-80 69.34 -59.66 0.48 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.347 0.594 . . . . 0.0 109.758 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.7 OUTLIER -162.48 26.14 0.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.329 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 155' ' ' VAL . 15.0 t -98.07 155.35 3.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 121.255 0.55 . . . . 0.0 111.327 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.439 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -115.26 77.76 0.27 Allowed Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.619 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.604 HD22 ' O ' ' A' ' 168' ' ' ALA . 80.1 mt -76.73 25.69 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.964 0.412 . . . . 0.0 111.614 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.6 OUTLIER -152.85 53.69 0.77 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.336 0.589 . . . . 0.0 110.777 179.434 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.86 28.24 0.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.716 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.6 t -150.64 -74.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.122 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 3.8 mtm 175.17 169.0 0.31 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.711 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.52 ' O ' HG23 ' A' ' 169' ' ' VAL . 14.5 p-80 -54.96 -29.87 57.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.942 0.401 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -73.41 -48.39 34.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.178 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.716 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -70.62 -36.58 73.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.904 0.383 . . . . 0.0 110.583 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.718 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.42 -36.27 73.92 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.058 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.765 ' HA ' HD23 ' A' ' 172' ' ' LEU . 5.5 t -72.07 -42.55 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.538 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.17 -30.81 66.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.627 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 160' ' ' LEU . . . -77.68 -25.95 49.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.248 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -81.32 -39.85 24.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.953 0.406 . . . . 0.0 110.11 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -26.51 58.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.5 -9.89 55.75 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.669 ' HB ' HG21 ' A' ' 179' ' ' VAL . 7.7 p -50.96 -178.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 111.8 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -103.02 169.46 8.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.376 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.424 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.6 t70 -52.16 -21.32 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.535 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.499 HG13 HG22 ' A' ' 104' ' ' ILE . 40.4 t -147.58 91.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.714 0.292 . . . . 0.0 110.341 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.669 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.24 148.3 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.116 0.484 . . . . 0.0 112.3 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -102.53 124.18 47.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.798 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -104.68 146.22 29.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.012 0.434 . . . . 0.0 111.334 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.699 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -96.46 115.76 27.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.233 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 101' ' ' ILE . 17.8 t -101.83 160.35 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.145 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.834 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -139.57 132.72 29.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.252 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 7.7 mtpm? -83.89 146.62 49.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 31.9 Cg_exo -58.4 155.49 35.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.556 2.171 . . . . 0.0 112.193 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.2 t -79.77 94.93 5.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.468 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 12.6 p30 45.36 33.06 1.15 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.41 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.153 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.827 0.346 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.423 HG23 ' N ' ' B' ' 3' ' ' VAL . 10.3 m -132.53 -45.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.228 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.425 HG13 ' O ' ' B' ' 3' ' ' VAL . 11.4 p -98.51 125.54 42.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.414 ' O ' ' CG ' ' B' ' 5' ' ' PHE . 50.0 Cg_exo -53.6 169.37 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.465 2.11 . . . . 0.0 112.358 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.414 ' CG ' ' O ' ' B' ' 4' ' ' PRO . 5.0 m-85 -169.72 36.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 m 58.98 167.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 0.3 OUTLIER -113.92 120.0 39.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.063 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 116.34 31.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.986 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.786 HG21 HD13 ' A' ' 77' ' ' LEU . 11.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 117.97 -1.014 . . . . 0.0 111.017 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.819 0.343 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 m -88.28 123.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.184 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.452 HG23 ' O ' ' C' ' 3' ' ' VAL . 10.9 m -117.29 80.2 12.13 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.27 -46.24 32.43 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.614 2.209 . . . . 0.0 112.408 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -177.12 -31.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.406 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.531 ' CB ' HG21 ' A' ' 132' ' ' THR . 87.7 p -72.98 174.43 7.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.744 0.307 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 28.3 t -98.81 115.96 29.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.995 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 42.9 t -98.63 105.44 17.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.546 HG13 ' OXT' ' C' ' 9' ' ' VAL . 11.1 p . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.041 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.791 0.329 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -135.26 161.45 35.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.228 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -121.64 154.76 36.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 23.8 mm-40 -145.82 118.25 8.49 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.561 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.457 ' HG2' ' CG ' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -125.1 95.76 4.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -126.79 -169.62 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 111.922 -178.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.657 HG23 ' HD2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -119.69 135.03 54.99 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.637 179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.9 tp -128.2 91.35 3.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.785 0.802 . . . . 0.0 110.022 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.0 OUTLIER -72.69 160.64 31.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.438 -1.255 . . . . 0.0 111.12 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -70.5 95.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.925 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -51.11 -25.92 11.44 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.478 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -172.45 -86.85 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.143 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -109.35 30.74 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.97 -179.77 21.86 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.922 -1.132 . . . . 0.0 112.419 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.94 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.2 mp -84.43 -48.74 9.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.805 0.336 . . . . 0.0 111.515 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 76.29 1.31 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.742 -0.742 . . . . 0.0 114.1 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.525 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.5 p90 -164.66 148.68 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.689 0.28 . . . . 0.0 110.756 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 36' ' ' ILE . 16.8 m -100.73 126.86 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 111.392 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.771 HG22 HG12 ' A' ' 36' ' ' ILE . 2.9 pt -125.06 164.31 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.743 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.07 154.78 7.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 120.46 -113.54 2.43 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.281 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.81 150.12 22.15 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.544 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 2.8 t -58.21 -18.44 26.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.837 ' HB2' HG22 ' A' ' 69' ' ' THR . 1.9 m-20 -93.44 -49.71 5.79 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 111.262 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -121.96 79.35 41.82 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.438 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.95 136.9 22.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.606 2.204 . . . . 0.0 112.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.409 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 26.8 t60 -70.38 -21.8 62.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.108 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.502 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -109.61 -29.29 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.935 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.52 29.55 9.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.505 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.17 35.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -163.9 95.97 1.0 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.46 -23.24 30.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.488 2.126 . . . . 0.0 112.005 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -76.18 142.53 41.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' HB ' HD11 ' A' ' 57' ' ' ILE . 9.1 mt -93.18 154.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 111.182 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.9 p90 -142.39 167.82 21.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.299 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.775 ' HB ' ' HA ' ' A' ' 53' ' ' VAL . 40.5 mt -98.09 152.44 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.646 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 p -108.62 -36.34 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.673 0.273 . . . . 0.0 111.453 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.923 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -163.81 154.52 15.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.969 0.414 . . . . 0.0 111.291 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.2 141.18 27.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.999 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' B' ' 8' ' ' SER . 2.8 mt -85.44 123.61 72.66 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.108 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.6 Cg_exo -66.06 64.02 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.532 2.155 . . . . 0.0 112.166 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.68 -52.99 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' LEU . . . -59.34 166.8 8.34 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.362 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.55 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -62.03 -23.05 66.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.691 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -61.88 -57.37 12.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.712 0.291 . . . . 0.0 111.167 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.14 -28.1 67.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.534 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.12 -38.44 69.28 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.999 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.475 ' HB3' ' CD ' ' A' ' 50' ' ' ARG . 40.7 m-20 -87.56 -25.27 23.7 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 33.58 70.58 0.13 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.947 -0.57 . . . . 0.0 113.593 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CD ' ' HB3' ' A' ' 48' ' ' ASP . 0.3 OUTLIER -109.46 -14.06 14.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.541 0.21 . . . . 0.0 111.371 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.648 HD13 HD11 ' A' ' 86' ' ' LEU . 2.1 pt? -141.63 168.87 18.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 111.813 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -104.71 165.12 11.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.121 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.923 HG11 ' HA ' ' A' ' 38' ' ' LYS . 33.9 m -71.54 -47.77 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 53' ' ' VAL . 13.6 m-80 -62.24 4.63 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.564 ' OD2' HG21 ' A' ' 88' ' ' VAL . 44.2 p30 -86.99 170.57 11.45 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.298 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 m -120.37 116.15 24.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.579 0.228 . . . . 0.0 110.648 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.912 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -60.47 94.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.226 0.536 . . . . 0.0 111.19 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.669 HD11 ' CG ' ' A' ' 89' ' ' MET . 59.6 mt -70.07 -28.81 65.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.18 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 143.11 17.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.042 0.449 . . . . 0.0 111.601 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG23 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -152.22 131.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.587 179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' O ' HG23 ' A' ' 63' ' ' VAL . 1.1 t-20 52.09 40.47 28.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.942 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 62.0 26.96 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 61' ' ' ASN . 21.5 t -120.81 131.47 72.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.067 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -72.3 100.93 2.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 65' ' ' VAL . 25.0 t -112.71 41.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.012 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.95 9.7 38.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.655 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -177.76 37.59 0.0 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.814 0.34 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 65' ' ' VAL . 14.9 m -118.96 150.57 21.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.447 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.837 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.9 OUTLIER -49.56 156.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.705 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.473 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 2.8 t-160 -58.23 -48.56 80.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.554 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 p -59.45 -34.79 72.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.366 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.98 -37.45 78.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.36 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.37 65.26 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 109.693 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' CG2' HD11 ' A' ' 19' ' ' ILE . 78.9 t -64.2 -35.05 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.684 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 4.3 tt0 -69.19 -33.99 74.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.96 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.52 -41.42 76.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.466 0.651 . . . . 0.0 110.466 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.1 pp -79.92 -27.05 39.93 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.368 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -70.87 -35.56 72.41 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.141 179.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.78 21.64 10.21 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.655 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.87 16.27 5.77 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.048 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.52 95.83 0.11 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.781 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.1 m 169.59 -66.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.79 94.96 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.249 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -101.31 140.33 20.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.657 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.87 95.02 9.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.677 HD21 ' CG1' ' A' ' 88' ' ' VAL . 2.2 tm? -84.81 115.53 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 0.0 112.067 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CG ' ' HG2' ' A' ' 5' ' ' GLU . 1.3 t80 -121.75 114.44 21.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.912 HG12 ' HA ' ' A' ' 57' ' ' ILE . 20.7 m -129.3 168.06 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.669 ' CG ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -118.46 109.08 15.8 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.631 178.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.444 ' HD2' ' HB2' ' A' ' 52' ' ' ARG . 45.7 ttp180 -124.08 146.56 48.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.819 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.31 133.51 37.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -54.7 149.06 23.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.5 Cg_endo -66.14 129.58 22.1 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.557 2.171 . . . . 0.0 112.021 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 16.6 Cg_exo -66.66 -161.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.352 2.035 . . . . 0.0 112.028 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -121.27 25.19 9.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -77.56 140.84 39.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.615 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -151.16 -178.92 6.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 111.317 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.1 135.14 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -115.7 166.73 11.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.152 0.501 . . . . 0.0 111.415 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -135.14 106.41 6.75 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 183' ' ' VAL . 3.7 mm -114.15 155.26 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.1 OUTLIER -113.04 123.28 49.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.257 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 110' ' ' LEU . 2.0 tt -124.8 118.6 26.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.587 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.528 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -97.04 144.68 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.115 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -75.17 155.93 36.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.847 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.2 -177.85 15.19 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.905 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 -33.43 16.23 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.064 1.843 . . . . 0.0 112.093 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.53 18.22 13.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.111 0.481 . . . . 0.0 110.416 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA3' ' OXT' ' C' ' 9' ' ' VAL . . . 106.4 -148.1 16.37 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.457 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.768 HD22 HD22 ' A' ' 103' ' ' LEU . 14.5 mt -86.57 -18.84 30.47 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.213 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.64 49.95 6.32 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.083 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.76 151.99 0.75 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.709 0.29 . . . . 0.0 110.718 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.403 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 67.2 m -113.48 116.88 30.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.942 HD11 HD22 ' A' ' 172' ' ' LEU . 10.4 pt -128.78 155.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.607 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -155.33 125.14 6.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 0.0 111.886 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.83 -175.1 25.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.449 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . 104.16 -174.13 21.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.596 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 119' ' ' GLY . 46.1 t -100.76 155.02 4.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 111.4 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 96.49 -26.77 20.23 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.28 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -173.9 74.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -76.5 130.76 38.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.006 -179.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.766 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 16.1 t60 -43.28 -34.69 1.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.049 0.928 . . . . 0.0 110.64 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -107.27 138.3 19.85 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.901 -178.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.556 ' HD2' HG22 ' A' ' 123' ' ' ILE . 58.2 Cg_endo -71.52 61.21 2.78 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.361 2.041 . . . . 0.0 112.719 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.72 48.76 0.08 OUTLIER Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.26 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.42 96.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.044 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -58.14 -22.43 51.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 m -53.9 136.87 40.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.642 ' HB ' HD12 ' A' ' 152' ' ' ILE . 4.8 mt -73.85 120.62 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.999 0.428 . . . . 0.0 111.229 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.743 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.4 m-85 -116.28 147.57 41.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.396 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 150' ' ' ASP . 39.4 t -83.96 139.51 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.791 0.329 . . . . 0.0 110.629 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.589 HG21 ' OG ' ' C' ' 6' ' ' SER . 11.5 p -97.49 -58.9 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.627 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.403 ' HG3' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -155.15 150.86 27.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.081 0.467 . . . . 0.0 111.468 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 111' ' ' GLY . 2.9 mt -127.87 141.77 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.767 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.4 mt -74.36 173.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.608 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.631 ' H ' HG22 ' A' ' 135' ' ' ILE . 2.2 tt0 -87.06 146.29 26.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.28 26.1 55.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.62 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.1 164.27 45.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -58.71 -52.32 66.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.994 0.426 . . . . 0.0 111.201 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.666 ' HB2' HD21 ' A' ' 103' ' ' LEU . . . -70.12 -32.01 69.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -56.27 -54.63 43.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.202 0.525 . . . . 0.0 110.377 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -72.83 -50.75 22.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.092 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.56 -59.58 2.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.062 0.458 . . . . 0.0 111.886 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.476 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -55.6 -50.05 62.33 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.169 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.98 19.52 10.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.757 0.313 . . . . 0.0 110.653 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.625 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -94.16 79.86 4.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.771 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 175.32 0.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 132' ' ' THR . 27.4 mt -49.75 129.53 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.159 0.504 . . . . 0.0 111.295 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 114.5 -24.35 11.35 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.571 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.9 OUTLIER -60.74 129.33 40.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.753 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.839 ' HD2' ' HB3' ' A' ' 184' ' ' ALA . 1.9 pttp -117.47 125.28 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.999 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.642 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -100.46 132.26 46.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.116 0.484 . . . . 0.0 110.756 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.6 OUTLIER -99.41 -1.28 39.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.158 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 171.35 158.86 0.09 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.831 0.348 . . . . 0.0 111.298 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.742 HG12 HD22 ' A' ' 156' ' ' ASN . 20.6 t -116.44 100.07 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.195 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.742 HD22 HG12 ' A' ' 155' ' ' VAL . 14.2 m-80 68.84 -59.3 0.47 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.225 0.536 . . . . 0.0 109.814 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 97.4 p -163.4 26.6 0.09 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.385 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 5.6 t -102.47 155.02 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 CA-C-O 121.07 0.462 . . . . 0.0 111.314 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -118.09 79.05 0.3 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.685 HD13 ' HB3' ' A' ' 172' ' ' LEU . 18.6 mt -77.61 24.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.92 0.391 . . . . 0.0 112.048 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.83 38.68 1.99 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.099 0.476 . . . . 0.0 110.736 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.77 28.62 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.311 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.731 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.8 OUTLIER -145.83 -75.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.388 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 172.84 166.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.657 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 50.9 t-80 -53.99 -29.92 45.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.79 0.328 . . . . 0.0 110.649 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.31 -46.45 49.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.731 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -72.42 -36.89 68.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.975 0.417 . . . . 0.0 110.419 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.64 -34.97 72.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.511 ' HA ' ' CD2' ' A' ' 172' ' ' LEU . 4.0 t -72.08 -40.28 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.83 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.92 -36.33 69.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.35 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.593 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -75.42 -26.88 58.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.942 HD22 HD11 ' A' ' 114' ' ' ILE . 4.1 pp -82.07 -36.88 27.17 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.829 0.347 . . . . 0.0 110.377 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.883 ' N ' HD12 ' A' ' 172' ' ' LEU . 1.0 OUTLIER -75.07 -26.4 59.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -69.54 -9.59 54.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.188 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 1.2 p -42.34 166.91 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.059 0.457 . . . . 0.0 112.2 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' HB3' HG13 ' A' ' 179' ' ' VAL . 75.0 t80 -96.95 167.26 11.19 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.44 ' N ' ' CG ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -47.83 -29.2 3.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.315 -179.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 104' ' ' ILE . 41.1 t -147.9 91.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 110.7 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.68 148.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.686 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' CZ ' ' OD1' ' A' ' 156' ' ' ASN . 27.6 p90 -103.51 125.23 49.95 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.179 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.74 HD21 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -106.75 155.9 19.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.829 -178.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.603 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.88 113.45 24.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.55 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 101' ' ' ILE . 13.1 t -102.2 164.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.839 ' HB3' ' HD2' ' A' ' 151' ' ' LYS . . . -130.48 129.05 42.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.64 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -83.72 129.81 58.09 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.812 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -48.86 142.43 19.36 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.385 2.057 . . . . 0.0 112.117 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.66 -174.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -65.68 74.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.024 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.171 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.842 0.353 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.609 ' O ' HG13 ' B' ' 2' ' ' VAL . 9.1 p -177.6 71.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' B' ' 4' ' ' PRO . 2.3 t -86.63 -48.45 0.51 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.209 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' B' ' 3' ' ' VAL . 7.6 Cg_exo -73.08 -22.1 19.79 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.804 2.336 . . . . 0.0 112.214 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 65.96 141.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.66 177.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.041 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.9 t -108.14 124.52 50.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.675 ' HB2' HD11 ' A' ' 40' ' ' ILE . 61.7 p -99.14 141.0 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.903 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.525 HG23 ' CE1' ' A' ' 17' ' ' PHE . 14.4 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.871 0.367 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.24 -33.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.486 ' O ' HG13 ' C' ' 3' ' ' VAL . 12.4 p -120.16 121.48 29.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.16 101.76 1.01 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.334 2.023 . . . . 0.0 112.358 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -60.42 -30.75 69.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.589 ' OG ' HG21 ' A' ' 132' ' ' THR . 34.8 t -133.91 149.69 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -106.86 96.46 6.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.95 125.16 28.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.402 ' OXT' ' HA3' ' A' ' 109' ' ' GLY . 11.6 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.401 -0.809 . . . . 0.0 111.095 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.793 0.33 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.26 154.12 20.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HD2' ' HH ' ' A' ' 87' ' ' TYR . 3.1 m-85 -135.68 170.65 15.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' OE1' HD12 ' A' ' 6' ' ' ILE . 6.4 tt0 -178.29 125.79 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.415 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 4.8 pt-20 -110.22 106.55 16.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.347 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.665 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -122.35 -167.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.008 0.432 . . . . 0.0 111.639 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 135.94 44.65 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.487 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.789 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -120.32 88.97 3.04 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.6 0.714 . . . . 0.0 110.986 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -73.21 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.886 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASN . 8.5 mtt180 -44.43 105.04 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.82 0.343 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.91 66.11 0.33 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.48 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' ARG . 11.2 m-80 77.03 -73.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.632 0.253 . . . . 0.0 110.891 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 p -109.29 30.41 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.67 -176.92 18.08 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.948 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.27 -51.32 7.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.198 -0.501 . . . . 0.0 111.278 -179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 97.5 69.12 0.97 Allowed Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.94 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 5.5 p90 -164.93 155.82 14.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.813 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.636 ' O ' HG23 ' A' ' 36' ' ' ILE . 12.9 m -117.53 138.19 52.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.551 HG22 HG12 ' A' ' 36' ' ' ILE . 3.3 pt -127.08 166.12 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.026 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.05 160.7 33.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 27' ' ' HIS . . . 112.51 -132.48 10.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.09 146.95 7.82 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -61.76 -16.3 48.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.689 ' CB ' HG22 ' A' ' 69' ' ' THR . 30.2 p-10 -102.04 -39.29 7.37 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.704 0.288 . . . . 0.0 110.92 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.38 76.57 53.5 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.634 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' CG ' ' HA ' ' A' ' 30' ' ' ASP . 99.8 Cg_exo -43.72 155.55 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.944 2.43 . . . . 0.0 112.344 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 6.0 t60 -122.7 -11.95 8.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.691 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.579 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.16 -58.08 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' ASP . . . -173.74 33.93 0.11 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.088 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HA ' ' CG ' ' A' ' 26' ' ' PRO . 1.1 t0 81.51 53.23 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.835 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -118.92 114.8 35.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.695 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . 32.3 Cg_exo -59.18 82.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.78 2.32 . . . . 0.0 112.165 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.75 143.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -106.29 148.27 10.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.026 0.441 . . . . 0.0 111.185 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.579 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -142.61 145.28 33.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.365 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 18' ' ' SER . 70.9 mt -72.94 144.9 12.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.216 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.641 ' O ' HG21 ' A' ' 53' ' ' VAL . 21.8 p -95.49 -43.25 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.655 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 158.46 27.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.202 0.525 . . . . 0.0 111.743 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.45 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -116.92 141.85 33.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.85 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.92 133.9 45.08 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.006 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.35 77.82 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.56 2.173 . . . . 0.0 112.189 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.57 -31.52 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.328 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -61.12 168.95 10.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.543 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.92 -21.16 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -54.87 -57.58 11.02 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.929 0.395 . . . . 0.0 111.306 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.42 69.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -72.05 -37.51 69.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.665 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.74 -20.25 36.34 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.375 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.05 72.43 1.25 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.985 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.563 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.51 35.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.688 0.28 . . . . 0.0 111.125 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 88' ' ' VAL . 1.5 pp 37.57 -156.91 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.056 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' N ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.08 138.09 58.29 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.015 0.436 . . . . 0.0 111.223 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 37' ' ' THR . 31.6 m -65.24 -37.85 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.342 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -53.19 -15.27 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.23 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 90' ' ' ARG . 25.6 p-10 -59.05 170.64 0.83 Allowed 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -123.27 114.11 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.696 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.3 pt -58.6 94.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.078 0.466 . . . . 0.0 110.699 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 58' ' ' LEU . 7.4 mt -62.03 -29.0 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.878 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.03 125.55 4.59 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.926 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG12 ' HG ' ' A' ' 86' ' ' LEU . 4.9 m -114.33 118.59 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.648 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.683 HD22 HG12 ' A' ' 84' ' ' VAL . 0.5 OUTLIER 53.87 41.99 31.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 111.002 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 66.91 29.56 8.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.02 136.45 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.963 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -82.5 111.05 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.014 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 HG12 HG21 ' A' ' 68' ' ' VAL . 26.9 m -128.55 25.6 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.226 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -79.65 5.11 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.21 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' HB2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -163.96 41.32 0.09 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.023 0.44 . . . . 0.0 109.908 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 65' ' ' VAL . 35.3 m -118.55 143.24 30.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 112.529 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.762 ' N ' HG22 ' A' ' 23' ' ' THR . 21.5 p -49.52 171.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.131 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.551 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.1 t-160 -70.16 -48.66 56.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.861 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -44.14 74.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.12 -33.81 73.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.409 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.82 -41.55 68.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.392 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG23 ' CD2' ' A' ' 70' ' ' HIS . 53.9 t -64.96 -36.83 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.64 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.611 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -69.41 -30.64 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.575 179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -70.25 -36.7 74.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.299 0.571 . . . . 0.0 110.561 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -82.13 -25.84 34.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.85 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.35 -32.87 58.88 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.104 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -115.56 29.87 7.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.577 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -88.41 -24.24 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.64 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.06 -135.33 12.07 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.775 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 83' ' ' ILE . 1.9 m -131.24 11.46 4.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 111.566 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.688 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.7 mt -151.56 92.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 3.5 m -104.26 115.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.71 91.92 7.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.85 ' HG ' HG12 ' A' ' 60' ' ' VAL . 1.7 mp -93.16 144.51 25.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.45 ' HH ' ' HD2' ' A' ' 3' ' ' TYR . 17.7 t80 -122.81 114.38 20.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.97 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 57' ' ' ILE . 31.4 m -115.25 168.48 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.202 0.525 . . . . 0.0 112.289 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.404 ' HB2' HD12 ' A' ' 58' ' ' LEU . 6.9 ttt -138.15 109.05 6.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.491 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.483 ' CG ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -110.78 130.97 55.43 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -75.26 124.72 27.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' N ' ' CD ' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -77.05 -49.78 2.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.116 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' LYS . 98.7 Cg_exo -43.83 127.89 6.67 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.594 2.196 . . . . 0.0 112.583 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -93.54 106.7 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.172 2.581 . . . . 0.0 112.361 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' H ' ' HB2' ' A' ' 188' ' ' ASN . . . -96.21 29.67 2.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.904 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -44.23 128.64 6.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.366 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -112.09 130.6 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.561 HG23 HD21 ' A' ' 153' ' ' LEU . 11.6 p -82.94 133.95 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.992 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.7 mmt -112.27 166.48 11.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.273 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.54 106.41 7.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.406 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.618 HG13 HG21 ' A' ' 183' ' ' VAL . 3.1 mm -114.95 155.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.515 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 4.8 mptt -113.1 126.97 56.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.634 HD22 ' HG ' ' A' ' 110' ' ' LEU . 4.0 tt -130.6 118.84 21.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.694 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.522 HG22 HG13 ' A' ' 178' ' ' VAL . 5.1 pt -92.7 144.79 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.979 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -69.01 164.42 22.39 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.159 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -142.88 -162.52 9.31 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.786 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.42 -35.28 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.166 1.911 . . . . 0.0 112.554 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 20.54 7.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.957 0.408 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.87 -127.85 9.22 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.696 HD22 HD13 ' A' ' 172' ' ' LEU . 1.2 mp -86.77 -30.88 21.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.65 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 99.69 38.1 3.77 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.875 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -177.93 160.15 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 111.305 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -110.51 117.06 32.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.527 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 172' ' ' LEU . 45.5 pt -113.43 173.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.138 0.494 . . . . 0.0 111.488 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.07 -176.0 3.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.368 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 165' ' ' HIS . . . -145.72 143.61 11.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.47 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.22 -66.33 2.43 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.061 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.9 t -103.82 153.29 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.205 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 83.62 -9.78 61.26 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.038 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 168.39 81.17 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.845 0.355 . . . . 0.0 110.122 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.559 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 4.1 mt-30 -64.54 -15.1 60.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.331 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.559 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.1 t60 71.82 -54.99 0.67 Allowed 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.6 0.714 . . . . 0.0 110.612 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.859 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.9 mt -92.02 143.37 27.56 Favored Pre-proline 0 C--N 1.31 -1.112 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.659 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 123' ' ' ILE . 38.4 Cg_exo -60.37 77.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.366 2.044 . . . . 0.0 112.247 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 87.77 65.14 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.745 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.4 OUTLIER -162.12 94.0 0.9 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -55.13 -23.46 21.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.0 p -57.92 120.2 8.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.62 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 160' ' ' LEU . 21.9 mt -70.56 122.67 22.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.859 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.6 m-85 -111.84 151.01 29.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.962 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 150' ' ' ASP . 42.5 t -86.31 121.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.304 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 148' ' ' ILE . 9.2 p -79.28 -59.06 2.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.649 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -151.12 152.75 33.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.597 HD11 ' O ' ' A' ' 146' ' ' LEU . 2.5 mt -118.19 141.38 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.844 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.5 mt -75.31 172.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.613 ' H ' HG22 ' A' ' 135' ' ' ILE . 64.9 mt-10 -103.7 30.45 5.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.822 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.04 -28.61 58.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.65 10.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.672 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.01 -82.35 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 110.937 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.573 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.06 -31.71 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 135' ' ' ILE . 1.3 m170 -52.15 -62.2 1.79 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.828 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -72.74 -42.14 64.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.577 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.21 -59.36 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' CA ' HD23 ' A' ' 146' ' ' LEU . . . -70.84 -41.16 63.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.198 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.37 22.34 9.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.911 0.386 . . . . 0.0 110.536 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.603 ' CD1' HG21 ' A' ' 131' ' ' VAL . 0.3 OUTLIER -95.71 85.45 4.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.92 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.45 166.67 8.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.523 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -47.44 116.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.262 0.553 . . . . 0.0 111.38 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.89 -14.42 6.33 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.666 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.6 OUTLIER -73.92 120.06 18.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.787 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -99.96 122.8 43.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.671 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -101.33 118.54 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.438 . . . . 0.0 110.211 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -82.58 -0.64 47.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.744 -179.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 175.18 159.25 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.513 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.897 HG13 HD22 ' A' ' 181' ' ' LEU . 45.6 t -121.73 98.96 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.276 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.75 ' ND2' HG12 ' A' ' 155' ' ' VAL . 31.8 m-80 69.27 -57.19 0.53 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.416 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.7 m -147.01 -20.24 0.4 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.688 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -76.16 140.72 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.408 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.73 12.68 33.77 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.897 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 129' ' ' ILE . 24.7 mt 38.96 33.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.229 0.538 . . . . 0.0 111.985 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.52 68.48 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 163' ' ' VAL . 5.9 m-20 -162.92 26.49 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.848 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.588 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -161.9 -82.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.674 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 169.65 170.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.049 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -54.03 -30.6 48.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.815 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -47.92 38.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.995 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.588 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.37 -32.37 62.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 110.313 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.816 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.762 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.7 t -70.03 -40.5 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.559 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.433 ' HA ' ' HG2' ' A' ' 173' ' ' LYS . . . -71.08 -30.43 66.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.672 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.98 -25.83 48.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.5 OUTLIER -81.28 -40.69 23.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.968 0.413 . . . . 0.0 110.105 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 170' ' ' ALA . 0.8 OUTLIER -75.41 -26.63 58.55 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.068 179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.85 -21.4 65.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.544 ' HB ' HG21 ' A' ' 179' ' ' VAL . 47.7 p -54.73 -173.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.365 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -100.88 171.33 7.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -58.48 -14.51 8.04 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.429 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.522 HG13 HG22 ' A' ' 104' ' ' ILE . 41.4 t -147.55 90.9 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 0.0 110.288 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.544 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -120.15 148.49 23.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.729 -179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -100.03 127.62 46.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.379 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.897 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -108.23 153.96 22.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.981 0.419 . . . . 0.0 110.671 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 5.6 mttt -96.59 119.04 34.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.398 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.618 HG21 HG13 ' A' ' 101' ' ' ILE . 39.2 t -101.82 164.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.336 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.536 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -130.91 140.74 50.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 111.691 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.89 146.19 48.54 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.436 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.45 61.17 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.809 2.339 . . . . 0.0 113.119 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 58.7 p 42.73 -161.59 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.352 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.492 ' HB2' ' H ' ' A' ' 95' ' ' ALA . 29.2 t-20 -69.37 61.5 0.14 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.832 0.349 . . . . 0.0 110.876 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.054 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.518 ' O ' HG23 ' B' ' 2' ' ' VAL . 30.9 m -126.1 114.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.6 HG13 ' CE1' ' B' ' 5' ' ' PHE . 11.8 p -95.19 133.39 26.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.465 2.11 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . 0.6 ' CE1' HG13 ' B' ' 3' ' ' VAL . 78.4 m-85 -146.09 151.83 38.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -119.02 156.59 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.5 97.75 9.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 56.6 m -109.28 109.37 20.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.547 ' OXT' HG22 ' B' ' 9' ' ' VAL . 13.4 p . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.152 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.843 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.693 HG22 ' HD2' ' C' ' 4' ' ' PRO . 14.2 p -57.53 152.91 2.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' C' ' 4' ' ' PRO . 0.1 OUTLIER -80.17 -61.56 0.43 Allowed Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.901 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.693 ' HD2' HG22 ' C' ' 2' ' ' VAL . 53.9 Cg_endo -69.3 119.85 6.77 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.274 1.982 . . . . 0.0 112.092 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -96.65 36.51 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.996 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -128.11 139.33 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.424 ' OG ' ' CD2' ' A' ' 165' ' ' HIS . 21.8 m -69.54 86.64 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.846 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.552 ' O ' HG13 ' C' ' 9' ' ' VAL . 35.9 t -83.63 109.57 17.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 8' ' ' SER . 4.0 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.952 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.823 0.345 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -91.02 156.75 17.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.196 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -151.46 145.85 25.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.577 179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -176.82 156.27 1.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.946 0.403 . . . . 0.0 111.402 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -86.5 167.74 14.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.454 179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.605 HD13 ' HG3' ' A' ' 50' ' ' ARG . 6.9 tt -164.94 165.88 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.944 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.767 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -137.48 126.34 24.08 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.992 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.849 ' HG ' HD23 ' A' ' 15' ' ' LEU . 1.6 tp -122.01 88.58 2.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.457 0.646 . . . . 0.0 111.367 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pm0 -73.66 152.35 40.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.271 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 19.4 mtt180 -67.32 93.63 0.33 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.717 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -51.07 -25.46 10.38 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.638 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.62 -91.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -109.1 30.8 6.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.14 -178.98 25.37 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.144 -1.027 . . . . 0.0 112.135 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.849 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.34 -47.59 10.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.816 0.341 . . . . 0.0 111.293 -179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.36 74.18 1.25 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.084 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.645 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -164.85 169.34 16.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.312 . . . . 0.0 110.922 178.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.27 130.8 53.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.459 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HG12 ' A' ' 36' ' ' ILE . 1.2 pt -125.54 164.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.59 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 70' ' ' HIS . . . -169.77 164.1 9.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 111.503 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 112.84 -119.22 4.83 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.481 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.99 145.06 14.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.427 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.76 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -53.9 -24.75 17.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.761 0.315 . . . . 0.0 111.27 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.587 ' HB2' HG23 ' A' ' 69' ' ' THR . 3.1 t70 -81.73 -55.99 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -120.25 83.06 31.67 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.49 132.01 29.0 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.573 2.182 . . . . 0.0 112.437 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 25.8 t60 -68.05 -21.38 65.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.497 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.72 -28.11 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.118 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.11 29.65 12.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.37 33.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.733 0.301 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 2.7 m-20 -173.03 111.05 0.34 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 31' ' ' ASP . 21.4 Cg_exo -65.92 -27.91 50.66 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.126 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.79 128.02 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -80.19 150.34 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.3 p90 -142.48 151.09 41.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.684 HG23 ' O ' ' A' ' 18' ' ' SER . 77.2 mt -77.13 146.17 9.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.257 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.547 ' O ' HG21 ' A' ' 53' ' ' VAL . 66.0 m -99.77 -35.98 9.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.541 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -166.03 158.29 14.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.513 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.5 mt -115.94 141.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 HD11 ' OG ' ' B' ' 8' ' ' SER . 3.0 mt -85.76 123.71 71.99 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.058 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -66.18 63.52 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.493 2.129 . . . . 0.0 112.103 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.23 -54.27 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.485 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.21 -175.77 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -27.53 57.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.631 0.253 . . . . 0.0 111.369 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -57.56 -29.19 64.22 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.063 0.459 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.86 -27.45 49.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.636 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -71.46 -43.5 66.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.018 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.39 -31.65 15.95 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.17 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 84.48 -27.56 4.64 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.655 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.687 ' NH1' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER 45.21 30.37 0.64 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 110.865 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.553 HD23 ' HD3' ' A' ' 90' ' ' ARG . 2.1 mp 65.17 -173.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.401 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 131.1 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.763 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 36' ' ' ILE . 34.4 m -53.5 -37.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.731 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -62.15 -3.93 1.5 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.354 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -58.34 175.3 0.24 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.741 0.305 . . . . 0.0 110.671 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.9 t -130.24 102.78 6.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.463 ' O ' ' CG1' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.02 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.424 0.63 . . . . 0.0 111.475 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 58' ' ' LEU . 3.2 mt -59.84 -35.39 74.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.433 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 1.5 m-85 -158.57 123.57 4.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.409 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.473 ' HA ' ' CB ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -114.16 119.85 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 53.8 37.52 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.67 30.34 12.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.74 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.88 133.74 64.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' ' CZ ' ' A' ' 59' ' ' PHE . 1.4 m-20 -72.79 77.64 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.631 ' HA ' HG23 ' A' ' 68' ' ' VAL . 21.1 t -107.65 35.11 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.024 0.44 . . . . 0.0 111.055 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -101.08 1.04 38.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.083 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -156.1 33.74 0.34 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.758 0.314 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -124.0 158.28 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.18 0.514 . . . . 0.0 110.807 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.76 ' N ' HG22 ' A' ' 23' ' ' THR . 7.3 m -50.07 163.08 0.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.056 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.637 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -61.34 -48.56 80.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.834 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 t -52.73 -35.87 56.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.441 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.24 -35.07 77.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.964 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -71.96 -41.62 67.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.221 0.534 . . . . 0.0 109.652 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.637 HG23 ' CD2' ' A' ' 70' ' ' HIS . 42.0 t -64.4 -36.01 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.4 -33.39 72.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.815 179.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.48 -41.76 75.71 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.435 0.636 . . . . 0.0 110.476 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 74' ' ' VAL . 3.0 pp -79.69 -26.92 40.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.552 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -72.63 -37.85 67.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.955 179.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -100.34 25.79 7.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.401 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.95 -23.67 23.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.18 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.27 -152.3 22.05 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.543 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 83' ' ' ILE . 3.9 m -101.51 11.74 38.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.497 0.189 . . . . 0.0 111.338 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 mt -151.53 92.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.5 t -90.59 149.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.052 0.453 . . . . 0.0 111.673 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.767 ' HG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -137.67 102.29 4.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.976 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -132.9 154.01 50.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 1.3 t80 -105.68 114.8 29.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.614 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.45 168.03 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.324 0.583 . . . . 0.0 112.414 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.427 ' HG3' ' CD1' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -136.25 109.66 7.9 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.134 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.553 ' HD3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -112.57 106.95 15.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.064 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -67.96 141.06 56.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.934 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.36 66.19 76.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.95 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 39.3 Cg_exo -58.99 -47.39 18.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.45 2.1 . . . . 0.0 112.696 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 188' ' ' ASN . 98.4 Cg_endo -91.68 -167.57 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.775 2.317 . . . . 0.0 112.276 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.31 26.1 0.6 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.802 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 187' ' ' SER . 70.4 mm-40 -158.13 -173.71 4.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.78 -175.37 5.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.024 0.44 . . . . 0.0 111.29 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -99.26 144.49 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.268 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.0 166.41 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.424 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -133.19 106.6 7.68 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.57 155.92 16.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.742 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' HB3' ' CE2' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.95 126.07 54.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.104 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.655 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.4 tt -126.38 118.54 25.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.708 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.563 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 4.4 pt -96.84 144.65 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.034 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -70.45 158.44 36.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -136.02 -175.11 13.65 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.869 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.51 -40.75 9.85 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.269 1.98 . . . . 0.0 112.31 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -91.99 19.97 6.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.957 0.408 . . . . 0.0 110.488 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.02 -141.27 15.22 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 6.6 mp -86.53 -22.35 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.926 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 78.43 58.39 3.12 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.887 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CE2' HD13 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.96 155.43 0.98 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.726 0.298 . . . . 0.0 110.838 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.417 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 2.7 t -116.38 116.9 28.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.891 0.377 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.632 HD11 HD22 ' A' ' 172' ' ' LEU . 10.3 pt -134.16 154.82 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.757 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.31 124.74 10.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.091 0.472 . . . . 0.0 112.048 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.588 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.94 -174.99 25.51 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.494 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.63 -176.54 52.41 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.536 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 119' ' ' GLY . 26.0 t -81.45 154.8 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 76.06 6.1 81.96 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.19 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 165' ' ' HIS . 1.1 t30 -168.69 52.97 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -33.35 -43.47 0.11 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.096 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 47.6 t60 73.28 -45.53 0.62 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 122.027 0.918 . . . . 0.0 108.891 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.78 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.6 OUTLIER -122.65 130.85 24.48 Favored Pre-proline 0 C--N 1.313 -1.005 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.161 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.24 89.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.445 2.097 . . . . 0.0 112.919 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.95 44.93 4.97 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.217 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -150.71 78.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.195 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -53.92 -22.97 11.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.218 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -55.31 145.49 21.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.715 0.293 . . . . 0.0 110.82 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.588 HG12 ' HA3' ' A' ' 116' ' ' GLY . 8.2 mt -80.03 117.43 25.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 0.0 111.555 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.78 ' CG ' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -114.92 156.25 25.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.521 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 150' ' ' ASP . 47.5 t -95.52 155.63 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.212 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.546 ' O ' HD13 ' A' ' 148' ' ' ILE . 0.7 OUTLIER -130.17 -32.51 1.8 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.417 ' HG3' ' CB ' ' A' ' 113' ' ' SER . 1.8 pttp -160.66 145.63 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.842 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 146' ' ' LEU . 5.1 mt -131.64 141.8 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.74 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 136' ' ' GLU . 3.5 mm -73.54 175.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.403 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.694 ' H ' HG22 ' A' ' 135' ' ' ILE . 4.0 tt0 -99.47 139.71 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.48 29.18 60.38 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.583 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -81.91 -132.45 1.52 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.578 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -110.38 -61.29 1.69 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.934 0.397 . . . . 0.0 111.184 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.655 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -67.15 -31.4 71.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -51.81 -60.39 3.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.042 0.449 . . . . 0.0 110.781 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -46.12 54.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.305 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.48 -59.5 2.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.564 ' HA3' HD23 ' A' ' 146' ' ' LEU . . . -62.31 -44.93 96.97 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.262 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 145' ' ' ARG . 0.7 OUTLIER 61.26 20.34 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.822 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.584 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -91.75 82.79 5.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.709 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 169.84 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.751 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.546 HD13 ' O ' ' A' ' 132' ' ' THR . 33.6 mt -47.91 121.86 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.276 0.56 . . . . 0.0 111.235 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.5 -22.5 6.19 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.376 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.781 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -68.85 124.97 25.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -112.73 128.96 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -102.71 130.72 52.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.072 0.463 . . . . 0.0 110.538 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.4 pp -98.42 -1.16 42.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.294 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.19 152.6 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.719 0.295 . . . . 0.0 111.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.945 HG13 HD23 ' A' ' 181' ' ' LEU . 40.2 t -107.4 99.7 9.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.104 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.445 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.9 m-80 69.18 -59.44 0.48 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.319 0.58 . . . . 0.0 109.739 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.02 27.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.172 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 11.5 t -100.6 155.22 4.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.277 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -117.0 77.4 0.28 Allowed Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.572 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.62 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 31.9 mt -79.11 24.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.94 0.4 . . . . 0.0 111.928 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -139.73 32.7 2.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 110.652 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.79 28.05 1.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.193 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.656 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.2 OUTLIER -143.29 -77.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.175 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 163' ' ' VAL . 0.9 OUTLIER 174.74 165.83 0.25 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.605 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.9 p-80 -53.9 -30.7 47.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.841 0.353 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -45.2 54.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.279 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.656 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -72.66 -37.08 68.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 -179.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.67 -36.54 73.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.107 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.564 ' HA ' HD23 ' A' ' 172' ' ' LEU . 13.4 t -73.81 -42.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.504 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.43 -33.01 69.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.051 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.494 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -77.78 -27.71 50.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.465 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.632 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.05 -36.72 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.44 -26.85 60.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.519 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.1 -9.89 59.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.293 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.676 ' HB ' HG21 ' A' ' 179' ' ' VAL . 69.9 p -52.59 -176.76 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.926 0.393 . . . . 0.0 111.515 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -103.61 169.8 8.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.379 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 3.5 t70 -54.31 -18.85 4.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.4 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.437 HG13 HG22 ' A' ' 104' ' ' ILE . 39.0 t -147.58 92.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.676 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.94 148.19 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 112.006 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -95.65 127.16 41.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 179.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.945 HD23 HG13 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -106.87 144.32 33.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.988 0.423 . . . . 0.0 110.869 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.36 112.45 24.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.153 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.579 HG21 HG13 ' A' ' 101' ' ' ILE . 15.6 t -101.91 161.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.51 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -144.78 140.09 28.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.83 0.347 . . . . 0.0 111.188 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.455 ' CB ' ' HB3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -96.38 146.32 31.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.56 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.75 89.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.172 2.581 . . . . 0.0 112.91 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.515 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 0.9 OUTLIER -58.71 166.8 1.73 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.73 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 8.9 m120 39.74 32.96 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.653 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.118 -179.932 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.657 HG23 HG23 ' B' ' 3' ' ' VAL . 4.8 m -134.66 -50.03 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.379 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.657 HG23 HG23 ' B' ' 2' ' ' VAL . 5.3 t -84.41 -48.02 0.67 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.677 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' B' ' 3' ' ' VAL . 88.3 Cg_endo -82.09 157.02 17.64 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.356 2.037 . . . . 0.0 112.402 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -145.46 169.94 17.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.0 m -84.84 160.58 20.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 4.8 m -80.54 117.18 21.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.975 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.495 ' OG ' HD11 ' A' ' 40' ' ' ILE . 33.6 t -94.16 122.12 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 8' ' ' SER . 14.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.858 0.361 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.33 -58.71 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.611 ' O ' HG13 ' C' ' 3' ' ' VAL . 8.9 p -163.16 106.92 1.0 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.47 166.54 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.433 2.089 . . . . 0.0 112.38 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.92 141.9 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 13.0 m -149.72 138.93 21.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.96 95.2 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.469 ' O ' HG13 ' C' ' 9' ' ' VAL . 97.6 p -91.23 119.33 31.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.469 HG13 ' O ' ' C' ' 8' ' ' SER . 14.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.327 -0.845 . . . . 0.0 111.195 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.81 0.338 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -142.83 149.22 38.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.27 162.69 26.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.415 179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.7 161.49 2.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.95 0.405 . . . . 0.0 111.639 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.75 165.33 14.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.568 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.502 HG23 ' NH2' ' A' ' 50' ' ' ARG . 2.0 tt -164.45 166.49 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.797 0.332 . . . . 0.0 111.809 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -133.82 138.96 45.97 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.677 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.776 ' HG ' HD23 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -135.73 86.73 2.26 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.596 0.712 . . . . 0.0 110.99 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -76.63 155.23 33.63 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.248 179.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -66.3 86.7 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.727 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.85 -26.03 10.41 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.42 -0.895 . . . . 0.0 111.781 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.25 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.728 -0.236 . . . . 0.0 110.386 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.1 m -109.12 30.81 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.0 -179.09 27.05 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.424 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.776 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.33 -42.74 15.47 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.822 0.344 . . . . 0.0 111.407 -179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . 88.01 64.81 1.34 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.803 -0.713 . . . . 0.0 114.042 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 6.0 p90 -161.78 139.57 8.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.919 0.39 . . . . 0.0 110.594 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 36' ' ' ILE . 73.9 m -91.76 130.98 37.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.689 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.42 ' CG2' HG12 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -132.56 163.59 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.634 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 164.0 4.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.878 0.371 . . . . 0.0 111.378 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 27' ' ' HIS . . . 121.79 -113.84 2.38 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.534 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.96 141.45 9.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.293 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.719 HG22 ' N ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -56.2 -21.26 22.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.578 0.228 . . . . 0.0 111.609 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.756 ' CB ' HG23 ' A' ' 69' ' ' THR . 38.0 t0 -93.53 -43.92 8.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -123.83 78.48 57.27 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.207 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.3 142.15 9.35 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.708 2.272 . . . . 0.0 112.633 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB2' ' CA ' ' A' ' 21' ' ' GLY . 22.7 t60 -74.97 -19.41 60.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.87 -27.34 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.274 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.09 28.89 9.45 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.377 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -171.14 32.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.6 111.75 0.44 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.6 -29.03 52.58 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.707 2.271 . . . . 0.0 112.009 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -62.26 169.59 2.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.59 149.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.981 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 10.3 p90 -142.84 144.71 32.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.578 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 18' ' ' SER . 57.9 mt -72.69 146.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.119 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.504 ' O ' HG21 ' A' ' 53' ' ' VAL . 16.6 m -101.19 -33.17 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.598 0.237 . . . . 0.0 111.508 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -168.94 152.67 5.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.427 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.4 mt -116.36 141.25 34.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.598 HD11 ' HA2' ' A' ' 16' ' ' GLY . 3.4 pt -92.74 141.49 24.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.163 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.78 61.58 6.29 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.513 2.142 . . . . 0.0 112.392 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.23 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.462 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.99 175.64 23.43 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.709 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . . . -76.11 -15.33 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.81 -57.46 11.94 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.95 0.405 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.8 -28.55 69.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.933 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -71.92 -35.72 69.74 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -84.88 -25.37 28.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.009 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . 82.37 56.07 2.91 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.392 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -70.15 42.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.633 HD21 HG21 ' A' ' 88' ' ' VAL . 1.2 pp 33.34 -153.49 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' N ' HD12 ' A' ' 51' ' ' LEU . 4.8 tpm_? -63.81 144.29 57.17 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.791 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -70.61 -37.62 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.515 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -54.86 -13.95 1.26 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.364 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 51' ' ' LEU . 32.2 p-10 -57.45 163.1 2.5 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.271 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.6 p -122.16 110.48 15.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.786 0.327 . . . . 0.0 110.707 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.724 HG22 HG12 ' A' ' 88' ' ' VAL . 2.9 pt -58.99 94.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 5.8 mt -65.14 -31.97 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.037 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 9.3 m-85 -146.18 168.6 20.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.105 0.479 . . . . 0.0 111.83 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.692 HG13 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -147.18 -177.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.547 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 60' ' ' VAL . 15.6 p-10 -53.96 82.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.786 0.327 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.7 OUTLIER 65.5 26.74 11.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.82 -179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 2.5 t -121.24 141.86 39.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 111.368 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -109.49 76.36 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.777 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG12 HG21 ' A' ' 68' ' ' VAL . 16.7 m -99.48 31.25 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.356 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -12.88 59.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -173.37 56.99 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.117 0.484 . . . . 0.0 109.706 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' C ' ' HB ' ' A' ' 23' ' ' THR . 19.1 m -117.31 140.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.756 HG23 ' CB ' ' A' ' 24' ' ' ASP . 1.5 m -50.25 169.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.201 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.612 ' CD2' HG23 ' A' ' 74' ' ' VAL . 1.8 t-160 -51.08 -48.75 61.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -51.63 -47.9 63.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.862 0.363 . . . . 0.0 111.536 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -60.24 -32.46 71.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.938 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.97 -43.86 64.46 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.616 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 ' CD2' ' A' ' 70' ' ' HIS . 43.0 t -65.1 -35.22 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.739 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.32 -32.17 71.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.822 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.44 -43.13 73.95 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.4 0.619 . . . . 0.0 110.385 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -76.33 -26.66 55.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.559 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -72.08 -39.51 68.93 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.383 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.26 29.06 7.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.628 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -81.35 -27.49 34.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.304 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.53 -132.43 11.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.499 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.498 ' O ' HG12 ' A' ' 83' ' ' ILE . 5.4 m -125.97 5.72 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.501 0.191 . . . . 0.0 111.397 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -151.06 91.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 80' ' ' ALA . 1.7 t -93.75 148.56 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.035 0.445 . . . . 0.0 111.897 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HD2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -133.7 108.28 8.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.692 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -130.3 153.8 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.512 0.672 . . . . 0.0 112.629 -178.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 59' ' ' PHE . 6.6 t80 -106.32 115.11 29.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.298 178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 57' ' ' ILE . 27.1 m -104.24 168.07 2.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.446 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -127.08 109.51 11.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.954 179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -120.5 146.58 46.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.731 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -93.75 133.68 36.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.729 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 90' ' ' ARG . 1.2 mmmt -141.39 77.16 20.12 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.492 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.21 111.86 2.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.797 2.331 . . . . 0.0 113.195 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.686 ' HB2' ' HA ' ' A' ' 188' ' ' ASN . 11.2 Cg_exo -69.55 -146.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.817 2.345 . . . . 0.0 111.776 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 161.33 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.531 ' CA ' ' HA ' ' A' ' 187' ' ' SER . 15.0 tt0 -54.39 125.98 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.024 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.66 120.44 5.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.043 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 98' ' ' VAL . 10.0 p -82.96 116.65 27.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.472 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 1.8 tpt -101.31 166.04 10.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.485 0.659 . . . . 0.0 111.942 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -137.32 106.59 6.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.56 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.741 HD12 ' HA2' ' A' ' 144' ' ' GLY . 3.7 mm -113.22 155.13 14.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HE2' ' CZ ' ' A' ' 180' ' ' TYR . 5.5 tttt -120.89 119.11 31.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.966 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.032 HD12 ' HB2' ' A' ' 140' ' ' ALA . 9.6 tt -120.67 118.7 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.047 0.451 . . . . 0.0 111.48 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.67 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 pt -95.13 144.75 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.597 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.2 tttm -55.69 143.63 29.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.975 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -175.46 14.09 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.814 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.59 -38.9 3.98 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 121.978 1.785 . . . . 0.0 112.1 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.25 18.32 11.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.107 0.479 . . . . 0.0 110.302 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.5 -132.64 11.12 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.5 mp -87.08 -27.31 23.21 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.886 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.7 47.24 4.03 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.93 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.07 149.23 0.55 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.922 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 13.6 m -109.2 124.31 50.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.625 HG21 ' CE2' ' A' ' 112' ' ' PHE . 10.4 pt -135.76 155.44 36.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.991 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' C' ' 6' ' ' SER . . . -152.39 125.15 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.429 . . . . 0.0 111.868 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.587 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.69 -174.99 25.31 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.195 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.11 -179.5 46.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.793 -0.718 . . . . 0.0 113.196 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 164' ' ' MET . 39.5 t -78.99 145.83 8.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.758 0.313 . . . . 0.0 110.922 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.9 -32.12 5.81 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.624 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HB3' ' CG ' ' A' ' 165' ' ' HIS . 2.7 t-20 -157.11 66.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.9 OUTLIER -70.67 -4.18 22.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.96 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 57.2 t60 72.28 -57.71 0.61 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.449 0.642 . . . . 0.0 110.478 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.879 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.3 mt -91.67 128.43 46.35 Favored Pre-proline 0 C--N 1.312 -1.039 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.442 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.57 74.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.421 2.08 . . . . 0.0 112.423 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 117.93 47.74 0.43 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.84 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.747 ' HB3' HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -165.98 93.75 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.866 0.365 . . . . 0.0 110.839 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -56.86 -22.08 34.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.308 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.7 m -56.02 151.13 12.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 0.0 111.005 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 160' ' ' LEU . 6.4 mt -89.02 119.44 36.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.335 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.879 ' CD1' HD11 ' A' ' 123' ' ' ILE . 5.2 m-85 -115.77 155.09 28.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.29 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.568 HG22 HG22 ' A' ' 114' ' ' ILE . 47.6 t -84.33 155.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.739 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 148' ' ' ILE . 6.4 p -117.62 -57.89 2.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.486 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.28 146.28 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 146' ' ' LEU . 4.7 mt -129.66 141.38 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.883 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -79.29 173.36 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.651 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 135' ' ' ILE . 45.3 mt-10 -87.05 143.38 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.797 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 63.05 22.88 65.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.56 -173.82 23.49 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.37 -69.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.032 ' HB2' HD12 ' A' ' 103' ' ' LEU . . . -63.28 -31.63 72.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 145' ' ' ARG . 23.4 t-160 -53.38 -62.1 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.993 0.425 . . . . 0.0 111.115 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -38.2 67.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.178 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -80.33 -59.29 2.76 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.741 ' HA2' HD12 ' A' ' 101' ' ' ILE . . . -80.81 -18.87 69.16 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.006 -0.616 . . . . 0.0 114.024 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER 50.95 26.99 2.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.15 0.475 . . . . 0.0 110.791 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 140' ' ' ALA . 0.4 OUTLIER -87.4 81.25 7.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -67.59 175.14 3.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.536 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 132' ' ' THR . 33.0 mt -46.85 126.5 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.25 0.548 . . . . 0.0 111.293 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 120.12 -23.21 8.24 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.514 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 146' ' ' LEU . 0.6 OUTLIER -63.84 159.23 20.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.678 0.275 . . . . 0.0 110.456 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 130' ' ' TYR . 1.0 OUTLIER -145.82 138.8 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.004 0.431 . . . . 0.0 111.388 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -105.3 132.22 52.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.491 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 1.2 pp -99.62 -1.87 37.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.292 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.71 154.38 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.798 0.332 . . . . 0.0 111.204 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 158' ' ' VAL . 35.4 t -108.61 99.74 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.875 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.542 HD22 HG12 ' A' ' 155' ' ' VAL . 68.6 m-80 69.53 -59.51 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.404 0.621 . . . . 0.0 109.578 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 82.9 p -164.33 28.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.028 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.5 t -102.33 155.09 5.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.489 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -114.85 76.74 0.25 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.304 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.736 HD22 HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -81.09 25.76 0.46 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.46 56.2 1.44 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.333 0.587 . . . . 0.0 110.796 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -165.29 29.37 0.06 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.352 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.68 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.2 t -141.59 -76.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.553 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.434 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 176.62 167.76 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.605 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.459 ' O ' HG23 ' A' ' 169' ' ' VAL . 10.8 t-80 -54.46 -30.11 51.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.69 -49.16 27.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.049 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.68 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -71.66 -33.12 68.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.033 0.444 . . . . 0.0 110.225 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.686 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.23 -41.17 73.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.487 0.66 . . . . 0.0 109.484 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.818 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.9 t -69.03 -43.99 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.153 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -32.44 71.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.222 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.07 -26.42 48.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.983 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -81.22 -38.47 26.93 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.868 ' HE3' HG21 ' C' ' 9' ' ' VAL . 4.0 mttp -75.19 -26.66 59.19 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.924 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -68.53 -9.91 52.25 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.399 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.404 ' CB ' HG21 ' A' ' 179' ' ' VAL . 1.1 p -42.85 147.21 0.32 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.834 0.349 . . . . 0.0 111.544 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -90.34 170.47 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.4 OUTLIER -44.93 -32.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.869 -179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 104' ' ' ILE . 39.9 t -148.22 91.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.404 HG21 ' CB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.22 148.32 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 0.0 111.925 -179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.439 ' CZ ' ' HE2' ' A' ' 102' ' ' LYS . 7.8 m-85 -101.71 133.35 46.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.771 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -118.98 149.62 41.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.941 0.401 . . . . 0.0 111.092 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 152' ' ' ILE . 22.0 mttt -96.52 112.02 23.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.506 HG21 HG13 ' A' ' 101' ' ' ILE . 11.5 t -102.78 159.5 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.328 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.45 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -133.22 146.27 51.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.921 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.54 146.24 31.86 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.14 109.71 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.663 2.242 . . . . 0.0 111.922 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.531 ' HA ' ' CA ' ' A' ' 96' ' ' GLU . 36.4 t -54.74 161.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.681 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.686 ' HA ' ' HB2' ' A' ' 94' ' ' PRO . 3.1 m120 -67.27 63.13 0.06 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.335 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.408 ' N ' ' HG2' ' A' ' 94' ' ' PRO . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.092 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t 69.91 -64.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.282 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' B' ' 7' ' ' SER . 7.4 p -56.57 121.53 44.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.266 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.26 -71.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.288 1.992 . . . . 0.0 112.032 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -122.84 -91.52 0.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.547 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.73 -56.44 3.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.807 0.336 . . . . 0.0 110.231 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.782 ' HB2' HG23 ' B' ' 3' ' ' VAL . 7.0 t 74.52 -165.86 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.461 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 9.6 t -59.14 143.63 48.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.402 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.518 ' OXT' HD12 ' A' ' 15' ' ' LEU . 25.1 t . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.697 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.817 0.341 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.56 -32.72 59.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t 59.7 84.2 0.2 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.33 -27.33 28.65 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.585 2.19 . . . . 0.0 112.418 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -170.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . 54.6 p -116.22 -176.25 2.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.16 88.43 6.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.802 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.591 ' O ' HG13 ' C' ' 9' ' ' VAL . 98.7 p -86.28 110.77 19.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.868 HG21 ' HE3' ' A' ' 173' ' ' LYS . 3.6 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.038 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG3' ' HG2' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.853 0.359 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -97.22 173.87 7.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.099 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.49 164.04 35.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.838 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -179.79 152.58 0.49 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.15 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' N ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -84.11 148.66 26.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.691 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 50' ' ' ARG . 19.3 mt -148.44 152.84 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.239 0.542 . . . . 0.0 111.834 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 ' HG2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -116.21 130.28 56.72 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.9 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.826 ' HG ' HD23 ' A' ' 15' ' ' LEU . 3.7 tp -134.98 91.5 2.76 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.608 0.718 . . . . 0.0 110.451 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.0 mt-10 -69.6 168.86 13.87 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.721 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HB2' ' CB ' ' A' ' 82' ' ' SER . 2.6 mtt180 -72.63 104.26 3.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.796 ' CA ' ' HB2' ' A' ' 44' ' ' ALA . . . -69.69 65.74 0.63 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.108 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 75.83 -76.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.782 0.325 . . . . 0.0 110.261 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.8 m -109.31 30.53 6.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.4 -177.95 17.2 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.826 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.5 -52.28 6.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.28 -179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 78.14 1.4 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.845 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.3 p90 -164.74 155.76 14.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.74 0.305 . . . . 0.0 110.732 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' ILE . 7.5 m -109.29 126.84 53.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.74 HG22 HG12 ' A' ' 36' ' ' ILE . 2.7 pt -120.73 164.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.755 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.75 157.84 4.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.956 0.408 . . . . 0.0 111.305 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.93 -118.11 3.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.265 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 144.46 11.24 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.683 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -57.37 -19.27 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.555 0.217 . . . . 0.0 111.483 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.773 ' HB2' HG22 ' A' ' 69' ' ' THR . 3.7 m-20 -88.78 -54.7 4.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.868 0.366 . . . . 0.0 111.064 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -120.33 81.83 30.65 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.318 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.9 138.04 21.42 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.643 2.229 . . . . 0.0 112.508 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 35' ' ' PHE . 18.5 t60 -70.02 -19.55 63.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.216 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.29 -30.43 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.49 28.79 8.23 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.496 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -172.91 33.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -163.07 112.66 1.04 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HB2' ' CB ' ' A' ' 67' ' ' GLU . 23.7 Cg_exo -64.29 -29.32 63.72 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.739 2.293 . . . . 0.0 112.135 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.21 176.29 2.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.789 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 HD11 ' O ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -123.88 152.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 2.2 p90 -139.79 168.56 19.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.74 HG12 HG22 ' A' ' 19' ' ' ILE . 46.6 mt -95.45 153.44 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.64 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.68 -31.33 7.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 9.7 tmtt? -171.32 150.21 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.029 0.442 . . . . 0.0 111.594 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -110.58 141.34 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.846 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 2.9 mt -85.81 123.5 72.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.009 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 40' ' ' ILE . 20.2 Cg_exo -65.59 64.79 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.558 2.172 . . . . 0.0 112.218 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -166.17 -51.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.508 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.39 174.08 5.12 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.438 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.796 ' HB2' ' CA ' ' A' ' 11' ' ' GLY . . . -59.23 -34.6 72.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 0.0 111.369 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.696 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -50.9 -44.47 59.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.92 -28.24 63.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.623 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -71.9 -39.16 69.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.682 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' C ' ' A' ' 49' ' ' GLY . 1.2 m-20 -85.96 -28.17 24.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.051 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 19.38 59.27 0.01 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.941 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CG ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.61 -15.35 13.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 51' ' ' LEU . 1.5 pt? -118.36 167.72 11.3 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.061 0.458 . . . . 0.0 111.281 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -107.75 159.05 16.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.049 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.4 m -70.88 -48.25 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 112.023 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' N ' HG23 ' A' ' 53' ' ' VAL . 15.9 m-80 -61.22 1.37 0.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -84.52 160.91 20.41 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.149 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.21 113.22 18.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.774 0.321 . . . . 0.0 110.735 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 HG12 ' A' ' 88' ' ' VAL . 16.6 pt -56.27 95.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.037 0.446 . . . . 0.0 110.931 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -65.24 -21.79 66.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.757 -179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.672 ' HA ' HG12 ' A' ' 65' ' ' VAL . 2.5 t80 -155.78 145.35 21.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.64 HG22 ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -129.56 117.18 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.722 179.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 56.77 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.827 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 60' ' ' VAL . 29.1 mt-10 -150.76 30.11 0.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.578 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 21.4 t -120.86 141.69 40.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.427 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 4.8 m-20 -77.39 90.58 3.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' ' 57' ' ' ILE . 15.0 p -103.2 33.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.423 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.13 6.04 38.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 32' ' ' PRO . 1.0 OUTLIER 173.87 53.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 0.0 110.011 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.709 ' CG2' HG23 ' A' ' 65' ' ' VAL . 31.5 m -115.64 141.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.004 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.773 HG22 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -49.95 157.85 0.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.466 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -51.58 -48.57 63.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.508 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -55.8 -42.69 76.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.748 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.37 69.13 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.547 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.561 ' HA ' HD21 ' A' ' 77' ' ' LEU . 47.5 t -64.6 -35.55 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.649 178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -69.53 -33.71 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.839 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.41 -43.46 73.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.393 0.616 . . . . 0.0 110.491 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.57 -26.76 55.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.42 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 4.6 tttm -69.95 -38.56 76.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.067 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.27 27.29 7.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.442 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -86.23 -25.15 25.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.329 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.7 -152.91 30.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.656 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.513 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -101.82 11.09 39.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.641 0.258 . . . . 0.0 111.438 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 mt -150.64 92.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' THR . 2.8 t -85.23 148.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.401 0.62 . . . . 0.0 111.869 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 7' ' ' THR . 2.3 mmt85 -138.16 84.13 2.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.562 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 86' ' ' LEU . 1.7 pp -115.6 154.02 30.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.397 0.618 . . . . 0.0 112.569 -177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CE1' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -104.84 114.84 29.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.608 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 57' ' ' ILE . 33.0 m -105.83 167.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.121 0.486 . . . . 0.0 112.193 -178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.4 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 29.4 ttp -131.62 109.44 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.312 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 90' ' ' ARG . 21.2 ttp-105 -120.17 146.52 45.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.581 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -52.5 160.94 0.76 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.234 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.24 164.45 61.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.01 171.94 5.52 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.803 2.335 . . . . 0.0 112.489 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.586 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 37.7 Cg_exo -60.14 -147.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.888 2.392 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 82.34 53.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.156 0.503 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' HG3' ' HB3' ' A' ' 185' ' ' LYS . 1.4 mm-40 -64.51 -160.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.492 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.91 -178.96 3.98 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.94 125.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.84 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 31.3 mtm -102.18 164.14 11.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.337 0.589 . . . . 0.0 112.08 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -127.98 106.8 9.33 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.492 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -115.86 155.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.627 ' HE3' HG12 ' A' ' 178' ' ' VAL . 9.9 tttp -117.15 118.65 32.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.376 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.78 ' HB2' HD11 ' A' ' 181' ' ' LEU . 7.9 tt -115.69 118.71 33.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.966 0.412 . . . . 0.0 111.137 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 178' ' ' VAL . 4.5 pt -98.42 144.69 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.8 tttm -74.64 161.18 29.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.965 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.08 -168.66 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.849 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.09 -40.02 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.076 1.851 . . . . 0.0 112.167 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -93.75 20.58 7.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.81 -142.83 15.56 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mp -86.65 -21.31 26.8 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.869 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.84 50.77 8.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.895 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CE2' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -176.52 148.01 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.873 0.368 . . . . 0.0 111.029 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.3 t -107.01 116.9 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.677 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.882 HD11 HD22 ' A' ' 172' ' ' LEU . 48.2 pt -115.38 173.6 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.003 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 129' ' ' ILE . . . -99.13 -176.53 3.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.82 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.426 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -143.15 149.14 21.08 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.103 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -47.47 -94.72 0.01 OUTLIER Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.072 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.444 ' HB ' ' HG3' ' A' ' 164' ' ' MET . 34.3 t -87.38 148.63 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.28 -21.19 41.73 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.388 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -174.93 69.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.976 0.417 . . . . 0.0 110.259 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.57 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.7 pt20 -59.83 -19.85 53.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.274 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' GLN . 49.6 t60 72.51 -52.62 0.7 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 110.817 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.862 HD11 ' CD1' ' A' ' 130' ' ' TYR . 3.2 mt -93.3 141.09 23.53 Favored Pre-proline 0 C--N 1.311 -1.071 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.839 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.569 ' HD2' HG22 ' A' ' 123' ' ' ILE . 52.9 Cg_exo -54.7 83.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.4 2.067 . . . . 0.0 112.233 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 80.01 62.13 2.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.797 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.533 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.2 t0 -159.91 93.22 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -55.98 -22.34 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.269 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.0 p -54.67 122.88 11.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.755 0.312 . . . . 0.0 110.778 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.805 HD12 ' HB3' ' A' ' 160' ' ' LEU . 17.1 mt -72.19 117.8 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.085 0.469 . . . . 0.0 111.744 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.862 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.8 m-85 -111.95 153.9 26.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.299 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 114' ' ' ILE . 60.1 t -91.05 134.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.25 -45.35 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -122.09 132.59 54.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.021 0.439 . . . . 0.0 111.745 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 131' ' ' VAL . 56.1 mt -137.36 128.63 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.943 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -74.74 173.23 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.738 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.596 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.0 OUTLIER -92.29 144.0 25.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.35 15.19 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.616 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.85 -157.41 3.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.583 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -83.54 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.277 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.17 -31.81 69.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.379 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -55.3 -58.06 9.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.196 0.522 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.8 -47.5 45.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.041 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -80.69 -59.42 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' CG2' ' A' ' 101' ' ' ILE . . . -61.24 -35.87 91.55 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.19 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 61.1 20.13 10.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.807 0.337 . . . . 0.0 110.875 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 150' ' ' ASP . 0.4 OUTLIER -96.72 81.28 3.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.798 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' HA ' HD12 ' A' ' 134' ' ' ILE . 5.0 pt20 -65.68 176.31 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.508 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.9 mt -47.82 129.47 4.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.182 0.515 . . . . 0.0 111.214 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 116.28 -24.92 9.58 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.532 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.3 m-20 -63.99 133.44 53.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.349 . . . . 0.0 110.749 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' CB ' ' CD1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -122.9 130.1 52.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.95 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -104.53 137.03 35.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 2.6 pp -98.91 -2.71 36.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.762 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 165.4 147.77 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.124 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.739 HG23 HD11 ' A' ' 160' ' ' LEU . 47.5 t -101.36 99.69 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.448 ' ND2' HG12 ' A' ' 155' ' ' VAL . 68.2 m-80 69.44 -58.73 0.51 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.243 0.544 . . . . 0.0 109.666 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 155' ' ' VAL . 81.3 p -163.1 25.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.728 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 155' ' ' VAL . 23.9 t -91.59 156.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.075 0 CA-C-O 121.364 0.602 . . . . 0.0 111.524 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 161' ' ' GLU . . . -99.29 74.05 0.51 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.749 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.805 ' HB3' HD12 ' A' ' 129' ' ' ILE . 37.7 mt -70.61 24.1 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.717 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 159' ' ' GLY . 8.3 pt-20 -176.26 56.63 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.3 0.572 . . . . 0.0 110.924 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -161.48 27.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.573 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.678 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -153.23 -76.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.146 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.444 ' HG3' ' HB ' ' A' ' 118' ' ' VAL . 5.5 mtp 173.06 164.48 0.13 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.482 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 169' ' ' VAL . 2.6 p-80 -53.83 -29.86 42.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.939 0.399 . . . . 0.0 110.446 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.57 -45.41 53.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.151 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.678 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -73.22 -35.66 66.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.968 0.413 . . . . 0.0 110.604 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.71 73.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.776 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.704 ' HA ' HD23 ' A' ' 172' ' ' LEU . 14.0 t -74.01 -39.94 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.493 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.82 68.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.671 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.0 -28.36 49.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.882 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -80.79 -36.79 31.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -26.88 60.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.493 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -76.26 -12.8 60.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.207 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.501 ' HB ' HG21 ' A' ' 179' ' ' VAL . 70.9 p -55.66 -172.59 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.805 0.336 . . . . 0.0 111.341 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -107.68 170.22 8.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -55.47 -16.96 4.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.347 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.627 HG12 ' HE3' ' A' ' 102' ' ' LYS . 39.1 t -147.88 92.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.501 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.92 148.41 20.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.071 0.463 . . . . 0.0 111.987 -178.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.408 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -94.81 131.19 40.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.28 179.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -118.36 146.99 43.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.957 0.408 . . . . 0.0 110.978 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -96.13 108.11 20.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.08 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 101' ' ' ILE . 5.6 t -102.71 157.57 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.062 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -141.67 153.83 44.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.505 ' HB3' ' HG3' ' A' ' 96' ' ' GLU . 7.3 mmtp -123.7 141.95 37.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.612 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.44 97.45 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.753 2.302 . . . . 0.0 112.931 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.3 m -67.84 149.06 50.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.84 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 46.34 30.06 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.281 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.058 -179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.723 0.297 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.577 HG22 ' O ' ' B' ' 2' ' ' VAL . 10.7 p -88.62 51.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.152 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.418 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 22.7 t 56.59 64.39 4.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.426 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' B' ' 3' ' ' VAL . 13.1 Cg_exo -69.66 92.72 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.666 2.244 . . . . 0.0 112.119 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.18 82.08 1.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -164.91 86.46 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 104.5 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.25 110.73 22.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.772 ' OXT' HD12 ' A' ' 15' ' ' LEU . 26.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.12 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.857 0.36 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . . . . . . . . . 31.3 m -71.5 135.67 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.38 91.81 25.49 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.8 132.87 38.18 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.487 2.125 . . . . 0.0 112.359 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.44 118.4 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 54.4 m 59.44 162.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 73.9 m -113.65 109.94 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.916 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 30.7 p -94.22 116.38 28.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.006 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 112' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.2 ptm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.61 163.49 12.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.33 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -159.41 154.47 25.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 179.28 156.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.54 158.45 35.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.313 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.652 HD12 HG21 ' A' ' 88' ' ' VAL . 3.5 mt -152.78 142.39 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.294 0.568 . . . . 0.0 111.942 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -122.22 119.38 31.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.965 178.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.888 HD21 ' HB2' ' A' ' 45' ' ' ALA . 3.1 tp -125.31 93.96 4.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.637 0.732 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -79.08 165.32 23.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.911 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.9 93.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -50.67 -25.89 9.75 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.595 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -173.53 -85.6 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 30.6 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.622 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.04 177.02 18.59 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.213 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.804 HD23 ' HG ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -84.22 -43.45 14.88 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.742 0.306 . . . . 0.0 111.113 -179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 92.95 71.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.713 . . . . 0.0 114.078 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.557 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 1.3 p90 -164.77 155.27 14.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.794 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' ILE . 1.4 m -112.97 126.96 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.446 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.49 164.07 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.26 142.31 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 0.0 111.197 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 136.76 -126.89 3.89 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.71 128.47 4.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.665 HG22 ' N ' ' A' ' 69' ' ' THR . 2.2 t -49.58 -25.78 3.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 69' ' ' THR . 53.5 t0 -91.75 -40.92 10.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -123.82 77.24 57.31 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.67 134.89 34.22 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.644 2.23 . . . . 0.0 112.413 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.425 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.0 t60 -68.51 -21.41 64.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -111.61 -31.6 2.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.12 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.02 28.34 8.28 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.597 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -176.69 36.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 32' ' ' PRO . 4.7 t0 -162.38 95.67 1.2 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 31' ' ' ASP . 12.3 Cg_endo -55.68 -23.71 42.15 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.458 2.106 . . . . 0.0 112.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.14 159.27 32.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.604 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.01 150.77 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.033 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.52 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.4 p90 -142.53 144.96 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' SER . 64.8 mt -74.43 147.25 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.786 ' O ' HG21 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -96.59 -46.52 6.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.62 -179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.44 158.29 39.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.093 0.473 . . . . 0.0 111.671 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -111.09 141.23 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' GLY . 2.7 mt -84.5 118.16 70.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.22 76.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.42 2.08 . . . . 0.0 112.099 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . 174.22 -45.62 0.14 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.422 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.62 -178.47 0.67 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.466 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.561 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.95 -28.41 57.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.588 0.232 . . . . 0.0 111.396 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.888 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.74 -43.6 76.77 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.959 0.409 . . . . 0.0 110.749 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.87 -28.09 65.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.866 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -71.57 -40.89 69.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.695 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -86.44 -25.01 25.45 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.273 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.87 -39.24 2.82 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.616 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 35.23 37.05 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.348 0.594 . . . . 0.0 111.095 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' ARG . 1.5 pp 40.99 -162.21 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.401 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.32 146.88 54.35 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.243 0.544 . . . . 0.0 111.8 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 37' ' ' THR . 19.6 m -71.0 -36.0 61.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.329 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -54.36 -15.12 1.45 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.103 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -57.17 178.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.477 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 t -136.97 110.45 7.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 111.082 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.804 ' HA ' HG12 ' A' ' 88' ' ' VAL . 14.2 pt -58.96 95.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.812 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -64.6 -21.98 66.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.542 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER -157.18 148.36 21.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.153 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.549 HG12 ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -142.69 125.77 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.591 179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.522 HD21 HG12 ' A' ' 84' ' ' VAL . 31.7 m-20 45.85 47.94 12.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 64.69 26.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 16.8 t -120.79 141.76 39.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.016 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.63 127.47 35.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.16 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' HG13 ' A' ' 68' ' ' VAL . 34.3 m -143.71 32.52 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.076 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -76.29 2.38 13.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.555 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -173.28 46.99 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.108 0.48 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' C ' ' HB ' ' A' ' 23' ' ' THR . 35.6 m -110.6 141.19 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.754 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.665 ' N ' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -50.23 160.89 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.706 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.603 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -50.97 -48.58 61.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.404 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.61 -40.86 63.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.933 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.26 -33.84 75.38 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.373 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.87 -40.17 69.14 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.429 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.603 HG23 ' CD2' ' A' ' 70' ' ' HIS . 47.9 t -64.64 -36.06 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.54 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 7.8 mt-10 -69.54 -33.12 72.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.787 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.34 -42.81 74.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.424 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.828 HD13 HG11 ' B' ' 9' ' ' VAL . 3.0 pp -76.84 -26.84 54.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.352 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -72.65 -44.53 61.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.098 179.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -102.27 29.19 5.3 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.04 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.851 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -75.85 -29.87 58.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.444 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.3 -152.51 32.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.474 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.507 ' O ' HG12 ' A' ' 83' ' ' ILE . 2.8 m -108.76 5.51 24.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.1 mt -155.85 93.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.851 HG11 ' HB1' ' A' ' 80' ' ' ALA . 30.2 m -95.13 111.46 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.31 68.64 5.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.819 ' CD1' HG13 ' A' ' 88' ' ' VAL . 4.4 pp -89.21 153.97 20.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.636 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CD1' HD21 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -109.45 120.13 41.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.476 178.39 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.819 HG13 ' CD1' ' A' ' 86' ' ' LEU . 8.6 m -117.67 167.87 10.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.369 0.604 . . . . 0.0 112.458 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.412 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 5.1 ptm -147.89 109.21 4.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.845 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 26.1 ttp180 -107.33 111.88 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.087 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 93' ' ' PRO . 2.8 mtm180 -73.85 144.97 45.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.397 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -106.5 71.97 0.28 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.297 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 75.4 Cg_endo -75.65 142.41 25.91 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.476 2.118 . . . . 0.0 112.409 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 93' ' ' PRO . 10.1 Cg_exo -70.57 -153.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.577 2.184 . . . . 0.0 111.678 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 188' ' ' ASN . . . -90.65 12.01 20.3 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.316 0.579 . . . . 0.0 111.6 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 185' ' ' LYS . 1.5 pt-20 170.48 -174.41 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.442 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -179.77 -143.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 121.241 -0.184 . . . . 0.0 111.167 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.485 HG23 HD21 ' A' ' 153' ' ' LEU . 11.3 p -82.31 151.25 4.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.169 0.509 . . . . 0.0 111.833 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.92 166.85 20.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.858 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -122.46 106.82 11.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.497 HG13 HG21 ' A' ' 183' ' ' VAL . 1.6 mm -119.25 155.55 21.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.519 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 5.1 tttt -111.74 127.16 55.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.687 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.9 tt -125.43 118.56 26.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.522 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.782 HG22 HG13 ' A' ' 178' ' ' VAL . 4.2 pt -100.73 144.72 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -65.44 152.77 43.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.798 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' GLY . . . -132.37 157.71 22.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.829 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.52 -33.72 69.22 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.046 1.831 . . . . 0.0 112.16 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.59 ' HE3' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -96.05 18.38 13.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.035 0.445 . . . . 0.0 110.25 178.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 106' ' ' GLY . . . 104.33 -148.28 16.73 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 mp -86.56 -17.99 32.63 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.166 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 73.01 51.95 9.65 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.081 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.546 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -178.33 145.69 0.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.654 0.264 . . . . 0.0 110.695 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.2 t -110.95 116.75 31.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 110.737 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.844 HD11 HD22 ' A' ' 172' ' ' LEU . 7.3 pt -126.99 153.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.585 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.924 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -149.06 125.02 10.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.0 111.789 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.71 -175.09 25.44 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.199 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 121' ' ' GLN . . . 111.75 -178.43 19.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.352 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.49 144.4 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.709 0.29 . . . . 0.0 111.349 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.04 -21.17 46.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.541 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 173.0 79.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.501 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 117' ' ' GLY . 9.7 pm0 -103.4 -179.66 4.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.086 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.924 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 68.0 t60 -57.95 -50.24 74.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.042 0.925 . . . . 0.0 110.662 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.943 HD11 ' CG ' ' A' ' 130' ' ' TYR . 0.1 OUTLIER -102.61 102.86 28.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.033 -178.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.42 92.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.371 2.047 . . . . 0.0 112.237 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.99 20.87 3.63 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.935 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -155.64 91.3 1.3 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.871 0.367 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -49.99 -25.86 3.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 p -54.01 116.32 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.765 HG12 ' HA3' ' A' ' 116' ' ' GLY . 5.6 mt -61.61 121.08 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.388 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.943 ' CG ' HD11 ' A' ' 123' ' ' ILE . 3.2 m-85 -114.34 156.75 23.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.13 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 150' ' ' ASP . 53.2 t -84.1 155.5 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.691 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.476 HG22 ' CE1' ' A' ' 122' ' ' HIS . 10.5 p -119.87 -57.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.548 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -148.87 148.28 29.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 147' ' ' GLN . 26.5 mt -136.72 139.04 45.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.59 HD12 ' HE3' ' A' ' 108' ' ' LYS . 1.2 mt -79.56 173.25 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.758 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 135' ' ' ILE . 5.4 tt0 -90.86 149.52 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.0 25.33 45.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.89 177.4 54.13 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.511 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 104' ' ' ILE . . . -68.64 -60.36 2.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 111.209 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.61 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.03 -32.02 69.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.329 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -59.24 -45.74 90.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.121 0.486 . . . . 0.0 110.145 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -72.71 -57.07 4.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.572 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -80.32 -59.24 2.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.695 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -51.03 -49.16 43.83 Favored Glycine 0 CA--C 1.518 0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.889 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 63.13 18.11 10.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.597 0.237 . . . . 0.0 111.039 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 144' ' ' GLY . 0.3 OUTLIER -93.85 78.26 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.687 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -62.73 177.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.693 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.1 mt -47.2 134.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.084 0.468 . . . . 0.0 111.188 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 108.46 -27.44 13.73 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.539 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.829 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -63.37 140.58 58.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.337 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.489 ' HD2' ' CZ ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -125.31 131.74 53.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.054 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.636 HD12 ' HB ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -103.94 127.1 58.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 184' ' ' ALA . 1.7 pp -96.6 -1.55 46.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.353 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 174.49 158.74 0.17 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.881 0.372 . . . . 0.0 111.223 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.972 HG12 ' ND2' ' A' ' 156' ' ' ASN . 22.7 t -118.65 100.07 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.158 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.972 ' ND2' HG12 ' A' ' 155' ' ' VAL . 13.0 m-80 70.41 -59.36 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.329 0.585 . . . . 0.0 109.665 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 p -165.57 28.33 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.123 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 155' ' ' VAL . 4.2 t -103.11 154.81 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.367 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.85 78.6 0.29 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.557 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.699 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 15.5 mt -76.52 23.66 0.15 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.85 40.3 1.83 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.095 0.474 . . . . 0.0 110.803 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -148.35 28.38 0.9 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.459 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.1 t -148.75 -76.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 174.98 169.69 0.28 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.666 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 169' ' ' VAL . 44.4 t-80 -55.86 -29.94 60.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.877 0.37 . . . . 0.0 110.679 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.79 38.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.332 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.733 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -70.78 -36.93 73.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.999 0.428 . . . . 0.0 110.571 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 160' ' ' LEU . . . -70.64 -35.71 73.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.761 ' HA ' HD23 ' A' ' 172' ' ' LEU . 4.3 t -71.5 -39.94 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.93 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -36.07 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.9 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.56 ' HB3' HD22 ' A' ' 160' ' ' LEU . . . -76.03 -25.98 56.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.304 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.844 HD22 HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -80.32 -36.83 33.72 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -73.0 -26.87 61.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.385 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.82 -9.88 58.42 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.315 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.646 HG22 HG11 ' A' ' 155' ' ' VAL . 5.8 p -45.56 159.59 0.06 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.952 0.406 . . . . 0.0 111.633 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -92.6 168.94 10.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.197 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -47.23 -34.18 6.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.396 -179.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 104' ' ' ILE . 41.3 t -148.1 90.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.708 0.29 . . . . 0.0 110.757 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 156' ' ' ASN . 0.0 OUTLIER -123.49 148.58 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.359 . . . . 0.0 111.504 -179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 36.6 p90 -92.27 132.27 36.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.846 HD22 HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -112.01 153.86 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.432 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' HG22 ' A' ' 152' ' ' ILE . 25.2 mtpp -96.68 114.38 26.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.787 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.497 HG21 HG13 ' A' ' 101' ' ' ILE . 24.7 t -102.02 163.91 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.532 ' HB2' HD23 ' A' ' 153' ' ' LEU . . . -145.56 149.86 35.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.396 0.617 . . . . 0.0 112.161 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 6.5 mtpt -114.21 146.66 36.24 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.005 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.38 32.94 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.574 2.183 . . . . 0.0 114.126 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 96' ' ' GLU . 19.6 m 42.3 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.753 0.311 . . . . 0.0 111.034 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.715 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 26.0 p-10 -65.97 65.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.104 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 187' ' ' SER . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.114 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.962 0.411 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 6.4 m -114.39 -31.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -120.06 127.95 26.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.079 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.58 115.21 4.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.472 2.114 . . . . 0.0 112.366 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -101.69 33.39 3.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.84 129.48 34.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.61 106.96 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -89.61 118.6 29.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 77' ' ' LEU . 23.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.088 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.418 HG13 HG13 ' C' ' 3' ' ' VAL . 10.7 p -178.65 -39.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.418 HG13 HG13 ' C' ' 2' ' ' VAL . 7.8 m -92.69 157.0 40.51 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.153 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.17 -3.29 13.4 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.609 2.206 . . . . 0.0 112.803 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 65.86 -77.1 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.022 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.404 ' OG ' HG21 ' A' ' 132' ' ' THR . 3.4 m 62.5 131.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.71 85.58 6.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 36.8 m -85.71 118.64 25.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.362 -0.828 . . . . 0.0 111.086 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.8 mtm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.828 0.347 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 156.37 17.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -163.07 128.2 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.543 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -178.03 174.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.414 . . . . 0.0 111.641 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -93.55 149.67 21.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.632 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD13 ' HG3' ' A' ' 50' ' ' ARG . 11.3 mt -148.05 150.01 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 111.561 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.9 OUTLIER -115.27 119.87 37.78 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.665 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HG ' HD23 ' A' ' 15' ' ' LEU . 10.9 tp -121.91 93.62 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.45 0.643 . . . . 0.0 110.097 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -75.27 151.4 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.001 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 82' ' ' SER . 32.3 mtt180 -72.02 103.87 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.605 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.9 -26.89 6.09 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.774 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -169.47 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 p -109.28 30.73 6.33 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.39 173.73 17.89 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.519 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.896 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.5 OUTLIER -84.4 -50.02 8.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.753 0.311 . . . . 0.0 111.138 -179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 100.93 79.15 1.4 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.686 -0.768 . . . . 0.0 113.674 178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.798 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -164.7 159.2 18.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.684 0.278 . . . . 0.0 110.607 178.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 36' ' ' ILE . 30.8 t -112.74 126.85 55.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 36' ' ' ILE . 4.7 pt -118.21 171.71 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.881 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.62 149.02 2.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 111.219 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.44 -120.66 4.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.196 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA2' HG12 ' A' ' 34' ' ' ILE . . . 105.23 145.68 13.86 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.686 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' N ' ' A' ' 69' ' ' THR . 1.2 t -50.67 -24.94 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.682 0.277 . . . . 0.0 111.472 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.681 ' CB ' HG23 ' A' ' 69' ' ' THR . 19.2 t0 -86.68 -48.2 8.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.814 0.34 . . . . 0.0 111.213 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -123.89 80.36 56.75 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.281 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 126.64 19.12 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.596 2.197 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 35' ' ' PHE . 17.0 t60 -67.3 -19.42 65.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.87 -26.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.257 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.14 34.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -168.32 111.56 0.56 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.925 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' CB ' ' HG2' ' A' ' 67' ' ' GLU . 23.3 Cg_exo -64.83 -28.73 59.01 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.614 2.209 . . . . 0.0 112.151 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -72.88 144.21 47.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 35' ' ' PHE . 15.0 mt -93.55 157.4 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.163 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.478 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 1.4 p90 -142.39 153.5 43.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 18' ' ' SER . 59.9 mt -84.8 150.74 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.44 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.589 ' O ' HG21 ' A' ' 53' ' ' VAL . 61.2 p -100.02 -46.61 5.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.871 0.367 . . . . 0.0 111.037 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -157.07 155.92 31.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.344 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.443 HG13 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mt -113.87 141.4 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.927 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.25 134.43 43.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.982 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.55 60.38 5.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.094 . . . . 0.0 112.301 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.7 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.65 168.81 26.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.58 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' GLY . . . -61.73 -25.86 67.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.658 0.266 . . . . 0.0 111.506 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.557 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -59.4 -57.54 12.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 111.046 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.2 -28.27 69.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.956 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -72.1 -41.95 66.68 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -72.61 -33.27 66.56 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.414 178.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 29.31 39.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.838 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.808 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.8 ptm180 -98.69 28.45 4.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.294 . . . . 0.0 111.355 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.645 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -176.43 164.89 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.858 0.361 . . . . 0.0 111.002 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.89 164.09 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.656 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.901 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.8 m -70.93 -47.27 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.015 0.436 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' N ' HG23 ' A' ' 53' ' ' VAL . 40.7 m-80 -58.87 -4.85 0.51 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.645 ' OD2' HD12 ' A' ' 51' ' ' LEU . 21.6 p-10 -62.31 175.27 0.77 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.312 -0.242 . . . . 0.0 110.552 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 p -141.52 106.03 4.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.134 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -54.55 98.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.429 0.633 . . . . 0.0 111.159 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.32 -25.66 63.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.118 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 64' ' ' ASP . 1.5 t80 -163.87 144.03 8.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.711 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.687 HG22 ' H ' ' A' ' 61' ' ' ASN . 1.1 p -103.92 -176.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.012 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.687 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.7 m120 -21.59 -51.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.601 0.563 . . . . 0.0 111.857 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 tt0 -163.72 27.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.702 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.601 ' HB ' HG12 ' A' ' 60' ' ' VAL . 2.8 t -121.59 142.0 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.693 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 23.5 p30 -79.63 84.34 5.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.058 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 HG21 ' A' ' 68' ' ' VAL . 5.8 m -91.04 26.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 112.02 -179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -95.91 9.26 41.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.286 . . . . 0.0 110.991 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' HG2' ' CB ' ' A' ' 32' ' ' PRO . 3.9 mt-10 -166.14 37.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.256 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.458 HG21 HG12 ' A' ' 65' ' ' VAL . 35.9 m -118.68 141.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.9 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.766 ' N ' HG22 ' A' ' 23' ' ' THR . 3.8 m -50.34 166.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.447 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.501 ' NE2' HD11 ' A' ' 19' ' ' ILE . 2.5 t-160 -59.09 -48.71 80.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.2 m -60.73 -36.86 79.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.33 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.976 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.08 -42.32 66.33 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.69 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.532 ' HA ' HD21 ' A' ' 77' ' ' LEU . 72.8 t -64.65 -35.96 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.806 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -69.49 -33.2 72.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.798 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.53 -42.4 74.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.375 0.607 . . . . 0.0 110.416 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.9 pp -78.18 -26.85 47.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.439 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -71.71 -40.03 69.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.072 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.07 26.16 6.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.525 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -95.08 -19.49 20.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.342 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.37 -120.03 6.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.637 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.541 ' O ' HG12 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -137.17 18.13 2.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.548 0.213 . . . . 0.0 111.244 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.5 mt -153.76 94.42 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 8' ' ' LEU . 34.8 m -90.39 112.75 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -101.2 80.9 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.964 HD13 HG13 ' A' ' 88' ' ' VAL . 1.7 pp -109.79 153.08 24.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.258 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 4.7 t80 -102.04 114.66 28.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 108.847 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.964 HG13 HD13 ' A' ' 86' ' ' LEU . 35.3 m -112.05 167.98 5.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.209 0.528 . . . . 0.0 112.172 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 mtp -127.87 109.52 11.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.817 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -121.03 132.9 55.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.87 0.367 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.47 137.21 32.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.908 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 84.94 0.8 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.741 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.33 108.47 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.647 2.232 . . . . 0.0 112.478 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -95.46 109.54 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.258 2.638 . . . . 0.0 112.049 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.717 ' HB3' ' CA ' ' A' ' 188' ' ' ASN . . . -86.54 25.49 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.067 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 187' ' ' SER . 0.1 OUTLIER -91.81 178.26 5.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.344 179.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.1 140.02 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.85 142.59 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.71 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -126.24 166.42 17.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.112 0.482 . . . . 0.0 111.366 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.84 106.21 8.28 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 183' ' ' VAL . 3.2 mm -116.84 155.34 18.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.648 -177.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 17.7 pttm -114.15 126.57 55.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.359 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.663 HD13 HD23 ' A' ' 110' ' ' LEU . 3.9 tt -127.58 118.64 24.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.562 HG22 HG13 ' A' ' 178' ' ' VAL . 4.4 pt -95.97 144.69 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -72.82 156.28 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.975 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.55 -168.79 12.33 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.821 -0.705 . . . . 0.0 111.826 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -74.25 -39.55 1.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.107 1.871 . . . . 0.0 112.294 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.55 19.6 8.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.049 0.452 . . . . 0.0 110.334 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.92 -143.21 15.78 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.275 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.663 HD23 HD13 ' A' ' 103' ' ' LEU . 5.7 mp -86.72 -21.5 26.58 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.184 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.51 54.23 4.38 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.701 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.14 148.58 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.667 0.27 . . . . 0.0 110.833 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -108.6 116.96 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.872 HD11 HD22 ' A' ' 172' ' ' LEU . 27.4 pt -121.79 162.78 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.636 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -122.96 127.62 49.12 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.838 ' HA2' HG12 ' A' ' 129' ' ' ILE . . . -80.63 156.8 39.18 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.715 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 121' ' ' GLN . . . -49.58 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 164' ' ' MET . 15.7 t -54.38 134.37 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 0.0 111.822 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 94.6 -26.14 19.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.693 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 165.92 83.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 0.5 OUTLIER -67.44 2.7 1.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.954 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 79.9 t60 79.63 -60.54 0.33 Allowed 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.799 0.809 . . . . 0.0 110.497 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.633 HG12 ' CD2' ' A' ' 122' ' ' HIS . 1.5 mm -118.06 101.25 51.77 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.514 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -50.42 94.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.478 2.119 . . . . 0.0 112.092 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.95 -15.61 1.54 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.774 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.4 84.57 2.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.903 0.382 . . . . 0.0 110.482 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -41.65 -28.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 m -51.8 152.69 2.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.546 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.838 HG12 ' HA2' ' A' ' 116' ' ' GLY . 51.1 mt -75.44 124.64 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.977 0.418 . . . . 0.0 111.285 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.465 ' CG ' ' HB3' ' A' ' 151' ' ' LYS . 4.9 m-85 -114.71 132.26 56.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 150' ' ' ASP . 40.7 t -61.68 155.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.96 0.41 . . . . 0.0 111.345 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 148' ' ' ILE . 12.3 p -118.61 -57.71 2.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.396 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 143.64 25.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.246 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 131' ' ' VAL . 5.3 mt -129.96 141.63 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.801 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.3 mt -77.39 173.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.643 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.603 ' H ' HG22 ' A' ' 135' ' ' ILE . 1.7 mt-10 -93.12 149.1 21.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.99 29.29 51.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.67 -167.55 43.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.54 -55.08 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.027 0.442 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.565 ' HB2' HD11 ' A' ' 103' ' ' LEU . . . -70.13 -31.88 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.267 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -57.04 -55.67 31.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 0.0 110.316 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -72.8 -48.56 37.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.56 -59.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.891 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -58.5 -49.74 73.81 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.851 -0.613 . . . . 0.0 113.077 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 18.23 11.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 0.0 110.645 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.62 HD12 HG21 ' A' ' 131' ' ' VAL . 0.4 OUTLIER -96.17 81.01 3.29 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.715 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -62.41 171.2 2.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.678 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 132' ' ' THR . 35.1 mt -46.67 127.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.316 0.579 . . . . 0.0 111.22 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 117.09 -24.81 9.15 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.339 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 131' ' ' VAL . 1.2 m-20 -67.95 131.59 45.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.753 0.311 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.465 ' HB3' ' CG ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -116.87 134.11 55.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.118 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 182' ' ' LYS . 0.2 OUTLIER -105.39 131.94 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -96.71 -4.1 41.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.231 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 153' ' ' LEU . . . 169.19 149.87 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 111.435 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 158' ' ' VAL . 38.4 t -103.92 99.7 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.759 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.759 ' ND2' HG12 ' A' ' 155' ' ' VAL . 36.5 m-80 69.28 -59.41 0.48 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.338 0.59 . . . . 0.0 109.592 -178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.4 m -165.02 29.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.941 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 155' ' ' VAL . 10.0 t -104.26 155.08 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.564 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 158' ' ' VAL . . . -110.91 74.57 0.21 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.645 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -78.05 25.22 0.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.984 0.421 . . . . 0.0 111.586 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -155.79 27.87 0.38 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.709 179.307 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.53 27.74 2.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.476 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.652 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.4 t -144.99 -72.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.643 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.57 ' HG3' HG21 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 174.78 162.58 0.22 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.241 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.3 OUTLIER -53.54 -30.09 40.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.976 0.417 . . . . 0.0 110.271 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.81 -45.17 53.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.403 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.652 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -73.1 -35.37 66.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.918 0.39 . . . . 0.0 110.637 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -70.58 -34.92 72.71 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.167 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.628 ' HA ' HD23 ' A' ' 172' ' ' LEU . 10.5 t -71.93 -44.09 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.99 67.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.128 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.73 -27.7 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.377 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.75 -39.44 24.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.005 0.431 . . . . 0.0 110.192 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -26.69 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.055 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -10.0 59.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.198 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.535 ' HB ' HG21 ' A' ' 179' ' ' VAL . 63.8 p -58.91 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.794 0.331 . . . . 0.0 111.264 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -102.19 169.95 8.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.26 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 12.9 t70 -55.7 -17.41 5.83 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.361 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 104' ' ' ILE . 40.7 t -147.41 91.71 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.783 0.325 . . . . 0.0 110.271 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.535 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -117.9 148.14 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.733 -179.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 11.9 m-85 -101.71 125.9 48.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.1 OUTLIER -111.83 152.72 27.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -96.58 120.37 36.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.884 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.562 HG21 HG13 ' A' ' 101' ' ' ILE . 18.1 t -102.21 160.67 4.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.189 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.493 ' N ' HG12 ' A' ' 183' ' ' VAL . . . -124.87 133.89 52.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -84.04 146.18 48.06 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 189' ' ' ALA . 9.8 Cg_endo -52.87 111.81 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.59 2.193 . . . . 0.0 112.16 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 0.8 OUTLIER -58.8 148.91 28.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.183 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.717 ' CA ' ' HB3' ' A' ' 95' ' ' ALA . 1.4 t-20 54.6 28.33 9.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 186' ' ' PRO . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.825 0.345 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 2' ' ' VAL . 5.6 m -130.78 97.16 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 18.4 m -139.06 123.8 11.58 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.83 152.86 21.45 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.485 2.123 . . . . 0.0 112.296 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -115.59 -38.33 3.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 85.8 p -108.85 135.3 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.46 163.7 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -136.72 126.25 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.575 ' OXT' HG12 ' B' ' 9' ' ' VAL . 20.7 t . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.775 0.321 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.454 HG22 ' N ' ' C' ' 3' ' ' VAL . 11.8 p -116.35 156.71 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.454 ' N ' HG22 ' C' ' 2' ' ' VAL . 21.7 t -130.52 133.71 25.18 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.067 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.78 -159.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.434 2.09 . . . . 0.0 112.267 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -47.42 81.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . . . . . . . . . 11.3 m -124.44 -169.93 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . 0.4 ' OG ' HG21 ' A' ' 169' ' ' VAL . 1.3 m -77.85 128.35 33.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -117.12 118.01 31.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.445 HG11 HD11 ' A' ' 172' ' ' LEU . 10.4 p . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.34 -0.838 . . . . 0.0 111.111 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.689 0.281 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 90' ' ' ARG . 8.5 tp10 -117.79 155.27 30.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.869 0.366 . . . . 0.0 111.148 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -110.82 161.39 15.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.628 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -176.69 141.34 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.889 0.375 . . . . 0.0 111.482 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 16.3 pt-20 -110.35 154.62 23.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.355 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -166.11 159.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 111.972 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.652 HG23 HH11 ' A' ' 85' ' ' ARG . 0.8 OUTLIER -107.17 123.44 48.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.364 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.827 ' HG ' HD23 ' A' ' 15' ' ' LEU . 2.5 tp -116.1 93.52 4.28 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.598 0.713 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.744 ' HG2' HG23 ' A' ' 83' ' ' ILE . 11.2 mt-10 -66.66 143.1 57.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.798 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.68 101.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.485 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' HB2' ' A' ' 44' ' ' ALA . . . -48.22 -27.4 5.39 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.725 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.6 -81.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 p -109.28 30.63 6.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.883 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.04 -179.65 20.43 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.008 -1.091 . . . . 0.0 112.248 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.827 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -84.47 -63.19 1.38 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.649 0.262 . . . . 0.0 111.309 -179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.79 62.66 0.39 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.599 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.728 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 7.9 p90 -149.5 138.9 21.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.319 . . . . 0.0 110.543 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.799 ' O ' HG23 ' A' ' 36' ' ' ILE . 5.9 m -79.48 126.69 31.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.012 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 36' ' ' ILE . 23.5 pt -131.23 155.11 41.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.31 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.95 152.7 2.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.74 -122.82 2.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.632 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.36 128.82 4.46 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.404 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 69' ' ' THR . 1.9 t -51.84 -27.23 11.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.87 -42.01 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 0.0 110.981 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.79 77.45 57.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.977 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.26 146.21 13.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.718 2.279 . . . . 0.0 112.529 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -77.57 -19.38 55.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.002 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.528 HG12 ' CZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.15 -32.74 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 0.0 111.007 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.95 26.04 6.53 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.539 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -177.49 38.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.37 96.64 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.04 -22.68 48.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.485 2.124 . . . . 0.0 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.86 158.66 33.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.74 149.27 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 28' ' ' ILE . 7.1 p90 -142.73 163.5 32.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.898 0.38 . . . . 0.0 111.042 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.799 HG23 ' O ' ' A' ' 18' ' ' SER . 45.7 mt -94.82 148.49 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -104.4 -33.99 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.627 0.251 . . . . 0.0 111.401 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.909 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.34 150.93 4.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.38 . . . . 0.0 111.348 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.4 mt -111.45 141.07 27.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.641 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.9 pt -89.63 136.03 30.05 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.67 58.2 6.7 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.53 2.153 . . . . 0.0 112.387 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.0 -61.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.618 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.56 -173.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.628 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB2' ' N ' ' A' ' 11' ' ' GLY . . . -72.04 -26.45 62.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.576 0.227 . . . . 0.0 111.522 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -54.1 -57.4 11.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -60.08 -27.85 67.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -71.87 -45.68 60.5 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -68.39 -35.49 77.76 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.252 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . 22.07 48.4 0.01 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.276 -0.875 . . . . 0.0 114.203 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.96 20.62 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.732 0.266 . . . . 0.0 111.291 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.494 HD12 ' OD2' ' A' ' 55' ' ' ASP . 2.6 pt? -158.23 162.96 37.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.334 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' CB ' ' HG3' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -98.18 158.25 15.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.396 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.909 HG11 ' HA ' ' A' ' 38' ' ' LYS . 35.2 m -71.2 -46.14 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.507 ' N ' HG23 ' A' ' 53' ' ' VAL . 11.4 p30 -62.83 3.96 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.738 ' OD2' HG21 ' A' ' 88' ' ' VAL . 53.0 p-10 -76.17 174.15 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.9 t -129.8 102.86 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 110.961 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.977 HD11 HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -55.65 95.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 0.0 110.734 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -22.65 60.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.1 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 1.5 m-85 -153.46 155.22 35.88 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.06 0.457 . . . . 0.0 111.965 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.977 HG13 HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -152.52 130.99 2.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.447 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.58 35.07 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.228 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 71.13 30.96 2.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 60' ' ' VAL . 17.4 t -120.92 141.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -73.34 116.02 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.003 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.698 HG13 ' CG2' ' A' ' 68' ' ' VAL . 33.4 t -143.98 40.71 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -100.3 9.24 43.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.153 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 178.5 44.1 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.928 0.394 . . . . 0.0 110.515 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.698 ' CG2' HG13 ' A' ' 65' ' ' VAL . 6.6 m -109.63 147.26 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.562 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.69 ' N ' HG22 ' A' ' 23' ' ' THR . 65.0 p -49.32 170.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.845 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.2 t-160 -63.67 -49.02 74.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.323 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -36.34 83.68 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.84 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.79 -35.53 72.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.23 64.74 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 109.804 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' HD21 ' A' ' 77' ' ' LEU . 58.4 t -63.99 -36.57 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -69.52 -32.81 71.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.74 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -43.37 73.3 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 110.636 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.556 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.8 pp -76.78 -26.77 54.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.461 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -70.73 -40.64 72.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.134 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 8.8 tt0 -101.24 27.32 6.26 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.317 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.77 -23.06 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.423 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.93 -161.81 24.82 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.785 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 9.7 t -86.23 -51.29 6.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.744 HG23 ' HG2' ' A' ' 9' ' ' GLU . 17.0 mt -99.25 84.69 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.9 m -85.24 116.26 28.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.677 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.652 HH11 HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -77.2 80.5 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.651 ' HB2' HD12 ' A' ' 57' ' ' ILE . 2.4 pp -84.89 135.41 34.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.24 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -116.72 114.49 24.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.391 178.558 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.797 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.1 m -124.89 168.41 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.093 0.473 . . . . 0.0 111.998 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.96 109.06 15.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.802 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -122.77 116.52 23.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.675 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 2.4 ptt180 -43.01 137.91 2.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.88 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -156.28 157.66 31.22 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -45.58 97.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.277 2.651 . . . . 0.0 112.613 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.581 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 85.5 Cg_endo -98.83 -157.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.607 2.871 . . . . 0.0 112.393 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 82.37 35.72 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.821 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' N ' ' HA ' ' A' ' 187' ' ' SER . 4.2 tt0 74.67 164.98 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.284 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -172.18 118.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.62 111.7 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.936 0.398 . . . . 0.0 110.755 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 mmm -93.61 166.66 12.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.398 0.618 . . . . 0.0 111.798 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -136.34 106.54 6.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.541 HG21 ' CD2' ' A' ' 146' ' ' LEU . 2.7 mm -112.7 155.16 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -110.82 126.13 54.32 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.304 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.837 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.7 tt -127.16 118.56 24.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.472 HG22 HG13 ' A' ' 178' ' ' VAL . 4.6 pt -96.44 144.64 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.43 157.47 30.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.966 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.19 -169.38 12.29 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.921 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.69 -30.78 9.24 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.145 1.896 . . . . 0.0 112.283 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.52 18.38 12.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.061 0.458 . . . . 0.0 110.598 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 105.2 -146.34 16.06 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.427 ' HB2' HG23 ' C' ' 9' ' ' VAL . 7.4 mp -86.46 -20.36 28.24 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.908 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 134' ' ' ILE . . . 80.74 46.13 7.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.346 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -178.58 154.48 0.77 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.687 0.244 . . . . 0.0 110.98 179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -119.31 126.33 51.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.649 HG22 HG22 ' A' ' 131' ' ' VAL . 9.0 pt -134.97 153.18 34.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.633 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 122' ' ' HIS . . . -150.55 124.91 9.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.106 0.479 . . . . 0.0 111.854 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.67 -175.11 25.43 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.065 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 161' ' ' GLU . . . 77.38 -169.25 54.8 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.422 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 119' ' ' GLY . 38.9 t -78.64 154.56 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.337 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 118' ' ' VAL . . . 92.45 -25.59 17.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.278 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.03 77.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 122' ' ' HIS . 1.1 pt20 -72.91 6.83 2.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.384 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 71.2 t60 72.72 -59.17 0.57 Allowed 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.53 0.681 . . . . 0.0 111.331 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.867 HD11 ' CD1' ' A' ' 130' ' ' TYR . 0.4 OUTLIER -87.7 111.58 43.03 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.895 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.92 79.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.475 2.117 . . . . 0.0 112.243 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . 121.68 40.24 0.54 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.523 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -175.52 96.53 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.79 0.328 . . . . 0.0 110.74 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -57.55 -23.36 50.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.469 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 58.3 m -47.44 128.34 12.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.184 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.54 HG12 ' HA3' ' A' ' 116' ' ' GLY . 37.7 mt -65.9 123.96 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.934 0.397 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.867 ' CD1' HD11 ' A' ' 123' ' ' ILE . 3.0 m-85 -122.89 156.91 33.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.499 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 114' ' ' ILE . 72.8 t -89.32 151.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.747 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 122' ' ' HIS . 11.3 p -111.44 -58.46 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.496 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 147.91 28.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' GLY . 6.5 mt -128.37 141.59 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.794 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 136' ' ' GLU . 4.3 mm -66.06 175.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.623 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.718 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -92.93 133.67 35.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.857 -179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.5 25.19 33.87 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.536 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.85 -160.72 1.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.513 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.57 -59.72 2.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.0 111.277 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HG ' ' A' ' 103' ' ' LEU . . . -70.13 -31.97 69.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.582 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -53.88 -54.34 40.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.19 0.519 . . . . 0.0 110.392 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -72.9 -53.15 12.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.043 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.74 -59.29 2.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.153 0.502 . . . . 0.0 111.943 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' C ' HD23 ' A' ' 146' ' ' LEU . . . -49.02 -46.94 32.9 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.453 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 65.76 16.99 10.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.617 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.541 ' CD2' HG21 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -106.87 83.36 1.83 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.483 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.96 175.81 3.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 132' ' ' THR . 33.3 mt -47.46 122.59 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.354 0.597 . . . . 0.0 111.169 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 125.06 -21.73 6.47 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.311 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.611 ' OD1' HG21 ' A' ' 131' ' ' VAL . 8.5 p-10 -64.2 131.99 49.03 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.882 0.372 . . . . 0.0 110.409 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -108.24 125.05 51.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -104.61 133.92 47.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.046 0.451 . . . . 0.0 110.647 179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 154' ' ' ALA . 0.5 OUTLIER -93.98 -4.03 50.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.637 ' HB2' HD23 ' A' ' 160' ' ' LEU . . . 173.52 156.65 0.12 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.936 0.398 . . . . 0.0 110.857 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 158' ' ' VAL . 39.2 t -109.92 100.07 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.57 ' ND2' ' HB ' ' A' ' 179' ' ' VAL . 2.1 m-80 56.82 32.21 20.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 p 82.92 25.83 0.13 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.856 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 171' ' ' ALA . 1.8 t -135.21 146.44 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-O 121.426 0.631 . . . . 0.0 112.659 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 160' ' ' LEU . . . 96.29 -73.54 0.8 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.584 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.637 HD23 ' HB2' ' A' ' 154' ' ' ALA . 0.0 OUTLIER 35.83 33.5 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.821 -0.689 . . . . 0.0 111.955 179.155 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 128' ' ' SER . 0.9 OUTLIER 35.82 34.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.926 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -114.43 36.95 3.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.702 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.485 HG11 ' CG ' ' A' ' 167' ' ' ASP . 0.4 OUTLIER -151.17 -71.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.344 0.592 . . . . 0.0 110.607 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 118' ' ' VAL . 1.1 mtm 175.42 160.45 0.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.502 ' O ' HG23 ' A' ' 169' ' ' VAL . 74.7 t60 -53.68 -31.43 47.71 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.175 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -73.92 -41.03 62.67 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.485 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -74.58 -38.43 62.65 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.683 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.6 -38.96 74.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.648 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.655 ' HA ' HD23 ' A' ' 172' ' ' LEU . 29.3 t -72.99 -46.93 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.092 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.38 69.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.36 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 158' ' ' VAL . . . -76.42 -33.99 58.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.373 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -81.34 -36.85 29.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.945 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' C' ' 9' ' ' VAL . 7.4 mmtt -72.94 -26.83 61.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.482 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.29 -10.04 59.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.264 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 179' ' ' VAL . 31.9 p -60.44 -169.78 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.958 0.408 . . . . 0.0 111.486 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -114.28 173.12 6.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.159 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -13.08 3.69 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG13 HG22 ' A' ' 104' ' ' ILE . 40.6 t -147.34 91.11 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.785 0.326 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.728 HG21 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -128.93 148.61 33.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.995 -178.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' LYS . 39.3 p90 -107.61 135.29 49.31 Favored 'General case' 0 C--N 1.335 -0.041 0 CA-C-O 121.052 0.453 . . . . 0.0 111.99 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' HB2' HG21 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -111.06 159.3 17.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.677 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -100.28 117.35 34.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 184' ' ' ALA . 12.8 t -101.9 159.67 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.833 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.648 ' HB3' ' HG3' ' A' ' 151' ' ' LYS . . . -126.3 141.04 52.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.541 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -102.17 145.83 31.21 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 24.1 Cg_exo -63.63 134.05 42.41 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.57 2.18 . . . . 0.0 112.542 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -76.08 143.29 41.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 t30 47.76 28.91 1.41 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.17 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.748 0.308 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 m -75.17 133.41 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.56 HG13 ' O ' ' B' ' 3' ' ' VAL . 9.2 p -153.95 63.78 4.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.053 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' B' ' 3' ' ' VAL . 31.1 Cg_exo -59.03 140.57 95.87 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.619 2.212 . . . . 0.0 112.313 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.23 -72.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.671 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 2.0 t -112.97 -170.73 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.576 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.16 -153.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.55 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.48 ' O ' HG13 ' B' ' 9' ' ' VAL . 2.2 p -52.59 122.09 8.31 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.48 HG13 ' O ' ' B' ' 8' ' ' SER . 14.2 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.066 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.826 0.346 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.569 ' O ' HG13 ' C' ' 2' ' ' VAL . 10.9 p -108.16 63.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 m -77.49 126.02 85.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.91 143.04 62.15 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.354 2.036 . . . . 0.0 112.287 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -137.34 79.11 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -168.73 -175.11 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.63 103.4 16.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 52.9 p -92.63 118.78 31.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 173' ' ' LYS . 19.5 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.245 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.804 0.335 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.54 ' OE2' ' HB3' ' A' ' 95' ' ' ALA . 17.7 mt-10 -136.24 171.33 14.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -134.04 166.05 23.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.583 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -176.63 159.06 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 111.266 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 87' ' ' TYR . 13.6 pt-20 -96.05 154.76 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.851 HG22 ' O ' ' A' ' 86' ' ' LEU . 19.2 tt -153.37 164.64 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.568 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -123.27 122.82 39.32 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.704 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 45' ' ' ALA . 1.2 tp -125.8 93.04 3.73 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.628 0.728 . . . . 0.0 110.752 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.761 ' HG3' HG23 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -73.65 166.08 23.92 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.591 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -80.97 95.37 6.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.821 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -49.69 -26.63 8.03 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.598 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -168.98 -89.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.069 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -109.22 30.85 6.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.51 177.07 24.93 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.993 -1.099 . . . . 0.0 112.395 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -84.43 -48.66 9.41 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.766 0.317 . . . . 0.0 111.5 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.24 65.53 0.67 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.77 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 15' ' ' LEU . 1.4 p90 -164.69 162.9 21.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.727 0.298 . . . . 0.0 110.689 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.75 133.79 54.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.531 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 pt -120.43 171.28 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.693 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.8 152.34 3.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.345 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 27' ' ' HIS . . . 119.08 -115.25 3.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.49 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 146.23 15.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.257 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.775 HG22 ' N ' ' A' ' 69' ' ' THR . 1.3 t -54.05 -23.87 15.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.615 0.245 . . . . 0.0 111.475 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 69' ' ' THR . 0.5 OUTLIER -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.83 0.347 . . . . 0.0 111.443 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.06 77.55 41.63 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.414 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 129.14 21.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.422 ' N ' ' HA2' ' A' ' 21' ' ' GLY . 28.8 t60 -66.57 -20.67 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.206 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG12 ' HZ ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.32 -27.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.309 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.31 26.51 18.12 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.628 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -168.69 33.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -166.29 100.85 0.7 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.754 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.68 -26.85 67.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.401 2.068 . . . . 0.0 112.142 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -66.95 177.94 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.614 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -125.88 153.43 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HZ ' HG12 ' A' ' 28' ' ' ILE . 3.0 p90 -142.49 148.89 38.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.537 ' C ' ' HB ' ' A' ' 53' ' ' VAL . 73.2 mt -75.15 150.45 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.794 ' O ' HG21 ' A' ' 53' ' ' VAL . 2.5 p -102.88 -40.51 6.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.601 0.239 . . . . 0.0 111.621 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.885 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -165.77 146.26 6.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.059 0.457 . . . . 0.0 111.437 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -103.52 141.33 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.108 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 3.8 mm -85.28 136.28 38.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.937 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 40' ' ' ILE . 72.9 Cg_endo -76.29 58.79 5.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.212 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.58 -54.34 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.03 -175.38 0.2 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.477 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -75.86 -31.4 59.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.666 0.269 . . . . 0.0 111.224 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -55.72 -26.25 44.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.542 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 40' ' ' ILE . . . -78.14 -27.49 48.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.574 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -71.35 -43.75 66.36 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.954 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -93.74 -29.02 15.6 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.492 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' ALA . . . 89.15 -33.69 4.2 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.63 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HG3' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 48.32 25.17 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.846 HD13 ' CZ ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER 66.86 -167.58 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.959 179.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 153.05 25.08 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.097 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.885 HG11 ' HA ' ' A' ' 38' ' ' LYS . 28.5 m -71.16 -36.72 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.495 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -52.06 -16.14 0.71 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.512 ' OD2' HG21 ' A' ' 88' ' ' VAL . 37.0 p-10 -59.03 156.31 12.01 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 35.6 m -121.55 126.28 48.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 0.0 111.151 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.954 ' HA ' HG12 ' A' ' 88' ' ' VAL . 9.4 pt -65.63 94.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 121.276 0.56 . . . . 0.0 111.038 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.55 HD11 ' SD ' ' A' ' 89' ' ' MET . 24.5 mt -76.77 -28.2 55.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.482 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.409 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -150.89 116.15 5.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.432 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' CG1' HD12 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -131.69 125.55 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.902 179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.611 HD21 HG13 ' A' ' 84' ' ' VAL . 28.9 m120 55.02 36.87 27.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.13 27.49 17.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.25 141.69 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.34 72.04 2.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 65' ' ' VAL . 20.2 t -98.04 34.34 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.945 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -9.63 27.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.348 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.51 43.53 0.23 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.76 0.314 . . . . 0.0 111.615 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -123.94 155.57 30.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.232 0.539 . . . . 0.0 111.038 179.195 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.775 ' N ' HG22 ' A' ' 23' ' ' THR . 21.2 m -49.99 161.8 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.901 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CD2' HG23 ' A' ' 74' ' ' VAL . 2.5 t-160 -58.98 -48.49 81.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.531 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 m -52.09 -37.53 54.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.401 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.37 80.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.59 66.47 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.264 0.554 . . . . 0.0 109.578 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 70' ' ' HIS . 55.0 t -64.81 -35.29 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.682 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 47.4 tt0 -69.65 -32.33 70.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.938 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -69.36 -41.54 76.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.378 0.609 . . . . 0.0 110.361 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD21 ' HA ' ' A' ' 74' ' ' VAL . 2.7 pp -76.31 -26.22 55.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 4.1 tttt -72.39 -35.21 68.37 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.051 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -113.35 28.76 8.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.203 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 76' ' ' ALA . . . -92.42 -21.44 20.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.424 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.63 -137.51 13.39 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.505 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 83' ' ' ILE . 8.6 t -121.17 17.49 11.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.675 0.274 . . . . 0.0 111.414 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.761 HG23 ' HG3' ' A' ' 9' ' ' GLU . 1.5 mt -154.07 95.84 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 61' ' ' ASN . 0.9 OUTLIER -102.01 143.38 14.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.215 0.531 . . . . 0.0 112.429 -178.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 15.9 tpp85 -100.35 93.4 5.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.782 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.851 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -88.4 115.36 25.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.347 0.594 . . . . 0.0 112.555 -177.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -110.5 114.06 27.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.06 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.5 m -132.21 168.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.55 ' SD ' HD11 ' A' ' 58' ' ' LEU . 1.3 ttp -107.91 109.23 20.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.492 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.846 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.4 146.74 52.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.071 0.463 . . . . 0.0 111.551 -178.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -71.01 142.09 50.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.183 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -143.74 119.72 6.4 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.696 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 31.4 Cg_exo -57.57 -46.75 25.2 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.411 2.074 . . . . 0.0 112.546 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 93' ' ' PRO . 96.6 Cg_endo -86.48 -159.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.579 2.186 . . . . 0.0 112.346 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.54 ' HB3' ' OE2' ' A' ' 2' ' ' GLU . . . 63.83 28.27 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.883 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' N ' ' HA ' ' A' ' 187' ' ' SER . 0.2 OUTLIER 76.89 143.33 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.981 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.62 130.87 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.828 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.63 HG13 HD21 ' A' ' 153' ' ' LEU . 21.5 t -82.78 148.13 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.432 ' HB2' ' HB ' ' A' ' 183' ' ' VAL . 13.9 mtp -124.21 166.73 15.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.137 0.494 . . . . 0.0 111.208 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.98 106.3 7.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.053 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.54 HG13 HG21 ' A' ' 183' ' ' VAL . 3.4 mm -113.62 155.38 14.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.418 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -114.99 128.43 56.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.989 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.799 ' HG ' ' HB2' ' A' ' 140' ' ' ALA . 6.1 tt -130.39 118.32 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.071 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 177' ' ' ASP . 4.7 pt -94.73 144.53 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-O 120.987 0.422 . . . . 0.0 111.059 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 177' ' ' ASP . 4.0 tttt -66.93 149.11 51.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.979 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.08 -174.6 13.65 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.006 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -68.44 -36.8 14.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.317 2.011 . . . . 0.0 112.317 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -93.84 19.46 8.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.938 0.399 . . . . 0.0 110.498 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.73 -140.97 15.12 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.514 ' HG ' HD22 ' A' ' 103' ' ' LEU . 7.4 mp -86.64 -22.39 26.19 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.01 46.9 5.2 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.013 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.58 ' CE2' HG21 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -177.36 146.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.611 0.243 . . . . 0.0 110.861 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.1 m -108.67 116.85 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.67 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.907 HG22 HG22 ' A' ' 131' ' ' VAL . 8.5 pt -129.15 152.9 37.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.561 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' C' ' 6' ' ' SER . . . -151.82 125.84 9.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 112.063 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.626 ' HA3' HG12 ' A' ' 129' ' ' ILE . . . -154.64 -175.26 25.57 Favored Glycine 0 CA--C 1.519 0.284 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.882 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 126.91 176.49 14.49 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.732 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.66 153.65 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.854 0.359 . . . . 0.0 111.357 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.16 -5.89 65.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 172.72 79.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.87 142.49 27.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.447 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.547 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 8.3 t60 -45.08 -37.85 4.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.803 0.811 . . . . 0.0 110.517 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.83 HD11 ' CD1' ' A' ' 130' ' ' TYR . 1.5 mt -100.43 143.14 25.97 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.583 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 123' ' ' ILE . 45.4 Cg_exo -56.7 83.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.529 2.153 . . . . 0.0 112.615 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.13 53.49 2.81 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.102 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.668 ' HB3' HD12 ' A' ' 123' ' ' ILE . 1.5 t70 -154.7 87.62 1.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.725 0.298 . . . . 0.0 111.149 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -52.85 -24.4 8.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.9 m -52.12 125.55 16.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.641 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 1.041 HD12 HD22 ' A' ' 160' ' ' LEU . 3.3 mt -73.69 113.4 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.833 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.83 ' CD1' HD11 ' A' ' 123' ' ' ILE . 4.1 m-85 -106.96 172.83 6.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.722 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.907 HG22 HG22 ' A' ' 114' ' ' ILE . 48.3 t -109.44 148.73 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.813 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.8 -29.05 1.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 137.65 31.34 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.835 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 147' ' ' GLN . 43.9 mt -137.12 138.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 136' ' ' GLU . 1.2 mt -82.67 173.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -87.25 140.94 29.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.876 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.02 26.23 55.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.33 -175.07 9.29 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.545 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.08 -66.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.324 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.829 ' HB1' HD21 ' A' ' 146' ' ' LEU . . . -70.01 -37.34 75.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.429 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -51.96 -45.85 64.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.038 0.446 . . . . 0.0 110.67 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -57.3 4.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.038 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.56 -59.59 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 140' ' ' ALA . . . -61.64 -33.6 85.59 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.176 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 59.94 20.96 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.829 HD21 ' HB1' ' A' ' 140' ' ' ALA . 1.2 pp -83.79 83.79 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.437 ' HA ' HD12 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -67.62 170.92 6.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.556 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.63 120.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.277 0.56 . . . . 0.0 111.272 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 127.28 -19.7 5.97 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -66.29 118.39 9.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.784 0.326 . . . . 0.0 110.735 179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.462 ' HB2' ' CE1' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -99.28 123.85 43.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.985 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -99.86 121.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.028 0.442 . . . . 0.0 110.067 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.63 HD21 HG13 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -87.44 -0.44 56.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.72 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 158' ' ' VAL . . . 172.97 159.98 0.12 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.562 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.857 HG13 HD23 ' A' ' 181' ' ' LEU . 36.9 t -117.52 98.85 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.661 HD22 HG12 ' A' ' 155' ' ' VAL . 7.1 m-80 68.32 -57.72 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.394 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.8 p -146.01 -18.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.613 ' O ' ' HB1' ' A' ' 154' ' ' ALA . 0.0 OUTLIER -78.02 129.14 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.42 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.68 7.75 1.38 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.041 HD22 HD12 ' A' ' 129' ' ' ILE . 20.3 mt 42.71 29.38 0.17 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.469 0.634 . . . . 0.0 112.044 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -178.14 75.36 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.304 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 163' ' ' VAL . 1.4 p30 -157.68 26.7 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.071 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.738 HG11 ' CG ' ' A' ' 167' ' ' ASP . 1.8 t -157.0 -74.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.923 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 178.63 -172.01 0.13 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.693 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.667 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.9 t-80 -67.45 -37.42 82.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.892 0.377 . . . . 0.0 111.027 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.57 -39.95 64.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.738 ' CG ' HG11 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -75.3 -35.55 61.26 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.854 -179.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.7 ' HB1' HD11 ' A' ' 129' ' ' ILE . . . -69.69 -37.24 76.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.745 ' HA ' HD23 ' A' ' 172' ' ' LEU . 39.4 t -69.44 -41.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.355 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.28 -29.27 64.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.727 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.94 49.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.879 HD22 HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -81.28 -39.45 25.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.109 0.481 . . . . 0.0 109.929 179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.403 ' N ' ' HG ' ' A' ' 172' ' ' LEU . 12.0 pttt -75.18 -26.78 59.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.102 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -20.75 23.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 179' ' ' VAL . 76.6 p -54.52 -172.12 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 178' ' ' VAL . 8.8 p90 -125.03 -162.24 1.08 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.484 ' O ' ' HB ' ' A' ' 104' ' ' ILE . 2.7 m-20 -59.7 -21.6 60.84 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 38.2 t -147.66 91.87 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 118.728 0.694 . . . . 0.0 111.511 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.629 HG11 ' HB ' ' A' ' 175' ' ' THR . 0.0 OUTLIER -119.92 148.16 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.919 0.39 . . . . 0.0 111.887 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.441 ' CE1' ' HA ' ' A' ' 156' ' ' ASN . 21.8 p90 -105.23 126.18 51.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.328 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.857 HD23 HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -106.75 149.05 27.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 152' ' ' ILE . 13.8 mtpt -96.39 119.16 34.36 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.927 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.54 HG21 HG13 ' A' ' 101' ' ' ILE . 11.8 t -101.89 161.82 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.697 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.591 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -134.78 144.76 47.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 111.64 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 0.4 OUTLIER -94.93 146.21 30.94 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 185' ' ' LYS . 3.2 Cg_exo -77.83 38.53 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.98 2.453 . . . . 0.0 113.229 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.449 ' HA ' ' N ' ' A' ' 96' ' ' GLU . 2.5 p 50.35 -179.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.996 0.427 . . . . 0.0 111.054 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 37.0 34.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.867 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.188 -179.856 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.804 0.335 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 27.7 t -106.42 -30.6 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.066 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.522 ' O ' HG23 ' B' ' 3' ' ' VAL . 14.5 m -118.8 96.02 49.67 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.04 91.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.582 2.188 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.11 58.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.78 145.16 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 37.6 m -106.65 150.02 26.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.533 ' O ' HG13 ' B' ' 9' ' ' VAL . 29.5 t -133.3 114.69 14.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.533 HG13 ' O ' ' B' ' 8' ' ' SER . 6.0 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.102 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' VAL . . . . . 0.547 ' O ' HG23 ' C' ' 3' ' ' VAL . 21.6 t -98.46 146.33 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.547 HG23 ' O ' ' C' ' 2' ' ' VAL . 34.7 t -158.08 -64.36 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.052 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' C' ' 3' ' ' VAL . 23.8 Cg_endo -60.91 -165.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.321 2.014 . . . . 0.0 112.171 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 64.21 -169.97 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.986 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' SER . . . . . 0.626 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 43.9 m -65.58 151.07 47.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' SER . . . . . . . . . . . . . 3.9 t -88.36 109.3 19.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.998 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 4.9 t -83.47 111.31 18.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.164 -179.961 . . . . . . . . 0 0 . 1 stop_ save_